PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bray, GA				Bray, George A.			Gastrointestinal hormones and weight management	LANCET			English	Editorial Material							METAANALYSIS		Louisiana State Univ, Pennington Biomed Res Ctr, Dietary Obes Lab, Div Clin Obes & Metab, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bray, GA (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Dietary Obes Lab, Div Clin Obes & Metab, Baton Rouge, LA 70808 USA.	George.Bray@pbrc.edu						Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chaudhri OB, 2008, INT J OBESITY, V32, pS28, DOI 10.1038/ijo.2008.235; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Stonehouse A, 2008, CURR DIABETES REV, V4, P101, DOI 10.2174/157339908784220705; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vray M, 2005, THERAPIE, V60, P17, DOI 10.2515/therapie:2005002	10	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 7	2009	374	9701					1570	1571		10.1016/S0140-6736(09)61560-9	http://dx.doi.org/10.1016/S0140-6736(09)61560-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19853907				2022-12-28	WOS:000271674600005
J	Finckh, A; Bansback, N; Marra, CA; Anis, AH; Michaud, K; Lubin, S; White, M; Sizto, S; Liang, MH				Finckh, Axel; Bansback, Nick; Marra, Carlo A.; Anis, Aslam H.; Michaud, Kaleb; Lubin, Stanley; White, Marc; Sizto, Sonia; Liang, Matthew H.			Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ONSET UNDIFFERENTIATED ARTHRITIS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; METHOTREXATE TREATMENT; TREATMENT STRATEGIES; RADIOGRAPHIC DAMAGE; COMBINATION THERAPY; PLUS METHOTREXATE; PREDICTION RULE; CLINICAL-TRIALS	Background: Long-term control or remission of rheumatoid arthritis (RA) may be possible with very early treatment. However, no optimal first therapeutic strategy has been determined. Objective: To assess the potential cost-effectiveness of major therapeutic strategies for very early RA. Design: Decision analytic model with probabilistic sensitivity analyses. Data Sources: Published data, the National Data Bank for Rheumatic Diseases, and actual 2007 hospital costs. Target Population: U.S. adults with very early RA (symptom duration <= 3 months). Time Horizon: Lifetime. Perspective: Health care provider and societal. Intervention: 3 management strategies were compared: a symptomatic or "pyramid" strategy with initial nonsteroidal anti-inflammatory drugs, patient education, pain management, and low-dose glucocorticoids, and disease-modifying antirheumatic drugs (DMARDs) at 1 year for nonresponders; early DMARD therapy with methotrexate; and early therapy with biologics and methotrexate. Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: By reducing the progression of joint erosions and subsequent functional disability, both early inter-vention strategies increase quality-adjusted life more than the pyramid strategy and save long-term costs. When the cost of very early intervention is factored in, the cost-effectiveness ratio of the early DMARD strategy is $4849 per QALY (95% CI, $0 to $16 354 per QALY) compared with the pyramid strategy, whereas the benefits gained through the early biologic strategy come at a substantial incremental cost. The early DMARD strategy maximizes the effectiveness of early DMARDs and reserves the use of biologics for patients with more treatment-resistant disease of longer duration, for which the incremental benefit of biologics is greater. Results of Sensitivity Analysis: The early biologic strategy becomes more cost-effective if drug prices are reduced, risk for death is permanently lowered through biologic therapy, patients experience drug-free remission, responders can be selected before therapy initiation, or effective alternative antirheumatic agents are available for patients for whom several biologics have failed. Limitations: Data on the long-term effect of very early therapeutic interventions on the natural progression in disability and joint erosions are limited. The study considered only tumor necrosis factor inhibitors and not the newer biologics. Conclusion: According to the most objective measures of RA progression, very early intervention with conventional DMARDs is cost-effective. The cost-effectiveness of very early intervention with biologics remains uncertain.	Univ Geneva, Geneva, Switzerland; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Nebraska Med Ctr, Omaha, NE USA; Natl Data Bank Rheumat Dis, Wichita, KS USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University of Geneva; University of British Columbia; University of Nebraska System; University of Nebraska Medical Center; National Data Bank for Rheumatic Diseases; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Finckh, A (corresponding author), Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, 26 Ave Beau Sejour, CH-1211 Geneva 14, Switzerland.		White, Marc/N-8404-2015; Marra, Carlo/AAE-4904-2021	White, Marc/0000-0001-7623-1268; Marra, Carlo/0000-0002-2625-2121; Finckh, Axel/0000-0002-1210-4347; Bansback, Nick/0000-0002-1510-3462	Arthritis Foundation	Arthritis Foundation	By an unrestricted research grant from the Arthritis Foundation and an anonymous donor.	Aletaha D, 2002, ANN RHEUM DIS, V61, P630, DOI 10.1136/ard.61.7.630; Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARIAS E, 2004, NATL VITAL STAT REPO; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; CHAN KWA, 1994, ARTHRITIS RHEUM-US, V37, P814, DOI 10.1002/art.1780370606; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, pxi; Choi HK, 2002, J RHEUMATOL, V29, P1156; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; Donahue KE, 2008, ANN INTERN MED, V148, P124, DOI 10.7326/0003-4819-148-2-200801150-00192; Drossaers-Bakker KW, 2000, RHEUMATOLOGY, V39, P998, DOI 10.1093/rheumatology/39.9.998; Feldman DE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1419, DOI 10.1002/art.23086; Finckh A, 2006, ANN RHEUM DIS, V65, P746, DOI 10.1136/ard.2005.045062; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Fleurence R, 2006, J RHEUMATOL, V33, P2124; FRIES JF, 1982, J RHEUMATOL, V9, P789; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gold MR, 1996, COST EFFECTIVENESS H; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006; Hwang A, 2008, NAT CLIN PRACT RHEUM, V4, P114, DOI 10.1038/ncprheum0724; Ikeda K, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2177; Jacobsson LTH, 2007, ANN RHEUM DIS, V66, P670, DOI 10.1136/ard.2006.062497; JOHANNESSON M, 1993, J HEALTH ECON, V12, P459, DOI 10.1016/0167-6296(93)90005-Y; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS200; Kumar K, 2007, RHEUMATOLOGY, V46, P1438, DOI 10.1093/rheumatology/kem130; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Machold KP, 2003, CLIN EXP RHEUMATOL, V21, pS113; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nixon R, 2007, RHEUMATOLOGY, V46, P1140, DOI 10.1093/rheumatology/kem072; Pincus T, 1997, CLIN EXP RHEUMATOL, V15, pS27; Potter T, 2002, RHEUMATOLOGY, V41, P953, DOI 10.1093/rheumatology/41.8.953; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Symmons D, 2000, GLOBAL BURDEN RHEUMA; Tamal M, 2007, J RHEUMATOL, V34, P2154; *US BUR LAB STAT, 2008, CONS PRIC IND DAT; van Aken J, 2006, ANN RHEUM DIS, V65, P20, DOI 10.1136/ard.2005.038471; van den Hout WB, 2009, ARTHRIT RHEUM-ARTHR, V61, P291, DOI 10.1002/art.24169; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; VANDERBIJL AE, 2006, ANN RHEUM DIS, pP180; Wailoo A, 2006, MODELING COST EFFECT; Wailoo AJ, 2008, ARTHRITIS RHEUM-US, V58, P939, DOI 10.1002/art.23374; Wolfe F, 2005, CLIN EXP RHEUMATOL, V23, pS168; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P2751, DOI 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6; WOLFE F, 2007, ARTHRITIS RHEUM, pS403	61	75	79	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					612	W198		10.7326/0003-4819-151-9-200911030-00006	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884622				2022-12-28	WOS:000271387700003
J	Hu, SH; Xie, Z; Onishi, A; Yu, XP; Jiang, LZ; Lin, J; Rho, HS; Woodard, C; Wang, H; Jeong, JS; Long, SY; He, XF; Wade, H; Blackshaw, S; Qian, J; Zhu, H				Hu, Shaohui; Xie, Zhi; Onishi, Akishi; Yu, Xueping; Jiang, Lizhi; Lin, Jimmy; Rho, Hee-sool; Woodard, Crystal; Wang, Hong; Jeong, Jun-Seop; Long, Shunyou; He, Xiaofei; Wade, Herschel; Blackshaw, Seth; Qian, Jiang; Zhu, Heng			Profiling the Human Protein-DNA Interactome Reveals ERK2 as a Transcriptional Repressor of Interferon Signaling	CELL			English	Article							REGULATORY MOTIFS; GENE-EXPRESSION; SYSTEMATIC DISCOVERY; BINDING; MICROARRAY; DATABASE; GENOME; IDENTIFICATION; PREDICTION; SEQUENCES	Protein-DNA interactions (PDIs) mediate a broad range of functions essential for cellular differentiation, function, and survival. However, it is still a daunting task to comprehensively identify and profile sequence-specific PDIs in complex genomes. Here, we have used a combined bioinformatics and protein microarray-based strategy to systematically characterize the human protein-DNA interactome. We identified 17,718 PDIs between 460 DNA motifs predicted to regulate transcription and 4,191 human proteins of various functional classes. Among them, we recovered many known PDIs for transcription factors (TFs). We identified a large number of unanticipated PDIs for known TFs, as well as for previously uncharacterized TFs. We also found that over three hundred unconventional DNA-binding proteins (uDBPs)-which include RNA-binding proteins, mitochondrial proteins, and protein kinases-showed sequence-specific PDIs. One such uDBP, ERK2, acts as a transcriptional repressor for interferon gamma-induced genes, suggesting important biological roles for such proteins.	[Xie, Zhi; Yu, Xueping; Blackshaw, Seth; Qian, Jiang] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Hu, Shaohui; Rho, Hee-sool; Woodard, Crystal; Jeong, Jun-Seop; He, Xiaofei; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Onishi, Akishi; Jiang, Lizhi; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hu, Shaohui; Onishi, Akishi; Jiang, Lizhi; Rho, Hee-sool; Woodard, Crystal; Wang, Hong; Jeong, Jun-Seop; Long, Shunyou; He, Xiaofei; Blackshaw, Seth; Zhu, Heng] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA; [Onishi, Akishi; Jiang, Lizhi; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Lin, Jimmy] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Wade, Herschel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Qian, Jiang; Zhu, Heng] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	sblack@jhmi.edu; jiang.qian@jhmi.edu; heng.zhu@jhmi.edu	Hu, Shaohui/AAE-4433-2020; Xie, Zhi/A-3108-2012	Xie, Zhi/0000-0002-5589-4836	National Institutes of Health [GM076102, RR020839]; NEI Vision Core; Ruth and Milton Steinbach Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Vision Core; Ruth and Milton Steinbach Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. J. Boeke, P. Cole, J. Nathans, G. Seydoux, T. Shimogori, S. Chen, D. Griffin, S. Taverna, J. Pomerantz, and D. Zack for their comments and suggestions. We also thank Drs. K. Dalby, D. Kalvakolanu, and R. Weiner for providing reagents; and D. McClellan for editorial assistance. This work was supported by the National Institutes of Health (GM076102 to H. Z., J. Q., RR020839 to H. Z., NEI Vision Core Grant to J. Q.), a W. M. Keck Foundation Distinguished Young Investigator in Medical Research Award to S. B., a grant from the Ruth and Milton Steinbach Fund to S. B., and a generous gift from Mr. and Mrs. Robert and Clarice Smith.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Ho SW, 2006, P NATL ACAD SCI USA, V103, P9940, DOI 10.1073/pnas.0509185103; Huang C, 2008, CELL BIOL INT, V32, P1081, DOI 10.1016/j.cellbi.2008.04.019; Jensen Pia Honnerup, 2005, J Biomol Tech, V16, P336; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; KIPREOS ET, 1992, SCIENCE, V256, P382, DOI 10.1126/science.256.5055.382; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Liang F, 2004, NUCLEIC ACIDS RES, V32, pD595, DOI 10.1093/nar/gkh118; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Westfall P.H., 1993, RESAMPLING BASED MUL; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	41	279	288	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					610	622		10.1016/j.cell.2009.08.037	http://dx.doi.org/10.1016/j.cell.2009.08.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879846	Bronze, Green Accepted			2022-12-28	WOS:000271259600024
J	Reinhard, CT; Raiswell, R; Scott, C; Anbar, AD; Lyons, TW				Reinhard, Christopher T.; Raiswell, Rob; Scott, Clint; Anbar, Ariel D.; Lyons, Timothy W.			A Late Archean Sulfidic Sea Stimulated by Early Oxidative Weathering of the Continents	SCIENCE			English	Article							MASS-INDEPENDENT FRACTIONATION; ATMOSPHERIC OXYGEN; REACTIVE IRON; SULFUR; TRANSITION; DEPOSITION; VOLCANISM; SEDIMENTS; INSIGHTS; SULFATE	Iron speciation data for the late Archean Mount McRae Shale provide evidence for a euxinic (anoxic and sulfidic) water column 2.5 billion years ago. Sulfur isotope data compiled from the same stratigraphic section suggest that euxinic conditions were stimulated by an increase in oceanic sulfate concentrations resulting from weathering of continental sulfide minerals exposed to an atmosphere with trace amounts of photosynthetically produced oxygen. Variability in local organic matter flux likely confined euxinic conditions to midportions of the water column on the basin margin. These findings indicate that euxinic conditions may have been common on a variety of spatial and temporal scales both before and immediately after the Paleoproterozoic rise in atmospheric oxygen, hinting at previously unexplored texture and variability in deep ocean chemistry during Earth's early history.	[Reinhard, Christopher T.; Scott, Clint; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Raiswell, Rob] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of California System; University of California Riverside; University of Leeds; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Lyons, TW (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	timothyl@ucr.edu	Reinhard, Christopher/A-1736-2011		NASA Astrobiology Institute and Exobiology Program; NSF Geobiology and Low Temperature Geochemistry Program	NASA Astrobiology Institute and Exobiology Program; NSF Geobiology and Low Temperature Geochemistry Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The NASA Astrobiology Institute and Exobiology Program and the NSF Geobiology and Low Temperature Geochemistry Program provided financial support. The authors thank B. Gill, S. Severmann, N. Planavsky, M. Claire, J. Kaufman, and R. Buick for helpful discussions, and G. Arnold for handling of core material.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; Erickson BE, 2000, GEOCHIM COSMOCHIM AC, V64, P1149, DOI 10.1016/S0016-7037(99)00423-8; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; ISLEY AE, 1995, J GEOL, V103, P169, DOI 10.1086/629734; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; PARTRIDGE M, 2008, EARTH PLANET SCI LET; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Wijsman JWM, 2001, MAR GEOL, V172, P167, DOI 10.1016/S0025-3227(00)00122-5; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	29	196	204	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					713	716		10.1126/science.1176711	http://dx.doi.org/10.1126/science.1176711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900929				2022-12-28	WOS:000271233200033
J	Glocker, EO; Hennigs, A; Nabavi, M; Schaffer, AA; Woellner, C; Salzer, U; Pfeifer, D; Veelken, H; Warnatz, K; Tahami, F; Jamal, S; Manguiat, A; Rezaei, N; Amirzargar, AA; Plebani, A; Hannesschlager, N; Gross, O; Ruland, J; Grimbacher, B				Glocker, Erik-Oliver; Hennigs, Andre; Nabavi, Mohammad; Schaeffer, Alejandro A.; Woellner, Cristina; Salzer, Ulrich; Pfeifer, Dietmar; Veelken, Hendrik; Warnatz, Klaus; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Rezaei, Nima; Amirzargar, Ali Akbar; Plebani, Alessandro; Hannesschlaeger, Nicole; Gross, Olaf; Ruland, Juergen; Grimbacher, Bodo			A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; HYPER-IGE SYNDROME; COMMON VARIABLE IMMUNODEFICIENCY; PATTERN-RECOGNITION RECEPTOR; INNATE IMMUNE-RESPONSES; LINKAGE ANALYSIS; TH17 CELLS; ANTIFUNGAL IMMUNITY; SINGLE-FAMILY; HOST-DEFENSE	BACKGROUND Chronic mucocutaneous candidiasis may be manifested as a primary immunodeficiency characterized by persistent or recurrent infections of the mucosa or the skin with candida species. Most cases are sporadic, but both autosomal dominant inheritance and autosomal recessive inheritance have been described. METHODS We performed genetic studies in 36 members of a large, consanguineous five-generation family, in which 4 members had recurrent fungal infections and an additional 3 members died during adolescence, 2 after invasive infection of the brain with candida species. All 36 family members were enrolled in the study, and 22 had blood samples taken for DNA analysis. Homozygosity mapping was used to locate the mutated gene. In the 4 affected family members (patients) and the 18 unaffected members we sequenced CARD9, the gene encoding the caspase recruitment domain-containing protein 9, carried out T-cell phenotyping, and performed functional studies, with the use of either leukocytes from the patients or a reconstituted murine model of the genetic defect. RESULTS We found linkage (lod score, 3.6) to a genomic interval on chromosome 9q, including CARD9. All four patients had a homozygous point mutation in CARD9, resulting in a premature termination codon (Q295X). Healthy family members had wild-type expression of the CARD9 protein; the four patients lacked wild-type expression, which was associated with low numbers of Th17 cells (helper T cells producing interleukin- 17). Functional studies based on genetic reconstitution of myeloid cells from Card9(-/-) mice showed that the Q295X mutation impairs innate signaling from the antifungal pattern-recognition receptor dectin-1. CONCLUSIONS An autosomal recessive form of susceptibility to chronic mucocutaneous candidiasis is associated with homozygous mutations in CARD9.	[Glocker, Erik-Oliver; Woellner, Cristina; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Grimbacher, Bodo] Royal Free Hosp, Dept Immunol & Mol Pathol, London NW3 2QG, England; [Glocker, Erik-Oliver; Woellner, Cristina; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Grimbacher, Bodo] UCL, London, England; [Hennigs, Andre; Salzer, Ulrich; Warnatz, Klaus] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Pfeifer, Dietmar; Veelken, Hendrik] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Nabavi, Mohammad] Semnan Univ Med Sci, Semnan, Iran; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Childrens Med Ctr, Growth & Dev Res Ctr,Ctr Excellence Pediat, Tehran, Iran; [Amirzargar, Ali Akbar] Univ Tehran Med Sci, Sch Med, Dept Immunol, Immunogenet Lab, Tehran, Iran; [Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Plebani, Alessandro] Spedali Civil Brescia, Ist Med Mol Angelo Nocivelli, I-25125 Brescia, Italy; [Hannesschlaeger, Nicole; Gross, Olaf; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, Neuherberg, Germany	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Freiburg; University of Freiburg; Semnan University of Medical Sciences; National Institutes of Health (NIH) - USA; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Brescia; Hospital Spedali Civili Brescia; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Grimbacher, B (corresponding author), Royal Free Hosp, Dept Immunol & Mol Pathol, Pond St, London NW3 2QG, England.	b.grimbacher@ucl.ac.uk	Schaffer, Alejandro A/F-2902-2012; Gross, Olaf/E-4570-2010; Schaffer, Alejandro/N-1222-2019; Ruland, Jürgen/Q-6680-2018; Plebani, Alessandro/C-8593-2011; Warnatz, Klaus/AAD-3464-2022; Rezaei, Nima/B-4245-2008	Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Rezaei, Nima/0000-0002-3836-1827; Veelken, Hendrik/0000-0002-9108-3125; Hennigs, Andre/0000-0002-7998-3796; Nabavi, Mohammad/0000-0001-6558-0390; Salzer, Ulrich/0000-0002-1769-1157	European Commission [MEXT-CT-2006-042316]; European Society for Immunodeficiencies; National Institutes of Health (NIH), National Library of Medicine; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); European Society for Immunodeficiencies; National Institutes of Health (NIH), National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported in part by a European Commission Marie Curie Excellence Grant (MEXT-CT-2006-042316); the young investigator award of 2008 from the European Society for Immunodeficiencies; the Intramural Research Program of the National Institutes of Health (NIH), National Library of Medicine; a Max Eder Program Grant from Deutsche Krebshilfe (to Dr. Ruland); and Sonderforschungsbereich grants from the Deutsche Forschungsgemeinschaft (to Dr. Ruland).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Atkinson TP, 2001, AM J HUM GENET, V69, P791, DOI 10.1086/323611; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; CANALES L, 1969, LANCET, V2, P567; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; DROUHET E, 1980, REV INFECT DIS, V2, P606; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Finck A, 2006, EUR J HUM GENET, V14, P867, DOI 10.1038/sj.ejhg.5201634; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Giovannetti A, 2002, BLOOD, V100, P4082, DOI 10.1182/blood-2002-03-0976; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hruz P, 2008, CURR OPIN GASTROEN, V24, P108, DOI 10.1097/MOG.0b013e3282f50fdf; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; KAUFFMAN CA, 1981, ARCH INTERN MED, V141, P1076, DOI 10.1001/archinte.141.8.1076; Kirkpatrick CH, 2001, PEDIATR INFECT DIS J, V20, P197, DOI 10.1097/00006454-200102000-00017; KROLL JJ, 1973, ARCH DERMATOL, V108, P259, DOI 10.1001/archderm.108.2.259; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lilic D, 2002, CURR OPIN INFECT DIS, V15, P143, DOI 10.1097/00001432-200204000-00007; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Loeys BL, 1999, EUR J PEDIATR, V158, P650, DOI 10.1007/s004310051169; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mangino M, 2003, EUR J HUM GENET, V11, P433, DOI 10.1038/sj.ejhg.5200985; Miething C, 2003, ONCOGENE, V22, P4642, DOI 10.1038/sj.onc.1206575; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pfeifer D, 2007, IMMUNOGENETICS, V59, P913, DOI 10.1007/s00251-007-0257-z; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rogers NC, 2005, IMMUNITY, V22, P773, DOI 10.1016/j.immuni.2005.06.005; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; SAMS WM, 1979, AM J MED, V67, P948, DOI 10.1016/0002-9343(79)90635-1; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thorpe E., 1929, ARCH PEDIAT ADOL MED, V38, P328, DOI 10.1001/archpedi.1929.01930080104011; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; VANTWOUT JW, 1988, SCAND J INFECT DIS, V20, P193, DOI 10.3109/00365548809032437; WELLS RS, 1972, J MED GENET, V9, P302, DOI 10.1136/jmg.9.3.302; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	59	567	588	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1727	1735		10.1056/NEJMoa0810719	http://dx.doi.org/10.1056/NEJMoa0810719			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864672	Green Accepted			2022-12-28	WOS:000271185600005
J	Olah, S; Miklos, F; Gergely, K; Csaba, V; Rita, B; Pal, B; Gabor, T				Olah, Szabolcs; Miklos Fuele; Gergely Komlosi; Csaba Varga; Rita Baldi; Pal Barzo; Gabor Tamas			Regulation of cortical microcircuits by unitary GABA-mediated volume transmission	NATURE			English	Article							NEURONAL EXCITABILITY; TONIC INHIBITION; RECEPTORS; ACTIVATION; INTERNEURONS; MODULATION; SPILLOVER; CELLS	GABA (gamma-aminobutyric acid) is predominantly released by local interneurons in the cerebral cortex to particular subcellular domains of the target cells(1,2). This suggests that compartmentalized, synapse-specific action of GABA is required in cortical networks for phasic inhibition(2-4). However, GABA released at the synaptic cleft diffuses to receptors outside the postsynaptic density and thus tonically activates extrasynaptic GABA(A) and GABA(B) receptors, which include subtypes of both receptor families especially sensitive to low concentrations of GABA(3-7). The synaptic and extrasynaptic action of GABA corroborates the idea that neurons of the brain use synaptic (or wiring) transmission and non-synaptic (or volume) transmission for communication(8,9). However, re-uptake mechanisms restrict the spatial extent of extrasynaptic GABA-mediated effects(10,11), and it has been proposed that the concerted action of several presynaptic interneurons, the sustained firing of individual cells or an increase in release-site density is required to reach ambient GABA levels sufficient to activate extrasynaptic receptors(4,9,11-13). Here we show that individual neurogliaform cells release enough GABA for volume transmission within the axonal cloud and, thus, that neurogliaform cells do not require synapses to produce inhibitory responses in the overwhelming majority of nearby neurons. Neurogliaform cells suppress connections between other neurons acting on presynaptic terminals that do not receive synapses at all in the cerebral cortex. They also reach extrasynaptic, delta-subunit-containing GABA(A) (GABA(A delta)) receptors responsible for tonic inhibition. We show that GABA(A delta) receptors are localized to neurogliaform cells preferentially among cortical interneurons. Neurosteroids, which are modulators of GABA(A delta) receptors, alter unitary GABA-mediated effects between neurogliaform cells. In contrast to the specifically placed synapses formed by other interneurons, the output of neurosteroid-sensitive neurogliaform cells represents the ultimate form of the lack of spatial specificity in GABA-mediated systems, leading to long-lasting network hyperpolarization combined with widespread suppression of communication in the local circuit.	[Olah, Szabolcs; Miklos Fuele; Gergely Komlosi; Csaba Varga; Rita Baldi; Gabor Tamas] Univ Szeged, Dept Physiol Anat & Neurosci, Res Grp Cort Microcircuits, Hungarian Acad Sci, H-6726 Szeged, Hungary; [Pal Barzo] Univ Szeged, Dept Neurosurg, H-6725 Szeged, Hungary	Hungarian Academy of Sciences; Szeged University; Szeged University	Gabor, T (corresponding author), Univ Szeged, Dept Physiol Anat & Neurosci, Res Grp Cort Microcircuits, Hungarian Acad Sci, Kozep Fasor 52, H-6726 Szeged, Hungary.	gtamas@bio.u-szeged.hu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Varga, Csaba/0000-0002-9188-1282	European Young Investigator Award; Hungarian National Office for Research and Technology Polanyi Award; Howard Hughes Medical Institute; US National Institutes of Health [NS535915]; Boehringer Ingelheim Fonds; Hungarian Academy of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035915] Funding Source: NIH RePORTER	European Young Investigator Award; Hungarian National Office for Research and Technology Polanyi Award(National Office for Research and Technology); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank W. Sieghart for donating antibody, A. Lorincz and Z. Nusser for initial testing of the GABA<INF>A delta</INF> antibody, I. Mody for the GABA<INF>A delta</INF> -/- animals, and A. Simon and E. Toth for reconstructions. This work was supported by the European Young Investigator Award, the Hungarian National Office for Research and Technology Polanyi Award, the Howard Hughes Medical Institute, US National Institutes of Health grant NS535915, the Boehringer Ingelheim Fonds and the Hungarian Academy of Sciences.	Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kulik A, 2003, J NEUROSCI, V23, P11026; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1998, J NEUROSCI, V18, P1693; Overstreet LS, 2003, J NEUROSCI, V23, P2618; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Peters A., 1991, FINE STRUCTURE NERVO; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Vardya I, 2008, J NEUROPHYSIOL, V100, P526, DOI 10.1152/jn.01224.2007; Vizi ES, 2000, PHARMACOL REV, V52, P63	30	256	260	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1278	U113		10.1038/nature08503	http://dx.doi.org/10.1038/nature08503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865171	Green Accepted			2022-12-28	WOS:000271190800048
J	Salvaterra, R; Della Valle, M; Campana, S; Chincarini, G; Covino, S; D'Avanzo, P; Fernandez-Soto, A; Guidorzi, C; Mannucci, F; Margutti, R; Thoene, CC; Antonelli, LA; Barthelmy, SD; De Pasquale, M; D'Elia, V; Fiore, F; Fugazza, D; Hunt, LK; Maiorano, E; Marinoni, S; Marshall, FE; Molinari, E; Nousek, J; Pian, E; Racusin, JL; Stella, L; Amati, L; Andreuzzi, G; Cusumano, G; Fenimore, EE; Ferrero, P; Giommi, P; Guetta, D; Holland, ST; Hurley, K; Israel, GL; Mao, J; Markwardt, CB; Masetti, N; Pagani, C; Palazzi, E; Palmer, DM; Piranomonte, S; Tagliaferri, G; Testa, V				Salvaterra, R.; Della Valle, M.; Campana, S.; Chincarini, G.; Covino, S.; D'Avanzo, P.; Fernandez-Soto, A.; Guidorzi, C.; Mannucci, F.; Margutti, R.; Thoene, C. C.; Antonelli, L. A.; Barthelmy, S. D.; De Pasquale, M.; D'Elia, V.; Fiore, F.; Fugazza, D.; Hunt, L. K.; Maiorano, E.; Marinoni, S.; Marshall, F. E.; Molinari, E.; Nousek, J.; Pian, E.; Racusin, J. L.; Stella, L.; Amati, L.; Andreuzzi, G.; Cusumano, G.; Fenimore, E. E.; Ferrero, P.; Giommi, P.; Guetta, D.; Holland, S. T.; Hurley, K.; Israel, G. L.; Mao, J.; Markwardt, C. B.; Masetti, N.; Pagani, C.; Palazzi, E.; Palmer, D. M.; Piranomonte, S.; Tagliaferri, G.; Testa, V.			GRB 090423 at a redshift of z approximate to 8.1	NATURE			English	Article							GAMMA-RAY BURSTS; LUMINOSITY; EVOLUTION; GALAXIES; EPOCH; PROBE; MASS	Gamma-ray bursts (GRBs) are produced by rare types of massive stellar explosion. Their rapidly fading afterglows are often bright enough at optical wavelengths that they are detectable at cosmological distances. Hitherto, the highest known redshift for a GRB was z = 6.7 (ref. 1), for GRB 080913, and for a galaxy was z = 6.96 (ref. 2). Here we report observations of GRB 090423 and the near-infrared spectroscopic measurement of its redshift, z = 8.1(-0.3)(+0.1). This burst happened when the Universe was only about 4 per cent of its current age(3). Its properties are similar to those of GRBs observed at low/intermediate redshifts, suggesting that the mechanisms and progenitors that gave rise to this burst about 600,000,000 years after the Big Bang are not markedly different from those producing GRBs about 10,000,000,000 years later.	[Salvaterra, R.; Campana, S.; Chincarini, G.; Covino, S.; D'Avanzo, P.; Margutti, R.; Thoene, C. C.; Fugazza, D.; Molinari, E.; Mao, J.; Tagliaferri, G.] Osserv Astron Brera, INAF, I-23807 Merate, LC, Italy; [Della Valle, M.] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [Della Valle, M.] European So Observ, D-85748 Garching, Germany; [Della Valle, M.] Int Ctr Relativist Astrophys, I-65122 Pescara, Italy; [Chincarini, G.; D'Avanzo, P.; Margutti, R.] Univ Milano Bicocca, Dipartimento Fis G Occhialini, I-20126 Milan, Italy; [Fernandez-Soto, A.] Univ Cantabria, CSIC, Inst Fis Cantabria, E-39005 Santander, Spain; [Guidorzi, C.] Univ Ferrara, Dipartimento Fis, I-44100 Ferrara, Italy; [Mannucci, F.; Hunt, L. K.] Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; [Antonelli, L. A.; D'Elia, V.; Fiore, F.; Stella, L.; Guetta, D.; Israel, G. L.; Piranomonte, S.; Testa, V.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Rome, Italy; [Barthelmy, S. D.; Marshall, F. E.; Holland, S. T.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [De Pasquale, M.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Maiorano, E.; Amati, L.; Masetti, N.; Palazzi, E.] IASF Bologna, INAF, I-40129 Bologna, Italy; [Marinoni, S.; Molinari, E.; Andreuzzi, G.] Fdn Galileo Galilei, INAF, Brena Baja 38712, TF, Spain; [Marinoni, S.] Univ Bologna, I-40127 Bologna, Italy; [Nousek, J.; Racusin, J. L.; Pagani, C.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Pian, E.] Trieste Astron Observ, INAF, I-34143 Trieste, Italy; [Pian, E.] Scuola Normale Super Pisa, I-56100 Pisa, Italy; [Cusumano, G.; Palmer, D. M.] Ist Astrofis Spaziale & Fis Cosm Palermo, INAF, I-90146 Palermo, Italy; [Fenimore, E. E.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Ferrero, P.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Giommi, P.] ESRIN, ASDC, ASI Sci Data Ctr, I-00044 Frascati, Italy; [Holland, S. T.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Holland, S. T.; Markwardt, C. B.] Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Hurley, K.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Markwardt, C. B.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); European Southern Observatory; University of Milano-Bicocca; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); University of Ferrara; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; University College London; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Bologna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Istituto Nazionale Astrofisica (INAF); Scuola Normale Superiore di Pisa; Istituto Nazionale Astrofisica (INAF); United States Department of Energy (DOE); Los Alamos National Laboratory; Agenzia Spaziale Italiana (ASI); European Space Agency; Universities Space Research Association (USRA); University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park	Salvaterra, R (corresponding author), Osserv Astron Brera, INAF, Via E Bianchi 46, I-23807 Merate, LC, Italy.	salvaterra@mib.infn.it	Racusin, Judith L/D-2935-2012; Molinari, Emilio/GYR-1322-2022; Fernandez-Soto, Alberto/A-2443-2009; Tagliaferri, Gianpiero/ABD-7556-2021; Della Valle, Massimo/AAE-8884-2021; De Pasquale, Massimiliano/AAC-5695-2020; Covino, Stefano/AAQ-5188-2021; Campana, Sergio/AAL-6012-2020; Palazzi, Eliana/N-4746-2015; Barthelmy, Scott D/D-2943-2012; giommi, paolo/L-1006-2018; Thone, Christina/Q-3938-2017; Amati, Lorenzo/N-5586-2015	Molinari, Emilio/0000-0002-1742-7735; Fernandez-Soto, Alberto/0000-0002-5732-3121; Tagliaferri, Gianpiero/0000-0003-0121-0723; Della Valle, Massimo/0000-0003-3142-5020; Covino, Stefano/0000-0001-9078-5507; Campana, Sergio/0000-0001-6278-1576; Masetti, Nicola/0000-0001-9487-7740; Antonelli, Lucio Angelo/0000-0002-5037-9034; Pian, Elena/0000-0001-8646-4858; Cusumano, Giancarlo/0000-0002-8151-1990; Palazzi, Eliana/0000-0002-8691-7666; Maiorano, Elisabetta/0000-0003-2593-4355; Hunt, Leslie/0000-0001-9162-2371; D'Elia, Valerio/0000-0002-7320-5862; Markwardt, Craig/0000-0001-9803-3879; mannucci, filippo/0000-0002-4803-2381; Fiore, Fabrizio/0000-0002-4031-4157; giommi, paolo/0000-0002-2265-5003; guetta, dafne/0000-0002-7349-1109; Israel, GianLuca/0000-0001-5480-6438; Marinoni, Silvia/0000-0001-7990-6849; Salvaterra, Ruben/0000-0002-9393-8078; Thone, Christina/0000-0002-7978-7648; Guidorzi, Cristiano/0000-0001-6869-0835; D'Avanzo, Paolo/0000-0001-7164-1508; Stella, Luigi/0000-0002-0018-1687; Fugazza, Dino Pierluigi/0000-0001-9942-277X; Amati, Lorenzo/0000-0001-5355-7388; Testa, Vincenzo/0000-0003-1033-1340	Agenzia Spaziale Italiana; Ministero dell'Universita e della Ricerca; Ministero degli Affari Esteri; NASA; US National Science Foundation; STFC [PP/E001173/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E001173/1] Funding Source: researchfish	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy)); NASA(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the TNG staff for useful support during target-of-opportunity observations, in particular A. Fiorenzano, N. Sacchi and A. G. de Gurtubai Escudero. Wethank A. Ferrara for discussions. This research was supported by the Agenzia Spaziale Italiana, the Ministero dell'Universita e della Ricerca, the Ministero degli Affari Esteri, NASA and the US National Science Foundation.	Amati L, 2007, ASTRON ASTROPHYS, V463, P913, DOI 10.1051/0004-6361:20065994; Bolton JS, 2007, MON NOT R ASTRON SOC, V382, P325, DOI 10.1111/j.1365-2966.2007.12372.x; Bromm V, 2006, ASTROPHYS J, V642, P382, DOI 10.1086/500799; Chary RR, 2008, ASTROPHYS J, V680, P32, DOI 10.1086/587737; Choudhury TR, 2008, MON NOT R ASTRON SOC, V385, pL58, DOI 10.1111/j.1745-3933.2008.00433.x; DEPASQUALE M, 2009, 9210 GCN; FERNANDEZSOTO A, 2009, 9222 GCN; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Furlanetto SR, 2009, MON NOT R ASTRON SOC, V394, P1667, DOI 10.1111/j.1365-2966.2009.14449.x; Greiner J, 2009, ASTROPHYS J, V693, P1610, DOI 10.1088/0004-637X/693/2/1610; Guetta D, 2005, ASTROPHYS J, V619, P412, DOI 10.1086/423125; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Nagamine K, 2006, NEW ASTRON REV, V50, P29, DOI 10.1016/j.newar.2005.11.002; PALMER DM, 2009, 9204 GCN; Salvaterra R, 2007, ASTROPHYS J, V656, pL49, DOI 10.1086/512606; Salvaterra R, 2009, MON NOT R ASTRON SOC, V396, P299, DOI 10.1111/j.1365-2966.2008.14343.x; Schady P, 2007, MON NOT R ASTRON SOC, V377, P273, DOI 10.1111/j.1365-2966.2007.11592.x; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Stiavelli M., 2009, 1 LIGHT REIONIZATION; Stratta G, 2007, ASTROPHYS J, V661, pL9, DOI 10.1086/518502; STRATTA G, 2009, 9212 GCN; THOENE CC, 2009, 9216 GCN; VONKIENLIN A, 2009, 9229 GCN; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Zhang B, 2007, CHINESE J ASTRON AST, V7, P1, DOI 10.1088/1009-9271/7/1/01	29	382	386	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1258	1260		10.1038/nature08445	http://dx.doi.org/10.1038/nature08445			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865166	Green Submitted			2022-12-28	WOS:000271190800043
J	Harris, SR; Olivotto, IA				Harris, Susan R.; Olivotto, Ivo A.			A Patient's Journey Communication during breast cancer treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harris, Susan R.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Olivotto, Ivo A.] British Columbia Canc Agcy, Radiat Therapy Program, Vancouver, BC V5Z 4E6, Canada; [Olivotto, Ivo A.] Univ British Columbia, Radiat Therapy Program, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Harris, SR (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	shar@interchange.ubc.ca; iolivott@bccancer.bc.ca	Harris, Susan/GSE-3905-2022	Harris, Susan/0000-0003-2679-6548					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2009	339								b4166	10.1136/bmj.b4166	http://dx.doi.org/10.1136/bmj.b4166			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PP	19854841				2022-12-28	WOS:000271102700004
J	Ahmed, HU				Ahmed, Hashim Uddin			The Index Lesion and the Origin of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY; MEN		[Ahmed, Hashim Uddin] Univ Coll, Div Surg & Intervent Sci, London, England; [Ahmed, Hashim Uddin] Univ Coll Hosp, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	University of London; University College London; University of London; University College London	Ahmed, HU (corresponding author), Univ Coll, Div Surg & Intervent Sci, London, England.		Ahmed, Hashim U./AAU-1037-2020; Ahmed, Hashim U/C-5744-2008	Ahmed, Hashim U./0000-0003-1674-6723; 	MRC [G0701302] Funding Source: UKRI; Medical Research Council [G0701302, G1002509] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed HU, 2007, NAT CLIN PRACT ONCOL, V4, P632, DOI 10.1038/ncponc0959; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Andriole GL, 2009, NEW ENGL J MED, V360, P1797; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Liu WN, 2009, NAT MED, V15, P819, DOI 10.1038/nm0709-819a; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Stamey TA, 2001, EUR UROL, V39, P22, DOI 10.1159/000052577	7	249	258	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1704	1706		10.1056/NEJMcibr0905562	http://dx.doi.org/10.1056/NEJMcibr0905562			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846858				2022-12-28	WOS:000270977400016
J	Eisenstein, M				Eisenstein, Michael			Putting neurons on the map	NATURE			English	Editorial Material							NERVOUS-SYSTEM											Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chi KR, 2009, NAT METHODS, V6, P15, DOI 10.1038/NMETH.F.234; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	9	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1149	1154		10.1038/4611149a	http://dx.doi.org/10.1038/4611149a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847270	Bronze			2022-12-28	WOS:000270987600050
J	Clark, J				Clark, James			Becoming T-rex	SCIENCE			English	Editorial Material							CHINA		George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Clark, J (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jclark@gwu.edu						Chang M., 2003, JEHOL BIOTA; DALTON R, NATURE; LI D, 2009, P ROY SOC B; Miles CA, 2009, CURR SCI INDIA, V96, P65; Novas F.E., 1992, DINOSAURIOS ENTORNO, P125; SCHEIBLE S, 2009, PATRIOT LEDGER  0921; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; SIMONS LM, 2000, NATL GEOGR, V198, P128; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855	11	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					373	374		10.1126/science.1181276	http://dx.doi.org/10.1126/science.1181276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833946				2022-12-28	WOS:000270818600031
J	Hussey, PS; Eibner, C; Ridgely, S; McGlynn, EA				Hussey, Peter S.; Eibner, Christine; Ridgely, Susan; McGlynn, Elizabeth A.			Controlling US Health Care Spending - Separating Promising from Unpromising Approaches	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hussey, Peter S.; Eibner, Christine; Ridgely, Susan; McGlynn, Elizabeth A.] RAND Hlth, Santa Monica, CA USA	RAND Corporation	Hussey, PS (corresponding author), RAND Hlth, Santa Monica, CA USA.							Congressional Budget Office, 2008, BUDG OPT, V1; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Eibner C, 2009, CONTROLLING HLTH CAR; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346	4	71	71	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2109	2111		10.1056/NEJMp0910315	http://dx.doi.org/10.1056/NEJMp0910315			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	524BC	19907037				2022-12-28	WOS:000272117800003
J	Anderson, T				Anderson, Tatum			International Aid: Innovative financing of health care	BRITISH MEDICAL JOURNAL			English	Editorial Material												tatum.anderson@tiscali.co.uk							0	1	1	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2009	339								b4235	10.1136/bmj.b4235	http://dx.doi.org/10.1136/bmj.b4235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19889731				2022-12-28	WOS:000271833900021
J	Koretz, D				Koretz, Daniel			Moving Past No Child Left Behind	SCIENCE			English	Editorial Material									Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University	Koretz, D (corresponding author), Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA.	daniel_koretz@harvard.edu						Booher-Jennings J, 2005, AM EDUC RES J, V42, P231, DOI 10.3102/00028312042002231; Campbell Donald T., 1979, EVAL PROGRAM PLANN, V2, P67, DOI [10.1016/0149-7189(79)90048-X, DOI 10.1016/0149-7189(79)90048-X, 10.1016/0149-7189(79)90048-x]; Hambleton R.K., 1995, REV MEASUREMENT QUAL; KLEIN SP, 2000, IP202 RAND; Koretz D, 2006, ED MEASUREMENT, P531; KORETZ D, 2001, 551 CSE U CA; KORETZ DM, 1991, ANN M AM ED RES ASS; Mullis I. V. S., 2008, TIMSS 2019 INT RESUL; STECHER B, 2002, TEST BASED ACCOUNTAB, P79	9	4	4	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					803	804		10.1126/science.1177459	http://dx.doi.org/10.1126/science.1177459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	515KG	19892967				2022-12-28	WOS:000271468000025
J	Nelson, AL; Cohen, JT; Greenberg, D; Kent, DM				Nelson, Aaron L.; Cohen, Joshua T.; Greenberg, Dan; Kent, David M.			Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE COSTS; COGNITIVE-BEHAVIOR THERAPY; UTILITY ANALYSIS; CONTINGENT VALUATION; PART 2; STRATEGIES; INTERVENTION; ECONOMICS; PHYSIOTHERAPY; BENEFITS	Under conditions of constrained resources, cost-saving innovations may improve overall outcomes, even when they are slightly less effective than available options, by permitting more efficient reallocation of resources. The authors systematically reviewed all MEDLINE-cited cost-utility analyses written in English from 2002 to 2007 to identify and describe cost- and quality-decreasing medical innovations that might offer favorable "decrementally" cost- effective tradeoffs-defined as saving at least $100 000 per quality-adjusted life-year lost. Of 2128 cost- effectiveness ratios from 887 publications, only 9 comparisons (0.4% of total) described 8 innovations that were deemed to be decrementally cost- effective. Examples included percutaneous coronary intervention (instead of coronary artery bypass graft) for multivessel coronary disease, repetitive transcranial magnetic stimulation (instead of electroconvulsive therapy) for drug-resistant major depression, watchful waiting for inguinal hernias, and hemodialyzer sterilization and reuse. On a per-patient basis, these innovations yielded savings from $122 to almost $12 000 but losses of 0.001 to 0.021 quality-adjusted life-years (approximately 8 hours to 1 week). These findings demonstrate the rarity of decrementally cost-effective innovations in the medical literature.	Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Tufts Medical Center; Tufts University; Ben Gurion University	Kent, DM (corresponding author), 800 Washington St,Box 63, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org		Greenberg, Dan/0000-0002-6759-3985; Cohen, Joshua/0000-0003-1737-0991				ARROW KJ, 1963, AM ECON REV, V53, P941; Baker L, 2003, HLTH AFF MILLWOOD S; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Byford S, 2003, PSYCHOL MED, V33, P977, DOI 10.1017/S0033291703008183; Carthy T, 1998, J RISK UNCERTAINTY, V17, P187, DOI 10.1023/A:1007782800868; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Cohen JT, 2007, HEALTH AFFAIR, V26, P636, DOI 10.1377/hlthaff.26.3.636; Coupe VMH, 2007, ANN RHEUM DIS, V66, P215, DOI 10.1136/ard.2006.054478; Cram P, 2003, VALUE HEALTH, V6, P466, DOI 10.1046/j.1524-4733.2003.64224.x; Dowie J, 2004, HEALTH ECON, V13, P453, DOI 10.1002/hec.861; Erstad BL, 2004, CRIT CARE MED, V32, P1277, DOI 10.1097/01.CCM.0000127261.09066.6E; Esnaola NF, 2002, J CLIN ONCOL, V20, P263, DOI 10.1200/JCO.20.1.263; Garside R, 2004, BJOG-INT J OBSTET GY, V111, P1103, DOI 10.1111/j.1471-0528.2004.00265.x; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Gomez-Outes A, 2006, PHARMACOECONOMICS, V24, P81, DOI 10.2165/00019053-200624010-00007; Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; Honkanen LA, 2006, J AM GERIATR SOC, V54, P1658, DOI 10.1111/j.1532-5415.2006.00939.x; Hrung JM, 1999, RADIOLOGY, V213, P39, DOI 10.1148/radiology.213.1.r99oc5139; Kent DM, 2004, MED DECIS MAKING, V24, P281, DOI 10.1177/0272989X04265478; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Kozel FA, 2004, CNS SPECTRUMS, V9, P476; Kunz K, 1996, INT J TECHNOL ASSESS, V12, P436; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Manca A, 2006, INT J TECHNOL ASSESS, V22, P67, DOI 10.1017/S0266462306050859; Manns BJ, 2002, INT J TECHNOL ASSESS, V18, P81; McKay Andrew, 2007, HPB (Oxford), V9, P42, DOI 10.1080/13651820600994541; McNeil BJ, 2001, NEW ENGL J MED, V345, P1612, DOI 10.1056/NEJMsa011810; NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3; Nietert PJ, 2003, GASTROINTEST ENDOSC, V57, P311, DOI 10.1067/mge.2003.101; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; O'Connor JB, 2002, DIGEST DIS SCI, V47, P1516, DOI 10.1023/A:1015811001267; Oestreicher N, 2005, GENET MED, V7, P380, DOI 10.1097/01.GIM.0000170776.31248.75; Okunade AA, 2002, J HEALTH ECON, V21, P147, DOI 10.1016/S0167-6296(01)00122-9; Orszag PR, 2007, NEW ENGL J MED, V357, P1793, DOI 10.1056/NEJMp078190; Palmer S, 2006, J PERS DISORD, V20, P466, DOI 10.1521/pedi.2006.20.5.466; Pyne JM, 2003, J AFFECT DISORDERS, V74, P23, DOI 10.1016/S0165-0327(02)00115-5; Romagnuolo J, 2002, ANN SURG, V236, P191, DOI 10.1097/00000658-200208000-00007; Serrano-Blanco A, 2006, ACTA PSYCHIAT SCAND, V114, P39, DOI 10.1111/j.1600-0447.2006.00918.x; Spigel BMR, 2002, GASTROENTEROLOGY, V122, P1270, DOI 10.1053/gast.2002.33019; Stroupe KT, 2006, J AM COLL SURGEONS, V203, P458, DOI 10.1016/j.jamcollsurg.2006.06.010; Struijs PAA, 2006, BRIT J SPORT MED, V40, P637, DOI 10.1136/bjsm.2006.026187; Tan MC, 2008, VALUE HEALTH, V11, P842, DOI 10.1111/j.1524-4733.2008.00334.x; U-King-Im JM, 2005, ANN NEUROL, V58, P506, DOI 10.1002/ana.20591; Valenzuela MT, 2005, VACCINE, V23, P4110, DOI 10.1016/j.vaccine.2005.03.021; Wagmiller JA, 2006, J ONCOL PRACT, V2, P57, DOI 10.1200/JOP.2.2.57; Weintraub WS, 2004, HEART, V90, P782, DOI 10.1136/hrt.2003.015057; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; You JHS, 2006, HUM REPROD, V21, P1878, DOI 10.1093/humrep/del088	51	58	59	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					662	W219		10.7326/0003-4819-151-9-200911030-00011	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514IM	19884627				2022-12-28	WOS:000271387700008
J	Elshakry, M				Elshakry, Marwa			Global Darwin: Eastern enchantment	NATURE			English	Editorial Material									Columbia Univ, New York, NY 10027 USA	Columbia University	Elshakry, M (corresponding author), Columbia Univ, 611 Fayerweather Hall, New York, NY 10027 USA.								0	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 29	2009	461	7268					1200	1201		10.1038/4611200a	http://dx.doi.org/10.1038/4611200a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511TF	19865145				2022-12-28	WOS:000271190800020
J	Stiell, IG; Clement, CM; Grimshaw, J; Brison, RJ; Rowe, BH; Schull, MJ; Lee, JS; Brehaut, J; McKnight, RD; Eisenhauer, MA; Dreyer, J; Letovsky, E; Rutledge, T; MacPhail, I; Ross, S; Shah, A; Perry, JJ; Holroyd, BR; Ip, U; Lesiuk, H; Wells, GA				Stiell, Ian G.; Clement, Catherine M.; Grimshaw, Jeremy; Brison, Robert J.; Rowe, Brian H.; Schull, Michael J.; Lee, Jacques S.; Brehaut, Jamie; McKnight, R. Douglas; Eisenhauer, Mary A.; Dreyer, Jonathan; Letovsky, Eric; Rutledge, Tim; MacPhail, Iain; Ross, Scott; Shah, Amit; Perry, Jeffrey J.; Holroyd, Brian R.; Ip, Urbain; Lesiuk, Howard; Wells, George A.			Implementation of the Canadian C-Spine Rule: prospective 12 centre cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL DECISION RULES; CERVICAL-SPINE; PREDICTION RULES; RADIOGRAPHY; DESIGN; ALERT; INTERVENTIONS; GUIDELINES; RADIATION; CRITERIA	Objective To evaluate the effectiveness of an active strategy to implement the validated Canadian C-Spine Rule into multiple emergency departments. Design Matched pair cluster randomised trial. Setting University and community emergency departments in Canada. Participants 11 824 alert and stable adults presenting with blunt trauma to the head or neck at one of 12 hospitals. Interventions Six hospitals were randomly allocated to the intervention and six to the control. At the intervention sites, active strategies were used to implement the Canadian C-Spine Rule, including education, policy, and real time reminders on radiology requisitions. No specific intervention was introduced to alter the behaviour of doctors requesting cervical spine imaging at the control sites. Main outcome measure Diagnostic imaging rate of the cervical spine during two 12 month before and after periods. Results Patients were balanced between control and intervention sites. From the before to the after periods, the intervention group showed a relative reduction in cervical spine imaging of 12.8% (95% confidence interval 9% to 16%; 61.7% v 53.3%; P=0.01) and the control group a relative increase of 12.5% (7% to 18%; 52.8% v 58.9%; P=0.03). These changes were significant when both groups were compared (P<0.001). No fractures were missed and no adverse outcomes occurred. Conclusions Implementation of the Canadian C-Spine Rule led to a significant decrease in imaging without injuries being missed or patient morbidity. Final imaging rates were much lower at intervention sites than at most US hospitals. Widespread implementation of this rule could lead to reduced healthcare costs and more efficient patient flow in busy emergency departments worldwide. Trial registration Clinical trials NCT00290875 [ClinicalTrials.gov]	[Stiell, Ian G.; Perry, Jeffrey J.] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada; [Stiell, Ian G.; Clement, Catherine M.; Grimshaw, Jeremy; Brehaut, Jamie; Perry, Jeffrey J.; Wells, George A.] Univ Alberta, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Edmonton, AB, Canada; [Brehaut, Jamie; Wells, George A.] Univ Ottawa, Dept Med, Ottawa, ON K1N 6N5, Canada; [Lesiuk, Howard] Univ Ottawa, Div Neurosurg, Ottawa, ON K1N 6N5, Canada; [Rowe, Brian H.; Ross, Scott; Holroyd, Brian R.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Brison, Robert J.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Schull, Michael J.; Lee, Jacques S.; Letovsky, Eric; Rutledge, Tim] Univ Toronto, Div Emergency Med, Toronto, ON M5S 1A1, Canada; [Eisenhauer, Mary A.; Dreyer, Jonathan; Shah, Amit] Univ Western Ontario, Div Emergency Med, London, ON, Canada; [McKnight, R. Douglas; MacPhail, Iain; Ip, Urbain] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; University of Alberta; University of Ottawa; University of Ottawa; University of Alberta; Queens University - Canada; University of Toronto; Western University (University of Western Ontario); University of British Columbia	Stiell, IG (corresponding author), Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada.	istiell@ohri.ca	Grimshaw, Jeremy/D-8726-2013; Schull, Michael J/A-7955-2013; Lee, Jacques/CAF-4380-2022	Schull, Michael J/0000-0002-1318-6364; Lee, Jacques/0000-0002-9143-6285; Grimshaw, Jeremy/0000-0001-8015-8243; Holroyd, Brian/0000-0001-8221-1327; Perry, Jeffrey/0000-0003-2134-9597; Stiell, Ian/0000-0002-2583-6408	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study received support for peer review from the Canadian Institutes of Health Research. The funding agency had no role in the design, conduct, or reporting of the study.	Abboud PAC, 2001, ANN EMERG MED, V38, P703, DOI 10.1067/mem.2001.119945; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Brehaut JC, 2006, ACAD EMERG MED, V13, P413, DOI 10.1197/j.aem.2005.11.080; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DONNER A, 1987, STAT MED, V6, P43, DOI 10.1002/sim.4780060106; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; GRIMSHAW JM, 2002, HLTH TECHNOL ASSESS; HAHN S, 2005, BMC MED RES METHODOL, P5; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Kerr D, 2005, J EMERG MED, V28, P127, DOI 10.1016/j.jemermed.2004.08.016; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; KORN R, 1984, APPL STAT, V33, P230; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEE TH, 1990, J GEN INTERN MED, V5, P528, DOI 10.1007/BF02600886; Martin DR, 2006, LANCET, V367, P1712, DOI 10.1016/S0140-6736(06)68748-5; MCCAIG LF, 2006, NATL HOSP AMBULATORY, P372; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell IG, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-4; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 1997, CAN MED ASSOC J, V156, P1537; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.278.23.2075; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P611, DOI 10.1001/jama.275.8.611; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; STIELL IG, 1995, ANN EMERG MED, V26, P405, DOI 10.1016/S0196-0644(95)70106-0; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8	38	77	79	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2009	339								b4146	10.1136/bmj.b4146	http://dx.doi.org/10.1136/bmj.b4146			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AO	19875425	hybrid, Green Published			2022-12-28	WOS:000271365900003
J	Correll, CU; Manu, P; Olshanskiy, V; Napolitano, B; Kane, JM; Malhotra, AK				Correll, Christoph U.; Manu, Peter; Olshanskiy, Vladimir; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.			Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; 3RD NATIONAL-HEALTH; INDUCED WEIGHT-GAIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; DOUBLE-BLIND; CARDIOVASCULAR RISK; GLUCOSE-TOLERANCE	Context Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication. Objective To study the association of second-generation antipsychotic medications with body composition and metabolic parameters in patients without prior antipsychotic medication exposure. Design, Setting, and Patients Nonrandomized Second-Generation Antipsychotic Treatment Indications, Effectiveness and Tolerability in Youth ( SATIETY) cohort study, conducted between December 2001 and September 2007 at semi-urban, tertiary care, academic inpatient and outpatient clinics in Queens, New York, with a catchment area of 4.5-million individuals. Of 505 youth aged 4 to 19 years with 1 week or less of antipsychotic medication exposure, 338 were enrolled (66.9%). Of these patients, 272 had at least 1 postbaseline assessment (80.5%), and 205 patients who completed the study ( 60.7%). Patients had mood spectrum (n=130; 47.8%), schizophrenia spectrum (n=82; 30.1%), and disruptive or aggressive behavior spectrum (n=60; 22.1%) disorders. Fifteen patients who refused participation or were non-adherent served as a comparison group. Intervention Treatment with aripiprazole, olanzapine, quetiapine, or risperidone for 12 weeks. Main Outcome Measures Weight gain and changes in lipid and metabolic parameters. Results After a median of 10.8 weeks (interquartile range, 10.5-11.2 weeks) of treatment, weight increased by 8.5 kg (95% confidence interval [CI], 7.4 to 9.7 kg) with olanzapine (n=45), by 6.1 kg ( 95% CI, 4.9 to 7.2 kg) with quetiapine (n=36), by 5.3 kg ( 95% CI, 4.8 to 5.9 kg) with risperidone (n=135), and by 4.4 kg ( 95% CI, 3.7 to 5.2 kg) with aripiprazole (n=41) compared with the minimal weight change of 0.2 kg ( 95% CI, -1.0 to 1.4 kg) in the untreated comparison group (n=15). With olanzapine and quetiapine, respectively, mean levels increased significantly for total cholesterol (15.6 mg/dL [ 95% CI, 6.9 to 24.3 mg/dL] P < .001 and 9.1 mg/dL [ 95% CI, 0.4 to 17.7 mg/dL] P=.046), triglycerides ( 24.3 mg/dL [ 95% CI, 9.8 to 38.9 mg/dL] P=.002 and 37.0 mg/dL [ 95% CI, 10.1 to 63.8 mg/dL] P=.01), non-high-density lipoprotein (HDL) cholesterol (16.8 mg/dL [ 95% CI, 9.3 to 24.3 mg/dL] P < .001 and 9.9 mg/dL [ 95% CI, 1.4 to 18.4 mg/dL] P=.03), and ratio of triglycerides to HDL cholesterol (0.6 [95% CI, 0.2 to 0.9] P=.002 and (1.2 [ 95% CI, 0.4 to 2.0] P=.004). With risperidone, triglycerides increased significantly ( mean level, 9.7 mg/dL [95% CI, 0.5 to 19.0 mg/dL]; P=.04). Metabolic baseline-to-end-point changes were not significant with aripiprazole or in the untreated comparison group. Conclusions First-time second-generation antipsychotic medication use was associated with significant weight gain with each medication. Metabolic changes varied among the 4 antipsychotic medications. JAMA. 2009;302(16):1765-1773 www.jama.com	[Correll, Christoph U.; Manu, Peter; Olshanskiy, Vladimir; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA; [Correll, Christoph U.; Manu, Peter; Kane, John M.; Malhotra, Anil K.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Correll, Christoph U.; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.] Feinstein Inst Med Res, Manhasset, NY USA; [Napolitano, Barbara] N Shore Univ Hosp, Manhasset, NY USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Northwell Health; North Shore University Hospital	Correll, CU (corresponding author), Zucker Hillside Hosp, 75-59 263rd St, Glen Oaks, NY 11004 USA.	ccorrell@lij.edu	Correll, Christoph U/AAY-3179-2021; Correll, Christoph/D-3530-2011	Correll, Christoph/0000-0002-7254-5646	National Institutes of Health [MH01760]; National Alliance for Research in Schizophrenia and Depression Independent Investigator [074543-01]; National Center for Research Resources [M01 RR018535]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH074543, K23MH001760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research in Schizophrenia and Depression Independent Investigator(NARSAD); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported in parts by grant MH01760 to Dr Malhotra from the National Institutes of Health, a National Alliance for Research in Schizophrenia and Depression Independent Investigator Award to Dr Malhotra, grant MH 074543-01 to Dr Kane for the Zucker Hillside Hospital National Institute of Mental Health Advanced Center for Intervention and Services Research for the Study of Schizophrenia, and by funding from the Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System General Clinical Research Center, and grant M01 RR018535 from the National Center for Research Resources, which is a component of the National Institutes of Health.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Calarge CA, 2009, J CHILD ADOL PSYCHOP, V19, P101, DOI 10.1089/cap.2008.007; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2008, J CLIN PSYCHIAT, V69, P26; Daumit GL, 2008, SCHIZOPHR RES, V105, P175, DOI 10.1016/j.schres.2008.07.006; De Michele M, 2002, STROKE, V33, P2923, DOI 10.1161/01.STR.0000038989.90931.BE; Fleischhacker WW, 2008, J CLIN PSYCHIAT, V69, P514, DOI 10.4088/JCP.v69n0401; Fraguas D, 2008, J CLIN PSYCHIAT, V69, P1166, DOI 10.4088/JCP.v69n0717; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; Hoffman RP, 2008, PEDIATR DIABETES, V9, P57, DOI 10.1111/j.1399-5448.2007.00350.x; Juonala M, 2006, ATHEROSCLEROSIS, V185, P388, DOI 10.1016/j.atherosclerosis.2005.06.016; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Kryzhanovskaya LA, 2009, J CLIN PSYCHIAT, V70, P247, DOI 10.4088/JCP.08m03538; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Lloyd-Jones DM, 2007, CIRCULATION, V115, P1004, DOI 10.1161/CIRCULATIONAHA.106.648642; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Meyer JM, 2008, SCHIZOPHR RES, V103, P104, DOI 10.1016/j.schres.2008.04.023; Morrato EH, 2008, J CLIN PSYCHIAT, V69, P316, DOI 10.4088/JCP.v69n0219; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P679, DOI 10.1001/archpsyc.63.6.679; Perez-Iglesias R, 2007, J CLIN PSYCHIAT, V68, P1733, DOI 10.4088/JCP.v68n1113; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Robinson DG, 2006, AM J PSYCHIAT, V163, P2096, DOI 10.1176/ajp.2006.163.12.2096; Safer DJ, 2004, J CLIN PSYCHOPHARM, V24, P429, DOI 10.1097/01.jcp.0000130558.86125.5b; Schimmelmann BG, 2007, J CHILD ADOL PSYCHOP, V17, P768, DOI 10.1089/cap.2007.0048; Sikich L, 2004, NEUROPSYCHOPHARMACOL, V29, P133, DOI 10.1038/sj.npp.1300327; Sikich L, 2008, AM J PSYCHIAT, V165, P1420, DOI 10.1176/appi.ajp.2008.08050756; Simon V, 2009, J CLIN PSYCHIAT, V70, P1041, DOI 10.4088/JCP.08r04392; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Straker D, 2005, AM J PSYCHIAT, V162, P1217, DOI 10.1176/appi.ajp.162.6.1217; Verma S, 2009, AUST NZ J PSYCHIAT, V43, P812, DOI 10.1080/00048670903107609; Winkleby MA, 1999, JAMA-J AM MED ASSOC, V281, P1006, DOI 10.1001/jama.281.11.1006	39	701	710	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1765	1773		10.1001/jama.2009.1549	http://dx.doi.org/10.1001/jama.2009.1549			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861668	Green Accepted, Bronze			2022-12-28	WOS:000271150300019
J	Estrada-Oyuela, R				Estrada-Oyuela, Raul			Copenhagen needs a strong lead negotiator	NATURE			English	Editorial Material												eoy@estrada-oyuela.com.ar							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1056	1057		10.1038/4611056a	http://dx.doi.org/10.1038/4611056a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847245				2022-12-28	WOS:000270987600020
J	Noris, M; Remuzzi, G				Noris, Marina; Remuzzi, Giuseppe			MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMPLEMENT-FACTOR-H; MEMBRANE COFACTOR PROTEIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; LIVER-KIDNEY TRANSPLANTATION; SUCCESSFUL PLASMA THERAPY; FACTOR-I; RENAL-TRANSPLANTATION; REGULATORY PROTEINS; ENDOTHELIAL-CELLS; SELF-ASSOCIATION		[Noris, Marina; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Div Nephrol & Dialysis, I-24100 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Via Gavazzeni 11, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	NORIS, MARINA/ABG-2219-2020; Remuzzi, Giuseppe/V-9766-2017	NORIS, MARINA/0000-0001-7651-5033; Remuzzi, Giuseppe/0000-0002-6194-3446	Fondazione ART La Ricerca Sui Trapianti; Fondazione Aiuto Ricerca Malattie Rare; Istituto Superiore di Sanita; Telethon Foundation	Fondazione ART La Ricerca Sui Trapianti; Fondazione Aiuto Ricerca Malattie Rare; Istituto Superiore di Sanita; Telethon Foundation(Fondazione Telethon)	Supported in part by grants from Fondazione ART La Ricerca Sui Trapianti, Fondazione Aiuto Ricerca Malattie Rare, Istituto Superiore di Sanita, and the Telethon Foundation.	Ariceta G, 2009, PEDIATR NEPHROL, V24, P687, DOI 10.1007/s00467-008-0964-1; BARRE P, 1977, ARCH PATHOL LAB MED, V101, P357; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Benz K, 2009, THROMB HAEMOSTASIS, V101, P265, DOI 10.1160/TH07-12-0761; Besbas N, 2006, KIDNEY INT, V70, P423, DOI 10.1038/sj.ki.5001581; Bresin E, 2006, CLIN J AM SOC NEPHRO, V1, P88, DOI 10.2215/CJN.00050505; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; CAMPBELL S, 1965, ARCH DIS CHILD, V40, P654, DOI 10.1136/adc.40.214.654; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; CARRERAS L, 1981, JAMA-J AM MED ASSOC, V245, P602, DOI 10.1001/jama.245.6.602; Chan MR, 2009, AM J KIDNEY DIS, V53, P321, DOI 10.1053/j.ajkd.2008.06.027; Cho HY, 2007, PEDIATR NEPHROL, V22, P874, DOI 10.1007/s00467-007-0438-x; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; Davin JC, 2008, PEDIATR NEPHROL, V23, P1517, DOI 10.1007/s00467-008-0833-y; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P10749; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Devaux P, 1999, EUR J IMMUNOL, V29, P815; Donne RL, 2002, AM J KIDNEY DIS, V40, DOI 10.1053/ajkd.2002.36938; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Dragon-Durey MA, 2005, SPRINGER SEMIN IMMUN, V27, P359, DOI 10.1007/s00281-005-0003-2; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Esparza-Gordillo J, 2006, MOL IMMUNOL, V43, P1769, DOI 10.1016/j.molimm.2005.11.008; Fakhouri F, 2008, BLOOD, V112, P4542, DOI 10.1182/blood-2008-03-144691; Fang CJ, 2008, BLOOD, V111, P624, DOI 10.1182/blood-2007-04-084533; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; Fremeaux-Bacchi V, 2007, AM J KIDNEY DIS, V49, P323, DOI 10.1053/j.ajkd.2006.10.022; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017; Gruppo RA, 2009, NEW ENGL J MED, V360, P544, DOI 10.1056/NEJMc0809959; Heinen S, 2007, J AM SOC NEPHROL, V18, P506, DOI 10.1681/ASN.2006091069; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Jalanko H, 2008, AM J TRANSPLANT, V8, P216, DOI 10.1111/j.1600-6143.2007.02029.x; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kaplan BS, 1998, J AM SOC NEPHROL, V9, P1126; KAPLAN BS, 1975, NEW ENGL J MED, V292, P1090, DOI 10.1056/NEJM197505222922102; Karthikeyan V, 2003, AM J TRANSPLANT, V3, P1289, DOI 10.1046/j.1600-6143.2003.00222.x; Kavanagh D, 2005, J AM SOC NEPHROL, V16, P2150, DOI 10.1681/ASN.2005010103; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; KIM Y, 1977, J LAB CLIN MED, V89, P845; Koziolek MJ, 2008, KIDNEY INT, V74, P384, DOI 10.1038/ki.2008.133; Kwon T, 2008, NEPHROL DIAL TRANSPL, V23, P2088, DOI 10.1093/ndt/gfn063; Landau D, 2001, J PEDIATR-US, V138, P412, DOI 10.1067/mpd.2001.112649; Lapeyraque AL, 2008, PEDIATR NEPHROL, V23, P1363, DOI 10.1007/s00467-008-0803-4; Le Quintrec M, 2008, AM J TRANSPLANT, V8, P1694, DOI 10.1111/j.1600-6143.2008.02297.x; Licht C, 2005, AM J KIDNEY DIS, V45, P415, DOI 10.1053/j.ajkd.2004.10.018; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; LOIRAT C, 1988, PEDIATR NEPHROL, V2, P279, DOI 10.1007/BF00858677; Loirat C, 2008, PEDIATR NEPHROL, V23, P1957, DOI 10.1007/s00467-008-0872-4; Loirat C, 2008, PEDIATR TRANSPLANT, V12, P619, DOI 10.1111/j.1399-3046.2008.00910.x; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Martinez-Barricarte R, 2008, J AM SOC NEPHROL, V19, P639, DOI 10.1681/ASN.2007080923; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; NAKANISHI I, 1994, EUR J IMMUNOL, V24, P1529, DOI 10.1002/eji.1830240711; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Nathanson S, 2001, PEDIATR NEPHROL, V16, P554, DOI 10.1007/s004670100609; Nathanson S, 2006, PEDIATR NEPHROL, V21, P1769, DOI 10.1007/s00467-006-0237-9; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Noris M, 2009, NAT REV NEPHROL, V5, P186, DOI 10.1038/nrneph.2009.28; Nurnberger J, 2009, NEW ENGL J MED, V360, P542, DOI 10.1056/NEJMc0808527; NURNBERGER J, 2009, NEW ENGL J MED, V360, P2487; Olie KH, 2005, AM J KIDNEY DIS, V45, pE12, DOI 10.1053/j.ajkd.2004.09.012; Olie KH, 2004, PEDIATR NEPHROL, V19, P1173, DOI 10.1007/s00467-004-1565-2; Pangburn MK, 2009, J IMMUNOL, V182, P1061, DOI 10.4049/jimmunol.182.2.1061; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Remuzzi G, 2005, AM J TRANSPLANT, V5, P1146, DOI 10.1111/j.1600-6143.2005.00783.x; Remuzzi G, 2002, LANCET, V359, P1671, DOI 10.1016/S0140-6736(02)08560-4; REMUZZI G, 1978, LANCET, V2, P871; REMUZZI G, 1979, CLIN NEPHROL, V12, P279; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; RIZZONI G, 1988, J PEDIATR-US, V112, P284, DOI 10.1016/S0022-3476(88)80071-4; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Ruggenenti P, 2002, KIDNEY INT, V62, P1093, DOI 10.1046/j.1523-1755.2002.00543.x; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Ruggenenti P, 2008, THERAPY NEPHROLOGY H, P294; Saland JM, 2006, AM J TRANSPLANT, V6, P1948, DOI 10.1111/j.1600-6143.2006.01375.x; Saland JM, 2009, J AM SOC NEPHROL, V20, P940, DOI 10.1681/ASN.2008080906; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; SEIFERT PS, 1989, ARTERIOSCLEROSIS, V9, P802, DOI 10.1161/01.ATV.9.6.802; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2392, DOI 10.1681/ASN.2006080811; Skerka C, 2009, THROMB HAEMOSTASIS, V101, P227, DOI 10.1160/TH08-05-0322; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; STUHLINGER W, 1974, LANCET, V2, P788; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Venables JP, 2006, PLOS MED, V3, P1957, DOI 10.1371/journal.pmed.0030431; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Zakarija A, 2005, SEMIN THROMB HEMOST, V31, P681, DOI 10.1055/s-2005-925474; Zarifian A, 1999, KIDNEY INT, V55, P2457, DOI 10.1046/j.1523-1755.1999.00492.x; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	102	836	923	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1676	1687		10.1056/NEJMra0902814	http://dx.doi.org/10.1056/NEJMra0902814			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846853				2022-12-28	WOS:000270977400010
J	Weisz, C; Glowatzki, E; Fuchs, P				Weisz, Catherine; Glowatzki, Elisabeth; Fuchs, Paul			The postsynaptic function of type II cochlear afferents	NATURE			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; SPIRAL GANGLION NEURONS; RIBBON SYNAPSE; RAT COCHLEA; HORSERADISH-PEROXIDASE; TRANSMITTER RELEASE; RECEPTOR SUBUNITS; INNERVATION; FIBERS	The mammalian cochlea is innervated by two classes of sensory neurons. Type I neurons make up 90-95% of the cochlear nerve and contact single inner hair cells to provide acoustic analysis as we know it. In contrast, the far less numerous type II neurons arborize extensively among outer hair cells (OHCs)(1,2) and supporting cells(3,4). Their scarcity and smaller calibre axons have made them the subject of much speculation, but little experimental progress for the past 50 years. Here we record from type II fibres near their terminal arbors under OHCs to show that they receive excitatory glutamatergic synaptic input. The type II peripheral arbor conducts action potentials, but the small and infrequent glutamatergic excitation indicates a requirement for strong acoustic stimulation. Furthermore, we show that type II neurons are excited by ATP. Exogenous ATP depolarized type II neurons, both directly and by evoking glutamatergic synaptic input(5). These results prove that type II neurons function as cochlear afferents, and can be modulated by ATP. The lesser magnitude of synaptic drive dictates a fundamentally different role in auditory signalling from that of type I afferents.	[Weisz, Catherine; Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fuchs, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pfuchs1@jhmi.edu		Glowatzki, Elisabeth/0000-0003-3135-658X; Weisz, Catherine/0000-0002-2595-835X	NIDCD [R01 DC000276, R01 DC006476, T32 DC000023]; Blaustein Pain Foundation of Johns Hopkins; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023, R01DC006476, P30DC005211, R01DC000276] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Blaustein Pain Foundation of Johns Hopkins; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIDCD grants R01 DC000276 and R01 DC006476, T32 DC000023 and a grant from the Blaustein Pain Foundation of Johns Hopkins.	BERGLUND AM, 1987, J COMP NEUROL, V255, P560, DOI 10.1002/cne.902550408; BERGLUND AM, 1994, HEARING RES, V75, P121, DOI 10.1016/0378-5955(94)90063-9; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; BROWN MC, 1987, J COMP NEUROL, V260, P591, DOI 10.1002/cne.902600411; BROWN MC, 1988, J COMP NEUROL, V278, P591, DOI 10.1002/cne.902780410; Burgess BJ, 1997, HEARING RES, V108, P74, DOI 10.1016/S0378-5955(97)00040-3; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; DUNN RA, 1975, P NATL ACAD SCI USA, V72, P3599, DOI 10.1073/pnas.72.9.3599; Fechner FP, 2001, J COMP NEUROL, V429, P289, DOI 10.1002/1096-9861(20000108)429:2<289::AID-CNE9>3.0.CO;2-Z; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; HASHIMOTO S, 1988, ACTA OTO-LARYNGOL, V105, P64, DOI 10.3109/00016488809119447; Huang LC, 2005, J COMP NEUROL, V484, P133, DOI 10.1002/cne.20442; Jagger DJ, 2003, J PHYSIOL-LONDON, V552, P525, DOI 10.1111/j.1469-7793.2003.00525.x; Jarlebark LE, 2000, J COMP NEUROL, V421, P289, DOI 10.1002/(SICI)1096-9861(20000605)421:3<289::AID-CNE1>3.0.CO;2-0; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Lorente de No R, 1937, LARYNGOSCOPE, V47, P373; Matsubara A, 1996, J NEUROSCI, V16, P4457; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; NAKAGAWA T, 1990, J NEUROPHYSIOL, V63, P1068, DOI 10.1152/jn.1990.63.5.1068; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; PERKINS RE, 1975, J COMP NEUROL, V163, P129, DOI 10.1002/cne.901630202; Reid MA, 2004, J NEUROSCI, V24, P733, DOI 10.1523/JNEUROSCI.3923-03.2004; ROBERTSON D, 1984, HEARING RES, V15, P113, DOI 10.1016/0378-5955(84)90042-X; SIMMONS DD, 1988, J COMP NEUROL, V270, P145, DOI 10.1002/cne.902700112; Thiers FA, 2008, JARO-J ASSOC RES OTO, V9, P477, DOI 10.1007/s10162-008-0135-x; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Wang JCC, 2003, NEUROREPORT, V14, P817, DOI 10.1097/00001756-200305060-00008	30	108	109	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1126	U226		10.1038/nature08487	http://dx.doi.org/10.1038/nature08487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847265	Green Accepted			2022-12-28	WOS:000270987600045
J	Richards, JB; Kavvoura, FK; Rivadeneira, F; Styrkarsdottir, U; Estrada, K; Halldorsson, BV; Hsu, YH; Zillikens, MC; Wilson, SG; Mullin, BH; Amin, N; Aulchenko, YS; Cupples, LA; Deloukas, P; Demissie, S; Hofman, A; Kong, A; Karasik, D; van Meurs, JB; Oostra, BA; Pols, HAP; Sigurdsson, G; Thorsteinsdottir, U; Soranzo, N; Williams, FMK; Zhou, YH; Ralston, SH; Thorleifsson, G; van Duijn, CM; Kiel, DP; Stefansson, K; Uitterlinden, AG; Ioannidis, JPA; Spector, TD				Richards, J. Brent; Kavvoura, Fotini K.; Rivadeneira, Fernando; Styrkarsdottir, Unnur; Estrada, Karol; Halldorsson, Bjarni V.; Hsu, Yi-Hsiang; Zillikens, M. Carola; Wilson, Scott G.; Mullin, Benjamin H.; Amin, Najaf; Aulchenko, Yurii S.; Cupples, L. Adrienne; Deloukas, Panagiotis; Demissie, Serkalem; Hofman, Albert; Kong, Augustine; Karasik, David; van Meurs, Joyce B.; Oostra, Ben A.; Pols, Huibert A. P.; Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Soranzo, Nicole; Williams, Frances M. K.; Zhou, Yanhua; Ralston, Stuart H.; Thorleifsson, Gudmar; van Duijn, Cornelia M.; Kiel, Douglas P.; Stefansson, Kari; Uitterlinden, Andre G.; Ioannidis, John P. A.; Spector, Tim D.		GEFOS Consortium	Collaborative Meta-analysis: Associations of 150 Candidate Genes With Osteoporosis and Osteoporotic Fracture	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; BONE-MINERAL DENSITY; LARGE-SCALE ANALYSIS; SUSCEPTIBILITY LOCI; POLYMORPHISMS; EPIDEMIOLOGY; POPULATION; IMPUTATION; VARIANTS; HEART	Background: Osteoporosis is a highly heritable trait. Many candidate genes have been proposed as being involved in regulating bone mineral density (BMD). Few of these findings have been replicated in independent studies. Objective: To assess the relationship between BMD and fracture and all common single-nucleotide polymorphisms (SNPs) in previously proposed osteoporosis candidate genes. Design: Large-scale meta-analysis of genome-wide association data. Setting: 5 international, multicenter, population-based studies. Participants: Data on BMD were obtained from 19 195 participants (14 277 women) from 5 populations of European origin. Data on fracture were obtained from a prospective cohort (n = 5974) from the Netherlands. Measurements: Systematic literature review using the Human Genome Epidemiology Navigator identified autosomal genes previously evaluated for association with osteoporosis. We explored the common SNPs arising from the haplotype map of the human genome (HapMap) across all these genes. BMD at the femoral neck and lumbar spine was measured by dual-energy x-ray absorptiometry. Fractures were defined as clinically apparent, site-specific, validated nonvertebral and vertebral low-energy fractures. Results: 150 candidate genes were identified and 36 016 SNPs in these loci were assessed. SNPs from 9 gene loci (ESR1, LRP4, ITGA1, LRP5, SOST, SPP1, TNFRSF11A, TNFRSF11B, and TNFSF11) were associated with BMD at either site. For most genes, no SNP was statistically significant. For statistically significant SNPs (n = 241), effect sizes ranged from 0.04 to 0.18 SD per allele. SNPs from the LRP5, SOST, SPP1, and TNFRSF11A loci were significantly associated with fracture risk; odds ratios ranged from 1.13 to 1.43 per allele. These effects on fracture were partially independent of BMD at SPP1 and SOST. Limitation: Only common polymorphisms in linkage disequilibrium with SNPs in HapMap could be assessed, and previously reported associations for SNPs in some candidate genes could not be excluded. Conclusion: In this large-scale collaborative genome-wide meta-analysis, 9 of 150 candidate genes were associated with regulation of BMD, 4 of which also significantly affected risk for fracture. However, most candidate genes had no consistent association with BMD.	[Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Kings Coll London, London WC2R 2LS, England; McGill Univ, Montreal, PQ, Canada; Erasmus MC, Rotterdam, Netherlands; Netherlands Consortium Healthy Ageing, Leiden, Netherlands; Univ Iceland, deCODE Genet, Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Western Australia, Crawley, Australia; Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; Wellcome Trust Sanger Inst, Cambridge, England; Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Ioannina; University of London; King's College London; McGill University; Erasmus University Rotterdam; Erasmus MC; University of Iceland; Landspitali National University Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Tufts University; University of Western Australia; University of Western Australia; Wellcome Trust Sanger Institute; University of Edinburgh	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, POB 1186, GR-45110 Ioannina, Greece.	a.g.uitterlinden@erasmusmc.nl; jioannid@cc.uoi.gr	Rivadeneira, Fernando/O-5385-2015; Richards, J Brent/AAF-4225-2019; Aulchenko, Yurii/M-8270-2013; Spector, Tim D/F-6533-2012; Mullin, Benjamin/H-5493-2014; Stefansson, Kari/AAE-7187-2019; Deloukas, Panos/B-2922-2013; Ioannidis, John P. A./G-9836-2011	Rivadeneira, Fernando/0000-0001-9435-9441; Richards, J Brent/0000-0002-3746-9086; Aulchenko, Yurii/0000-0002-7899-1575; Deloukas, Panos/0000-0001-9251-070X; Williams, Frances/0000-0002-2998-2744; Cupples, L. Adrienne/0000-0003-0273-7965; Halldorsson, Bjarni/0000-0003-0756-0767; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771; Styrkarsdottir, Unnur/0000-0001-8146-8278; Demissie, Serkalem/0000-0002-8009-0987; van Meurs, Joyce/0000-0001-6245-2123; Kong, Augustine/0000-0001-8193-5438; Soranzo, Nicole/0000-0003-1095-3852; Kiel, Douglas/0000-0001-8474-0310; Karasik, David/0000-0002-8826-0530; Wilson, Scott/0000-0002-0357-1373; Mullin, Benjamin/0000-0003-0743-770X	European Union [FP7-Health-F2-2008201865-GEFOS, HEALTH-LRP4-2008-201865]; Wellcome Trust; National Institutes of Health; Canadian Institutes of Health Research; deCODE Genetics; Netherlands Organisation for Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI); European Commission Framework [FP7/2007-2013)]; ENGAGE [HEALTH-F4-2007-201413]; FP5 GenomEUtwin [QLG2-CT-2002-01254]; Arthritis Research Campaign; Chronic Disease Research Foundation; National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging [R01 AR/AG 41398, R01 AR 050066]; National Heart, Lung, and Blood Institute [N01-HC-25195]; Affymetrix [N02-HL-6-4278]; Research Institute for Diseases in the Elderly [014-93-015]; NGI/NWO [050-060-810]; NGI/Netherlands Consortium on Healthy Ageing; Erasmus Medical Center and Erasmus University; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Municipality of Rotterdam; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050066, R01AR041398] Funding Source: NIH RePORTER	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); deCODE Genetics; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI); European Commission Framework(European Commission); ENGAGE; FP5 GenomEUtwin; Arthritis Research Campaign(Versus Arthritis); Chronic Disease Research Foundation; National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix; Research Institute for Diseases in the Elderly; NGI/NWO(Netherlands Organization for Scientific Research (NWO)); NGI/Netherlands Consortium on Healthy Ageing; Erasmus Medical Center and Erasmus University; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Municipality of Rotterdam; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Grant Support: By the European Union (grant FP7-Health-F2-2008201865-GEFOS), and in part by the European Union FP5 (grant HEALTH-LRP4-2008-201865), the Wellcome Trust, the National Institutes of Health, the Canadian Institutes of Health Research, deCODE Genetics, Netherlands Organisation for Scientific Research (NWO), Research Institute for Diseases in the Elderly, and Netherlands Genomics Initiative (NGI). For more details of the GEFOS Consortium, see www.gefos.org. The TwinsUK study was funded by the Wellcome Trust, European Commission Framework (FP7/2007-2013), ENGAGE project HEALTH-F4-2007-201413, and the FP5 GenomEUtwin Project (QLG2-CT-2002-01254). It also receives support from the Arthritis Research Campaign, Chronic Disease Research Foundation, the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, and a Biotechnology and Biological Sciences Research Council project grant (G20234). Dr. Spector is an NIHR senior investigator. The Framingham Osteoporosis Study was funded by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute on Aging (R01 AR/AG 41398 [Dr. Kiel] and R01 AR 050066 [Dr. Karasik]). The Framingham Heart Study was supported by the National Heart, Lung, and Blood Institute (contract N01-HC-25195) and by Affymetrix (contracted for genotyping services; contract N02-HL-6-4278). Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource project. A portion of this research was conducted by using the Linux Cluster for Genetic Analysis, funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The generation and management of GWAS genotype data for the Rotterdam Study are supported by the NWO Investments (175.010.2005.011, 911-03-012). The Rotterdam Study is funded by the Research Institute for Diseases in the Elderly (014-93-015); NGI/NWO (project 050-060-810); NGI/Netherlands Consortium on Healthy Ageing; Erasmus Medical Center and Erasmus University; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.	Albagha OME, 2006, RHEUM DIS CLIN N AM, V32, P659, DOI 10.1016/j.rdc.2006.08.001; Andrew T, 2005, J BONE MINER RES, V20, P67, DOI 10.1359/JBMR.041015; Arden NK, 1996, J BONE MINER RES, V11, P530; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Calnan M, 2006, J CLIN EPIDEMIOL, V59, P1312, DOI 10.1016/j.jclinepi.2006.05.002; Cheung CL, 2009, HUM MOL GENET, V18, P679, DOI 10.1093/hmg/ddn397; Cummings SR, 2008, J BONE MINER RES, V23, pS80; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; *DIAB GEN IN, 2008, NAT GENET, V40, P575; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fang Y, 2003, J BONE MINER RES, V18, P1632, DOI 10.1359/jbmr.2003.18.9.1632; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2009, ANN INTERN MED, V150, P139, DOI 10.7326/0003-4819-150-2-200901200-00012; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; Kavvoura FK, 2008, AM J EPIDEMIOL, V168, P855, DOI 10.1093/aje/kwn206; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Langdahl BL, 2008, BONE, V42, P969, DOI 10.1016/j.bone.2007.11.007; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Mori S, 2009, J BONE MINER METAB, V27, P213, DOI 10.1007/s00774-008-0031-9; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; RIVADENEIRA F, NATURE GENE IN PRESS; Rivadeneira F, 2006, J BONE MINER RES, V21, P1443, DOI 10.1359/JBMR.060605; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Wiktorowicz ME, 2001, OSTEOPOROSIS INT, V12, P271, DOI 10.1007/s001980170116; Wiliams FMK, 2007, ACTA REUMATOL PORT, V32, P231; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; YU W, 2008, HUGE NAVIGATOR; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	65	202	215	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					528	U32		10.7326/0003-4819-151-8-200910200-00006	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19841454	Green Accepted			2022-12-28	WOS:000271386200002
J	Sahin, NT; Pinker, S; Cash, SS; Schomer, D; Halgren, E				Sahin, Ned T.; Pinker, Steven; Cash, Sydney S.; Schomer, Donald; Halgren, Eric			Sequential Processing of Lexical, Grammatical, and Phonological Information Within Broca's Area	SCIENCE			English	Article							WORD FORM AREA; BRAIN; LANGUAGE; MODEL; COMPREHENSION; FREQUENCY; REGION; NOUNS; VERBS; FMRI	Words, grammar, and phonology are linguistically distinct, yet their neural substrates are difficult to distinguish in macroscopic brain regions. We investigated whether they can be separated in time and space at the circuit level using intracranial electrophysiology (ICE), namely by recording local field potentials from populations of neurons using electrodes implanted in language-related brain regions while people read words verbatim or grammatically inflected them (present/past or singular/plural). Neighboring probes within Broca's area revealed distinct neuronal activity for lexical (similar to 200 milliseconds), grammatical (similar to 320 milliseconds), and phonological (similar to 450 milliseconds) processing, identically for nouns and verbs, in a region activated in the same patients and task in functional magnetic resonance imaging. This suggests that a linguistic processing sequence predicted on computational grounds is implemented in the brain in fine-grained spatiotemporally patterned activity.	[Sahin, Ned T.; Halgren, Eric] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA; [Sahin, Ned T.; Pinker, Steven] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Schomer, Donald] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of California System; University of California San Diego; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Sahin, NT (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA.	sahin@post.harvard.edu	Pinker, Steven/GPX-7942-2022		NIH [NS18741, NS44623, HD18381, T32-MH070328, NCRR P41-RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; Sackler Scholars Programme in Psychobiology; Harvard Mind/Brain/Behavior Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH070328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044623, R01NS018741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Illness and Neuroscience Discovery (MIND) Institute; Sackler Scholars Programme in Psychobiology; Harvard Mind/Brain/Behavior Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants NS18741 (E. H.), NS44623 (E. H.), HD18381 (S. P.), T32-MH070328 (N. T. S.), NCRR P41-RR14075; and the Mental Illness and Neuroscience Discovery (MIND) Institute (N. T. S.), Sackler Scholars Programme in Psychobiology (N. T. S.), and Harvard Mind/Brain/Behavior Initiative (N. T. S.). We heartily thank the patients. We also thank E. Papavassiliou and J. Wu for access to their patients; S. Narayanan, N. Dehghani, M. T. Wheeler, F. Kampmann, and L. Gruber for assistance with intracranial electrophysiological data; R. Raizada for manuscript suggestions; N. M. Sahin; and two anonymous reviewers whose suggestions and encouragement greatly improved this paper.	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Friederici AD, 1997, CLIN NEUROSCI, V4, P64; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Grodzinsky Y, 2000, BEHAV BRAIN SCI, V23, P1, DOI 10.1017/S0140525X00002399; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Janssen DP, 2002, LANG COGNITIVE PROC, V17, P209, DOI 10.1080/01690960143000182; Joanisse MF, 1999, P NATL ACAD SCI USA, V96, P7592, DOI 10.1073/pnas.96.13.7592; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MACWHINNEY B, 1991, COGNITION, V40, P121, DOI 10.1016/0010-0277(91)90048-9; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pinker Steven, 1994, LANGUAGE INSTINCT; PLUNKETT K, 1991, COGNITION, V38, P43, DOI 10.1016/0010-0277(91)90022-V; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Sahin NT, 2006, CORTEX, V42, P540, DOI 10.1016/S0010-9452(08)70394-0; SAHIN NT, 2007, NEUROIMAGE, V36, pS74; Shapiro K, 2003, TRENDS COGN SCI, V7, P201, DOI 10.1016/S1364-6613(03)00060-3; ZURIF EB, 1972, NEUROPSYCHOLOGIA, V10, P405, DOI 10.1016/0028-3932(72)90003-6	31	275	278	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					445	449		10.1126/science.1174481	http://dx.doi.org/10.1126/science.1174481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZM	19833971	Green Accepted			2022-12-28	WOS:000270818600059
J	Perrin, RJ; Fagan, AM; Holtzman, DM				Perrin, Richard J.; Fagan, Anne M.; Holtzman, David M.			Multimodal techniques for diagnosis and prognosis of Alzheimer's disease	NATURE			English	Review							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID A-BETA(42); AMYLOID-BETA; LIPID-PEROXIDATION; IN-VIVO; CSF BIOMARKERS; TAU PROTEINS; HUMAN BRAIN; PLASMA; PREDICTION	Alzheimer's disease affects millions of people around the world. Currently, there are no treatments that prevent or slow the disease. Like other neurodegenerative diseases, Alzheimer's disease is characterized by protein misfolding in the brain. This process and the associated brain damage begin years before the substantial neurodegeneration that accompanies dementia. Studies using new neuroimaging techniques and fluid biomarkers suggest that Alzheimer's disease pathology can be detected preclinically. These advances should allow the design of new clinical trials and early mechanism-based therapeutic intervention.	[Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Perrin, Richard J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Perrin, Richard J.; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Perrin, Richard J.; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	Longo, Kenneth A/A-5631-2010		US National Institutes of Health [P01-AG026276, PO1-AG03991, P50AG00568125, T32NS007205]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P01AG026276, P50AG005681] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Cirrito and MedPIC, the art and design centre at Washington University School of Medicine, for assistance with graphic design. Work in the authors' laboratories was supported by US National Institutes of Health grants P01-AG026276, PO1-AG03991, P50AG00568125 and T32NS007205.	Abe T, 2002, J NEUROSCI RES, V70, P447, DOI 10.1002/jnr.10349; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ALZHEIMER A, 1987, ALZHEIMERS DISEASE A, V1, P7; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; CAIRNS NJ, ARCH NEUROL IN PRESS; Carlson NE, 2008, NEUROLOGY, V70, P828, DOI 10.1212/01.wnl.0000280577.43413.d9; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; de Leon MJ, 2007, J NEUROL, V254, P1666, DOI 10.1007/s00415-007-0610-z; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Hirvonen J, 2009, CLIN PHARMACOL THER, V85, P506, DOI 10.1038/clpt.2008.241; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Loeffler DA, 1997, NEUROBIOL AGING, V18, P555, DOI 10.1016/S0197-4580(97)00110-3; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 1999, AM J PATHOL, V155, P863, DOI 10.1016/S0002-9440(10)65185-1; Montine TJ, 2000, ANN NEUROL, V48, P950, DOI 10.1002/1531-8249(200012)48:6<950::AID-ANA23>3.0.CO;2-F; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; MORRIS JC, ARCH NEUROL IN PRESS; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; NAKAMURA S, 1990, ACTA NEUROPATHOL, V80, P419, DOI 10.1007/BF00307697; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Portelius E, 2008, J PROTEOME RES, V7, P2114, DOI 10.1021/pr7008669; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; SMYTH MD, 1994, NEUROBIOL AGING, V15, P609, DOI 10.1016/0197-4580(94)00055-7; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thal DR, 1997, BRAIN RES, V777, P223, DOI 10.1016/S0006-8993(97)01021-4; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Vas A, 2008, J NEUROL SCI, V264, P9, DOI 10.1016/j.jns.2007.07.018; WELSHBOHMER KA, 2006, HDB DEMENTING ILLNES, P59; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919	79	475	515	5	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					916	922		10.1038/nature08538	http://dx.doi.org/10.1038/nature08538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829371	Green Accepted			2022-12-28	WOS:000270817700036
J	Costello, EK; Lauber, CL; Hamady, M; Fierer, N; Gordon, JI; Knight, R				Costello, Elizabeth K.; Lauber, Christian L.; Hamady, Micah; Fierer, Noah; Gordon, Jeffrey I.; Knight, Rob			Bacterial Community Variation in Human Body Habitats Across Space and Time	SCIENCE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; FLORA	Elucidating the biogeography of bacterial communities on the human body is critical for establishing healthy baselines from which to detect differences associated with diseases. To obtain an integrated view of the spatial and temporal distribution of the human microbiota, we surveyed bacteria from up to 27 sites in seven to nine healthy adults on four occasions. We found that community composition was determined primarily by body habitat. Within habitats, interpersonal variability was high, whereas individuals exhibited minimal temporal variability. Several skin locations harbored more diverse communities than the gut and mouth, and skin locations differed in their community assembly patterns. These results indicate that our microbiota, although personalized, varies systematically across body habitats and time; such trends may ultimately reveal how microbiome changes cause or prevent disease.	[Costello, Elizabeth K.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Hamady, Micah] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Knight, Rob] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Howard Hughes Medical Institute	Knight, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Knight, Rob/D-1299-2010	FIERER, NOAH/0000-0002-6432-4261; Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute; NIH [DK78669, DK64540]; Bill and Melinda Gates Foundation; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, P50DK064540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the volunteers for their participation; J. Manchester for pyrosequencing; D. McDonald and J. Kuczynski for bioinformatics support; K. Ramirez and R. Gesumaria for sample collection and processing; L. Kyro for graphical design; and M. Blaser, P. Hugenholtz, G. Huttley, N. Pace, and members of the Knight laboratory for valuable feedback. This work was supported in part by the Howard Hughes Medical Institute, and by grants from the NIH (DK78669, DK64540), the Bill and Melinda Gates Foundation, and the Crohns and Colitis Foundation of America. Sequences were deposited in the European Read Archive (accession number ERA000159).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wilson M., 2008, BACTERIOLOGY HUMANS	17	2017	2111	27	794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1694	1697		10.1126/science.1177486	http://dx.doi.org/10.1126/science.1177486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19892944	Green Accepted			2022-12-28	WOS:000272839000053
J	Berg, AO; Baird, MA; Botkin, JR; Driscoll, DA; Fishman, PA; Guarino, PD; Hiatt, RA; Jarvik, GP; Millon-Underwood, S; Morgan, TM; Mulvihill, JJ; Pollin, TI; Schimmel, SR; Stefanek, ME; Vollmer, WM; Williams, JK				Berg, Alfred O.; Baird, Macaran A.; Botkin, Jeffrey R.; Driscoll, Deborah A.; Fishman, Paul A.; Guarino, Peter D.; Hiatt, Robert A.; Jarvik, Gail P.; Millon-Underwood, Sandra; Morgan, Thomas M.; Mulvihill, John J.; Pollin, Toni I.; Schimmel, Selma R.; Stefanek, Michael Edward; Vollmer, William M.; Williams, Janet K.			National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health	ANNALS OF INTERNAL MEDICINE			English	Article									[Berg, Alfred O.] Univ Washington, Seattle, WA 98195 USA; Grp Hlth Res Inst, Seattle, WA 98101 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; Kaiser Permanente, Portland, OR 97227 USA; Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94107 USA; Univ Utah, Salt Lake City, UT 84113 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Vanderbilt Univ, Nashville, TN 37232 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Iowa, Iowa City, IA 52252 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Amer Canc Soc, Atlanta, GA 30303 USA; Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; Coll Nursing, Milwaukee, WI 53211 USA; Vital Opt Int, Studio City, CA 91604 USA	University of Washington; University of Washington Seattle; University of Oklahoma System; University of Oklahoma Health Sciences Center; Kaiser Permanente; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; University of Pennsylvania; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; American Cancer Society; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Berg, AO (corresponding author), Univ Washington, 4225 Roosevelt Way NE,Box 354696, Seattle, WA 98195 USA.		Jarvik, Gail P/N-6476-2014; Hiatt, Robert/AAQ-1537-2021; Morgan, Tom/C-3478-2012	Jarvik, Gail P/0000-0002-6710-8708; Williams, Janet Karen/0000-0001-8218-3338	University of Connecticut/Hartford Hospital Evidence-based Practice Center [290-2007-10067-I]; Agency for Healthcare Research and Quality [290-2007-10067-I]	University of Connecticut/Hartford Hospital Evidence-based Practice Center; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	University of Connecticut/Hartford Hospital Evidence-based Practice Center (contract 290-2007-10067-I) with the Agency for Healthcare Research and Quality		0	128	128	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					872	U10		10.7326/0000605-200912150-00165	http://dx.doi.org/10.7326/0000605-200912150-00165			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	19884615				2022-12-28	WOS:000272728900005
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			The American Public and the Next Phase of the Health Care Reform Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							BLENDON RJ, 1995, HEALTH AFFAIR, V14, P7, DOI 10.1377/hlthaff.14.2.7; Blendon RJ, 2008, HEALTH AFFAIR, V27, pW556, DOI 10.1377/hlthaff.27.6.w556	2	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21								10.1056/NEJMp0906394	http://dx.doi.org/10.1056/NEJMp0906394			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521DA	19890106				2022-12-28	WOS:000271898600006
J	Glocker, EO; Kotlarz, D; Boztug, K; Gertz, EM; Schaffer, AA; Noyan, F; Perro, M; Diestelhorst, J; Allroth, A; Murugan, D; Hatscher, N; Pfeifer, D; Sykora, KW; Sauer, M; Kreipe, H; Lacher, M; Nustede, R; Woellner, C; Baumann, U; Salzer, U; Koletzko, S; Shah, N; Segal, AW; Sauerbrey, A; Buderus, S; Snapper, SB; Grimbacher, B; Klein, C				Glocker, Erik-Oliver; Kotlarz, Daniel; Boztug, Kaan; Gertz, E. Michael; Schaeffer, Alejandro A.; Noyan, Fatih; Perro, Mario; Diestelhorst, Jana; Allroth, Anna; Murugan, Dhaarini; Haetscher, Nadine; Pfeifer, Dietmar; Sykora, Karl-Walter; Sauer, Martin; Kreipe, Hans; Lacher, Martin; Nustede, Rainer; Woellner, Cristina; Baumann, Ulrich; Salzer, Ulrich; Koletzko, Sibylle; Shah, Neil; Segal, Anthony W.; Sauerbrey, Axel; Buderus, Stephan; Snapper, Scott B.; Grimbacher, Bodo; Klein, Christoph			Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL RECESSIVE ENTEROCOLITIS; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; INTESTINAL INFLAMMATION; CYTOKINE PRODUCTION; ULCERATIVE-COLITIS; SEQUENCE VARIANTS; CRYSTAL-STRUCTURE; LOCI CONTRIBUTE; IL-10	BACKGROUND The molecular cause of inflammatory bowel disease is largely unknown. METHODS We performed genetic-linkage analysis and candidate-gene sequencing on samples from two unrelated consanguineous families with children who were affected by early-onset inflammatory bowel disease. We screened six additional patients with early-onset colitis for mutations in two candidate genes and carried out functional assays in patients' peripheral-blood mononuclear cells. We performed an allogeneic hematopoietic stem-cell transplantation in one patient. RESULTS In four of nine patients with early-onset colitis, we identified three distinct homozygous mutations in genes IL10RA and IL10RB, encoding the IL10R1 and IL10R2 proteins, respectively, which form a heterotetramer to make up the interleukin-10 receptor. The mutations abrogate interleukin-10-induced signaling, as shown by deficient STAT3 (signal transducer and activator of transcription 3) phosphorylation on stimulation with interleukin-10. Consistent with this observation was the increased secretion of tumor necrosis factor alpha and other proinflammatory cytokines from peripheral-blood mononuclear cells from patients who were deficient in IL10R subunit proteins, suggesting that interleukin-10-dependent "negative feedback" regulation is disrupted in these cells. The allogeneic stem-cell transplantation performed in one patient was successful. CONCLUSIONS Mutations in genes encoding the IL10R subunit proteins were found in patients with early-onset enterocolitis, involving hyperinflammatory immune responses in the intestine. Allogeneic stem-cell transplantation resulted in disease remission in one patient.	[Kotlarz, Daniel; Boztug, Kaan; Noyan, Fatih; Diestelhorst, Jana; Allroth, Anna; Murugan, Dhaarini; Haetscher, Nadine; Sykora, Karl-Walter; Sauer, Martin; Klein, Christoph] Hannover Med Sch, Dept Pediat Hematol Oncol, D-30625 Hannover, Germany; [Kreipe, Hans] Hannover Med Sch, Dept Pathol, D-30625 Hannover, Germany; [Nustede, Rainer] Hannover Med Sch, Dept Pediat Surg, D-30625 Hannover, Germany; [Baumann, Ulrich] Hannover Med Sch, Dept Pediat Pulmonol, D-30625 Hannover, Germany; [Glocker, Erik-Oliver; Perro, Mario; Woellner, Cristina; Grimbacher, Bodo] Royal Free Hosp, Dept Immunol, London NW3 2QG, England; [Segal, Anthony W.] UCL, Dept Med, London, England; [Shah, Neil] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London, England; [Gertz, E. Michael; Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Pfeifer, Dietmar] Univ Freiburg, Med Ctr, Dept Hematol Oncol, Core Facil Genom 2, D-7800 Freiburg, Germany; [Salzer, Ulrich] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Lacher, Martin; Koletzko, Sibylle] Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany; [Sauerbrey, Axel] HELIOS Hosp Erfurt, Dept Pediat, Erfurt, Germany; [Buderus, Stephan] St Marien Hosp Bonn, Dept Pediat, Bonn, Germany; [Snapper, Scott B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Snapper, Scott B.] Harvard Univ, Sch Med, Boston, MA USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; University of Freiburg; University of Freiburg; University of Munich; St. Marien Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	b.grimbacher@ucl.ac.uk; klein.christoph@mh-hannover.de	Schaffer, Alejandro/N-1222-2019; Boztug, Kaan/AAM-4161-2021; Saborowski, Anna/GQH-4609-2022; Kotlarz, Daniel/HGA-2077-2022; Perro, Mario/AAB-5554-2021; Schaffer, Alejandro A/F-2902-2012; Buderus, Stephan/AAQ-6518-2021; Noyan, Fatih/B-9449-2018	Boztug, Kaan/0000-0001-8387-9185; Saborowski, Anna/0000-0003-4857-4276; Kotlarz, Daniel/0000-0002-4576-6769; Perro, Mario/0000-0003-1375-8155; Buderus, Stephan/0000-0002-3662-0549; Gertz, E. Michael/0000-0001-8390-4387; Segal, Anthony/0000-0001-7602-9043; Salzer, Ulrich/0000-0002-1769-1157; Murugan, Dhaarini/0000-0001-8505-5868	European Commission Marie Curie Excellence program [MEXT-CT-2006-042316]; Deutsche Forschungsgemeinschaft [SFB621]; German Federal Ministry of Education and Research (PID-NET); Intramural Research Program of the National Institutes of Health; Deutsche Jose Carreras Leukmie-Stiftung; Else-Krner-Fresenius-Stiftung; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050950, R01AI050950] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	European Commission Marie Curie Excellence program(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (PID-NET)(Federal Ministry of Education & Research (BMBF)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Jose Carreras Leukmie-Stiftung; Else-Krner-Fresenius-Stiftung; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by grants from the European Commission Marie Curie Excellence program (MEXT-CT-2006-042316,to Dr. Grim- bacher), Deutsche Forschungsgemeinschaft (SFB621, to Dr. Klein), and the German Federal Ministry of Education and Research (PID-NET), to Drs. Klein and Grimbacher; by the Intramural Research Program of the National Institutes of Health; and by fellowships from Deutsche Jose Carreras Leukmie-Stiftung (to Dr. Kotlarz) and Else-Krner-Fresenius-Stiftung ( to Dr. Boztug).	Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; FRIED K, 1974, CLIN GENET, V6, P195; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Megarbane A, 2007, CLIN GENET, V71, P89, DOI 10.1111/j.1399-0004.2007.00735.x; Mizoguchi A, 2008, J GASTROENTEROL, V43, P1, DOI 10.1007/s00535-007-2111-3; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shen BR, 2003, BIOINFORMATICS, V19, P2161, DOI 10.1093/bioinformatics/btg293; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Thusberg J, 2006, HUM MUTAT, V27, P1230, DOI 10.1002/humu.20407; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	45	969	1014	2	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2033	2045		10.1056/NEJMoa0907206	http://dx.doi.org/10.1056/NEJMoa0907206			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19890111	Green Accepted			2022-12-28	WOS:000271898600008
J	Iglehart, JK				Iglehart, John K.			Compromises and Controversies - Moving Forward on Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ELMENDORF D, 2009, COMMUNICATION   1029; Rosenbaum S, 2009, NEW ENGL J MED, V361, P2009, DOI 10.1056/NEJMp0909449	2	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21								10.1056/NEJMp0910493	http://dx.doi.org/10.1056/NEJMp0910493			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521DA	19890108				2022-12-28	WOS:000271898600005
J	Stewart, AM				Stewart, Alexandra M.			Mandatory Vaccination of Health Care Workers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stewart, Alexandra M.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Stewart, Alexandra M.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA	George Washington University; George Washington University	Stewart, AM (corresponding author), George Washington Univ, Med Ctr, Washington, DC 20037 USA.							DAINES RF, 2009, COMMUNICATION   0924	1	69	72	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2015	2017		10.1056/NEJMp0910151	http://dx.doi.org/10.1056/NEJMp0910151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19890107				2022-12-28	WOS:000271898600003
J	Soussain, C; Ricard, D; Fike, JR; Mazeron, JJ; Psimaras, D; Delattre, JY				Soussain, Carole; Ricard, Damien; Fike, John R.; Mazeron, Jean-Jacques; Psimaras, Dimitri; Delattre, Jean-Yves			CNS complications of radiotherapy and chemotherapy	LANCET			English	Review							CENTRAL-NERVOUS-SYSTEM; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; WHOLE-BRAIN IRRADIATION; MAGNETIC-RESONANCE-SPECTROSCOPY; INDUCED COGNITIVE DYSFUNCTION; HIGH-DOSE METHOTREXATE; LONG-TERM SURVIVORS; LOW-GRADE GLIOMAS; RADIATION-THERAPY; SPINAL-CORD	Treatment-induced CNS toxicity remains a major cause of morbidity in patients with cancer. Advances in the design of safe radiation procedures have been counterbalanced by widespread use of combined radiotherapy and chemotherapy, development of radiosurgery, and the increasing number of long-term survivors. Although classic radionecrosis and chemonecrosis have become less common, subtle changes such as progressive cognitive dysfunction are increasingly reported after radiotherapy (radiation-induced leukoencephalopathy) or chemotherapy (given alone or in combination). We review the most important and controversial complications of radiotherapy, chemotherapy, and combined treatments in the CNS, and discuss new diagnostic tools, practical management, prevention, and pathophysiological data that will affect future management of patients with cancer.	[Psimaras, Dimitri] Grp Hosp Pitie Salpetriere, AP HP, Serv Neurol Mazarin, F-75634 Paris, France; [Soussain, Carole; Ricard, Damien; Delattre, Jean-Yves] INSERM, U975, Paris, France; [Soussain, Carole; Ricard, Damien; Delattre, Jean-Yves] Univ Paris 06, Fac Med Pitie Salpetriere, CNRS, UMR 7225, Paris, France; [Soussain, Carole; Ricard, Damien; Delattre, Jean-Yves] Univ Paris 06, UMR S975, Paris, France; [Soussain, Carole] Serv Hematol, Ctr Lutte Canc Rene Huguenin, St Cloud, France; [Ricard, Damien] Hop Val de Grace, Serv Neurol, F-75005 Paris, France; [Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Mazeron, Jean-Jacques] Grp Hosp Pitie Salpetriere, Serv Radiotherapie, AP HP, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Rene Huguenin Hospital; Val-de-Grace Hospital; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Ricard, D (corresponding author), Hop Val de Grace, Serv Neurol, 74 Blvd Port Royal, F-75005 Paris, France.	damien.ricard@m4x.org						Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; ALLEN JC, 1991, NEUROLOGY, V41, P148, DOI 10.1212/WNL.41.1.148; Amirjamshidi A, 2000, CHILD NERV SYST, V16, P390, DOI 10.1007/s003819900125; Armstrong CL, 2002, NEUROLOGY, V59, P40, DOI 10.1212/WNL.59.1.40; Armstrong CL, 2000, NEUROPSY NEUROPSY BE, V13, P101; Atkinson S, 2003, INT J RADIAT ONCOL, V57, P1093, DOI 10.1016/S0360-3016(03)00735-1; Baumgartner JE, 2003, PEDIATR NEUROSURG, V39, P201, DOI 10.1159/000072472; Behin A, 2004, SEMIN NEUROL, V24, P405, DOI 10.1055/s-2004-861535; BERNSTEIN M, 1993, J NEURO-ONCOL, V17, P253, DOI 10.1007/BF01049980; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Brown WR, 2005, RADIAT RES, V164, P662, DOI 10.1667/RR3453.1; Chan AS, 2004, CANCER, V100, P398, DOI 10.1002/cncr.11885; Chuba PJ, 1997, CANCER-AM CANCER SOC, V80, P2005, DOI 10.1002/(SICI)1097-0142(19971115)80:10<2005::AID-CNCR19>3.0.CO;2-0; Cohen IJ, 2004, J PEDIAT HEMATOL ONC, V26, P156, DOI 10.1097/00043426-200403000-00004; Correa DD, 2007, ANN ONCOL, V18, P1145, DOI 10.1093/annonc/mdl464; Correa DD, 2004, NEUROLOGY, V62, P548, DOI 10.1212/01.WNL.0000109673.75316.D8; Daigle JL, 2001, CANCER RES, V61, P8859; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; del Rio MS, 2009, ONCOLOGIST, V14, P526, DOI 10.1634/theoncologist.2008-0236; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Ducray F, 2008, NEURO-ONCOLOGY, V10, P1035, DOI 10.1215/15228517-2008-069; Eberly AL, 2008, PHARMACOTHERAPY, V28, P1502, DOI 10.1592/phco.28.12.1502; Erbayraktar S, 2006, MOL MED, V12, P74, DOI 10.2119/2006-00042.Erbayraktar; Esik O, 2003, PATHOL ONCOL RES, V9, P115, DOI 10.1007/BF03033755; Faithfull S, 1998, Clin Oncol (R Coll Radiol), V10, P250, DOI 10.1016/S0936-6555(98)80011-3; Feldmeier JJ, 2002, UNDERSEA HYPERBAR M, V29, P4; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; FIKE JR, 1994, RADIAT RES, V138, P99, DOI 10.2307/3578852; Flickinger JC, 2000, INT J RADIAT ONCOL, V46, P1143, DOI 10.1016/S0360-3016(99)00513-1; Gavrilovic IT, 2006, J CLIN ONCOL, V24, P4570, DOI 10.1200/JCO.2006.06.6910; GLANTZ MJ, 1994, NEUROLOGY, V44, P2020, DOI 10.1212/WNL.44.11.2020; Gonzalez J, 2007, INT J RADIAT ONCOL, V67, P323, DOI 10.1016/j.ijrobp.2006.10.010; Graus F, 1990, NEUROLOGICAL ADVERSE, P87; Grill J, 1999, ANN NEUROL, V45, P393, DOI 10.1002/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B; Gutierrez AN, 2007, INT J RADIAT ONCOL, V69, P589, DOI 10.1016/j.ijrobp.2007.05.038; Heckl S, 2002, CANCER, V94, P3285, DOI 10.1002/cncr.10596; HORNSEY S, 1990, INT J RADIAT ONCOL, V18, P1437, DOI 10.1016/0360-3016(90)90319-F; Hunault-Berger M, 2008, HAEMATOL-HEMATOL J, V93, P1488, DOI 10.3324/haematol.12948; Hustinx R, 2005, RADIOL CLIN N AM, V43, P35, DOI 10.1016/j.rcl.2004.09.009; IMPERATO JP, 1990, ANN NEUROL, V28, P818, DOI 10.1002/ana.410280614; Inagaki M, 2007, CANCER, V109, P146, DOI 10.1002/cncr.22368; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Jagannathan J, 2004, AM J CLIN ONCOL-CANC, V27, P441, DOI 10.1097/01.coc.0000128721.94095.e4; Jensen FK, 1997, ACTA RADIOL, V38, P37, DOI 10.1080/02841859709171239; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kastrup O, 2008, J NEUROL, V255, P452, DOI 10.1007/s00415-008-0732-y; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Kleinschmidt-DeMasters BK, 2006, J NEUROPATH EXP NEUR, V65, P204, DOI 10.1097/01.jnen.0000205146.62081.29; Kremer JM, 2006, ANN RHEUM DIS, V65, P1121, DOI 10.1136/ard.2006.051789; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; Lamproglou I, 2003, INT J RADIAT ONCOL, V57, P1109, DOI 10.1016/S0360-3016(03)00775-2; Lamproglou I, 1998, INT J RADIAT ONCOL, V42, P179, DOI 10.1016/S0360-3016(98)00202-8; Lee AWM, 1998, INT J RADIAT ONCOL, V40, P35, DOI 10.1016/S0360-3016(97)00580-4; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Malone S, 2000, INT J RADIAT ONCOL, V47, P185, DOI 10.1016/S0360-3016(99)00554-4; MANDELL LR, 1989, CANCER, V63, P1975, DOI 10.1002/1097-0142(19890515)63:10<1975::AID-CNCR2820631017>3.0.CO;2-I; Martin G, 2007, J CLIN ONCOL, V25, P3559, DOI 10.1200/JCO.2007.12.8710; MASTAGLIA FL, 1976, BRAIN, V99, P101, DOI 10.1093/brain/99.1.101; Meyers CA, 1998, J CLIN ONCOL, V16, P2522, DOI 10.1200/JCO.1998.16.7.2522; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moore-Maxwell CA, 2004, MODERN PATHOL, V17, P241, DOI 10.1038/modpathol.3800049; Moretti R, 2005, J NEUROL SCI, V229, P195, DOI 10.1016/j.jns.2004.11.027; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029; NAGAT AT, 1991, CRYST RES TECHNOL, V26, P19, DOI 10.1002/crat.2170260105; Nicholson HS, 2007, CANCER, V110, P1542, DOI 10.1002/cncr.22961; Nordal RA, 2004, J NEUROPATH EXP NEUR, V63, P474, DOI 10.1093/jnen/63.5.474; Nordal RA, 2004, CLIN CANCER RES, V10, P3342, DOI 10.1158/1078-0432.CCR-03-0426; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Onujiogu N, 2008, GYNECOL ONCOL, V111, P537, DOI 10.1016/j.ygyno.2008.04.032; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Papadakis V, 2000, BONE MARROW TRANSPL, V26, P153, DOI 10.1038/sj.bmt.1702475; Patel PN, 2006, ANN PHARMACOTHER, V40, P299, DOI 10.1345/aph.1G114; PELLMAR TC, 1990, RADIAT RES, V122, P209, DOI 10.2307/3577608; Pelosini M, 2008, ANN HEMATOL, V87, P405, DOI 10.1007/s00277-007-0411-6; Pels H, 2003, J CLIN ONCOL, V21, P4489, DOI 10.1200/JCO.2003.04.056; Pena LA, 2000, CANCER RES, V60, P321; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; POSNER JB, 1995, NEUROLOGIC COMPLICAT, P311; Prigent-Le Jeune F, 2006, J NEURO-ONCOL, V77, P177, DOI 10.1007/s11060-005-9018-8; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Rajasekhar A, 2007, ONCOLOGIST, V12, P1332, DOI 10.1634/theoncologist.12-11-1332; Remsen LG, 1995, CLIN CANCER RES, V1, P731; Robbins ME, 2006, INT J RADIAT ONCOL, V64, P6, DOI 10.1016/j.ijrobp.2005.08.033; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; ROWLAND JH, 1984, J CLIN ONCOL, V2, P1327, DOI 10.1200/JCO.1984.2.12.1327; Ruben JD, 2006, INT J RADIAT ONCOL, V65, P499, DOI 10.1016/j.ijrobp.2005.12.002; Shah GD, 2007, J CLIN ONCOL, V25, P4730, DOI 10.1200/JCO.2007.12.5062; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; SHELINE GE, 1977, CANCER, V39, P873, DOI 10.1002/1097-0142(197702)39:2+<873::AID-CNCR2820390725>3.0.CO;2-Y; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Sibtain NA, 2007, CLIN RADIOL, V62, P109, DOI 10.1016/j.crad.2006.09.012; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; SIMONIAN NA, 1993, NEUROLOGY, V43, P2700, DOI 10.1212/WNL.43.12.2700; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; SUGIMOTO S, 1995, J NEURO-ONCOL, V24, P229, DOI 10.1007/BF01052839; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Tilly H, 2003, BLOOD, V102, P4284, DOI 10.1182/blood-2003-02-0542; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Torcuator R, 2009, J NEURO-ONCOL, V94, P63, DOI 10.1007/s11060-009-9801-z; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Verdecchia A, 2008, EUR J PUBLIC HEALTH, V18, P527, DOI 10.1093/eurpub/ckn022; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Vigliani MC, 1999, J NEURO-ONCOL, V41, P137, DOI 10.1023/A:1006183730847; Vigliani MC, 1996, INT J RADIAT ONCOL, V35, P527, DOI 10.1016/0360-3016(96)00097-1; VIGLIANI MC, 1997, HDB CLIN NEUROLOGY, P371; Wassenberg MWM, 2001, J NEURO-ONCOL, V52, P73, DOI 10.1023/A:1010676807228; Wick A, 2007, J CLIN ONCOL, V25, P3357, DOI 10.1200/JCO.2007.10.7722; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Yoneoka Y, 1999, BRIT J RADIOL, V72, P1196, DOI 10.1259/bjr.72.864.10703477; Yoshikawa E, 2005, BREAST CANCER RES TR, V92, P81, DOI 10.1007/s10549-005-1412-6; YOUNG DF, 1974, CANCER, V34, P1069, DOI 10.1002/1097-0142(197410)34:4<1069::AID-CNCR2820340416>3.0.CO;2-4; Zakarija A, 2005, SEMIN THROMB HEMOST, V31, P681, DOI 10.1055/s-2005-925474; Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418	127	259	280	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1639	1651		10.1016/S0140-6736(09)61299-X	http://dx.doi.org/10.1016/S0140-6736(09)61299-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19897130				2022-12-28	WOS:000271674600038
J	Ollerton, J; Coulthard, E				Ollerton, Jeff; Coulthard, Emma			Evolution of Animal Pollination	SCIENCE			English	Editorial Material							INSECT POLLINATION; FLOWERS; NECTAR; POLLEN; FLIES; DROPS		[Ollerton, Jeff; Coulthard, Emma] Univ Northampton, Sch Appl Sci, Landscape & Biodivers Res Grp, Northampton NN2 7AL, England	University of Northampton	Ollerton, J (corresponding author), Univ Northampton, Sch Appl Sci, Landscape & Biodivers Res Grp, Park Campus, Northampton NN2 7AL, England.	jeff.ollerton@northampton.ac.uk	Ollerton, Jeff/I-3946-2012; Ollerton, Jeff/AAE-3946-2020	Ollerton, Jeff/0000-0002-0887-8235; Ollerton, Jeff/0000-0002-0887-8235; Coulthard, Emma/0000-0001-8935-9092				[Anonymous], 1862, VARIOUS CONTRIVANCES; Crepet WL, 1996, REV PALAEOBOT PALYNO, V90, P339, DOI 10.1016/0034-6667(95)00091-7; CREPET WL, 1979, BIOSCIENCE, V29, P102, DOI 10.2307/1307746; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Labandeira CC, 2007, TAXON, V56, P663, DOI 10.2307/25065853; Nepi M, 2009, ANN BOT-LONDON, V104, P205, DOI 10.1093/aob/mcp124; Ollerton Jeff, 2003, Ecotropica (Bonn), V9, P107; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Proctor M., 1996, NATURAL HIST POLLINA; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Thien LB, 2009, AM J BOT, V96, P166, DOI 10.3732/ajb.0800016; Waser NM., 2006, PLANT POLLINATOR INT; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857	16	13	15	9	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					808	809		10.1126/science.1181154	http://dx.doi.org/10.1126/science.1181154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892970				2022-12-28	WOS:000271468000028
J	Chakladar, A; Adams, H				Chakladar, Abhijoy; Adams, Hazel			Patient safety Dangers of listening to the fetal heart at home	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adams, Hazel] Brighton & Sussex Univ Hosp NHS Trust, Princess Royal Hosp, Dept Anaesthesia, Haywards Heath RH16 4EX, W Sussex, England	Brighton and Sussex University Hospitals NHS Trust		chakladar@gmail.com		Chakladar, Abhijoy/0000-0002-8236-1488				Aust T., 2009, BRIT MED J, V339, pB3220; Mangesi L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004909.pub2	2	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2009	339								b4308	10.1136/bmj.b4308	http://dx.doi.org/10.1136/bmj.b4308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UD	19892799				2022-12-28	WOS:000271567900003
J	Perez-Caballero, D; Zang, T; Ebrahimi, A; McNatt, MW; Gregory, DA; Johnson, MC; Bieniasz, PD				Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Gregory, Devon A.; Johnson, Marc C.; Bieniasz, Paul D.			Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells	CELL			English	Article							PARTICLE RELEASE; VPU PROTEIN; RESTRICTION; SURFACE; CLONING	Tetherin is an interferon-induced protein whose expression blocks the release of HIV-1 and other enveloped viral particles. The underlying mechanism by which tetherin functions and whether it directly or indirectly causes virion retention are unknown. Here, we elucidate the mechanism by which tetherin exerts its antiviral activity. We demonstrate, through mutational analyses and domain replacement experiments, that tetherin configuration rather than primary sequence is critical for antiviral activity. These findings allowed the design of a completely artificial protein, lacking sequence homology with native tetherin, that nevertheless mimicked its antiviral activity. We further show that tetherin is incorporated into HIV-1 particles as a parallel homodimer using either of its two membrane anchors. These results indicate that tetherin functions autonomously and directly and that infiltration of virion envelopes by one or both of tetherin's membrane anchors is necessary, and likely sufficient, to tether enveloped virus particles that bud through the plasma membrane.	[Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA; [Zang, Trinity; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; [Gregory, Devon A.; Johnson, Marc C.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; University of Missouri System; University of Missouri Columbia	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	pbienias@adarc.org	Sánchez, Juan/D-2036-2016; Moretón, Auxiliadora/D-1334-2016	Sánchez, Juan/0000-0003-4703-3435; Moretón, Auxiliadora/0000-0003-4703-3435	National Institutes of Health [RO1AI50111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073098, R01AI050111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Bieniasz laboratory for helpful discussions and T. Kinoshita for PIGL-defective cells. This work was supported by National Institutes of Health grant RO1AI50111. P. D. B. is an Investigator of the Howard Hughes Medical Institute.	Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	22	442	461	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					499	511		10.1016/j.cell.2009.08.039	http://dx.doi.org/10.1016/j.cell.2009.08.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879838	Bronze, Green Accepted			2022-12-28	WOS:000271259600015
J	Edelman, E; Eng, C				Edelman, Emily; Eng, Charis			A practical guide to interpretation and clinical application of personal genomic screening	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK; PREDICTION; VARIANTS		[Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Edelman, Emily] Natl Coalit Hlth Profess Educ Genet, Lutherville Timonium, MD 21093 USA	Cleveland Clinic Foundation	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,NE 50, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145				*AM COLL MED GEN, 2005, GENET MED, V7, P650; [Anonymous], 2007, MOR GEN DIR; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; *EUROGENTEST, 2008, SUMM GUID GEN COUNS; Foster MW, 2009, GENET MED, V11, P570, DOI 10.1097/GIM.0b013e3181a2743e; Genetics and Public Policy Center, 2009, DIR TO CONS GEN TEST; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Henrikson NB, 2009, GENOME MED, V1, DOI 10.1186/gm37; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; *HUM GEN COMM, 2009, MOR GEN DIR; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Kaye J, 2008, HUM MOL GENET, V17, pR180, DOI 10.1093/hmg/ddn253; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pletcher BA, 2007, GENET MED, V9, P385, DOI 10.1097/GIM.0b013e318064e70c; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Wilson JMG, 1968, PRINCIPLES PRACTICE	22	18	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2009	339								b4253	10.1136/bmj.b4253	http://dx.doi.org/10.1136/bmj.b4253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AO	19875427				2022-12-28	WOS:000271365900005
J	Ferwerda, B; Ferwerda, G; Plantinga, TS; Willment, JA; van Spriel, AB; Venselaar, H; Elbers, CC; Johnson, MD; Cambi, A; Huysamen, C; Jacobs, L; Jansen, T; Verheijen, K; Masthoff, L; Morre, SA; Vriend, G; Williams, DL; Perfect, JR; Joosten, LAB; Wijmenga, C; van der Meer, JWM; Adema, GJ; Kullberg, BJ; Brown, GD; Netea, MG				Ferwerda, Bart; Ferwerda, Gerben; Plantinga, Theo S.; Willment, Janet A.; van Spriel, Annemiek B.; Venselaar, Hanka; Elbers, Clara C.; Johnson, Melissa D.; Cambi, Alessandra; Huysamen, Cristal; Jacobs, Liesbeth; Jansen, Trees; Verheijen, Karlijn; Masthoff, Laury; Morre, Servaas A.; Vriend, Gert; Williams, David L.; Perfect, John R.; Joosten, Leo A. B.; Wijmenga, Cisca; van der Meer, Jos W. M.; Adema, Gosse J.; Kullberg, Bart Jan; Brown, Gordon D.; Netea, Mihai G.			Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOLL-LIKE RECEPTORS; VAGINAL EPITHELIAL-CELLS; BETA-GLUCAN RECEPTOR; HYPER-IGE SYNDROME; CANDIDA-ALBICANS; HOST-DEFENSE; RECOGNITION; LECTIN; ASSOCIATION; INDUCTION	Mucocutaneous fungal infections are typically found in patients who have no known immune defects. We describe a family in which four women who were affected by either recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon mutation Tyr238X in the beta-glucan receptor dectin-1. The mutated form of dectin-1 was poorly expressed, did not mediate beta-glucan binding, and led to defective production of cytokines (interleukin-17, tumor necrosis factor, and interleukin-6) after stimulation with beta-glucan or Candida albicans. In contrast, fungal phagocytosis and fungal killing were normal in the patients, explaining why dectin-1 deficiency was not associated with invasive fungal infections and highlighting the specific role of dectin-1 in human mucosal antifungal defense.	[Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med 463, Nijmegen Inst Infect Inflammat & Immun, NL-6525 GA Nijmegen, Netherlands; [Ferwerda, Bart; Ferwerda, Gerben; Plantinga, Theo S.; Jacobs, Liesbeth; Jansen, Trees; Verheijen, Karlijn; Masthoff, Laury; Joosten, Leo A. B.; van der Meer, Jos W. M.; Kullberg, Bart Jan; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [van Spriel, Annemiek B.; Cambi, Alessandra; Adema, Gosse J.] Radboud Univ Nijmegen, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Elbers, Clara C.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Div Biomed Genet, Dept Med Genet, Complex Genet Sect, Utrecht, Netherlands; [Elbers, Clara C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Morre, Servaas A.] Vrije Univ Amsterdam, Immunogenet Lab, Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Willment, Janet A.; Huysamen, Cristal; Brown, Gordon D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Johnson, Melissa D.; Perfect, John R.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Williams, David L.] E Tennessee State Univ, Dept Surg, Johnson City, TN 37614 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; University of Groningen; University of Cape Town; Duke University; East Tennessee State University	Netea, MG (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med 463, Nijmegen Inst Infect Inflammat & Immun, Geert Grootepl 8, NL-6525 GA Nijmegen, Netherlands.	m.netea@aig.umcn.nl	Venselaar, Hanka/D-2009-2016; brown, gordon/B-4249-2012; van Spriel, Annemiek/O-1639-2013; Johnson, Melissa D/AAT-2078-2020; Kullberg, BJ/C-8520-2013; van der Meer, Jos W.M./C-8521-2013; van Spriel, Annemiek/Q-6044-2019; Ferwerda, J.G./L-4305-2015; Vriend, Gert/D-6730-2011; Vriend, G./H-8112-2014; Wijmenga, Cisca/AAE-7719-2019; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014; Wijmenga, Cisca/D-2173-2009; Joosten, Leo AB/H-3138-2015; Adema, G.J./H-8007-2014; Cambi, Alessandra/L-4242-2015	Venselaar, Hanka/0000-0001-9824-6559; Johnson, Melissa D/0000-0002-6606-9460; Kullberg, BJ/0000-0002-6813-8167; van der Meer, Jos W.M./0000-0001-5120-3690; van Spriel, Annemiek/0000-0002-3590-2368; Wijmenga, Cisca/0000-0002-5635-1614; Plantinga, Theo S./0000-0003-4990-6084; Joosten, Leo AB/0000-0001-6166-9830; Cambi, Alessandra/0000-0003-1597-1582; brown, gordon/0000-0002-0287-5383; Willment, Janet/0000-0002-7040-0857; Ferwerda, Bart/0000-0002-7050-5931	Netherlands Organization for Scientific Research; Wellcome Trust [068545/Z/02]; Dutch Cancer Society [2007-3917]; U.K. Medical Research Council [G0000934]; Medical Research Council [G0000934] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI051537] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Cancer Society(KWF Kankerbestrijding); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Netherlands Organization for Scientific Research (a Vidi Grant to Dr. Netea and Veni Grants to Drs. Cambi and van Spriel), the Wellcome Trust (to Dr. Brown), and the Dutch Cancer Society (2007-3917, to Dr. van Spriel). The use of genotypes from the British 1958 birth cohort collection was funded by grants from the U.K. Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02).	Babula O, 2005, CLIN INFECT DIS, V40, P1258, DOI 10.1086/429246; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barousse MM, 2001, J INFECT DIS, V184, P1489, DOI 10.1086/324532; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Scher RK, 2007, J AM ACAD DERMATOL, V56, P939, DOI 10.1016/j.jaad.2006.12.019; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vonk AG, 2002, J MICROBIOL METH, V49, P55, DOI 10.1016/S0167-7012(01)00348-7; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200	32	540	565	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1760	1767		10.1056/NEJMoa0901053	http://dx.doi.org/10.1056/NEJMoa0901053			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864674	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000271185600008
J	Miesenbock, G				Miesenboeck, Gero			The Optogenetic Catechism	SCIENCE			English	Review							GREEN FLUORESCENT PROTEINS; REMOTE-CONTROL; NEURAL ACTIVITY; GLUTAMATE-RECEPTOR; ANTENNAL LOBE; ION CHANNELS; IN-VIVO; NEURONS; LIGHT; CIRCUITS	An emerging set of methods enables an experimental dialogue with biological systems composed of many interacting cell types-in particular, with neural circuits in the brain. These methods are sometimes called "optogenetic" because they use light-responsive proteins ("opto-") encoded in DNA ("-genetic"). Optogenetic devices can be introduced into tissues or whole organisms by genetic manipulation and be expressed in anatomically or functionally defined groups of cells. Two kinds of devices perform complementary functions: Light-driven actuators control electrochemical signals, while light-emitting sensors report them. Actuators pose questions by delivering targeted perturbations; sensors ( and other measurements) signal answers. These catechisms are beginning to yield previously unattainable insight into the organization of neural circuits, the regulation of their collective dynamics, and the causal relationships between cellular activity patterns and behavior.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	gero.miesenboeck@dpag.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228	Medical Research Council; NIH; Office of Naval Research; Human Frontier Science Program; Searle Scholars Program; Alfred P. Sloan, Beckman, Dana, Klingenstein, and McKnight foundations; MRC [G0700888, G0701225] Funding Source: UKRI; Medical Research Council [G0700888, G0701225] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Human Frontier Science Program(Human Frontier Science Program); Searle Scholars Program; Alfred P. Sloan, Beckman, Dana, Klingenstein, and McKnight foundations(Klingenstein Philanthropies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	I thank J. Flint, D. Kaetzel, P. Overton, E. Vrontou, and S. Waddell for comments. Work in my laboratory was supported by the Medical Research Council, the NIH, the Office of Naval Research, the Human Frontier Science Program, the Searle Scholars Program, and the Alfred P. Sloan, Beckman, Dana, Klingenstein, and McKnight foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; [Anonymous], J MINISTRY AGR; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Judson HF., 1979, 8 DAY CREATION; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Miesenbck G, 2008, SCI AM, V299, P52, DOI 10.1038/scientificamerican1008-52; Miesenbock G, 1997, P NATL ACAD SCI USA, V94, P3402, DOI 10.1073/pnas.94.7.3402; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rieke F., 1997, SPIKES EXPLORING NEU; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Sjulson L, 2008, CHEM REV, V108, P1588, DOI 10.1021/cr078221b; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	42	178	187	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					395	399		10.1126/science.1174520	http://dx.doi.org/10.1126/science.1174520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833960				2022-12-28	WOS:000270818600044
J	Moore, M; Yuen, HM; Dunn, N; Mullee, MA; Maskell, J; Kendrick, T				Moore, Michael; Yuen, Ho Ming; Dunn, Nick; Mullee, Mark A.; Maskell, Joe; Kendrick, Tony			Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; TRENDS; DEPRESSION; UK; PREVALENCE; GUIDELINES	Objective To explore the reasons behind the recent increase in antidepressant prescribing in the United Kingdom. Design Detailed retrospective analysis of data on general practitioner consultations and antidepressant prescribing. Data source Data were obtained from the general practice research database, which contains linked anonymised records of over 3 million patients registered in the UK. Data were extracted for all new incident cases of depression between 1993 and 2005. Review methods Detailed analysis of general practitioner consultations and antidepressant prescribing was restricted to 170 practices that were contributing data for the full duration of the study. Results In total, 189 851 people within the general practice research database experienced their first episode of depression between 1993 and 2005, of whom 150 825 (79.4%) received a prescription for antidepressants in the first year of diagnosis. This proportion remained stable across all the years examined. The incidence of new cases of depression rose in young women but fell slightly in other groups such that overall incidence increased then declined slightly (men: 7.83 cases per 1000 patient years in 1993 to 5.97 in 2005, women: 15.83 cases per 1000 patient years in 1993 to 10.06 in 2005). Antidepressant prescribing nearly doubled during the study period-the average number of prescriptions issued per patient increased from 2.8 in 1993 to 5.6 in 2004. The majority of antidepressant prescriptions were given as long term treatment or as intermittent treatment to patients with multiple episodes of depression. Conclusions The rise in antidepressant prescribing is mainly explained by small changes in the proportion of patients receiving long term treatment. Previous clinical guidelines have focused on antidepressant initiation and appropriate targeting of antidepressants. To address the costly rise in antidepressant prescribing, future research and guidance needs to concentrate on appropriate long term prescribing for depression and regular review of medication.	[Moore, Michael; Kendrick, Tony] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Dunn, Nick] Univ Southampton, Div Med Educ, Sch Med, Southampton SO16 7PX, Hants, England; [Yuen, Ho Ming; Mullee, Mark A.; Maskell, Joe] Univ Southampton, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	Moore, M (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	mvm198@soton.ac.uk	Moore, Michael/C-3447-2011; Kendrick, Tony/H-8558-2014	Moore, Michael/0000-0002-5127-4509; Kendrick, Tony/0000-0003-1618-9381				Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Cruickshank Gillian, 2008, Ment Health Fam Med, V5, P105; Dunn RL, 1999, J PSYCHOPHARMACOL, V13, P136, DOI 10.1177/026988119901300204; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Hyde J, 2005, BRIT J GEN PRACT, V55, P846; Hyde J, 2005, BRIT J GEN PRACT, V55, P755; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; KENDRICK T, 2009, BRIT MED J, V339, P750; Leydon GM, 2007, FAM PRACT, V24, P570, DOI 10.1093/fampra/cmm069; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Middleton N, 2001, J PUBLIC HEALTH MED, V23, P262, DOI 10.1093/pubmed/23.4.262; Munoz-Arroyo R, 2006, BRIT J GEN PRACT, V56, P423; *NAT I CLIN EXC, 2004, CLIN GUID NAT I CLIN, V23; *NHS EMPL BMA, 2006, REV GMS CONTR 2006 7; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Petty DR, 2006, AGE AGEING, V35, P523, DOI 10.1093/ageing/afl023; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; *PRESCR PRIC AUTH, 2007, PRESCR REV DRUGS US; Raymond CB, 2007, PSYCHIAT SERV, V58, P79, DOI 10.1176/appi.ps.58.1.79-a; REID I, 2009, PRESCRIBER, V20, P18; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; 2006, PHARMAC, V24	24	170	170	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2009	339								b3999	10.1136/bmj.b3999	http://dx.doi.org/10.1136/bmj.b3999			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DQ	19833707	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000270908300002
J	Wang, XQ; Tsai, JW; Imai, JH; Lian, WN; Vallee, RB; Shi, SH				Wang, Xiaoqun; Tsai, Jin-Wu; Imai, Janice H.; Lian, Wei-Nan; Vallee, Richard B.; Shi, Song-Hai			Asymmetric centrosome inheritance maintains neural progenitors in the neocortex	NATURE			English	Article							RADIAL GLIAL-CELLS; STEM-CELL; NEURONAL MIGRATION; SPINDLE ORIENTATION; CORTICAL-NEURONS; DIVISION; CYCLE; CENTRIOLES; MOTHER; NINEIN	Asymmetric divisions of radial glia progenitors produce self-renewing radial glia and differentiating cells simultaneously in the ventricular zone (VZ) of the developing neocortex. Whereas differentiating cells leave the VZ to constitute the future neocortex, renewing radial glia progenitors stay in the VZ for subsequent divisions. The differential behaviour of progenitors and their differentiating progeny is essential for neocortical development; however, the mechanisms that ensure these behavioural differences are unclear. Here we show that asymmetric centrosome inheritance regulates the differential behaviour of renewing progenitors and their differentiating progeny in the embryonic mouse neocortex. Centrosome duplication in dividing radial glia progenitors generates a pair of centrosomes with differently aged mother centrioles. During peak phases of neurogenesis, the centrosome retaining the old mother centriole stays in the VZ and is preferentially inherited by radial glia progenitors, whereas the centrosome containing the new mother centriole mostly leaves the VZ and is largely associated with differentiating cells. Removal of ninein, a mature centriole-specific protein, disrupts the asymmetric segregation and inheritance of the centrosome and causes premature depletion of progenitors from the VZ. These results indicate that preferential inheritance of the centrosome with the mature older mother centriole is required for maintaining radial glia progenitors in the developing mammalian neocortex.	[Wang, Xiaoqun; Imai, Janice H.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Tsai, Jin-Wu; Lian, Wei-Nan; Vallee, Richard B.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Tsai, Jin-Wu; Lian, Wei-Nan; Vallee, Richard B.] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Imai, Janice H.; Shi, Song-Hai] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Columbia University; Columbia University; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	shis@mskcc.org		Tsai, Jin-Wu/0000-0003-0135-759X	March of Dimes Birth Defects Foundation; Whitehall Foundation; Dana Foundation; Autism Speaks Foundation; Klingenstein Foundation; NARSAD; NIH; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Whitehall Foundation; Dana Foundation; Autism Speaks Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Hall, A. L. Joyner, K. V. Anderson, J. Kaltschmidt, B. M. Tsou, Y. Chin and L. A. McDowell for comments on the manuscript; members of the Shi laboratory for discussions; A. K. Hadjantonakis for human centrin 1 cDNA; M. Bornens for EGFP-Nin (mouse) and Nin truncation mutant plasmids; Y.-R. Hong for EGFP-Nin (human) plasmid; A. Miyawaki for pCS21-Kaede plasmid; and H. Zhong, K. Svoboda and R. Tsien for DsRedexpress and mPlum cDNA constructs. Wethank C. T. Anderson and T. Stearns for sharing unpublished data. This work is supported by grants from March of Dimes Birth Defects Foundation, Whitehall Foundation, Dana Foundation, Autism Speaks Foundation, Klingenstein Foundation, NARSAD (to S.-H. S.) and NIH (to S.-H. S. and R. B. V.).	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 2002, CURR BIOL, V12, pR71, DOI 10.1016/S0960-9822(01)00678-9; BoucksonCastaing V, 1996, J CELL SCI, V109, P179; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cabernard C, 2007, CURR BIOL, V17, pR465, DOI 10.1016/j.cub.2007.04.016; Cai L, 1997, J NEUROSCI, V17, P2079; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ou YY, 2002, J CELL SCI, V115, P1825; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Spradling AC, 2007, SCIENCE, V315, P469, DOI 10.1126/science.1138237; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wigley WC, 1999, J CELL BIOL, V145, P481; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	50	324	328	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					947	U206		10.1038/nature08435	http://dx.doi.org/10.1038/nature08435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829375	Green Accepted			2022-12-28	WOS:000270817700040
J	Weissman, JS; Bigby, J				Weissman, Joel S.; Bigby, JudyAnn			Massachusetts Health Care Reform - Near-Universal Coverage at What Cost?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weissman, Joel S.; Bigby, JudyAnn] Massachusetts Execut Off Hlth & Human Serv, Boston, MA USA		Weissman, JS (corresponding author), Massachusetts Execut Off Hlth & Human Serv, Boston, MA USA.							Gabel JR, 2008, HEALTH AFFAIR, V27, pW566, DOI 10.1377/hlthaff.27.6.w566; Long SK, 2009, HEALTH AFFAIR, V28, pW578, DOI 10.1377/hlthaff.28.4.w578; Massachusetts Taxpayers Foundation, 2009, MASS HLTH REF MYTH U; Seifert RW, 2009, SHARED RESPONSIBILIT; Tanner MD, 2009, MASSACHUSETTS MIRACL	5	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2012	2015		10.1056/NEJMp0909295	http://dx.doi.org/10.1056/NEJMp0909295			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521DA	19846843				2022-12-28	WOS:000271898600002
J	Hanushek, EA				Hanushek, Eric A.			Building on No Child Left Behind	SCIENCE			English	Editorial Material							ACCOUNTABILITY		Stanford Univ, Hoover Inst, Stanford, CA 94305 USA	Stanford University	Hanushek, EA (corresponding author), Stanford Univ, Hoover Inst, Stanford, CA 94305 USA.	hanushek@stanford.edu		Hanushek, Eric/0000-0002-7090-7535				[Anonymous], 2003, NO CHILD LEFT; BISHOP JH, 2006, HDB EC ED, P909; Carnoy M, 2002, EDUC EVAL POLICY AN, V24, P305, DOI 10.3102/01623737024004305; Chubb JE, 2009, LEARNING NO CHILD LE; *CTR ED POL, 2007, ANSW QUEST MATT MOST; Figlio DN, 2006, J PUBLIC ECON, V90, P239, DOI 10.1016/j.jpubeco.2005.08.005; GRISSMER D, 1998, EXPLORING RAPID ACHI; Hanushek E. A., 2006, HDB EC ED, P1051, DOI [10.1016/S1574-0692(06)02018-6, DOI 10.1016/S1574-0692(06)02018-6]; Hanushek EA, 2005, J POLICY ANAL MANAG, V24, P297, DOI 10.1002/pam.20091; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hanushek Eric A., 2009, SCHOOLH COURTH STAT; Howell W., 2007, ED NEXT, V7, P12; Lips Dan, 2009, ED NEXT, V9, P20; MCNEIL M, 2009, ED WEEK, V28, P16; *NAT CTR ED STAT, 2007, MAPP 2005 STAT PROF; PETERSON PE, 2006, ED NEXT, V6, P77; PETERSON PE, 2006, REFORMING ED FLORIDA, P49; *US DEP ED, 2008, ADM DIFF ACC STAT; *US DEP ED, ADM LEAD MAN MY SCH; VANNEMAN A, 2009, 2009455 NCES US DOE; Woessmann L., 2009, SCH ACCOUNTABILITY A	21	7	7	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					802	803		10.1126/science.1177458	http://dx.doi.org/10.1126/science.1177458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	515KG	19892966				2022-12-28	WOS:000271468000024
J	Tefferi, A; Vardiman, JW				Tefferi, Ayalew; Vardiman, James W.			Mechanisms of Disease: Myelodysplastic Syndromes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MYELOID-LEUKEMIA; PROGNOSTIC SCORING SYSTEM; WORLD-HEALTH-ORGANIZATION; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; DNA MICROARRAY ANALYSIS; LOW-DOSE CYTARABINE; REGULATORY T-CELLS; BONE-MARROW; HIGH-RISK		[Tefferi, Ayalew] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA; [Vardiman, James W.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Mayo Clinic; University of Chicago	Tefferi, A (corresponding author), Mayo Clin, Dept Med, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	tefferi.ayalew@mayo.edu						Alter Blanche P, 2007, Hematology Am Soc Hematol Educ Program, P29, DOI 10.1182/asheducation-2007.1.29; Anderson K, 2002, CANCER GENET CYTOGEN, V136, P101, DOI 10.1016/S0165-4608(02)00515-0; ASANO H, 1994, BLOOD, V84, P588; BACHER U, 2009, ANN HEMATOL     0505; Bacher U, 2007, HAEMATOLOGICA, V92, P744, DOI 10.3324/haematol.10869; Benesch M, 2003, LEUKEMIA, V17, P2460, DOI 10.1038/sj.leu.2403180; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Beran M, 2001, CANCER-AM CANCER SOC, V92, P1999, DOI 10.1002/1097-0142(20011015)92:8<1999::AID-CNCR1538>3.0.CO;2-B; Bernasconi P, 2007, BRIT J HAEMATOL, V137, P193, DOI 10.1111/j.1365-2141.2007.06537.x; Bomford RR, 1941, Q J MED, V10, P175; Boultwood J, 2007, BRIT J HAEMATOL, V139, P578, DOI 10.1111/j.1365-2141.2007.06833.x; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Buonamici S, 2005, J CLIN INVEST, V115, P2296, DOI 10.1172/JCI200421716C1; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Chamuleau MED, 2009, HAEMATOL-HEMATOL J, V94, P496, DOI 10.3324/haematol.13612; Chang CK, 2007, BLOOD, V110, P1379, DOI 10.1182/blood-2007-02-076307; Chee CE, 2008, AM J HEMATOL, V83, P611, DOI 10.1002/ajh.21192; Chen GB, 2004, BLOOD, V104, P4210, DOI 10.1182/blood-2004-01-0103; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; Cutler CS, 2004, BLOOD, V104, P579, DOI 10.1182/blood-2004-01-0338; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; DELFORGE M, 1995, BLOOD, V86, P3660, DOI 10.1182/blood.V86.10.3660.bloodjournal86103660; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Della Porta MG, 2008, LEUKEMIA, V22, P530, DOI 10.1038/sj.leu.2405069; Della Porta MG, 2009, J CLIN ONCOL, V27, P754, DOI 10.1200/JCO.2008.18.2246; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Epling-Burnette PK, 2007, LEUKEMIA, V21, P659, DOI 10.1038/sj.leu.2404590; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fozza C, 2009, EXP HEMATOL, V37, P947, DOI 10.1016/j.exphem.2009.04.009; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Gattermann N, 2008, INT J HEMATOL, V88, P24, DOI 10.1007/s12185-008-0118-z; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Germing U, 2005, LEUKEMIA, V19, P2223, DOI 10.1038/sj.leu.2403963; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Greenberg, 1998, BLOOD, V91, P1100; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Greenberg Peter L, 2008, J Natl Compr Canc Netw, V6, P942; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Huang WT, 2009, LEUKEMIA RES, V33, P847, DOI 10.1016/j.leukres.2008.10.008; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; Keith T, 2007, BRIT J HAEMATOL, V137, P206, DOI 10.1111/j.1365-2141.2007.06539.x; Kerbauy DMB, 2004, BLOOD, V104, P2202, DOI 10.1182/blood-2004-04-1518; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Kotsianidis I, 2009, LEUKEMIA, V23, P510, DOI 10.1038/leu.2008.333; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Luzzatto AM, 1907, RIV VEN, V47, P193; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Martino R, 2006, BLOOD, V108, P836, DOI 10.1182/blood-2005-11-4503; MEHROTRA B, 1995, BLOOD, V86, P1139; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; MILLER KB, 1992, ANN HEMATOL, V65, P162, DOI 10.1007/BF01703109; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Miyazato A, 2001, BLOOD, V98, P422, DOI 10.1182/blood.V98.2.422; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Mohamedali A, 2009, BRIT J HAEMATOL, V144, P157, DOI 10.1111/j.1365-2141.2008.07447.x; NAGLER A, 1990, LEUKEMIA, V4, P193; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; NISSE C, 1995, LEUKEMIA, V9, P693; Nowak D, 2009, EXP HEMATOL, V37, P215, DOI 10.1016/j.exphem.2008.10.012; Ogata K, 2002, BLOOD, V100, P3887, DOI 10.1182/blood-2002-01-0222; Omidvar N, 2007, CANCER RES, V67, P11657, DOI 10.1158/0008-5472.CAN-07-0196; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pozdnyakova O, 2008, CANCER-AM CANCER SOC, V113, P3331, DOI 10.1002/cncr.23977; Raza A, 2008, BLOOD, V111, P86, DOI 10.1182/blood-2007-01-068833; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; SAWADA K, 1993, BRIT J HAEMATOL, V83, P349, DOI 10.1111/j.1365-2141.1993.tb04656.x; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Slape C, 2008, BLOOD, V112, P2017, DOI 10.1182/blood-2008-01-135186; Soenen V, 1998, BLOOD, V91, P1008, DOI 10.1182/blood.V91.3.1008.1008_1008_1015; Sole F, 2005, HAEMATOLOGICA, V90, P1168; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; TEFFERI A, 1990, BLOOD, V75, P1770; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Ueda M, 2003, BRIT J HAEMATOL, V123, P288, DOI 10.1046/j.1365-2141.2003.04601.x; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; VARDIMAN JW, 2001, WHO CLASSIFICATION T, P17; Verburgh E, 2007, LEUKEMIA, V21, P668, DOI 10.1038/sj.leu.2404564; Warlick ED, 2009, BIOL BLOOD MARROW TR, V15, P30, DOI 10.1016/j.bbmt.2008.10.012; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Zwierzina H, 2005, LEUKEMIA, V19, P1929, DOI 10.1038/sj.leu.2403934	108	503	542	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1872	1885		10.1056/NEJMra0902908	http://dx.doi.org/10.1056/NEJMra0902908			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890130				2022-12-28	WOS:000271405800012
J	Gao, YG; Selmer, M; Dunham, CM; Weixlbaumer, A; Kelley, AC; Ramakrishnan, V				Gao, Yong-Gui; Selmer, Maria; Dunham, Christine M.; Weixlbaumer, Albert; Kelley, Ann C.; Ramakrishnan, V.			The Structure of the Ribosome with Elongation Factor G Trapped in the Posttranslocational State	SCIENCE			English	Article							LARGE CONFORMATIONAL-CHANGES; ACID-BINDING SITE; FUSIDIC ACID; TRANSFER-RNA; 70S RIBOSOME; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; EF-G; GTPASE ACTIVATION; MESSENGER-RNA	Elongation factor G (EF-G) is a guanosine triphosphatase (GTPase) that plays a crucial role in the translocation of transfer RNAs (tRNAs) and messenger RNA (mRNA) during translation by the ribosome. We report a crystal structure refined to 3.6 angstrom resolution of the ribosome trapped with EF-G in the posttranslocational state using the antibiotic fusidic acid. Fusidic acid traps EF-G in a conformation intermediate between the guanosine triphosphate and guanosine diphosphate forms. The interaction of EF-G with ribosomal elements implicated in stimulating catalysis, such as the L10-L12 stalk and the L11 region, and of domain IV of EF-G with the tRNA at the peptidyl-tRNA binding site (P site) and with mRNA shed light on the role of these elements in EF-G function. The stabilization of the mobile stalks of the ribosome also results in a more complete description of its structure.	[Gao, Yong-Gui; Selmer, Maria; Dunham, Christine M.; Weixlbaumer, Albert; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Gao, Yong Gui/A-2187-2011; Gao, Yonggui/A-9473-2015; Weixlbaumer, Albert/P-3587-2016; Weixlbaumer, Albert/AAI-8474-2021	Gao, Yonggui/0000-0001-7298-0835; Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844; Ramakrishnan, V/0000-0002-4699-2194; Selmer, Maria/0000-0001-9079-2774	U.K. Medical Research Council; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Schulze-Briese, M. Fuchs, and M. Wang for help with data collection at the Swiss Light Source; J. Frank for coordinates of the ratcheted ribosome obtained from modeling into cryo-EM maps; J. Hentschel for help with crystallization trials; M. Schmeing and R. Voorhees for help with data collection, making figures, and critical feedback; and C. Neubauer and L. Ng for useful discussions. V. R. was supported by the U. K. Medical Research Council, a Wellcome Trust program grant, and awards from the Agouron Institute and the Louis-Jeantet Foundation. Coordinates for the structure have been deposited in the Protein Data Bank as four split entries with codes 2wri, 2wrj, 2wrk, and 2wrl.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; BODLEY JW, 1970, J BIOL CHEM, V245, P5662; Cameron DM, 2004, J BACTERIOL, V186, P5819, DOI 10.1128/JB.186.17.5819-5825.2004; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 1998, FEBS LETT, V434, P205, DOI 10.1016/S0014-5793(98)00982-X; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; MURRAY IA, 1995, J MOL BIOL, V254, P993, DOI 10.1006/jmbi.1995.0671; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; SCHMEING TM, 2009, SCIENCE         1015, DOI DOI 10.1126/SCIENCE.1179700; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Seo HS, 2006, BIOCHEMISTRY-US, V45, P2504, DOI 10.1021/bi0516677; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	46	376	384	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					694	699		10.1126/science.1179709	http://dx.doi.org/10.1126/science.1179709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19833919	Green Accepted			2022-12-28	WOS:000271233200028
J	Ogunseitan, OA; Schoenung, JM; Saphores, JDM; Shapiro, AA				Ogunseitan, Oladele A.; Schoenung, Julie M.; Saphores, Jean-Daniel M.; Shapiro, Andrew A.			The Electronics Revolution: From E-Wonderland to E-Wasteland	SCIENCE			English	Editorial Material							DIPHENYL ETHERS; CALIFORNIA; CHINA; WILLINGNESS; MANAGEMENT		[Ogunseitan, Oladele A.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA; [Ogunseitan, Oladele A.] Univ Calif Irvine, Sch Social Ecol, Irvine, CA 92697 USA; [Schoenung, Julie M.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Saphores, Jean-Daniel M.] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA 92697 USA; [Saphores, Jean-Daniel M.] Univ Calif Irvine, Dept Econ, Irvine, CA 92697 USA; [Shapiro, Andrew A.] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ogunseitan, OA (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.	Oladele.Ogunseitan@uci.edu	Saphores, Jean Daniel/Q-5445-2019; Ogunseitan, oladele/AAF-8528-2020	Saphores, Jean Daniel/0000-0001-9514-0994; Ogunseitan, oladele/0000-0003-1317-6219; Schoenung, Julie/0000-0002-4093-1489; Shapiro, Andrew/0000-0002-2650-8107				ABRAMS F, 2008, ELECT DESIGN ST 0205; Bandyopadhyay A, 2008, ENVIRON ENG SCI, V25, P1507, DOI 10.1089/ees.2007.0342; *BAS CONV CONTR TR, NAIR DECL ENV SOUND; *EL TAK BACK COAT, STAT LEG; Hayes K, 2003, COLTAN MINING DEMOCR; Holden A, 2009, ENVIRON TOXICOL CHEM, V28, P1906, DOI 10.1897/08-594.1; Huo X, 2007, ENVIRON HEALTH PERSP, V115, P1113, DOI 10.1289/ehp.9697; Kang HY, 2007, ENVIRON SCI TECHNOL, V41, P373, DOI 10.1021/es060739u; Kang HY, 2005, RESOUR CONSERV RECY, V45, P368, DOI 10.1016/j.resconrec.2005.06.001; Khetriwal DS, 2009, J ENVIRON MANAGE, V90, P153, DOI 10.1016/j.jenvman.2007.08.019; Lincoln JD, 2008, IEEE T ELECTRON PACK, V31, P211, DOI 10.1109/TEPM.2008.926273; Lincoln JD, 2007, ENVIRON SCI TECHNOL, V41, P2572, DOI 10.1021/es0610479; McDonough W., 2002, CRADLE CRADLE REMAKI; Ni HG, 2009, ENVIRON SCI TECHNOL, V43, P3991, DOI 10.1021/es802725m; Ogunseitan OA, 2007, JOM-US, V59, P12, DOI 10.1007/s11837-007-0082-8; Petreas M, 2009, CHEMOSPHERE, V74, P996, DOI 10.1016/j.chemosphere.2008.09.093; Saphores JDM, 2006, ENVIRON BEHAV, V38, P183, DOI 10.1177/0013916505279045; Saphores JDM, 2007, J ENVIRON PLANN MAN, V50, P113, DOI 10.1080/09640560601048549; Saphores JDM, 2009, J ENVIRON MANAGE, V90, P3322, DOI 10.1016/j.jenvman.2009.05.008; SCHOENUNG JM, 2009, P IEEE INT S SUST SY; Schoenung Julie M., 2004, Journal of Industrial Ecology, V8, P59, DOI 10.1162/1088198043630496; Shapiro AA, 2006, IEEE T COMPON PACK T, V29, P60, DOI [10.1109/TCAPT.2005.850514, 10.1109/TCAPT.2006.]; Stone R, 2009, SCIENCE, V325, P1055, DOI 10.1126/science.325_1055; *UNEP, 2005, ENV ALERT B, V5, P1; *UNEP SOC ENV TOX, 2009, GUID SOC LIF CYC ASS; Widmer R, 2005, ENVIRON IMPACT ASSES, V25, P436, DOI 10.1016/j.eiar.2005.04.001; Zimmerman J. B., 2009, ACS SYM SER, V1011, P137	27	162	168	5	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					670	671		10.1126/science.1176929	http://dx.doi.org/10.1126/science.1176929			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	512GB	19900918				2022-12-28	WOS:000271233200018
J	Tushir, JS; Zamore, PD; Zhang, Z				Tushir, Jogender S.; Zamore, Phillip D.; Zhang, Zhao			SnapShot: Fly piRNAs, PIWI Proteins, and the Ping-Pong Cycle	CELL			English	Editorial Material							DROSOPHILA; GERMLINE; ELEMENTS		[Tushir, Jogender S.] Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tushir, JS (corresponding author), Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BRENNECKE J, 2007, DROSOPHILA CELL, V128, P1089; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	10	13	14	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					634	U196	634.e1	10.1016/j.cell.2009.10.021	http://dx.doi.org/10.1016/j.cell.2009.10.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879848	Bronze			2022-12-28	WOS:000271259600026
J	Ham, C				Ham, Chris			Lessons from the past decade for future health reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Ham, C (corresponding author), Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.	c.j.ham@bham.ac.uk						*AUD COMM HLTH CAR, 2008, IS TREATM WORK; Baker R, 2008, HIGH PERFORMING HEAL; BEVAN H, 2008, NEXT LEG JOURNEY WE; Ham C, 2003, LANCET, V361, P1978, DOI 10.1016/S0140-6736(03)13593-3; Ham C., 2009, HLTH POLICY BRITAIN, V6th; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; Hawkes N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1484; Heclo H., 1974, MODERN SOCIAL POLITI; Jellison JM, 2006, MANAGING DYNAMICS CH; *SECR STAT HLTH, 2004, NHS IMPR PLAN; Secretary of State for Health, 2008, HIGH QUAL CAR ALL; Secretary of State for Health, 2000, NHS PLAN; Secretary of State for Health, 2002, DEL NHS PLAN; Secretary of State for Health, 1997, NEW NHS MOD DEP	14	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2009	339								b4372	10.1136/bmj.b4372	http://dx.doi.org/10.1136/bmj.b4372			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AN	19864686				2022-12-28	WOS:000271365800005
J	Patel, L; Abraham, S				Patel, Leena; Abraham, Sonya			Picture Quiz Painful ears and a cough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RELAPSING POLYCHONDRITIS; RESPIRATORY COMPLICATIONS; SUSTAINED RESPONSE; ANTIBODY		[Patel, Leena; Abraham, Sonya] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Rheumatol, London W6 8RF, England	Imperial College London	Patel, L (corresponding author), Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Rheumatol, London W6 8RF, England.	leenapatel410@hotmail.com						ASKARI AD, 1984, J AM ACAD DERMATOL, V10, P507, DOI 10.1016/S0190-9622(84)80102-4; BARRANCO VP, 1976, ARCH DERMATOL, V112, P1286, DOI 10.1001/archderm.112.9.1286; Barretto SN, 2002, MAYO CLIN PROC, V77, P971; BUCKLEY LM, 1992, ARTHRITIS RHEUM-US, V35, P812, DOI 10.1002/art.1780350716; Carter JD, 2005, J RHEUMATOL, V32, P1413; CROCKFORD MP, 1988, CLIN RADIOL, V39, P386, DOI 10.1016/S0009-9260(88)80277-0; DelRosso A, 1997, SEMIN ARTHRITIS RHEU, V26, P840, DOI 10.1016/S0049-0172(97)80028-5; FOIDART JM, 1978, NEW ENGL J MED, V299, P1203, DOI 10.1056/NEJM197811302992202; Frances C, 2001, MEDICINE, V80, P173, DOI 10.1097/00005792-200105000-00003; Gergely P, 2004, BEST PRACT RES CL RH, V18, P723, DOI 10.1016/j.berh.2004.05.012; GIBSON GJ, 1974, THORAX, V29, P726, DOI 10.1136/thx.29.6.726; GIORDANO M, 1984, RHEUMATOL INT, V4, P191, DOI 10.1007/BF00541214; Herrera I, 2002, Reumatismo, V54, P301; HOANGXAUN T, 1991, OPHTHALMOLOGY, V97, P892; ISAAK BL, 1986, OPHTHALMOLOGY, V93, P681; Kawai M, 2009, RHEUMATOLOGY, V48, P318, DOI 10.1093/rheumatology/ken468; Kent Peter D., 2004, Current Opinion in Rheumatology, V16, P56, DOI 10.1097/00002281-200401000-00011; Leroux G, 2009, ARTHRIT RHEUM-ARTHR, V61, P577, DOI 10.1002/art.24366; Letko E, 2002, SEMIN ARTHRITIS RHEU, V31, P384, DOI 10.1053/sarh.2002.32586; LIPNICK RN, 1991, J RHEUMATOL, V18, P98; MANNA R, 1988, CLIN RHEUMATOL, V4, P478; Mark KA, 2002, J AM ACAD DERMATOL, V46, pS22, DOI 10.1067/mjd.2002.105477; MARTIN J, 1976, ARCH DERMATOL, V112, P1272, DOI 10.1001/archderm.112.9.1272; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; MICHET CJ, 1986, ANN INTERN MED, V129, P114; Molina JF, 2000, BEST PRACT RES CL RH, V14, P97, DOI 10.1053/berh.1999.0079; Mpofu S, 2003, RHEUMATOLOGY, V42, P1117, DOI 10.1093/rheumatology/keg280; NEILLY JB, 1985, THORAX, V40, P78, DOI 10.1136/thx.40.1.78; OHANLAN M, 1976, ARTHRITIS RHEUM, V19, P191, DOI 10.1002/art.1780190210; Rosen O, 2000, ARTHRITIS RES, V2, P327, DOI 10.1186/ar107; RUHLEN JL, 1981, JAMA-J AM MED ASSOC, V245, P847, DOI 10.1001/jama.245.8.847; Saadoun D, 2003, J RHEUMATOL, V30, P1394; Seymour MW, 2007, RHEUMATOLOGY, V46, P1738, DOI 10.1093/rheumatology/kem229; SVENSON KLG, 1984, SCAND J RHEUMATOL, V13, P329, DOI 10.3109/03009748409111304; TERATO K, 1990, ARTHRITIS RHEUM, V33, P1493, DOI 10.1002/art.1780331006; Trentham DE, 1998, ANN INTERN MED, V129, P114, DOI 10.7326/0003-4819-129-2-199807150-00011; VANDERLUBBE PA, 1991, LANCET, V337, P1349, DOI 10.1016/0140-6736(91)93023-3; Vounotrypidis P, 2006, RHEUMATOLOGY, V45, P491, DOI 10.1093/rheumatology/kel041	38	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2009	339								b4150	10.1136/bmj.b4150	http://dx.doi.org/10.1136/bmj.b4150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AN	19864687				2022-12-28	WOS:000271365800002
J	Hwang, SW; Wilkins, R; Tjepkema, M; O'Campo, PJ; Dunn, JR				Hwang, Stephen W.; Wilkins, Russell; Tjepkema, Michael; O'Campo, Patricia J.; Dunn, James R.			Mortality among residents of shelters, rooming houses, and hotels in Canada: 11 year follow-up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOMELESS ADULTS; STREET YOUTH; HEALTH; COHORT; PEOPLE; DEATH; MEN	Objective To examine mortality in a representative nationwide sample of homeless and marginally housed people living in shelters, rooming houses, and hotels. Design Follow-up study. Setting Canada 1991-2001. Participants 15 100 homeless and marginally housed people enumerated in 1991 census. Main outcome measures Age specific and age standardised mortality rates, remaining life expectancies at age 25, and probabilities of survival from age 25 to 75. Data were compared with data from the poorest and richest income fifths as well as with data for the entire cohort Results Of the homeless and marginally housed people, 3280 died. Mortality rates among these people were substantially higher than rates in the poorest income fifth, with the highest rate ratios seen at younger ages. Among those who were homeless or marginally housed, the probability of survival to age 75 was 32% (95% confidence interval 30% to 34%) in men and 60% (56% to 63%) in women. Remaining life expectancy at age 25 was 42 years (42 to 43) and 52 years (50 to 53), respectively. Compared with the entire cohort, mortality rate ratios for men and women, respectively, were 11.5 (8.8 to 15.0) and 9.2 (5.5 to 15.2) for drug related deaths, 6.4 (5.3 to 7.7) and 8.2 (5.0 to 13.4) for alcohol related deaths, 4.8 (3.9 to 5.9) and 3.8 (2.7 to 5.4) for mental disorders, and 2.3 (1.8 to 3.1) and 5.6 (3.2 to 9.6) for suicide. For both sexes, the largest differences in mortality rates were for smoking related diseases, ischaemic heart disease, and respiratory diseases. Conclusions Living in shelters, rooming houses, and hotels is associated with much higher mortality than expected on the basis of low income alone. Reducing the excessively high rates of premature mortality in this population would require interventions to address deaths related to smoking, alcohol, and drugs, and mental disorders and suicide, among other causes.	[Hwang, Stephen W.; O'Campo, Patricia J.; Dunn, James R.] St Michaels Hosp, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [Wilkins, Russell] STAT Canada, Hlth Informat & Res Div, Ottawa, ON, Canada; [Wilkins, Russell] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Tjepkema, Michael] STAT Canada, Hlth Informat & Res Div, Toronto, ON, Canada; [Tjepkema, Michael; O'Campo, Patricia J.; Dunn, James R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [O'Campo, Patricia J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Reprod & Family Hlth, Baltimore, MD USA; [Dunn, James R.] Univ Toronto, Dept Geog & Programme Planning, Toronto, ON, Canada; [Dunn, James R.] Canadian Inst Adv Res, Successful Soc Program, Toronto, ON, Canada; [Dunn, James R.] McMaster Univ, Dept Hlth Aging & Soc, Hamilton, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Statistics Canada; University of Ottawa; Statistics Canada; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; Canadian Institute for Advanced Research (CIFAR); McMaster University	Hwang, SW (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	hwangs@smh.toronto.on.ca	Dunn, James R/G-1543-2016; Hwang, Stephen W./D-2297-2011; Hwang, Stephen W./GVR-7773-2022	Hwang, Stephen W./0000-0002-1276-1101; Dunn, James/0000-0003-1054-9956	Canadian Population Health Initiative; Canadian Institute for Health Information; Ontario Ministry of Health; Canadian Institutes of Health Research; Public Health Agency of Canada	Canadian Population Health Initiative; Canadian Institute for Health Information(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada	The Canadian census mortality follow-up study was funded by the Canadian Population Health Initiative, part of the Canadian Institute for Health Information. The Centre for Research on Inner City Health gratefully acknowledges the support of the Ontario Ministry of Health and Long-Term Care. JRD was supported by a Canadian Institutes of Health Research and Public Health Agency of Canada Chair in Applied Public Health. The authors' work was independent of the funders. The views expressed in this article are those of the authors and do not necessarily reflect the views of the above-named organizations or of the institutions with which they are affiliated.	[Anonymous], 2005, Health Stat Q, P52; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Beijer U, 2007, NORD J PSYCHIAT, V61, P363, DOI 10.1080/08039480701644637; Bourbeau R., 1997, NEW BIRTH COHORT LIF; *CAN MORTG HOUS CO, 2006, RES HIGHL PROF ROOM; Carriere KC, 1997, MED CARE, V35, P57, DOI 10.1097/00005650-199701000-00005; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Chiang CL, 1984, LIFE TABLE ITS APPL; Davey Smith G., 2003, HLTH INEQUALITIES LI; Fair M, 2004, AUSTR J STAT, V33, P37; Fair ME, 2006, OCCUPATIONAL ENV HLT; Golden A, 1999, REPORT MAYORS HOMELE; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; *HOM COUNT COMM, 2000, COUNT HOM PERS EDM; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Hwang SW, 2003, CAN J PUBLIC HEALTH, V94, P436, DOI 10.1007/BF03405081; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Kasprow WJ, 2000, J NERV MENT DIS, V188, P141, DOI 10.1097/00005053-200003000-00003; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; NAGNUR D, 1986, LONGEVITY HIST LIFE; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Riley ED, 2005, JAIDS-J ACQ IMM DEF, V38, P191, DOI 10.1097/00126334-200502010-00010; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Shaw M, 1999, ENVIRON PLANN A, V31, P2239, DOI 10.1068/a312239; Shaw M, 1998, LANCET, V352, P743, DOI 10.1016/S0140-6736(05)60868-9; *STAT CAN, 1994, COV; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Wilkins Russell, 2008, Health Rep, V19, P25	32	228	229	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2009	339								b4036	10.1136/bmj.b4036	http://dx.doi.org/10.1136/bmj.b4036			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AI	19858533	Green Published, hybrid			2022-12-28	WOS:000271365300002
J	Heinze, G; Kainz, A; Horl, WH; Oberbauer, R				Heinze, Georg; Kainz, Alexander; Hoerl, Walter H.; Oberbauer, Rainer			Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; WORKING CLASSIFICATION; EPOETIN-ALPHA; ANEMIA; SURVIVAL; TRIAL; RADIOTHERAPY; HEMATOCRIT; MANAGEMENT; PATHOLOGY	Objective To determine the optimal range of increase in haemoglobin concentration with treatment with erythropoietins that is safe and is not associated with mortality. Design Retrospective cohort study. The analysis was adjusted for several covariables with Cox regression analysis with spline functions. Use of erythropoietins, haemoglobin concentration, and covariables were included in a time varying manner; variable selection was based on the purposeful selection algorithm. Setting Transplantation centres in Austria. Participants 1794 renal transplant recipients recorded in the Austrian Dialysis and Transplant Registry who received a transplant between 1 January 1992 and 31 December 2004 and survived at least three months. Main outcome measures Survival time and haemoglobin concentration after treatment with erythropoietins. Results The prevalence of use of erythropoietins has increased over the past 15 years to 25%. Unadjusted extended Kaplan-Meier analysis suggests higher mortality in patients treated with erythropoietins, in whom 10 year survival was 57% compared with 78% in those not treated with erythropoietins (P<0.001). In the treated patients there were 5.4 events/100 person years, compared with 2.6 events/100 person years in those not treated (P<0.001). After adjustment for confounding by indication, comorbidities, comedication, and laboratory readings, haemoglobin concentrations >125 g/l were associated with increased mortality in treated patients (hazard ratio 2.8 (95% confidence interval 1.0 to 7.9) for haemoglobin concentration 140 g/l v 125 g/l), but not in those not treated (0.7, 0.4 to 1.5). When haemoglobin concentrations were 147 g/l or above, patients treated with erythropoietins showed significantly higher mortality than those who were not treated (3.0, 1.0 to 9.4). Conclusion Increasing haemoglobin concentrations to above 125 g/l with erythropoietins in renal transplant recipients is associated with an increase in mortality. This increase was significant at concentrations above 140 g/l.	[Kainz, Alexander; Hoerl, Walter H.; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, A-1090 Vienna, Austria; [Heinze, Georg] Med Univ Vienna, Core Unit Med Stat & Informat, A-1090 Vienna, Austria; [Oberbauer, Rainer] Austrian Dialysis & Transplant Registry, A-4010 Linz, Austria; [Oberbauer, Rainer] KH Elisabethinen, Dept Nephrol, A-4010 Linz, Austria	Medical University of Vienna; Medical University of Vienna; Ordensklinikum Linz Elisabethinen	Oberbauer, R (corresponding author), Med Univ Vienna, Dept Nephrol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Kainz, Alexander/AAM-7296-2021	Heinze, Georg/0000-0003-1147-8491	Austrian Science Fund [P-18325-B13]; Austrian Academy of Sciences	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences	This study was funded by the Austrian Science Fund (P-18325-B13 to R. O.) and the Austrian Academy of Sciences.	BENYAMINI Y, 1995, J R STAT SOC B, V57, P289; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2008, NEW ENGL J MED, V358, P433, DOI 10.1056/NEJMc076523; Brown ER, 2005, BIOMETRICS, V61, P64, DOI 10.1111/j.0006-341X.2005.030929.x; Churg J, 1982, RENAL DIS CLASSIFICA, P211; COX DR, 1972, J R STAT SOC B, V187, P220; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kamar N, 2008, TRANSPLANTATION, V85, P1120, DOI 10.1097/TP.0b013e31816a8a1f; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Lorenz M, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133794; Molnar MZ, 2007, AM J TRANSPLANT, V7, P818, DOI 10.1111/j.1600-6143.2006.01727.x; Overgaard J, 2007, EJC SUPPL, V5, P7, DOI 10.1016/S1359-6349(07)70099-X; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh AK, 2008, AM J KIDNEY DIS, V52, pS5, DOI 10.1053/j.ajkd.2008.09.010; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Vanrenterghem Y, 2003, AM J TRANSPLANT, V3, P835, DOI 10.1034/j.1600-6143.2003.00133.x; Winkelmayer WC, 2004, J AM SOC NEPHROL, V15, P1347, DOI 10.1097/01.ASN.0000125551.59739.2E; Winkelmayer WC, 2008, CLIN J AM SOC NEPHRO, V3, pS49, DOI 10.2215/CJN.03290807	26	61	65	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2009	339								b4018	10.1136/bmj.b4018	http://dx.doi.org/10.1136/bmj.b4018			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PP	19854839	Green Published, hybrid			2022-12-28	WOS:000271102700002
J	Larson, EB				Larson, Eric B.			Group Health Cooperative - One Coverage-and-Delivery Model for Accountable Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA	Group Health Cooperative	Larson, EB (corresponding author), Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA.							Crowley W., 1996, SERVE GREATEST NUMBE; Fisher ES, 2009, NEW ENGL J MED, V360, P2495, DOI 10.1056/NEJMp0903923; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Starr P, 1982, SOCIAL TRANSFORMATIO	5	7	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1620	1622		10.1056/NEJMp0909021	http://dx.doi.org/10.1056/NEJMp0909021			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508YW	19846846				2022-12-28	WOS:000270977400002
J	Keiser, MJ; Setola, V; Irwin, JJ; Laggner, C; Abbas, AI; Hufeisen, SJ; Jensen, NH; Kuijer, MB; Matos, RC; Tran, TB; Whaley, R; Glennon, RA; Hert, J; Thomas, KLH; Edwards, DD; Shoichet, BK; Roth, BL				Keiser, Michael J.; Setola, Vincent; Irwin, John J.; Laggner, Christian; Abbas, Atheir I.; Hufeisen, Sandra J.; Jensen, Niels H.; Kuijer, Michael B.; Matos, Roberto C.; Tran, Thuy B.; Whaley, Ryan; Glennon, Richard A.; Hert, Jerome; Thomas, Kelan L. H.; Edwards, Douglas D.; Shoichet, Brian K.; Roth, Bryan L.			Predicting new molecular targets for known drugs	NATURE			English	Article							SEROTONIN RECEPTORS; REUPTAKE INHIBITOR; CHEMICAL BIOLOGY; DOUBLE-BLIND; AGONIST; N,N-DIMETHYLTRYPTAMINE; HALLUCINOGEN; PHARMACOLOGY; PROMISCUITY; MECHANISM	Although drugs are intended to be selective, at least some bind to several physiological targets, explaining side effects and efficacy. Because many drug-target combinations exist, it would be useful to explore possible interactions computationally. Here we compared 3,665 US Food and Drug Administration (FDA)-approved and investigational drugs against hundreds of targets, defining each target by its ligands. Chemical similarities between drugs and ligand sets predicted thousands of unanticipated associations. Thirty were tested experimentally, including the antagonism of the beta(1) receptor by the transporter inhibitor Prozac, the inhibition of the 5-hydroxytryptamine (5-HT) transporter by the ion channel drug Vadilex, and antagonism of the histamine H-4 receptor by the enzyme inhibitor Rescriptor. Overall, 23 new drug-target associations were confirmed, five of which were potent (<100 nM). The physiological relevance of one, the drug N,N-dimethyltryptamine (DMT) on serotonergic receptors, was confirmed in a knockout mouse. The chemical similarity approach is systematic and comprehensive, and may suggest side-effects and new indications for many drugs.	[Keiser, Michael J.; Irwin, John J.; Laggner, Christian; Hert, Jerome; Thomas, Kelan L. H.; Edwards, Douglas D.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Keiser, Michael J.] Univ Calif San Francisco, Grad Grp Bioinformat, San Francisco, CA 94143 USA; [Setola, Vincent; Kuijer, Michael B.; Matos, Roberto C.; Tran, Thuy B.; Whaley, Ryan; Roth, Bryan L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Cleveland, OH 44106 USA; [Abbas, Atheir I.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Hufeisen, Sandra J.; Jensen, Niels H.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Div Med Chem & Nat Prod, Chapel Hill, NC 27759 USA; [Hufeisen, Sandra J.; Jensen, Niels H.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC 27759 USA; [Glennon, Richard A.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Thomas, Kelan L. H.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Virginia Commonwealth University; University of Michigan System; University of Michigan	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94143 USA.	shoichet@cgl.ucsf.edu; bryan_roth@med.unc.edu	Abbas, Atheir/AAI-2158-2019; Roth, Bryan L/F-3928-2010; Thomas, Kelan/AAZ-8575-2021; Keiser, Michael J./F-2825-2016; Hert, Jerome/A-8158-2008; Roth, Bryan/ABE-7032-2020	Thomas, Kelan/0000-0003-2818-270X; Keiser, Michael J./0000-0002-1240-2192; Roth, Bryan/0000-0002-0561-6520; Irwin, John/0000-0002-1195-6417; Abbas, Atheir/0000-0002-7080-3509; Setola, Vincent/0000-0002-9791-2270; Hert/0000-0003-3062-8029	National Institutes of Health (NIH); National Science Foundation; European Commission; Max Kade Foundation; NARSAD; Michael Hooker Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Kade Foundation; NARSAD(NARSAD); Michael Hooker Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the National Institutes of Health (NIH) supporting chemoinformatics (to B. K. S. and J. J. I.) and NIH grants and contracts supporting drug discovery and receptor pharmacology (to B. L. R). M. J. K., J. H. and C. L. were supported by fellowships from the National Science Foundation, the 6th FP of the European Commission, and the Max Kade Foundation, respectively. B. L. R. was also supported by a Distinguished Investigator Award from the NARSAD and the Michael Hooker Chair. We thank T. Oprea of Sunset Molecular for WOMBAT, Elsevier MDL for the MDDR, Scitegic for PipelinePilot, J. Overington of the European Bioinformatics Institute (EMBL-EBI) for StARlite, Daylight Chemical Information Systems Inc. for the Daylight toolkit, and J. Gingrich for 5-HT2A knockout mice.	Abbas AI, 2009, J NEUROSCI, V29, P7124, DOI 10.1523/JNEUROSCI.1090-09.2009; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bajorath J, 2008, CURR OPIN CHEM BIOL, V12, P352, DOI 10.1016/j.cbpa.2008.01.044; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Dijkstra D, 2008, J INVEST DERMATOL, V128, P1696, DOI 10.1038/sj.jid.5701250; Ehrlich P., 1911, FOLIASEROLOGICA, V7, P697; *FDA, 2004, TALK PAP FDA WARNS W; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gankina E. M., 1993, Eksperimental'naya i Klinicheskaya Farmakologiya, V56, P22; Gankina E. M., 1992, PHARM CHEM J, V26, P373; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; HEYKANTS J, 1981, European Journal of Drug Metabolism and Pharmacokinetics, V6, P61; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JAMES C, 1992, DAYLIGHT THEORY MANU; Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kohen R, 1996, J NEUROCHEM, V66, P47; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; KURLAND A A, 1962, J New Drugs, V2, P352, DOI 10.1177/009127006200200605; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; Marona-Lewicka D, 2007, PHARMACOL BIOCHEM BE, V87, P453, DOI 10.1016/j.pbb.2007.06.001; Marona-Lewicka D, 2009, BEHAV PHARMACOL, V20, P114, DOI 10.1097/FBP.0b013e3283242f1a; MASANORI I, 1987, BIOCHEM PHARMACOL, V36, P1947; MEHVAR R, 1987, DRUG METAB DISPOS, V15, P250; Michelson D, 2000, BRIT J PSYCHIAT, V176, P363, DOI 10.1192/bjp.176.4.363; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Nigsch F, 2008, J CHEM INF MODEL, V48, P2313, DOI 10.1021/ci800079x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Olah M., 2007, CHEM BIOL SMALL MOL, P760; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Peterson RT, 2008, NAT CHEM BIOL, V4, P635, DOI 10.1038/nchembio1108-635; PIERCE PA, 1989, PSYCHOPHARMACOLOGY, V97, P118, DOI 10.1007/BF00443425; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Schuffenhauer A, 2002, J CHEM INF COMP SCI, V42, P947, DOI 10.1021/ci010385k; Scott LJ, 2000, DRUGS, V60, P1411, DOI 10.2165/00003495-200060060-00013; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel MG, 2007, DRUG DISCOV TODAY, V12, P71, DOI 10.1016/j.drudis.2006.11.011; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Stork D, 2007, BRIT J PHARMACOL, V151, P1368, DOI 10.1038/sj.bjp.0707356; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004; Walsh CT, 2009, P NATL ACAD SCI USA, V106, P1689, DOI 10.1073/pnas.0813405106; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	53	1167	1203	7	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					175	U48		10.1038/nature08506	http://dx.doi.org/10.1038/nature08506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19881490	Green Accepted, Green Submitted			2022-12-28	WOS:000271655100034
J	Di Angelantonio, E; Sarwar, N; Perry, P; Kaptoge, S; Ray, KK; Thompson, A; Wood, AM; Lewington, S; Sattar, N; Packard, CJ; Collins, R; Thompson, SG; Danesh, J				Di Angelantonio, Emanuele; Sarwar, Nadeem; Perry, Philip; Kaptoge, Stephen; Ray, Kausik K.; Thompson, Alexander; Wood, Angela M.; Lewington, Sarah; Sattar, Naveed; Packard, Chris J.; Collins, Rory; Thompson, Simon G.; Danesh, John		Emerging Risk Factors Collaboratio	Major Lipids, Apolipoproteins, and Risk of Vascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; ASSOCIATION; CORONARY; STROKE; PARTICIPANTS	Context Associations of major lipids and apolipoproteins with the risk of vascular disease have not been reliably quantified. Objective To assess major lipids and apolipoproteins in vascular risk. Design, Setting, and Participants Individual records were supplied on 302 430 people without initial vascular disease from 68 long-term prospective studies, mostly in Europe and North America. During 2.79 million person-years of follow-up, there were 8857 nonfatal myocardial infarctions, 3928 coronary heart disease [CHD] deaths, 2534 ischemic strokes, 513 hemorrhagic strokes, and 2536 unclassified strokes. Main Outcome Measures Hazard ratios (HRs), adjusted for several conventional factors, were calculated for 1-SD higher values: 0.52 log(e) triglyceride, 15 mg/dL high-density lipoprotein cholesterol (HDL-C), 43 mg/dL non-HDL-C, 29 mg/dL apolipoprotein AI, 29 mg/dL apolipoprotein B, and 33 mg/dL directly measured low-density lipoprotein cholesterol (LDL-C). Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. Results The rates of CHD per 1000 person-years in the bottom and top thirds of baseline lipid distributions, respectively, were 2.6 and 6.2 with triglyceride, 6.4 and 2.4 with HDL-C, and 2.3 and 6.7 with non-HDL-C. Adjusted HRs for CHD were 0.99 (95% CI, 0.94-1.05) with triglyceride, 0.78 (95% CI, 0.74-0.82) with HDL-C, and 1.50 (95% CI, 1.39-1.61) with non-HDL-C. Hazard ratios were at least as strong in participants who did not fast as in those who did. The HR for CHD was 0.35 (95% CI, 0.30-0.42) with a combination of 80 mg/dL lower non-HDL-C and 15 mg/dL higher HDL-C. For the subset with apolipoproteins or directly measured LDL-C, HRs were 1.50 (95% CI, 1.38-1.62) with the ratio non-HDL-C/HDL-C, 1.49 (95% CI, 1.39-1.60) with the ratio apo B/apo AI, 1.42 (95% CI, 1.06-1.91) with non-HDL-C, and 1.38 (95% CI, 1.09-1.73) with directly measured LDL-C. Hazard ratios for ischemic stroke were 1.02 (95% CI, 0.94-1.11) with triglyceride, 0.93 (95% CI, 0.84-1.02) with HDL-C, and 1.12 (95% CI, 1.04-1.20) with non-HDL-C. Conclusion Lipid assessment in vascular disease can be simplified by measurement of either total and HDL cholesterol levels or apolipoproteins without the need to fast and without regard to triglyceride. JAMA. 2009; 302(18): 1993-2000	[Danesh, John] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England; [Lewington, Sarah; Collins, Rory] Univ Oxford, Oxford, England; [Sattar, Naveed; Packard, Chris J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; University of Oxford; University of Glasgow; MRC Biostatistics Unit	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Benn, Marianne/O-4164-2019; Meisinger, Christine/B-5358-2014; Ulmer, Hanno/S-6615-2019; Lennon, Lucy/ABB-9433-2020; Tanne, David/F-2560-2010; Brunner, Eric/H-2114-2011; Gudnason, Vilmundur/K-6885-2015; Tikhonoff, Valerie/AAC-3728-2019; Marmot, M G/Y-3920-2019; de la Camara, Agustin Gomez/S-7123-2018; Lamarche, Benoit/ABA-4785-2021; DiAngelantonio, Emanuele/ABE-6852-2020; Thompson, Alexander/A-6109-2010; vhmpp, aks/F-9756-2012; Wood, Angela/GZA-5762-2022; Ray, Kausik/Z-2055-2019; Dankner, Rachel/Q-5245-2019; Stefanadis, Christodoulos/ABH-2232-2020	Benn, Marianne/0000-0002-1701-595X; Ulmer, Hanno/0000-0001-5911-1002; Lennon, Lucy/0000-0002-1738-1351; Tanne, David/0000-0002-6699-2220; Brunner, Eric/0000-0002-0595-4474; Gudnason, Vilmundur/0000-0001-5696-0084; Tikhonoff, Valerie/0000-0001-7846-0101; Marmot, M G/0000-0002-2431-6419; Lamarche, Benoit/0000-0002-4443-5378; Wood, Angela/0000-0002-7937-304X; Dankner, Rachel/0000-0001-6454-6000; Amouyel, Philippe/0000-0001-9088-234X; Woodward, Mark/0000-0001-9800-5296; Pennells, Lisa Anne/0000-0002-8594-3061; White, Ian/0000-0002-6718-7661; Chen, Zhengming/0000-0001-6423-105X; Di Angelantonio, Emanuele/0000-0001-8776-6719; Bladbjerg, Else Marie/0000-0003-0912-2437; Ramachandran, Vasan/0000-0001-7357-5970; Jorgensen, Torben/0000-0001-9453-2830; Lawlor, Debbie A/0000-0002-6793-2262; Jespersen, Jorgen/0000-0002-3059-2356; Whincup, Peter/0000-0002-5589-4107; Sutherland, Susan/0000-0001-7184-8920; Wensley, Frances/0000-0003-4371-5340; Lewington, Sarah/0000-0002-4496-4771; Rothenbacher, Dietrich/0000-0002-3563-2791; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Stefanadis, Christodoulos/0000-0001-5974-6454; Engstrom, Gunnar/0000-0002-8618-9152	British Heart Foundation [RG/08/014]; UK Medical Research Council; BUPA Foundation; GlaxoSmithKline; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600705, MC_U137686853, G0501792, MC_U105260792, MC_U137686857, MC_U137686851] Funding Source: UKRI; British Heart Foundation [RG/08/013/25942, RG/08/014/24067, RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U137686857, MC_U105260792, G19/35, MC_U137686853, G0401527, G0100222, G8802774, MC_U137686851, G0501792, G0600705] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; GlaxoSmithKline(GlaxoSmithKline); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The ERFC Coordinating Centre is underpinned by a program grant from the British Heart Foundation (RG/08/014) and supported by grants from the UK Medical Research Council and the BUPA Foundation and an unrestricted educational grant from GlaxoSmithKline. A variety of sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://www.phpc.cam.ac.uk/MEU/. Drs Di Angelantonio, Sarwar, Perry, and Thompson have been supported by PhD studentships of the UK Medical Research Council. Dr Ray is supported by a BHF Intermediate Research Fellowship.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2008, AM J CARDIOL, V101, P1428, DOI 10.1016/j.amjcard.2008.02.092; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CLINICALTRIALS GO, TREATM HDL RED INC V; *CLINICALTRIALS GO, AIM HIGH NIAC PLUS S; *CLINICALTRIALS GO, STUDY RO4607381 STAB; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Parish S, 2009, EUR HEART J, V30, P2137, DOI 10.1093/eurheartj/ehp221; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Tirschwell DL, 2004, NEUROLOGY, V63, P1868, DOI 10.1212/01.WNL.0000144282.42222.DA; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233	34	1821	1863	7	174	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1993	2000						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903920	Green Accepted, Green Published			2022-12-28	WOS:000271619700026
J	Astrup, A; Rossner, S; Van Gaal, L; Rissanen, A; Niskanen, L; Al Hakim, M; Madsen, J; Rasmussen, MF; Lean, MEJ				Astrup, Arne; Rossner, Stephan; Van Gaal, Luc; Rissanen, Aila; Niskanen, Leo; Al Hakim, Mazin; Madsen, Jesper; Rasmussen, Mads F.; Lean, Michael E. J.		NN8022-1807 Study Grp	Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; QUALITY-OF-LIFE; HUMAN GLP-1 ANALOG; GLYCEMIC CONTROL; ENERGY-INTAKE; BODY-WEIGHT; INSULIN-SECRETION; PLASMA-GLUCOSE; FOOD-INTAKE	Background The frequency of obesity has risen dramatically in recent years but only few safe and effective drugs are currently available. We assessed the effect of liraglutide on bodyweight and tolerability in obese individuals without type 2 diabetes. Methods We did a double-blind, placebo-controlled 20-week trial, with open-label orlistat comparator in 19 sites in Europe. 564 individuals (18-65 years of age, body-mass index 30-40 kg/m(2)) were randomly assigned, with a telephone or web-based system, to one of four liraglutide doses (1.2 mg, 1.8 mg, 2.4 mg, or 3.0 mg, n=90-95) or to placebo (n=98) administered once a day subcutaneously, or orlistat (120 mg, n=95) three times a day orally. All individuals had a 500 kcal per day energy-deficit diet and increased their physical activity throughout the trial, including the 2-week run-in. Weight change analysed by intention to treat was the primary endpoint. An 84-week open-label extension followed. This study is registered with ClinicalTrials.gov, number NCT00422058. Findings Participants on liraglutide lost significantly more weight than did those on placebo (p=0.003 for liraglutide 1.2 mg and p<0.0001 for liraglutide 1.8-3.0 mg) and orlistat (p=0.003 for liraglutide 2.4 mg and p<0.0001 for liraglutide 3.0 mg). Mean weight loss with liraglutide 1.2-3.0 mg was 4.8 kg, 5.5 kg, 6.3 kg, and 7.2 kg compared with 2.8 kg with placebo and 4.1 kg with orlistat, and was 2.1 kg (95% CI 0.6-3.6) to 4.4 kg (2.9-6.0) greater than that with placebo. More individuals (76%, n=70) lost more than 5% weight with liraglutide 3.0 mg that with placebo (30%, n=29) or orlistat (44%, n=42). Liraglutide reduced blood pressure at all doses, and reduced the prevalence of prediabetes (84-96% reduction) with 1.8-3.0 mg per day. Nausea and vomiting occurred more often in individuals on liraglutide than in those on placebo, but adverse events were mainly transient and rarely led to discontinuation of treatment. Interpretation Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity-related risk factors, and reduces prediabetes.	[Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, DK-1958 Frederiksberg, Denmark; [Rossner, Stephan] Karolinska Univ Hosp, Obes Unit, Huddinge, Sweden; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Diabet Endocrinol & Metab, Antwerp, Belgium; [Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Niskanen, Leo] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Al Hakim, Mazin] EB FlevoRes, Dept Med, Almere, Netherlands; [Madsen, Jesper] Novo Nordisk AS, Dept Biostat, DK-2880 Bagsvaerd, Denmark; [Rasmussen, Mads F.] Novo Nordisk AS, Med & Sci, DK-2880 Bagsvaerd, Denmark; [Lean, Michael E. J.] Univ Glasgow, Glasgow Royal Infirm, Dept Human Nutr, Glasgow G31 2ER, Lanark, Scotland	University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; University of Antwerp; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Novo Nordisk; Novo Nordisk; University of Glasgow	Astrup, A (corresponding author), Univ Copenhagen, Dept Human Nutr, Fac Life Sci, Rolighedsvej 30, DK-1958 Frederiksberg, Denmark.	ast@life.ku.dk	Ridderstråle, Martin/F-7678-2012; Svacina, Stepan/C-1962-2017; Finer, Nicholas/B-9981-2009; Astrup, Arne/B-1407-2015	Svacina, Stepan/0000-0002-0894-4116; Finer, Nicholas/0000-0003-2468-6804; Astrup, Arne/0000-0001-8968-8996; Carraro, Raffaele/0000-0002-5874-8076; Madsbad, Sten/0000-0002-5017-1815	Novo Nordisk A/S, Bagsvaerd, Denmark	Novo Nordisk A/S, Bagsvaerd, Denmark(Novo Nordisk)	Funding Novo Nordisk A/S, Bagsvaerd, Denmark.	Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Courreges JP, 2008, DIABETIC MED, V25, P1129, DOI 10.1111/j.1464-5491.2008.02484.x; Degn KB, 2004, DIABETES, V53, P1187, DOI 10.2337/diabetes.53.5.1187; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Garber AJ, 2009, DIABETES, V58, pA42; Genuth S, 2003, DIABETES CARE, V26, P3160; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; Harder H, 2004, DIABETES CARE, V27, P1915, DOI 10.2337/diacare.27.8.1915; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; *INT C HARM, ICH HARM TRIP GUID G; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kaukua J, 2003, INT J OBESITY, V27, P1072, DOI 10.1038/sj.ijo.0802366; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Larsen PJ, 2001, DIABETES, V50, P2530, DOI 10.2337/diabetes.50.11.2530; LEAN MEJ, 1986, LANCET, V1, P723; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Madsbad S, 2004, DIABETES CARE, V27, P1335, DOI 10.2337/diacare.27.6.1335; Madsbad Sten, 2009, Expert Rev Endocrinol Metab, V4, P119, DOI 10.1586/17446651.4.2.119; Mari A, 2007, DIABETES CARE, V30, P2032, DOI 10.2337/dc07-0310; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mensah GA., 2004, ATLAS HEART DIS STRO; Naslund E, 1999, INT J OBESITY, V23, P304, DOI 10.1038/sj.ijo.0800818; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pi-Sunyer FX, 2008, POSTGRAD MED, V120, P5, DOI 10.3810/pgm.2008.07.1785; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Raun K, 2007, OBESITY, V15, P1710, DOI 10.1038/oby.2007.204; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VanGaal LF, 1997, INT J OBESITY, V21, pS5; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vilsboll T, 2008, DIABETIC MED, V25, P152, DOI 10.1111/j.1464-5491.2007.02333.x; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; York DA, 2004, CIRCULATION, V110, pE463, DOI 10.1161/01.CIR.0000140125.26161.49; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zelissen PMJ, 2005, DIABETES OBES METAB, V7, P755, DOI 10.1111/j.1463-1326.2005.00468.x	46	706	739	1	112	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1606	1616		10.1016/S0140-6736(09)61375-1	http://dx.doi.org/10.1016/S0140-6736(09)61375-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19853906				2022-12-28	WOS:000271674600034
J	Lipsman, N				Lipsman, Nir			Curtains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												nir.lipsman@utoronto.ca							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1845	1845		10.1001/jama.2009.1537	http://dx.doi.org/10.1001/jama.2009.1537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19887655				2022-12-28	WOS:000271375300001
J	Thomsen, ND; Berger, JM				Thomsen, Nathan D.; Berger, James M.			Running in Reverse: The Structural Basis for Translocation Polarity in Hexameric Helicases	CELL			English	Article							TRANSCRIPTION-TERMINATION FACTOR; RHO-DEPENDENT TERMINATION; ESCHERICHIA-COLI RHO; RNA PACKAGING MOTOR; SINGLE-STRANDED-DNA; BINDING SITE; ATP-BINDING; MACROMOLECULAR MACHINES; CRYSTAL-STRUCTURE; ARCHAEAL MCM	Hexameric helicases couple ATP hydrolysis to processive separation of nucleic acid duplexes, a process critical for gene expression, DNA replication, and repair. All hexameric helicases fall into two families with opposing translocation polarities: the 30/50 AAA+ and 5'/3' RecA-like enzymes. To understand how a RecA-like hexameric helicase engages and translocates along substrate, we determined the structure of the E. coli Rho transcription termination factor bound to RNA and nucleotide. Interior nucleic acid-binding elements spiral around six bases of RNA in a manner unexpectedly reminiscent of an AAA+ helicase, the papillomavirus E1 protein. Four distinct ATP-binding states, representing potential catalytic intermediates, are coupled to RNA positioning through a complex allosteric network. Comparative studies with E1 suggest that RecA and AAA+ hexameric helicases use different portions of their chemomechanical cycle for translocating nucleic acid and track in opposite directions by reversing the firing order of ATPase sites around the hexameric ring. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Thomsen, Nathan D.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Quantitat Biosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Quantitat Biosci Inst, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NIH [GM071747]; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Keck, Andreas Martin, Allyn Schoeffler, and Nancy Crisona for helpful discussions and editing of the manuscript and Emmanuel Skordalakes and Berger lab members for assistance in various stages of the project. Special thanks go to the staff at SSRL beamlines 9.2 and 11.1; Scott Classen, George Meigs, and James Holton at ALS beamlines 12.3.1 and 8.3.1; Steve Gamblin for assistance with data processing; and Nat Echols for assistance with programs from the Yale Morph Server. This work was supported by funding from the NIH (GM071747) and the G. Harold and Leila Y. Mathers Foundation.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; DeLano W.L, PYMOL MOL GRAPHICS S; DOLAN JW, 1990, J BIOL CHEM, V265, P5747; DOMBROSKI AJ, 1988, P NATL ACAD SCI USA, V85, P2538, DOI 10.1073/pnas.85.8.2538; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Huiskonen JT, 2007, J STRUCT BIOL, V158, P156, DOI 10.1016/j.jsb.2006.08.021; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; LAU LF, 1983, J BIOL CHEM, V258, P9391; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; MORGAN WD, 1983, J BIOL CHEM, V258, P9565; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON JP, 1986, J MOL BIOL, V189, P413, DOI 10.1016/0022-2836(86)90313-X; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sakakibara N, 2009, BIOCHEMISTRY-US, V48, P2330, DOI 10.1021/bi801921j; SEIFRIED SE, 1992, P NATL ACAD SCI USA, V89, P10454, DOI 10.1073/pnas.89.21.10454; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Weber TP, 2003, BIOCHEMISTRY-US, V42, P1652, DOI 10.1021/bi020601y; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Xu Y, 2003, J BIOL CHEM, V278, P13719, DOI 10.1074/jbc.M212979200	67	221	223	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					523	534		10.1016/j.cell.2009.08.043	http://dx.doi.org/10.1016/j.cell.2009.08.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879839	Green Accepted, Bronze			2022-12-28	WOS:000271259600017
J	Martins, N; Morris, P; Kelly, PM				Martins, Nelson; Morris, Peter; Kelly, Paul M.			Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PULMONARY TUBERCULOSIS; MICRONUTRIENT SUPPLEMENTATION; DOUBLE-BLIND; VITAMIN-A; ADULTS; MORTALITY; THERAPY; MALNUTRITION; ADHERENCE; MWANZA	Objective To determine the effectiveness of the provision of whole food to enhance completion of treatment for tuberculosis. Design Parallel group randomised controlled trial. Setting Three primary care clinics in Dili, Timor-Leste. Participants 270 adults aged >= 18 with previously untreated newly diagnosed pulmonary tuberculosis. Main outcome measures Completion of treatment (including cure). Secondary outcomes included adherence to treatment, weight gain, and clearance of sputum smears. Outcomes were assessed remotely, blinded to allocation status. Interventions Participants started standard tuberculosis treatment and were randomly assigned to intervention (nutritious, culturally appropriate daily meal (weeks 1-8) and food package (weeks 9-32) (n=137) or control (nutritional advice, n=133) groups. Randomisation sequence was computer generated with allocation concealment by sequentially numbered, opaque, sealed envelopes. Results Most patients with tuberculosis were poor, malnourished men living close to the clinics; 265/270 (98%) contributed to the analysis. The intervention had no significant beneficial or harmful impact on the outcome of treatment (76% v 78% completion, P=0.7) or adherence (93% for both groups, P=0.7) but did lead to improved weight gain at the end of treatment (10.1% v 7.5% improvement, P=0.04). Itch was more common in the intervention group (21% v 9%, P<0.01). In a subgroup analysis of patients with positive results on sputum smears, there were clinically important improvements in one month sputum clearance (85% v 67%, P=0.13) and completion of treatment (78% v 68%, P=0.3). Conclusion Provision of food did not improve outcomes with tuberculosis treatment in these patients in Timor-Leste. Further studies in different settings and measuring different outcomes are required.	[Martins, Nelson; Morris, Peter; Kelly, Paul M.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Martins, Nelson; Morris, Peter] Charles Darwin Univ, Inst Adv Studies, Darwin, NT 0909, Australia; [Martins, Nelson] Univ Da Paz, Fac Saude Publ, Dili, Timor Leste, Australia; [Martins, Nelson] Minist Hlth, Dili, Timor Leste, Australia; [Morris, Peter] Flinders Univ S Australia, No Terr Clin Sch, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Flinders University South Australia; Northern Territory Government	Kelly, PM (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Coll Med Biol & Environm, Bldg 62,Corner Mills & Eggleston Rds, Canberra, ACT 0200, Australia.	paul.kelly@anu.edu.au		Martins, Nelson/0000-0002-6699-7603	Unicef/UNDP/World Bank/WHO; Australia's National Health and Medical Research Council	Unicef/UNDP/World Bank/WHO(World Health Organization); Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the Unicef/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, which also provided a PhD scholarship for NM. Australia's National Health and Medical Research Council provides salary support for PMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub2; *AS DEV BANK, 2009, TIMORLESTE COUNTR IN; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Hanekom WA, 1997, J PEDIATR-US, V131, P925, DOI 10.1016/S0022-3476(97)70046-5; Karyadi E, 2002, AM J CLIN NUTR, V75, P720, DOI 10.1093/ajcn/75.4.720; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Kelly PM, 2002, INT J TUBERC LUNG D, V6, P980; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Liu Q, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub2; Martins N, 2008, INT J TUBERC LUNG D, V12, P532; Martins N, 2006, INT J TUBERC LUNG D, V10, P975; Morcos M M, 1998, Boll Chim Farm, V137, P157; NHMRC (National Health and Medical Research Council), 2006, NUTR REF VAL AUSTR N; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Papathakis P, 2008, US AGENCY INT DEV AF, P145; Paton NI, 2004, AM J CLIN NUTR, V80, P460, DOI 10.1093/ajcn/80.2.460; Perez-Guzman C, 2005, CHEST, V127, P643, DOI 10.1378/chest.127.2.643; Range N, 2006, BRIT J NUTR, V95, P762, DOI 10.1079/BJN20051684; Range N, 2005, TROP MED INT HEALTH, V10, P826, DOI 10.1111/j.1365-3156.2005.01463.x; Schon T, 2003, EUR RESPIR J, V21, P483, DOI 10.1183/09031936.03.00090702; Semba RD, 2007, INT J TUBERC LUNG D, V11, P854; Seyedrezazadeh E, 2008, RESPIROLOGY, V13, P294, DOI 10.1111/j.1440-1843.2007.01200.x; van Lettow M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-61; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; WHO, 2008, GLOBAL TUBERCULOSIS; World Health Organization, 2008, GLOB DAT BOD MASS IN; ZWI AB, 2007, TIMORLESTE HLTH SECT	31	57	58	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2009	339								b4248	10.1136/bmj.b4248	http://dx.doi.org/10.1136/bmj.b4248			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AI	19858174	Green Published, hybrid			2022-12-28	WOS:000271365300005
J	Min, W; Lu, SJ; Chong, SS; Roy, R; Holtom, GR; Xie, XS				Min, Wei; Lu, Sijia; Chong, Shasha; Roy, Rahul; Holtom, Gary R.; Xie, X. Sunney			Imaging chromophores with undetectable fluorescence by stimulated emission microscopy	NATURE			English	Article							RAMAN-SCATTERING MICROSCOPY; TOLUIDINE BLUE; SPECTROSCOPY; BIOLOGY; CELLS	Fluorescence, that is, spontaneous emission, is generally more sensitive than absorption measurement, and is widely used in optical imaging(1,2). However, many chromophores, such as haemoglobin and cytochromes, absorb but have undetectable fluorescence because the spontaneous emission is dominated by their fast non-radiative decay(3). Yet the detection of their absorption is difficult under a microscope. Here we use stimulated emission, which competes effectively with the nonradiative decay, to make the chromophores detectable, and report a new contrast mechanism for optical microscopy. In a pump-probe experiment, on photoexcitation by a pump pulse, the sample is stimulated down to the ground state by a time-delayed probe pulse, the intensity of which is concurrently increased. We extract the miniscule intensity increase with shot-noise-limited sensitivity by using a lock-in amplifier and intensity modulation of the pump beam at a high megahertz frequency. The signal is generated only at the laser foci owing to the nonlinear dependence on the input intensities, providing intrinsic three-dimensional optical sectioning capability. In contrast, conventional one-beam absorption measurement exhibits low sensitivity, lack of three-dimensional sectioning capability, and complication by linear scattering of heterogeneous samples. We demonstrate a variety of applications of stimulated emission microscopy, such as visualizing chromoproteins, non-fluorescent variants of the green fluorescent protein, monitoring lacZ gene expression with a chromogenic reporter, mapping transdermal drug distributions without histological sectioning, and label-free microvascular imaging based on endogenous contrast of haemoglobin. For all these applications, sensitivity is orders of magnitude higher than for spontaneous emission or absorption contrast, permitting non-fluorescent reporters for molecular imaging.	[Min, Wei; Lu, Sijia; Chong, Shasha; Roy, Rahul; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Wei, Min/GSI-8510-2022; Roy, Rahul/D-5329-2009; Roy, Rahul/Y-5878-2019	Roy, Rahul/0000-0003-3329-8803; Roy, Rahul/0000-0003-3329-8803; Chong, Shasha/0000-0002-5372-311X	National Science Foundation [CHE-0634788]; US Department of Energy's Basic Energy Sciences Program [DE-FG02-07ER15875]	National Science Foundation(National Science Foundation (NSF)); US Department of Energy's Basic Energy Sciences Program(United States Department of Energy (DOE))	We thank K. Lukyanov and A. Miyawaki for the gifts of chromoprotein gtCP and cjBlue plasmid DNA, respectively; Coherent Inc. for lending us a femtosecond optical parametric oscillator; and P. Choi for preparing X-gal E. coli cells. We also thank B. G. Saar, C. W. Freudiger, S. Basu, J. W. Lichtman and C. B. Schaffer for discussions, and R. Tsien for suggesting the use of chromoproteins. This work was supported by a National Science Foundation ( grant CHE-0634788) and the US Department of Energy's Basic Energy Sciences Program (DE-FG02-07ER15875).	[Anonymous], 1991, MODERN MOL PHOTOCHEM; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CANTOR CR, 1980, BIOPHYSICAL CHEM, P361; Chan MCY, 2006, J BIOL CHEM, V281, P37813, DOI 10.1074/jbc.M606921200; Chelvanayagam DK, 1997, J NEUROSCI METH, V72, P49, DOI 10.1016/S0165-0270(96)00155-0; Clay GO, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2404678; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dong CY, 1995, BIOPHYS J, V69, P2234, DOI 10.1016/S0006-3495(95)80148-7; Du H, 1998, PHOTOCHEM PHOTOBIOL, V68, P141, DOI 10.1562/0031-8655(1998)068<0141:PACADA>2.3.CO;2; Einstein A, 1917, PHYS Z, V18, P121; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2007, OPT LETT, V32, P2641, DOI 10.1364/OL.32.002641; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HAMILTON CE, 1986, ANNU REV PHYS CHEM, V37, P493; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Miller J. M., 1972, EXPT MOL GNETICS, P171; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Rittweger E, 2007, CHEM PHYS LETT, V442, P483, DOI 10.1016/j.cplett.2007.06.017; SEIGMAN AE, 1986, LASERS, P264; Tremblay JF, 2002, PHOTOCH PHOTOBIO SCI, V1, P852, DOI 10.1039/b204385h; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Ye J, 1998, J OPT SOC AM B, V15, P6, DOI 10.1364/JOSAB.15.000006; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	29	223	229	7	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1105	1109		10.1038/nature08438	http://dx.doi.org/10.1038/nature08438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847261	Green Submitted			2022-12-28	WOS:000270987600040
J	Esserman, L; Shieh, Y; Thompson, I				Esserman, Laura; Shieh, Yiwey; Thompson, Ian			Rethinking Screening for Breast Cancer and Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA IN-SITU; UNITED-STATES; ACTIVE SURVEILLANCE; ADJUVANT THERAPY; SEATTLE AREA; RISK; MORTALITY; PREVENTION; WOMEN; MAMMOGRAPHY	After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. JAMA. 2009;302(15):1685-1692	[Esserman, Laura] Univ Calif San Francisco, Carol Franc Buck Canc Ctr, Dept Surg & Radiol, San Francisco, CA 94115 USA; [Shieh, Yiwey] Univ Calif San Francisco, Sch Med, San Francisco, CA 94115 USA; [Thompson, Ian] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio	Esserman, L (corresponding author), Univ Calif San Francisco, Carol Franc Buck Canc Ctr, Dept Surg & Radiol, 1600 Divisadero St,Box 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org		Shieh, Yiwey/0000-0002-0159-7748	 [U01CA111234];  [U01CA086402]; NATIONAL CANCER INSTITUTE [U01CA111234, U01CA086402] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This article grew out of collaboration initiated within the Early Detection Research Network and was supported by grants U01CA111234 and U01CA086402.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; *ATHENA BREAST HLT, 2009, ATHENA BREAST HLTH N; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Burnside E, 2001, Clin Breast Cancer, V2, P145, DOI 10.3816/CBC.2001.n.019; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; ESSERMAN LJ, 2009, J CLIN ONCOL S, V27; FRIDLAND J, 2008, AM SOC CLIN ONC 2008; Garwood ER, 2009, ANN SURG, V249, P26, DOI 10.1097/SLA.0b013e31818e41a7; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Gotzsche PC, 2006, COCHRANE DB SYST REV; Grove AS, 2005, JAMA-J AM MED ASSOC, V294, P490, DOI 10.1001/jama.294.4.490; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Hwang ES, 2004, ANN SURG ONCOL, V11, p37S, DOI 10.1007/BF02524794; IKEDA DM, 1992, AM J ROENTGENOL, V159, P287, DOI 10.2214/ajr.159.2.1632342; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Klotz L, 2008, WORLD J UROL, V26, P437, DOI 10.1007/s00345-008-0330-8; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; Lin C, 2009, J CLIN ONCOL, V27; Logothetis CJ, 2008, CANCER PREV RES, V1, P151, DOI 10.1158/1940-6207.CAPR-08-0085; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Lu-Yao G, 2008, J GEN INTERN MED, V23, P1809, DOI 10.1007/s11606-008-0785-8; Lucia MS, 2008, CANCER PREV RES, V1, P167, DOI 10.1158/1940-6207.CAPR-08-0078; LUYAO GL, 1994, LANCET, V343, P251, DOI 10.1016/S0140-6736(94)91109-6; *NAT BREAST SCREEN, 2008, SAV LIV SCREEN; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Oliver S, 2000, LANCET, V355, P1788, DOI 10.1016/S0140-6736(00)02269-8; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Ozanne EM, 2004, CANCER EPIDEM BIOMAR, V13, P2043; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Ries L MD, 2008, SEER CANC STAT REV 1; Schilling FH, 2003, CANCER LETT, V197, P19, DOI 10.1016/S0304-3835(03)00077-6; Schrag D, 2000, JAMA-J AM MED ASSOC, V283, P617, DOI 10.1001/jama.283.5.617; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36; Shao YH, 2009, JNCI-J NATL CANCER I, V101, P1280, DOI 10.1093/jnci/djp262; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Thompson IM, 2008, J UROLOGY, V180, P1219, DOI 10.1016/j.juro.2008.07.089; Thompson IM, 2008, UROLOGY, V71, P854, DOI 10.1016/j.urology.2008.01.025; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; van't Veer LJ, 2009, J CLIN ONCOL, V27; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Welch HG, 2004, SHOULD I BE TESTED C; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; WINAWER SJ, 1977, JAMA-J AM MED ASSOC, V238, P2014, DOI 10.1001/jama.238.19.2014; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	71	395	404	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1685	1692		10.1001/jama.2009.1498	http://dx.doi.org/10.1001/jama.2009.1498			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843904				2022-12-28	WOS:000270941200024
J	Scanziani, M; Hausser, M				Scanziani, Massimo; Hausser, Michael			Electrophysiology in the age of light	NATURE			English	Review							WHOLE-CELL RECORDINGS; IN-VIVO; ACTION-POTENTIALS; VISUAL-CORTEX; FLUORESCENT PROTEINS; NEURONAL-ACTIVITY; CORTICAL-NEURONS; NEURAL ACTIVITY; REMOTE-CONTROL; ION CHANNELS	Electrophysiology, the 'gold standard' for investigating neuronal signalling, is being challenged by a new generation of optical probes. Together with new forms of microscopy, these probes allow us to measure and control neuronal signals with spatial resolution and genetic specificity that already greatly surpass those of electrophysiology. We predict that the photon will progressively replace the electron for probing neuronal function, particularly for targeted stimulation and silencing of neuronal populations. Although electrophysiological characterization of channels, cells and neural circuits will remain necessary, new combinations of electrophysiology and imaging should lead to transformational discoveries in neuroscience.	[Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Hausser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Hausser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of London; University College London; University of London; University College London	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Howard Hughes Medical Institute; US National Institutes of Health; Wellcome Trust; European Union; Gatsby Charitable Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Gatsby Charitable Foundation	We are grateful to T. Branco, S. J. Caddick, M. Carandini, B. Clark, W. Denk, D. Kleinfeld, J. Isaacson, B. Judkewitz, R. Malinow, R. Morris, A. Roth, S. J. Smith, S. L. Smith, K. Svoboda and C. Wilms for helpful discussions and/or comments on the manuscript. We apologize to our colleagues whose work could not be cited owing to space constraints. Work in our laboratories is supported by grants from the Howard Hughes Medical Institute and the US National Institutes of Health (M. S.); and the Wellcome Trust, the European Union and the Gatsby Charitable Foundation (M. H.).	Aaron G, 2006, SYNAPSE, V60, P437, DOI 10.1002/syn.20316; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Akemann W, 2009, BIOPHYS J, V96, P3959, DOI 10.1016/j.bpj.2009.02.046; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Dombeck DA, 2004, J NEUROSCI, V24, P999, DOI 10.1523/JNEUROSCI.4840-03.2004; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fromherz P, 2006, ANN NY ACAD SCI, V1093, P143, DOI 10.1196/annals.1382.011; GALVANI L, 1791, BONON SCI ART I ACAD, V7, P364; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Heller I, 2005, NANO LETT, V5, P137, DOI 10.1021/nl048200m; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Krapf D, 2006, NANO LETT, V6, P105, DOI 10.1021/nl052163x; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miller EK, 2008, NEURON, V60, P483, DOI 10.1016/j.neuron.2008.10.033; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Piccolino M, 2002, TRENDS NEUROSCI, V25, P51, DOI 10.1016/S0166-2236(00)02003-8; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Qiao Y, 2005, NANOTECHNOLOGY, V16, P1598, DOI 10.1088/0957-4484/16/9/032; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rickgauer J. P., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SALZBERG BM, 1983, NATURE, V306, P36, DOI 10.1038/306036a0; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Smith SL, 2004, J NEUROSCI METH, V133, P109, DOI 10.1016/j.jneumeth.2003.10.001; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; STEPNOSKI RA, 1991, P NATL ACAD SCI USA, V88, P9382, DOI 10.1073/pnas.88.21.9382; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; TIAN L, NATURE METH IN PRESS; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	100	306	317	8	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					930	939		10.1038/nature08540	http://dx.doi.org/10.1038/nature08540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829373				2022-12-28	WOS:000270817700038
J	Hanna, J; Saha, K; Pando, B; van Zon, J; Lengner, CJ; Creyghton, MP; van Oudenaarden, A; Jaenisch, R				Hanna, Jacob; Saha, Krishanu; Pando, Bernardo; van Zon, Jeroen; Lengner, Christopher J.; Creyghton, Menno P.; van Oudenaarden, Alexander; Jaenisch, Rudolf			Direct cell reprogramming is a stochastic process amenable to acceleration	NATURE			English	Article							PLURIPOTENT STEM-CELLS; TUMOR-SUPPRESSOR; NANOG; INDUCTION; FIBROBLASTS; EXPRESSION; GENERATION; CIRCUITRY; OCT4; KLF4	Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells can be achieved by overexpression of Oct4, Sox2, Klf4 and c-Myc transcription factors, but only a minority of donor somatic cells can be reprogrammed to pluripotency. Here we demonstrate that reprogramming by these transcription factors is a continuous stochastic process where almost all mouse donor cells eventually give rise to iPS cells on continued growth and transcription factor expression. Additional inhibition of the p53/p21 pathway or overexpression of Lin28 increased the cell division rate and resulted in an accelerated kinetics of iPS cell formation that was directly proportional to the increase in cell proliferation. In contrast, Nanog overexpression accelerated reprogramming in a predominantly cell-division-rate-independent manner. Quantitative analyses define distinct cell-division-rate-dependent and -independent modes for accelerating the stochastic course of reprogramming, and suggest that the number of cell divisions is a key parameter driving epigenetic reprogramming to pluripotency.	[Hanna, Jacob; Saha, Krishanu; Lengner, Christopher J.; Creyghton, Menno P.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Pando, Bernardo; van Zon, Jeroen; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02142 USA; [van Zon, Jeroen; van Oudenaarden, Alexander; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	Hanna@wi.mit.edu; Jaenisch@wi.mit.edu	van Zon, Jeroen/C-8313-2018; van Oudenaarden, Alexander/AAA-1705-2019; Hanna, Jacob/K-1339-2012; Saha, Krishanu/J-3980-2014	van Zon, Jeroen/0000-0002-6021-2924; Hanna, Jacob/0000-0003-2042-9974; Lengner, Christopher/0000-0002-0574-5189; Saha, Krishanu/0000-0003-2837-0858	NIH [RO1-HDO45022, R37-CA084198, RO1-CA087869]; Helen Hay Whitney Foundation; Society in Science: The Brano- Weiss fellowship; Human Frontiers Science Program; National Cancer Institute [U54CA143874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198, U54CA143874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Society in Science: The Brano- Weiss fellowship; Human Frontiers Science Program(Human Frontier Science Program); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank N. Maheshri, K. Wood, Y. Bugnanim, B. Carey, J. Cassady and F. Soldner for commenting on the manuscript; J. Dausmann, S. Markoulaki, P. Schorderet and M. Pawlak for conducting blastocysts injections; and members of the Jaenisch laboratory for discussions. R. J. is supported by grants from the NIH (RO1-HDO45022, R37-CA084198, RO1-CA087869). J. H. is supported by a postdoctoral fellowship from Helen Hay Whitney Foundation. K. S. is supported by the Society in Science: The Brano- Weiss fellowship. J. v. Z. is supported by the Human Frontiers Science Program. A. v. O. is supported by a National Institutes of Health ( NIH) Director's Pioneer award and an award from the National Cancer Institute (U54CA143874).	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, COLD SH Q B, V73, P147, DOI 10.1101/sqb.2008.73.025; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	730	791	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					595	U63		10.1038/nature08592	http://dx.doi.org/10.1038/nature08592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898493	Green Accepted, Green Published			2022-12-28	WOS:000272277900030
J	Bolotin, KI; Ghahari, F; Shulman, MD; Stormer, HL; Kim, P				Bolotin, Kirill I.; Ghahari, Fereshte; Shulman, Michael D.; Stormer, Horst L.; Kim, Philip			Observation of the fractional quantum Hall effect in graphene	NATURE			English	Article								When electrons are confined in two dimensions and subject to strong magnetic fields, the Coulomb interactions between them can become very strong, leading to the formation of correlated states of matter, such as the fractional quantum Hall liquid(1,2). In this strong quantum regime, electrons and magnetic flux quanta bind to form complex composite quasiparticles with fractional electronic charge; these are manifest in transport measurements of the Hall conductivity as rational fractions of the elementary conductance quantum. The experimental discovery of an anomalous integer quantum Hall effect in graphene has enabled the study of a correlated two-dimensional electronic system, in which the interacting electrons behave like massless chiral fermions(3,4). However, owing to the prevailing disorder, graphene has so far exhibited only weak signatures of correlated electron phenomena(5,6), despite intense experimental and theoretical efforts(7-14). Here we report the observation of the fractional quantum Hall effect in ultraclean, suspended graphene. In addition, we show that at low carrier density graphene becomes an insulator with a magnetic-field-tunable energy gap. These newly discovered quantum states offer the opportunity to study correlated Dirac fermions in graphene in the presence of large magnetic fields.	[Bolotin, Kirill I.; Ghahari, Fereshte; Stormer, Horst L.; Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Shulman, Michael D.; Stormer, Horst L.; Kim, Philip] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	Columbia University; Columbia University	Kim, P (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	pk2015@columbia.edu	Kim, Philip/N-1886-2013; Bolotin, Kirill/O-5101-2016	Kim, Philip/0000-0002-8255-0086; Ghahari Kermani, Fereshte/0000-0003-0317-4009	Microsoft Project Q; DARPA; Department of Energy (DOE)	Microsoft Project Q(Microsoft); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Energy (DOE)(United States Department of Energy (DOE))	We thank D. Abanin, A. Pinczuk and B. Feldman for discussions. We acknowledge A. Young, P. Cadden-Zimansky and V. Deshpande for careful reading of the manuscript. We especially thank E. Andrei for discussing her results and sample fabrication before publication. This research was supported by the Microsoft Project Q, DARPA and the Department of Energy (DOE).	Abanin DA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035416; Apalkov VM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.126801; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Bolotin KI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096802; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Checkelsky JG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115434; Cobden DH, 1999, PHYS REV LETT, V82, P4695, DOI 10.1103/PhysRevLett.82.4695; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Goerbig MO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.241405; Jain JK, 2007, COMPOSITE FERMIONS, P1, DOI 10.1017/CBO9780511607561; Jiang Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106802; Khveshchenko DV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153405; Martin J, 2009, NAT PHYS, V5, P669, DOI 10.1038/NPHYS1344; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ozyilmaz B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166804; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Sarma S. D., 1997, PERSPECTIVES QUANTUM; Shibata N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235426; Toke C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245440; Toke C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235417; Willett RL, 1997, PHYS REV LETT, V78, P4478, DOI 10.1103/PhysRevLett.78.4478; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yang K, 2007, SOLID STATE COMMUN, V143, P27, DOI 10.1016/j.ssc.2007.03.051; Yang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075423; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	28	741	754	13	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					196	199		10.1038/nature08582	http://dx.doi.org/10.1038/nature08582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19881489	Green Submitted			2022-12-28	WOS:000271655100038
J	Bodmer, M; Brauchli, YB; Krahenbuhl, S; Jick, SS; Meier, CR				Bodmer, Michael; Brauchli, Yolanda B.; Krahenbuhl, Stephan; Jick, Susan S.; Meier, Christoph R.			Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC CHOLESTEROL-METABOLISM; GALLBLADDER-DISEASE; PHYSICAL-ACTIVITY; LIPID-COMPOSITION; BILE COMPOSITION; SIMVASTATIN; PRAVASTATIN; ASSOCIATION; CONSUMPTION; DISSOLUTION	Context Gallstone disease is a leading cause of morbidity in western countries and carries a high economic burden. Statins decrease hepatic cholesterol biosynthesis and may therefore lower the risk of cholesterol gallstones by reducing the cholesterol concentration in the bile. Data on this association in humans are scarce. Objective To study the association between the use of statins, fibrates, or other lipid-lowering agents and the risk of incident gallstone disease followed by cholecystectomy. Design, Setting, and Participants Case-control analysis using the UK-based General Practice Research Database. Incident patients between 1994 and 2008 and 4 controls per each patient were identified and matched on age, sex, general practice, calendar time, and years of history in the database. The study population was 76% women and the mean (SD) age was 53.4 (15.0) years at the index date. Conditional logistic regression was used to estimate the odds ratio (OR) of developing gallstones followed by cholecystectomy in relation to exposure to lipid-lowering agents, stratified by exposure timing and duration. The ORs and 95% confidence intervals (CIs) were adjusted for smoking, body mass index, ischemic heart disease, stroke, and estrogen use. Main Outcome Measure The adjusted OR (AOR) for developing gallstone disease followed by cholecystectomy in relation to exposure to lipid-lowering agents. Results A total of 27 035 patients with cholecystectomy and 106 531 matched controls were identified, including 2396 patients and 8868 controls who had statin use. Compared with nonuse, current statin use (last prescription recorded within 90 days before the first-time diagnosis of the disease) was 1.0% for patients and 0.8% for controls (AOR, 1.10; 95% CI, 0.95-1.27) for 1 to 4 prescriptions; 2.6% vs 2.4% (AOR, 0.85; 95% CI, 0.77-0.93) for 5 to 19 prescriptions, and 3.2% vs 3.7% (AOR, 0.64; 95% CI, 0.59-0.70) for 20 or more prescriptions. The AORs for current use of statins defined as 20 or more prescriptions were similar (around 0.6) across age, sex, and body mass index categories, and across the statin class. Conclusion Long-term use of statins was associated with a decreased risk of gallstones followed by cholecystectomy. JAMA. 2009; 302(18): 2001-2007	[Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland; [Bodmer, Michael; Krahenbuhl, Stephan] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland; [Brauchli, Yolanda B.; Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Div Clin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Jick, Susan S.; Meier, Christoph R.] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA	University of Basel; University of Basel; University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Hosp Pharm, Basel Pharmacoepidemiol Unit, Spitalstr 26, CH-4031 Basel, Switzerland.	meierch@uhbs.ch	Bodmer, Michael/K-1873-2013; Bodmer, Michael/F-3178-2012; Krähenbühl, Stephan/Z-4744-2019	Jick, Susan/0000-0002-2215-1067	AstraZeneca	AstraZeneca(AstraZeneca)	The Division of Clinical Pharmacology and Toxicology, University Hospital Basel (Drs Bodmer and Krahenbuhl), Basel Pharmacoepidemiology Unit, University of Basel (Drs Brauchli and Meier), and the Boston Collaborative Drug Surveillance Program (Drs Jick and Meier) reported having a research collaboration with various companies in the pharmaceutical industry. Regarding drug companies producing and selling statins, the Basel Pharmacoepidemiology Unit as well as the Boston Collaborative Drug Surveillance Program had or currently have a research collaboration with AstraZeneca and Novartis. The Division of Clinical Pharmacology and Toxicology at the University Hospital Basel currently receives an unconditional grant from AstraZeneca. All of these funded research collaborations are unrelated to this article. We have conducted numerous studies using the UK-based General Practice Research Database in the past, and we are presently working on several projects. Some, but not all of the studies are industry-sponsored. This particular study was not funded. Our group has been conducting research for the pharmaceutical industry for many years, and these collaborations involve numerous companies including Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, and Merck Sharp & Dohme. Drs Brauchli, Jick, and Meier reported conducting research related to psoriasis in the past for MerckSerono, Switzerland. Additional Information: The eFigure and eTables 1 through 7 are available at http://www.jama.com.	Abedin MZ, 2002, DIGEST DIS SCI, V47, P2192, DOI 10.1023/A:1020174908650; Caroli-Bosc FX, 2001, DIGEST DIS SCI, V46, P540, DOI 10.1023/A:1005643014395; Chapman BA, 1998, DIGEST DIS SCI, V43, P349, DOI 10.1023/A:1018862507469; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Davis KG, 2003, OBES SURG, V13, P865, DOI 10.1381/096089203322618678; Filion KB, 2007, PHARMACOEPIDEM DR S, V16, P1, DOI 10.1002/pds.1314; Fruchart JC, 1998, AM J CARDIOL, V81, P912; Gonzalez-Perez A, 2007, PHARMACOEPIDEM DR S, V16, P524, DOI 10.1002/pds.1346; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kallien G, 1999, HEPATOLOGY, V30, P14, DOI 10.1002/hep.510300119; Lammert F, 2008, J HEPATOL, V48, pS124, DOI 10.1016/j.jhep.2008.01.012; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 2005, ARCH INTERN MED, V165, P567, DOI 10.1001/archinte.165.5.567; Leitzmann MF, 1999, JAMA-J AM MED ASSOC, V281, P2106, DOI 10.1001/jama.281.22.2106; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Miettinen TE, 1998, HEPATOLOGY, V27, P649, DOI 10.1002/hep.510270302; Pagliarulo M, 2004, DIGEST LIVER DIS, V36, P130, DOI 10.1016/j.dld.2003.10.007; PETITTI DB, 1981, NEW ENGL J MED, V304, P1396, DOI 10.1056/NEJM198106043042305; Porsch-Ozcurumez M, 2001, EUR J CLIN PHARMACOL, V56, P873, DOI 10.1007/s002280000254; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Post SM, 2001, ARTERIOSCL THROM VAS, V21, P1840, DOI 10.1161/hq1101.098228; Reid FDA, 2002, HEART, V88, P15, DOI 10.1136/heart.88.1.15; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Sharma BC, 1997, J CLIN GASTROENTEROL, V25, P433, DOI 10.1097/00004836-199709000-00007; SMIT JWA, 1995, HEPATOLOGY, V21, P1523; Smith JL, 2000, J GASTROEN HEPATOL, V15, P871, DOI 10.1046/j.1440-1746.2000.02231.x; STAHLBERG D, 1995, HEPATOLOGY, V21, P1025, DOI 10.1016/0270-9139(95)90250-3; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; SYLWESTROWICZ TA, 1988, GASTROENTEROLOGY, V95, P740, DOI 10.1016/S0016-5085(88)80023-4; THIJS C, 1990, GASTROENTEROLOGY, V99, P843, DOI 10.1016/0016-5085(90)90978-A; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; Tsai CJ, 2009, GASTROENTEROLOGY, V136, P1593, DOI 10.1053/j.gastro.2009.01.042; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WILSON IR, 1994, J GASTROEN HEPATOL, V9, P447, DOI 10.1111/j.1440-1746.1994.tb01272.x; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004	40	79	82	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2001	2007		10.1001/jama.2009.1601	http://dx.doi.org/10.1001/jama.2009.1601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903921				2022-12-28	WOS:000271619700027
J	Kondo, N; Sembajwe, G; Kawachi, I; van Dam, RM; Subramanian, SV; Yamagata, Z				Kondo, Naoki; Sembajwe, Grace; Kawachi, Ichiro; van Dam, Rob M.; Subramanian, S. V.; Yamagata, Zentaro			Income inequality, mortality, and self rated health: metaanalysis of multilevel studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION HEALTH; RELATIVE DEPRIVATION; UNITED-STATES; LEVEL ANALYSIS; ASSOCIATION; US; DIFFERENCE; AFFLUENCE; EXPOSURE; EXPLAIN	Objective To provide quantitative evaluations on the association between income inequality and health. Design Random effects meta-analyses, calculating the overall relative risk for subsequent mortality among prospective cohort studies and the overall odds ratio for poor self rated health among cross sectional studies. Data sources PubMed, the ISI Web of Science, and the National Bureau for Economic Research database. Review methods Peer reviewed papers with multilevel data. Results The meta-analysis included 59 509 857 subjects in nine cohort studies and 1 280 211 subjects in 19 cross sectional studies. The overall cohort relative risk and cross sectional odds ratio (95% confidence intervals) per 0.05 unit increase in Gini coefficient, a measure of income inequality, was 1.08 (1.06 to 1.10) and 1.04 (1.02 to 1.06), respectively. Meta-regressions showed stronger associations between income inequality and the health outcomes among studies with higher Gini (>= 0.3), conducted with data after 1990, with longer duration of follow-up (>7 years), and incorporating time lags between income inequality and outcomes. By contrast, analyses accounting for unmeasured regional characteristics showed a weaker association between income inequality and health. Conclusions The results suggest a modest adverse effect of income inequality on health, although the population impact might be larger if the association is truly causal. The results also support the threshold effect hypothesis, which posits the existence of a threshold of income inequality beyond which adverse impacts on health begin to emerge. The findings need to be interpreted with caution given the heterogeneity between studies, as well as the attenuation of the risk estimates in analyses that attempted to control for the unmeasured characteristics of areas with high levels of income inequality.	[Kondo, Naoki; Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, Chuo, Yamanashi 4093898, Japan; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of Yamanashi; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kondo, N (corresponding author), Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	nkondo@yamanashi.ac.jp	Kondo, Naoki/ABC-5865-2020; Kondo, Naoki/K-3898-2012; van Dam, Rob M/F-9674-2010; Sembajwe, Grace/H-3288-2017	Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; van Dam, Rob M/0000-0002-7354-8734; Sembajwe, Grace/0000-0002-7163-4743	Pfizer Health Research Foundation; Social Science Research Council; American Council of Learned Societies; Japan Foundation Center for Global Partnership; National Institute of Health Career Development Award [1k25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Pfizer Health Research Foundation; Social Science Research Council; American Council of Learned Societies; Japan Foundation Center for Global Partnership; National Institute of Health Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by the Pfizer Health Research Foundation. NK is a recipient of the fellowship award by the Abe Fellowship Program administered by the Social Science Research Council and the American Council of Learned Societies in cooperation with and funded by the Japan Foundation Center for Global Partnership. SVS is supported by the National Institute of Health Career Development Award (NHLBI 1k25 HL081275). These sponsors were not involved in study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication. Competing interest: None declared.	Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P318, DOI 10.1136/jech.54.4.318; Blakely TA, 2002, BRIT MED J, V324, P1336; Blakely TA, 2002, SOC SCI MED, V54, P65, DOI 10.1016/S0277-9536(01)00007-7; Blakely TA, 2001, J EPIDEMIOL COMMUN H, V55, P352, DOI 10.1136/jech.55.5.352; Blakely TA, 2001, AM J PUBLIC HEALTH, V91, P99; Charafeddine R, 2008, ENVIRON RES, V106, P81, DOI 10.1016/j.envres.2007.09.005; Coburn D, 2004, SOC SCI MED, V58, P41, DOI 10.1016/S0277-9536(03)00159-X; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CSDH, 2008, CLOS GAP GEN HLTH EQ; Dahl E, 2006, SOC SCI MED, V63, P2562, DOI 10.1016/j.socscimed.2006.06.002; DEATON A, 1999, NBER WORKING PAPER S, V7140; DEATON A, 1999, NBER WORKING PAPER S, V7141; DEATON A, 2001, NBER WORKING PAPERS, V8370; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FORSTER M, 2005, OECD SOCIAL EMPLOYME, P22; Gravelle H, 2003, J EPIDEMIOL COMMUN H, V57, P125, DOI 10.1136/jech.57.2.125; Henriksson G, 2006, SCAND J PUBLIC HEALT, V34, P287, DOI 10.1080/14034940500228364; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hou F, 2005, SOC SCI MED, V60, P1557, DOI 10.1016/j.socscimed.2004.08.033; Hsieh C.-C., 1993, CRIMINAL JUSTICE REV, V18, P182, DOI [10.1177/073401689301800203, DOI 10.1177/073401689301800203]; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jones AM, 2008, J HEALTH ECON, V27, P308, DOI 10.1016/j.jhealeco.2007.05.007; Kawachi I, 1997, SOC SCI MED, V45, P1121, DOI 10.1016/S0277-9536(97)00044-0; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; Kondo N, 2008, SOC SCI MED, V67, P982, DOI 10.1016/j.socscimed.2008.06.002; Kunitz SJ, 2006, HLTH POPULATIONS GEN; LeClere FB, 2000, AM J PUBLIC HEALTH, V90, P1892, DOI 10.2105/AJPH.90.12.1892; Li H, 2006, J COMP ECON, V34, P668, DOI 10.1016/j.jce.2006.08.005; LIPSEY MW, 2000, SELECTING COMPUTING, P34; Lorgelly PK, 2008, HEALTH ECON, V17, P249, DOI 10.1002/hec.1254; *LUX INC STUD, 2008, LUX INC STUD DAT; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Mansyur C, 2008, SOC SCI MED, V66, P43, DOI 10.1016/j.socscimed.2007.08.015; Mayer SE, 2005, SOC SCI MED, V60, P439, DOI 10.1016/j.socscimed.2004.06.005; Mellor JM, 2002, J HUM RESOUR, V37, P510, DOI 10.2307/3069680; Mellor JM, 2003, HEALTH SERV RES, V38, P137, DOI 10.1111/1475-6773.00109; *OECD RIGHTS TRANS, 2008, GROW UN INC DISTR PO; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Osler M, 2003, INT J EPIDEMIOL, V32, P375, DOI 10.1093/ije/dyg074; Shi LY, 2000, INT J HEALTH SERV, V30, P541, DOI 10.2190/N4M8-303M-72UA-P1K1; Soobader MJ, 1999, SOC SCI MED, V48, P733, DOI 10.1016/S0277-9536(98)00401-8; *STAT IC, 2008, RISK POV INC DISTR 2; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P596, DOI 10.1093/ije/dym102; Subramanian SV, 2006, INT J SOC WELF, V15, pS13, DOI 10.1111/j.1468-2397.2006.00440.x; Subramanian SV, 2006, HEALTH PLACE, V12, P141, DOI 10.1016/j.healthplace.2004.11.001; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Subramanian SV, 2003, HEALTH SERV RES, V38, P153, DOI 10.1111/1475-6773.00110; Subramanian SV, 2001, SOC SCI MED, V53, P9, DOI 10.1016/S0277-9536(00)00309-9; *UN DEV PROGR, 2007, HUM DEV REP 2007 200, P281; *US BUR CENS, TABL S4 GIN RAT STAT; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Wen M, 2003, SOC SCI MED, V57, P843, DOI 10.1016/S0277-9536(02)00457-4; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR; Zimmerman FJ, 2008, SOC SCI MED, V66, P1882, DOI 10.1016/j.socscimed.2007.12.037	59	371	377	1	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2009	339								b4471	10.1136/bmj.b4471	http://dx.doi.org/10.1136/bmj.b4471			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520HL	19903981	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000271833800005
J	Wolan, DW; Zorn, JA; Gray, DC; Wells, JA				Wolan, Dennis W.; Zorn, Julie A.; Gray, Daniel C.; Wells, James A.			Small-Molecule Activators of a Proenzyme	SCIENCE			English	Article							IN-VITRO; CASPASE ACTIVATION; CYSTEINE PROTEASE; ALLOSTERIC SITE; APOPTOSIS; INHIBITION; MECHANISMS; INDUCTION; DOMAIN; DEATH	Virtually all of the 560 human proteases are stored as inactive proenyzmes and are strictly regulated. We report the identification and characterization of the first small molecules that directly activate proenzymes, the apoptotic procaspases-3 and -6. It is surprising that these compounds induce autoproteolytic activation by stabilizing a conformation that is both more active and more susceptible to intermolecular proteolysis. These procaspase activators bypass the normal upstream proapoptotic signaling cascades and induce rapid apoptosis in a variety of cell lines. Systematic biochemical and biophysical analyses identified a cluster of mutations in procaspase-3 that resist small-molecule activation both in vitro and in cells. Compounds that induce gain of function are rare, and the activators reported here will enable direct control of the executioner caspases in apoptosis and in cellular differentiation. More generally, these studies presage the discovery of other proenzyme activators to explore fundamental processes of proenzyme activation and their fate-determining roles in biology.	[Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Byers Hall,1700 4th St, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016	Wolan, Dennis/0000-0001-9879-8353	National Institutes of Health [R21 N5057022, R01 CA136779]; National Cancer Institute Postdoctoral Fellowship [F32 CA119641-03]; UC Cancer Research Committee Fellowship; Hartwell Foundation; NATIONAL CANCER INSTITUTE [F32CA119641, R01CA136779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Postdoctoral Fellowship; UC Cancer Research Committee Fellowship; Hartwell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Williams, B. Wolff and the University of California, San Francisco (UCSF) Small Molecule Discovery Center for assistance in the HTS of procaspase-3 activators; S. Mahrus, H. Yoshihara, A. Renslo, M. Burlingame, and J. Sadowsky for critical suggestions; I. Wilson, J. Taunton, and Z. Gartner for critical reading of the manuscript, J. Gao for procaspase-1; J. Gray for cell lines; and C. Craik and D. Hostetter for granzyme B. This research was supported by grants from the National Institutes of Health (R21 N5057022, R01 CA136779), National Cancer Institute Postdoctoral Fellowship (F32 CA119641-03) ( to D. W. W.), UC Cancer Research Committee Fellowship ( to D. C. G.) and the Hartwell Foundation.	Abdul-Ghani M, 2008, CELL STEM CELL, V2, P515, DOI 10.1016/j.stem.2008.05.013; ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Blanc C, 2000, CANCER RES, V60, P4386; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Denault JB, 2007, NAT CHEM BIOL, V3, P519, DOI 10.1038/nchembio0907-519; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; PORTER AG, 2007, NAT CHEM BIOL, V3, P520; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Rominger CM, 2007, ARCH BIOCHEM BIOPHYS, V464, P130, DOI 10.1016/j.abb.2007.04.004; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; STACK MS, 1993, J BIOL CHEM, V268, P18924; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; WALKER PR, 1991, CANCER RES, V51, P1078; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	32	127	134	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					853	858		10.1126/science.1177585	http://dx.doi.org/10.1126/science.1177585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	515KG	19892984	Green Accepted			2022-12-28	WOS:000271468000044
J	Eichenfield, M; Chan, J; Camacho, RM; Vahala, KJ; Painter, O				Eichenfield, Matt; Chan, Jasper; Camacho, Ryan M.; Vahala, Kerry J.; Painter, Oskar			Optomechanical crystals	NATURE			English	Article							WAVE-GUIDES; BAND-GAP; CAVITY; LIGHT	Periodicity in materials yields interesting and useful phenomena. Applied to the propagation of light, periodicity gives rise to photonic crystals(1), which can be precisely engineered for such applications as guiding and dispersing optical beams(2,3), tightly confining and trapping light resonantly(4), and enhancing nonlinear optical interactions(5). Photonic crystals can also be formed into planar lightwave circuits for the integration of optical and electrical microsystems(6). In a photonic crystal, the periodicity of the host medium is used to manipulate the properties of light, whereas a phononic crystal uses periodicity to manipulate mechanical vibrations(7-13). As has been demonstrated in studies of Raman-like scattering in epitaxially grown vertical cavity structures(14) and photonic crystal fibres(15), the simultaneous confinement of mechanical and optical modes in periodic structures can lead to greatly enhanced light-matter interactions. A logical next step is thus to create planar circuits that act as both photonic and phononic crystals(16): optomechanical crystals. Here we describe the design, fabrication and characterization of a planar, silicon-chip-based optomechanical crystal capable of co-localizing and strongly coupling 200-terahertz photons and 2-gigahertz phonons. These planar optomechanical crystals bring the powerful techniques of optics and photonic crystals to bear on phononic crystals, providing exquisitely sensitive (near quantum-limited), optical measurements of mechanical vibrations, while simultaneously providing strong nonlinear interactions for optics in a large and technologically relevant range of frequencies.	[Eichenfield, Matt; Chan, Jasper; Camacho, Ryan M.; Vahala, Kerry J.; Painter, Oskar] CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Painter, O (corresponding author), CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA.	opainter@caltech.edu	Camacho, Ryan M/B-1841-2010; Chan, Jasper/E-6801-2011	Camacho, Ryan M/0000-0001-9644-1422; Painter, Oskar/0000-0002-1581-9209	DARPA [HR0011-08-0002]; National Science Foundation [0622246, DMR-0520565, EEC-0812072]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by a DARPA seed grant (grant no. HR0011-08-0002) and the National Science Foundation (EMT grant no. 0622246, MRSEC grant no. DMR-0520565, and CIAN grant no. EEC-0812072 through University of Arizona).	Akahane Y, 2005, OPT EXPRESS, V13, P1202, DOI 10.1364/OPEX.13.001202; Chan J, 2009, OPT EXPRESS, V17, P3802, DOI 10.1364/OE.17.003802; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; de Espinosa FRM, 1998, PHYS REV LETT, V80, P1208, DOI 10.1103/PhysRevLett.80.1208; Favero I, 2009, NAT PHOTONICS, V3, P201, DOI 10.1038/NPHOTON.2009.42; Hossein-Zadeh M, 2008, IEEE PHOTONIC TECH L, V20, P234, DOI 10.1109/LPT.2007.912991; Johnson SG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066611; Kang MS, 2009, NAT PHYS, V5, P276, DOI 10.1038/NPHYS1217; Khelif A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.024302; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; KUSHWAHA MS, 1993, PHYS REV LETT, V71, P2022, DOI 10.1103/PhysRevLett.71.2022; LIN Q, 2009, COHERENT MIXING MECH; Maldovan M, 2006, APPL PHYS B-LASERS O, V83, P595, DOI 10.1007/s00340-006-2241-y; Maldovan M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216885; McNab SJ, 2003, OPT EXPRESS, V11, P2927, DOI 10.1364/OE.11.002927; Michael CP, 2007, OPT EXPRESS, V15, P4745, DOI 10.1364/OE.15.004745; Mohanty P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085416; Notomi M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.253902; Olsson RH, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/012002; Olsson RH, 2008, SENSOR ACTUAT A-PHYS, V145, P87, DOI 10.1016/j.sna.2007.10.081; Robertson WM, 1998, J ACOUST SOC AM, V104, P694, DOI 10.1121/1.423344; Rokhsari H, 2005, OPT EXPRESS, V13, P5293, DOI 10.1364/OPEX.13.005293; Sanchez-Perez JV, 1998, PHYS REV LETT, V80, P5325, DOI 10.1103/PhysRevLett.80.5325; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Soljacic M, 2002, J OPT SOC AM B, V19, P2052, DOI 10.1364/JOSAB.19.002052; Trigo M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.227402; Weinstein D, 2007, INT EL DEVICES MEET, P415, DOI 10.1109/IEDM.2007.4418961; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273	30	809	825	14	413	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					78	82		10.1038/nature08524	http://dx.doi.org/10.1038/nature08524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19838165	Green Submitted, Green Accepted			2022-12-28	WOS:000271419200035
J	Fullwood, MJ; Liu, MH; Pan, YF; Liu, J; Xu, H; Bin Mohamed, Y; Orlov, YL; Velkov, S; Ho, A; Mei, PH; Chew, EGY; Huang, PYH; Welboren, WJ; Han, YY; Ooi, HS; Ariyaratne, PN; Vega, VB; Luo, YQ; Tan, PY; Choy, PY; Wansa, KDSA; Zhao, B; Lim, KS; Leow, SC; Yow, JS; Joseph, R; Li, HX; Desai, KV; Thomsen, JS; Lee, YK; Karuturi, RKM; Herve, T; Bourque, G; Stunnenberg, HG; Ruan, XL; Cacheux-Rataboul, V; Sung, WK; Liu, ET; Wei, CL; Cheung, E; Ruan, YJ				Fullwood, Melissa J.; Liu, Mei Hui; Pan, You Fu; Liu, Jun; Xu, Han; Bin Mohamed, Yusoff; Orlov, Yuriy L.; Velkov, Stoyan; Ho, Andrea; Mei, Poh Huay; Chew, Elaine G. Y.; Huang, Phillips Yao Hui; Welboren, Willem-Jan; Han, Yuyuan; Ooi, Hong Sain; Ariyaratne, Pramila N.; Vega, Vinsensius B.; Luo, Yanquan; Tan, Peck Yean; Choy, Pei Ye; Wansa, K. D. Senali Abayratna; Zhao, Bing; Lim, Kar Sian; Leow, Shi Chi; Yow, Jit Sin; Joseph, Roy; Li, Haixia; Desai, Kartiki V.; Thomsen, Jane S.; Lee, Yew Kok; Karuturi, R. Krishna Murthy; Herve, Thoreau; Bourque, Guillaume; Stunnenberg, Hendrik G.; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Liu, Edison T.; Wei, Chia-Lin; Cheung, Edwin; Ruan, Yijun			An oestrogen-receptor-alpha-bound human chromatin interactome	NATURE			English	Article							CHROMOSOME CONFORMATION; BINDING-SITES; HUMAN GENOME; TRANSCRIPTION; GENES; FOXA1; CHIP; ELEMENTS; REVEALS; DEFINES	Genomes are organized into high-level three-dimensional structures, and DNA elements separated by long genomic distances can in principle interact functionally. Many transcription factors bind to regulatory DNA elements distant from gene promoters. Although distal binding sites have been shown to regulate transcription by long-range chromatin interactions at a few loci, chromatin interactions and their impact on transcription regulation have not been investigated in a genome-wide manner. Here we describe the development of a new strategy, chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) for the de novo detection of global chromatin interactions, with which we have comprehensively mapped the chromatin interaction network bound by oestrogen receptor alpha (ER-alpha) in the human genome. We found that most high-confidence remote ER-alpha-binding sites are anchored at gene promoters through long-range chromatin interactions, suggesting that ER-alpha functions by extensive chromatin looping to bring genes together for coordinated transcriptional regulation. We propose that chromatin interactions constitute a primary mechanism for regulating transcription in mammalian genomes.	[Fullwood, Melissa J.; Liu, Mei Hui; Pan, You Fu; Liu, Jun; Xu, Han; Bin Mohamed, Yusoff; Orlov, Yuriy L.; Velkov, Stoyan; Ho, Andrea; Mei, Poh Huay; Chew, Elaine G. Y.; Huang, Phillips Yao Hui; Han, Yuyuan; Ooi, Hong Sain; Ariyaratne, Pramila N.; Vega, Vinsensius B.; Luo, Yanquan; Tan, Peck Yean; Choy, Pei Ye; Wansa, K. D. Senali Abayratna; Zhao, Bing; Lim, Kar Sian; Leow, Shi Chi; Yow, Jit Sin; Joseph, Roy; Li, Haixia; Desai, Kartiki V.; Thomsen, Jane S.; Lee, Yew Kok; Karuturi, R. Krishna Murthy; Herve, Thoreau; Bourque, Guillaume; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Liu, Edison T.; Wei, Chia-Lin; Cheung, Edwin; Ruan, Yijun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Welboren, Willem-Jan; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Dept Comp Sci, Singapore 117543, Singapore; [Cheung, Edwin; Ruan, Yijun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Cheung, Edwin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Radboud University Nijmegen; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ruan, YJ (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore.	cheungcwe@gis.a-star.edu.sg; ruanyj@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Fullwood, Melissa/G-5713-2011; Liu, Mei Hui/J-9750-2013; Velkov, Stoyan/ABV-5313-2022; Orlov, Yuriy L/F-1520-2013; Xu, Han/H-1963-2012; Desai, Kartiki/ABF-3538-2021; Stunnenberg, Hendrik G./D-6875-2012; Bourque, Guillaume/AFR-2927-2022	Fullwood, Melissa/0000-0003-0321-7865; Orlov, Yuriy L/0000-0003-0587-1609; Stunnenberg, Hendrik G./0000-0002-0066-1576; Bourque, Guillaume/0000-0002-3933-9656; Han, Brenda/0000-0002-3212-875X; Sung, Wing-Kin/0000-0001-7806-7086; Liu, Mei Hui/0000-0001-7405-7008; Velkov, Stoyan/0000-0003-2390-7097; THOREAU, HERVE/0000-0001-6643-167X; Huang, Phillips Y./0000-0001-5807-1133; Pan, You-Fu/0000-0002-9996-8892; Chew, Elaine/0000-0001-9763-703X; /0000-0001-9150-3954; Desai, Kartiki V/0000-0001-8974-0707	L'Oreal-UNESCO; A*STAR of Singapore; NIH [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004456, R01HG003521, U54HG004557] Funding Source: NIH RePORTER	L'Oreal-UNESCO(L'Oreal Group); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the Genome Technology and Biology Group at the Genome Institute of Singapore for technical support; A. Shahab, C. C. Seng and F. H. Mulawadi for computing support; S. Luo and G. Schroth for Illumina sequencing support; and W. de Laat, B. Ren and X. S. Liu for advice. M. J. F., P. Y. H. H., Y. H., P. Y. T. and Y. K. L. are supported by A*STAR Scholarships. M. J. F. is supported by a L'Oreal-UNESCO For Women In Science National Fellowship. Y. R. and C. L. W. are supported by A*STAR of Singapore and NIH ENCODE grants (R01 HG004456-01, R01HG003521-01 and part of 1U54HG004557-01).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	31	1151	1210	7	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					58	64		10.1038/nature08497	http://dx.doi.org/10.1038/nature08497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890323	Green Accepted			2022-12-28	WOS:000271419200031
J	Marshall, NM; Garner, DK; Wilson, TD; Gao, YG; Robinson, H; Nilges, MJ; Lu, Y				Marshall, Nicholas M.; Garner, Dewain K.; Wilson, Tiffany D.; Gao, Yi-Gui; Robinson, Howard; Nilges, Mark J.; Lu, Yi			Rationally tuning the reduction potential of a single cupredoxin beyond the natural range	NATURE			English	Article							BLUE COPPER CENTER; PI-PI-INTERACTION; ACTIVE-SITE; CRYSTAL-STRUCTURE; AXIAL METHIONINE; AZURIN; RUSTICYANIN; PROTEINS; MUTAGENESIS; GRAPHITE	Redox processes are at the heart of numerous functions in chemistry and biology, from long-range electron transfer in photosynthesis and respiration to catalysis in industrial and fuel cell research. These functions are accomplished in nature by only a limited number of redox-active agents. A long-standing issue in these fields is how redox potentials are fine-tuned over a broad range with little change to the redox-active site or electron-transfer properties. Resolving this issue will not only advance our fundamental understanding of the roles of long-range, non-covalent interactions in redox processes, but also allow for design of redox-active proteins having tailor-made redox potentials for applications such as artificial photosynthetic centres(1,2) or fuel cell catalysts(3) for energy conversion. Here we show that two important secondary coordination sphere interactions, hydrophobicity and hydrogen-bonding, are capable of tuning the reduction potential of the cupredoxin azurin over a 700 mV range, surpassing the highest and lowest reduction potentials reported for any mononuclear cupredoxin, without perturbing the metal binding site beyond what is typical for the cupredoxin family of proteins. We also demonstrate that the effects of individual structural features are additive and that redox potential tuning of azurin is now predictable across the full range of cupredoxin potentials.	[Marshall, Nicholas M.; Garner, Dewain K.; Wilson, Tiffany D.; Gao, Yi-Gui; Nilges, Mark J.; Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@illinois.edu	Lu, Yi/GQQ-1069-2022; liu, yi/GXE-9662-2022; Lu, Yi/B-5461-2010	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709	US National Science Foundation [CHE 05-52008]; National Institutes of Health [5 T32 GM070421]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based on work supported by the US National Science Foundation under award no. CHE 05-52008. We thank E. Marshall, D. Poe, A. Huang and J. Li for discussions, and for help in protein expression and purification, and in spectroscopic and electrochemical data collection. N. M. M. is an NIH Predoctoral trainee, supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 5 T32 GM070421 from the National Institute of General Medical Sciences.	Abdelhamid RF, 2007, J BIOL INORG CHEM, V12, P165, DOI 10.1007/s00775-006-0176-8; Alcaraz LA, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/54232; Battistuzzi G, 1999, J AM CHEM SOC, V121, P501, DOI 10.1021/ja982126q; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Berry SM, 2003, J AM CHEM SOC, V125, P8760, DOI 10.1021/ja029699u; Blanford CF, 2007, CHEM COMMUN, P1710, DOI 10.1039/b703114a; CHANG HR, 1988, J AM CHEM SOC, V110, P625, DOI 10.1021/ja00210a067; CHANG TK, 1991, P NATL ACAD SCI USA, V88, P1325, DOI 10.1073/pnas.88.4.1325; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Dey A, 2007, SCIENCE, V318, P1464, DOI 10.1126/science.1147753; Garner DK, 2006, J AM CHEM SOC, V128, P15608, DOI 10.1021/ja062732i; Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365; Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146; GROSSMANN JG, 1995, BIOCHEMISTRY-US, V34, P8406, DOI 10.1021/bi00026a023; Hall JF, 1998, BIOCHEMISTRY-US, V37, P11451, DOI 10.1021/bi980960m; Hall JF, 1999, BIOCHEMISTRY-US, V38, P12675, DOI 10.1021/bi990983g; Hart PJ, 1996, PROTEIN SCI, V5, P2175, DOI 10.1002/pro.5560051104; Jeuken LJC, 2001, J PHYS CHEM B, V105, P5271, DOI 10.1021/jp004283t; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6; LOWERY MD, 1992, INORG CHIM ACTA, V198, P233, DOI 10.1016/S0020-1693(00)92365-X; Lu Y., 2003, COMPREHENSIVE COORDI, V8, P91; MIZOGUCHI TJ, 1992, J AM CHEM SOC, V114, P10076, DOI 10.1021/ja00051a059; NILGES MJ, 1979, THESIS U ILLINOIS; ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; Vila AJ, 2001, HANDBOOK ON METALLOPROTEINS, P813; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Yanagisawa S, 2003, BIOCHEMISTRY-US, V42, P6853, DOI 10.1021/bi030030p; Yanagisawa S, 2006, BIOCHEMISTRY-US, V45, P8812, DOI 10.1021/bi0606851	32	229	229	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					113	U127		10.1038/nature08551	http://dx.doi.org/10.1038/nature08551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890331	Green Accepted			2022-12-28	WOS:000271419200043
J	Kotagal, M; Lee, P; Habiyakare, C; Dusabe, R; Kanama, P; Epino, HM; Rich, ML; Farmer, PE				Kotagal, Meera; Lee, Patrick; Habiyakare, Caste; Dusabe, Raymond; Kanama, Philibert; Epino, Henry M.; Rich, Michael L.; Farmer, Paul E.			Quality Improvement Report Improving quality in resource poor settings: observational study from rural Rwanda	BRITISH MEDICAL JOURNAL			English	Article							HEALTH; PROGRAM	Problem Hospitals in rural Africa, such as in Rwanda, often lack electricity, supplies, and staff. In our setting, basic care processes, such monitoring vital signs, giving drugs, and laboratory testing, were performed unreliably, resulting in delays in treatment owing to lack of information needed for clinical decision making. Design Simple quality improvement tools, including plan-do-study-act cycles and process maps, were used to improve system level processes in a stepwise fashion; resources were augmented where necessary. Setting 50 bed district hospital in rural Rwanda. Measurement of improvement Three key indicators ( percentage of vital signs taken by 9 am, drugs given as prescribed, and laboratory tests performed and documented) were tracked daily. Data were collected from a random sample of 25 charts from six inpatient wards. Strategy for change Our intervention had two components: staff education on quality improvement and routine care processes, and stepwise implementation of system level interventions. Real time performance data were reported to staff daily, with a goal of 95% performance for each indicator within two weeks. A Rwandan quality improvement team was trained to run the hospital's quality improvement initiatives. Effects of changes Within two weeks, all indicators achieved the 95% goal. The data for the three objectives were analysed by using time series analysis. Progress was compared against time by using run chart rules for statistical significance of improvement, showing significant improvement for all indicators. Doctors and nurses subjectively reported improved patient care and higher staff morale. Lessons learnt Four lessons are highlighted: making data visible and using them to inform subsequent interventions can promote change in resource poor settings; improvements can be made in advance of resource inputs, but sustained change in resource poor settings requires additional resources; local leadership is essential for success; and early successes were crucial for encouraging staff and motivating buy-in.	[Kotagal, Meera; Lee, Patrick; Epino, Henry M.; Farmer, Paul E.] Partners Hlth, Boston, MA 02215 USA; [Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Lee, Patrick] Newton Wellesley Hosp, Newton, MA 02462 USA; [Habiyakare, Caste; Dusabe, Raymond; Kanama, Philibert] Partners Hlth, Rwanda Minist Hlth, Kirehe Dist Hosp, Kigali, Rwanda; [Epino, Henry M.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Farmer, Paul E.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Partners Healthcare System; Harvard University; Harvard Medical School; Newton Wellesley Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Kotagal, M (corresponding author), Univ Washington, Dept Surg, Box 356410, Seattle, WA 98195 USA.	mkotagal@post.harvard.edu		Habiyakare, Caste/0000-0002-9347-6950	Harvard University Committee on General Scholarships; Sinclair Kennedy travelling fellowship	Harvard University Committee on General Scholarships; Sinclair Kennedy travelling fellowship	Harvard University Committee on General Scholarships; MK received a Sinclair Kennedy travelling fellowship.	ABDALLAH H, 2002, IMPROVING QUALITY CA; Barker P, 2006, B WORLD HEALTH ORGAN, V84, P663; Barker PM, 2007, J INFECT DIS, V196, pS457, DOI 10.1086/521110; Brown LD, 1995, INT J QUAL HEALTH C, V7, P419, DOI 10.1093/intqhc/7.4.419; Carey R.G., 2003, IMPROVING HEALTHCARE; Catsambas TT, 2008, EVALUATING HLTH CARE; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Du Mortier S, 2005, INT J QUAL HEALTH C, V17, P293, DOI 10.1093/intqhc/mzi042; Langley Gj., 1996, IMPROVEMENT GUIDE PR; McCannon CJ, 2007, JAMA-J AM MED ASSOC, V298, P1937, DOI 10.1001/jama.298.16.1937; Mohammadi SM, 2007, INT J QUAL HEALTH C, V19, P237, DOI 10.1093/intqhc/mzm021; Nolan T, 2004, IMPROVING RELIABILIT; Nolan TW, 2007, IHI INNOVATION SERIE; Reinertsen J, 2007, IHI INNOVATION SERIE; Sapag R, 2004, BRIT MED J, V329, P1186, DOI 10.1136/bmj.329.7475.1186; Wagstaff A., 2004, MILLENNIUM DEVELOPME; Weinberg M, 2001, ARCH INTERN MED, V161, P2357, DOI 10.1001/archinte.161.19.2357; *WHO, 2004, HIGH LEV FOR HLTH MD; *WHO, 2004, WHOHIVSPO0401; World Health Organization, 1995, WORLD HLTH REP 1995	20	23	23	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 30	2009	339								b3488	10.1136/bmj.b3488	http://dx.doi.org/10.1136/bmj.b3488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AQ	19880528				2022-12-28	WOS:000271366100001
J	Barrick, JE; Yu, DS; Yoon, SH; Jeong, H; Oh, TK; Schneider, D; Lenski, RE; Kim, JF				Barrick, Jeffrey E.; Yu, Dong Su; Yoon, Sung Ho; Jeong, Haeyoung; Oh, Tae Kwang; Schneider, Dominique; Lenski, Richard E.; Kim, Jihyun F.			Genome evolution and adaptation in a long-term experiment with Escherichia coli	NATURE			English	Article							POPULATION-GENETICS; PARALLEL CHANGES; MUTATIONS; DIVERGENCE; DYNAMICS; SEQUENCE	The relationship between rates of genomic evolution and organismal adaptation remains uncertain, despite considerable interest. The feasibility of obtaining genome sequences from experimentally evolving populations offers the opportunity to investigate this relationship with new precision. Here we sequence genomes sampled through 40,000 generations from a laboratory population of Escherichia coli. Although adaptation decelerated sharply, genomic evolution was nearly constant for 20,000 generations. Such clock-like regularity is usually viewed as the signature of neutral evolution, but several lines of evidence indicate that almost all of these mutations were beneficial. This same population later evolved an elevated mutation rate and accumulated hundreds of additional mutations dominated by a neutral signature. Thus, the coupling between genomic and adaptive evolution is complex and can be counterintuitive even in a constant environment. In particular, beneficial substitutions were surprisingly uniform over time, whereas neutral substitutions were highly variable.	[Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Yu, Dong Su; Yoon, Sung Ho; Jeong, Haeyoung; Oh, Tae Kwang; Kim, Jihyun F.] Korea Res Inst Biosci & Biotechnol, Ind Biotechnol & Bioenergy Res Ctr, Taejon 305806, South Korea; [Yu, Dong Su] Chungnam Natl Univ, Dept Comp Sci & Engn, Taejon 305764, South Korea; [Oh, Tae Kwang] 21C Frontier Microbial Genom & Applicat Ctr, Taejon 305806, South Korea; [Schneider, Dominique] Univ Grenoble 1, CNRS, UMR 5163, Inst Jean Roget,Lab Adaptat & Pathogenie Microorg, F-38042 Grenoble 9, France; [Kim, Jihyun F.] Univ Sci & Technol, Sch Sci, Funct Genom Program, Taejon 305333, South Korea	Michigan State University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu; jfk@kribb.re.kr	Barrick, Jeffrey/A-3046-2012; Schneider, Dominique/M-6019-2014; Kim, Jihyun F./B-6286-2013	Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375; Jeong, Haeyoung/0000-0002-4479-4573; Yoon, Sung Ho/0000-0003-0171-944X	DARPA 'Fun Bio' Program; US National Science Foundation; Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier; Ministry of Education, Science and Technology, Republic of Korea	DARPA 'Fun Bio' Program; US National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier(French National Research Agency (ANR)); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank collaborators in the Lenski and Schneider laboratories for sharing unpublished data; N. Hajela and J. I. Lee for isolation of genomic DNA; C. T. Brown, C. Epstein, C. H. Lee and J. Plotkin for discussion; N. Hajela, L. Ekunwe and S. Simpson for years of technical assistance with the long-term lines; and W. J. Dittmar for assistance with fluctuation tests. We acknowledge support from the DARPA 'Fun Bio' Program (to R. E. L.); the US National Science Foundation (to J. E. B. and R. E. L.); the Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier (to D. S.); and the 21C Frontier Microbial Genomics and Applications Center Program, Ministry of Education, Science and Technology, Republic of Korea (to J. F. K.).	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; [Anonymous], 1861, ORIGIN SPECIES MEANS; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; CHARLESWORTH B, 1982, EVOLUTION, V36, P474, DOI 10.1111/j.1558-5646.1982.tb05068.x; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fisher R.A., 1930, GENETICAL THEORY NAT; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; GOULD S J, 1977, Paleobiology, V3, P115; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kimura M., 1983, NEUTRAL THEORY MOL E; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; R Development Core Team, 2007, R LANG ENV STAT COMP; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider D, 2000, GENETICS, V156, P477; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	50	802	815	3	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1243	U74		10.1038/nature08480	http://dx.doi.org/10.1038/nature08480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19838166				2022-12-28	WOS:000271190800040
J	Perez-Miles, F; Panzera, A; Ortiz-Villatoro, D; Perdomo, C				Perez-Miles, Fernando; Panzera, Alejandra; Ortiz-Villatoro, David; Perdomo, Cintya			Silk production from tarantula feet questioned	NATURE			English	Letter							ARANEAE		[Perez-Miles, Fernando; Panzera, Alejandra; Ortiz-Villatoro, David; Perdomo, Cintya] Fac Ciencias, Secc Entomol, Montevideo 11400, Uruguay	Universidad de la Republica, Uruguay	Perez-Miles, F (corresponding author), Fac Ciencias, Secc Entomol, Igua 4225, Montevideo 11400, Uruguay.	myga@fcien.edu.uy		Perez-Miles, Fernando/0000-0002-4367-6276; Panzera, Alejandra/0000-0002-3593-3500				BOND JE, 1994, J ARACHNOL, V22, P19; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a; Griswold Charles E., 2005, Proceedings of the California Academy of Sciences, V56, P1; Merritt DJ, 2007, ADV INSECT PHYSIOL, V33, P192, DOI 10.1016/S0065-2806(06)33004-4; Niederegger S, 2006, J COMP PHYSIOL A, V192, P1223, DOI 10.1007/s00359-006-0157-y; Raven RJ, 2005, ZOOTAXA, P15; Ross E.S., 1991, P405	8	10	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					E9	E9		10.1038/nature08404	http://dx.doi.org/10.1038/nature08404			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847209				2022-12-28	WOS:000270987600032
J	Lee, YS; Kennedy, WD; Yin, YW				Lee, Young-Sam; Kennedy, W. Dexter; Yin, Y. Whitney			Structural Insight into Processive Human Mitochondrial DNA Synthesis and Disease-Related Polymerase Mutations	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; ACCESSORY SUBUNIT; ESCHERICHIA-COLI; AUTOSOMAL-DOMINANT; W748S MUTATION; GAMMA; PURIFICATION; REPLICATION; PROTEIN; POLG	Human mitochondrial DNA polymerase (Pol gamma) is the sole replicase in mitochondria. Pol gamma is vulnerable to nonselective antiretroviral drugs and is increasingly associated with mutations found in patients with mitochondriopathies. We determined crystal structures of the human heterotrimeric Pol gamma holoenzyme and, separately, a variant of its processivity factor, Pol gamma B. The holoenzyme structure reveals an unexpected assembly of the mitochondrial DNA replicase where the catalytic subunit Pol gamma A interacts with its processivity factor primarily via a domain that is absent in all other DNA polymerases. This domain provides a structural module for supporting both the intrinsic processivity of the catalytic subunit alone and the enhanced processivity of holoenzyme. The Pol gamma structure also provides a context for interpreting the phenotypes of disease-related mutations in the polymerase and establishes a foundation for understanding the molecular basis of toxicity of anti-retroviral drugs targeting HIV reverse transcriptase.	[Lee, Young-Sam; Kennedy, W. Dexter; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu			National Institutes of Health (NIH) [GM044613, GM083703]; Department of Energy [DE-AC02-06CH11357]; Welch Foundation [F-1592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613, R01GM083703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Molineux for his insight, helpful discussions, and critical comments on the manuscript and K. Johnson for his long-term support, help in initiating the crystallography of Pol gamma, and financial support through the National Institutes of Health (NIH; GM044613). We thank D. Bogenhagen, W. Copeland, and all members of the Y.W.Y. lab for helpful discussion. We are grateful for excellent technical support from S. Ginell and the staff at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is supported by the Department of Energy under contract DE-AC02-06CH11357. The research was supported by grants from the Welch Foundation (F-1592) and NIH (GM083703) to Y.W.Y.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Chinnery P.F., 2007, NEUROMUSCULAR DISORD, V18, P259; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DeLano W.L, PYMOL MOL GRAPHICS S; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Fersht A., 1985, ENZYME STRUCTURE MEC; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORI K, 1979, J BIOL CHEM, V254, P1591; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Klarmann GJ, 2007, BIOCHEMISTRY-US, V46, P2118, DOI 10.1021/bi061772w; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; TABOR S, 1987, J BIOL CHEM, V262, P16212; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	52	149	153	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					312	324		10.1016/j.cell.2009.07.050	http://dx.doi.org/10.1016/j.cell.2009.07.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837034	Green Accepted, Bronze			2022-12-28	WOS:000270857500015
J	Harvey, CD; Collman, F; Dombeck, DA; Tank, DW				Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.			Intracellular dynamics of hippocampal place cells during virtual navigation	NATURE			English	Article							THETA PHASE PRECESSION; BARREL CORTEX; UNIT-ACTIVITY; IN-VIVO; OSCILLATIONS; RECORDINGS; AWAKE; CODE; MECHANISMS; EXPERIENCE	Hippocampal place cells encode spatial information in rate and temporal codes. To examine the mechanisms underlying hippocampal coding, here we measured the intracellular dynamics of place cells by combining in vivo whole-cell recordings with a virtual-reality system. Head-restrained mice, running on a spherical treadmill, interacted with a computer-generated visual environment to perform spatial behaviours. Robust place-cell activity was present during movement along a virtual linear track. From whole-cell recordings, we identified three subthreshold signatures of place fields: an asymmetric ramp-like depolarization of the baseline membrane potential, an increase in the amplitude of intracellular theta oscillations, and a phase precession of the intracellular theta oscillation relative to the extracellularly recorded theta rhythm. These intracellular dynamics underlie the primary features of place-cell rate and temporal codes. The virtual-reality system developed here will enable new experimental approaches to study the neural circuits underlying navigation.	[Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu		Dombeck, Daniel/0000-0003-2576-5918; Collman, Forrest/0000-0002-0280-7022	NIH [1R01MH083686-01, 5R01MH060651-09]; Helen Hay Whitney Fellowship; Patterson Trust Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060651, R01MH083686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Fellowship; Patterson Trust Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Chaffin for help with mouse behaviour, J. Carmack and id Software for providing the Quake2 code, A. Shishlov for programming advice, G. Buzsaki, J. Magee, H. Dahmen and D. Markowitz for discussions, and C. Brody, M. Berry and E. Civillico for comments on the manuscript. This work was supported by the NIH (1R01MH083686-01, 5R01MH060651-09), a Helen Hay Whitney Fellowship (to C. D. H.), and a Patterson Trust Fellowship (to D. A. D.).	BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Chahl JS, 1997, APPL OPTICS, V36, P8275, DOI 10.1364/AO.36.008275; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; GREENE N, 1986, IEEE COMPUT GRAPH, V6, P21, DOI 10.1109/MCG.1986.276658; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SUN LD, 2003, THESIS MIT; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9	43	575	584	5	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					941	U196		10.1038/nature08499	http://dx.doi.org/10.1038/nature08499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829374	Green Accepted			2022-12-28	WOS:000270817700039
J	Frist, B; Sezibera, R				Frist, Bill; Sezibera, Richard			Time for renewed global action against childhood pneumonia	LANCET			English	Editorial Material									[Frist, Bill] Vanderbilt Univ, Nashville, TN 37240 USA; [Sezibera, Richard] Minist Hlth, Kigali, Rwanda	Vanderbilt University	Frist, B (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37240 USA.							Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; *GAVI ALL, 2009, RWAND BEC 1 DEV NAT; *GAVI ALL, 2009, MOR 2 MILL CHILDR CO; KABRA SK, 2006, COCHRANE DB SYST REV, V3, P4874; Madhi SA, 2008, B WORLD HEALTH ORGAN, V86, P365, DOI 10.2471/BLT.07.044503; Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872; Roth DE, 2008, B WORLD HEALTH ORGAN, V86, P356, DOI 10.2471/BLT.07.049114; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; W.H. Organization, 2009, WORLD HLTH STAT 2009; *WHO, 2009, EX SUMM; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1485	1486		10.1016/S0140-6736(09)61886-9	http://dx.doi.org/10.1016/S0140-6736(09)61886-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	517CS	19880006				2022-12-28	WOS:000271591300010
J	Cutland, CL; Madhi, SA; Zell, ER; Kuwanda, L; Laque, M; Groome, M; Gorwitz, R; Thigpen, MC; Patel, R; Velaphi, SC; Adrian, P; Klugman, K; Schuchat, A; Schrag, SJ				Cutland, Clare L.; Madhi, Shabir A.; Zell, Elizabeth R.; Kuwanda, Locadiah; Laque, Martin; Groome, Michelle; Gorwitz, Rachel; Thigpen, Michael C.; Patel, Roopal; Velaphi, Sithembiso C.; Adrian, Peter; Klugman, Keith; Schuchat, Anne; Schrag, Stephanie J.		PoPS Trial Team	Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial	LANCET			English	Article							MORTALITY; ANTISEPSIS; MORBIDITY; DISINFECTION; SAFETY; LABOR	Background About 500000 sepsis-related deaths per year arise in the first 3 days of life. On the basis of results non-randomised studies, use of vaginal chlorhexidine wipes during labour has been proposed as an intervention the prevention of early-onset neonatal sepsis in developing countries. We therefore assessed the efficacy chlorhexidine in early-onset neonatal sepsis and vertical transmission of group B streptococcus. Methods In a trial in Soweto, South Africa, 8011 women (aged 12-51 years) were randomly assigned in a 1:1 ratio chlorhexidine vaginal wipes or external genitalia water wipes during active labour, and their 8129 newborn were assigned to full-body (intervention group) or foot (control group) washes with chlorhexidine at birth, In a subset of mothers (n=5144), we gathered maternal lower vaginal swabs and neonatal skin swabs after delivery assess colonisation with potentially pathogenic bacteria. Primary outcomes were neonatal sepsis in the first 3 days life and vertical transmission of group B streptococcus. Analysis was by intention to treat. The trial is registered ClinicalTrials.gov, number NCT00136370. Findings Rates of neonatal sepsis did not differ between the groups (chlorhexidine 141 [3%] of 4072 vs control 148 of 4057; p=0.6518). Rates of colonisation with group B streptococcus in newborn babies born to mothers in chlorhexidine (217 [54%] of 401) and control groups (234 [55%] of 429] did not differ (efficacy 95% CI -9.5 to 7.9). Interpretation Because chlorhexidine intravaginal and neonatal wipes did not prevent neonatal sepsis or the acquisition of potentially pathogenic bacteria among neonates, we need other interventions to reduce childhood mortality.	[Cutland, Clare L.; Madhi, Shabir A.; Kuwanda, Locadiah; Laque, Martin; Groome, Michelle; Adrian, Peter; Klugman, Keith] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn,Resp & Meningeal Pathogens Res Unit, Vaccine Preventable Dis & Med Res Council, ZA-2013 Johannesburg, South Africa; [Zell, Elizabeth R.; Gorwitz, Rachel; Thigpen, Michael C.; Patel, Roopal; Schuchat, Anne; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Velaphi, Sithembiso C.] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Div Neonatol, Dept Paediat, Soweto, South Africa; [Klugman, Keith] Emory Univ, Dept Int Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith] Emory Univ, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA	National Research Foundation - South Africa; University of Witwatersrand; Centers for Disease Control & Prevention - USA; University of Witwatersrand; Emory University; Rollins School Public Health; Emory University	Cutland, CL (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn,Resp & Meningeal Pathogens Res Unit, Vaccine Preventable Dis & Med Res Council, POB 90753, ZA-2013 Johannesburg, South Africa.	cutlandc@hivsa.com	Groome, Michelle Jennifer/AAI-9967-2021; Cutland, Clare L./GXE-9967-2022	Groome, Michelle Jennifer/0000-0001-5893-3725; Cutland, Clare L./0000-0001-8250-8307	US Agency for International Development; National Vaccine Program Office and Centers for Disease Control's (CDC) Antimicrobial Resistance Working Group [U50/CCU021960, 5U01C1000318]; Bill & Melinda Gates Foundation [39415]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000318] Funding Source: NIH RePORTER	US Agency for International Development(United States Agency for International Development (USAID)); National Vaccine Program Office and Centers for Disease Control's (CDC) Antimicrobial Resistance Working Group(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This trial was supported by the US Agency for International Development, National Vaccine Program Office and Centers for Disease Control's (CDC) Antimicrobial Resistance Working Group via CDC Cooperative Agreement numbers U50/CCU021960 and 5U01C1000318, and Bill & Melinda Gates Foundation (grant number 39415). The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the sponsors. We thank the staff of the Departments of Obstetrics, Neonatology, and Paediatrics at Chris Ham Baragwanath hospital, Soweto, South Africa, for their dedication to their patients, including our trial participants; and the study midwives, nurses, laboratory staff, counsellors, and data capturers.	ADRIAANSE AH, 1995, EUR J OBSTET GYN R B, V61, P135, DOI 10.1016/0301-2115(95)02134-S; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Bakr AF, 2005, J WOMENS HEALTH, V14, P496, DOI 10.1089/jwh.2005.14.496; Biggar RJ, 2005, J WOMENS HEALTH, V14, P531, DOI 10.1089/jwh.2005.14.531; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Frangakis CE, 1999, BIOMETRIKA, V86, P365, DOI 10.1093/biomet/86.2.365; Frangakis CE, 2002, BIOMETRICS, V58, P21, DOI 10.1111/j.0006-341X.2002.00021.x; Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8; Goldenberg RL, 2006, OBSTET GYNECOL, V107, P1139, DOI 10.1097/01.AOG.0000215000.65665.dd; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LUMBIGANON P, 2004, COCHRANE DB SYST REV, V4; McClure EM, 2007, INT J GYNECOL OBSTET, V97, P89, DOI 10.1016/j.ijgo.2007.01.014; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Mullany LC, 2006, PEDIATR INFECT DIS J, V25, P665, DOI 10.1097/01.inf.0000223489.02791.70; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Stade B. C., 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD003520.pub2, DOI 10.1002/14651858.CD003520.PUB2]; Stray-Pedersen B, 1999, INT J ANTIMICROB AG, V12, P245, DOI 10.1016/S0924-8579(99)00068-0; Taha TE, 1997, BRIT MED J, V315, P216, DOI 10.1136/bmj.315.7102.216; Tolosa JE, 2006, PEDIATR INFECT DIS J, V25, P676, DOI 10.1097/01.inf.0000230265.19320.41; Wilson CM, 2004, JAIDS-J ACQ IMM DEF, V35, P138, DOI 10.1097/00126334-200402010-00006; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769; 2004, MMWR MORB MORTAL WKL, V53, P502	24	64	66	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1909	1916		10.1016/S0140-6736(09)61339-8	http://dx.doi.org/10.1016/S0140-6736(09)61339-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19846212				2022-12-28	WOS:000272646900024
J	Brodlie, M; Mckean, MC				Brodlie, Malcolm; Mckean, Michael C.			Picture Quiz Dyspnoea and cough in a toddler	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONGENITAL DIAPHRAGMATIC-HERNIA; PARAESOPHAGEAL HERNIA; HIATAL-HERNIA; DIAGNOSIS; CHILDREN		[Mckean, Michael C.] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Mckean, MC (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	michael.mckean@nuth.nhs.uk		Brodlie, Malcolm/0000-0003-4591-8299	MRC [G0800419] Funding Source: UKRI; Medical Research Council [G0800419] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Salem AH, 2000, SAUDI MED J, V21, P164; Baglaj M, 2005, PEDIATR RADIOL, V35, P478, DOI 10.1007/s00247-004-1389-z; Baglaj M, 2004, PEDIATR SURG INT, V20, P658, DOI 10.1007/s00383-004-1269-5; Barnewolt CE, 2007, J PEDIATR SURG, V42, P193, DOI 10.1016/j.jpedsurg.2006.09.018; Bonfils M, 2006, ARCH DIS CHILD-FETAL, V91, P363, DOI 10.1136/adc.2005.079392; Coakley FV, 1999, RADIOLOGY, V213, P691, DOI 10.1148/radiology.213.3.r99dc39691; Coren ME, 1997, PEDIATR PULM, V24, P119, DOI 10.1002/(SICI)1099-0496(199708)24:2<119::AID-PPUL8>3.3.CO;2-Y; Dipali RB, 2007, INDIAN J PEDIATR, V74, P310, DOI 10.1007/s12098-007-0054-6; Garne E, 2002, ULTRASOUND OBST GYN, V19, P329, DOI 10.1046/j.1469-0705.2002.00635.x; Holt PD, 2004, PEDIATR RADIOL, V34, P462, DOI 10.1007/s00247-004-1151-6; Imamoglu M, 2005, J PEDIATR SURG, V40, P1128, DOI 10.1016/j.jpedsurg.2005.03.060; Jawad AJ, 1998, PEDIATR SURG INT, V13, P91, DOI 10.1007/s003830050256; Karpelowsky JS, 2006, J PEDIATR SURG, V41, P1588, DOI 10.1016/j.jpedsurg.2006.05.020; Rees JE, 2004, EMERG MED J, V21, P749, DOI 10.1136/emj.2003.007310; Robinson PD, 2007, PAEDIATR RESPIR REV, V8, P323, DOI 10.1016/j.prrv.2007.08.004; Taylor GA, 2009, PEDIATR RADIOL, V39, P1, DOI 10.1007/s00247-008-0917-7; 2002, THORAX S1, V57, P1	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2009	339								b4436	10.1136/bmj.b4436	http://dx.doi.org/10.1136/bmj.b4436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906741				2022-12-28	WOS:000271833900003
J	Beaugerie, L; Brousse, N; Bouvier, AM; Colombel, JF; Lemann, M; Cosnes, J; Hebuterne, X; Cortot, A; Bouhnik, Y; Gendre, JP; Simon, T; Maynadie, M; Hermine, O; Faivre, J; Carrat, F				Beaugerie, Laurent; Brousse, Nicole; Bouvier, Anne Marie; Colombel, Jean Frederic; Lemann, Marc; Cosnes, Jacques; Hebuterne, Xavier; Cortot, Antoine; Bouhnik, Yoram; Gendre, Jean Pierre; Simon, Tabassome; Maynadie, Marc; Hermine, Olivier; Faivre, Jean; Carrat, Fabrice		CESAME Study Grp	Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study	LANCET			English	Article							SOLID-ORGAN TRANSPLANTATION; CROHNS-DISEASE; INCREASED RISK; LYMPHOMA RISK; AZATHIOPRINE; MAINTENANCE; CANCER; METHOTREXATE; METAANALYSIS; INFLIXIMAB	Background Reports of an increased risk of lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease are controversial. We assessed this risk in a prospective observational cohort study. Methods 19486 patients with inflammatory bowel disease, of whom 11759 (60.3%) had Crohn's disease and 7727 (39.7%) had ulcerative colitis or unclassified inflammatory bowel disease, were enrolled in a nationwide French cohort by 680 gastroenterologists, who reported details of immunosuppressive therapy during the observation period, cases of cancer, and deaths. The risk of lymphoproliferative disorder was assessed according to thiopurine exposure. Median follow-up was 35 months (IQR 29-40). Findings At baseline, 5867 (30.1%) of patients were receiving, 2809 (14.4%) had discontinued, and 10810 (55.5%) had never received thiopurines. 23 new cases of lymphoproliferative disorder were diagnosed, consisting of one case of Hodgkin's lymphoma and 22 cases of non-Hodgkin lymphoproliferative disorder. The incidence rates of lymphoproliferative disorder were 0.90 per 1000 (95% CI 0.50-1.49) patient-years in those receiving, 0.20/1000 (0.02-0.72) patient-years in those who had discontinued, and 0.26/1000 (0.10-0.57) patient-years in those who had never received thiopurines (p=0.0054). The multivariate-adjusted hazard ratio of lymphoproliferative disorder between patients receiving thiopurines and those who had never received the drugs was 5.28 (2.01-13.9, p=0.0007). Most cases associated with thiopurine exposure matched the pathological range of post-transplant disease. Interpretation Patients receiving thiopurines for inflammatory bowel disease have an increased risk of developing lymphoproliferative disorders.	[Beaugerie, Laurent] Univ Paris 06, Serv Gastroenterol & Nutr, Hop St Antoine, Dept Gastroenterol,AP HP, F-75571 Paris 12, France; [Simon, Tabassome] Univ Paris 06, Dept Pharmacol, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Simon, Tabassome] Univ Paris 06, URCEST, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Carrat, Fabrice] Univ Paris 06, Unit Publ Hlth, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Carrat, Fabrice] Univ Paris 06, INSERM, Hop St Antoine, AP HP,UMR S 707, F-75571 Paris 12, France; [Brousse, Nicole] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pathol, Paris, France; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Haematol, Paris, France; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Ctr Reference Mastocytoses, Paris, France; [Bouvier, Anne Marie; Faivre, Jean] Univ Bourgogne, CHU Dijon, Registre Bourguignon Canc Digestifs, Dijon, France; [Maynadie, Marc] Univ Bourgogne, CHU Dijon, Registre Hemopathies Malignes Cote Or, EA4184, Dijon, France; [Colombel, Jean Frederic; Cortot, Antoine] CHU Lille, Dept Hepatogastroenterol, F-59037 Lille, France; [Lemann, Marc] Univ Paris 07, Dept Gastroenterol, Hop St Louis, AP HP, Paris, France; [Bouhnik, Yoram] Univ Paris 07, Dept Gastroenterol, Hop Beaujon, AP HP, Paris, France; [Hebuterne, Xavier] Univ Nice Sophia Antipolis, Dept Gastroenterol, CHU Nice, INSERM ERI 21, Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Beaugerie, L (corresponding author), Univ Paris 06, Serv Gastroenterol & Nutr, Hop St Antoine, Dept Gastroenterol,AP HP, F-75571 Paris 12, France.	laurent.beaugerie@sat.aphp.fr	CORTOT, ANTOINE/I-7739-2016; gottrand, frederic F/G-7370-2015; Bourreille, Arnaud/K-2398-2015; Michaud, Laurent/S-2041-2018; Desreumaux, Pierre F/R-6877-2018; NANCEY, STEPHANE/Y-5093-2019; Carrat, Fabrice/AAU-8480-2020; Bouvier, Anne-Marie/GLU-3915-2022; BOUVIER, Anne-Marie/R-6600-2017; Hermine, Olivier/Q-7072-2018; CORTOT, Antoine/I-5796-2015; Maynadié, Marc/E-6271-2010	CORTOT, ANTOINE/0000-0002-1067-8996; gottrand, frederic F/0000-0002-5290-0436; Michaud, Laurent/0000-0002-5020-1367; Desreumaux, Pierre F/0000-0002-6127-5281; NANCEY, STEPHANE/0000-0003-2088-1442; Carrat, Fabrice/0000-0002-8672-7918; Bouvier, Anne-Marie/0000-0001-9070-1027; Hugot, Jean-Pierre/0000-0002-8446-6056; GARGOT, Dany/0000-0002-7369-9532; Siproudhis, laurent/0000-0002-2575-6790; Hermine, Olivier/0000-0003-2574-3874; Savoye, Guillaume/0000-0002-9200-2067; MION, Francois/0000-0002-2908-1591; SIMON, Tabassome/0000-0002-4550-0450; FLOURIE, bernard/0000-0002-3300-0299; Thiefin, Gerard/0000-0002-8626-8352; CHRISTIDIS, Christos/0000-0002-7565-0134; Ganne-Carrie, Nathalie/0000-0002-7351-5027; BENAMOUZIG, ROBERT/0000-0003-1952-6830; peyrin-biroulet, laurent/0000-0003-2536-6618	Programme Hospitalier de Recherche Clinique National [AOM05157]; Association Francois Aupetit; Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris; Ligue contre le Cancer; Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie	Programme Hospitalier de Recherche Clinique National; Association Francois Aupetit; Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris; Ligue contre le Cancer(Ligue nationale contre le cancer); Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie	Supported by grants from Programme Hospitalier de Recherche Clinique National (AOM05157), Association Francois Aupetit, Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris (AP-HP), Ligue contre le Cancer, and Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie. We thank Roger Salamon for his independent review of the study design.	Armitage P., 2001, STAT METHODS MED RES; Askling J, 2005, GUT, V54, P617, DOI 10.1136/gut.2004.051771; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Dayharsh GA, 2002, GASTROENTEROLOGY, V122, P72, DOI 10.1053/gast.2002.30328; DHaens G, 1997, GASTROENTEROLOGY, V112, P1475, DOI 10.1016/S0016-5085(97)70027-1; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x; Jones JL, 2007, INFLAMM BOWEL DIS, V13, P1299, DOI 10.1002/ibd.20211; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; KINLEN LJ, 1979, BRIT MED J, V2, P1461, DOI 10.1136/bmj.2.6203.1461; LAW CG, 1992, STAT MED, V11, P1569, DOI 10.1002/sim.4780111204; Lewis JD, 2000, GASTROENTEROLOGY, V118, P1018, DOI 10.1016/S0016-5085(00)70353-2; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Masunaga Y, 2007, ANN PHARMACOTHER, V41, P21, DOI 10.1345/aph.1H219; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Pearson DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000067; POSTHUMA EFM, 1995, GUT, V36, P311, DOI 10.1136/gut.36.2.311; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Seksik P, 2009, INFLAMM BOWEL DIS, V15, P734, DOI 10.1002/ibd.20828; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343; Takakuwa T, 2008, LEUKEMIA, V22, P620, DOI 10.1038/sj.leu.2405059; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	32	751	775	0	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1617	1625		10.1016/S0140-6736(09)61302-7	http://dx.doi.org/10.1016/S0140-6736(09)61302-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19837455				2022-12-28	WOS:000271674600035
J	Chamberlain, NL; Hill, RI; Kapan, DD; Gilbert, LE; Kronforst, MR				Chamberlain, Nicola L.; Hill, Ryan I.; Kapan, Durrell D.; Gilbert, Lawrence E.; Kronforst, Marcus R.			Polymorphic Butterfly Reveals the Missing Link in Ecological Speciation	SCIENCE			English	Article							HYBRIDIZING HELICONIUS BUTTERFLIES; REPRODUCTIVE ISOLATION; MATE PREFERENCE; POPULATION; MIMICRY; FROGS	Ecological speciation occurs when ecologically based, divergent selection causes the evolution of reproductive isolation. There are many empirical examples of this process; however, there exists a poorly characterized stage during which the traits that distinguish species ecologically and reproductively segregate in a single population. By using a combination of genetic mapping, mate-choice experiments, field observations, and population genetics, we studied a butterfly population with a mimetic wing color polymorphism and found that the butterflies exhibited partial, color-based, assortative mate preference. These traits represent the divergent, ecologically based signal and preference components of sexual isolation that usually distinguish incipient and sibling species. The association between behavior and recognition trait in a single population may enhance the probability of speciation and provides an example of the missing link between an interbreeding population and isolated species.	[Chamberlain, Nicola L.; Hill, Ryan I.; Kronforst, Marcus R.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Kapan, Durrell D.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Gilbert, Lawrence E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Harvard University; University of Hawaii System; University of Hawaii Manoa; University of Texas System; University of Texas Austin	Kronforst, MR (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	mkronforst@cgr.harvard.edu	Smola, Bohumil/P-7962-2016; Stulíková, Ivana/P-8010-2016	Smola, Bohumil/0000-0001-5551-2992; Stulíková, Ivana/0000-0002-4305-2041	NSF [DEB0640512]; NIH National Institute of General Medical Sciences [GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Olander and the staff of Heliconius Butterfly Works; T. and M. Quesenberry; and S. Villamar n, K. Kronforst, A. Gonzalez-Karlsson, I. Pagano, Ecuador's Ministerio del Ambiente, and the Museo Ecuatoriano de Ciencias Naturales for facilitating this work. We also thank C. Marshall for discussion and two anonymous reviewers for comments on the manuscript. Supported by NSF grant DEB0640512 and NIH National Institute of General Medical Sciences grant GM068763. DNA sequences have been deposited in GenBank with accession numbers GQ398158 through GQ398227.	Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; BUTLIN RK, 1989, BIOL J LINN SOC, V37, P237, DOI 10.1111/j.1095-8312.1989.tb01902.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Gilbert L.E., 1988, Journal of Research on the Lepidoptera, V26, P141; GILBERT LE, 2003, ECOLOGY EVOLUTION TA, P281; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Jiggins CD, 2008, BIOSCIENCE, V58, P541, DOI 10.1641/B580610; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Kronforst MR, 2006, EVOLUTION, V60, P1254, DOI 10.1554/06-005.1; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Pritchard JK, 2000, GENETICS, V155, P945; Reynolds RG, 2007, EVOLUTION, V61, P2253, DOI 10.1111/j.1558-5646.2007.00174.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SNAYDON RW, 1976, HEREDITY, V37, P9, DOI 10.1038/hdy.1976.62; Snowberg LK, 2008, AM NAT, V172, P733, DOI 10.1086/591692; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120	26	114	115	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					847	850		10.1126/science.1179141	http://dx.doi.org/10.1126/science.1179141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892982	Green Accepted			2022-12-28	WOS:000271468000042
J	Kaden, WE; Wu, TP; Kunkel, WA; Anderson, SL				Kaden, William E.; Wu, Tianpin; Kunkel, William A.; Anderson, Scott L.			Electronic Structure Controls Reactivity of Size-Selected Pd Clusters Adsorbed on TiO2 Surfaces	SCIENCE			English	Article							CO OXIDATION; CHEMICAL-PROPERTIES; PLATINUM CLUSTERS; FINAL-STATE; TIO2(110); OXYGEN; CATALYSTS; PHOTOELECTRON; PHOTOEMISSION; ADSORPTION	The catalytic activity of metal clusters of different sizes adsorbed on oxide surfaces can be explored systematically by using model catalysts. We studied the temperature-programmed reaction of CO with O-2 catalyzed by Pd clusters (Pdn, for n = 1, 2, 4, 7, 10, 16, 20, and 25) that were size-selected in the gas phase and deposited on rutile TiO2(110). X-ray photoemission spectroscopy revealed that the Pd 3d binding energy varied nonmonotonically with cluster size and that the changes correlated with strong size variations in CO oxidation activity. Taking final-state effects into account, low activity was correlated with higher-than-expected Pd 3d binding energy, which is attributed to a particularly stable valence electronic structure; electron transfer from the TiO2 support to the Pd clusters also occurs. Ion scattering shows that small clusters form single-layer islands on the surface and that formation of a second layer begins to occur for clusters larger than Pd-10.	[Kaden, William E.; Wu, Tianpin; Kunkel, William A.; Anderson, Scott L.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Anderson, SL (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East,Room 2020, Salt Lake City, UT 84112 USA.	anderson@chem.utah.edu	Wu, Tianpin/G-2483-2012; Anderson, Scott/B-8753-2014	Anderson, Scott/0000-0001-9985-8178; Kaden, William/0000-0003-0836-7109	Air Force Office of Scientific Research [FA9550-06-1-0100]; U. S. Department of Energy [DEFG03-99ER15003]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U. S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Air Force Office of Scientific Research grant FA9550-06-1-0100 and U. S. Department of Energy grant DEFG03-99ER15003	Abbet S, 2001, PHYS REV LETT, V86, P5950, DOI 10.1103/PhysRevLett.86.5950; Aizawa M, 2003, SURF SCI, V542, P253, DOI 10.1016/S0039-6028(03)00984-1; Aizawa M, 2002, J CHEM PHYS, V117, P5001, DOI 10.1063/1.1498477; Arenz M, 2007, CHEM PHYS SOLID SURF, V12, P1, DOI 10.1016/S1571-0785(07)12001-0; Aruna I, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973682; Canario AR, 2005, NUCL INSTRUM METH B, V230, P311, DOI 10.1016/j.nimb.2004.12.060; Chretien S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2806802; Diebold U., 1996, Surface Science Spectra, V4, P227, DOI 10.1116/1.1247794; DIEBOLD U, 2007, CHEM PHYS SOLID SURF, V9, P443; Epling WS, 1998, SURF SCI, V412-13, P333, DOI 10.1016/S0039-6028(98)00446-4; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Heiz U, 1999, J AM CHEM SOC, V121, P3214, DOI 10.1021/ja983616l; Henderson MA, 1999, J PHYS CHEM B, V103, P5328, DOI 10.1021/jp990655q; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; HOHLNEICHER G, 1985, J ELECTRON SPECTROSC, V37, P209, DOI 10.1016/0368-2048(85)80069-4; KUHRT C, 1991, SURF SCI, V245, P173, DOI 10.1016/0039-6028(91)90476-9; Landman U, 2007, TOP CATAL, V44, P145, DOI 10.1007/s11244-007-0288-6; Lee SS, 2004, J AM CHEM SOC, V126, P5682, DOI 10.1021/ja049436v; Lightstone JM, 2008, J PHYS CHEM C, V112, P11495, DOI 10.1021/jp711938m; LINSEBIGLER A, 1995, J CHEM PHYS, V103, P9438, DOI 10.1063/1.470005; Mathes M, 2004, SURF SCI, V552, pL58, DOI 10.1016/j.susc.2004.01.014; McClure SM, 2009, CHEM PHYS LETT, V469, P1, DOI 10.1016/j.cplett.2008.12.066; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Rabalais JW, 2003, PRINCIPLES APPL ION; Richter B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026805; Shaikhutdinov S, 2002, SURF SCI, V501, P270, DOI 10.1016/S0039-6028(01)01850-7; Tsud N, 2000, SURF SCI, V467, P169, DOI 10.1016/S0039-6028(00)00747-0; Vajda S, 2009, NAT MATER, V8, P213, DOI [10.1038/nmat2384, 10.1038/NMAT2384]; WAGNER CD, 1982, J ELECTRON SPECTROSC, V28, P211, DOI 10.1016/0368-2048(82)85044-5; Wang JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.136107; Wendt S, 2005, SURF SCI, V598, P226, DOI 10.1016/j.susc.2005.08.041; WERTHEIM GK, 1983, PHYS REV LETT, V51, P2310, DOI 10.1103/PhysRevLett.51.2310; WERTHEIM GK, 1988, PHYS REV B, V37, P844, DOI 10.1103/PhysRevB.37.844	33	476	482	18	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					826	829		10.1126/science.1180297	http://dx.doi.org/10.1126/science.1180297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892976				2022-12-28	WOS:000271468000036
J	Macdougall, IC; Rossert, J; Casadevall, N; Stead, RB; Duliege, AM; Froissart, M; Eckardt, KU				Macdougall, Iain C.; Rossert, Jerome; Casadevall, Nicole; Stead, Richard B.; Duliege, Anne-Marie; Froissart, Marc; Eckardt, Kai-Uwe			A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIERYTHROPOIETIN ANTIBODIES; STIMULATING AGENT; HEMATIDE; PATIENT; EPOETIN; ANEMIA; POTENT	Background: We investigated whether a novel, synthetic, peptide-based erythropoietin-receptor agonist (Hematide, Affymax) can stimulate erythropoiesis in patients with anemia that is caused by antierythropoietin antibodies. Methods: In this open-label, single-group trial, we enrolled patients with chronic kidney disease who had pure red-cell aplasia or hypoplasia due to antierythropoietin antibodies and treated them with a synthetic peptide-based erythropoietin-receptor agonist. The agonist was administered by subcutaneous injection at an initial dose of 0.05 mg per kilogram of body weight every 4 weeks. The primary end point was a hemoglobin concentration above 11 g per deciliter without the need for transfusions. Results: We treated 14 patients with the peptide agonist for a median of 28 months. The median hemoglobin concentration increased from 9.0 g per deciliter (with transfusion support in the case of 12 patients) before treatment to 11.4 g per deciliter at the time of the last administration of the agonist; transfusion requirements diminished within 12 weeks after the first dose, after which 13 of the 14 patients no longer required regular transfusions. Peak reticulocyte counts increased from a median of 10 x 10(sup 9) per liter before treatment to peak counts of greater than 100 x 10(sup 9) per liter. The level of antierythropoietin antibodies declined over the course of the study and became undetectable in six patients. One patient who initially responded to treatment had a diminished hematologic response a few months later despite increased doses of the agonist and required transfusions again; this patient was found to have antibodies against the agonist. One patient died 4 months after the last dose of the agonist, and a grade 3 or 4 adverse event occurred in seven other patients during the study period. Conclusions: This novel agonist of the erythropoietin receptor can correct anemia in patients with pure red-cell aplasia caused by antierythropoietin antibodies. (ClinicalTrials.gov number, NCT00314795.) N Engl J Med 2009;361:1848-55.	[Macdougall, Iain C.] Kings Coll Hosp London, Renal Unit, Dept Renal Med, London SE5 9RS, England; [Rossert, Jerome] Georges Pompidou European Hosp, AP HP, Dept Nephrol, Paris, France; [Froissart, Marc] Georges Pompidou European Hosp, AP HP, Dept Physiol, Paris, France; [Rossert, Jerome; Froissart, Marc] Paris Descartes Univ, Paris, France; [Casadevall, Nicole] Hop St Antoine, AP HP, Dept Hematol, F-75571 Paris, France; [Casadevall, Nicole] Univ Paris 06, Paris, France; [Casadevall, Nicole] INSERM, U790, Villejuif, France; [Stead, Richard B.] BioPharma Consulting Serv, Bellevue, WA USA; [Duliege, Anne-Marie] Affymax, Palo Alto, CA USA; [Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany	King's College Hospital NHS Foundation Trust; King's College Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Erlangen Nuremberg	Macdougall, IC (corresponding author), Kings Coll Hosp London, Renal Unit, Dept Renal Med, Denmark Hill, London SE5 9RS, England.	iain.macdougall@kch.nhs.uk	Froissart, Marc/L-7493-2014	Froissart, Marc/0000-0002-4010-3173	Roche; Affymax	Roche(Roche Holding); Affymax	Dr. Macdougall reports receiving consulting fees, lecture fees, and grant support from Amgen, Ortho Biotech, Roche, Shire, and Affymax; Dr. Rossert, receiving consulting or lecture fees, or both, from Affymax, Amgen, Ortho Biotech, and Shire and grant support from Roche and being currently employed by Amgen; Dr. Casadevall, receiving consulting fees from Shire and consulting and lecture fees from Amgen, Ortho Biotech, and Roche; Dr. Stead, receiving consulting fees from Affymax and owning equity in Affymax and Amgen; Dr. Froissart, receiving consulting fees from Roche, Genzyme, and Hospira, consulting and lecture fees from Shire, and grant support from Affymax and Roche; and Dr. Eckardt, receiving consulting fees from Amgen, Ortho Biotech, Roche, Affymax, Stada, and Sandoz ( Hexal) and lecture fees from Amgen, Ortho Biotech, and Roche. No other potential conflict of interest relevant to this article was reported.	Andrade J, 2005, NEPHROL DIAL TRANSPL, V20, P2548, DOI 10.1093/ndt/gfi018; Bennett CL, 2004, NEW ENGL J MED, V351, P1403, DOI 10.1056/NEJMoa040528; BESARAB A, 2007, NAT KIDN FDN SPRING; Bromberg ME, 2006, NEW ENGL J MED, V355, P1643, DOI 10.1056/NEJMp068169; Bussel JB, 2006, NEW ENGL J MED, V355, P2054; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Casadevall N, 1996, NEW ENGL J MED, V334, P630, DOI 10.1056/NEJM199603073341004; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Fan Q, 2006, EXP HEMATOL, V34, P1303, DOI 10.1016/j.exphem.2006.05.012; *FOOD DRUG ADM, 1995, ICHE2A FOOD DRUG ADM; Gershon SK, 2002, NEW ENGL J MED, V346, P1584; Howman R, 2007, NEPHROL DIAL TRANSPL, V22, P1462, DOI 10.1093/ndt/gfl727; Kaufman JS, 1998, NEW ENGL J MED, V339, P578, DOI 10.1056/NEJM199808273390902; Levin A, 2007, AM J KIDNEY DIS, V50, P471; MACDOUGALL IC, 2006, AM SOC NEPHR 11 ANN; Organization W.H, 1979, WHO HDB REP RES CANC; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Pickering LM, 2006, BLOOD, V108, p378A; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stead RB, 2006, BLOOD, V108, P1830, DOI 10.1182/blood-2006-04-015818; Stridsberg M., 1993, ERYTHROPOIETIN MOL P, P266; Verhelst D, 2004, LANCET, V363, P1768, DOI 10.1016/S0140-6736(04)16302-2; Weber G, 2002, J AM SOC NEPHROL, V13, P2381, DOI 10.1097/01.ASN.0000027031.79843.6C; Woodburn KW, 2007, EXP HEMATOL, V35, P1201, DOI 10.1016/j.exphem.2007.05.007; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	27	104	108	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1848	1855		10.1056/NEJMoa074037	http://dx.doi.org/10.1056/NEJMoa074037			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890127				2022-12-28	WOS:000271405800009
J	Burke, CJ; Thomas, R; Howlett, DC				Burke, C. J.; Thomas, R.; Howlett, D. C.			Picture Quiz An occult breast mass	BRITISH MEDICAL JOURNAL			English	Editorial Material							MUTATION CARRIERS; HIGH-RISK; CANCER; MAMMOGRAPHY; MRI; ULTRASOUND; BRCA1		[Burke, C. J.; Thomas, R.; Howlett, D. C.] Eastbourne Gen Hosp, Dept Radiol, Eastbourne BN21 2UD, E Sussex, England		Burke, CJ (corresponding author), 42 Arminger Rd, London W12 7BB, England.	drchristopherburke@gmail.com	Burke, Christopher/AAI-6000-2020	Burke, Christopher/0000-0001-7609-1146				Dahnert W, 2007, RADIOLOGY REV MANUAL; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Lalonde L, 2005, CAN ASSOC RADIOL J, V56, P301; Lee CH, 2004, RADIOL CLIN N AM, V42, P919, DOI 10.1016/j.rcl.2004.05.001; Lee JM, 2008, RADIOLOGY, V246, P763, DOI 10.1148/radiol.2463070224; Lopez JK, 2009, RADIOGRAPHICS, V29, P165, DOI 10.1148/rg.291085100; Lord SJ, 2007, EUR J CANCER, V43, P1905, DOI 10.1016/j.ejca.2007.06.007; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Pediconi F, 2007, RADIOLOGY, V243, P670, DOI 10.1148/radiol.2433060838; Vandermeer FQ, 2007, CANCER INVEST, V25, P384, DOI 10.1080/07357900701360013; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317	11	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2009	339								b4316	10.1136/bmj.b4316	http://dx.doi.org/10.1136/bmj.b4316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889732				2022-12-28	WOS:000271567800001
J	Ivanov, II; Atarashi, K; Manel, N; Brodie, EL; Shima, T; Karaoz, U; Wei, DG; Goldfarb, KC; Santee, CA; Lynch, SV; Tanoue, T; Imaoka, A; Itoh, K; Takeda, K; Umesaki, Y; Honda, K; Littman, DR				Ivanov, Ivaylo I.; Atarashi, Koji; Manel, Nicolas; Brodie, Eoin L.; Shima, Tatsuichiro; Karaoz, Ulas; Wei, Dongguang; Goldfarb, Katherine C.; Santee, Clark A.; Lynch, Susan V.; Tanoue, Takeshi; Imaoka, Akemi; Itoh, Kikuji; Takeda, Kiyoshi; Umesaki, Yoshinori; Honda, Kenya; Littman, Dan R.			Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria	CELL			English	Article							MURINE GASTROINTESTINAL-TRACT; MUCOSAL IMMUNE-SYSTEM; T-HELPER-CELLS; AUTOIMMUNE INFLAMMATION; HOST-DEFENSE; TGF-BETA; DIFFERENTIATION; INNATE; MICE; IL-23	The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.	[Atarashi, Koji; Tanoue, Takeshi; Takeda, Kiyoshi; Honda, Kenya] Osaka Univ, Lab Immune Regulat, Grad Sch Med, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Ivanov, Ivaylo I.; Manel, Nicolas; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Ivanov, Ivaylo I.; Manel, Nicolas; Littman, Dan R.] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Brodie, Eoin L.; Karaoz, Ulas; Goldfarb, Katherine C.; Santee, Clark A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Wei, Dongguang] Carl Zeiss SMT Inc, Nanotechnol Syst Div, Peabody, MA 01960 USA; [Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; [Shima, Tatsuichiro; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Itoh, Kikuji] Univ Tokyo, Dept Vet Publ Hlth, Bunkyo Ku, Tokyo 1138657, Japan; [Honda, Kenya] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; New York University; New York University; Howard Hughes Medical Institute; New York University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Carl Zeiss AG; University of California System; University of California San Francisco; Yakult Honsha Company, Limited; University of Tokyo; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Osaka Univ, Lab Immune Regulat, Grad Sch Med, WPI Immunol Frontier Res Ctr, 2-2 Yamada Oka, Osaka 5650871, Japan.	honda@ongene.med.osaka-u.ac.jp; littman@saturn.med.nyu.edu	Manel, Nicolas/E-2128-2011; Takeda, Kiyoshi/C-9331-2009; Atarashi, Koji/I-5363-2014; Honda, Kenya/N-5297-2015; Karaoz, Ulas/J-7093-2014; Lynch, Susan V/B-6272-2009; Brodie, Eoin L/A-7853-2008	Manel, Nicolas/0000-0002-1481-4430; Atarashi, Koji/0000-0001-5422-0736; Karaoz, Ulas/0000-0002-8238-6757; Brodie, Eoin L/0000-0002-8453-8435; Takeda, Kiyoshi/0000-0002-1778-6332	Crohn's and Colitis Foundation of America; Cancer Research Institute; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health [AI33856]; Ministry of Education, Culture, Sports, Science and Technology; PRESTO; JST; Senri Life Science Foundation; Naito Foundation; United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K99DK085329] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO; JST(Japan Science & Technology Agency (JST)); Senri Life Science Foundation; Naito Foundation(Naito Memorial Foundation); United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Littman laboratory for valuable discussions, Takeshi Egawa and Homer Boushey for their contribution to establishing the collaborative study, and Junichi Nishimura for technical assistance. We also thank Feng-Xia (Alice) Liang and Eric Roth from the New York Univeristy imaging core facility for performing transmission electron microscopy and for preparing samples for scanning electron microscopy. We also thank Jiri Zavadil and Agnes Viale and the genomic core facilities of NYU and Memorial Sloan Ketterring Cancer Center, respectively, for performing the array studies. We thank the staff at the Yakult Central Institute for gnotobiotic handling of the mice. The work was supported by Crohn's and Colitis Foundation of America (I. I. I.) and Cancer Research Institute (N.M.) fellowships and by the Howard Hughes Medical Institute (D. R. L.), the Helen and Martin Kimmel Center for Biology and Medicine (D. R. L.), National Institutes of Health grant AI33856 (D. R. L.), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (K. H.), PRESTO, JST (K. H.), the Senri Life Science Foundation, and the Naito Foundation (K. H.). Part of this work was performed under the auspices of the United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under contract DE-AC02-05CH11231.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GARLAND CD, 1982, MICROB ECOL, V8, P181, DOI 10.1007/BF02010451; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Glimcher LH, 2000, GENE DEV, V14, P1693; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; He R, 2006, J IMMUNOL, V177, P4072, DOI 10.4049/jimmunol.177.6.4072; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; KOOPMAN JP, 1987, LAB ANIM-UK, V21, P48, DOI 10.1258/002367787780740743; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Miyamoto Y, 2000, INT J SYST EVOL MICR, V50, P145, DOI 10.1099/00207713-50-1-145; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; O'Dell JR, 2006, ARTHRITIS RHEUM-US, V54, P621, DOI 10.1002/art.21620; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEVERIJNEN AJ, 1989, J RHEUMATOL, V16, P1061; Simelyte E, 2003, ANN RHEUM DIS, V62, P976, DOI 10.1136/ard.62.10.976; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	65	2961	3106	5	304	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					485	498		10.1016/j.cell.2009.09.033	http://dx.doi.org/10.1016/j.cell.2009.09.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19836068	Green Accepted, Bronze			2022-12-28	WOS:000271259600014
J	Zapka, M; Heyers, D; Hein, CM; Engels, S; Schneider, NL; Hans, J; Weiler, S; Dreyer, D; Kishkinev, D; Wild, JM; Mouritsen, H				Zapka, Manuela; Heyers, Dominik; Hein, Christine M.; Engels, Svenja; Schneider, Nils-Lasse; Hans, Joerg; Weiler, Simon; Dreyer, David; Kishkinev, Dmitry; Wild, J. Martin; Mouritsen, Henrik			Visual but not trigeminal mediation of magnetic compass information in a migratory bird	NATURE			English	Article							HOMING PIGEONS; MAGNETORECEPTION; ORIENTATION; SONGBIRDS; BEAK; SENSITIVITY; INTENSITY; ANIMALS; NERVE; BRAIN	Magnetic compass information has a key role in bird orientation(1-3), but the physiological mechanisms enabling birds to sense the Earth's magnetic field remain one of the unresolved mysteries in biology(2,4). Two biophysical mechanisms have become established as the most promising magnetodetection candidates. The iron-mineral-based hypothesis suggests that magnetic information is detected by magnetoreceptors in the upper beak and transmitted through the ophthalmic branch of the trigeminal nerve to the brain(5-10). The light-dependent hypothesis suggests that magnetic field direction is sensed by radical pair-forming photopigments in the eyes(11-15) and that this visual signal is processed in cluster N, a specialized, night-time active, light-processing forebrain region(16-19). Here we report that European robins with bilateral lesions of cluster N are unable to show oriented magnetic-compass-guided behaviour but are able to perform sun compass and star compass orientation behaviour. In contrast, bilateral section of the ophthalmic branch of the trigeminal nerve in European robins did not influence the birds' ability to use their magnetic compass for orientation. These data show that cluster N is required for magnetic compass orientation in this species and indicate that it may be specifically involved in processing of magnetic compass information. Furthermore, the data strongly suggest that a vision-mediated mechanism underlies the magnetic compass in this migratory songbird, and that the putative iron-mineral-based receptors in the upper beak connected to the brain by the trigeminal nerve(6-8) are neither necessary nor sufficient for magnetic compass orientation in European robins.	[Zapka, Manuela; Heyers, Dominik; Hein, Christine M.; Engels, Svenja; Schneider, Nils-Lasse; Hans, Joerg; Weiler, Simon; Dreyer, David; Kishkinev, Dmitry; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensorik Anim Nav, D-26111 Oldenburg, Germany; [Wild, J. Martin] Univ Auckland, Fac Med & Hlth Sci, Dept Anat, Auckland 1142, New Zealand	Carl von Ossietzky Universitat Oldenburg; University of Auckland	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensorik Anim Nav, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Heyers, Dominik/D-3885-2015; Mouritsen, Henrik/A-5401-2010; Kishkinev, Dmitry/S-1547-2016	Heyers, Dominik/0000-0002-2831-6985; Mouritsen, Henrik/0000-0001-7082-4839; Kishkinev, Dmitry/0000-0002-2619-1197	Volkswagenstiftung; Deutsche Forschungsgemeinschaft	Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Bourdonnais, D. Hugo, A. Kittel, C. Mora and several volunteer students for assistance, E. Jarvis for scientific discussions, Blumberg GmbH, Rattingen, Germany for providing the thermal paper, the workshops of the University of Oldenburg for building huts, magnetic coil systems and electronic controls and J. Rahn for assistance in the planetarium of the Fachhochschule Oldenburg/Elsfleth. Financial support was provided by the Volkswagenstiftung (to H. M. and D. H.) and by the Deutsche Forschungsgemeinschaft (to H. M.).	AKESSON S, 1994, ETHOLOGY, V98, P177; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Beason RC, 1996, J EXP BIOL, V199, P1241; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2008, J EXP BIOL, V211, P2046, DOI 10.1242/jeb.017608; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; PASTERNAK T, 1977, J COMP PHYSIOL PSYCH, V91, P485, DOI 10.1037/h0077349; PRESTI D, 1980, NATURE, V285, P99, DOI 10.1038/285099a0; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5	30	188	194	7	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1274	U108		10.1038/nature08528	http://dx.doi.org/10.1038/nature08528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865170				2022-12-28	WOS:000271190800047
J	Seiffert, ER; Perry, JMG; Simons, EL; Boyer, DM				Seiffert, Erik R.; Perry, Jonathan M. G.; Simons, Elwyn L.; Boyer, Doug M.			Convergent evolution of anthropoid-like adaptations in Eocene adapiform primates	NATURE			English	Article							MIDDLE EOCENE; FISSURE-FILLINGS; MOLECULAR-DATA; EGYPT; PHYLOGENY; FOSSIL; PALEOGENE; MYANMAR; AFRICA; CHINA	Adapiform or 'adapoid' primates first appear in the fossil record in the earliest Eocene epoch (similar to 55 million years (Myr) ago), and were common components of Palaeogene primate communities in Europe, Asia and North America(1). Adapiforms are commonly referred to as the 'lemur-like' primates of the Eocene epoch, and recent phylogenetic analyses have placed adapiforms as stem members of Strepsirrhini(2-4), a primate suborder whose crown clade includes lemurs, lorises and galagos. An alternative view is that adapiforms are stem anthropoids(5). This debate has recently been rekindled by the description of a largely complete skeleton of the adapiform Darwinius(6), from the middle Eocene of Europe, which has been widely publicised as an important 'link' in the early evolution of Anthropoidea(7). Here we describe the complete dentition and jaw of a large-bodied adapiform (Afradapis gen. nov.) from the earliest late Eocene of Egypt (similar to 37 Myr ago) that exhibits a striking series of derived dental and gnathic features that also occur in younger anthropoid primates-notably the earliest catarrhine ancestors of Old World monkeys and apes. Phylogenetic analysis of 360 morphological features scored across 117 living and extinct primates (including all candidate stem anthropoids) does not place adapiforms as haplorhines (that is, members of a Tarsius-Anthropoidea clade) or as stem anthropoids, but rather as sister taxa of crown Strepsirrhini; Afradapis and Darwinius are placed in a geographically widespread clade of caenopithecine adapiforms that left no known descendants. The specialized morphological features that these adapiforms share with anthropoids are therefore most parsimoniously interpreted as evolutionary convergences. As the largest non-anthropoid primate ever documented in Afro-Arabia, Afradapis nevertheless provides surprising new evidence for prosimian diversity in the Eocene of Africa, and raises the possibility that ecological competition between adapiforms and higher primates might have played an important role during the early evolution of stem and crown Anthropoidea in Afro-Arabia.	[Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Perry, Jonathan M. G.] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Simons, Elwyn L.] Duke Lemur Ctr, Div Fossil Primates, Durham, NC 27705 USA; [Boyer, Doug M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Midwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Seiffert, ER (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	erik.seiffert@stonybrook.edu		Boyer, Douglas/0000-0002-8697-2999	Research Foundation of SUNY; US National Science Foundation; The Leakey Foundation; Duke Lemur Center publication [1155]	Research Foundation of SUNY; US National Science Foundation(National Science Foundation (NSF)); The Leakey Foundation; Duke Lemur Center publication	We thank K. C. Beard, P. Chatrath, B. Engesser, M. Hellmund, J. Galkin, P. D. Gingerich, M. Godinot, G. Gunnell, E. Ladier, B. Marandat, L. Marivaux, K. D. Rose, I. Rutzky and P. Tassy for access to adapiform fossils and casts. F. Ankel-Simons and J. Fleagle provided comments on the manuscript. Collaborative palaeontological research in Egypt is made possible through cooperation with the Egyptian Mineral Resources Authority and the Egyptian Geological Museum. Fieldwork in Egypt is managed by P. Chatrath. This research has been funded by the Research Foundation of SUNY, and grants from the US National Science Foundation and The Leakey Foundation to E. R. S. and E. L. S. This is Duke Lemur Center publication 1155.	Beard K. Christopher, 2007, Bulletin of Carnegie Museum of Natural History, V39, P67, DOI 10.2992/0145-9058(2007)39[67:NSPFTE]2.0.CO;2; Beard KC, 2005, J HUM EVOL, V49, P468, DOI 10.1016/j.jhevol.2005.05.008; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Chaimanee Y, 1997, NATURE, V385, P429, DOI 10.1038/385429a0; Ciochon RL, 2001, P NATL ACAD SCI USA, V98, P7672, DOI 10.1073/pnas.051003298; Clochon RL, 2002, EVOL ANTHROPOL, V11, P156, DOI 10.1002/evan.10032; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Franzen Jens Lorenz, 2000, Senckenbergiana Lethaea, V80, P289; Gebo DL, 2001, AM J PHYS ANTHROPOL, V116, P83, DOI 10.1002/ajpa.1105; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; GINGERICH PD, 1992, U MICH PAP PALEONT, V30, P84; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; Gunnell Gregg F., 2002, Contributions from the Museum of Paleontology University of Michigan, V30, P337; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay Richard F., 2004, P91; MacPhee RDE, 1995, J HUM EVOL, V29, P501, DOI 10.1006/jhev.1995.1073; Marivaux L, 2005, P NATL ACAD SCI USA, V102, P8436, DOI 10.1073/pnas.0503469102; Masters JC, 2002, AM J PHYS ANTHROPOL, V117, P79, DOI 10.1002/ajpa.10001; Miller ER, 1997, P NATL ACAD SCI USA, V94, P13760, DOI 10.1073/pnas.94.25.13760; Rasmussen D. Tab, 1994, P335; RASMUSSEN DT, 1990, INT J PRIMATOL, V11, P439, DOI 10.1007/BF02196131; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; Ross Callum, 1994, P469; Ross CF, 2000, J HUM EVOL, V39, P225, DOI 10.1006/jhev.2000.0417; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Seiffert ER, 2006, P NATL ACAD SCI USA, V103, P5000, DOI 10.1073/pnas.0600689103; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; Simons EL, 1996, AM J PHYS ANTHROPOL, V100, P261, DOI 10.1002/(SICI)1096-8644(199606)100:2<261::AID-AJPA7>3.0.CO;2-#; Simons EL, 1995, J HUM EVOL, V29, P577, DOI 10.1006/jhev.1995.1076; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stehlin H.G, 1916, ABHANDL SCHWEIZERISC, V41, P1299; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tabuce R, 2005, ANTHROPOL SCI, V113, P27, DOI 10.1537/ase.04S004; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; TUDGE C, 2009, LINK UNCOVERING OUR; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472; WILSON JA, 1976, FOLIA PRIMATOL, V25, P294, DOI 10.1159/000155722; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801	48	84	90	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1118	U214		10.1038/nature08429	http://dx.doi.org/10.1038/nature08429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847263				2022-12-28	WOS:000270987600043
J	Staiger, DO; Auerbach, DI; Buerhaus, PI				Staiger, Douglas O.; Auerbach, David I.; Buerhaus, Peter I.			Comparison of Physician Workforce Estimates and Supply Projections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Estimates of physician supply in the United States have been based on data that may overestimate the number of older physicians in the workforce. Objective To compare physician workforce estimates and supply projections using the American Medical Association Physician Masterfile (Masterfile) data with estimates and projections using data from the US Census Bureau Current Population Survey (CPS). Design, Setting, and Participants Parallel retrospective cohort analyses of employment trends of the number of active physicians by age and sex using annual data from the Masterfile and the CPS between 1979 and 2008. Recent workforce trends were used to project future physician supply by age. Main Outcome Measure Annual number of physicians working at least 20 hours per week in 10-year age categories. Results In an average year in the sample period, the CPS estimated 67 000 (10%) fewer active physicians than did the Masterfile (95% confidence interval [CI], 57 00078 000; P < .001), almost entirely due to fewer active physicians aged 55 years or older. The CPS estimated more young physicians (ages 25-34 years) than did the Masterfile, with the difference increasing to an average of 17 000 (12%) during the final 15 years (95% CI, 13 000-22 000; P < .001). The CPS estimates of more young physicians were consistent with historical growth observed in the number of first-year residents, and the CPS estimates of fewer older physicians were consistent with lower Medicare billing by older physicians. Projections based on both the CPS and the Masterfile data indicate that the number of active physicians will increase by approximately 20% between 2005 and 2020. However, projections for 2020 using CPS data estimate nearly 100 000 (9%) fewer active physicians than projections using the Masterfile data (957 000 vs 1 050 000), and estimate that a smaller proportion of active physicians will be 65 years or older (9% vs 18%). The increasing proportion of female physicians had little effect on physician supply projections because, unlike male physicians, female physicians were found to maintain their work activity after age 55 years. Conclusion Compared with the Masterfile data, estimates using the CPS data found more young physicians entering the workforce and fewer older physicians remaining active, resulting in estimates of a smaller and younger physician workforce now and in the future. JAMA. 2009;302(15):1674-1680	[Staiger, Douglas O.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas O.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Auerbach, David I.] Congress Budget Off, Hlth & Human Resources Div, Washington, DC USA; [Buerhaus, Peter I.] Vanderbilt Univ, Sch Nursing, Inst Med & Publ Hlth,Med Ctr, Ctr Interdisciplinary Hlth Workforce Studies, Nashville, TN 37240 USA	Dartmouth College; National Bureau of Economic Research; Congressional Budget Office; Vanderbilt University	Staiger, DO (corresponding author), Dartmouth Coll, Dept Econ, 301 Rockefeller Hall, Hanover, NH 03755 USA.	doug.staiger@dartmouth.edu			National Institute on Aging [2 P01 AG19783-06]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant 2 P01 AG19783-06 from the National Institute on Aging (Dr Staiger).	*AM OST ASS, OST MED PROF REP 200; American Medical Association, 2009, PHYS CHAR DISTR US; [Anonymous], 2009, FUTURE NURSING WORKF; Baker H H, 1991, J Am Osteopath Assoc, V91, P1128; Blumenthal D, 2004, NEW ENGL J MED, V350, P1780, DOI 10.1056/NEJMhpr033066; Brotherton SE, 2008, JAMA-J AM MED ASSOC, V300, P1228, DOI 10.1001/jama.300.10.1228; Buerhaus PI, 2009, HEALTH AFFAIR, V28, pW657, DOI 10.1377/hlthaff.28.4.w657; Buerhaus PI, 2000, JAMA-J AM MED ASSOC, V283, P2948, DOI 10.1001/jama.283.22.2948; *BUR HLTH PROF, 2006, PHYS SUPPL DEM PROJ; Burkhart DN, 2008, J AM OSTEOPATH ASSOC, V108, P127; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; *COUNC GRAD MED ED, 2005, 16 HLTH RES SERV ADM; DEATON A, 1997, ANAL HOUSEHOLD SURVE, pCH2; Dill M. J., 2008, COMPLEXITIES PHYS SU; Freed GL, 2007, J PEDIATR-US, V151, P431, DOI 10.1016/j.jpeds.2007.04.066; Freed GL, 2006, ACAD MED, V81, P847, DOI 10.1097/00001888-200609000-00017; Goodman DC, 2008, NEW ENGL J MED, V358, P1658, DOI 10.1056/NEJMp0800319; Goodman DC, 2008, JAMA-J AM MED ASSOC, V299, P335, DOI 10.1001/jama.299.3.335; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; JONES T, 2007, FACTS FINDINGS ACCUR; KINDIG DA, 1994, JAMA-J AM MED ASSOC, V271, P1505, DOI 10.1001/jama.271.19.1505; Kirch DG, 2008, JAMA-J AM MED ASSOC, V299, P2680, DOI 10.1001/jama.299.22.2680; Kletke PR, 2004, HEALTH SERV RES, V39, P1251, DOI 10.1111/j.1475-6773.2004.00288.x; Konrad TR, 2000, J RURAL HEALTH, V16, P162, DOI 10.1111/j.1748-0361.2000.tb00450.x; *OFF UND DEF PERS, 2008, REP 10 QUADR REV MIL; PASCO T, 2000, PHYS CHARACTERISTICS; Phillips RL, 2007, CAN MED ASSOC J, V176, P1083, DOI 10.1503/cmaj.060525; Rittenhouse DR, 2004, HEALTH SERV RES, V39, P1571, DOI 10.1111/j.1475-6773.2004.00304.x; Shea JA, 1999, MED CARE, V37, P333, DOI 10.1097/00005650-199904000-00003; United States Department of Labor, LAB FORC STAT CURR P; *US BUR CENS, 66 US BUR CENS; *US BUR LAB STAT, HOUS DAT SECT EXPL N; WILLIAMS PT, 1996, J AM BOARD FAM PRACT, V9, P94	34	66	66	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1674	1680		10.1001/jama.2009.1461	http://dx.doi.org/10.1001/jama.2009.1461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508NX	19843902	Green Accepted			2022-12-28	WOS:000270941200022
J	Kim, JJ; Ortendahl, J; Goldie, SJ				Kim, Jane J.; Ortendahl, Jesse; Goldie, Sue J.			Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HPV TYPE-DISTRIBUTION; HEALTH-CARE; ECONOMIC-EVALUATION; SOCIETY GUIDELINE; PARTICLE VACCINE; FOLLOW-UP; DNA; PREVALENCE; WORLDWIDE; NEOPLASIA	Background: Women older than 30 years are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent girls, is unclear in this age group. Objective: To assess the health and economic outcomes of HPV vaccination in older U. S. women. Design: Cost-effectiveness analysis with an empirically calibrated model. Data Sources: Published literature. Target Population: U.S. women aged 35 to 45 years. Time Horizon: Lifetime. Perspective: Societal. Intervention: HPV vaccination added to screening strategies that differ by test (cytology or HPV DNA testing), frequency, and start age versus screening alone. Outcome Measures: Incremental cost-effectiveness ratios (2006 U.S. dollars per quality-adjusted life-year [QALY] gained). Results of Base-Case Analysis: In the context of annual or biennial screening, HPV vaccination of women aged 35 to 45 years ranged from $116 950 to $272 350 per QALY for cytology with HPV DNA testing for triage of equivocal results and from $193 690 to $381 590 per QALY for combined cytology and HPV DNA testing, depending on age and screening frequency. Results of Sensitivity Analysis: The probability of HPV vaccination being cost-effective for women aged 35 to 45 years was 0% with annual or biennial screening and less than 5% with triennial screening, at thresholds considered good value for money. Limitation: The natural history of the disease and the efficacy of the vaccine in older women are uncertain. Conclusion: Given currently available information, the effectiveness of HPV vaccination for women older than 30 years who are screened seems to be small. Compared with current screening that uses sensitive HPV DNA testing, HPV vaccination is associated with less attractive cost-effectiveness ratios in this population than those for other, well-accepted interventions in the United States.	[Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	jkim@hsph.harvard.edu		Ortendahl, Jesse/0000-0003-0911-340X	National Cancer Institute [R01 CA93435]; Centers for Disease Control and Prevention; American Cancer Society; Bill and Melinda Gates Foundation [30505]; NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Cancer Society(American Cancer Society); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (R01 CA93435), the Centers for Disease Control and Prevention, and the American Cancer Society, and also the Bill and Melinda Gates Foundation (30505) for related work in developing countries.	American College of Obstetricians and Gynecologists, 2003, Int J Gynaecol Obstet, V83, P237; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Cantor SB, 2006, MED DECIS MAKING, V26, P265, DOI 10.1177/027298906288679; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; *CTR MED MED SERV, 2005, 2006 CLIN LAB FEE SC; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Eltoum IA, 2007, CANCER CYTOPATHOL, V111, P34, DOI 10.1002/cncr.22487; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gold MR, 1996, COST EFFECTIVENESS H; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, OBSTET GYNECOL, V103, P619, DOI 10.1097/01.AOG.0000120143.50098.c7; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; Insinga RP, 2004, CANCER EPIDEM BIOMAR, V13, P355; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; King JT, 2005, MED DECIS MAKING, V25, P667, DOI 10.1177/0272989X05282640; Kulasingam SL, 2006, JNCI-J NATL CANCER I, V98, P92, DOI 10.1093/jnci/djj009; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Paavonen J, 2008, CURR MED RES OPIN, V24, P1623, DOI 10.1185/03007990802068151; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2005, CANC INCIDENCE 5 CON, VI-VIII; RIES LAG, 2004, SURVEILLANCE EPIDEMI; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schwarz TF, 2009, VACCINE, V27, P581, DOI 10.1016/j.vaccine.2008.10.088; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; SHIROIWA T, 2009, HLTH EC; Skinner SR, 2008, MED J AUSTRALIA, V188, P238, DOI 10.5694/j.1326-5377.2008.tb01593.x; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; *US BUR LAB STAT, 2009, CONS PRIC IND MED CA; *US CDCP, 1999, HIV COUNS TEST SYST; *US CDCP, 2008, HPV VACC INF YOUNG W; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Wong JB, 2009, ANN INTERN MED, V150, P274, DOI 10.7326/0003-4819-150-4-200902170-00010; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8	61	70	70	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					538	U45		10.7326/0003-4819-151-8-200910200-00007	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514HY	19841455	Green Accepted			2022-12-28	WOS:000271386200003
J	Shin, JH; Dawson, VL; Dawson, TM				Shin, Joo-Ho; Dawson, Valina L.; Dawson, Ted M.			SnapShot: Pathogenesis of Parkinson's Disease	CELL			English	Editorial Material									[Shin, Joo-Ho] Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Stem Cell Program, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Shin, JH (corresponding author), Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Baltimore, MD 21205 USA.		Shin, Joo-Ho/P-1417-2018; Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	NINDS NIH HHS [P50 NS038377] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2007, NATURE, V448, P759, DOI 10.1038/448759a; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lim KL, 2009, BBA-MOL BASIS DIS, V1792, P604, DOI 10.1016/j.bbadis.2008.10.005; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7	7	13	13	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 16	2009	139	2							440.e1	10.1016/j.cell.2009.09.026	http://dx.doi.org/10.1016/j.cell.2009.09.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837042	Bronze			2022-12-28	WOS:000270857500025
J	Yi, MS; Hong, N; Hong, YH				Yi, Meisheng; Hong, Ni; Hong, Yunhan			Generation of Medaka Fish Haploid Embryonic Stem Cells	SCIENCE			English	Article							ORYZIAS-LATIPES; DROSOPHILA-MELANOGASTER; MOUSE EMBRYOS; LINES; DIFFERENTIATION; ESTABLISHMENT; BIOLOGY; BLASTOCYSTS; DERIVATION; EXPRESSION	Haploid embryonic stem (ES) cells combine haploidy and pluripotency, enabling direct genetic analyses of recessive phenotypes in vertebrate cells. Haploid cells have been elusive for culture, due to their inferior growth and genomic instability. Here, we generated gynogenetic medaka embryos and obtained three haploid ES cell lines that retained pluripotency and competitive growth. Upon nuclear transfer into unfertilized oocytes, the haploid ES cells, even after genetic engineering, generated viable offspring capable of germline transmission. Hence, haploid medaka ES cells stably maintain normal growth, pluripotency, and genomic integrity. Mosaic oocytes created by combining a mitotic nucleus and a meiotic nucleus can generate fertile fish offspring. Haploid ES cells may offer a yeast-like system for analyzing recessive phenotypes in numerous cell lineages of vertebrates in vitro.	[Yi, Meisheng; Hong, Ni; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore	National University of Singapore	Hong, YH (corresponding author), Natl Univ Singapore, Dept Biol Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.	dbshyh@nus.edu.sg	Hong, Ni/Y-6114-2018; Test Account, SLB-WOS/E-5790-2010; Hong, Yunhan/D-4197-2009	Hong, Ni/0000-0002-9404-3110; 	Biomedical Research Council of Singapore [R-05-1-21-19-404, R-08-1-21-19-585, SBIC-SSCC C-002-2007]; Ministry of Education of Singapore [R-154-000-285-112]; National University of Singapore; Lee Hiok Kwee donation [R-154-000-153-720]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education of Singapore(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Lee Hiok Kwee donation	Supported by the Biomedical Research Council of Singapore (R-05-1-21-19-404, R-08-1-21-19-585 and SBIC-SSCC C-002-2007), the Ministry of Education of Singapore (R-154-000-285-112), the National University of Singapore, and the Lee Hiok Kwee donation (R-154-000-153-720). We thank J. Deng for fish breeding.	Araki K, 2001, DEV GROWTH DIFFER, V43, P591; Bejar J, 2003, DEVELOPMENT, V130, P6545, DOI 10.1242/dev.00872; BOTSTEIN D, 1988, SCIENCE, V240, P1439, DOI 10.1126/science.3287619; DEBEC A, 1984, EXP CELL RES, V151, P236, DOI 10.1016/0014-4827(84)90371-9; DEBEC A, 1978, NATURE, V274, P255, DOI 10.1038/274255a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FREED J J, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P337, DOI 10.1073/pnas.65.2.337; Hong YH, 1998, DEV GENES EVOL, V208, P595, DOI 10.1007/s004270050220; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hong Yunhan, 2006, V329, P3; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UWA H, 1981, P JPN ACAD B-PHYS, V57, P39, DOI 10.2183/pjab.57.39; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9	24	141	173	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					430	433		10.1126/science.1175151	http://dx.doi.org/10.1126/science.1175151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833967				2022-12-28	WOS:000270818600054
J	Carreiras, M; Seghier, ML; Baquero, S; Estevez, A; Lozano, A; Devlin, JT; Price, CJ				Carreiras, Manuel; Seghier, Mohamed L.; Baquero, Silvia; Estevez, Adelina; Lozano, Alfonso; Devlin, Joseph T.; Price, Cathy J.			An anatomical signature for literacy	NATURE			English	Article							BRAIN; MORPHOLOGY; DIFFUSION; DYSLEXIA; CHILDREN; LANGUAGE; SKILLS; INTEGRATION; MECHANISMS; HANDEDNESS	Language is a uniquely human ability that evolved at some point in the roughly 6,000,000 years since human and chimpanzee lines diverged(1,2). Even in the most linguistically impoverished environments, children naturally develop sophisticated language systems(3). In contrast, reading is a learnt skill that does not develop without intensive tuition and practice. Learning to read is likely to involve ontogenic structural brain changes(4-6), but these are nearly impossible to isolate in children owing to concurrent biological, environmental and social maturational changes. In Colombia, guerrillas are re-integrating into mainstream society and learning to read for the first time as adults. This presents a unique opportunity to investigate how literacy changes the brain, without the maturational complications present in children. Here we compare structural brain scans from those who learnt to read as adults (late-literates) with those from a carefully matched set of illiterates. Late-literates had more white matter in the splenium of the corpus callosum and more grey matter in bilateral angular, dorsal occipital, middle temporal, left supramarginal and superior temporal gyri. The importance of these brain regions for skilled reading was investigated in early literates, who learnt to read as children. We found anatomical connections linking the left and right angular and dorsal occipital gyri through the area of the corpus callosum where white matter was higher in late-literates than in illiterates; that reading, relative to object naming, increased the interhemispheric functional connectivity between the left and right angular gyri; and that activation in the left angular gyrus exerts top-down modulation on information flow from the left dorsal occipital gyrus to the left supramarginal gyrus. These findings demonstrate how the regions identified in late-literates interact during reading, relative to object naming, in early literates.	[Carreiras, Manuel] Basque Ctr Cognit Brain & Language, Donostia San Sebastian 20009, Spain; [Carreiras, Manuel] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Carreiras, Manuel] Univ Basque Country, Dept Filol Vasca, Bilbao 48940, Spain; [Carreiras, Manuel; Estevez, Adelina] Univ La Laguna, Tenerife 38055, Spain; [Seghier, Mohamed L.; Price, Cathy J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Baquero, Silvia; Lozano, Alfonso] Univ Nacl Colombia, Bogota 3165000, Colombia; [Devlin, Joseph T.] UCL, London WC1E 6BT, England	Basque Foundation for Science; University of Basque Country; Universidad de la Laguna; University of London; University College London; Universidad Nacional de Colombia; University of London; University College London	Carreiras, M (corresponding author), Basque Ctr Cognit Brain & Language, Donostia San Sebastian 20009, Spain.	m.carreiras@bcbl.eu; c.price@fil.ion.ucl.ac.uk	Seghier, Mohamed/O-8634-2019; Carreiras, Manuel/D-5267-2009; Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed/0000-0002-1146-8800; Carreiras, Manuel/0000-0001-6726-7613; Seghier, Mohamed L/0000-0002-1146-8800; Baquero Castellanos, Silvia/0000-0003-0503-9556; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Devlin, Joseph/0000-0001-9737-3070; Estevez, Adelina/0000-0003-3724-1767; Price, Catherine/0000-0001-7448-4835	Spanish Ministry of Education and Science; Wellcome Trust	Spanish Ministry of Education and Science(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank K. Friston for advice on data analyses and A. Leff, T. Munte and T. Shallice for their help with the presentation of the manuscript. This work was funded by a CONSOLIDER-INGENIO grant from the Spanish Ministry of Education and Science and by the Wellcome Trust.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; Booth JR, 2004, J COGNITIVE NEUROSCI, V16, P1234, DOI 10.1162/0898929041920496; Brambati SM, 2006, BRAIN RES, V1113, P174, DOI 10.1016/j.brainres.2006.06.099; Carreiras M, 2004, LANG COGNITIVE PROC, V19, P321, DOI 10.1080/01690960344000288; Castro-Caldas A, 1999, EUR J NEUROL, V6, P23, DOI 10.1046/j.1468-1331.1999.610023.x; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; LUNDBERG I, 1980, SCAND J PSYCHOL, V21, P159, DOI 10.1111/j.1467-9450.1980.tb00356.x; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; PENACASANOVA J, 1995, PROGRAMA INTEGRADO E; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 2006, NEUROIMAGE, V29, P643, DOI 10.1016/j.neuroimage.2005.07.044; Price CJ, 2005, CURR OPIN NEUROBIOL, V15, P231, DOI 10.1016/j.conb.2005.03.003; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Raven J.C., 1938, PROGR MATRICES PERCE; Reis A, 2003, APPL NEUROPSYCHOL, V10, P191, DOI 10.1207/s15324826an1004_1; Reis A, 1997, J INT NEUROPSYCH SOC, V3, P444, DOI 10.1017/S135561779700444X; Robichon F, 1998, BRAIN LANG, V62, P127, DOI 10.1006/brln.1997.1891; Rumsey JM, 1996, BIOL PSYCHIAT, V39, P769, DOI 10.1016/0006-3223(95)00225-1; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spreen O., 1991, PROFILE TEST RESULTS; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Stephan KE, 2007, J NEUROSCI, V27, P3512, DOI 10.1523/JNEUROSCI.4766-06.2007; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; VEGA FC, 1996, BATERIA EVALUACION P; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D., 1945, WECHSLER MEMORY SCAL; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029	50	288	294	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					983	U245		10.1038/nature08461	http://dx.doi.org/10.1038/nature08461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829380				2022-12-28	WOS:000270817700048
J	Westerlund, H; Kivimaki, M; Singh-Manoux, A; Melchior, M; Ferrie, JE; Pentti, J; Jokela, M; Leineweber, C; Goldberg, M; Zins, M; Vahtera, J				Westerlund, Hugo; Kivimaeki, Mika; Singh-Manoux, Archana; Melchior, Maria; Ferrie, Jane E.; Pentti, Jaana; Jokela, Markus; Leineweber, Constanze; Goldberg, Marcel; Zins, Marie; Vahtera, Jussi			Self-rated health before and after retirement in France (GAZEL): a cohort study	LANCET			English	Article							MENTAL-HEALTH; PHYSICAL HEALTH; NATIONAL-SURVEY; JOB STRAIN; MORTALITY; WORK; ASSOCIATION; COMMUNITY; RISK	Background Governments need to increase the proportion of the population in work in most developed countries because of ageing populations. We investigated longitudinally how self-perceived health is affected by work and retirement in older workers. Methods We examined trajectories of self-rated health in 14714 employees (11581 [79%] men) from the French national gas and electricity company, the GAZEL cohort, for up to 7 years before and 7 years after retirement, with yearly measurements from 1989 to 2007. We analysed data by use of repeated-measures logistic regression with generalised estimating equations. Findings Overall, suboptimum health increased with age. However, between the year before retirement and the year after, the estimated prevalence of suboptimum health fell from 19.2% (95% CI 18.5-19.9) to 14.3% (13.7-14.9), corresponding to a gain in health of 8-10 years. We noted this retirement-related improvement in men (odds ratio 0.68, 95% CI 0.64-0.73) and women (0.74, 0.67-0.83), and across occupational grades (low 0.72, 0.63-0.82; high 0.70, 0.63-0.77), and it was maintained throughout the 7 years after retirement. A poor work environment and health complaints before retirement were associated with a steeper yearly increase in the prevalence of suboptimum health while still in work, and a greater retirement-related improvement; however, people with a combination of high occupational grade, low demands, and high satisfaction at work showed no such retirement-related improvement. Interpretation These findings suggest that the burden of ill-health, in terms of perceived health problems, is substantially relieved by retirement for all groups of workers apart from those with ideal working conditions, and that working life for older workers needs to be redesigned to achieve higher labour-market participation.	[Westerlund, Hugo; Leineweber, Constanze] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Westerlund, Hugo; Kivimaeki, Mika; Singh-Manoux, Archana; Ferrie, Jane E.; Jokela, Markus] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaeki, Mika; Pentti, Jaana; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kivimaeki, Mika; Pentti, Jaana; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Singh-Manoux, Archana; Melchior, Maria; Goldberg, Marcel; Zins, Marie] Hop Paul Brousse, INSERM, IFR69, U687, Villejuif, France; [Jokela, Markus] Univ Helsinki, Dept Psychol, SF-00100 Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	Stockholm University; University of London; University College London; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Helsinki; University of Turku; University of Turku	Westerlund, H (corresponding author), Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden.	hugo.westerlund@stress.su.se	Singh-Manoux, Archana/F-6804-2013; Kivimaki, Mika/B-3607-2012; Vahtera, Jussi/J-3271-2013; Ferrie, Jane/AAZ-2009-2020; Jokela, Markus/A-4669-2009; Zins, Marie/AAX-6551-2021; Leineweber, Constanze/G-7052-2012; Goldberg, Marcel/I-7834-2012; Leineweber, Constanze/Z-1330-2019; Melchior, Maria/E-3992-2017; Westerlund, Hugo/A-3049-2012	Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Jokela, Markus/0000-0003-0117-0012; Leineweber, Constanze/0000-0001-8433-2405; Goldberg, Marcel/0000-0002-6161-5880; Westerlund, Hugo/0000-0002-8806-5698	Caisse centrale d'action sociale du personnel des industries electrique et gaziere; EDF-GDF; INSERM; Cohortes Sante TGIR Program; Swedish Council for Working Life and Social Research [2004-2021, 2007-1143]; Academy of Finland [117604, 124271, 124322, 129262]; BUPA Foundation; European Science Foundation; ESRC Research Seminar Series Competition 2007-08 [RES-451-26-0491]; Economic and Social Research Council [RES-451-26-0491] Funding Source: researchfish; ESRC [RES-451-26-0491] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	Caisse centrale d'action sociale du personnel des industries electrique et gaziere; EDF-GDF; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cohortes Sante TGIR Program; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Academy of Finland(Academy of Finland); BUPA Foundation; European Science Foundation(European Science Foundation (ESF)European Commission); ESRC Research Seminar Series Competition 2007-08(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank EDF-GDF, especially the Service General de Medecine de Controle for providing absenteeism data; the "Caisse centrale d'action sociale du personnel des industries electrique et gaziere" for partially funding the study; and the Risques Postprofessionnels-Cohortes de I'Unite mixte 687 Inserm-CNAMTS team who were responsible for the GAZEL database management. The GAZEL cohort study was funded by EDF-GDF and INSERM, and received grants from the Cohortes Sante TGIR Program. H W and CL are supported by the Swedish Council for Working Life and Social Research (FAS, grants numbers 2004-2021 and 2007-1143). JV and M K are supported by the Academy of Finland (grants numbers 117604, 124271, 124322, and 129262). M K is additionally supported by the BUPA Foundation Specialist research grant. ASM is supported by a EUYRI award from the European Science Foundation. This work was additionally supported by a grant from the ESRC Research Seminar Series Competition 2007-08 (RES-451-26-0491).	Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Barnay T, 2010, EUR J HEALTH ECON, V11, P127, DOI 10.1007/s10198-009-0155-4; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; BOSSE R, 1987, PSYCHOL AGING, V2, P383, DOI 10.1037/0882-7974.2.4.383; Butterworth P, 2006, SOC SCI MED, V62, P1179, DOI 10.1016/j.socscimed.2005.07.013; Buxton JW, 2005, SOC PSYCH PSYCH EPID, V40, P99, DOI 10.1007/s00127-005-0866-5; Chiron M, 2008, ACCIDENT ANAL PREV, V40, P1096, DOI 10.1016/j.aap.2007.12.001; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Drentea P, 2002, J AGING HEALTH, V14, P167, DOI 10.1177/089826430201400201; EKERDT DJ, 1983, AM J PUBLIC HEALTH, V73, P779, DOI 10.2105/AJPH.73.7.779; Fatas E, 2007, ECON INQ, V45, P602, DOI 10.1111/j.1465-7295.2007.00027.x; Gall TL, 1997, J GERONTOL B-PSYCHOL, V52, pP110, DOI 10.1093/geronb/52B.3.P110; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Goldberg P, 2001, J EPIDEMIOL COMMUN H, V55, P233, DOI 10.1136/jech.55.4.233; Groot W, 2000, J HEALTH ECON, V19, P403, DOI 10.1016/S0167-6296(99)00037-5; Gruber J, 1998, AM ECON REV, V88, P158; Hardin JW, 2012, GEN ESTIMATING EQUAT; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KRAUSE NM, 1994, MED CARE, V32, P930, DOI 10.1097/00005650-199409000-00004; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; LaMontagne AD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-181; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Melchior M, 2005, AM J PUBLIC HEALTH, V95, P1206, DOI 10.2105/AJPH.2004.048835; Mojon-Azzi S, 2007, SWISS MED WKLY, V137, P581; Niedhammer I, 2003, OCCUP ENVIRON MED, V60, P509, DOI 10.1136/oem.60.7.509; Niedhammer I, 2002, INT ARCH OCC ENV HEA, V75, P129, DOI 10.1007/s004200100270; OECD, 2005, FRAM BIOT STAT, P1; Scarpetta S., 1999, OECD EC DEP WORKING, V202; Singh-Manoux A, 2007, INT J EPIDEMIOL, V36, P1222, DOI 10.1093/ije/dym170; van Solinge H, 2007, RES AGING, V29, P225, DOI 10.1177/0164027506298223; Villamil E, 2006, PSYCHOL MED, V36, P999, DOI 10.1017/S0033291706007719; VOGEL J, 2006, HEALTHIER SOC ANAL A, P267	35	209	209	1	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1889	1896		10.1016/S0140-6736(09)61570-1	http://dx.doi.org/10.1016/S0140-6736(09)61570-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19897238	Green Submitted			2022-12-28	WOS:000272646900022
J	Birnkrant, D; Cox, E				Birnkrant, Debra; Cox, Edward			The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Birnkrant, Debra; Cox, Edward] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Birnkrant, D (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							*FOOD DRUG ADM, 2009, EM US AUTH PER FACT; *FOOD DRUG ADM, 2009, EM US AUTH MED PROD	2	147	152	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2204	2207		10.1056/NEJMp0910479	http://dx.doi.org/10.1056/NEJMp0910479			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ZM	19884645	Bronze			2022-12-28	WOS:000272257100002
J	Melcher, K; Ng, LM; Zhou, XE; Soon, FF; Xu, Y; Suino-Powell, KM; Park, SY; Weiner, JJ; Fujii, H; Chinnusamy, V; Kovach, A; Li, J; Wang, YH; Li, JY; Peterson, FC; Jensen, DR; Yong, EL; Volkman, BF; Cutler, SR; Zhu, JK; Xu, HE				Melcher, Karsten; Ng, Ley-Moy; Zhou, X. Edward; Soon, Fen-Fen; Xu, Yong; Suino-Powell, Kelly M.; Park, Sang-Youl; Weiner, Joshua J.; Fujii, Hiroaki; Chinnusamy, Viswanathan; Kovach, Amanda; Li, Jun; Wang, Yonghong; Li, Jiayang; Peterson, Francis C.; Jensen, Davin R.; Yong, Eu-Leong; Volkman, Brian F.; Cutler, Sean R.; Zhu, Jian-Kang; Xu, H. Eric			A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors	NATURE			English	Article							PHOSPHATASE-ACTIVITY; GENE-EXPRESSION; PROTEIN-KINASE; ARABIDOPSIS; BINDING; SYSTEM; TRANSDUCTION; DEHYDRATION; GERMINATION	Abscisic acid (ABA) is a ubiquitous hormone that regulates plant growth, development and responses to environmental stresses. Its action is mediated by the PYR/PYL/RCAR family of START proteins, but it remains unclear how these receptors bind ABA and, in turn, how hormone binding leads to inhibition of the downstream type 2C protein phosphatase (PP2C) effectors. Here we report crystal structures of apo and ABA-bound receptors as well as a ternary PYL2-ABA-PP2C complex. The apo receptors contain an open ligand-binding pocket flanked by a gate that closes in response to ABA by way of conformational changes in two highly conserved beta-loops that serve as a gate and latch. Moreover, ABA-induced closure of the gate creates a surface that enables the receptor to dock into and competitively inhibit the PP2C active site. A conserved tryptophan in the PP2C inserts directly between the gate and latch, which functions to further lock the receptor in a closed conformation. Together, our results identify a conserved gate-latch-lock mechanism underlying ABA signalling.	[Melcher, Karsten; Ng, Ley-Moy; Zhou, X. Edward; Soon, Fen-Fen; Xu, Yong; Suino-Powell, Kelly M.; Kovach, Amanda; Li, Jun; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Ng, Ley-Moy; Soon, Fen-Fen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynecol, Natl Univ Singapore Hosp, Yong Loo Lin Sch Med,Grad Sch Integrat Sci & Engn, Singapore 119074, Singapore; [Park, Sang-Youl; Fujii, Hiroaki; Chinnusamy, Viswanathan; Cutler, Sean R.; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Weiner, Joshua J.; Peterson, Francis C.; Jensen, Davin R.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Fujii, Hiroaki; Chinnusamy, Viswanathan; Zhu, Jian-Kang] King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China	Van Andel Institute; National University of Singapore; University of California System; University of California Riverside; Medical College of Wisconsin; King Abdullah University of Science & Technology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Volkman, Brian F./ABE-7312-2020; Cutler, Sean R/D-6617-2011; Xu, H. Eric/ABD-7487-2021; Volkman, Brian F./ABE-7306-2020; Zhu, Jian-Kang/F-7658-2011; Li, Jiayang/AAG-4377-2020; Melcher, Karsten/AAZ-3861-2020; Chinnusamy, Viswanathan/B-9079-2009	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Zhu, Jian-Kang/0000-0001-5134-731X; Melcher, Karsten/0000-0002-9125-4027; Chinnusamy, Viswanathan/0000-0003-2174-9064; Cutler, Sean/0000-0002-8593-0885; Fujii, Hiroaki/0000-0002-0013-5891; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy; Jay and Betty Van Andel Foundation; National Institutes of Health; National Science Foundation; NUS Graduate School for Integrative Sciences & Engineering (NGS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NUS Graduate School for Integrative Sciences & Engineering (NGS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of LS-CAT for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. Use of the Advanced Photon Source was supported by the Office of Science of the US Department of Energy. This work was supported by the Jay and Betty Van Andel Foundation ( H. E. X.), the National Institutes of Health (H. E. X., B. F. V. and J-K.Z.), and the National Science Foundation ( S. R. C.). L.-M.N. and F.-F.S. were supported by an overseas PhD scholarship from the NUS Graduate School for Integrative Sciences & Engineering (NGS).	Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H; Bertauche N, 1996, EUR J BIOCHEM, V241, P193, DOI 10.1111/j.1432-1033.1996.0193t.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Seedorf U, 2000, BBA-MOL CELL BIOL L, V1486, P45, DOI 10.1016/S1388-1981(00)00047-0; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	472	537	4	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					602	U72		10.1038/nature08613	http://dx.doi.org/10.1038/nature08613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898420	Green Submitted, Green Accepted			2022-12-28	WOS:000272277900031
J	Iliopoulos, D; Hirsch, HA; Struhl, K				Iliopoulos, Dimitrios; Hirsch, Heather A.; Struhl, Kevin			An Epigenetic Switch Involving NF-kappa B, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation	CELL			English	Article							IN-VITRO PROPAGATION; BREAST-CANCER CELLS; SURVIVAL; STAT3; TUMORIGENESIS; RAS; ACTIVATION; MECHANISMS; EXPRESSION; PATHWAY	Inflammation is linked clinically and epidemiologically to cancer, and NF-kappa B appears to play a causative role, but the mechanisms are poorly understood. We show that transient activation of Src oncoprotein can mediate an epigenetic switch from immortalized breast cells to a stably transformed line that forms self-renewing mammospheres that contain cancer stem cells. Src activation triggers an inflammatory response mediated by NF-kappa B that directly activates Lin28 transcription and rapidly reduces let-7 microRNA levels. Let-7 directly inhibits IL6 expression, resulting in higher levels of IL6 than achieved by NF-kappa B activation. IL6-mediated activation of the STAT3 transcription factor is necessary for transformation, and IL6 activates NF-kappa B, thereby completing a positive feedback loop. This regulatory circuit operates in other cancer cells lines, and its transcriptional signature is found in human cancer tissues. Thus, inflammation activates a positive feedback loop that maintains the epigenetic transformed state for many generations in the absence of the inducing signal.	[Iliopoulos, Dimitrios; Hirsch, Heather A.; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Iliopoulos, Dimitrios/AAE-9106-2019		American Cancer Society; National Institutes of Health [CA 107486]; NATIONAL CANCER INSTITUTE [R01CA107486] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Richard Gregory for suggesting the idea that lin-28 might be involved in the process, Philip N. Tsichlis for providing laboratory access and materials needed for the xenograft experiments, Fabio Petrocca for help in designing the mammosphere and cell sorting experiments, Savina A. Jaeger for bioinformatic analysis and identification of NF-KB binding sites in let-7a and lin-28B, Joan Brugge for providing the MCF10A ER-Src and control cell lines, William Farrar for providing the pGL3-IL6 luciferace vector, George Daley for providing the pBabe. Puro-Lin28B vector, Joshua T. Mendell for providing the Lin28B-P1 luciferase vector, and Koon Ho Wong for construction of the mutant luciferase vectors. This work was supported by a postdoctoral fellowship from the American Cancer Society to H. A. H. and a research grant to K. S. from the National Institutes of Health (CA 107486).	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; HIRSCH HA, 2009, CANC RES IN PRESS, V69; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Nagel S, 2005, LEUKEMIA, V19, P841, DOI 10.1038/sj.leu.2403716; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; SOULE HD, 1990, CANCER RES, V50, P6075; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	42	1100	1150	1	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					693	706		10.1016/j.cell.2009.10.014	http://dx.doi.org/10.1016/j.cell.2009.10.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19878981	Bronze, Green Accepted			2022-12-28	WOS:000271747200014
J	Chokshi, DA				Chokshi, Dave A.			Ensuring Progress in Primary Care -- What Can Health Care Reform Realistically Accomplish?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chokshi, Dave A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Chokshi, Dave A.] So Jamaica Plain Hlth Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital	Chokshi, DA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.			Chokshi, Dave/0000-0001-7467-4591				Bodenheimer T, 2009, NEW ENGL J MED, V360, P2693, DOI 10.1056/NEJMp0902909; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; *MASS MED SOC, 2009, MMS PHYS WORKF STUD; Patient Centered Primary Care Collaborative, 2007, JOINT PRINC PAT CTR; Sandy LG, 2009, HEALTH AFFAIR, V28, P1136, DOI 10.1377/hlthaff.28.4.1136	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20								10.1056/NEJMp0909345	http://dx.doi.org/10.1056/NEJMp0909345			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518AI	19864648				2022-12-28	WOS:000271660500005
J	Visscher, PM; Montgomery, GW				Visscher, Peter M.; Montgomery, Grant W.			Genome-wide Association Studies and Human Disease From Trickle to Flood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Visscher, Peter M.] Queensland Inst Med Res, Dept Stat Genet, Brisbane, Qld 4006, Australia; [Montgomery, Grant W.] Queensland Inst Med Res, Dept Mol Epidemiol, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Visscher, PM (corresponding author), Queensland Inst Med Res, Dept Stat Genet, 300 Herston Rd, Brisbane, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020	Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760				Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Majithia AR, 2009, CURR OPIN ENDOCRINOL, V16, P100, DOI 10.1097/MED.0b013e3283292354; National Human Genome Research Institute, CAT GEN WID ASS STUD; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489	9	43	45	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2028	2029		10.1001/jama.2009.1643	http://dx.doi.org/10.1001/jama.2009.1643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903925				2022-12-28	WOS:000271619700032
J	Shenvi, N; Roy, S; Tully, JC				Shenvi, Neil; Roy, Sharani; Tully, John C.			Dynamical Steering and Electronic Excitation in NO Scattering from a Gold Surface	SCIENCE			English	Article							VIBRATIONAL-ENERGY TRANSFER; METAL-SURFACE; MOLECULAR-DYNAMICS; RELAXATION; EMISSION	Nonadiabatic coupling of nuclear motion to electronic excitations at metal surfaces is believed to influence a host of important chemical processes and has generated a great deal of experimental and theoretical interest. We applied a recently developed theoretical framework to examine the nature and importance of nonadiabatic behavior in a system that has been extensively studied experimentally: the scattering of vibrationally excited nitric oxide molecules from a Au(111) surface. We conclude that the nonadiabatic transition rate depends strongly on both the N-O internuclear separation and the molecular orientation and, furthermore, that molecule-surface forces can steer the molecule into strong-coupling configurations. This mechanism elucidates key features of the experiments and provides several testable predictions regarding the dependence of vibrational energy transfer on the initial vibrational energy, molecular orientation, and incident angle.	[Shenvi, Neil; Roy, Sharani; Tully, John C.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Tully, JC (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	John.tully@yale.edu	Shenvi, Neil/B-5049-2009; Tully, John/GPX-7632-2022; Roy, Sharani/AAW-3257-2021	Roy, Sharani/0000-0002-1020-482X	U. S. Department of Energy [DE-FG02-05ER15677]	U. S. Department of Energy(United States Department of Energy (DOE))	The authors gratefully acknowledge funding from the U. S. Department of Energy, grant DE-FG02-05ER15677.	Born M, 1927, ANN PHYS-BERLIN, V84, P0457; GADZUK JW, 1983, J CHEM PHYS, V79, P6341, DOI 10.1063/1.445742; Gergen B, 2001, SCIENCE, V294, P2521, DOI 10.1126/science.1066134; HEADGORDON M, 1995, J CHEM PHYS, V103, P10137, DOI 10.1063/1.469915; HELLBERG L, 1995, PHYS REV LETT, V74, P4742, DOI 10.1103/PhysRevLett.74.4742; Huang YH, 2000, SCIENCE, V290, P111, DOI 10.1126/science.290.5489.111; Katz G, 2005, J PHYS CHEM B, V109, P18876, DOI 10.1021/jp052107k; Li SM, 2002, J CHEM PHYS, V117, P4499, DOI 10.1063/1.1498479; Mildner B, 2006, CHEM PHYS LETT, V432, P133, DOI 10.1016/j.cplett.2006.10.048; MORIN M, 1992, J CHEM PHYS, V96, P3950, DOI 10.1063/1.461897; Nahler NH, 2008, SCIENCE, V321, P1191, DOI 10.1126/science.1160040; Nienhaus H, 1999, PHYS REV LETT, V82, P446, DOI 10.1103/PhysRevLett.82.446; Park JY, 2006, CHEMPHYSCHEM, V7, P1409, DOI 10.1002/cphc.200600056; Roy S, 2009, J PHYS CHEM C, V113, P16311, DOI 10.1021/jp811393w; Roy S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3122989; Shenvi N, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3125436; TULLY JC, 1990, J CHEM PHYS, V93, P1061, DOI 10.1063/1.459170; White JD, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166360; White JD, 2005, NATURE, V433, P503, DOI 10.1038/nature03213; Wodtke AM, 2008, PROG SURF SCI, V83, P167, DOI 10.1016/j.progsurf.2008.02.001; Wodtke AM, 2005, CHEM PHYS LETT, V414, P138, DOI 10.1016/j.cplett.2005.08.018; Wodtke AM, 2005, CHEM PHYS LETT, V413, P326, DOI 10.1016/j.cplett.2005.06.031; Wodtke AM, 2004, INT REV PHYS CHEM, V23, P513, DOI 10.1080/01442350500037521; Wodtke AM, 2003, J CHEM PHYS, V118, P8033, DOI 10.1063/1.1560143	24	159	159	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					829	832		10.1126/science.1179240	http://dx.doi.org/10.1126/science.1179240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892977				2022-12-28	WOS:000271468000037
J	Parker, JM; Bhattacharjee, M				Parker, Jason M.; Bhattacharjee, Modushudan			Peripartum Diastasis of the Symphysis Pubis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas Houston, Sch Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Parker, JM (corresponding author), Univ Texas Houston, Sch Med, Houston, TX 77030 USA.	modushudan.bhattacharjee@uth.tmc.edu							0	17	20	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1886	1886		10.1056/NEJMicm0807117	http://dx.doi.org/10.1056/NEJMicm0807117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19890131				2022-12-28	WOS:000271405800014
J	Doust, J				Doust, Jenny			Diagnosis in General Practice Using probabilistic reasoning	BRITISH MEDICAL JOURNAL			English	Article							URINARY-TRACT INFECTIONS; TESTS		Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4029, Australia	Bond University	Doust, J (corresponding author), Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4029, Australia.	jdoust@bond.edu.au	Doust, Jenny/AGI-8773-2022	Doust, Jenny/0000-0002-4024-9308				BACHMAN JW, 1993, JAMA-J AM MED ASSOC, V270, P1971, DOI 10.1001/jama.270.16.1971; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Falk G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2899; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Heneghan C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b946; Jelinek M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4117; STRAS SE, 2005, EVIDENCE BASED MED P, P77; TREVENA L, 2006, AUSTR DOCTOR    0602, P25	9	21	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2009	339								b3823	10.1136/bmj.b3823	http://dx.doi.org/10.1136/bmj.b3823			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UB	19887528				2022-12-28	WOS:000271567700001
J	Yabroff, KR; Saraiya, M; Meissner, HI; Haggstrom, DA; Wideroff, L; Yuan, G; Berkowitz, Z; Davis, WW; Benard, VB; Coughlin, SS				Yabroff, K. Robin; Saraiya, Mona; Meissner, Helen I.; Haggstrom, David A.; Wideroff, Louise; Yuan, Gigi; Berkowitz, Zahava; Davis, William W.; Benard, Vicki B.; Coughlin, Steven S.			Specialty Differences in Primary Care Physician Reports of Papanicolaou Test Screening Practices: A National Survey, 2006 to 2007	ANNALS OF INTERNAL MEDICINE			English	Article							CERVICAL-CANCER PREVENTION; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; WOMEN; HEALTH; BREAST; NEOPLASIA; SERVICES; IMPACT; RECOMMENDATIONS	Background: Cervical cancer screening guidelines were substantially revised in 2002 and 2003. Little information is available about primary care physicians' current Papanicolaou (Pap) test screening practices, including initiation, frequency, and stopping. Objective: To assess current Pap test screening practices in the United States. Design: Cross-sectional survey. Setting: Nationally representative sample of physicians during 2006 to 2007. Participants: 1212 primary care physicians. Measurements: The survey included questions about physician and practice characteristics and recommendations for Pap screening presented as clinical vignettes describing women by age and by sexual and screening histories. A composite measure-guideline-consistent recommendations-was created by using responses to vignettes in which major guidelines were uniform. Results: Most physicians reported providing Pap tests to their eligible patients (91.0% [95% CI, 89.0% to 92.6%]). Among Pap test providers (n = 1114), screening practices, including number of tests ordered or performed, use of patient reminder systems, and cytology method used, varied by physician specialty (P < 0.001). Although most Pap test providers reported that screening guidelines were very influential in their clinical practice, few had guideline-consistent recommendations for starting and stopping Pap screening across multiple vignettes (22.3% [CI, 19.9% to 25.0%]). Guideline-consistent recommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%; and family or general practice, 21.1%). Compared with obstetricians/gynecologists, internal medicine specialists and family or general practice specialists were more likely to have guideline-consistent screening recommendations (odds ratio, 1.98 [CI, 1.22 to 3.23] and 1.45 [CI, 0.99 to 2.13], respectively) in multivariate analysis. Limitation: Physician self-report may reflect idealized rather than actual practice. Conclusion: Primary care physicians' recommendations for Pap test screening are not consistent with screening guidelines, reflecting overuse of screening. Implementation of effective interventions that focus on potentially modifiable physician and practice factors is needed to improve screening practice. Primary Funding Source: National Cancer Institute, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality.	[Yabroff, K. Robin] NCI, Hlth Serv, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Regenstrief Inst Hlth Care, Vet Affairs Med Ctr, Indianapolis, IN USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Dept Vet Affairs, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Information Management Services, Inc.; Centers for Disease Control & Prevention - USA; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis	Yabroff, KR (corresponding author), NCI, Hlth Serv, Execut Plaza N,Room 4005,6130 Execut Blvd, Bethesda, MD 20892 USA.	yabroffr@mail.nih.gov	Hernandez, Jessica/G-6527-2011	Yabroff, K. Robin/0000-0003-0644-5572	National Cancer Institute [N02-PC51308]; Centers for Disease Control and Prevention [Y3-PC-6017-01]; Agency for Healthcare Research and Quality [Y3-PC-5019-01, Y3-PC-5019-02]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the National Cancer Institute (contract N02-PC51308), Centers for Disease Control and Prevention (interagency agreement Y3-PC-6017-01), and Agency for Healthcare Research and Quality ( interagency agreements Y3-PC-5019-01 and Y3-PC-5019-02).	ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; [Anonymous], 2003, AM J NURS, V103, P108; Aro AR, 2000, EUR J CANCER, V36, P1089, DOI 10.1016/S0959-8049(00)00065-4; AVORN JL, 2001, ANTIBIOTIC RESISTANC, P1; Berg AO, 2003, AM J NURS, V103, P101; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Cooper CP, 2005, J WOMENS HEALTH, V14, P670, DOI 10.1089/jwh.2005.14.670; Coughlin SS, 2005, CANCER EPIDEM BIOMAR, V14, P1143, DOI 10.1158/1055-9965.EPI-04-0559; Coughlin SS, 2002, CANCER-AM CANCER SOC, V94, P2801, DOI 10.1002/cncr.10577; Goldrick BA, 2003, AM J NURS, V103, P105, DOI 10.1097/00000446-200303000-00043; Hawley ST, 2001, CANCER DETECT PREV, V25, P309; Heflin MT, 2006, J GERONTOL A-BIOL, V61, P844, DOI 10.1093/gerona/61.8.844; Helms LJ, 1999, MED CARE, V37, P652, DOI 10.1097/00005650-199907000-00005; Huang AJ, 2008, J GEN INTERN MED, V23, P1324, DOI 10.1007/s11606-008-0633-x; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; Lafata JE, 2004, CANCER EPIDEM BIOMAR, V13, P2126; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Leyden WA, 2005, JNCI-J NATL CANCER I, V97, P675, DOI 10.1093/jnci/dji115; Lipkus IM, 2000, PSYCHO-ONCOLOGY, V9, P402, DOI 10.1002/1099-1611(200009/10)9:5<402::AID-PON475>3.3.CO;2-L; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MAMON JA, 1990, PREV MED, V19, P363, DOI 10.1016/0091-7435(90)90036-J; Meissner HI, 2008, J GEN INTERN MED, V23, P1822, DOI 10.1007/s11606-008-0775-x; Melanson SEF, 2007, AM J CLIN PATHOL, V127, P604, DOI 10.1309/ELH5BPQ0T17RRK0M; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Murphy PA, 2008, J MIDWIFERY WOM HEAL, V53, P11, DOI 10.1016/j.jmwh.2007.06.014; *NAT CANC I CDCP A, NAT SURV PRIM CAR PH; *NCQA, 2003, HEDIS HLTH PLAN EMPL; Noller KL, 2003, OBSTET GYNECOL, V102, P259, DOI 10.1016/S0029-7844(03)00565-9; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; RANSOHOFF DF, 1991, ANN INTERN MED, V114, P177, DOI 10.7326/0003-4819-114-3-177; *RES TRIANGL I, 2004, SUDAAN LANG MAN REL; Ries L MD, 2008, SEER CANC STAT REV 1; Sabatino SA, 2008, AM J PREV MED, V35, pS67, DOI 10.1016/j.amepre.2008.04.008; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Saint M, 2005, AM J OBSTET GYNECOL, V192, P414, DOI 10.1016/j.ajog.2004.09.026; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; SCHWARTZ JS, 1991, ANN INTERN MED, V114, P46, DOI 10.7326/0003-4819-114-1-46; Sirovich BE, 2005, AM J MED, V118, P151, DOI 10.1016/j.amjmed.2004.08.021; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Stout NK, 2008, ARCH INTERN MED, V168, P1881, DOI 10.1001/archinte.168.17.1881; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Tiro JA, 2008, CANCER-AM CANCER SOC, V113, P3013, DOI 10.1002/cncr.23760; Tsui J, 2007, J WOMENS HEALTH, V16, P1447, DOI 10.1089/jwh.2006.0279; Yabroff KR, 2005, MED CARE RES REV, V62, P79, DOI 10.1177/1077558704271725; Yeazel MW, 2006, PREV MED, V43, P86, DOI 10.1016/j.ypmed.2006.03.021	49	80	82	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					602	W197		10.7326/0003-4819-151-9-200911030-00005	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514IM	19884621				2022-12-28	WOS:000271387700002
J	Liu, X; Long, FH; Peng, HC; Aerni, SJ; Jiang, M; Sanchez-Blanco, A; Murray, JI; Preston, E; Mericle, B; Batzoglou, S; Myers, EW; Kim, SK				Liu, Xiao; Long, Fuhui; Peng, Hanchuan; Aerni, Sarah J.; Jiang, Min; Sanchez-Blanco, Adolfo; Murray, John I.; Preston, Elicia; Mericle, Barbara; Batzoglou, Serafim; Myers, Eugene W.; Kim, Stuart K.			Analysis of Cell Fate from Single-Cell Gene Expression Profiles in C. elegans	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SPECIFICATION; LINEAGE; EMBRYOS; PAL-1; BLASTOMERE; SIGNATURES; INDUCTION; PROTEIN; SYSTEM	The C. elegans cell lineage provides a unique opportunity to look at how cell lineage affects patterns of gene expression. We developed an automatic cell lineage analyzer that converts high-resolution images of worms into a data table showing fluorescence expression with single-cell resolution. We generated expression profiles of 93 genes in 363 specific cells from L1 stage larvae and found that cells with identical fates can be formed by different gene regulatory pathways. Molecular signatures identified repeating cell fate modules within the cell lineage and enabled the generation of a molecular differentiation map that reveals points in the cell lineage when developmental fates of daughter cells begin to diverge. These results demonstrate insights that become possible using computational approaches to analyze quantitative expression from many genes in parallel using a digital gene expression atlas.	[Liu, Xiao; Jiang, Min; Sanchez-Blanco, Adolfo; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Long, Fuhui; Peng, Hanchuan; Myers, Eugene W.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Aerni, Sarah J.; Batzoglou, Serafim] Stanford Univ, Med Ctr, Dept Comp Sci, Stanford, CA 94305 USA; [Murray, John I.; Preston, Elicia; Mericle, Barbara] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Washington; University of Washington Seattle	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu	Peng, Hanchuan/A-1798-2011; Kersebaum, Kurt Christian/A-7558-2010; 2009, Secribsal/A-1266-2012	Kersebaum, Kurt Christian/0000-0002-3679-8427; Liu, Xiao/0000-0001-8354-4000	National Institutes of Aging; Howard Hughes Medical Foundation; Larry L. Hillblom Foundation; William R. Hewlett Stanford Graduate Fellowship; National Science Foundation Fellowship; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Larry L. Hillblom Foundation; William R. Hewlett Stanford Graduate Fellowship; National Science Foundation Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Denis Dupuy and Marc Vidal for promoter DNA, Andy Fire for the myo-3: GFP strain, and Erik Jorgensen for the dpy-30: mCherry strain. We thank Robert Waterston for mCherry strains. We thank members of the Kim and Batzoglou labs for discussion. This work was funded by the National Institutes of Aging and the Howard Hughes Medical Foundation. X. L. was funded by the Larry L. Hillblom Foundation. S. J. A. is supported by a William R. Hewlett Stanford Graduate Fellowship and a National Science Foundation Fellowship.	Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Bird AF, 1991, STRUCTURE NEMATODES; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Broitman-Maduro G, 2006, DEVELOPMENT, V133, P3097, DOI 10.1242/dev.02475; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lecuyer E, 2008, CURR OPIN GENET DEV, V18, P506, DOI 10.1016/j.gde.2008.08.003; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Maduro MF, 2006, BIOESSAYS, V28, P1010, DOI 10.1002/bies.20480; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; Peng HC, 2009, BIOINFORMATICS, V25, P695, DOI 10.1093/bioinformatics/btp046; Potti A, 2008, CURR OPIN GENET DEV, V18, P62, DOI 10.1016/j.gde.2008.01.018; Praitis V, 2001, GENETICS, V157, P1217; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; SCHNABEL R, 1994, SCIENCE, V263, P1449, DOI 10.1126/science.8128230; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	31	97	100	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					623	633		10.1016/j.cell.2009.08.044	http://dx.doi.org/10.1016/j.cell.2009.08.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879847	Green Accepted, Bronze			2022-12-28	WOS:000271259600025
J	Yue, R; Kang, JH; Zhao, C; Hu, WX; Tang, YW; Liu, XS; Pei, G				Yue, Rui; Kang, Jiuhong; Zhao, Cong; Hu, Wenxiang; Tang, Yawei; Liu, Xiaosong; Pei, Gang			beta-Arrestin1 Regulates Zebrafish Hematopoiesis through Binding to YY1 and Relieving Polycomb Group Repression	CELL			English	Article							EMBRYONIC STEM-CELLS; CDX-HOX PATHWAY; DEVELOPMENTAL REGULATORS; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; COMPLEXES; PROTEINS; NUCLEAR; METHYLATION	beta-Arrestin1 is a multifunctional protein critically involved in signal transduction. Recently, it is also identified as a nuclear transcriptional regulator, but the underlying mechanisms and physiological significance remain to be explored. Here, we identified beta-arrestin1 as an evolutionarily conserved protein essential for zebrafish development. Zebrafish embryos depleted of beta-arrestin1 displayed severe posterior defects and especially failed to undergo hematopoiesis. In addition, the expression of cdx4, a critical regulator of embryonic blood formation, and its downstream hox genes were downregulated by depletion of beta-arrestin1, while injection of cdx4, hoxa9a or hoxb4a mRNA rescued the hematopoietic defects. Further mechanistic studies revealed that beta-arrestin1 bound to and sequestered the polycomb group (PcG) recruiter YY1, and relieved PcG-mediated repression of cdx4-hox pathway, thus regulating hematopoietic lineage specification. Taken together, this study demonstrated a critical role of beta-arrestin1 during zebrafish primitive hematopoiesis, as well as an important regulator of PcG proteins and cdx4-hox pathway.	[Yue, Rui; Kang, Jiuhong; Zhao, Cong; Hu, Wenxiang; Tang, Yawei; Liu, Xiaosong; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Kang, Jiuhong; Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017	Hu, Wenxiang/0000-0002-6754-5625; Kang, Jiuhong/0000-0001-7538-1889	Ministry of Science and Technology [2005CB522406, 2006CB943901, 2007CB947904, 2007CB947103, 2007CB948003, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30871285, 90919028]; Shanghai Municipal Commission for Science and Technology [07PJ14099, 08dj1400500]; Chinese Academy of Sciences [2007KIP204, SIBS2008001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Dr. Jiulin Du, Jiwen Bu and National Zebrafish Resources of China for providing the zebrafish facilities, and performing the blastula transplant experiments. We thank Dr. Tingxi Liu for critical reading of the manuscript, his generous gifts of riboprobe plasmids and transgenic embryos. We are also grateful for Dr. Dangsheng Li for helpful discussions, Drs. John Kanki and Thomas Look at Dana-Farber Cancer Institute for offering the tp53 (M214K) zebrafish mutant (Berghmans et al., 2005), Ying Xi, Yanfang Fu, Ting Zhou and Yi Jin for technical assistance. This research was supported by grants from the Ministry of Science and Technology (2005CB522406, 2006CB943901, 2007CB947904, 2007CB947103, 2007CB948003, 2009CB941100), National Natural Science Foundation of China (30621091, 30625014, 30871285, 90919028), Shanghai Municipal Commission for Science and Technology (07PJ14099, 08dj1400500), Chinese Academy of Sciences (2007KIP204, SIBS2008001).	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beaulieu JM, 2005, CELL, V123, P755, DOI 10.1016/j.cell.2005.11.010; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; FU YF, 2008, BLOOD; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lengerke C, 2007, ANN NY ACAD SCI, V1106, P197, DOI 10.1196/annals.1392.006; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Wang L, 2008, DEV DYNAM, V237, P2139, DOI 10.1002/dvdy.21630; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193	45	42	45	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					535	546		10.1016/j.cell.2009.08.038	http://dx.doi.org/10.1016/j.cell.2009.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879840	Bronze			2022-12-28	WOS:000271259600018
J	Lau, JTF; Yeung, NCY; Choi, KC; Cheng, MYM; Tsui, HY; Griffiths, S				Lau, Joseph T. F.; Yeung, Nelson C. Y.; Choi, K. C.; Cheng, Mabel Y. M.; Tsui, H. Y.; Griffiths, Sian			Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE RESPIRATORY SYNDROME; HUMAN AVIAN INFLUENZA; BEHAVIORAL-RESPONSES; OUTBREAK; PERCEPTIONS; SARS; ASSOCIATIONS; TRANSMISSION; PREVENTION; EPIDEMIC	Objective To investigate the intention of the Hong Kong general population to take up vaccination against influenza A/H1N1. Setting Cross sectional population based anonymous survey. Participants Random sample of 301 adults interviewed by telephone (response rate 80%). Main outcome measure Intention to take up vaccination against influenza A/H1N1 under five hypothetical scenarios: vaccination is free; vaccination per dosage costs less than $HK100 (8; pound (sic)9; $13), $HK101-200, or more than $HK200; and no data are available on the efficacy and safety of the vaccine. Results 45% (n=135) of the participants reported that they would be highly likely take up vaccination if it was free. When vaccination incurred a cost, however, the prevalence of uptake decreased: 36%(n=108) would take up vaccination if it cost less than $HK100, 24% (n=72) if it cost $HK101-200, and 15% (n=45) if it cost more than $HK200; and in absence of proved efficacy and safety decreased to 5% (n=14). Moreover, 32% (n=95) considered universal A/H1N1 vaccination unnecessary. Overall, 39% (n=117) of participants believed that A/H1N1 vaccination would prevent the virus being contracted; 63% (n=189) erroneously believed that efficacy of the vaccine had been confirmed by clinical trials, and 16% (n=49) believed that it is necessary for everyone in Hong Kong to take up vaccination against influenza A/H1N1. Conclusions The uptake of vaccination against influenza A/H1N1 by the general population of Hong Kong is unlikely to be high and would be sensitive to personal cost. Evidence about safety and efficacy is critical in determining the prevalence of uptake of vaccination.	[Lau, Joseph T. F.; Yeung, Nelson C. Y.; Choi, K. C.; Cheng, Mabel Y. M.; Tsui, H. Y.; Griffiths, Sian] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Choi, Kai Chow/F-1398-2018	Choi, Kai Chow/0000-0001-7157-8668	Research Fund for the Control of Infectious Diseases, Food and Health Bureau; Hong Kong Special Administrative Region; Li Ka Shing Institue of Health Sciences	Research Fund for the Control of Infectious Diseases, Food and Health Bureau; Hong Kong Special Administrative Region; Li Ka Shing Institue of Health Sciences	This study was supported by the Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region and the Li Ka Shing Institue of Health Sciences.	[Anonymous], US OUTBR SWIN OR INF; *CENS STAT DEP, 2009, POP AG GROUP SEX; *CENS STAT DEP HON, 2009, CENS STAT DEP ANN RE; Chan SSC, 2007, INT J NURS STUD, V44, P1120, DOI 10.1016/j.ijnurstu.2006.04.019; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; *DEP HLTH AG AUSTR, 2009, VACC PROT PAND H1N1; *DIRECTGOV, 2009, SWIN FLU TREATM PREV; *ED BUR HONG KONG, 2009, EDB CALLS SCH PREP N; Fielding R, 2005, EMERG INFECT DIS, V11, P677, DOI 10.3201/eid1105.041225; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; *GOVHK, 2009, FIGHT PAND 3 NEW CAS; *GOVHK, 2009, FAT CAS HUM SWIN INF; *GOVHK, 2009, FIGHT PAND TEND HUM; *GOVHK, 2009, FIGHT PAND 492 NEW C; LAU J, 2006, INFLUENZA VACCINATIO; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18; Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010; Lau JTF, 2006, PREV MED, V43, P406, DOI 10.1016/j.ypmed.2006.06.007; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Lee S, 2009, PAIN MED, V10, P155, DOI 10.1111/j.1526-4637.2008.00541.x; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; *MSNBC, 2009, 1 BATCH SWIN FLU VAC; *MSNBC, 2009, BEST WAY STOP FLU VA; *MSNBC, 2009, WHO AS WILL BE SHORT; *NEW GOV HK, 2009, 4 GROUPS PEOPL WILL; *NEWS GOV HK, 2009, 10 BILL DOLL HAV BEE; Schooling CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001070; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; *US DEP HHS, 2009, VACC VACC ALL VACC R; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6; World Health Organization, 2009, WORLD NOW START 2009	36	66	66	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2009	339								b4164	10.1136/bmj.b4164	http://dx.doi.org/10.1136/bmj.b4164			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AK	19861377	Green Published, hybrid			2022-12-28	WOS:000271365500004
J	Nyirenda, MJ; Tang, JI; Padfield, PL; Seckl, JR				Nyirenda, Moffat J.; Tang, Justin I.; Padfield, Paul L.; Seckl, Jonathan R.			Hyperkalaemia	BRITISH MEDICAL JOURNAL			English	Review							CONVERTING ENZYME-INHIBITORS; CONGESTIVE-HEART-FAILURE; SPIRONOLACTONE; POTASSIUM		[Nyirenda, Moffat J.; Seckl, Jonathan R.] Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Padfield, Paul L.] Lothian Univ Hosp NHS Trust, Western Gen Hosp, Metab Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Nyirenda, MJ (corresponding author), Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.	m.nyirenda@ed.ac.uk	Seckl, Jonathan R/C-3555-2013	Medford, Andrew/0000-0001-5445-5949	Medical Research Council [G0501934] Funding Source: Medline; MRC [G0501934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Ahuja TS, 2000, AM J NEPHROL, V20, P268, DOI 10.1159/000013599; Allon M, 1996, AM J KIDNEY DIS, V28, P508, DOI 10.1016/S0272-6386(96)90460-6; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Charytan D, 2000, ARCH INTERN MED, V160, P1605, DOI 10.1001/archinte.160.11.1605; Cruz CS, 2003, NEPHROL DIAL TRANSPL, V18, P1814, DOI 10.1093/ndt/gfg295; Davey M, 2002, EMERG MED J, V19, P183, DOI 10.1136/emj.19.2.183; ETHIER JH, 1990, AM J KIDNEY DIS, V15, P309, DOI 10.1016/S0272-6386(12)80076-X; Greenberg A, 1998, SEMIN NEPHROL, V18, P46; Hollander-Rodriguez JC, 2006, AM FAM PHYSICIAN, V73, P283; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kamel KS, 2003, NEPHROL DIAL TRANSPL, V18, P2215, DOI 10.1093/ndt/gfg323; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Mahoney BA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003235.pub2; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007004.pub2; Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4; Perazella MA, 2001, AM J MED, V111, P64, DOI 10.1016/S0002-9343(01)00757-4; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Slovis C, 2002, BRIT MED J, V324, P1320, DOI 10.1136/bmj.324.7349.1320; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	22	58	59	2	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 23	2009	339								b4114	10.1136/bmj.b4114	http://dx.doi.org/10.1136/bmj.b4114			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PP	19854840				2022-12-28	WOS:000271102700003
J	Armstrong, L; Orr, V				Armstrong, Lawrence; Orr, Valerie			Picture Quiz Seizures in a 9 month old girl	BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; INFANTILE SPASMS; RANDOMIZED-TRIAL; EPILEPSY; VIGABATRIN; RHABDOMYOMA; MANAGEMENT; OUTCOMES; CHILDREN; AUTISM		[Armstrong, Lawrence; Orr, Valerie] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Armstrong, L (corresponding author), Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland.	lawrence.armstrong@nhs.net						Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Bader RS, 2003, J PEDIATR-US, V143, P620, DOI 10.1067/S0022-3476(03)00494-3; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Chiron C, 1997, EPILEPSY RES, V26, P389, DOI 10.1016/S0920-1211(96)01006-6; Goh S, 2005, NEUROLOGY, V65, P235, DOI 10.1212/01.wnl.0000168908.78118.99; Hancock E, 1999, J CHILD NEUROL, V14, P71, DOI 10.1177/088307389901400201; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Krueger Darcy A, 2008, Paediatr Drugs, V10, P299, DOI 10.2165/00148581-200810050-00004; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; MUHLER EG, 1994, BRIT HEART J, V72, P584; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; Osborne JP, 2008, ARCH DIS CHILD, V93, P728, DOI 10.1136/adc.2006.094938; Pulsifer MB, 2007, EPILEPSY BEHAV, V10, P402, DOI 10.1016/j.yebeh.2007.02.004; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; SMYTHE JF, 1990, AM J CARDIOL, V66, P1247, DOI 10.1016/0002-9149(90)91109-J; Stafstrom CE, 2003, NUTR NEUROSCI, V6, P67, DOI 10.1080/1028415031000084427; Webb DW, 1996, DEV MED CHILD NEUROL, V38, P146; Wong V, 2006, J CHILD NEUROL, V21, P199, DOI 10.2310/7010.2006.00046; Yoong M, 2009, ARCH DIS CHILDHOOD-E, V94, P1, DOI 10.1136/adc.2007.134049	21	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 21	2009	339								b4133	10.1136/bmj.b4133	http://dx.doi.org/10.1136/bmj.b4133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PL	19846480				2022-12-28	WOS:000271102300002
J	Sozou, PD; Sheldon, S; Hartshorne, GM				Sozou, Peter D.; Sheldon, Sally; Hartshorne, Geraldine M.			Personal View Withdrawal of consent by sperm donors	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sozou, Peter D.] Univ London London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, London WC2A 2AE, England; [Sheldon, Sally] Univ Kent, Canterbury CT2 7NZ, Kent, England; [Sozou, Peter D.] Warwick Med Sch, Clin Sci Res Inst, Coventry, W Midlands, England	University of London; London School Economics & Political Science; University of Kent; University of Warwick	Sozou, PD (corresponding author), Univ London London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, Houghton St, London WC2A 2AE, England.	p.sozou@lse.ac.uk		Sheldon, Sally/0000-0001-5472-9655	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 20	2009	339								b4297	10.1136/bmj.b4297	http://dx.doi.org/10.1136/bmj.b4297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510PJ	19843562				2022-12-28	WOS:000271102100006
J	Varga, V; Losonczy, A; Zemelman, BV; Borhegyi, Z; Nyiri, G; Domonkos, A; Hangya, B; Holderith, N; Magee, JC; Freund, TF				Varga, Viktor; Losonczy, Attila; Zemelman, Boris V.; Borhegyi, Zsolt; Nyiri, Gabor; Domonkos, Andor; Hangya, Balazs; Holderith, Noemi; Magee, Jeffrey C.; Freund, Tamas F.			Fast Synaptic Subcortical Control of Hippocampal Circuits	SCIENCE			English	Article							RAPHE NEURONS; MODULATION; DIVERSITY; RESPONSES; CONTAIN; RHYTHM	Cortical information processing is under state-dependent control of subcortical neuromodulatory systems. Although this modulatory effect is thought to be mediated mainly by slow nonsynaptic metabotropic receptors, other mechanisms, such as direct synaptic transmission, are possible. Yet, it is currently unknown if any such form of subcortical control exists. Here, we present direct evidence of a strong, spatiotemporally precise excitatory input from an ascending neuromodulatory center. Selective stimulation of serotonergic median raphe neurons produced a rapid activation of hippocampal interneurons. At the network level, this subcortical drive was manifested as a pattern of effective disynaptic GABAergic inhibition that spread throughout the circuit. This form of subcortical network regulation should be incorporated into current concepts of normal and pathological cortical function.	[Varga, Viktor; Borhegyi, Zsolt; Nyiri, Gabor; Domonkos, Andor; Hangya, Balazs; Holderith, Noemi; Freund, Tamas F.] Inst Expt Med, H-1083 Budapest, Hungary; [Losonczy, Attila; Zemelman, Boris V.; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Howard Hughes Medical Institute	Varga, V (corresponding author), Inst Expt Med, H-1083 Budapest, Hungary.	vargav@koki.hu; losonczya@janelia.hhmi.org	Hangya, Balazs/H-5964-2019; Domonkos, Andor/ABF-8641-2020; Borhegyi, Zsolt/G-2152-2010	Hangya, Balazs/0000-0003-2709-7407; Domonkos, Andor/0000-0002-0007-5948; Borhegyi, Zsolt/0000-0001-5556-8742; Zemelman, Boris/0000-0003-2463-4887; Nyiri, Gabor/0000-0002-4247-0356	NIH [NIH-MH-54671]; Howard Hughes Medical Institute [HHMI55005608]; Hungarian Scientific Research Fund [OTKA K-60927, NKTH-OTKA CNK 77793]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank A. Lee and B. Kocsis for their comments on the manuscript. We thank L. Acsady and B. K. Andrasfalvy for helping to establish the collaboration between V. V. and A. L. We thank B. Shields, K. Lengyel, and G. Goda for technical assistance. V. V. and G. N. were Janos Bolyai Research Fellows. This work was supported by grants from the NIH (NIH-MH-54671), Howard Hughes Medical Institute (HHMI55005608), and Hungarian Scientific Research Fund (OTKA K-60927 and NKTH-OTKA CNK 77793). Author contributions V. V., A. L., J. C. M, and T. F. F. conceived the experiments. V. V. conducted the in vivo physiological experiments with the help of A. D. B. V. Z performed the molecular experiments. A. L. performed the in vitro experiments. Z. B. and G. N performed most of the histological experiments. N. H. performed the in vitro experiments for the specificity of the NBQX effect. V. V. and A. L. analyzed most of the physiological data except firing pattern analysis carried out by B. H. A. L., V. V., B. V. Z., J. C. M., and T. F. F. wrote the paper.	Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Gras C, 2002, J NEUROSCI, V22, P5442; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Jackson J, 2009, SYNAPSE, V63, P31, DOI 10.1002/syn.20581; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kandel E., 2000, PRINCIPLES NEURAL SC; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Nitz DA, 1999, LEARN MEMORY, V6, P153; Paz RD, 2008, EUR NEUROPSYCHOPHARM, V18, P773, DOI 10.1016/j.euroneuro.2008.06.005; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1981, J NEUROPHYSIOL, V46, P1140, DOI 10.1152/jn.1981.46.5.1140	20	177	178	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					449	453		10.1126/science.1178307	http://dx.doi.org/10.1126/science.1178307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833972				2022-12-28	WOS:000270818600060
J	Wardlaw, T; Salama, P; Brocklehurst, C; Chopra, M; Mason, E				Wardlaw, Tessa; Salama, Peter; Brocklehurst, Clarissa; Chopra, Mickey; Mason, Elizabeth			Diarrhoea: why children are still dying and what can be done	LANCET			English	Editorial Material									[Wardlaw, Tessa] UNICEF, Div Policy & Practice, New York, NY 10017 USA; [Salama, Peter] UNICEF, Harare, Zimbabwe; [Brocklehurst, Clarissa; Chopra, Mickey] UNICEF, Programme Div, New York, NY 10017 USA; [Mason, Elizabeth] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	UNICEF; UNICEF; University of Geneva; World Health Organization	Wardlaw, T (corresponding author), UNICEF, Div Policy & Practice, New York, NY 10017 USA.	twardlaw@unicef.org						[Anonymous], 2009, DIARRH WHY CHILDR AR; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Editorial, 1978, LANCET, V312, P300; Kar K., 2005, SUBSIDY SELF RESPECT; PINTO CB, INT MATERNA IN PRESS; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; UNICEF WHO, 2004, JOINT STAT CLIN MAN; Walker CLF, 2009, B WORLD HEALTH ORGAN, V87, P780, DOI 10.2471/BLT.08.058990; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; WHO, 2008, SAF WAT BETT HLTH; World Health Organisation, 2009, EST ROT DEATHS CHILD; World Health Organization, 2008, GLOB BURD DIS 2004 U; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	13	125	132	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					870	872		10.1016/S0140-6736(09)61798-0	http://dx.doi.org/10.1016/S0140-6736(09)61798-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	19833382				2022-12-28	WOS:000275995300006
J	McComas, DJ; Allegrini, F; Bochsler, P; Bzowski, M; Christian, ER; Crew, GB; DeMajistre, R; Fahr, H; Fichtner, H; Frisch, PC; Funsten, HO; Fuselier, SA; Gloeckler, G; Gruntman, M; Heerikhuisen, J; Izmodenov, V; Janzen, P; Knappenberger, P; Krimigis, S; Kucharek, H; Lee, M; Livadiotis, G; Livi, S; MacDowall, RJ; Mitchell, D; Mobius, E; Moore, T; Pogorelov, NV; Reisenfeld, D; Roelof, E; Saul, L; Schwadron, NA; Valek, PW; Vanderspek, R; Wurz, P; Zank, GP				McComas, D. J.; Allegrini, F.; Bochsler, P.; Bzowski, M.; Christian, E. R.; Crew, G. B.; DeMajistre, R.; Fahr, H.; Fichtner, H.; Frisch, P. C.; Funsten, H. O.; Fuselier, S. A.; Gloeckler, G.; Gruntman, M.; Heerikhuisen, J.; Izmodenov, V.; Janzen, P.; Knappenberger, P.; Krimigis, S.; Kucharek, H.; Lee, M.; Livadiotis, G.; Livi, S.; MacDowall, R. J.; Mitchell, D.; Moebius, E.; Moore, T.; Pogorelov, N. V.; Reisenfeld, D.; Roelof, E.; Saul, L.; Schwadron, N. A.; Valek, P. W.; Vanderspek, R.; Wurz, P.; Zank, G. P.			Global Observations of the Interstellar Interaction from the Interstellar Boundary Explorer (IBEX)	SCIENCE			English	Article							WIND TERMINATION SHOCK; SOLAR-WIND; MAGNETIC-FIELD; HELIOSHEATH; VOYAGER-1	The Sun moves through the local interstellar medium, continuously emitting ionized, supersonic solar wind plasma and carving out a cavity in interstellar space called the heliosphere. The recently launched Interstellar Boundary Explorer (IBEX) spacecraft has completed its first all-sky maps of the interstellar interaction at the edge of the heliosphere by imaging energetic neutral atoms (ENAs) emanating from this region. We found a bright ribbon of ENA emission, unpredicted by prior models or theories, that may be ordered by the local interstellar magnetic field interacting with the heliosphere. This ribbon is superposed on globally distributed flux variations ordered by both the solar wind structure and the direction of motion through the interstellar medium. Our results indicate that the external galactic environment strongly imprints the heliosphere.	[McComas, D. J.; Allegrini, F.; Livadiotis, G.; Livi, S.; Valek, P. W.] SW Res Inst, San Antonio, TX 78228 USA; [McComas, D. J.; Allegrini, F.; Livi, S.; Valek, P. W.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Bochsler, P.; Saul, L.; Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Bzowski, M.] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [Christian, E. R.; MacDowall, R. J.; Moore, T.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Crew, G. B.; Vanderspek, R.] MIT, Cambridge, MA 02139 USA; [DeMajistre, R.; Krimigis, S.; Mitchell, D.; Roelof, E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Fahr, H.] Univ Bonn, D-53115 Bonn, Germany; [Fichtner, H.] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Frisch, P. C.] Univ Chicago, Chicago, IL 60637 USA; [Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Fuselier, S. A.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA; [Gloeckler, G.] Univ Michigan, Ann Arbor, MI 48109 USA; [Gruntman, M.] Univ Calif Los Angeles, Los Angeles, CA 90089 USA; [Heerikhuisen, J.; Pogorelov, N. V.; Zank, G. P.] Univ Alabama, Huntsville, AL 35805 USA; [Izmodenov, V.] Moscow MV Lomonosov State Univ, Moscow 119899, Russia; [Izmodenov, V.] Russian Acad Sci, Space Res Inst IKI, Moscow 117997, Russia; [Izmodenov, V.] Russian Acad Sci, Inst Problems Mech, Moscow 117526, Russia; [Janzen, P.; Reisenfeld, D.] Univ Montana, Missoula, MT 59812 USA; [Knappenberger, P.] Adler Planetarium, Chicago, IL 60605 USA; [Krimigis, S.] Acad Athens, Off Space Res & Technol, Athens 10679, Greece; [Kucharek, H.; Lee, M.; Moebius, E.] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; [Schwadron, N. A.] Boston Univ, Boston, MA 02215 USA	Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); University of Bern; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bonn; Ruhr University Bochum; University of Chicago; United States Department of Energy (DOE); Los Alamos National Laboratory; Lockheed Martin; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Huntsville; Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Ishlinsky Institute for Problems in Mechanics RAS; University of Montana System; University of Montana; Academy of Athens; University System Of New Hampshire; University of New Hampshire; Boston University	McComas, DJ (corresponding author), SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78228 USA.	dmccomas@swri.org	demajistre, robert/AAJ-7083-2020; Moore, Thomas Earle/D-4675-2012; Funsten, Herbert O/A-5702-2015; Christian, Eric/D-4974-2012; MacDowall, Robert J/D-2773-2012; Gruntman, Mike/A-5426-2008; McComas, David J/H-6202-2011; Roelof, Edmond/G-6654-2019; Wurz, Peter/R-2273-2017; Izmodenov, Vladislav V/K-6073-2012; Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019	demajistre, robert/0000-0003-0191-0287; Moore, Thomas Earle/0000-0002-3150-1137; Funsten, Herbert O/0000-0002-6817-1039; Christian, Eric/0000-0003-2134-3937; Gruntman, Mike/0000-0002-0830-010X; McComas, David J/0000-0001-6160-1158; Roelof, Edmond/0000-0002-2270-0652; Wurz, Peter/0000-0002-2603-1169; Izmodenov, Vladislav V/0000-0002-1748-0982; Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386; Moebius, Eberhard/0000-0002-2745-6978; Allegrini, Frederic/0000-0003-0696-4380; Crew, Geoffrey/0000-0002-2079-3189; Heerikhuisen, Jacob/0000-0001-7867-3633; Valek, Philip/0000-0002-2318-8750; Bzowski, Maciej/0000-0003-3957-2359; Fichtner, Horst/0000-0002-9151-5127	NASA [NNG05EC85C]	NASA(National Aeronautics & Space Administration (NASA))	We thank all the men and women who made the IBEX mission possible. IBEX was primarily funded by NASA as a part of the Explorers Program ( contract NNG05EC85C); foreign investigators were supported by their respective national agencies and institutions.	BARANOV VB, 1992, ASTRON ASTROPHYS, V261, P341; Borovikov SN, 2008, ASTROPHYS J, V682, P1404, DOI 10.1086/589634; Chalov SV, 1996, ASTRON ASTROPHYS, V311, P317; Decker RB, 2007, AIP CONF PROC, V932, P197, DOI 10.1063/1.2778964; Fahr HJ, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000214; Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Funsten HO, 2009, SPACE SCI REV, V146, P75, DOI 10.1007/s11214-009-9504-y; Fuselier SA, 2009, SCIENCE, V326, P962, DOI 10.1126/science.1180981; Fuselier SA, 2009, SPACE SCI REV, V146, P117, DOI 10.1007/s11214-009-9495-8; Izmodenov VV, 2009, SPACE SCI REV, V146, P329, DOI 10.1007/s11214-009-9528-3; Krimigis SM, 2009, SCIENCE, V326, P971, DOI 10.1126/science.1181079; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; Lee MA, 2009, SPACE SCI REV, V146, P275, DOI 10.1007/s11214-009-9522-9; McComas DJ, 2009, SPACE SCI REV, V146, P11, DOI 10.1007/s11214-009-9499-4; McComas DJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034896; Mobius E, 2009, SCIENCE, V326, P969, DOI 10.1126/science.1180971; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; PARKER EN, 1961, ASTROPHYS J, V134, P20, DOI 10.1086/147124; Pogorelov NV, 2009, ASTROPHYS J LETT, V695, pL31, DOI 10.1088/0004-637X/695/1/L31; Richardson JD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038421; Richardson JD, 2008, NATURE, V454, P63, DOI 10.1038/nature07024; Schwadron NA, 2009, SCIENCE, V326, P966, DOI 10.1126/science.1180986; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Stone EC, 2008, NATURE, V454, P71, DOI 10.1038/nature07022; Washimi H, 2007, ASTROPHYS J, V670, pL139, DOI 10.1086/524358; Wood BE, 2007, ASTROPHYS J, V657, P609, DOI 10.1086/510844; Wurz P, 2008, ASTROPHYS J, V683, P248, DOI 10.1029/2003JAO10282; Zank GP, 2009, SPACE SCI REV, V146, P295, DOI 10.1007/s11214-009-9497-6	28	425	429	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					959	962		10.1126/science.1180906	http://dx.doi.org/10.1126/science.1180906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833923				2022-12-28	WOS:000271712300028
J	Ho, WCG; Heinke, CO				Ho, Wynn C. G.; Heinke, Craig O.			A neutron star with a carbon atmosphere in the Cassiopeia A supernova remnant	NATURE			English	Article							EVOLUTION; HYDROGEN; OBJECT	The surface of hot neutron stars is covered by a thin atmosphere. If there is accretion after neutron-star formation, the atmosphere could be composed of light elements (H or He); if no accretion takes place or if thermonuclear reactions occur after accretion, heavy elements (for example, Fe) are expected. Despite detailed searches, observations have been unable to confirm the atmospheric composition of isolated neutron stars(1). Here we report an analysis of archival observations of the compact X-ray source in the centre of the Cassiopeia A supernova remnant. We show that a carbon atmosphere neutron star (with low magnetic field) produces a good fit to the spectrum. Our emission model, in contrast with others(2-4), implies an emission size consistent with theoretical predictions for the radius of neutron stars. This result suggests that there is nuclear burning in the surface layers(5,6) and also identifies the compact source as a very young (similar to 330-year-old) neutron star.	[Ho, Wynn C. G.] Univ Southampton, Sch Math, Southampton SO17 1BJ, Hants, England; [Heinke, Craig O.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada	University of Southampton; University of Alberta	Ho, WCG (corresponding author), Univ Southampton, Sch Math, Southampton SO17 1BJ, Hants, England.	wynnho@slac.stanford.edu; cheinke@phys.ualberta.ca		Ho, Wynn/0000-0002-6089-6836; Heinke, Craig/0000-0003-3944-6109	Science and Technology Facilities Council (STFC) in the United Kingdom; Natural Sciences and Engineering Research Council (NSERC) of Canada; STFC [PP/E001025/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E001025/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC) in the United Kingdom(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	W. C. G. H. thanks N. Badnell, P. Chang, and D. Lai for discussions. W. C. G. H. appreciates the use of the computer facilities at the Kavli Institute for Particle Astrophysics and Cosmology. W. C. G. H. acknowledges support from the Science and Technology Facilities Council (STFC) in the United Kingdom. C. O. H. acknowledges support from the Natural Sciences and Engineering Research Council (NSERC) of Canada.	ALCOCK C, 1980, ASTROPHYS J, V235, P534, DOI 10.1086/157656; Ashworth W. B.  Jr., 1980, Journal for the History of Astronomy, V11, P1; Chakrabarty D, 2001, ASTROPHYS J, V548, P800, DOI 10.1086/318994; Chang P, 2004, ASTROPHYS J, V605, P830, DOI 10.1086/382271; Davis JE, 2001, ASTROPHYS J, V562, P575, DOI 10.1086/323488; Fesen RA, 2006, ASTROPHYS J, V645, P283, DOI 10.1086/504254; Garmire GP, 2003, PROC SPIE, V4851, P28, DOI 10.1117/12.461599; Gotthelf EV, 2009, ASTROPHYS J LETT, V695, pL35, DOI 10.1088/0004-637X/695/1/L35; GREENSTEIN G, 1983, ASTROPHYS J, V271, P283, DOI 10.1086/161195; Heinke CO, 2006, ASTROPHYS J, V644, P1090, DOI 10.1086/503701; Ho WCG, 2001, MON NOT R ASTRON SOC, V327, P1081, DOI 10.1046/j.1365-8711.2001.04801.x; Lattimer JM, 2007, PHYS REP, V442, P109, DOI 10.1016/j.physrep.2007.02.003; Mori K, 2007, MON NOT R ASTRON SOC, V377, P905, DOI 10.1111/j.1365-2966.2007.11663.x; Murray SS, 2002, ASTROPHYS J, V566, P1039, DOI 10.1086/338224; MUSLIMOV A, 1995, ASTROPHYS J, V440, pL77, DOI 10.1086/187765; *OP PROJ TEAM, OP PROJ; Page D, 2006, NUCL PHYS A, V777, P497, DOI 10.1016/j.nuclphysa.2005.09.019; Pavlov GG, 2009, ASTROPHYS J, V703, P910, DOI 10.1088/0004-637X/703/1/910; Pavlov GG, 2000, ASTROPHYS J, V531, pL53, DOI 10.1086/312521; PAVLOV GG, 2002, P WE HER SEM NEUTR S, V270, P273; Predehl P, 2003, ASTRON NACHR, V324, P73, DOI 10.1002/asna.200310019; Rajagopal M, 1996, ASTROPHYS J, V461, P327, DOI 10.1086/177059; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; ROSEN LC, 1968, ASTROPHYS SPACE SCI, V1, P372, DOI 10.1007/BF00656008; TANANBAUM H, 1999, 7246 IAU; Tsuruta S, 2009, ASTROPHYS J, V691, P621, DOI 10.1088/0004-637X/691/1/621; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; Yakovlev DG, 2004, ANNU REV ASTRON ASTR, V42, P169, DOI 10.1146/annurev.astro.42.053102.134013; Zavlin VE, 1996, ASTRON ASTROPHYS, V315, P141	30	176	179	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					71	73		10.1038/nature08525	http://dx.doi.org/10.1038/nature08525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890325	Green Submitted			2022-12-28	WOS:000271419200033
J	Cheng, KCC; Klancer, R; Singson, A; Seydoux, G				Cheng, Ken Chih-Chien; Klancer, Richard; Singson, Andrew; Seydoux, Geraldine			Regulation of MBK-2/DYRK by CDK-1 and the Pseudophosphatases EGG-4 and EGG-5 during the Oocyte-to-Embryo Transition	CELL			English	Article							CYCLIN-DEPENDENT KINASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; DUAL-SPECIFICITY; ACTIVATION; MATURATION; DYRK; DEGRADATION; OMA-1	DYRKs are kinases that self-activate in vitro by autophosphorylation of a YTY motif in the kinase domain, but their regulation in vivo is not well understood. In C. elegans zygotes, MBK-2/DYRK phosphorylates oocyte proteins at the end of the meiotic divisions to promote the oocyte-to-embryo transition. Here we demonstrate that MBK-2 is under both positive and negative regulation during the transition. MBK-2 is activated during oocyte maturation by CDK-1-dependent phosphorylation of serine 68, a residue outside of the kinase domain required for full activity in vivo. The pseudotyrosine phosphatases EGG-4 and EGG-5 sequester activated MBK-2 until the meiotic divisions by binding to the YTY motif and inhibiting MBK-20s kinase activity directly, using a mixed-inhibition mechanism that does not involve tyrosine dephosphorylation. Our findings link cell-cycle progression to MBK-2/DYRK activation and the oocyte-to-embryo transition.	[Cheng, Ken Chih-Chien; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cheng, Ken Chih-Chien; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Klancer, Richard; Singson, Andrew] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Klancer, Richard; Singson, Andrew] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Ctr Cell Dynam, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health [R01HD37047, R01HD054681]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047, R01HD054681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully thank Chih-Long Chang for hosting K.C.-C.C. in 2009; Miranda Darby, Hani Zaher, and Rachel Green for help and advice; J. Pellettieri for strains; and Rueyling Lin and members of the Seydoux lab for comments on the manuscript. This research was supported by the National Institutes of Health (Grants R01HD37047 [G.S.] and R01HD054681 [A.S.]) and a Johnson & Johnson Discovery Award (A.S.). G. S. is an Investigator of the Howard Hughes Medical Institute.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Berg JM, 2006, BIOCHEMISTRY; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; BRENNER S, 1974, GENETICS, V77, P71; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Da Costa M, 2006, PLANT CELL, V18, P1426, DOI 10.1105/tpc.105.040485; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Hunter T, 1998, NAT GENET, V18, P303; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Lim S, 2002, J BIOL CHEM, V277, P49438, DOI 10.1074/jbc.M206840200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Maruyama R, 2007, CURR BIOL, V17, P1555, DOI 10.1016/j.cub.2007.08.011; McNally KL, 2005, DEV BIOL, V282, P218, DOI 10.1016/j.ydbio.2005.03.009; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Praitis V, 2001, GENETICS, V157, P1217; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Stitzel ML, 2007, CURR BIOL, V17, P1545, DOI 10.1016/j.cub.2007.08.049; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voronina E, 2003, CURR TOP DEV BIOL, V58, P53, DOI 10.1016/S0070-2153(03)58003-6; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	41	71	82	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					560	572		10.1016/j.cell.2009.08.047	http://dx.doi.org/10.1016/j.cell.2009.08.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879842	Green Accepted, Bronze			2022-12-28	WOS:000271259600020
J	Keirns, CC; Goold, SD				Keirns, Carla C.; Goold, Susan Dorr			Patient-Centered Care and Preference-Sensitive Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAY-FOR-PERFORMANCE; HEALTH-CARE; RECOMMENDATIONS; BELIEFS		[Keirns, Carla C.] SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Dept Prevent Med, Stony Brook, NY 11794 USA; [Keirns, Carla C.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Keirns, Carla C.; Goold, Susan Dorr] Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI USA; [Keirns, Carla C.; Goold, Susan Dorr] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Keirns, Carla C.; Goold, Susan Dorr] Univ Michigan, Bioeth Program, Ann Arbor, MI 48109 USA; [Keirns, Carla C.] Ann Arbor VA Hlth Syst, Dept Ambulatory Care, Ann Arbor, MI USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Keirns, CC (corresponding author), SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Dept Prevent Med, HSC Level 3,Room 080, Stony Brook, NY 11794 USA.	carla.keirns@stonybrook.edu	Keirns, Carla/AAT-9384-2020; Goold, Susan Dorr/N-6930-2014	Goold, Susan Dorr/0000-0002-0258-9774				Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Goff SL, 2008, J GEN INTERN MED, V23, P236, DOI 10.1007/s11606-007-0470-3; Heisler M, 2009, CHRONIC ILLN, V5, P165, DOI 10.1177/1742395309339258; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Michaels C, 2008, J AM ACAD NURSE PRAC, V20, P585, DOI 10.1111/j.1745-7599.2008.00372.x; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Schneider J.W., 1983, HAVING EPILEPSY EXPE; Wharam JF, 2009, J GEN INTERN MED, V24, P854, DOI 10.1007/s11606-009-0947-3; Wynia MK, 2009, J GEN INTERN MED, V24, P884, DOI 10.1007/s11606-009-0984-y	10	99	99	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1805	1806		10.1001/jama.2009.1550	http://dx.doi.org/10.1001/jama.2009.1550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861674				2022-12-28	WOS:000271150300025
J	Morris, JK; Alberman, E				Morris, Joan K.; Alberman, Eva			Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register	BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY TERMINATIONS; AGE; ASCERTAINMENT; PREVALENCE; RATES	Objectives To describe trends in the numbers of Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008. Design and setting The National Down Syndrome Cytogenetic Register holds details of 26488 antenatal and postnatal diagnoses of Down's syndrome made by all cytogenetic laboratories in England and Wales since 1989. Interventions Antenatal screening, diagnosis, and subsequent termination of Down's syndrome pregnancies. Main outcome measures The number of live births with Down's syndrome. Results Despite the number of births in 1989/90 being similar to that in 2007/8, antenatal and postnatal diagnoses of Down's syndrome increased by 71% (from 1075 in 1989/90 to 1843 in 2007/8). However, numbers of live births with Down's syndrome fell by 1% (752 to 743; 1.10 to 1.08 per 1000 births) because of antenatal screening and subsequent terminations. In the absence of such screening, numbers of live births with Down's syndrome would have increased by 48% (from 959 to 1422), since couples are starting families at an older age. Among mothers aged 37 years and older, a consistent 70% of affected pregnancies were diagnosed antenatally. In younger mothers, the proportions of pregnancies diagnosed antenatally increased from 3% to 43% owing to improvements in the availability and sensitivity of screening tests. Conclusions Since 1989, expansion of and improvements in antenatal screening have offset an increase in Down's syndrome resulting from rising maternal age. The proportion of antenatal diagnoses has increased most strikingly in younger women, whereas that in older women has stayed relatively constant. This trend suggests that, even with future improvements in screening, a large number of births with Down's syndrome are still likely, and that monitoring of the numbers of babies born with Down's syndrome is essential to ensure adequate provision for their needs.	[Morris, Joan K.; Alberman, Eva] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Morris, JK (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	j.k.morris@qmul.ac.uk	Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X	NHS	NHS	The NHS Fetal Anomaly Screening Programme funded the National Down Syndrome Cytogenetic Register to collect the data until March 2009. The funders played no role in the analysis or write up of this paper. JM and EA are independent of the Fetal Anomaly Screening Programme. JM and EA had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	ALBERMAN E, 1995, BRIT J OBSTET GYNAEC, V102, P445, DOI 10.1111/j.1471-0528.1995.tb11315.x; Boyd PA, 2005, BMJ-BRIT MED J, V330, P27, DOI 10.1136/bmj.38300.665301.3A; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Iliyasu Z, 2002, Health Bull (Edinb), V60, P20; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Melve KK, 2008, ACTA OBSTET GYN SCAN, V87, P824, DOI 10.1080/00016340802217184; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; MUTTON DE, 1991, BRIT MED J, V303, P1295, DOI 10.1136/bmj.303.6813.1295; NICHOLSON A, 1992, J INTELL DISABIL RES, V36, P505; *OFF NAT STAT FM1, BIRTH STAT, P18; Savva GM, 2009, ARCH DIS CHILD-FETAL, V94, pF23, DOI 10.1136/adc.2007.136465; Savva GM, 2006, PRENATAL DIAG, V26, P499, DOI 10.1002/pd.1443; Siffel C, 2004, BIRTH DEFECTS RES A, V70, P565, DOI 10.1002/bdra.20064; *UK NAT SCREEN COM, FET AN SCREEN PROGR	16	131	135	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 26	2009	339								b3794	10.1136/bmj.b3794	http://dx.doi.org/10.1136/bmj.b3794			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AI	19858532	hybrid, Green Published			2022-12-28	WOS:000271365300001
J	Bernskoetter, WH; Schauer, CK; Goldberg, KI; Brookhart, M				Bernskoetter, Wesley H.; Schauer, Cynthia K.; Goldberg, Karen I.; Brookhart, Maurice			Characterization of a Rhodium(I) sigma-Methane Complex in Solution	SCIENCE			English	Article							C-H BOND; ALKANE COMPLEXES; ACTIVATION; COORDINATION; PHOTOCHEMISTRY; REACTIVITY; CHEMISTRY; IRIDIUM; IR	Numerous transition metal-mediated reactions, including hydrogenations, hydrosilations, and alkane functionalizations, result in the cleavage of strong sigma bonds. Key intermediates in these reactions often involve coordination of the sigma bond of dihydrogen, silanes (Si-H), or alkanes (C-H) to the metal center without full scission of the bond. These sigma complexes have been characterized to varying degrees in solid state and solution. However, a sigma complex of the simplest hydrocarbon, methane, has eluded full solution characterization. Here, we report nuclear magnetic resonance spectra of a rhodium(I) sigma-methane complex obtained by protonation of a rhodium-methyl precursor in CDCl2F solvent at -110 degrees C. The sigma-methane complex is shown to be more stable than the corresponding rhodium(III)methyl hydride complex. Even at -110 degrees C, methane rapidly tumbles in the coordination sphere of rhodium, exchanging free and bound hydrogens. Kinetic studies reveal a half-life of about 83 minutes at-87 degrees C for dissociation of methane ( free energy of activation is 14.5 kilocalories per mole).	[Bernskoetter, Wesley H.; Schauer, Cynthia K.; Brookhart, Maurice] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Goldberg, Karen I.] Univ Washington, Dept Chem Box 351700, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Brookhart, M (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	mbrookhart@unc.edu			S. Kloek Hanson; NSF [CHE-0650456]; Center for Enabling New Technologies Through Catalysis (CENTC); NIH [GM28938]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028938] Funding Source: NIH RePORTER	S. Kloek Hanson; NSF(National Science Foundation (NSF)); Center for Enabling New Technologies Through Catalysis (CENTC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge S. Kloek Hanson for experimental assistance and funding by the NSF ( grant no. CHE-0650456) as part of the Center for Enabling New Technologies Through Catalysis (CENTC) and the NIH ( grant no. GM28938).	Ball GE, 2007, P NATL ACAD SCI USA, V104, P6927, DOI 10.1073/pnas.0610212104; Bercaw JE, 2007, P NATL ACAD SCI USA, V104, P6899, DOI 10.1073/pnas.0700902104; Bernskoetter WH, 2009, J AM CHEM SOC, V131, P8603, DOI 10.1021/ja901706b; BROOKHART M, 1988, PROG INORG CHEM, V36, P1; Brookhart M, 2007, P NATL ACAD SCI USA, V104, P6908, DOI 10.1073/pnas.0610747104; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Cobar EA, 2007, P NATL ACAD SCI USA, V104, P6963, DOI 10.1073/pnas.0610295104; Cowan AJ, 2007, P NATL ACAD SCI USA, V104, P6933, DOI 10.1073/pnas.0610567104; Cowan AJ, 2008, COORDIN CHEM REV, V252, P2504, DOI 10.1016/j.ccr.2008.05.008; Evans DR, 1997, J AM CHEM SOC, V119, P3633, DOI 10.1021/ja970008h; Hall C, 1996, CHEM REV, V96, P3125, DOI 10.1021/cr9502615; Heiberg H, 2003, INT J QUANTUM CHEM, V92, P391, DOI 10.1002/qua.10525; HERMANN H, 1982, J PHYS CHEM-US, V86, P5151, DOI 10.1021/j100223a019; Jensen MP, 2003, J AM CHEM SOC, V125, P8614, DOI 10.1021/ja028477t; Jones WD, 2003, ACCOUNTS CHEM RES, V36, P140, DOI 10.1021/ar020148i; KELLY JM, 1987, J CHEM SOC CHEM COMM, P1821, DOI 10.1039/c39870001821; Kubas G.J., 2001, METAL DIHYDROGEN SIG; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lawes DJ, 2006, ANGEW CHEM INT EDIT, V45, P4486, DOI 10.1002/anie.200600313; McNamara BK, 1999, J AM CHEM SOC, V121, P6437, DOI 10.1021/ja9904282; PERUTZ RN, 1975, J AM CHEM SOC, V97, P4791, DOI 10.1021/ja00850a001; PIERS WE, 1990, J AM CHEM SOC, V112, P9406, DOI 10.1021/ja00181a060; Siegbahn PEM, 1996, J AM CHEM SOC, V118, P1487, DOI 10.1021/ja952338c; Stahl SS, 1996, J AM CHEM SOC, V118, P5961, DOI 10.1021/ja960110z; Xavier ES, 2005, ORGANOMETALLICS, V24, P2262, DOI 10.1021/om049036g; Zaric S, 1997, J PHYS CHEM A, V101, P4646, DOI 10.1021/jp970792s	26	203	206	1	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					553	556		10.1126/science.1177485	http://dx.doi.org/10.1126/science.1177485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900892				2022-12-28	WOS:000271019400035
J	Prymula, R; Siegrist, CA; Chlibek, R; Zemlickova, H; Vackova, M; Smetana, J; Lommel, P; Kaliskova, E; Borys, D; Schuerman, L				Prymula, Roman; Siegrist, Claire-Anne; Chlibek, Roman; Zemlickova, Helena; Vackova, Marie; Smetana, Jan; Lommel, Patricia; Kaliskova, Eva; Borys, Dorota; Schuerman, Lode			Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; HEPATITIS-B; ACELLULAR PERTUSSIS; INACTIVATED POLIOVIRUS; ROTAVIRUS VACCINE; DOUBLE-BLIND; IMMUNOGENICITY; TETANUS; DIPHTHERIA; SAFETY	Background Although fever is part of the normal inflammatory process after immunisation, prophylactic antipyretic drugs are sometimes recommended to allay concerns of high fever and febrile convulsion. We assessed the effect of prophylactic administration of paracetamol at vaccination on infant febrile reaction rates and vaccine responses. Methods In two consecutive (primary and booster) randomised, controlled, open-label vaccination studies, 459 healthy infants were enrolled from ten centres in the Czech Republic. Infants were randomly assigned with a computer-generated randomisation list to receive three prophylactic paracetamol doses every 6-8 h in the first 24 h (n=226) or no prophylactic paracetamol (n=233) after each vaccination with a ten-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with the hexavalent diphtheria-tetanus-3-component acellular pertussis-hepatitis B-inactivated poliovirus types 1, 2, and 3-H influenzae type b (DTPa-HBV-IPV/Hib) and oral human rotavirus vaccines. The primary objective in both studies was the reduction in febrile reactions of 38.0 degrees C or greater in the total vaccinated cohort. The second objective was assessment of immunogenicity in the according-to-protocol cohort. These studies are registered with ClinicalTrials.gov, numbers NCT00370318 and NCT00496015. Findings Fever greater than 39.5 degrees C was uncommon in both groups (after primary: one of 226 participants [<1%] in prophylactic paracetamol group vs three of 233 [1%] in no prophylactic paracetamol group; after booster: three of 178 [2%] vs two of 172 [1%]). The percentage of children with temperature of 38 degrees C or greater after at least one dose was significantly lower in the prophylactic paracetamol group (94/226 [42%] after primary vaccination and 64/178 [36%] after booster vaccination) than in the no prophylactic paracetamol group (154/233 [66%] after primary vaccination and 100/172 [58%] after booster vaccination). Antibody geometric mean concentrations (GMCs) were significantly lower in the prophylactic paracetamol group than in the no prophylactic paracetamol group after primary vaccination for all ten pneumococcal vaccine serotypes, protein D, antipolyribosyl-ribitol phosphate, antidiphtheria, antitetanus, and antipertactin. After boosting, lower antibody GMCs persisted in the prophylactic paracetamol group for antitetanus, protein D, and all pneumococcal serotypes apart from 19F. Interpretation Although febrile reactions significantly decreased, prophylactic administration of antipyretic drugs at the time of vaccination should not be routinely recommended since antibody responses to several vaccine antigens were reduced.	[Prymula, Roman] Univ Def, Dept Epidemiol, Fac Mil Hlth Sci, Hradec Kralove 50012, Czech Republic; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Geneva, Switzerland; [Zemlickova, Helena] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Prague, Czech Republic; [Lommel, Patricia; Borys, Dorota; Schuerman, Lode] GlaxoSmithKline Biol, Global Clin Dev Ctr, Rixensart, Belgium; [Kaliskova, Eva] GlaxoSmithKline, Prague, Czech Republic	University of Defence - Czech Republic; University of Geneva; National Institute of Public Health (SZU) - Czech Republic; GlaxoSmithKline; GlaxoSmithKline	Prymula, R (corresponding author), Univ Def, Dept Epidemiol, Fac Mil Hlth Sci, Trebesska 1575, Hradec Kralove 50012, Czech Republic.	prymula@pmfhk.cz	Zemlickova, Helena/G-6105-2017; Prymula, Roman/AEG-7401-2022; Chlibek, Roman/P-9084-2016	Zemlickova, Helena/0000-0002-3868-0545; Prymula, Roman/0000-0003-1567-2259; Smetana, Jan/0000-0002-4566-3356	GSK Biologicals	GSK Biologicals(GlaxoSmithKline)	GSK Biologicals was the funding source for this study, and funded an costs associated with the development and the publishing of this report. Part of this study has been submitted in an abstract and accepted for poster presentation to Europediatrics (Moscow, Russia; July 3-6, 2009). We thank the parents and their children who participated in these trials; all the investigators, study nurses, clinicians, laboratory personnel, and other staff members in undertaking these studies, particularly all the regional coordinating investigators involved in these studies: J Dufka, M Kolarova, P Mikyska, V Nemec, L Petvaldska, R Ruzkova, R Stritecky, H Ticha, L Tyce; the clinical and serological laboratory teams of GSK Biologicals for their contribution to these studies; Aurelie Fanic for statistical analysis; Mircille Venken and Catherine Slegers (GSK Biologicals) for clinical report writing; Joanne Wolter (freelance) for medical writing; and Christine Vanderlinden (GSK Biologicals) for editorial assistance and manuscript coordination. Infanrix hexa, Rotarix, and Calpol are trademarks of the GSK Group of companies.	Adam H M, 1996, Pediatr Rev, V17, P330; *AUSTR GOV, 2008, AUSTR IMM HDB; Bermal N, 2009, PEDIATR INFECT DIS J, V28, pS89, DOI 10.1097/INF.0b013e318199f901; Concepcion NF, 2001, CLIN DIAGN LAB IMMUN, V8, P266, DOI 10.1128/CDLI.8.2.266-272.2001; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; Dennehy PH, 2005, PEDIATR INFECT DIS J, V24, P481, DOI 10.1097/01.inf.0000164763.55558.71; El-Radhi ASM, 2008, ARCH DIS CHILD, V93, P918, DOI 10.1136/adc.2008.139949; El-Radhi AS, 2003, ARCH DIS CHILD, V88, P641, DOI 10.1136/adc.88.7.641; Fetveit A, 2008, EUR J PEDIATR, V167, P17, DOI 10.1007/s00431-007-0577-x; Gatchalian S, 2005, HUM VACCINES, V1, P198, DOI 10.4161/hv.1.5.2163; Hanson DF, 1997, ANN NY ACAD SCI, V813, P453, DOI 10.1111/j.1749-6632.1997.tb51733.x; Henckaerts I, 2006, CLIN VACCINE IMMUNOL, V13, P356, DOI 10.1128/CVI.13.3.356-360.2006; HOPKINS CS, 1990, ARCH DIS CHILD, V65, P971, DOI 10.1136/adc.65.9.971; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Knuf A, 2006, VACCINE, V24, P4727, DOI 10.1016/j.vaccine.2006.03.032; Kroger Andrew T., 2006, Morbidity and Mortality Weekly Report, V55, P1; LONG SS, 1990, PEDIATRICS, V85, P294; MILLER KD, 2007, CLIN ADV HEMATOL ONC, V5, P1; Nolan T, 2007, VACCINE, V25, P8487, DOI 10.1016/j.vaccine.2007.10.013; Olivier C, 2008, VACCINE, V26, P3142, DOI 10.1016/j.vaccine.2007.11.096; Phua KB, 2005, J INFECT DIS, V192, pS6, DOI 10.1086/431511; Pichichero ME, 2007, J PEDIATR-US, V151, P43, DOI 10.1016/j.jpeds.2007.02.013; QUATAERT SA, 1995, CLIN DIAGN LAB IMMUN, V2, P590, DOI 10.1128/CDLI.2.5.590-597.1995; Reinert P, 2008, ARCH PEDIATRIE, V15, P263, DOI 10.1016/j.arcped.2007.10.014; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; Tichmann I, 2006, HUM VACCINES, V2, P249, DOI 10.4161/hv.2.6.3432; Tichmann-Schumann I, 2005, PEDIATR INFECT DIS J, V24, P70, DOI 10.1097/01.inf.0000148923.46453.48; UHARI M, 1988, ACTA PAEDIATR SCAND, V77, P747, DOI 10.1111/j.1651-2227.1988.tb10741.x; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; WARD RL, 1989, J INFECT DIS, V159, P79, DOI 10.1093/infdis/159.1.79; Waruiru C, 2004, ARCH DIS CHILD, V89, P751, DOI 10.1136/adc.2003.028449; WHO, 2005, WHO TECHN REP SER, V927; World Health Organization, 1993, GUID CONS MED PLANTS, P1; *WY PHARM, SUMM PRD CHAR; Zepp F, 2007, EUR J PEDIATR, V166, P857, DOI 10.1007/s00431-007-0506-z	39	225	228	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1339	1350		10.1016/S0140-6736(09)61208-3	http://dx.doi.org/10.1016/S0140-6736(09)61208-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19837254				2022-12-28	WOS:000271254600030
J	Claridge-Chang, A; Roorda, RD; Vrontou, E; Sjulson, L; Li, HY; Hirsh, J; Miesenbock, G				Claridge-Chang, Adam; Roorda, Robert D.; Vrontou, Eleftheria; Sjulson, Lucas; Li, Haiyan; Hirsh, Jay; Miesenboeck, Gero			Writing Memories with Light-Addressable Reinforcement Circuitry	CELL			English	Article							MUSHROOM BODY NEURONS; DROSOPHILA-MELANOGASTER; ADENYLATE-CYCLASE; OLFACTORY MEMORY; REMOTE-CONTROL; TERM-MEMORY; PREDICTION; OPERANT; PHOTOSTIMULATION; LOCALIZATION	Dopaminergic neurons are thought to drive learning by signaling changes in the expectations of salient events, such as rewards or punishments. Olfactory conditioning in Drosophila requires direct dopamine action on intrinsic mushroom body neurons, the likely storage sites of olfactory memories. Neither the cellular sources of the conditioning dopamine nor its precise postsynaptic targets are known. By optically controlling genetically circumscribed subsets of dopaminergic neurons in the behaving fly, we have mapped the origin of aversive reinforcement signals to the PPL1 cluster of 12 dopaminergic cells. PPL1 projections target restricted domains in the vertical lobes and heel of the mushroom body. Artificially evoked activity in a small number of identifiable cells thus suffices for programming behaviorally meaningful memories. The delineation of core reinforcement circuitry is an essential first step in dissecting the neural mechanisms that compute and represent valuations, store associations, and guide actions.	[Claridge-Chang, Adam; Roorda, Robert D.; Vrontou, Eleftheria; Sjulson, Lucas; Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Li, Haiyan; Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Oxford; University of Virginia	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	gero.miesenboeck@dpag.ox.ac.uk		Claridge-Chang, Adam/0000-0002-4583-3650; Miesenboeck, Gero/0000-0003-2940-3228	Medical Research Council; National Institutes of Health; Office of Naval Research; Dana Foundation; European Molecular Biology Organization; MRC [G0700888, G0701225] Funding Source: UKRI; Medical Research Council [G0700888, G0701225] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601, R01DA017297] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Dana Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Trevor Sharp and Paul Overton for 5-HT measurements, Simon Reeve for experiments on rutabaga mutants, Richard Axel, Michael Bate, Ronald Davis, Andre Fiala, and Scott Waddell for fly strains, and Shankar Srinivas for access to a confocal microscope. This work was supported by grants from the Medical Research Council (G. M.), the National Institutes of Health (G. M. and J. H.), the Office of Naval Research (G. M.), the Dana Foundation (G. M.), and the European Molecular Biology Organization (E. V.).	ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Brembs B, 2008, CURR BIOL, V18, P1168, DOI 10.1016/j.cub.2008.07.041; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; CONNOLLY JB, 1998, DROSOPHILA PRACTICAL, P265; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DAVID CT, 1979, J EXP BIOL, V82, P389; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Holland J. H., 1986, MACHINE LEARNING ART; Houk JC, 1995, MODELS INFORMATION P, P249; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kanerva P., 1988, SPARSE DISTRIBUTED M; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sjulson L, 2008, CHEM REV, V108, P1588, DOI 10.1021/cr078221b; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	53	320	322	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					405	415		10.1016/j.cell.2009.08.034	http://dx.doi.org/10.1016/j.cell.2009.08.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837039	Bronze, Green Accepted			2022-12-28	WOS:000270857500022
J	Higgins, MJ; Graham, SJH				Higgins, Matthew J.; Graham, Stuart J. H.			Balancing Innovation and Access: Patent Challenges Tip the Scales	SCIENCE			English	Editorial Material							RESEARCH-AND-DEVELOPMENT; PHARMACEUTICAL-INDUSTRY; PRICE-COMPETITION; DRUGS		[Higgins, Matthew J.; Graham, Stuart J. H.] Georgia Inst Technol, Coll Management, Atlanta, GA 30308 USA; [Graham, Stuart J. H.] Univ Calif Berkeley, Sch Law, Berkeley Ctr Law & Technol, Berkeley, CA 94720 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Berkeley	Higgins, MJ (corresponding author), Georgia Inst Technol, Coll Management, Atlanta, GA 30308 USA.	matt.higgins@mgt.gatech.edu						*AM INT PROP LAW A, 2007, REP EC SURV 2007; [Anonymous], 2000, PROTECTING THEIR INT; Arrow K., 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Cockburn IM, 2006, INNOV POLICY ECON, V7, P1; Congressional Budget Office, 1998, INCR COMP GEN DRUGS; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; *FED TRAD COMM, 2002, GEN ENTR PRIOR PAT E; Federal Trade Commission, 2009, AUTH GEN INT REP AUTH GEN INT REP; *FOOD DRUG ADM, 2009, OR BOOK APPR DRUG PR; GLASS G, 2009, PARAGRAPH 4 REPORT A; Grabowski H, 2002, J INT ECON LAW, V5, P849, DOI 10.1093/jiel/5.4.849; Grabowski H, 2007, PHARMACEUTICAL INNOVATION: INCENTIVES, COMPETITION, AND COST-BENEFIT ANALYSIS IN INTERNATIONAL PERSPECTIVE, P153, DOI 10.1017/CBO9780511618871.009; Grabowski HG, 2007, MANAG DECIS ECON, V28, P491, DOI 10.1002/mde.1356; GRABOWSKI HG, 1992, J LAW ECON, V35, P331, DOI 10.1086/467257; Graham S. J. H., 2008, TIMING NEW DRUG INTR; Groetken Troy A., 2008, NW J TECHNOL INTELL, V6, P331; Higgins MJ, 2006, J FINANC ECON, V80, P351, DOI 10.1016/j.jfineco.2005.04.004; Hughes B, 2008, NAT REV DRUG DISCOV, V7; Kapczynski A., 2005, BERKELEY TECHNOLOGY, V20, P1031; Lichtenberg FR, 2001, HEALTH AFFAIR, V20, P241, DOI 10.1377/hlthaff.20.5.241; Lichtenberg Frank R, 2005, Int J Health Care Finance Econ, V5, P47, DOI 10.1007/s10754-005-6601-7; *MERCK CO, 2008, 2008 ANN REP MERCK C; *NAT AC SCI ENG I, 2007, RIS GATH STORM EN EM; *PHARM RES MAN AM, 2009, 2009 ANN REP PHRMA, P14; *PHRMA, 2009, IND PROF 2009, P54; RICHWINE L, 2009, REUTERS         0625; Saha A, 2006, INT J ECON BUS, V13, P15, DOI 10.1080/13571510500519905; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; *TEV PHARM IND LTD, 2007, FORM 20 F; Vernon John A., 2002, REGULATION, V25, P22; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; 2004, OFFICIAL J L, V136, P34	33	55	55	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					370	371		10.1126/science.1176116	http://dx.doi.org/10.1126/science.1176116			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZM	19833944				2022-12-28	WOS:000270818600029
J	Holmberg, VC; Panthani, MG; Korgel, BA				Holmberg, Vincent C.; Panthani, Matthew G.; Korgel, Brian A.			Phase Transitions, Melting Dynamics, and Solid-State Diffusion in a Nano Test Tube	SCIENCE			English	Article							SEMICONDUCTOR NANOWIRES; GERMANIUM; TEMPERATURE; GROWTH; ALLOY; GOLD; SOLUBILITY; NANOTUBES; PRESSURE	Confined nanoscale geometry greatly influences physical transformations in materials. The electron microscope enables direct visualization of these changes. We examined the evolution of a germanium (Ge) nanowire attached to a gold (Au) nanocrystal as it was heated to 900 degrees C. The application of a carbon shell prevented changes in volume and interfacial area during the heating cycle. Au/Ge eutectic formation was visualized, occurring 15 degrees C below the bulk eutectic temperature. Capillary pressure pushed the melt into the cylindrical neck of the nanowire, and Ge crystallized in the spherical tip of the carbon shell. Solid-state diffusion down the length of the confined Ge nanowire was observed at temperatures above 700 degrees C; Au diffusion was several orders of magnitude slower than in a bulk Ge crystal.	[Holmberg, Vincent C.; Panthani, Matthew G.; Korgel, Brian A.] Univ Texas Austin, Dept Chem Engn, Texas Mat Inst, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Korgel, BA (corresponding author), Univ Texas Austin, Dept Chem Engn, Texas Mat Inst, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA.	korgel@che.utexas.edu	Panthani, Matthew G/C-8829-2014; Korgel, Brian A/I-5771-2013	Panthani, Matthew G/0000-0002-3795-2051; Holmberg, Vincent/0000-0002-9591-8951	NSF [DMR-0807065]; Robert A. Welch Foundation [F-1464]; Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program	NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	The authors thank NSF (DMR-0807065) and the Robert A. Welch Foundation ( grant no. F-1464) for partial financial support of the research. V. C. H. acknowledges the Fannie and John Hertz Foundation and the NSF Graduate Research Fellowship Program for financial support.	Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; ALMAZOUZI A, 1991, J APPL PHYS, V70, P1345, DOI 10.1063/1.349591; Banhart F, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.185502; BRACHT H, 1991, PHYS REV B, V43, P14465, DOI 10.1103/PhysRevB.43.14465; Eswaramoorthy SK, 2007, SCIENCE, V318, P1437, DOI 10.1126/science.1146511; Ferralis N, 2008, J AM CHEM SOC, V130, P2681, DOI 10.1021/ja7101983; Gao YH, 2002, NATURE, V415, P599, DOI 10.1038/415599a; GOLDSTEIN AN, 1992, SCIENCE, V256, P1425, DOI 10.1126/science.256.5062.1425; Jin CH, 2006, J PHYS CHEM B, V110, P5423, DOI 10.1021/jp057240r; Knaepen W, 2009, J APPL PHYS, V105, DOI 10.1063/1.3110722; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; MILLEA MF, 1966, J PHYS CHEM SOLIDS, V27, P309, DOI 10.1016/0022-3697(66)90037-0; MILLER JW, 1969, PHYS REV, V188, P1074, DOI 10.1103/PhysRev.188.1074; Okamoto H., 1984, B ALLOY PHASE DIAGR, V5, P601; Schwalbach EJ, 2008, NANO LETT, V8, P3739, DOI 10.1021/nl801987j; Sun L, 2006, SCIENCE, V312, P1199, DOI 10.1126/science.1124594; Sun LT, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156101; Sutter E, 2005, NANO LETT, V5, P2092, DOI 10.1021/nl051498b; Sutter E, 2008, NANO LETT, V8, P411, DOI 10.1021/nl0719630; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; Vanhellemont J, 2007, J APPL PHYS, V101, DOI 10.1063/1.2429718; WERNER M, 1985, PHYS REV B, V32, P3930, DOI 10.1103/PhysRevB.32.3930; Wu YY, 2001, ADV MATER, V13, P520, DOI 10.1002/1521-4095(200104)13:7<520::AID-ADMA520>3.0.CO;2-W; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	24	58	59	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					405	407		10.1126/science.1178179	http://dx.doi.org/10.1126/science.1178179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833963				2022-12-28	WOS:000270818600047
J	Billeter, JC; Atallah, J; Krupp, JJ; Millar, JG; Levine, JD				Billeter, Jean-Christophe; Atallah, Jade; Krupp, Joshua J.; Millar, Jocelyn G.; Levine, Joel D.			Specialized cells tag sexual and species identity in Drosophila melanogaster	NATURE			English	Article							CUTICULAR HYDROCARBONS; BEHAVIORAL-RESPONSES; GENETIC-CONTROL; COURTSHIP; PHEROMONES; SUBGROUP; COMMUNICATION; MALES	Social interactions depend on individuals recognizing each other, and in this context many organisms use chemical signals to indicate species and sex(1). Cuticular hydrocarbon signals are used by insects, including Drosophila melanogaster, to distinguish conspecific individuals from others(1-3). These chemicals also contribute to intraspecific courtship and mating interactions(1-3). However, the possibility that sex and species identification are linked by common chemical signalling mechanisms has not been formally tested. Here we provide direct evidence that a single compound is used to communicate female identity among D. melanogaster, and to define a reproductive isolation barrier between D. melanogaster and sibling species. A transgenic manipulation eliminated cuticular hydrocarbons by ablating the oenocytes, specialized cells required for the expression of these chemical signals. The resulting oenocyte-less (oe(-)) females elicited the normal repertoire of courtship behaviours from males, but were actually preferred over wild-type females by courting males. In addition, wild-type males attempted to copulate with oe(-) males. Thus, flies lacking hydrocarbons are a sexual hyperstimulus. Treatment of virgin females with the aversive male pheromone cis-vaccenyl acetate (cVA) significantly delayed mating of oe(-) females compared to wild-type females. This difference was eliminated when oe(-) females were treated with a blend of cVA and the female aphrodisiac (7Z,11Z)-heptacosadiene (7,11-HD), showing that female aphrodisiac compounds can attenuate the effects of male aversive pheromones. 7,11-HD also was shown to have a crucial role in heterospecific encounters. Specifically, the species barrier was lost because males of other Drosophila species courted oe(-) D. melanogaster females, and D. simulans males consistently mated with them. Treatment of oe(-) females with 7,11-HD restored the species barrier, showing that a single compound can confer species identity. These results identify a common mechanism for sexual and species recognition regulated by cuticular hydrocarbons.	[Billeter, Jean-Christophe; Atallah, Jade; Krupp, Joshua J.; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Toronto; University Toronto Mississauga; University of California System; University of California Riverside	Levine, JD (corresponding author), Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	joel.levine@utoronto.ca	Billeter, Jean-Christophe/G-5399-2012	Millar, Jocelyn/0000-0001-7639-9001; Billeter, Jean-Christophe/0000-0001-7796-4068	Swiss National Science Foundation; Canadian Institutes of Health Research; Canada Research Chair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank H. Pavlou for help with RNA collection; N. Gompel for sharing fly strains; and A. Dornan, S. Douglas, J. C. Hall, I. Dover, C. Kent, C. Kyriacou, K. Luoto, S. Goodwin, M. Ritchie, J. Schneider and M. Sokolowski for critical comments on the manuscript. J.-C. B. was supported by a fellowship for advanced researcher from the Swiss National Science Foundation. This work was supported by the Canadian Institutes of Health Research and Canada Research Chair grants awarded to J. D. L.	[Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; COBB M, 1985, BEHAVIOUR, V95, P203, DOI 10.1163/156853985X00136; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Imhof M, 1998, MOL ECOL, V7, P915, DOI 10.1046/j.1365-294x.1998.00382.x; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	30	264	266	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					987	U250		10.1038/nature08495	http://dx.doi.org/10.1038/nature08495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829381				2022-12-28	WOS:000270817700049
J	van der Poll, T; Opal, SM				van der Poll, Tom; Opal, Steven M.			Pathogenesis, treatment, and prevention of pneumococcal pneumonia	LANCET			English	Review							ALVEOLAR MACROPHAGE APOPTOSIS; COMMUNITY-ACQUIRED PNEUMONIA; MARGINAL ZONE MACROPHAGES; HIV-INFECTED ADULTS; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; HOST-DEFENSE; VIRULENCE FACTORS; INNATE IMMUNITY; T-CELLS	Pneumococcus remains the most common cause of community-acquired pneumonia worldwide. Streptococcus pneumoniae is well adapted to people, and is a frequent inhabitant of the upper airways in healthy hosts. This seemingly innocuous state of colonisation is a dynamic and competitive process in which the pathogen attempts to engage the host, proliferate, and invade the lower airways. The host in turn continuously deploys an array of innate and acquired cellular and humoral defences to prevent pneumococci from breaching tissue barriers. Discoveries into essential molecular mechanisms used by pneumococci to evade host-sensing systems that are designed to contain the pathogen provide new insights into potential treatment options. Versatility of the genome of pneumococci and the bacteria's polygenic virulence capabilities show that a multifaceted approach with many vaccine antigens, antibiotic combinations, and immunoadjuvant therapies will be needed to control this microbe.	[van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Opal, Steven M.] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	University of Amsterdam; Academic Medical Center Amsterdam; Brown University	van der Poll, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.vanderpoll@amc.uva.nl						Abdeldaim GMK, 2008, DIAGN MICR INFEC DIS, V60, P143, DOI 10.1016/j.diagmicrobio.2007.08.010; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Albrich WC, 2007, CLIN INFECT DIS, V44, P1569, DOI 10.1086/518149; Amory-Rivier CF, 2000, CRIT CARE MED, V28, P3249, DOI 10.1097/00003246-200009000-00021; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boulware DR, 2007, J INFECTION, V55, P300, DOI 10.1016/j.jinf.2007.06.014; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Bruce MG, 2008, EMERG INFECT DIS, V14, P25, DOI 10.3201/eid1401.071315; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Bruns AHW, 2007, CLIN INFECT DIS, V45, P983, DOI 10.1086/521893; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; CHERIAN T, 1994, JAMA-J AM MED ASSOC, V271, P695, DOI 10.1001/jama.271.9.695; Choi G, 2008, CRIT CARE MED, V36, P204, DOI 10.1097/01.CCM.0000292012.87482.F4; Crum NF, 2003, AM J PREV MED, V25, P107, DOI 10.1016/S0749-3797(03)00114-4; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Dudley S, 2001, J LAB CLIN MED, V138, P338, DOI 10.1067/mlc.2001.119311; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Garvy BA, 1996, INFLAMMATION, V20, P499, DOI 10.1007/BF01487042; Gauthier JF, 2007, INFECT IMMUN, V75, P5361, DOI 10.1128/IAI.02008-06; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jounblat R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-126; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kerr AR, 2002, INFECT IMMUN, V70, P1547, DOI 10.1128/IAI.70.3.1547-1557.2002; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kirby AC, 2007, J PATHOL, V212, P29, DOI 10.1002/path.2149; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Koppel EA, 2008, MOL IMMUNOL, V45, P2881, DOI 10.1016/j.molimm.2008.01.032; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marks M, 2007, INFECT IMMUN, V75, P1586, DOI 10.1128/IAI.01579-06; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Martin-Galiano AJ, 2004, MICROBIOL-SGM, V150, P2313, DOI 10.1099/mic.0.27097-0; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Moore LJ, 2003, J INFECT DIS, V188, P1040, DOI 10.1086/378238; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mufson MA, 1999, AM J MED, V107, P34, DOI 10.1016/S0002-9343(99)00098-4; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; Nakasone C, 2007, MICROBES INFECT, V9, P251, DOI 10.1016/j.micinf.2006.11.015; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ongkasuwan J, 2008, PEDIATRICS, V122, P34, DOI 10.1542/peds.2007-2703; Opal SM, 1996, J INFECT DIS, V173, P1415, DOI 10.1093/infdis/173.6.1415; OPAL SM, 2004, INFECT DIS, P1145; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Pallares R, 2002, AM J MED, V113, P120, DOI 10.1016/S0002-9343(02)01162-2; Paterson GK, 2006, MICROBES INFECT, V8, P145, DOI 10.1016/j.micinf.2005.06.009; Quin LR, 2005, J INFECT DIS, V192, P1996, DOI 10.1086/497605; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Rijneveld AW, 2005, J INFECT DIS, V191, P1755, DOI 10.1086/429633; Rijneveld AW, 2004, J INFECT DIS, V189, P711, DOI 10.1086/381392; Rijneveld AW, 2002, J INFECT DIS, V185, P91, DOI 10.1086/338122; Rijneveld AW, 2001, J IMMUNOL, V167, P5240, DOI 10.4049/jimmunol.167.9.5240; Romney MG, 2008, CLIN INFECT DIS, V47, P768, DOI 10.1086/591128; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Seo HS, 2008, INFECT IMMUN, V76, P206, DOI 10.1128/IAI.01140-07; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; SMITH T, 1993, EPIDEMIOL INFECT, V111, P27, DOI 10.1017/S0950268800056648; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van der Sluijs KF, 2006, AM J PHYSIOL-LUNG C, V290, pL194, DOI 10.1152/ajplung.00050.2005; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; vanderPoll T, 1997, AM J RESP CRIT CARE, V155, P603, DOI 10.1164/ajrccm.155.2.9032201; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; WATSON DA, 1993, CLIN INFECT DIS, V17, P913, DOI 10.1093/clinids/17.5.913; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Williams SP, 2007, J MICROBIOL METH, V70, P65, DOI 10.1016/j.mimet.2007.03.009; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705; Yamamoto N, 2004, MICROBES INFECT, V6, P1241, DOI 10.1016/j.micinf.2004.08.007; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617	140	488	503	0	156	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1543	1556		10.1016/S0140-6736(09)61114-4	http://dx.doi.org/10.1016/S0140-6736(09)61114-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19880020				2022-12-28	WOS:000271591300033
J	Bourjeily, G; Paidas, M; Khalil, H; Rosene-Montella, K; Rodger, M				Bourjeily, Ghada; Paidas, Michael; Khalil, Hanan; Rosene-Montella, Karen; Rodger, Marc			Pulmonary embolism in pregnancy	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; RECURRENT VENOUS THROMBOEMBOLISM; FACTOR-V-LEIDEN; D-DIMER LEVELS; TISSUE-PLASMINOGEN ACTIVATOR; SIMPLE CLINICAL-MODEL; VENA-CAVA FILTERS; UNFRACTIONATED HEPARIN; RISK-FACTORS; COMPUTED-TOMOGRAPHY	Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world. Mortality from PE in pregnancy might be related to challenges in targeting the right population for prevention, ensuring that diagnosis is suspected and adequately investigated, and initiating timely and best possible treatment of this disease. Pregnancy is an example of Virchow's triad: hypercoagulability, venous stasis, and vascular damage; together these factors lead to an increased incidence of venous thromboembolism. This disorder is often suspected in pregnant women because some of the physiological changes of pregnancy mimic its signs and symptoms. Despite concerns for fetal teratogenicity and oncogenicity associated with diagnostic testing, and potential adverse effects of pharmacological treatment, an accurate diagnosis of PE and a timely therapeutic intervention are crucial. Appropriate prophylaxis should be weighed against the risk of complications and offered according to risk stratification.	[Bourjeily, Ghada; Rosene-Montella, Karen] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Med, Providence, RI 02905 USA; [Khalil, Hanan] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Diagnost Imaging, Providence, RI 02905 USA; [Paidas, Michael] Yale Univ, Sch Med, Yale New Haven Hosp, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Rodger, Marc] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada	Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; Yale University; University of Ottawa; Ottawa Hospital Research Institute	Bourjeily, G (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Med Pulm & Crit Care Med, 100 Dudley St,3rd Floor, Providence, RI 02905 USA.	GBourjeily@wihri.org		Bourjeily, Ghada/0000-0002-0543-4719; Rodger, Marc/0000-0001-8166-3487	GTC Biotherapeutics; Novo-Nordisk; BioIncept; Celera; Hologic; Kronos Longevity Research Institute; Pfizer; Sanofi-Aventis; Leo Pharma	GTC Biotherapeutics; Novo-Nordisk(Novo Nordisk); BioIncept; Celera; Hologic; Kronos Longevity Research Institute; Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Leo Pharma(LEO Pharma)	MP has received honoraria from GTC Biotherapeutics, Novo-Nordisk, CSL Behring, Telacris, and Hologic, and research funding from GTC Biotherapeutics, Novo-Nordisk, BioIncept, Celera, and Hologic. MP was a coauthor of a consensus panel document whose meetings and editorial assistance were provided by Sanofi-Aventis, although funding was not received from the company. He is a consultant for the KEEPS trial, sponsored by the Kronos Longevity Research Institute. MR has received grant funding from Pfizer, Sanofi-Aventis, and Leo Pharma, and served on advisory boards for Sanofi-Aventis without payment. GB, HK, and KR-M declare that they have no conflicts of interest.	Abou-Nassar K, 2007, THROMB HAEMOSTASIS, V98, P163, DOI 10.1160/TH06-10-0574; Ahearn GS, 2002, ARCH INTERN MED, V162, P1221, DOI 10.1001/archinte.162.11.1221; AlMeshari A, 1996, INT J GYNECOL OBSTET, V52, P25, DOI 10.1016/0020-7292(95)02556-1; Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Andreou A, 2008, EUR RADIOL, V18, P2716, DOI 10.1007/s00330-008-1114-7; Balan KK, 1997, BRIT J RADIOL, V70, P338, DOI 10.1259/bjr.70.832.9166067; Barrellier MT, 2001, J MAL VASCUL, V26, P23; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bauersachs RM, 2007, J THROMB HAEMOST, V5, P438, DOI 10.1111/j.1538-7836.2007.02339.x; Beer JH, 2003, J THROMB HAEMOST, V1, P186, DOI 10.1046/j.1538-7836.2003.00005.x; Blanco-Molina A, 2007, THROMB HAEMOSTASIS, V97, P186, DOI 10.1160/TH06-11-0650; Boehlen F, 2005, Rev Med Suisse, V1, P296; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; BRENT RL, 1972, CURRENT PROBLEMS RAD, V2, P1; Brent RL, 2009, AM J OBSTET GYNECOL, V200, P4, DOI 10.1016/j.ajog.2008.06.032; Brieger D, 1996, THROMB HAEMOSTASIS, V75, P740; Brill-Edwards P, 2000, NEW ENGL J MED, V343, P1439, DOI 10.1056/NEJM200011163432002; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Campbell IA, 2003, THORAX, V58, P470; Carrier M, 2006, THROMB RES, V117, P469, DOI 10.1016/j.thromres.2005.04.005; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Casele HL, 1999, AM J OBSTET GYNECOL, V181, P1113, DOI 10.1016/S0002-9378(99)70091-8; Chabloz P, 2001, BRIT J HAEMATOL, V115, P150, DOI 10.1046/j.1365-2141.2001.03082.x; Chan WS, 2007, ANN INTERN MED, V147, P165, DOI 10.7326/0003-4819-147-3-200708070-00005; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Chunilal SD, 2002, THROMB HAEMOSTASIS, V87, P92; Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166; Couturaud F, 2001, THROMB HAEMOSTASIS, V86, P980; Dager WE, 2005, ANN PHARMACOTHER, V39, P1182, DOI 10.1345/aph.1E677; Danilenko-Dixon DR, 2001, AM J OBSTET GYNECOL, V184, P104, DOI 10.1067/mob.2001.107919; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; De Stefano V, 2006, BRIT J HAEMATOL, V135, P386, DOI 10.1111/j.1365-2141.2006.06317.x; DESWIET M, 1977, NEW ENGL J MED, V297, P1471; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Doshi SK, 2008, BRIT J RADIOL, V81, P653, DOI 10.1259/bjr/22775594; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Douma RA, 2007, SEMIN THROMB HEMOST, V33, P821, DOI 10.1055/s-2007-1000371; Doyle NM, 2004, AM J OBSTET GYNECOL, V191, P1019, DOI 10.1016/j.ajog.2004.06.048; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Epiney M, 2005, J THROMB HAEMOST, V3, P268, DOI 10.1111/j.1538-7836.2004.01108.x; GATES S, 2002, COCHRANE DB SYST REV, V2, P1689; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Ginsberg JS, 1998, CHEST, V114, p524S, DOI 10.1378/chest.114.5_Supplement.524S; GINSBERG JS, 1995, BLOOD, V86, P3685, DOI 10.1182/blood.V86.10.3685.bloodjournal86103685; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; Grandone E, 1998, AM J OBSTET GYNECOL, V179, P1324, DOI 10.1016/S0002-9378(98)70155-3; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Groves AM, 2006, RADIOLOGY, V240, P765, DOI 10.1148/radiol.2403050910; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hirsh J, 2008, CHEST, V133, p141S, DOI 10.1378/chest.08-0689; Hopper KD, 1997, RADIOLOGY, V205, P853, DOI 10.1148/radiology.205.3.9393547; HOWELL R, 1983, BRIT J OBSTET GYNAEC, V90, P1124, DOI 10.1111/j.1471-0528.1983.tb06458.x; Huang WH, 2000, OBSTET GYNECOL, V96, P838, DOI 10.1016/S0029-7844(00)00966-2; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; Hunt BJ, 1997, THROMB HAEMOSTASIS, V77, P39; Hurwitz LM, 2006, AM J ROENTGENOL, V186, P1718, DOI 10.2214/AJR.04.1917; Hurwitz LM, 2006, AM J ROENTGENOL, V186, P871, DOI 10.2214/AJR.04.1915; ICRP, 2003, ANN ICRP, P1, DOI [10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00021-6]; *INT COMM RAD PROT, 2000, ANN ICRP, P3; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; Jamjute P, 2006, J MATERN-FETAL NEO M, V19, P741, DOI 10.1080/14767050600631443; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kalva SP, 2008, J VASC INTERV RADIOL, V19, P1041, DOI 10.1016/j.jvir.2008.03.026; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kjellberg U, 1999, THROMB HAEMOSTASIS, V81, P527; Kobayashi T, 2008, CIRC J, V72, P753, DOI 10.1253/circj.72.753; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee KW, 2003, ARCH INTERN MED, V163, P2368, DOI 10.1001/archinte.163.19.2368; LEGNAIN M, 2000, E MEDITERR HEALTH J, V66, P283; Leonhardt G, 2006, J THROMB THROMBOLYS, V21, P271, DOI 10.1007/s11239-006-5709-z; LEVINE MN, 1994, ARCH INTERN MED, V154, P49, DOI 10.1001/archinte.154.1.49; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Mac Gillavry MR, 2000, THROMB HAEMOSTASIS, V84, P973; Macklon NS, 1997, BRIT J OBSTET GYNAEC, V104, P191, DOI 10.1111/j.1471-0528.1997.tb11043.x; Malcolm Janine C, 2002, J Obstet Gynaecol Can, V24, P568; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; McConville RM, 2009, CARDIOVASC INTER RAD, V32, P174, DOI 10.1007/s00270-008-9393-6; Middeldorp S, 2001, ANN INTERN MED, V135, P322, DOI 10.7326/0003-4819-135-5-200109040-00008; Morse M, 2004, J THROMB HAEMOST, V2, P1202, DOI 10.1111/j.1538-7836.2004.00776.x; National Council on Radiation Protection and Measurement, 1977, 54 NAT COUNC RAD PRO; ORME ML, 1977, BRIT MED J, V1, P1564, DOI 10.1136/bmj.1.6076.1564; Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x; Panting-Kemp A, 2000, AM J OBSTET GYNECOL, V183, P1207, DOI 10.1067/mob.2000.108846; Payne SM, 2003, ANN PHARMACOTHER, V37, P655, DOI 10.1345/aph.1C327; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pettila V, 2002, THROMB HAEMOSTASIS, V87, P182; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Powrie RO, 1998, AM J OBSTET GYNECOL, V178, P394, DOI 10.1016/S0002-9378(98)80031-8; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Richter C, 2001, BRIT J CLIN PHARMACO, V52, P708, DOI 10.1046/j.0306-5251.2001.01517.x; Rodger M, 2000, AM J CARDIOL, V86, P807, DOI 10.1016/S0002-9149(00)01090-0; Rodger MA, 2000, AM J RESP CRIT CARE, V162, P2105, DOI 10.1164/ajrccm.162.6.2004204; Rodger MA, 2005, THROMB RES, V116, P101, DOI 10.1016/j.thromres.2004.10.011; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Russell JR, 1997, HEALTH PHYS, V73, P756, DOI 10.1097/00004032-199711000-00003; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; STEIN PD, 1994, ANN INTERN MED, V121, P313, DOI 10.7326/0003-4819-121-5-199409010-00001; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; Sullivan EA, 2004, AUST NZ J OBSTET GYN, V44, P452, DOI 10.1111/j.1479-828X.2004.00313.x; Torres JA, 1999, ANGIOLOGIA, V51, P71; TREFFERS PE, 1983, INT J GYNECOL OBSTET, V21, P327, DOI 10.1016/0020-7292(83)90024-3; Trukhacheva E, 2005, OBSTET GYNECOL, V106, P1156, DOI 10.1097/01.AOG.0000164059.72933.9c; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van Walraven C, 2003, BRIT MED J, V326, P791, DOI 10.1136/bmj.326.7393.791; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581	135	171	187	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					500	512		10.1016/S0140-6736(09)60996-X	http://dx.doi.org/10.1016/S0140-6736(09)60996-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	19889451				2022-12-28	WOS:000274757900033
J	Zeqiraj, E; Filippi, BM; Deak, M; Alessi, DR; van Aalten, DMF				Zeqiraj, Elton; Filippi, Beatrice Maria; Deak, Maria; Alessi, Dario R.; van Aalten, Daan M. F.			Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; LKB1; STRAD	The LKB1 tumor suppressor is a protein kinase that controls the activity of adenosine monophosphate-activated protein kinase (AMPK). LKB1 activity is regulated by the pseudokinase STRAD alpha and the scaffolding protein MO25 alpha through an unknown, phosphorylation-independent, mechanism. We describe the structure of the core heterotrimeric LKB1-STRAD alpha-MO25 alpha complex, revealing an unusual allosteric mechanism of LKB1 activation. STRAD alpha adopts a closed conformation typical of active protein kinases and binds LKB1 as a pseudosubstrate. STRAD alpha and MO25 alpha promote the active conformation of LKB1, which is stabilized by MO25 alpha interacting with the LKB1 activation loop. This previously undescribed mechanism of kinase activation may be relevant to understanding the evolution of other pseudokinases. The structure also reveals how mutations found in Peutz-Jeghers syndrome and in various sporadic cancers impair LKB1 function.	[Zeqiraj, Elton; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Zeqiraj, Elton; Filippi, Beatrice Maria; Deak, Maria; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk		Alessi, Dario/0000-0002-2140-9185; van Aalten, Daan/0000-0002-1499-6908; Zeqiraj, Elton/0000-0003-0239-5926; Filippi, Beatrice Maria/0000-0002-8816-1559	TENOVUS Scotland; Wellcome Trust; Medical Research Council; Cancer Research UK [C33794/A10969]; MRC [G0900138, MC_U127070193] Funding Source: UKRI; Medical Research Council [G0900138, MC_U127070193] Funding Source: researchfish	TENOVUS Scotland; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the European Synchrotron Radiation Facility, Grenoble, for beam time at station ID14-3 and T. J. Richmond and I. Berger (ETH Zurich) for providing the MultiBac expression vectors. Supported by a TENOVUS Scotland studentship (E. Z.), a Wellcome Trust Senior Research Fellowship (D. M. F. v. A.), the Medical Research Council (D. R. A.), Cancer Research UK grant C33794/A10969, and the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck & Co. Inc., Merck KgaA, and Pfizer). The coordinates and structure factors have been deposited with PDB entry 2WTK.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	25	230	241	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1707	1711		10.1126/science.1178377	http://dx.doi.org/10.1126/science.1178377			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19892943	Green Accepted			2022-12-28	WOS:000272839000057
J	Mobius, E; Bochsler, P; Bzowski, M; Crew, GB; Funsten, HO; Fuselier, SA; Ghielmetti, A; Heirtzler, D; Izmodenov, VV; Kubiak, M; Kucharek, H; Lee, MA; Leonard, T; McComas, DJ; Petersen, L; Saul, L; Scheer, JA; Schwadron, N; Witte, M; Wurz, P				Moebius, E.; Bochsler, P.; Bzowski, M.; Crew, G. B.; Funsten, H. O.; Fuselier, S. A.; Ghielmetti, A.; Heirtzler, D.; Izmodenov, V. V.; Kubiak, M.; Kucharek, H.; Lee, M. A.; Leonard, T.; McComas, D. J.; Petersen, L.; Saul, L.; Scheer, J. A.; Schwadron, N.; Witte, M.; Wurz, P.			Direct Observations of Interstellar H, He, and O by the Interstellar Boundary Explorer	SCIENCE			English	Article							NEUTRAL GAS; PICKUP ION; HYDROGEN; HELIOSPHERE; PARAMETERS; HELIUM; ORIGIN; WIND	Neutral gas of the local interstellar medium flows through the inner solar system while being deflected by solar gravity and depleted by ionization. The dominating feature in the energetic neutral atom Interstellar Boundary Explorer ( IBEX) all-sky maps at low energies is the hydrogen, helium, and oxygen interstellar gas flow. The He and O flow peaked around 8 February 2009 in accordance with gravitational deflection, whereas H dominated after 26 March 2009, consistent with approximate balance of gravitational attraction by solar radiation pressure. The flow distributions arrive from a few degrees above the ecliptic plane and show the same temperature for He and O. An asymmetric O distribution in ecliptic latitude points to a secondary component from the outer heliosheath.	[Moebius, E.; Bochsler, P.; Heirtzler, D.; Kucharek, H.; Lee, M. A.; Leonard, T.; Petersen, L.] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; [Moebius, E.; Bochsler, P.; Heirtzler, D.; Kucharek, H.; Lee, M. A.; Leonard, T.; Petersen, L.] Univ New Hampshire, Dept Phys, Durham, NH 03824 USA; [Bochsler, P.; Saul, L.; Scheer, J. A.; Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Bzowski, M.; Kubiak, M.] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [Crew, G. B.] MIT, Cambridge, MA 02139 USA; [Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Fuselier, S. A.; Ghielmetti, A.] Lockheed Martin Adv Technol Lab, Palo Alto, CA USA; [Izmodenov, V. V.] Moscow MV Lomonosov State Univ, Moscow 119899, Russia; [Izmodenov, V. V.] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [McComas, D. J.] SW Res Inst, San Antonio, TX 78228 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Schwadron, N.] Boston Univ, Dept Astron, Boston, MA 02215 USA; [Witte, M.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of Bern; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Los Alamos National Laboratory; Lockheed Martin; Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); Boston University; Max Planck Society	Mobius, E (corresponding author), Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA.	Eberhard.moebius@unh.edu	Izmodenov, Vladislav V/K-6073-2012; McComas, David J/H-6202-2011; Funsten, Herbert O/A-5702-2015; Wurz, Peter/R-2273-2017	Izmodenov, Vladislav V/0000-0002-1748-0982; McComas, David J/0000-0001-6160-1158; Funsten, Herbert O/0000-0002-6817-1039; Wurz, Peter/0000-0002-2603-1169; Moebius, Eberhard/0000-0002-2745-6978; Kubiak, Marzena A./0000-0002-5204-9645; Bzowski, Maciej/0000-0003-3957-2359; Crew, Geoffrey/0000-0002-2079-3189	NASA [NNG05EC85C]; Swiss National Science Foundation; Programme de Developpement d'Experiences Scientifiques (PRODEX); Space Research Centre of the Polish Academy of Sciences; Russian Federation	NASA(National Aeronautics & Space Administration (NASA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Programme de Developpement d'Experiences Scientifiques (PRODEX); Space Research Centre of the Polish Academy of Sciences; Russian Federation(Russian Federation)	We thank the many individuals who made this mission possible. This work is supported by NASA under contract NNG05EC85C, by the Swiss National Science Foundation, the Programme de Developpement d'Experiences Scientifiques (PRODEX), the Space Research Centre of the Polish Academy of Sciences, and the Russian Federation.	BERTAUX JL, 1971, ASTRON ASTROPHYS, V11, P200; Bzowski M, 2008, ASTRON ASTROPHYS, V491, P7, DOI 10.1051/0004-6361:20078810; Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Fuselier SA, 2009, SCIENCE, V326, P962, DOI 10.1126/science.1180981; FUSELIER SA, 2009, SPACE SCI REV, DOI DOI 10.1007/S11214-009-9495; GLOECKLER G, 1993, SCIENCE, V261, P70, DOI 10.1126/science.261.5117.70; GRUNTMAN MA, 1993, PLANET SPACE SCI, V41, P307, DOI 10.1016/0032-0633(93)90026-X; Izmodenov V, 2005, ASTRON ASTROPHYS, V437, pL35, DOI 10.1051/0004-6361:200500132; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; MCCOMAS DJ, 2009, SPACE SCI REV, DOI DOI 10.1007/S11214-009-9499; Mobius E, 2004, ASTRON ASTROPHYS, V426, P897, DOI 10.1051/0004-6361:20035834; MOBIUS E, 1985, NATURE, V318, P426, DOI 10.1038/318426a0; Mobius E, 2009, SPACE SCI REV, V146, P149, DOI 10.1007/s11214-009-9498-5; Quemerais E, 2006, ASTRON ASTROPHYS, V455, P1135, DOI 10.1051/0004-6361:20065169; Stone EC, 2008, NATURE, V454, P71, DOI 10.1038/nature07022; WELLER CS, 1974, ASTROPHYS J, V193, P471, DOI 10.1086/153182; Witte M, 1996, SPACE SCI REV, V78, P289, DOI 10.1007/BF00170815; Wurz P, 2004, AIP CONF PROC, V719, P195, DOI 10.1063/1.1809517; Wurz P, 2008, J APPL PHYS, V103, DOI 10.1063/1.2842398	20	118	121	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					969	971		10.1126/science.1180971	http://dx.doi.org/10.1126/science.1180971			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833917				2022-12-28	WOS:000271712300032
J	Goyder, C; McPherson, A; Glasziou, P				Goyder, Clare; McPherson, Ann; Glasziou, Paul			Diagnosis in General Practice Self diagnosis	BRITISH MEDICAL JOURNAL			English	Article							RELIABILITY; INFECTION; PREGNANCY		[Goyder, Clare; Glasziou, Paul] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [McPherson, Ann] Univ Oxford, Dept Primary Care, DIPEx, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Goyder, C (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	cgoyder@doctors.org.uk	; Glasziou, Paul/A-7832-2008	Goyder, Clare/0000-0002-7461-9661; Glasziou, Paul/0000-0001-7564-073X				Ansell J, 1997, TROP MED INT HEALTH, V2, P1180, DOI 10.1046/j.1365-3156.1997.d01-209.x; DeAlleaume L, 2006, J FAM PRACTICE, V55, P338; Ferris DG, 2002, OBSTET GYNECOL, V99, P419, DOI 10.1016/S0029-7844(01)01759-8; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Heneghan C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b946; Herxheimer A, 2001, ANN INTERN MED, V135, P51, DOI 10.7326/0003-4819-135-1-200107030-00013; Kovacs Fabiana Thais, 2006, An. Bras. Dermatol., V81, P335, DOI 10.1590/S0365-05962006000400005; LAUGHEY WF, 1993, CEPHALALGIA, V13, P136, DOI 10.1046/j.1468-2982.1993.1302136.x; Muula AS, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-168; PEARSON RV, 1991, EYE, V5, P145, DOI 10.1038/eye.1991.26; Pilger D, 2008, REV INST MED TROP SP, V50, P121, DOI 10.1590/S0036-46652008000200011; RAMOSKA EA, 1989, ANN EMERG MED, V18, P48, DOI 10.1016/S0196-0644(89)80310-5; Sihvo S, 2000, FAM PRACT, V17, P145, DOI 10.1093/fampra/17.2.145; Strote J, 2006, EMERG MED J, V23, P554, DOI 10.1136/emj.2005.031146; Summerton N, 2007, PATIENT CTR DIAGNOSI; Wiley DJ, 2002, CLIN INFECT DIS, V35, P39, DOI 10.1086/340743	16	7	7	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2009	339								b4418	10.1136/bmj.b4418	http://dx.doi.org/10.1136/bmj.b4418			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906747				2022-12-28	WOS:000271833900002
J	Hutchings, A; Durand, MA; Grieve, R; Harrison, D; Rowan, K; Green, J; Cairns, J; Black, N				Hutchings, Andrew; Durand, Mary Alison; Grieve, Richard; Harrison, David; Rowan, Kathy; Green, Judith; Cairns, John; Black, Nick			Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE; OUTREACH SERVICES; NATIONAL-AUDIT; IMPACT; MORTALITY; UNIT; ICU	Objective To evaluate the impact and cost effectiveness of a programme to transform adult critical care throughout England initiated in late 2000. Design Evaluation of trends in inputs, processes, and outcomes during 1998-2000 compared with last quarter of 2000-6. Setting 96 critical care units in England. Participants 349 817 admissions to critical care units. Interventions Adoption of key elements of modernisation and increases in capacity. Units were categorised according to when they adopted key elements of modernisation and increases in capacity. Main outcome measures Trends in inputs (beds, costs), processes (transfers between units, discharge practices, length of stay, readmissions), and outcomes (unit and hospital mortality), with adjustment for case mix. Differences in annual costs and quality adjusted life years (QALYs) adjusted for case mix were used to calculate net monetary benefits (valuing a QALY gain at 20 pound 000 ($33 170, (sic)22 100)). The incremental net monetary benefits were reported as the difference in net monetary benefits after versus before 2000. Results In the six years after 2000, the risk of unit mortality adjusted for case mix fell by 11.3% and hospital mortality by 13.4% compared with the steady state in the three preceding years. This was accompanied by substantial reductions both in transfers between units and in unplanned night discharges. The mean annual net monetary benefit increased significantly after 2000 (from 402 pound ($667, (sic)445) to 1096 pound ($1810, (sic)1210)), indicating that the changes were relatively cost effective. The relative contribution of the different initiatives to these improvements is unclear. Conclusion Substantial improvements in NHS critical care have occurred in England since 2000. While it is unclear which factors were responsible, collectively the interventions represented a highly cost effective use of NHS resources.	[Hutchings, Andrew; Grieve, Richard; Green, Judith; Cairns, John; Black, Nick] Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England; [Harrison, David; Rowan, Kathy] Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre	Hutchings, A (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	andrew.hutchings@lshtm.ac.uk	Cairns, John/AAD-1168-2020; Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Grieve, Richard/0000-0001-8899-1301; Durand, Mary Alison/0000-0003-2205-4002; Rowan, Kathryn/0000-0001-8217-5602; Hutchings, Andrew/0000-0003-0215-9923; Green, Judith/0000-0002-2315-5326	NIHR SDO research and development programme [SDO/133/2006]; MRC [G106/1240] Funding Source: UKRI; Medical Research Council [G106/1240] Funding Source: researchfish	NIHR SDO research and development programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the NIHR SDO research and development programme (grant SDO/133/2006). AH was supported by a MRC special training fellowship in health services research. The study funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent from the funders	Calhoun AW, 2008, MED CARE, V46, P635, DOI 10.1097/MLR.0b013e3181649412; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cocanour CS, 2006, J TRAUMA, V61, P122, DOI 10.1097/01.ta.0000223971.25845.b3; Crunden Eddie, 2005, Nurs Crit Care, V10, P242; DAWSON D, 2006, CRIT CARE NURSE, V22, P4; *DEP HLTH, 2004, AG CHANG FIN AGR; *DEP HLTH, 2000, COMPR CRIT CAR REV A; *DEP HLTH, 2000, HOSP ACT STAT; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2009, NHS REF COSTS 2007 0; Department of Health, 2005, IMPL IMP HOSP NIGHT; Esmonde L, 2006, INTENS CARE MED, V32, P1713, DOI 10.1007/s00134-006-0380-6; Gao F, 2005, CRIT CARE, V9, pR764, DOI 10.1186/cc3909; Gao H, 2007, CRIT CARE, V11, DOI 10.1186/cc6163; Hampton Debra C, 2005, Rehabil Nurs, V30, P160; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Jain M, 2006, QUAL SAF HEALTH CARE, V15, P235, DOI 10.1136/qshc.2005.016576; Keenan SP, 2002, CRIT CARE MED, V30, P501, DOI 10.1097/00003246-200203000-00002; McDonnell A, 2007, J CRIT CARE, V22, P212, DOI 10.1016/j.jcrc.2007.02.002; NHS England, 2004, 10 HIGH IMP CHANG SE; *NHS EX, 2007, HOSP COMM HLTH SERV; *OFF NAT STAT, 2008, INT LIF TABL 2000 20; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Robson W, 2006, Intensive Crit Care Nurs, V22, P1, DOI 10.1016/j.iccn.2005.09.006; Stevens K, 2005, APPL HEALTH ECON HEA, V4, P257, DOI 10.2165/00148365-200504040-00008; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Wordsworth Sarah, 2005, Eur J Health Econ, V6, P38, DOI 10.1007/s10198-004-0259-9; Youngquist P, 2007, JT COMM J QUAL PATIE, V33, P219, DOI 10.1016/S1553-7250(07)33026-2	30	72	73	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2009	339								b4353	10.1136/bmj.b4353	http://dx.doi.org/10.1136/bmj.b4353			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906740	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000271833900001
J	Arneth, A; Unger, N; Kulmala, M; Andreae, MO				Arneth, Almut; Unger, Nadine; Kulmala, Markku; Andreae, Meinrat O.			Clean the Air, Heat the Planet?	SCIENCE			English	Editorial Material							AEROSOLS		[Arneth, Almut] Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden; [Arneth, Almut; Kulmala, Markku] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Unger, Nadine] Columbia Univ, Ctr Climate Syst Res, NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany	Lund University; University of Helsinki; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Max Planck Society	Arneth, A (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden.	almut.arneth@nateko.lu.se	Andreae, Meinrat O./B-1068-2008; Kulmala, Markku T/I-7671-2016; Unger, Nadine/AAI-4462-2021; Unger, Nadine/M-9360-2015; Arneth, Almut/B-2702-2013	Andreae, Meinrat O./0000-0003-1968-7925; Kulmala, Markku T/0000-0003-3464-7825; Unger, Nadine/0000-0001-7739-2290; Arneth, Almut/0000-0001-6616-0822				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; ARNETH A, 2009, BIOGEOSCIENCES DISCU, V6, P7717; Bond TC, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045030; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Kaiser J, 2005, SCIENCE, V307, P1858; Kloster S, 2010, CLIM DYNAM, V34, P1177, DOI 10.1007/s00382-009-0573-0; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Levy H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009176; Parrish DD, 2009, SCIENCE, V326, P674, DOI 10.1126/science.1176064; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Shindell D, 2009, NAT GEOSCI, V2, P294, DOI 10.1038/NGEO473; Shindell DT, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009152; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Shine KP, 2007, SCIENCE, V315, P1804, DOI 10.1126/science.1141677; Unger N, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008683; West JJ, 2006, P NATL ACAD SCI USA, V103, P3988, DOI 10.1073/pnas.0600201103	20	83	86	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					672	673		10.1126/science.1181568	http://dx.doi.org/10.1126/science.1181568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	512GB	19900919				2022-12-28	WOS:000271233200019
J	Hammonds, J; Spearman, P				Hammonds, Jason; Spearman, Paul			Tetherin Is as Tetherin Does	CELL			English	Editorial Material							RELEASE; VPU		[Hammonds, Jason; Spearman, Paul] Emory Univ & Childrens Healthcare, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Emory University	Spearman, P (corresponding author), Emory Univ & Childrens Healthcare, Atlanta, GA 30322 USA.	paul.spearman@emory.edu	Hammonds, Jason/AAC-5330-2019	Hammonds, Jason/0000-0002-1649-9008	NIAID NIH HHS [R01 AI058828] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058828] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		LETORTOREC A, 2009, J VIROL; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	5	6	7	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					456	457		10.1016/j.cell.2009.10.011	http://dx.doi.org/10.1016/j.cell.2009.10.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879831	Bronze			2022-12-28	WOS:000271259600007
J	Franklin, GM; Budenholzer, BR				Franklin, Gary M.; Budenholzer, Brian R.			Implementing Evidence-Based Health Policy in Washington State	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Franklin, Gary M.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Franklin, Gary M.] Washington State Dept Labor & Ind, Olympia, WA 98504 USA; [Budenholzer, Brian R.] Washington Hlth Technol Assessment Clin Comm, Olympia, WA USA; [Budenholzer, Brian R.] Washington Hlth Technol Assessment Program, Olympia, WA USA; [Budenholzer, Brian R.] Grp Hlth Cooperat, Spokane, WA USA	University of Washington; University of Washington Seattle; Group Health Cooperative	Franklin, GM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.							Newsom-Davis J, 2008, ANN NY ACAD SCI, V1132, P344, DOI 10.1196/annals.1405.014; Schoen C, 2007, BENDING CURVE OPTION; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; *WA HLTH TECHN ASS, HLTH TECHN ASS FIND	4	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1722	1725		10.1056/NEJMp0907384	http://dx.doi.org/10.1056/NEJMp0907384			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511RY	19864671				2022-12-28	WOS:000271185600003
J	Chen, RT; Clark, TA; Halperin, SA				Chen, Robert T.; Clark, Thomas A.; Halperin, Scott A.			The yin and yang of paracetamol and paediatric immunisations	LANCET			English	Editorial Material							ACELLULAR PERTUSSIS VACCINES; ADVERSE REACTIONS; DTP VACCINATION		[Chen, Robert T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Clark, Thomas A.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA 30333 USA; Dalhousie Univ, Halifax, NS, Canada	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Dalhousie University	Chen, RT (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	rtc1@cdc.gov	Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367; Halperin, Scott/0000-0003-0525-589X				Centers for Disease Control (CDC), 1987, MMWR Morb Mortal Wkly Rep, V36, P281; DECKER MD, 1995, PEDIATRICS, V96, P557; EDWARDS KM, 1995, PEDIATRICS, V96, P548; Graham Garry G, 2005, Am J Ther, V12, P46, DOI 10.1097/00045391-200501000-00008; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; IPP MM, 1987, PEDIATR INFECT DIS J, V6, P721, DOI 10.1097/00006454-198708000-00005; LEWIS K, 1988, AM J DIS CHILD, V142, P62, DOI 10.1001/archpedi.1988.02150010072025; LONG SS, 1990, PEDIATRICS, V85, P294; McVernon J, 2004, LANCET INFECT DIS, V4, P40, DOI 10.1016/S1473-3099(03)00859-4; *NAT ADV COMM IMM, 2002, CAN IMM GUID, P174; Porkert M., 1974, THEORETICAL FDN CHIN; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; UHARI M, 1988, ACTA PAEDIATR SCAND, V77, P747, DOI 10.1111/j.1651-2227.1988.tb10741.x	13	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1305	1306		10.1016/S0140-6736(09)61802-X	http://dx.doi.org/10.1016/S0140-6736(09)61802-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19837236				2022-12-28	WOS:000271254600005
J	Hall, W; Degenhardt, L				Hall, Wayne; Degenhardt, Louisa			Adverse health effects of non-medical cannabis use	LANCET			English	Review							ILLICIT DRUG-USE; PRENATAL MARIJUANA EXPOSURE; LUNG-CANCER; TESTING HYPOTHESES; RISK; SMOKING; YOUNG; SCHIZOPHRENIA; TOBACCO; ALCOHOL	For over two decades, cannabis, commonly known as marijuana, has been the most widely used illicit drug by young people in high-income countries, and has recently become popular on a global scale. Epidemiological research during the past 10 years suggests that regular use of cannabis during adolescence and into adulthood can have adverse effects. Epidemiological, clinical, and laboratory studies have established an association between cannabis use and adverse outcomes. We focus on adverse health effects of greatest potential public health interest-that is, those that are most likely to occur and to affect a large number of cannabis users. The most probable adverse effects include a dependence syndrome, increased risk of motor vehicle crashes, impaired respiratory function, cardiovascular disease, and adverse effects of regular use on adolescent psychosocial development and mental health.	[Hall, Wayne] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Queensland; University of New South Wales Sydney	Hall, W (corresponding author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008; Degenhardt, Louisa J/D-4515-2012	Hall, Wayne D/0000-0003-1984-0096; Degenhardt, Louisa J/0000-0002-8513-2218	Commonwealth Department of Health and Ageing in Australia; Beckley Foundation (WH); NHMRC; National Drug and Alcohol Research Centre, University of New South Wales	Commonwealth Department of Health and Ageing in Australia(Australian GovernmentDepartment of Health & Ageing); Beckley Foundation (WH); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Drug and Alcohol Research Centre, University of New South Wales	We thank Sarah Yeates for assistance in searching publications and preparing this report; Bianca Calabria for her assistance in identifying publications on the adverse health effects of cannabis and her comments on an early draft; Amanda Feilding for suggesting an update of the review of the adverse health effects and for comments on the report; and Robin Room for his contributions to the report that was undertaken for the Beckley Foundation. This report is the updated version of a review originally funded by the Commonwealth Department of Health and Ageing in Australia in 1994, subsequently updated in 2001 and 2003. Funding for this report was provided by the Beckley Foundation (WH), an NHMRC Australia Fellowship (WH), the National Drug and Alcohol Research Centre, University of New South Wales (LD), and WHO as part of a study of the contribution of illicit drug use to the global burden of disease (LD and WH). The views expressed are solely those of the authors. None of the funding bodies influenced the decision to publish or had any editorial control over the content of the report.	Abel E.L., 1980, MARIHUANA 1 12 THOUS; *ADV COUNC MUS DRU, 2008, CANN CLASS PUBL HLTH; Ajdacic-Gross V, 2007, SCHIZOPHR RES, V95, P9, DOI 10.1016/j.schres.2007.06.001; Aldington S, 2008, EUR RESPIR J, V31, P280, DOI 10.1183/09031936.00065707; Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; [Anonymous], 2002, STAGES PATHWAYS DRUG; Anthony J.C., 2006, CANNABIS DEPENDENCE, DOI [10.1017/CBO9780511544248.006, DOI 10.1017/CBO9780511544248.006]; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Arseneault L, 2002, BRIT MED J, V325, P1212, DOI 10.1136/bmj.325.7374.1212; Bachman J. G, 1997, SMOKING DRINKING DRU; Beautrais AL, 1999, ADDICTION, V94, P1155, DOI 10.1046/j.1360-0443.1999.94811555.x; Begg S., 2007, BURDEN DIS INJURY AU; Berthiller J, 2008, J THORAC ONCOL, V3, P1398, DOI 10.1097/JTO.0b013e31818ddcde; Blochs E, 1983, CANNABIS HLTH HAZARD, P355; Block RI, 2000, NEUROREPORT, V11, P749, DOI 10.1097/00001756-200003200-00019; Block RI, 2002, PHARMACOL BIOCHEM BE, V72, P237, DOI 10.1016/S0091-3057(01)00771-7; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Boydell J, 2006, PSYCHOL MED, V36, P1441, DOI 10.1017/S0033291706008440; Budney AJ, 2006, CURR OPIN PSYCHIATR, V19, P233, DOI 10.1097/01.yco.0000218592.00689.e5; Chang L, 2007, NEUROSCIENTIST, V13, P422, DOI 10.1177/1073858406296601; DAY NL, 1994, NEUROTOXICOL TERATOL, V16, P169, DOI 10.1016/0892-0362(94)90114-7; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; *DUTCH NAT ALC DRU, 2004, LADIS B; Ellickson P, 1998, J DRUG ISSUES, V28, P357, DOI 10.1177/002204269802800205; ELSOHLY MA, 2008, 100 U MISS NAT CTR N; English DR, 1997, ADDICTION, V92, P1553; Eyler FD, 1999, CLIN PERINATOL, V26, P107, DOI 10.1016/S0095-5108(18)30075-7; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Fergusson DM, 2008, DRUG ALCOHOL DEPEN, V96, P165, DOI 10.1016/j.drugalcdep.2008.03.003; Fergusson DM, 1997, ADDICTION, V92, P279; Fergusson DM, 2003, PSYCHOL MED, V33, P15, DOI 10.1017/S0033291702006402; Fergusson DM, 2002, BJOG-INT J OBSTET GY, V109, P21, DOI 10.1016/S1470-0328(02)01020-0; Fergusson DM, 2006, ADDICTION, V101, P556, DOI 10.1111/j.1360-0443.2005.01322.x; FERGUSSON DM, 2008, ADDICTION, V103, P77; Forrester MB, 2007, J TOXICOL ENV HEAL A, V70, P7, DOI 10.1080/15287390600748799; Fried PA, 2001, NEUROTOXICOL TERATOL, V23, P1, DOI 10.1016/S0892-0362(00)00119-7; Gable RS, 2004, ADDICTION, V99, P686, DOI 10.1111/j.1360-0443.2004.00744.x; Gardner EL, 1999, MARIHUANA AND MEDICINE, P187; Gerberich SG, 2003, ANN EPIDEMIOL, V13, P230, DOI 10.1016/S1047-2797(02)00411-8; Goldschmidt L, 2000, NEUROTOXICOL TERATOL, V22, P325, DOI 10.1016/S0892-0362(00)00066-0; GOTTSCHALK LA, 1977, BIOL PSYCHIAT, V12, P255; Green B, 2003, DRUG ALCOHOL REV, V22, P453, DOI 10.1080/09595230310001613976; Grotenhermen F, 2007, ADDICTION, V102, P1910, DOI 10.1111/j.1360-0443.2007.02009.x; Hall W, 2003, CANNABIS USE DEPENDE; Hall W, 2007, CURR OPIN PSYCHIATR, V20, P393, DOI 10.1097/YCO.0b013e32812144cc; Hall WD, 2005, DRUG ALCOHOL REV, V24, P39, DOI 10.1080/09595230500126698; Hashibe M, 2005, ALCOHOL, V35, P265, DOI 10.1016/j.alcohol.2005.04.008; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P1829, DOI 10.1158/1055-9965.EPI-06-0330; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Hickman M, 2007, ADDICTION, V102, P597, DOI 10.1111/j.1360-0443.2006.01710.x; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Iversen L., 2008, SCI MARIJUANA; Jones RT, 2002, J CLIN PHARMACOL, V42, p58S, DOI 10.1002/j.1552-4604.2002.tb06004.x; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Law MG, 2001, ADDICTION, V96, P433, DOI 10.1046/j.1360-0443.2001.9634337.x; Lessem JM, 2006, BEHAV GENET, V36, P498, DOI 10.1007/s10519-006-9064-9; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; Manzanares J, 1999, TRENDS PHARMACOL SCI, V20, P287, DOI 10.1016/S0165-6147(99)01339-5; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; Mehra R, 2006, ARCH INTERN MED, V166, P1359, DOI 10.1001/archinte.166.13.1359; Mittleman MA, 2001, CIRCULATION, V103, P2805; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Mortier E, 2002, AM J GASTROENTEROL, V97, P504, DOI 10.1111/j.1572-0241.2002.05519.x; Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049; Mura P, 2003, FORENSIC SCI INT, V133, P79, DOI 10.1016/S0379-0738(03)00052-5; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Patton GC, 1997, PSYCHOL MED, V27, P715, DOI 10.1017/S003329179600462X; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Quickfall J, 2006, J NEUROPSYCH CLIN N, V18, P318, DOI 10.1176/appi.neuropsych.18.3.318; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; ROBBE HWJ, 1994, THESIS U LIMBERG MAA; Sidney S, 2002, J CLIN PHARMACOL, V42, p64S, DOI 10.1002/j.1552-4604.2002.tb06005.x; Sidney S, 1997, CANCER CAUSE CONTROL, V8, P722, DOI 10.1023/A:1018427320658; Smileys A, 1999, HLTH EFFECTS CANNABI, P171; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Solowij N., 1998, CANNABIS COGNITIVE F; Tashkin D P, 2005, Monaldi Arch Chest Dis, V63, P93; Tashkin DP, 2002, J CLIN PHARMACOL, V42, p71S, DOI 10.1002/j.1552-4604.2002.tb06006.x; Tashkins D., 1999, HLTH EFFECTS CANNABI, P311; Taylor DR, 2002, ADDICTION, V97, P1055, DOI 10.1046/j.1360-0443.2002.00169.x; Tenness K., 1985, CURRENT RES CONSEQUE, P48; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; *UNODX, 2006, WORLD DRUG REP, V1; *UNODX, 2007, WORLD DRUG REP 2008; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; Wachtel SR, 2002, PSYCHOPHARMACOLOGY, V161, P331, DOI 10.1007/s00213-002-1033-2; Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918; *WHO PROGR SUBST A, 1997, CANN HLTH PERSP RES; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071; ZUCKERMAN B, 1989, NEW ENGL J MED, V320, P762, DOI 10.1056/NEJM198903233201203	97	761	776	5	321	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1383	1391		10.1016/S0140-6736(09)61037-0	http://dx.doi.org/10.1016/S0140-6736(09)61037-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19837255				2022-12-28	WOS:000271254600034
J	Herrington, WG; Al-Mossawi, MH; Roberts, IS; O'Callaghan, CA				Herrington, William G.; Al-Mossawi, Mohammad H.; Roberts, Ian S.; O'Callaghan, Chris A.			The hyponatraemic hairdresser: highlighting the differentials	LANCET			English	Editorial Material									[Herrington, William G.; Al-Mossawi, Mohammad H.] John Radcliffe Hosp, Oxford Kidney Unit, Oxford OX3 9DU, England; [Roberts, Ian S.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England; [O'Callaghan, Chris A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Herrington, WG (corresponding author), Churchill Hosp, Oxford Kidney Unit, Old Rd, Oxford OX3 7LJ, England.	w.herrington@doctors.org.uk	Al-Mossawi, Hussein/I-5903-2015	Al-Mossawi, Hussein/0000-0002-2312-3754; Herrington, William/0000-0003-1172-8243	Medical Research Council [G116/165] Funding Source: Medline; MRC [G116/165] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Arimura Y, 1999, NEPHROL DIAL TRANSPL, V14, P957, DOI 10.1093/ndt/14.4.957; Hildebrandt F, 2001, KIDNEY INT, V59, P434, DOI 10.1046/j.1523-1755.2001.059002434.x; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1392	1392		10.1016/S0140-6736(09)61198-3	http://dx.doi.org/10.1016/S0140-6736(09)61198-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19837256				2022-12-28	WOS:000271254600035
J	Cuthbertson, BH; Rattray, J; Campbell, MK; Gager, M; Roughton, S; Smith, A; Hull, A; Breeman, S; Norrie, J; Jenkinson, D; Hernandez, R; Johnston, M; Wilson, E; Waldmann, C				Cuthbertson, B. H.; Rattray, J.; Campbell, M. K.; Gager, M.; Roughton, S.; Smith, A.; Hull, A.; Breeman, S.; Norrie, J.; Jenkinson, D.; Hernandez, R.; Johnston, M.; Wilson, E.; Waldmann, C.		PRaCTICaL Study Grp	The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; ILL PATIENTS; SURVIVORS	Objectives To test the hypothesis that nurse led follow-up programmes are effective and cost effective in improving quality of life after discharge from intensive care. Design A pragmatic, non-blinded, multicentre, randomised controlled trial. Setting Three UK hospitals (two teaching hospitals and one district general hospital). Participants 286 patients aged >= 18 years were recruited after discharge from intensive care between September 2006 and October 2007. Intervention Nurse led intensive care follow-up programmes versus standard care. Main outcome measure(s) Health related quality of life (measured with the SF-36 questionnaire) at 12 months after randomisation. A cost effectiveness analysis was also performed. Results 286 patients were recruited and 192 completed one year follow-up. At 12 months, there was no evidence of a difference in the SF-36 physical component score (mean 42.0 (SD 10.6) v 40.8 (SD 11.9), effect size 1.1 (95% CI -1.9 to 4.2), P=0.46) or the SF-36 mental component score (effect size 0.4 (-3.0 to 3.7), P=0.83). There were no statistically significant differences in secondary outcomes or subgroup analyses. Follow-up programmes were significantly more costly than standard care and are unlikely to be considered cost effective. Conclusions A nurse led intensive care follow-up programme showed no evidence of being effective or cost effective in improving patients' quality of life in the year after discharge from intensive care. Further work should focus on the roles of early physical rehabilitation, delirium, cognitive dysfunction, and relatives in recovery from critical illness. Intensive care units should review their follow-up programmes in light of these results.	[Cuthbertson, B. H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Rattray, J.; Smith, A.] Univ Dundee, Sch Nursing & Midwifery, Dundee, Scotland; [Campbell, M. K.; Roughton, S.; Breeman, S.; Jenkinson, D.; Hernandez, R.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB32, Scotland; [Gager, M.; Waldmann, C.] Royal Berkshire & Battle Hosp, Intens Care Unit, Reading, Berks, England; [Roughton, S.] Aberdeen Royal Infirm, Intens Care Unit, Aberdeen, Scotland; [Hull, A.] Murray Royal Hosp, Dept Mental Hlth, Perth, WA, Australia; [Norrie, J.] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Hernandez, R.] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB9 1FX, Scotland; [Johnston, M.] Univ Aberdeen, Hlth Psychol Unit, Aberdeen AB9 1FX, Scotland; [Wilson, E.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Anaesthesia & Intens Care Med, Dundee DD1 9SY, Scotland	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Dundee; University of Aberdeen; University of Aberdeen; University of Glasgow; University of Aberdeen; University of Aberdeen; University of Dundee	Cuthbertson, BH (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	brian.cuthbertson@sunnybrook.ca	Campbell, Marion/ABB-7063-2020; Ramsay, Craig/AAD-8249-2021	Ramsay, Craig/0000-0003-4043-7349; Hernandez, Rodolfo/0000-0003-2619-8230; Campbell, Marion/0000-0001-5386-4097	Chief Scientist Office of the Scottish Government Health Directorates; University of Aberdeen; Chief Scientist Office [HERU2, CZG/2/202, HERU1, HSRU2] Funding Source: researchfish	Chief Scientist Office of the Scottish Government Health Directorates; University of Aberdeen; Chief Scientist Office	The study is supported by a research grant from the Chief Scientist Office of the Scottish Government Health Directorates. The Health Services Research Unit is also funded by the Chief Scientist Office of the Scottish Government Health Directorates. The researchers are completely independent of the funders, and the views expressed are those of the authors alone. The study sponsor was the University of Aberdeen, which had no role in the study design; collection, analysis, and interpretation of data; writing of the article; or the decision to submit it for publication. The researchers are completely independent of the sponsors in their research activities.	Brooks N, 1996, NURS CRIT CARE, V1, P90; Broomhead LR, 2002, CRIT CARE, V6, P411, DOI 10.1186/cc1532; Cameron JI, 2006, CRIT CARE MED, V34, P81, DOI 10.1097/01.CCM.0000190428.71765.31; Crocker Cheryl, 2003, Br J Nurs, V12, P910; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Cuthbertson BH, 2004, INTENS CARE MED, V30, P450, DOI 10.1007/s00134-003-2004-8; Cuthbertson BH, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-116; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Denehy L, 2008, OPEN CRIT CARE MED J, V1, P39; *DEP HLTH, 2000, COMPR CRIT CAR REV A; Department of Health, 2003, CRIT CAR OUTR PROGR; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Gordon SM, 2004, INTENS CARE MED, V30, P1997, DOI 10.1007/s00134-004-2418-y; GRANT L, 1999, J RES DEV EDUC, V33, P15; Green A, 1996, Intensive Crit Care Nurs, V12, P131, DOI 10.1016/S0964-3397(96)80435-6; Griffiths JA, 2006, ANAESTHESIA, V61, P950, DOI 10.1111/j.1365-2044.2006.04792.x; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Lipsett PA, 2000, J TRAUMA, V49, P737, DOI 10.1097/00005373-200010000-00024; Niskanen M, 1999, CRIT CARE MED, V27, P1132, DOI 10.1097/00003246-199906000-00035; Rattray J, 2004, J ADV NURS, V47, P64, DOI 10.1111/j.1365-2648.2004.03066.x; Ridley SA, 1997, ANAESTHESIA, V52, P195, DOI 10.1111/j.1365-2044.1997.073-az0068.x; *ROYAL PHARM SOC G, 2007, BRIT NAT FORM; Rundshagen I, 2002, INTENS CARE MED, V28, P38, DOI 10.1007/s00134-001-1168-3; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Scottish Intensive Care Society, 2007, ANN AUD; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Ware JE, 2001, SCORE VERSION 2 SF 3; Williams, 1995, 138 CTR HLTH EC; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Wright JC, 2003, ANAESTHESIA, V58, P637, DOI 10.1046/j.1365-2044.2003.03205.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	214	218	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2009	339								b3723	10.1136/bmj.b3723	http://dx.doi.org/10.1136/bmj.b3723			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DS	19837741	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000270908500002
J	Dippold, HC; Ng, MM; Farber-Katz, SE; Lee, SK; Kerr, ML; Peterman, MC; Sim, R; Wiharto, PA; Galbraith, KA; Madhavarapu, S; Fuchs, GJ; Meerloo, T; Farquhar, MG; Zhou, HL; Field, SJ				Dippold, Holly C.; Ng, Michelle M.; Farber-Katz, Suzette E.; Lee, Sun-Kyung; Kerr, Monica L.; Peterman, Marshall C.; Sim, Ronald; Wiharto, Patricia A.; Galbraith, Kenneth A.; Madhavarapu, Swetha; Fuchs, Greg J.; Meerloo, Timo; Farquhar, Marilyn G.; Zhou, Huilin; Field, Seth J.			GOLPH3 Bridges Phosphatidylinositol-4-Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding	CELL			English	Article							PDZ-CONTAINING MYOSIN; ACTIN DYNAMICS; TRANSPORT; COMPLEX; BINDING; LOCALIZATION; TRAFFICKING; SECRETION; PROTEINS; CELLS	Golgi membranes, from yeast to humans, are uniquely enriched in phosphatidylinositol-4-phosphate (PtdIns(4)P), although the role of this lipid remains poorly understood. Using a proteomic lipid-binding screen, we identify the Golgi protein GOLPH3 (also called GPP34, GMx33, MIDAS, or yeast Vps74p) as a PtdIns(4)P-binding protein that depends on PtdIns(4)P for its Golgi localization. We further show that GOLPH3 binds the unconventional myosin MYO18A, thus connecting the Golgi to F-actin. We demonstrate that this linkage is necessary for normal Golgi trafficking and morphology. The evidence suggests that GOLPH3 binds to PtdIns(4) P-rich trans-Golgi membranes and MYO18A conveying a tensile force required for efficient tubule and vesicle formation. Consequently, this tensile force stretches the Golgi into the extended ribbon observed by fluorescence microscopy and the familiar flattened form observed by electron microscopy.	[Dippold, Holly C.; Ng, Michelle M.; Farber-Katz, Suzette E.; Lee, Sun-Kyung; Peterman, Marshall C.; Sim, Ronald; Wiharto, Patricia A.; Galbraith, Kenneth A.; Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Fuchs, Greg J.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Meerloo, Timo; Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kerr, Monica L.; Madhavarapu, Swetha] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center	Field, SJ (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	sjfield@ucsd.edu		Field, Seth/0000-0002-8893-4806; Zhou, Huilin/0000-0002-1350-4430	NIDDK Postdoctoral Training Grant; American Cancer Society Fellowship; Burroughs Wellcome Fund; V Foundation; NIH New Innovator Award; NATIONAL CANCER INSTITUTE [R01CA138676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK065108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	NIDDK Postdoctoral Training Grant; American Cancer Society Fellowship(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); V Foundation; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Cantley, S. Emr, G. Rosenfeld, and C. Min for helpful advice, reagents, and support. We thank R. Tsien, P. Mayinger, J. Lippincott-Schwartz, V. Malhotra, O. Ohara, and Z. Chroneos for generous gifts of reagents. We thank K. Messer of the UCSD-Moores Cancer Center for help with statistical analyses. We acknowledge the following support: M.M.N. by NIDDK Postdoctoral Training Grant and American Cancer Society Fellowship; S.E.F.-K. by NIDDK Pre-Doctoral Training Grant; and S. J. F. by the Burroughs Wellcome Fund, the V Foundation, NIDDK, and NIH New Innovator Award.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Barr FA, 1996, SEMIN CELL DEV BIOL, V7, P505, DOI 10.1006/scdb.1996.0063; Beh CT, 2001, GENETICS, V157, P1117; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DAVIDSON MW, 2004, MOL EXPRESSIONS CELL; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hirschberg K, 2000, METHOD ENZYMOL, V327, P69, DOI 10.1016/S0076-6879(00)27268-6; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; KRISTEN U, 1983, EUR J CELL BIOL, V29, P262; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Raychaudhuri S, 2006, BIOCHEM SOC T, V34, P359, DOI 10.1042/BST0340359; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Varnai P, 2007, PFLUG ARCH EUR J PHY, V455, P69, DOI 10.1007/s00424-007-0270-y; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	61	280	299	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					337	351		10.1016/j.cell.2009.07.052	http://dx.doi.org/10.1016/j.cell.2009.07.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837035	Green Accepted, Bronze			2022-12-28	WOS:000270857500017
J	Stern, P				Stern, Peter			So You Want to Learn How to Network? INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					385	385		10.1126/science.326_385	http://dx.doi.org/10.1126/science.326_385			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833955				2022-12-28	WOS:000270818600039
J	Cueto, S				Cueto, Santiago			Conditional cash-transfer programmes in developing countries	LANCET			English	Editorial Material							CHILD-DEVELOPMENT		GRADE, Lima 27, Peru		Cueto, S (corresponding author), GRADE, Lima 27, Peru.	scueto@grade.org.pe	Cueto, Santiago/Q-7168-2019	Cueto, Santiago/0000-0002-0639-3429				Adato M., 2008, INTEGRATING SURVEY E; CUETO S, 2006, EDUC STUD MATH, V62, P25; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fiszbein A, 2009, CONDITIONAL CASH TRA; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Ponce J, 2008, IMPACT CASH TRANSFER	7	4	4	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1952	1953		10.1016/S0140-6736(09)61640-8	http://dx.doi.org/10.1016/S0140-6736(09)61640-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19892393				2022-12-28	WOS:000272727000007
J	Bray, GA; Chatellier, A; Duncan, C; Greenway, FL; Levy, E; Ryan, DH; Polonsky, KS; Tobian, J; Ehrmann, D; Matulik, MJ; Clark, B; Czech, K; DeSandre, C; Hilbrich, R; McNabb, W; Semenske, AR; Goldstein, BJ; Smith, KA; Wildman, W; Pepe, C; Goldberg, RB; Calles, J; Ojito, J; Castillo-Florez, S; Florez, HJ; Giannella, A; Lara, O; Veciana, B; Haffner, SM; Montez, MG; Lorenzo, C; Martinez, A; Hamman, RF; Testaverde, L; Bouffard, A; Dabelea, D; Jenkins, T; Lenz, D; Perreault, L; Price, DW; Steinke, SC; Horton, ES; Poirier, CS; Swift, K; Caballero, E; Jackson, SD; Lambert, L; Lawton, KE; Ledbury, S; Kahn, SE; Montgomery, BK; Fujimoto, W; Knopp, RH; Lipkin, EW; Marr, M; Murillo, A; Trence, D; Kitabchi, AE; Murphy, ME; Applegate, WB; Bryer-Ash, M; Dagogo-Jack, S; Frieson, SL; Lambeth, H; Lichtermann, LC; Otkaei, H; Rutledge, LMK; Sherman, AR; Smith, CM; Soberman, JE; Williams-Cleaves, B; Metzger, BE; Molitch, ME; Johnson, MK; Giles, MM; Larsen, D; Niznik, C; Pen, SC; Schinleber, PA; Nathan, DM; McKitrick, C; Turgeon, H; Abbott, K; Altshuler, D; Anderson, E; Bissett, L; Cagliero, E; D'Anna, K; Delahanty, L; Florez, JC; Goldman, V; Poulos, A; Tseng, B; Barrett-Connor, E; Carrion-Petersen, ML; Horne, J; Leos, D; Mudaliar, S; Smith, J; Vejvoda, K; Pi-Sunyer, FX; Lee, JE; Foo, ST; Hagamen, S; Marrero, DG; Kelly, SM; Ackermann, RT; Fineberg, ES; Hadden, A; Jackson, MA; Kirkman, MS; Mather, KJ; Roach, PJ; Wheeler, ML; Ratner, RE; Aroda, V; Shapiro, S; Bavido-Arrage, C; Gibbs, P; Uwaifo, G; Wiggins, R; Saad, MF; Watson, K; Botrous, M; Jinagouda, S; Budget, M; Conzues, C; Magpuri, P; Ngo, K; Xapthalamous, K; White, NH; Das, S; Santiago, A; Brown, AL; Wernimont, C; Saudek, CD; Whittington, T; Clark, JM; Greene, A; Jiggetts, D; Mosley, H; Reusing, J; Rubin, RR; Stephen, S; Utsey, E; Schade, DS; Adams, KS; Hemphill, C; Hyde, P; Butler, L; Canady, JL; Colleran, K; Gonzales, Y; Hernandez-McGinnis, DA; Katz, P; King, C; Crandall, J; Brown-Friday, JO; Adorno, E; Duffy, H; Martinez, H; Pompi, D; Shamoon, H; Walker, EA; Wylie-Rosett, J; Orchard, T; Jeffries, S; Kramer, MK; Smith, M; Kriska, A; Pettigrew, J; Semler, L; Venditti, E; Weinzierl, V; Arakaki, RF; Baker-Ladao, NK; Isonaga, MK; Bermudez, NE; Mau, MK; Knowler, WC; Cooeyate, N; Hoskin, MA; Natewa, C; Percy, CA; Acton, KJ; Andre, VL; Begay, S; Bucca, BC; Cook, S; Doughty, MS; Glass, J; Glass, M; Hanson, RL; Hassenpflug, D; Ingraham, LE; Kobus, KM; Krakoff, J; Manus, C; McCabe, C; Michaels, S; Morgan, T; Nelson, JA; Roy, RJ; Smart, M; Tonemah, DP; Wilson, C; Fowler, S; Brenneman, T; Abebe, S; Bamdad, J; Callaghan, J; Christophi, CA; Edelstein, SL; Gao, Y; Gooding, R; Gottlieb, A; Grover, N; Hoffman, H; Jablonski, K; Katz, R; Kolinjivadi, P; Lachin, JM; Ma, Y; Reamer, S; Sapozhnikova, A; Sherif, H; Temprosa, M; Venditti, EM; Kriska, AM; Semler, L; Weinzierl, V; Marcovina, S; Strylewicz, G; Albers, J; Prineas, RJ; Alexander, T; Campbell, C; Hall, S; Hensley, S; Li, Y; Mills, M; Soliman, E; Zhang, Z; Fradkin, J; Garfield, S; Mayer-Davis, E; Moran, RR; Ganiats, T; Sarkin, AJ				Bray, G. A.; Chatellier, A.; Duncan, C.; Greenway, F. L.; Levy, E.; Ryan, D. H.; Polonsky, K. S.; Tobian, J.; Ehrmann, D.; Matulik, M. J.; Clark, B.; Czech, K.; DeSandre, C.; Hilbrich, R.; McNabb, W.; Semenske, A. R.; Goldstein, B. J.; Smith, K. A.; Wildman, W.; Pepe, C.; Goldberg, R. B.; Calles, J.; Ojito, J.; Castillo-Florez, S.; Florez, H. J.; Giannella, A.; Lara, O.; Veciana, B.; Haffner, S. M.; Montez, M. G.; Lorenzo, C.; Martinez, A.; Hamman, R. F.; Testaverde, L.; Bouffard, A.; Dabelea, D.; Jenkins, T.; Lenz, D.; Perreault, L.; Price, D. W.; Steinke, S. C.; Horton, E. S.; Poirier, C. S.; Swift, K.; Caballero, E.; Jackson, S. D.; Lambert, L.; Lawton, K. E.; Ledbury, S.; Kahn, S. E.; Montgomery, B. K.; Fujimoto, W.; Knopp, R. H.; Lipkin, E. W.; Marr, M.; Murillo, A.; Trence, D.; Kitabchi, A. E.; Murphy, M. E.; Applegate, W. B.; Bryer-Ash, M.; Dagogo-Jack, S.; Frieson, S. L.; Lambeth, H.; Lichtermann, L. C.; Otkaei, H.; Rutledge, L. M. K.; Sherman, A. R.; Smith, C. M.; Soberman, J. E.; Williams-Cleaves, B.; Metzger, B. E.; Molitch, M. E.; Johnson, M. K.; Giles, M. M.; Larsen, D.; Niznik, C.; Pen, S. C.; Schinleber, P. A.; Nathan, D. M.; McKitrick, C.; Turgeon, H.; Abbott, K.; Altshuler, D.; Anderson, E.; Bissett, L.; Cagliero, E.; D'Anna, K.; Delahanty, L.; Florez, J. C.; Goldman, V.; Poulos, A.; Tseng, B.; Barrett-Connor, E.; Carrion-Petersen, M. L.; Horne, J.; Leos, D.; Mudaliar, S.; Smith, J.; Vejvoda, K.; Pi-Sunyer, F. X.; Lee, J. E.; Foo, S. T.; Hagamen, S.; Marrero, D. G.; Kelly, S. M.; Ackermann, R. T.; Fineberg, E. S.; Hadden, A.; Jackson, M. A.; Kirkman, M. S.; Mather, K. J.; Roach, P. J.; Wheeler, M. L.; Ratner, R. E.; Aroda, V.; Shapiro, S.; Bavido-Arrage, C.; Gibbs, P.; Uwaifo, Gl; Wiggins, R.; Saad, M. F.; Watson, K.; Botrous, M.; Jinagouda, S.; Budget, M.; Conzues, C.; Magpuri, P.; Ngo, K.; Xapthalamous, K.; White, N. H.; Das, S.; Santiago, A.; Brown, A. L.; Wernimont, C.; Saudek, C. D.; Whittington, T.; Clark, J. M.; Greene, A.; Jiggetts, D.; Mosley, H.; Reusing, J.; Rubin, R. R.; Stephen, S.; Utsey, E.; Schade, D. S.; Adams, K. S.; Hemphill, C.; Hyde, P.; Butler, L.; Canady, J. L.; Colleran, K.; Gonzales, Y.; Hernandez-McGinnis, D. A.; Katz, P.; King, C.; Crandall, J.; Brown-Friday, J. O.; Adorno, E.; Duffy, H.; Martinez, H.; Pompi, D.; Shamoon, H.; Walker, E. A.; Wylie-Rosett, J.; Orchard, T.; Jeffries, S.; Kramer, M. K.; Smith, M.; Kriska, A.; Pettigrew, J.; Semler, L.; Venditti, E.; Weinzierl, V.; Arakaki, R. F.; Baker-Ladao, N. K.; Isonaga, M. K.; Bermudez, N. E.; Mau, M. K.; Knowler, W. C.; Cooeyate, N.; Hoskin, M. A.; Natewa, C.; Percy, C. A.; Acton, K. J.; Andre, V. L.; Begay, S.; Bucca, B. C.; Cook, S.; Doughty, M. S.; Glass, J.; Glass, M.; Hanson, R. L.; Hassenpflug, D.; Ingraham, L. E.; Kobus, K. M.; Krakoff, J.; Manus, C.; McCabe, C.; Michaels, S.; Morgan, T.; Nelson, J. A.; Roy, R. J.; Smart, M.; Tonemah, D. P.; Wilson, C.; Fowler, S.; Brenneman, T.; Abebe, S.; Bamdad, J.; Callaghan, J.; Christophi, C. A.; Edelstein, S. L.; Gao, Y.; Gooding, R.; Gottlieb, A.; Grover, N.; Hoffman, H.; Jablonski, K.; Katz, R.; Kolinjivadi, P.; Lachin, J. M.; Ma, Y.; Reamer, S.; Sapozhnikova, A.; Sherif, H.; Temprosa, M.; Venditti, E. M.; Kriska, A. M.; Semler, L.; Weinzierl, V.; Marcovina, S.; Strylewicz, G.; Albers, J.; Prineas, R. J.; Alexander, T.; Campbell, C.; Hall, S.; Hensley, S.; Li, Y.; Mills, M.; Soliman, E.; Zhang, Z.; Fradkin, J.; Garfield, S.; Mayer-Davis, E.; Moran, R. R.; Ganiats, T.; Sarkin, A. J.		Diabet Prevention Program Res Grp	10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; PEOPLE; MELLITUS; RISK	Background In the 2.8 years of the Diabetes Prevention Program (DPP) randomised clinical trial, diabetes incidence in high-risk adults was reduced by 58% with intensive lifestyle intervention and by 31% with metformin, compared with placebo. We investigated the persistence of these effects in the long term. Methods All active DPP participants were eligible for continued follow-up. 2766 of 3150 (88%) enrolled for a median additional follow-up of 5.7 years (IQR 5.5-5.8). 910 participants were from the lifestyle, 924 from the metformin, and 932 were from the original placebo groups. On the basis of the benefits from the intensive lifestyle intervention in the DPP, all three groups were offered group-implemented lifestyle intervention. Metformin treatment was continued in the original metformin group (850 mg twice daily as tolerated), with participants unmasked to assignment, and the original lifestyle intervention group was offered additional lifestyle support. The primary outcome was development of diabetes according to American Diabetes Association criteria. Analysis was by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00038727. Findings During the 10.0-year (IQR 9.0-10.5) follow-up since randomisation to DPP, the original lifestyle group lost, then partly regained weight. The modest weight loss with metformin was maintained. Diabetes incidence rates during the DPP were 4.8 cases per 100 person-years (95% CI 4.1-5.7) in the intensive lifestyle intervention group, 7.8 (6.8-8.8) in the metformin group, and 11.0 (9.8-12.3) in the placebo group. Diabetes incidence rates in this follow-up study were similar between treatment groups: 5.9 per 100 person-years (5.1-6.8) for lifestyle, 4.9 (4.2-5.7) for metformin, and 5.6 (4.8-6.5) for placebo. Diabetes incidence in the 10 years since DPP randomisation was reduced by 34% (24-42) in the lifestyle group and 18% (7-28) in the metformin group compared with placebo. Interpretation During follow-up after DPP, incidences in the former placebo and metformin groups fell to equal those in the former lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group. Prevention or delay of diabetes with lifestyle intervention or metformin can persist for at least 10 years.	[Bray, G. A.; Fowler, S.; Brenneman, T.; Abebe, S.; Bamdad, J.; Callaghan, J.; Christophi, C. A.; Edelstein, S. L.; Gao, Y.; Gooding, R.; Gottlieb, A.; Grover, N.; Hoffman, H.; Jablonski, K.; Katz, R.; Kolinjivadi, P.; Lachin, J. M.; Ma, Y.; Reamer, S.; Sapozhnikova, A.; Sherif, H.; Temprosa, M.] George Washington Univ, Diabet Prevent Program Coordinating Ctr, Ctr Biostat, Rockville, MD 20852 USA; [Bray, G. A.; Chatellier, A.; Duncan, C.; Greenway, F. L.; Levy, E.; Ryan, D. H.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Polonsky, K. S.; Tobian, J.; Ehrmann, D.; Matulik, M. J.; Clark, B.; Czech, K.; DeSandre, C.; Hilbrich, R.; McNabb, W.; Semenske, A. R.] Univ Chicago, Chicago, IL 60637 USA; [Goldstein, B. J.; Smith, K. A.; Wildman, W.; Pepe, C.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Goldberg, R. B.; Calles, J.; Ojito, J.; Castillo-Florez, S.; Florez, H. J.; Giannella, A.; Lara, O.; Veciana, B.] Univ Miami, Miami, FL USA; [Haffner, S. M.; Montez, M. G.; Lorenzo, C.; Martinez, A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Hamman, R. F.; Testaverde, L.; Bouffard, A.; Dabelea, D.; Jenkins, T.; Lenz, D.; Perreault, L.; Price, D. W.; Steinke, S. C.] Univ Colorado, Denver, CO 80202 USA; [Horton, E. S.; Poirier, C. S.; Swift, K.; Caballero, E.; Jackson, S. D.; Lambert, L.; Lawton, K. E.; Ledbury, S.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, S. E.; Montgomery, B. K.; Fujimoto, W.; Knopp, R. H.; Lipkin, E. W.; Marr, M.; Murillo, A.; Trence, D.] Univ Washington, Seattle, WA 98195 USA; [Kitabchi, A. E.; Murphy, M. E.; Applegate, W. B.; Bryer-Ash, M.; Dagogo-Jack, S.; Frieson, S. L.; Lambeth, H.; Lichtermann, L. C.; Otkaei, H.; Rutledge, L. M. K.; Sherman, A. R.; Smith, C. M.; Soberman, J. E.; Williams-Cleaves, B.] Univ Tennessee, Memphis, TN USA; [Metzger, B. E.; Molitch, M. E.; Johnson, M. K.; Giles, M. M.; Larsen, D.; Niznik, C.; Pen, S. C.; Schinleber, P. A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Nathan, D. M.; McKitrick, C.; Turgeon, H.; Abbott, K.; Altshuler, D.; Anderson, E.; Bissett, L.; Cagliero, E.; D'Anna, K.; Delahanty, L.; Florez, J. C.; Goldman, V.; Poulos, A.; Tseng, B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Barrett-Connor, E.; Carrion-Petersen, M. L.; Horne, J.; Leos, D.; Mudaliar, S.; Smith, J.; Vejvoda, K.] Univ Calif San Diego, San Diego, CA 92103 USA; [Pi-Sunyer, F. X.; Lee, J. E.; Foo, S. T.; Hagamen, S.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Marrero, D. G.; Kelly, S. M.; Ackermann, R. T.; Fineberg, E. S.; Hadden, A.; Jackson, M. A.; Kirkman, M. S.; Mather, K. J.; Roach, P. J.; Wheeler, M. L.] Indiana Univ, Indianapolis, IN 46204 USA; [Ratner, R. E.; Aroda, V.; Shapiro, S.; Bavido-Arrage, C.; Gibbs, P.; Uwaifo, Gl; Wiggins, R.] Medstar Res Inst, Washington, DC USA; [Saad, M. F.; Watson, K.; Botrous, M.; Jinagouda, S.; Budget, M.; Conzues, C.; Magpuri, P.; Ngo, K.; Xapthalamous, K.] Univ Calif Los Angeles, Univ So Calif, Res Ctr, Alhambra, CA USA; [White, N. H.; Das, S.; Santiago, A.; Brown, A. L.; Wernimont, C.] Washington Univ, St Louis, MO USA; [Saudek, C. D.; Whittington, T.; Clark, J. M.; Greene, A.; Jiggetts, D.; Mosley, H.; Reusing, J.; Rubin, R. R.; Stephen, S.; Utsey, E.] Johns Hopkins Sch Med, Baltimore, MD USA; [Schade, D. S.; Adams, K. S.; Hemphill, C.; Hyde, P.; Butler, L.; Canady, J. L.; Colleran, K.; Gonzales, Y.; Hernandez-McGinnis, D. A.; Katz, P.; King, C.] Univ New Mexico, Albuquerque, NM 87131 USA; [Crandall, J.; Brown-Friday, J. O.; Adorno, E.; Duffy, H.; Martinez, H.; Pompi, D.; Shamoon, H.; Walker, E. A.; Wylie-Rosett, J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Orchard, T.; Jeffries, S.; Kramer, M. K.; Smith, M.; Kriska, A.; Pettigrew, J.; Semler, L.; Venditti, E.; Weinzierl, V.] Univ Pittsburgh, Pittsburgh, PA USA; [Arakaki, R. F.; Baker-Ladao, N. K.; Isonaga, M. K.; Bermudez, N. E.; Mau, M. K.] Univ Hawaii, Honolulu, HI 96822 USA; [Knowler, W. C.; Cooeyate, N.; Hoskin, M. A.; Natewa, C.; Percy, C. A.; Acton, K. J.; Andre, V. L.; Begay, S.; Bucca, B. C.; Cook, S.; Doughty, M. S.; Glass, J.; Glass, M.; Hanson, R. L.; Hassenpflug, D.; Ingraham, L. E.; Kobus, K. M.; Krakoff, J.; Manus, C.; McCabe, C.; Michaels, S.; Morgan, T.; Nelson, J. A.; Roy, R. J.; Smart, M.; Tonemah, D. P.; Wilson, C.] SW Amer Indian Ctr, Phoenix, AZ USA; [Knowler, W. C.; Cooeyate, N.; Hoskin, M. A.; Natewa, C.; Percy, C. A.; Acton, K. J.; Andre, V. L.; Begay, S.; Bucca, B. C.; Cook, S.; Doughty, M. S.; Glass, J.; Glass, M.; Hanson, R. L.; Hassenpflug, D.; Ingraham, L. E.; Kobus, K. M.; Krakoff, J.; Manus, C.; McCabe, C.; Michaels, S.; Morgan, T.; Nelson, J. A.; Roy, R. J.; Smart, M.; Tonemah, D. P.; Wilson, C.] SW Amer Indian Ctr, Shiprock, NM USA; [Knowler, W. C.; Cooeyate, N.; Hoskin, M. A.; Natewa, C.; Percy, C. A.; Acton, K. J.; Andre, V. L.; Begay, S.; Bucca, B. C.; Cook, S.; Doughty, M. S.; Glass, J.; Glass, M.; Hanson, R. L.; Hassenpflug, D.; Ingraham, L. E.; Kobus, K. M.; Krakoff, J.; Manus, C.; McCabe, C.; Michaels, S.; Morgan, T.; Nelson, J. A.; Roy, R. J.; Smart, M.; Tonemah, D. P.; Wilson, C.] SW Amer Indian Ctr, Zuni, NM USA; [Marcovina, S.; Strylewicz, G.; Albers, J.] Cent Biochem Lab, Seattle, WA USA; [Prineas, R. J.; Alexander, T.; Campbell, C.; Hall, S.; Hensley, S.; Li, Y.; Mills, M.; Soliman, E.; Zhang, Z.] Epidemiol Cardiol Res Ctr Epicare, Winston Salem, NC USA; [Fradkin, J.; Garfield, S.] NIDDK, NIH, Bethesda, MD USA; [Mayer-Davis, E.; Moran, R. R.] Nutr Coding Ctr, Columbia, SC USA; [Ganiats, T.; Sarkin, A. J.] Qual Well Being Ctr, La Jolla, CA USA	George Washington University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Chicago; Jefferson University; University of Miami; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Denver; Harvard University; Joslin Diabetes Center, Inc.; University of Washington; University of Washington Seattle; University of Tennessee System; University of Tennessee Health Science Center; Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; Mount Sinai St. Luke's; Mount Sinai West; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; University of Southern California; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; University of New Mexico; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bray, GA (corresponding author), George Washington Univ, Diabet Prevent Program Coordinating Ctr, Ctr Biostat, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu	Mather, Kieren/ABE-4117-2020; Watson, Karol/ABD-7425-2021; Uwaifo, Gabriel I/M-2361-2016; Mudaliar, Sunder/R-2781-2019; Mudaliar, Sunder/N-5813-2019; Clark, Jeanne/AGG-8199-2022; Greenway, Frank/N-1966-2017; Altshuler, David M/A-4476-2009	Uwaifo, Gabriel I/0000-0002-6962-9304; Clark, Jeanne/0000-0003-1194-0092; Greenway, Frank/0000-0002-1766-6111; Altshuler, David M/0000-0002-7250-4107; Kriska, Andrea/0000-0002-3522-0869; Brenneman, Anthony/0000-0003-2716-7014	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489, U01DK048406] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as a cooperative agreement. We thank the participants of the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study for their commitment and dedication; the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health for funding to the clinical and coordinating centres that designed and undertook the study, and collected, managed, analysed and interpreted the data; and the General Clinical Research Center Program and the National Center for Research Resources for support of data collection at many of the clinical centres. The Southwestern American Indian Centers were supported directly by the NIDDK, including its Intramural Research Program, and by the Indian Health Service. Funding was also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the National Eye Institute, the National Heart Lung and Blood Institute, the Office of Women's Health, the National Center for Minority Health and Human Disease, the Centers for Disease Control and Prevention, and the American Diabetes Association. Lipha (Merck-Sante) provided medicines, and LifeScan donated materials. The opinions expressed are those of the investigators and do not necessarily reflect the views of the funding agencies.	Bray GA, 1999, DIABETES CARE, V22, P623; Brown H., 1999, APPL MIXED MODELS ME; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Crandall JP, 2008, NAT CLIN PRACT ENDOC, V4, P382, DOI 10.1038/ncpendmet0843; *DIAB PREV PROGR R, 2005, DIABETES CARE, V28, P150; *DIAB PREV PROGR R, 2005, DIABETES, V4, P1566; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Engelgau MM, 2005, ANN INTERN MED, V143, P301, DOI 10.7326/0003-4819-143-4-200508160-00011; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; GILLIES CL, 2007, BMJ-BRIT MED J, V334, P2997; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; The Diabetes Prevention Program Research Group, 2006, DIABETES CARE, V29, P2192; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Venditti EM, 2008, INT J OBESITY, V32, P1537, DOI 10.1038/ijo.2008.134; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	28	1792	1825	5	195	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1677	1686		10.1016/S0140-6736(09)61457-4	http://dx.doi.org/10.1016/S0140-6736(09)61457-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19878986	Green Accepted			2022-12-28	WOS:000271999700023
J	Siegel, MD; Rubinowitz, AN				Siegel, Mark D.; Rubinowitz, Ami N.			Routine daily vs on-demand chest radiographs in intensive care	LANCET			English	Editorial Material							MECHANICALLY VENTILATED PATIENTS; UNIT; ICU; UTILITY; DELPHI		[Siegel, Mark D.] Yale Univ, Sch Med, Dept Internal Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA; [Rubinowitz, Ami N.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA	Yale University; Yale University	Siegel, MD (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Pulm & Crit Care Sect, 333 Cedar St, New Haven, CT 06520 USA.	mark.siegel@yale.edu						*AM COLL RAD, 2006, ACR APPR CRIT ROUT R; Chahine-Malus N, 2001, CRIT CARE, V5, P271, DOI 10.1186/cc1045; Clec'h C, 2008, INTENS CARE MED, V34, P264, DOI 10.1007/s00134-007-0919-1; Graat ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3955; Graat Marleen E, 2006, BMC Med Imaging, V6, P8, DOI 10.1186/1471-2342-6-8; Graat ME, 2007, INTENS CARE MED, V33, P639, DOI 10.1007/s00134-007-0542-1; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; Hejblum G, 2009, LANCET, V374, P1687, DOI 10.1016/S0140-6736(09)61459-8; Hendrikse KA, 2007, CHEST, V132, P823, DOI 10.1378/chest.07-1162; IBERTI TJ, 1991, CRIT CARE MED, V19, P597, DOI 10.1097/00003246-199105000-00002; Krivopal M, 2003, CHEST, V123, P1607, DOI 10.1378/chest.123.5.1607; Lessnau KD, 2008, CHEST, V133, P1060, DOI 10.1378/chest.07-2337; Rubinowitz AN, 2007, CRIT CARE CLIN, V23, P539, DOI 10.1016/j.ccc.2007.06.001	13	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1656	1658		10.1016/S0140-6736(09)61632-9	http://dx.doi.org/10.1016/S0140-6736(09)61632-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19896185				2022-12-28	WOS:000271999700005
J	Cartier, N; Hacein-Bey-Abina, S; Bartholomae, CC; Veres, G; Schmidt, M; Kutschera, I; Vidaud, M; Abel, U; Dal-Cortivo, L; Caccavelli, L; Mahlaoui, N; Kiermer, V; Mittelstaedt, D; Bellesme, C; Lahlou, N; Lefrere, F; Blanche, S; Audit, M; Payen, E; Leboulch, P; l'Homme, B; Bougneres, P; Von Kalle, C; Fischer, A; Cavazzana-Calvo, M; Aubourg, P				Cartier, Nathalie; Hacein-Bey-Abina, Salima; Bartholomae, Cynthia C.; Veres, Gabor; Schmidt, Manfred; Kutschera, Ina; Vidaud, Michel; Abel, Ulrich; Dal-Cortivo, Liliane; Caccavelli, Laure; Mahlaoui, Nizar; Kiermer, Veronique; Mittelstaedt, Denice; Bellesme, Celine; Lahlou, Najiba; Lefrere, Francois; Blanche, Stephane; Audit, Muriel; Payen, Emmanuel; Leboulch, Philippe; l'Homme, Bruno; Bougneres, Pierre; Von Kalle, Christof; Fischer, Alain; Cavazzana-Calvo, Marina; Aubourg, Patrick			Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; INTEGRATION SITE SELECTION; LONG-TERM ENGRAFTMENT; HUMAN CD34(+) CELLS; NOD/SCID MICE; MOUSE MODEL; HIV VECTORS; MICROGLIA; DIFFERENTIATE	X-linked adrenoleukodystrophy (ALD) is a severe brain demyelinating disease in boys that is caused by a deficiency in ALD protein, an adenosine triphosphate-binding cassette transporter encoded by the ABCD1 gene. ALD progression can be halted by allogeneic hematopoietic cell transplantation (HCT). We initiated a gene therapy trial in two ALD patients for whom there were no matched donors. Autologous CD34(+) cells were removed from the patients, genetically corrected ex vivo with a lentiviral vector encoding wild-type ABCD1, and then re-infused into the patients after they had received myeloablative treatment. Over a span of 24 to 30 months of follow-up, we detected polyclonal reconstitution, with 9 to 14% of granulocytes, monocytes, and T and B lymphocytes expressing the ALD protein. These results strongly suggest that hematopoietic stem cells were transduced in the patients. Beginning 14 to 16 months after infusion of the genetically corrected cells, progressive cerebral demyelination in the two patients stopped, a clinical outcome comparable to that achieved by allogeneic HCT. Thus, lentiviral-mediated gene therapy of hematopoietic stem cells can provide clinical benefits in ALD.	[Cartier, Nathalie; Vidaud, Michel; l'Homme, Bruno; Aubourg, Patrick] Univ Paris 05, INSERM, UMR745, F-75279 Paris, France; [Cartier, Nathalie; Bellesme, Celine; Bougneres, Pierre; Aubourg, Patrick] Hop St Vincent de Paul, AP HP, Dept Pediat Endocrinol & Neurol, F-75674 Paris, France; [Hacein-Bey-Abina, Salima; Dal-Cortivo, Liliane; Caccavelli, Laure; Lefrere, Francois; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapy, F-75743 Paris, France; [Hacein-Bey-Abina, Salima; Fischer, Alain; Cavazzana-Calvo, Marina] Univ Paris 05, INSERM, UMR768, F-75743 Paris, France; [Hacein-Bey-Abina, Salima; Dal-Cortivo, Liliane; Caccavelli, Laure; Cavazzana-Calvo, Marina] Grp Hosp Univ Ouest, AP HP, INSERM, Clin Invest Ctr Biotherapy, F-75743 Paris, France; [Bartholomae, Cynthia C.; Schmidt, Manfred; Kutschera, Ina; Abel, Ulrich; Von Kalle, Christof] German Canc Res Ctr, Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; Kutschera, Ina; Abel, Ulrich; Von Kalle, Christof] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Mahlaoui, Nizar; Blanche, Stephane; Fischer, Alain] Hop Necker Enfants Malad, Dept Pediat Immunohematol, F-75743 Paris, France; [Kiermer, Veronique] Nat Publishing Grp, New York, NY 10013 USA; [Lahlou, Najiba] Hop St Vincent de Paul, Dept Biochem, F-75674 Paris, France; [Payen, Emmanuel; Leboulch, Philippe] CEA, Inst Emerging Dis & Innovat Therapies iMETI, F-92265 Fontenay Aux Roses, France; [Audit, Muriel] Genosafe, F-91002 Evry, France; [Payen, Emmanuel; Leboulch, Philippe] INSERM, U962, F-92265 Fontenay Aux Roses, France; [Payen, Emmanuel; Leboulch, Philippe] Univ Paris 11, CEA, IMETI, F-92265 Fontenay Aux Roses, France; [Leboulch, Philippe] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Univ, Sch Med, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Aubourg, P (corresponding author), Univ Paris 05, INSERM, UMR745, F-75279 Paris, France.	patrick.aubourg@inserm.fr	Payen, Emmanuel/S-5357-2018; cartier, nathalie/C-3103-2012; Vidaud, Michel/O-7346-2017; MAHLAOUI, Nizar/AAH-6103-2020; Mahlaoui, Nizar/J-7928-2017; Caccavelli, Laure/H-8880-2017	Payen, Emmanuel/0000-0002-1329-2327; cartier, nathalie/0000-0003-2298-5261; MAHLAOUI, Nizar/0000-0002-0030-8094; Mahlaoui, Nizar/0000-0002-0030-8094; Caccavelli, Laure/0000-0001-6324-2304; Kiermer, Veronique/0000-0001-8771-7239; Cavazzana, Marina/0000-0002-0264-0891	INSERM; European Leukodystrophy Association; Association Francaise contre les Myopathies; La Fondation de France; STOP-ALD foundation; La Fondation Avenir; Etablissement Francais des Greffes; Thermo Fisher Scientific; 6th Framework European Economic Community ( EEC) Programme [LSHM-CT2004-502987]; Programme Hospitalier de Recherche Clinique [AOM 3043]; Assistance Publique-H pitaux de Paris; Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies; Deutsche Forschungsgemeinschaft [SPP 1230]; German Ministry of Education and Research (TREATID); Helmholtz Association; 6th Framework EEC Programme (CONSERT, CLINIGENE)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Leukodystrophy Association; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); La Fondation de France(Fondation de France); STOP-ALD foundation; La Fondation Avenir; Etablissement Francais des Greffes; Thermo Fisher Scientific; 6th Framework European Economic Community ( EEC) Programme(European Commission); Programme Hospitalier de Recherche Clinique; Assistance Publique-H pitaux de Paris; Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research (TREATID)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); 6th Framework EEC Programme (CONSERT, CLINIGENE)	We thank A. Salzman and R. Salzman for their continuous help and support in this project; the pediatricians and nurses of the Unite d'Endocrinologie et Neurologie Pediatriques, Hopital Saint-Vincent de Paul and the Unite d'Immunologie et d'Hematologie Pediatriques, Hopital Necker-Enfants Malades for patient care; A. Pujol and C. Sever Bermejo for patient referral; C. Adamsbaum for neuroimaging studies; F. Audat for cytapheresis; P. Lebon for HIV and VSV. G serologies; C. Lagresle-Peyrou for setting up the transduction protocol; P. Working and Cell Genesys staff for the lenti-MND-ALD vector; PeproTech for SCF, Flt-3, MGDF, and IL-3 cytokines; Takara Bio for the CH-296 fibronectin fragment; and E. Postaire and C. Sebastiani at INSERM. P. A. and N. C. were supported by grants from INSERM, European Leukodystrophy Association, Association Francaise contre les Myopathies, La Fondation de France, the STOP-ALD foundation, La Fondation Avenir, Etablissement Francais des Greffes, Thermo Fisher Scientific, the 6th Framework European Economic Community ( EEC) Programme (LSHM-CT2004-502987) and the Programme Hospitalier de Recherche Clinique (AOM 3043, French Health Ministry). S. H.-B.- A., L. D.-C., L. C., F. L., A. F., and M. C.-C. were supported by INSERM, Assistance Publique-H pitaux de Paris, Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies. C. V. K. and M. S. were supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1230), the German Ministry of Education and Research (TREATID), the Helmholtz Association, and the 6th Framework EEC Programme (CONSERT, CLINIGENE). P. Leboulch owns stock in Genetix Pharmaceuticals, and G. Veres, V. Kiermer, and D. Mittelstaedt were formerly employed at Cell Genesys. This gene therapy trial was approved by AFSSAPS on 15 November 2005 and CCPPRB Paris- Cochin ( local Institutional Review Board) on 7 September 2004. Informed consent was obtained from the parents of the patients after the nature and possible consequences of the studies were explained.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; AUBOURG P, 1990, NEW ENGL J MED, V322, P1860, DOI 10.1056/NEJM199006283222607; Benhamida S, 2003, MOL THER, V7, P317, DOI 10.1016/S1525-0016(03)00002-9; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939	26	1076	1144	1	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					818	823		10.1126/science.1171242	http://dx.doi.org/10.1126/science.1171242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892975				2022-12-28	WOS:000271468000034
J	Lopez-Bueno, A; Tamames, J; Velazquez, D; Moya, A; Quesada, A; Alcami, A				Lopez-Bueno, Alberto; Tamames, Javier; Velazquez, David; Moya, Andres; Quesada, Antonio; Alcami, Antonio			High Diversity of the Viral Community from an Antarctic Lake	SCIENCE			English	Article							FRESH-WATER; MARINE VIRUSES; ECOSYSTEMS; BIODIVERSITY; ISLAND; LIFE	Viruses are the most abundant biological entities and can control microbial communities, but their identity in terrestrial and freshwater Antarctic ecosystems is unknown. The genetic structure of an Antarctic lake viral community revealed unexpected genetic richness distributed across the highest number of viral families that have been found to date in aquatic viral metagenomes. In contrast to other known aquatic viromes, which are dominated by bacteriophage sequences, this Antarctic virus assemblage had a large proportion of sequences related to eukaryotic viruses, including phycodnaviruses and single-stranded DNA (ssDNA) viruses not previously identified in aquatic environments. We also observed that the transition from an ice-covered lake in spring to an open-water lake in summer led to a change from a ssDNA- to a double-stranded DNA-virus-dominated assemblage, possibly reflecting a seasonal shift in host organisms.	[Lopez-Bueno, Alberto; Alcami, Antonio] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Tamames, Javier; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Tamames, Javier; Moya, Andres] Generalitat Valenciana, Conselleria Sanidad, Ctr Super Invest Salud Publ, Valencia, Spain; [Tamames, Javier; Moya, Andres] Ctr Invest Biomed Red Epidemiol & Salud Publ, Barcelona, Spain; [Velazquez, David] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Alcami, Antonio] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Madrid; University of Cambridge	Alcami, A (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	aalcami@cbm.uam.es	Velazquez, David/M-2309-2017; Moya, Andrés/A-8190-2008; Alcami, Antonio/F-8512-2015; Quesada, Antonio/L-2430-2013	Velazquez, David/0000-0002-4127-8370; Moya, Andrés/0000-0002-2867-1119; Alcami, Antonio/0000-0002-3333-6016; Quesada, Antonio/0000-0002-8913-5993; Lopez-Bueno, Alberto/0000-0002-6324-8623; Lopez Bueno, Alberto/0000-0003-2449-4562; Tamames, Javier/0000-0003-4547-8932	Spanish Ministry of Science and Innovation [CGL2005-06549-C02-01/ANT, CGL200729843-E/ANT, CTM2008-05134-E/ANT, BFU200804501-E];  [FJ791185-247];  [FJ791175-84]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; 	We thank the Maritime Technology Unit (CSIC) and Las Palmas crew (Spanish Navy) for the logistic help and support that made this expedition possible. We also thank M. Toro, A. Camacho, and other members of the Limnopolar Project for help and discussions; A. Alejo for helpful comments and reviewing the manuscript; and M. Pignatelli for technical support. This work was funded by grants from the Spanish Ministry of Science and Innovation (CGL2005-06549-C02-01/ANT, CGL200729843-E/ANT, CTM2008-05134-E/ANT, and BFU200804501-E). Spring and summer viral metagenomes from the Antarctic Lake Limnopolar have been submitted to GenBank and assigned the genome project accession number 34669. The metagenomes are also publicly accessible from the ftp server of the SEED public database (ftp://ftp.theseed.org/metagenomes) under the project accession numbers 4441778.3 and 4441558.3 for the spring and summer viromes, respectively. PCR-obtained sequences encoding the gp23 protein of Antarctic T4-phages and the MCP protein of Antarctic phycodnavirus have been also deposited at GenBank as "environmental sequences" and are listed under accession numbers FJ791185-247 and FJ791175-84, respectively.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Chown SL, 2007, PHILOS T R SOC B, V362, P2307, DOI 10.1098/rstb.2006.1949; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Convey P, 2007, SCIENCE, V317, P1877, DOI 10.1126/science.1147261; Cowan DA, 2004, ANNU REV MICROBIOL, V58, P649, DOI 10.1146/annurev.micro.57.030502.090811; Derelle E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002250; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Filee J, 2005, P NATL ACAD SCI USA, V102, P12471, DOI 10.1073/pnas.0503404102; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Kepner RL, 1998, LIMNOL OCEANOGR, V43, P1754, DOI 10.4319/lo.1998.43.7.1754; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Laybourn-Parry J, 2001, FRESHWATER BIOL, V46, P1279, DOI 10.1046/j.1365-2427.2001.00749.x; Laybourn-Parry J, 2007, PHILOS T R SOC B, V362, P2273, DOI 10.1098/rstb.2006.1945; Laybourn-Parry J, 2009, SCIENCE, V324, P1521, DOI 10.1126/science.1173645; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Pearce DA, 2003, ANTARCT SCI, V15, P319, DOI 10.1017/S0954102003001330; Peck LS, 2005, POLAR BIOL, V28, P351, DOI 10.1007/s00300-004-0671-8; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Sawstrom C, 2008, EXTREMOPHILES, V12, P167, DOI 10.1007/s00792-007-0134-6; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Toro M, 2007, POLAR BIOL, V30, P635, DOI 10.1007/s00300-006-0223-5; Wilson WH, 2000, POLAR BIOL, V23, P657, DOI 10.1007/s003000000152	26	287	308	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					858	861		10.1126/science.1179287	http://dx.doi.org/10.1126/science.1179287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892985				2022-12-28	WOS:000271468000045
J	Bland, B				Bland, Ben			Global Health Commercial solutions to malnutrition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												theasiafile@gmail.com						[Anonymous], 2008, LANCET; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Darnton-Hill I, 2002, P NUTR SOC, V61, P231, DOI 10.1079/PNS2002150; *WORLD FOOD PROGR, 2008, HOUS FOOD SEC NUTR A; Zlotkin SH, 2005, PLOS MED, V2, P24, DOI 10.1371/journal.pmed.0020001	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2009	339								b4482	10.1136/bmj.b4482	http://dx.doi.org/10.1136/bmj.b4482			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889735				2022-12-28	WOS:000271567800003
J	Mulder, MB; Bowles, S; Hertz, T; Bell, A; Beise, J; Clark, G; Fazzio, I; Gurven, M; Hill, K; Hooper, PL; Irons, W; Kaplan, H; Leonetti, D; Low, B; Marlowe, FW; McElreath, R; Naidu, S; Nolin, D; Piraino, P; Quinlan, R; Schniter, E; Sear, R; Shenk, M; Smith, EA; von Rueden, C; Wiessner, P				Mulder, Monique Borgerhoff; Bowles, Samuel; Hertz, Tom; Bell, Adrian; Beise, Jan; Clark, Greg; Fazzio, Ila; Gurven, Michael; Hill, Kim; Hooper, Paul L.; Irons, William; Kaplan, Hillard; Leonetti, Donna; Low, Bobbi; Marlowe, Frank W.; McElreath, Richard; Naidu, Suresh; Nolin, David; Piraino, Patrizio; Quinlan, Rob; Schniter, Eric; Sear, Rebecca; Shenk, Mary; Smith, Eric Alden; von Rueden, Christopher; Wiessner, Polly			Intergenerational Wealth Transmission and the Dynamics of Inequality in Small-Scale Societies	SCIENCE			English	Article							INHERITANCE; INVESTMENT; HERITABILITY; CONSTRAINTS; MORTALITY; POLYGYNY; CHILD; KIN	Small-scale human societies range from foraging bands with a strong egalitarian ethos to more economically stratified agrarian and pastoral societies. We explain this variation in inequality using a dynamic model in which a population's long-run steady-state level of inequality depends on the extent to which its most important forms of wealth are transmitted within families across generations. We estimate the degree of intergenerational transmission of three different types of wealth (material, embodied, and relational), as well as the extent of wealth inequality in 21 historical and contemporary populations. We show that intergenerational transmission of wealth and wealth inequality are substantial among pastoral and small-scale agricultural societies (on a par with or even exceeding the most unequal modern industrial economies) but are limited among horticultural and foraging peoples (equivalent to the most egalitarian of modern industrial populations). Differences in the technology by which a people derive their livelihood and in the institutions and norms making up the economic system jointly contribute to this pattern.	[Mulder, Monique Borgerhoff; McElreath, Richard] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Mulder, Monique Borgerhoff; McElreath, Richard] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Bowles, Samuel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, Santa Fe, NM 87501 USA; [Hertz, Tom] Int Univ Coll Turin, I-10121 Turin, Italy; [Bell, Adrian] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Beise, Jan] UN, Dept Econ & Social Affairs, New York, NY 10017 USA; [Clark, Greg] Univ Calif Davis, Dept Econ, Davis, CA 95616 USA; [Fazzio, Ila] London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England; [Gurven, Michael; Schniter, Eric] Univ Calif Santa Barbara, Integrat Anthropol Sci Program, Santa Barbara, CA 93106 USA; [Hill, Kim] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Hooper, Paul L.; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Irons, William] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Leonetti, Donna; Smith, Eric Alden] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Low, Bobbi] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Marlowe, Frank W.] Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; [Naidu, Suresh] Harvard Univ, Harvard Acad Int Studies, Cambridge, MA 02138 USA; [Nolin, David] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [Quinlan, Rob] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Sear, Rebecca] London Sch Econ, Dept Social Policy, London WC2A 2AE, England; [Shenk, Mary] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [von Rueden, Christopher] Univ Calif Santa Barbara, Integrat Anthropol Sci Program, Santa Barbara, CA 93106 USA; [Wiessner, Polly] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	University of California System; University of California Davis; University of California System; University of California Davis; The Santa Fe Institute; University of California System; University of California Davis; University of California System; University of California Davis; University of London; London School Economics & Political Science; University of California System; University of California Santa Barbara; Arizona State University; Arizona State University-Tempe; University of New Mexico; Northwestern University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; State University System of Florida; Florida State University; Harvard University; University of North Carolina; University of North Carolina Chapel Hill; Washington State University; University of London; London School Economics & Political Science; University of Missouri System; University of Missouri Columbia; University of California System; University of California Santa Barbara; Utah System of Higher Education; University of Utah	Mulder, MB (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	mborgerhoffmulder@ucdavis.edu	Marlowe, Frank/G-9752-2012; Schniter, Eric/AAC-3583-2019; Sear, Rebecca/K-9616-2019; von Rueden, Christopher/T-5422-2018	Schniter, Eric/0000-0002-2381-3616; Sear, Rebecca/0000-0002-4315-0223; Kaplan, Hillard/0000-0002-7398-7358; Piraino, Patrizio/0000-0003-3899-2706; Shenk, Mary/0000-0003-2002-1469; McElreath, Richard/0000-0002-0387-5377; Gurven, Michael/0000-0002-5661-527X	Santa Fe Institute; Russell Sage Foundation; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, R24HD042828, T32HD007543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024119, R56AG024119] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0921429] Funding Source: National Science Foundation	Santa Fe Institute; Russell Sage Foundation; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The authors declare no competing interests. Financial support for this research was provided by the Behavioral Sciences Program of the Santa Fe Institute, the Russell Sage Foundation, and the NSF. We would like to thank the participating members of the populations we studied for their cooperation and M. Alexander, W. Cote, P. Lindert, C. Resnicke, T. Taylor, D. Ulibarri, and H. Wright for their contributions to this research.	Alvard MS, 2002, CURR ANTHROPOL, V43, P533, DOI 10.1086/341653; ATKINSON A, 1983, STUDIES DEPRIVATION, P94; BECKER GS, 1979, J POLIT ECON, V87, P1153, DOI 10.1086/260831; Bjorklund A., 2009, OXFORD HDB EC INEQUA, P491; BOEHM C, 2000, HIERARCHY FOREST; Bollig M., 2006, RISK MANAGEMENT HAZA; Bowles S, 2002, J ECON PERSPECT, V16, P3, DOI 10.1257/089533002760278686; BOWLES S, 1972, J POLIT ECON, V80, pS219, DOI 10.1086/259996; Brandolini A., 2009, OXFORD HDB EC INEQUA, P71; Charles KK, 2003, J POLIT ECON, V111, P1155, DOI 10.1086/378526; Clark G, 2007, PRINC ECON HIST W WO; Coleman JS., 1990, FDN SOCIAL THEORY; FAZZIO I, 2008, PARENTAL INVESTMENT; Galton F, 1889, NATURAL INHERITANCE, P1; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; HARTUNG J, 1982, CURR ANTHROPOL, V23, P1, DOI 10.1086/202775; Hawkes K, 2000, HIERARCHIES ACTION C, P59; Hayden B, 1997, PITHOUSES KEATLEY CR; Hertz T, 2007, BE J ECON ANAL POLI, V7, DOI 10.2202/1935-1682.1775; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Irons W., 1975, YOMUT TURKMEN STUDY; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Kaplan HS, 2003, OFFSPRING, P170; Keen I, 2006, CURR ANTHROPOL, V47, P7, DOI 10.1086/497672; Leonetti D., 2005, GRANDMOTHERHOOD EVOL, P194; LOW BS, 1991, J FAM HIST, V16, P117, DOI 10.1177/036319909101600202; MARLOWE FW, HADZA IN PRESS; McElreath R, 2004, AM ANTHROPOL, V106, P308, DOI 10.1525/aa.2004.106.2.308; MULDER MB, 1995, CURR ANTHROPOL, V36, P573, DOI 10.1086/204405; MULDER MB, 1992, HUM ECOL, V20, P383, DOI 10.1007/BF00890427; Mulder MB, 2009, HUM NATURE-INT BIOS, V20, P130, DOI 10.1007/s12110-009-9060-x; Murphy M, 1999, SOC BIOL, V46, P122; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Parker Pearson M., 1999, ARCHAEOLOGY DEATH BU; Pettay JE, 2005, P NATL ACAD SCI USA, V102, P2838, DOI 10.1073/pnas.0406709102; Quinlan RJ, 2006, AM ANTHROPOL, V108, P464, DOI 10.1525/aa.2006.108.3.464; ROBERTS DF, 1978, ANN HUM GENET, V42, P15, DOI 10.1111/j.1469-1809.1978.tb00928.x; Schneider H. K, 1979, LIVESTOCK EQUALITY E; SCHULTZ TW, 1961, AM ECON REV, V51, P1; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Shenk MK, 2005, HUM NATURE-INT BIOS, V16, P81, DOI 10.1007/s12110-005-1008-1; Smith EA, 2003, BEHAV ECOL, V14, P116, DOI 10.1093/beheco/14.1.116; VOLAND E, 1990, BEHAV ECOL SOCIOBIOL, V26, P65; Wiessner P, 2002, CURR ANTHROPOL, V43, P233, DOI 10.1086/338301; Wiessner P., 1982, POLITICS HIST BAND S, P61; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707	47	237	239	4	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					682	688		10.1126/science.1178336	http://dx.doi.org/10.1126/science.1178336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	512GB	19900925	Green Accepted, Green Submitted			2022-12-28	WOS:000271233200026
J	Rouault, TA				Rouault, Tracey A.			An Ancient Gauge for Iron	SCIENCE			English	Editorial Material							HOMEOSTASIS; DIOXYGEN; PROTEINS; LIGASE		NICHHD, Program Mol Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Program Mol Med, Bethesda, MD 20892 USA.	trou@helix.nih.gov			Intramural NIH HHS [ZIA HD001602-25] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Kurtz DM, 1999, ESSAYS BIOCHEM, V34, P85, DOI 10.1042/bse0340085; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004	12	20	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					676	677		10.1126/science.1181938	http://dx.doi.org/10.1126/science.1181938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900922	Green Accepted			2022-12-28	WOS:000271233200022
J	Taylor, CR; Gandhi, RT; Handwerker, J; Duncan, LM				Taylor, Charles R.; Gandhi, Rajesh T.; Handwerker, Jason; Duncan, Lyn M.			A Man with Sore Throat, Fever, and Rash PLEVA (pityriasis lichenoides et varioliformis acuta)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUCHA-HABERMANN-DISEASE; ARCANOBACTERIUM-HAEMOLYTICUM		[Taylor, Charles R.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Handwerker, Jason] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Duncan, Lyn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Taylor, Charles R.] Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA; [Gandhi, Rajesh T.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Handwerker, Jason] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Duncan, Lyn M.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Taylor, CR (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.				Tibotec	Tibotec	Dr. Gandhi reports receiving lecture fees from GlaxoSmithKline and grant support from Tibotec. No other potential conflict of interest relevant to this article was reported.	BANCK G, 1986, J INFECT DIS, V154, P1037, DOI 10.1093/infdis/154.6.1037; Barbagallo Joseph, 2002, Am J Clin Dermatol, V3, P319, DOI 10.2165/00128071-200203050-00004; BARNHAM M, 1992, J LARYNGOL OTOL, V106, P1000, DOI 10.1017/S0022215100121590; Barrionuevo C, 2002, APPL IMMUNOHISTO M M, V10, P7, DOI 10.1097/00022744-200203000-00002; Bowers S, 2006, J AM ACAD DERMATOL, V55, P557, DOI 10.1016/j.jaad.2005.07.058; Ersoy-Evans S, 2007, J AM ACAD DERMATOL, V56, P205, DOI 10.1016/j.jaad.2006.08.023; Ito N, 2003, J AM ACAD DERMATOL, V49, P1142, DOI 10.1016/S0190-9622(03)00461-4; Iwatsuki K, 2006, ARCH DERMATOL, V142, P587, DOI 10.1001/archderm.142.5.587; Jowkar F, 2008, J DERMATOL TREAT, V19, P249, DOI 10.1080/09546630701713493; MACKENZIE A, 1995, CLIN INFECT DIS, V21, P177, DOI 10.1093/clinids/21.1.177; MACLEAN PD, 1946, J INFECT DIS, V79, P67, DOI 10.1093/infdis/79.1.69; Magro C, 2002, HUM PATHOL, V33, P788, DOI 10.1053/hupa.2002.125381; MILLER RA, 1986, ANN INTERN MED, V105, P867, DOI 10.7326/0003-4819-105-6-867; Nassef Nashaat E., 1997, Journal of the Egyptian Society of Parasitology, V27, P93; NYMAN M, 1990, J INFECT DIS, V161, P261, DOI 10.1093/infdis/161.2.261; OSTERLUND A, 1995, SCAND J INFECT DIS, V27, P131, DOI 10.3109/00365549509018992; Sotiriou E, 2008, ACTA DERM-VENEREOL, V88, P350, DOI 10.2340/00015555-0441; Yanaba K, 2002, BRIT J DERMATOL, V147, P1249, DOI 10.1046/j.1365-2133.2002.05039.x; Younus F, 2002, J INFECTION, V45, P114, DOI 10.1053/jinf.2002.1024	19	2	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1787	1796		10.1056/NEJMcpc0905543	http://dx.doi.org/10.1056/NEJMcpc0905543			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864678				2022-12-28	WOS:000271185600013
J	Drazen, JM; Van der Weyden, MB; Sahni, P; Rosenberg, J; Marusic, A; Laine, C; Kotzin, S; Horton, R; Hebert, PC; Haug, C; Godlee, F; Frizelle, FA; de Leeuw, PW; DeAngelis, CD				Drazen, Jeffrey M.; Van der Weyden, Martin B.; Sahni, Peush; Rosenberg, Jacob; Marusic, Ana; Laine, Christine; Kotzin, Sheldon; Horton, Richard; Hebert, Paul C.; Haug, Charlotte; Godlee, Fiona; Frizelle, Frank A.; de Leeuw, Peter W.; DeAngelis, Catherine D.			Uniform format for disclosure of competing interests in ICMJE journals	LANCET			English	Editorial Material									[Kotzin, Sheldon] Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)				Sahni, Peush/0000-0002-6910-062X					0	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 24	2009	374	9699					1395	1396		10.1016/S0140-6736(09)61796-7	http://dx.doi.org/10.1016/S0140-6736(09)61796-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19836071				2022-12-28	WOS:000271255000004
J	Falk, A; Heckman, JJ				Falk, Armin; Heckman, James J.			Lab Experiments Are a Major Source of Knowledge in the Social Sciences	SCIENCE			English	Review							LABORATORY EXPERIMENTS; GIFT EXCHANGE; ECONOMICS; PREFERENCES; FAIRNESS; COMPETITION; INCENTIVES; PUNISHMENT; ANONYMITY; IMPACT	Laboratory experiments are a widely used methodology for advancing causal knowledge in the physical and life sciences. With the exception of psychology, the adoption of laboratory experiments has been much slower in the social sciences, although during the past two decades the use of lab experiments has accelerated. Nonetheless, there remains considerable resistance among social scientists who argue that lab experiments lack "realism" and generalizability. In this article, we discuss the advantages and limitations of laboratory social science experiments by comparing them to research based on nonexperimental data and to field experiments. We argue that many recent objections against lab experiments are misguided and that even more lab experiments should be conducted.	[Falk, Armin] Inst Study Labor IZA, Ctr Econ Policy Res, Ctr Econ Studies, D-53113 Bonn, Germany; [Falk, Armin] Inst Study Labor IZA, Ifo Inst Econ Res, D-53113 Bonn, Germany; [Falk, Armin] Univ Bonn, D-53113 Bonn, Germany; [Heckman, James J.] Yale Univ, Univ Coll Dublin, Cowles Fdn, Chicago, IL 60637 USA; [Heckman, James J.] Univ Chicago, Chicago, IL 60637 USA	IZA Institute Labor Economics; Ifo Institut; IZA Institute Labor Economics; University of Bonn; Yale University; University of Chicago	Falk, A (corresponding author), Inst Study Labor IZA, Ctr Econ Policy Res, Ctr Econ Studies, D-53113 Bonn, Germany.							AKERLOF GA, 1990, Q J ECON, V105, P255, DOI 10.2307/2937787; Bellemare C, 2008, ECONOMETRICA, V76, P815, DOI 10.1111/j.1468-0262.2008.00860.x; Bolton GE, 1998, INT J GAME THEORY, V27, P269, DOI 10.1007/s001820050072; BROWNING M, 1999, HDB MACROECONOMICS A, V1, P543; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dohmen T., 2005, IZA DISCUSSION PAPER, V1730; Dohmen T, 2009, ECON J, V119, P592, DOI 10.1111/j.1468-0297.2008.02242.x; Falk A, 2007, ECONOMETRICA, V75, P1501, DOI 10.1111/j.1468-0262.2007.00800.x; Fehr E, 1998, J LABOR ECON, V16, P324, DOI 10.1086/209891; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; FEHR E, 1993, Q J ECON, V108, P437, DOI 10.2307/2118338; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fehr E, 2004, J EUR ECON ASSOC, V2, DOI 10.1162/1542476042782297; Friedman S., 1994, EXPT METHODS PRIMER, DOI 10.1017/cbo9781139174176; Heckman J.J., 1999, HDB LABOR EC, V3, P1865, DOI [10.1016/S1573-4463(99)03012-6, DOI 10.1016/S1573-4463.(99)03012-6]; Heckman JJ, 2008, INT STAT REV, V76, P1, DOI 10.1111/j.1751-5823.2007.00024.x; HECKMAN JJ, 1995, J ECON PERSPECT, V9, P85, DOI 10.1257/jep.9.2.85; HECKMAN JJ, 1974, J POLIT ECON, V82, pS136, DOI 10.1086/260297; HECKMAN JJ, 1992, EVALUATING WELFARE AND TRAINING PROGRAMS, P201; HECKMAN JJ, 2009, REANALYSIS HIGHSCOPE; HECKMAN JJ, 2007, HBK ECON, V2, P4779, DOI DOI 10.1016/S1573-4412(07)06070-9; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Holt Charles, 2006, MARKETS GAMES STRATE; Houser D, 2004, ECONOMETRICA, V72, P781, DOI 10.1111/j.1468-0262.2004.00512.x; JONES SRG, 1992, AM J SOCIOL, V98, P451, DOI 10.1086/230046; KAGEL JH, 1986, AM ECON REV, V76, P894; Kagel JH, 2000, Q J ECON, V115, P201, DOI 10.1162/003355300554719; Kagel JH, 1995, HDB EXPT EC; Karlan DS, 2005, AM ECON REV, V95, P1688, DOI 10.1257/000282805775014407; LAURY SK, 1995, J ECON BEHAV ORGAN, V27, P365, DOI 10.1016/0167-2681(94)00073-N; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Levitt SD, 2009, EUR ECON REV, V53, P1, DOI 10.1016/j.euroecorev.2008.12.001; List JA, 2006, J POLIT ECON, V114, P1, DOI 10.1086/498587; MOOK DG, 1983, AM PSYCHOL, V38, P379, DOI 10.1037/0003-066X.38.4.379; Ostrom E, 2006, J ECON BEHAV ORGAN, V61, P149, DOI 10.1016/j.jebo.2005.02.008; PLOTT CR, 1986, SCIENCE, V232, P732, DOI 10.1126/science.232.4751.732; RASSENTI SJ, 1982, BELL J ECON, V13, P402, DOI 10.2307/3003463; Reuben E, 2008, J PUBLIC ECON, V92, P34, DOI 10.1016/j.jpubeco.2007.04.012; Roth, 1987, LAB EXPT EC 6 POINTS, P193; Roth AE, 2002, ECONOMETRICA, V70, P1341, DOI 10.1111/1468-0262.00335; Siegel S., 1988, NONPARAMETRIC STAT B; SMITH VL, 1994, J ECON PERSPECT, V8, P113, DOI 10.1257/jep.8.1.113; Smith VL, 2003, AM ECON REV, V93, P465, DOI 10.1257/000282803322156954; SMITH VL, 1988, ECONOMETRICA, V56, P1119, DOI 10.2307/1911361; Todd PE, 2006, AM ECON REV, V96, P1384, DOI 10.1257/aer.96.5.1384; Verhoogen E., 2005, FIELD EXPT EC, P261; Webster M., 2007, LAB EXPT SOCIAL SCI; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	63	497	505	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					535	538		10.1126/science.1168244	http://dx.doi.org/10.1126/science.1168244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19900889	Green Submitted			2022-12-28	WOS:000271019400030
J	de Moya, MA; del Carmen, MG; Allain, RM; Hirschberg, RE; Shepard, JAO; Kradin, RL				de Moya, Marc A.; del Carmen, Marcela G.; Allain, Rae M.; Hirschberg, Ronald E.; Shepard, Jo-Anne O.; Kradin, Richard L.			A Woman with Fever, Abdominal Pain, and Hypotension after Cesarean SectionCase 33-2009: A 35-Year-Old Woman with Fever, Abdominal Pain, and Hypotension after Cesarean Section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIC-SHOCK-SYNDROME; A STREPTOCOCCUS INFECTIONS; SOFT-TISSUE INFECTION; TUMOR-NECROSIS-FACTOR; NECROTIZING FASCIITIS; SEPTIC SHOCK; SEVERE SEPSIS; MANAGEMENT; PYOGENES; THERAPY		[de Moya, Marc A.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [del Carmen, Marcela G.] Massachusetts Gen Hosp, Div Gynecol Oncol, Boston, MA 02114 USA; [Allain, Rae M.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [de Moya, Marc A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [del Carmen, Marcela G.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Allain, Rae M.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Hirschberg, Ronald E.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	de Moya, MA (corresponding author), Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA.							Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; Anteby E Y, 1999, Infect Dis Obstet Gynecol, V7, P276, DOI 10.1155/S1064744999000514; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; DELLINGER EP, 1981, JAMA-J AM MED ASSOC, V246, P1717, DOI 10.1001/jama.246.15.1717; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; FAST DJ, 1989, INFECT IMMUN, V57, P291, DOI 10.1128/IAI.57.1.291-294.1989; HACKETT SP, 1992, J INFECT DIS, V165, P879, DOI 10.1093/infdis/165.5.879; HAUSER AR, 1991, J CLIN MICROBIOL, V29, P1562, DOI 10.1128/JCM.29.8.1562-1567.1991; MARRACK P, 1990, SCIENCE, V248, P1066; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; MOLLICK JA, 1991, CLIN RES, V39, pA213; NORRBYTEGLUND A, 1994, INFECT IMMUN, V62, P5227, DOI 10.1128/IAI.62.12.5227-5233.1994; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; Saenz AJ, 2009, VIRCHOWS ARCH, V455, P87, DOI 10.1007/s00428-009-0781-3; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; STAMENKOVIC I, 1984, NEW ENGL J MED, V310, P1689, DOI 10.1056/NEJM198406283102601; STEVENS DL, 1992, CLIN INFECT DIS, V14, P2, DOI 10.1093/clinids/14.1.2; Stevens DL, 2000, ANNU REV MED, V51, P271, DOI 10.1146/annurev.med.51.1.271; Wall DB, 2000, J AM COLL SURGEONS, V191, P227, DOI 10.1016/S1072-7515(00)00318-5; Wong Chin-Ho, 2005, Curr Opin Infect Dis, V18, P101, DOI 10.1097/01.qco.0000160896.74492.ea; 2005, CIRCULATION S4, V112, P1	24	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1689	1697		10.1056/NEJMcpc0900646	http://dx.doi.org/10.1056/NEJMcpc0900646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846855				2022-12-28	WOS:000270977400013
J	Perilongo, G; Maibach, R; Shafford, E; Brugieres, L; Brock, P; Morland, B; de Camargo, B; Zsiros, J; Roebuck, D; Zimmermann, A; Aronson, D; Childs, M; Widing, E; Laithier, V; Plaschkes, J; Pritchard, J; Scopinaro, M; MacKinlay, G; Czauderna, P				Perilongo, Giorgio; Maibach, Rudolf; Shafford, Elisabeth; Brugieres, Laurence; Brock, Penelope; Morland, Bruce; de Camargo, Beatriz; Zsiros, Jozsef; Roebuck, Derek; Zimmermann, Arthur; Aronson, Daniel; Childs, Margaret; Widing, Eva; Laithier, Veronique; Plaschkes, Jack; Pritchard, Jon; Scopinaro, Marcello; MacKinlay, Gordon; Czauderna, Piotr			Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRETREATMENT PROGNOSTIC-FACTORS; PEDIATRIC-ONCOLOGY-GROUP; CHILDHOOD HEPATOBLASTOMA; INTERNATIONAL SOCIETY; LIVER-TUMOR; INFUSION DOXORUBICIN; CHILDREN; CHEMOTHERAPY; TOXICITY; SYSTEM	Background Preoperative cisplatin alone may be as effective as cisplatin plus doxorubicin in standard-risk hepatoblastoma (a tumor involving three or fewer sectors of the liver that is associated with an alpha-fetoprotein level of >100 ng per milliliter). Methods Children with standard-risk hepatoblastoma who were younger than 16 years of age were eligible for inclusion in the study. After they received one cycle of cisplatin (80 mg per square meter of body-surface area per 24 hours), we randomly assigned patients to receive cisplatin (every 14 days) or cisplatin plus doxorubicin administered in three preoperative cycles and two postoperative cycles. The primary outcome was the rate of complete resection, and the trial was powered to test the noninferiority of cisplatin alone (<10% difference in the rate of complete resection). Results Between June 1998 and December 2006, 126 patients were randomly assigned to receive cisplatin and 129 were randomly assigned to receive cisplatin plus doxorubicin. The rate of complete resection was 95% in the cisplatin-alone group and 93% in the cisplatin-doxorubicin group in the intention-to-treat analysis (difference, 1.4%; 95% confidence interval [CI],-4.1 to 7.0); these rates were 99% and 95%, respectively, in the per-protocol analysis. Three-year event-free survival and overall survival were, respectively, 83% (95% CI, 77 to 90) and 95% (95% CI, 91 to 99) in the cisplatin group, and 85% (95% CI, 79 to 92) and 93% (95% CI, 88 to 98) in the cisplatin-doxorubicin group (median follow-up, 46 months). Acute grade 3 or 4 adverse events were more frequent with combination therapy (74.4% vs. 20.6%). Conclusions As compared with cisplatin plus doxorubicin, cisplatin monotherapy achieved similar rates of complete resection and survival among children with standard-risk hepatoblastoma. Doxorubicin can be safely omitted from the treatment of standard-risk hepatoblastoma. (ClinicalTrials.gov number, NCT00003912.)	[Perilongo, Giorgio] Univ Hosp Padua, Dept Pediat, Div Hematol Oncol, I-35128 Padua, Italy; [Maibach, Rudolf] Int Breast Canc Study Grp, Coordinating Ctr, Bern, Switzerland; [Zimmermann, Arthur] Univ Bern, Inst Pathol, Dept Surg Pathol, Bern, Switzerland; [Plaschkes, Jack] Univ Childrens Hosp, Dept Surg, Bern, Switzerland; [Shafford, Elisabeth; Childs, Margaret] Childrens Canc & Leukaemia Grp, Ctr Data, Leicester, Leics, England; [Brock, Penelope; Roebuck, Derek] Great Ormond St Hosp Sick Children, London, England; [Morland, Bruce] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Pritchard, Jon; MacKinlay, Gordon] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Brugieres, Laurence; Laithier, Veronique] Inst Gustave Roussy, Dept Pediat, Villejuif, France; [de Camargo, Beatriz] Hosp Canc, Dept Res, Sao Paulo, Brazil; [Zsiros, Jozsef] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Aronson, Daniel] Radboud Univ Nijmegen, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Widing, Eva] Ullevaal Univ Hosp, Dept Pediat, Oslo, Norway; [Scopinaro, Marcello] Prof Dr Juan P Garrahan Childrens Hosp, Serv Hematooncol, Buenos Aires, DF, Argentina; [Czauderna, Piotr] Med Univ Gdansk, Dept Surg & Urol Children & Adolescents, Gdansk, Poland	University of Padua; Azienda Ospedaliera - Universita di Padova; International Breast Cancer Study Group; University of Bern; University of Bern; University Hospital of Bern; University of Leicester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Birmingham; UNICANCER; Gustave Roussy; A.C.Camargo Cancer Center; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Oslo; Hospital de Pediatria Doctor Juan Garrahan; Fahrenheit Universities; Medical University Gdansk	Perilongo, G (corresponding author), Univ Hosp Padua, Dept Pediat, Div Hematol Oncol, Via Giustiniani 3, I-35128 Padua, Italy.	giorgio.perilongo@unipd.it	de Camargo, Beatriz/I-8414-2014; Czauderna, Piotr/AAR-8455-2020; Roebuck, Derek/ABB-8690-2021	de Camargo, Beatriz/0000-0002-5794-1042; Czauderna, Piotr/0000-0002-5266-8665; PERILONGO, GIORGIO/0000-0002-3712-0386; Roebuck, Derek/0000-0003-1734-2536	Cancer Research UK; Cancer Research Switzerland/Oncosuisse	Cancer Research UK(Cancer Research UK); Cancer Research Switzerland/Oncosuisse	Supported in part by grants from Cancer Research UK and Cancer Research Switzerland/Oncosuisse.	Aronson DC, 2005, J CLIN ONCOL, V23, P1245, DOI 10.1200/JCO.2005.07.145; BROCK PR, 1991, MED PEDIATR ONCOL, V19, P295, DOI 10.1002/mpo.2950190415; Brown J, 2000, EUR J CANCER, V36, P1418, DOI 10.1016/S0959-8049(00)00074-5; De Ioris M, 2008, EUR J CANCER, V44, P545, DOI 10.1016/j.ejca.2007.11.022; DOUGLASS EC, 1993, J CLIN ONCOL, V11, P96, DOI 10.1200/JCO.1993.11.1.96; Finegold MJ, 2002, MED PEDIATR ONCOL, V39, P484, DOI 10.1002/mpo.10172; Fuchs J, 2002, CANCER-AM CANCER SOC, V95, P172, DOI 10.1002/cncr.10632; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; NINANE J, 1991, MED PEDIATR ONCOL, V19, P199, DOI 10.1002/mpo.2950190310; Ortega JA, 2000, J CLIN ONCOL, V18, P2665, DOI 10.1200/JCO.2000.18.14.2665; ORTEGA JA, 1991, J CLIN ONCOL, V9, P2167, DOI 10.1200/JCO.1991.9.12.2167; Perilongo G, 2004, EUR J CANCER, V40, P411, DOI 10.1016/j.ejca.2003.06.003; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2006, JAMA-J AM MED ASSOC, V296, P1842; Pritchard J, 2000, J CLIN ONCOL, V18, P3819, DOI 10.1200/JCO.2000.18.22.3819; Sasaki F, 2002, J PEDIATR SURG, V37, P851, DOI 10.1053/jpsu.2002.32886; Trobaugh-Lotrario AD, 2009, PEDIATR BLOOD CANCER, V52, P328, DOI 10.1002/pbc.21834; vonSchweinitz D, 1997, EUR J CANCER, V33, P1243	18	180	198	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1662	1670		10.1056/NEJMoa0810613	http://dx.doi.org/10.1056/NEJMoa0810613			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846851	Green Published			2022-12-28	WOS:000270977400008
J	Thomsen, RW; Schoonen, WM; Farkas, DK; Riis, A; Jacobsen, J; Fryzek, JP; Sorensen, HT				Thomsen, Reimar W.; Schoonen, W. Marieke; Farkas, Dora K.; Riis, Anders; Jacobsen, Jacob; Fryzek, Jon P.; Sorensen, Henrik Toft			Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; MORTALITY; BACTEREMIA; PROPHYLAXIS; PNEUMONIA; SEPSIS; ADULTS	Background: Splenectomy has been associated with increased risk for infection. Objective: To assess the magnitude and duration of risk for hospital contact with infection associated with splenectomy. Design: Population-based cohort study. Setting: Denmark. Patients: All 3812 persons in Denmark who underwent splenectomy from 1996 to 2005. Splenectomized patients were matched to 3 comparison cohorts: the general population, appendectomized patients, and unsplenectomized patients with indications for splenectomy. Measurements: Relative risks were assessed for hospital contact involving any infection, pneumonia, and microbiologically confirmed bacteremia among 3812 splenectomized patients and their matched comparisons, during different follow-up periods and after regression analysis for confounder adjustment. Results: The adjusted relative risk for any hospital contact with infection was highest within 90 days of splenectomy: 10.2% vs. 0.6% among general population comparisons (adjusted odds ratio, 18.1 [95% CI, 14.8 to 22.1]) and 10.2% vs. 4.2% among appendectomized patients (adjusted odds ratio, 2.4 [ CI, 2.1 to 2.8]). The hazard of infection was 4.6-fold (CI, 3.8 to 5.5) higher in splenectomized patients than in general population comparisons from 91 to 365 days after splenectomy and 2.5 times (CI, 2.2 to 2.8) higher more than 365 days after splenectomy. The risks were similar for pneumonia and were higher for bacteremia. Markedly increased risks were also found when compared with those of appendectomized patients. Modest increases in infection risk were seen with splenectomy matched-indication comparisons (adjusted 90-day odds ratio, 1.7 [CI, 1.5 to 2.1]; hazard ratios, 1.5 [CI, 1.2 to 1.8] from 91 to 365 days after splenectomy and 1.2 [CI, 1.1 to 1.4] beyond 365 days after splenectomy). Relative risks for infection were highest in patients who had splenectomy because of hematologic disorders. Limitation: Increased surveillance among splenectomized patients may have affected the findings. Conclusion: Splenectomy is associated with increased long-term risk for infections involving hospital contact.	[Thomsen, Reimar W.] Aarhus Univ Hosp, Aalborg Hosp, Sci & Innovat Ctr, Dept Clin Epidemiol, DK-9000 Aalborg, Denmark; [Schoonen, W. Marieke] Amgen Inc, Uxbridge UB8 1DH, Middx, England; [Farkas, Dora K.; Riis, Anders; Jacobsen, Jacob; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus, Denmark; [Fryzek, Jon P.] Amgen Inc, Thousand Oaks, CA 91360 USA	Aalborg University; Aalborg University Hospital; Aarhus University; Amgen; Amgen Limited; Aarhus University; Amgen	Thomsen, RW (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Sci & Innovat Ctr, Dept Clin Epidemiol, Sondre Skovvej 15, DK-9000 Aalborg, Denmark.	thomsen@rn.dk; hts@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Thomsen, Reimar/0000-0001-9135-3474; Riis, Anders Hammerich/0000-0002-6684-4068	Amgen; Clinical Epidemiological Research Founddation at Aarhus University; Karen Elise Jensens Foundation	Amgen(Amgen); Clinical Epidemiological Research Founddation at Aarhus University; Karen Elise Jensens Foundation	Grant Support: By Amgen, the Clinical Epidemiological Research Founddation at Aarhus University, and the Karen Elise Jensens Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; BIRGENS HS, 2003, BENIGNE HAEMATOLOGIS; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; CHAPLIN DD, 2003, FUNDAMENTAL IMMUNOLO, P419; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; DEODHAR HA, 1993, BRIT MED J, V307, P1408, DOI 10.1136/bmj.307.6916.1408; Ejstrud P, 1997, EUR J SURG, V163, P733; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; Ernstrom F, 1998, Ugeskr Laeger, V160, P2887; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; GORDON S, 2003, FUNDAMENTAL IMMUNOLO, P482; KINNERSLEY P, 1993, BRIT MED J, V307, P1398, DOI 10.1136/bmj.307.6916.1398; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Kyaw MH, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.07.044; Kyaw MH, 2002, J CLIN PATHOL, V55, P472, DOI 10.1136/jcp.55.6.472; MELLEMKJAER L, 1995, CANCER, V75, P577, DOI 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K; Newland A, 2005, BRIT MED J, V331, P417, DOI 10.1136/bmj.331.7514.417; Sampath S, 2007, AM J SURG, V193, P580, DOI 10.1016/j.amjsurg.2007.02.002; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Schonheyder Henrik C, 2007, Ugeskr Laeger, V169, P4175; SCHWARTZ PE, 1982, JAMA-J AM MED ASSOC, V248, P2279, DOI 10.1001/jama.248.18.2279; Sogaard M, 2008, J AM GERIATR SOC, V56, P1593, DOI 10.1111/j.1532-5415.2008.01855.x; Sorensen HT, 1996, INT J EPIDEMIOL, V25, P435, DOI 10.1093/ije/25.2.435; *STAT SER I, EPI NEWS NAT SURV CO; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Wiseman J, 2006, AM SURGEON, V72, P947	29	105	110	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					546	U56		10.7326/0003-4819-151-8-200910200-00008	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19841456				2022-12-28	WOS:000271386200004
J	Nash, R				Nash, Robert			The "killing season": does inexperience cost lives?	LANCET			English	Editorial Material									Northwick Pk Hosp & Clin Res Ctr, NW London Hosp NHS Trust, London HA1 3UJ, England	Imperial College London	Nash, R (corresponding author), Northwick Pk Hosp & Clin Res Ctr, NW London Hosp NHS Trust, London HA1 3UJ, England.	robertnash@doctors.org.uk	Nash, Robert/AAO-9847-2020	Nash, Robert/0000-0002-7861-3734				AYLIN P, 1994, BRIT MED J, V309, P1690, DOI 10.1136/bmj.309.6970.1690; BARRY WA, 2001, SURGERY, V130, P346; Borenstein SH, 2004, J SURG RES, V122, P162, DOI 10.1016/j.jss.2004.05.014; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Shulkin D J, 1995, Am J Med Qual, V10, P14, DOI 10.1177/0885713X9501000104	5	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 17	2009	374	9698					1313	1314		10.1016/S0140-6736(09)61805-5	http://dx.doi.org/10.1016/S0140-6736(09)61805-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19837239				2022-12-28	WOS:000271254600010
J	Zou, LN; Cheng, X; Rivers, ML; Jaeger, HM; Nagel, SR				Zou, Ling-Nan; Cheng, Xiang; Rivers, Mark L.; Jaeger, Heinrich M.; Nagel, Sidney R.			The Packing of Granular Polymer Chains	SCIENCE			English	Article							RANDOM CLOSE PACKING; DENSITY; RELAXATION; DYNAMICS; LIQUIDS	Rigid particles pack into structures, such as sand dunes on the beach, whose overall stability is determined by the average number of contacts between particles. However, when packing spatially extended objects with flexible shapes, additional concepts must be invoked to understand the stability of the resulting structure. Here, we examine the disordered packing of chains constructed out of flexibly connected hard spheres. Using x-ray tomography, we find that long chains pack into a low-density structure whose mechanical rigidity is mainly provided by the backbone. On compaction, randomly oriented, semi-rigid loops form along the chain, and the packing of chains can be understood as the jamming of these elements. Finally, we uncover close similarities between the packing of chains and the glass transition in polymers.	[Zou, Ling-Nan; Cheng, Xiang; Jaeger, Heinrich M.; Nagel, Sidney R.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Zou, Ling-Nan; Cheng, Xiang; Jaeger, Heinrich M.; Nagel, Sidney R.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Cheng, Xiang] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Rivers, Mark L.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Rivers, Mark L.] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Cornell University; University of Chicago; University of Chicago	Zou, LN (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	zou@uchicago.edu	Cheng, Xiang/G-1802-2015; Cheng, Xiang/G-5704-2017; Cheng, Xiang/E-7494-2012	Cheng, Xiang/0000-0002-2759-764X	NSF Materials Research Science and Engineering Center [DMR-0820054]; U. S. Department of Energy (DOE) [DE-FG02-03ER46088, DE-FG02-94ER14466, DE-AC02-06CH11357]; NSF [EAR-0622171]	NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); U. S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	We thank P. Eng for his assistance and T. Witten for fruitful discussions. This work is supported by grants from NSF Materials Research Science and Engineering Center (DMR-0820054) and the U. S. Department of Energy (DOE) (DE-FG02-03ER46088). GSECARS is supported by grants from NSF (EAR-0622171) and DOE (DE-FG02-94ER14466). Use of the Advanced Photon Source is supported by DOE, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Aste T., 2008, PURSUIT PERFECT PACK, V2nd; BERNAL JD, 1959, NATURE, V183, P141, DOI 10.1038/183141a0; CAHN RW, 1980, CONTEMP PHYS, V21, P43, DOI 10.1080/00107518008210940; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; Edwards SF, 2002, ADV PHYS, V51, P1669, DOI 10.1080/0001873021000030780; Eisenberg A., 1993, PHYS PROPERTIES POLY; FINNEY JL, 1970, PROC R SOC LON SER-A, V319, P479, DOI [10.1098/rspa.1970.0189, 10.1098/rspa.1970.0190]; FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711; JERNIGAN RL, 1969, J CHEM PHYS, V50, P4178, DOI 10.1063/1.1670883; KNIGHT JB, 1995, PHYS REV E, V51, P3957, DOI 10.1103/PhysRevE.51.3957; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Man WN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198001; Nowak ER, 1998, PHYS REV E, V57, P1971, DOI 10.1103/PhysRevE.57.1971; SCOTT GD, 1962, NATURE, V194, P956, DOI 10.1038/194956a0; Silbert LE, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041304; Villarruel FX, 2000, PHYS REV E, V61, P6914, DOI 10.1103/PhysRevE.61.6914; Williams SR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051301; Zallen R., 1998, PHYS AMORPHOUS SOLID; Zeravcic Z, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/26001	22	95	98	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					408	410		10.1126/science.1177114	http://dx.doi.org/10.1126/science.1177114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833964	Green Submitted			2022-12-28	WOS:000270818600048
J	Levin, EJ; Quick, M; Zhou, M				Levin, Elena J.; Quick, Matthias; Zhou, Ming			Crystal structure of a bacterial homologue of the kidney urea transporter	NATURE			English	Article							AMMONIA TRANSPORT; COLLECTING DUCT; MOLECULAR-BASIS; CHANNEL; WATER; MECHANISM; PHOSPHORYLATION; CLONING; FAMILY; UT-A1	Urea is highly concentrated in the mammalian kidney to produce the osmotic gradient necessary for water re-absorption. Free diffusion of urea across cell membranes is slow owing to its high polarity, and specialized urea transporters have evolved to achieve rapid and selective urea permeation. Here we present the 2.3 angstrom structure of a functional urea transporter from the bacterium Desulfovibrio vulgaris. The transporter is a homotrimer, and each subunit contains a continuous membrane-spanning pore formed by the two homologous halves of the protein. The pore contains a constricted selectivity filter that can accommodate several dehydrated urea molecules in single file. Backbone and side-chain oxygen atoms provide continuous coordination of urea as it progresses through the filter, and well-placed alpha-helix dipoles provide further compensation for dehydration energy. These results establish that the urea transporter operates by a channel-like mechanism and reveal the physical and chemical basis of urea selectivity.	[Levin, Elena J.; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu			US National Institutes of Health [HL086392, T32HL087745]; NIH [GM075026]; American Heart Association [0630148N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392, T32HL087745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. MacKinnon for advice and support throughout the project, C. Miller and E. Gouaux for comments on the manuscript, J. Love and NYCOMPS for cloning and the initial screen of protein expression levels, Y. Pan for messenger RNA preparation and oocyte injection, and J. Weng and Y. Cao for crystal screening and data collection at the synchrotrons. Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the NSLS and the NE-CAT 24ID- E at the Advanced Photon Source. This work was supported by the US National Institutes of Health (HL086392 to M. Z. and T32HL087745 to E. J. L.), the NYCOMPS that is supported by the NIH Protein Structure Initiatives PSI- II (GM075026 to W. A. Hendrickson), and the American Heart Association (0630148N to M. Z.). M. Z. is a Pew Scholar in Biomedical Sciences.	Bagnasco SM, 2005, PFLUG ARCH EUR J PHY, V450, P217, DOI 10.1007/s00424-005-1403-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blount MA, 2007, AM J PHYSIOL-RENAL, V293, pF1308, DOI 10.1152/ajprenal.00197.2007; Bradford AD, 2001, AM J PHYSIOL-RENAL, V281, pF133, DOI 10.1152/ajprenal.2001.281.1.F133; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOU CL, 1989, AM J PHYSIOL, V257, pF359, DOI 10.1152/ajprenal.1989.257.3.F359; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hediger MA, 1996, KIDNEY INT, V49, P1615, DOI 10.1038/ki.1996.235; Imai YN, 2009, J COMPUT CHEM, V30, P2267, DOI 10.1002/jcc.21212; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kojima S, 2006, J MEMBRANE BIOL, V212, P83, DOI 10.1007/s00232-006-0868-6; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Levin MH, 2007, FASEB J, V21, P551, DOI 10.1096/fj.06-6979com; Lucien N, 2002, J BIOL CHEM, V277, P34101, DOI 10.1074/jbc.M205073200; MacIver B, 2008, AM J PHYSIOL-RENAL, V294, pF956, DOI 10.1152/ajprenal.00229.2007; MANNUZZU LM, 1993, J MEMBRANE BIOL, V133, P85; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minocha R, 2003, RECEPTOR CHANNEL, V9, P345, DOI 10.3109/714041015; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Raunser S, 2009, J MOL BIOL, V387, P619, DOI 10.1016/j.jmb.2009.02.005; Sands JM, 2003, ANNU REV PHYSIOL, V65, P543, DOI 10.1146/annurev.physiol.65.092101.142638; Sebbane F, 2002, MOL MICROBIOL, V45, P1165, DOI 10.1046/j.1365-2958.2002.03096.x; Shayakul C, 2004, PFLUG ARCH EUR J PHY, V447, P603, DOI 10.1007/s00424-003-1124-x; Shayakul C, 1996, J CLIN INVEST, V98, P2580, DOI 10.1172/JCI119077; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Terris JM, 2001, AM J PHYSIOL-RENAL, V280, pF325, DOI 10.1152/ajprenal.2001.280.2.F325; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valladares A, 2002, MOL MICROBIOL, V43, P703, DOI 10.1046/j.1365-2958.2002.02778.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang BX, 2002, J BIOL CHEM, V277, P36782, DOI 10.1074/jbc.M206948200; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0; Zhang C, 2002, AM J PHYSIOL-RENAL, V282, pF85, DOI 10.1152/ajprenal.0054.2001; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	47	78	85	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					757	U72		10.1038/nature08558	http://dx.doi.org/10.1038/nature08558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19865084	Green Accepted			2022-12-28	WOS:000272559900031
J	Rittenhouse, DR; Shortell, SM; Fisher, ES				Rittenhouse, Diane R.; Shortell, Stephen M.; Fisher, Elliott S.			Primary Care and Accountable Care -- Two Essential Elements of Delivery-System Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL HOME		[Rittenhouse, Diane R.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Fisher, Elliott S.] Dartmouth Med Sch, Lebanon, NH USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Dartmouth College; Dartmouth College	Rittenhouse, DR (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.							Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; McKethan A., 2009, HLTH AFFAIRS BL 0820; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Tollen L., 2008, PHYS ORG RELATION QU	5	267	268	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2301	2303		10.1056/NEJMp0909327	http://dx.doi.org/10.1056/NEJMp0909327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	529VS	19864649				2022-12-28	WOS:000272547600001
J	Pfeffer, MA; Burdmann, EA; Chen, CY; Cooper, ME; de Zeeuw, D; Eckardt, KU; Feyzi, JM; Ivanovich, P; Kewalramani, R; Levey, AS; Lewis, EF; McGill, JB; McMurray, JJV; Parfrey, P; Parving, HH; Remuzzi, G; Singh, AK; Solomon, SD; Toto, R				Pfeffer, Marc A.; Burdmann, Emmanuel A.; Chen, Chao-Yin; Cooper, Mark E.; de Zeeuw, Dick; Eckardt, Kai-Uwe; Feyzi, Jan M.; Ivanovich, Peter; Kewalramani, Reshma; Levey, Andrew S.; Lewis, Eldrin F.; McGill, Janet B.; McMurray, John J. V.; Parfrey, Patrick; Parving, Hans-Henrik; Remuzzi, Giuseppe; Singh, Ajay K.; Solomon, Scott D.; Toto, Robert		TREAT Investigators	A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; STAGE RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; HEMODIALYSIS-PATIENTS; ANEMIA CORRECTION; EPOETIN-ALPHA; RISK-FACTOR; MORTALITY; INTERVENTION; METAANALYSIS	BACKGROUND Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested. METHODS In this study involving 4038 patients with diabetes, chronic kidney disease, and anemia, we randomly assigned 2012 patients to darbepoetin alfa to achieve a hemoglobin level of approximately 13 g per deciliter and 2026 patients to placebo, with rescue darbepoetin alfa when the hemoglobin level was less than 9.0 g per deciliter. The primary end points were the composite outcomes of death or a cardiovascular event (nonfatal myocardial infarction, congestive heart failure, stroke, or hospitalization for myocardial ischemia) and of death or end-stage renal disease. RESULTS Death or a cardiovascular event occurred in 632 patients assigned to darbepoetin alfa and 602 patients assigned to placebo ( hazard ratio for darbepoetin alfa vs. placebo, 1.05; 95% confidence interval [CI], 0.94 to 1.17; P = 0.41). Death or end-stage renal disease occurred in 652 patients assigned to darbepoetin alfa and 618 patients assigned to placebo ( hazard ratio, 1.06; 95% CI, 0.95 to 1.19; P = 0.29). Fatal or nonfatal stroke occurred in 101 patients assigned to darbepoetin alfa and 53 patients assigned to placebo ( hazard ratio, 1.92; 95% CI, 1.38 to 2.68; P<0.001). Red-cell transfusions were administered to 297 patients assigned to darbepoetin alfa and 496 patients assigned to placebo (P<0.001). There was only a modest improvement in patient-reported fatigue in the darbepoetin alfa group as compared with the placebo group. CONCLUSIONS The use of darbepoetin alfa in patients with diabetes, chronic kidney disease, and moderate anemia who were not undergoing dialysis did not reduce the risk of either of the two primary composite outcomes ( either death or a cardiovascular event or death or a renal event) and was associated with an increased risk of stroke. For many persons involved in clinical decision making, this risk will outweigh the potential benefits. (ClinicalTrials.gov number, NCT00093015.)	[Pfeffer, Marc A.] Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Dept Med,Med Sch, Boston, MA 02115 USA; [Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Burdmann, Emmanuel A.] Hosp Base, Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, Brazil; [Chen, Chao-Yin; Kewalramani, Reshma] Amgen Inc, Global Biostat & Epidemiol & Global Clin Dev, Thousand Oaks, CA USA; [Cooper, Mark E.] Baker Heart Res Inst, Melbourne, Vic, Australia; [de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Div Clin Pharmacol, NL-9713 AV Groningen, Netherlands; [Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Feyzi, Jan M.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Ivanovich, Peter] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [McGill, Janet B.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [McMurray, John J. V.] British Heart Fdn Glasgow Cardiovasc Res Ctr, Dept Cardiol, Glasgow, Lanark, Scotland; [Parfrey, Patrick] Hlth Sci Ctr, Div Nephrol, St John, NF, Canada; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Parving, Hans-Henrik] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Toto, Robert] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Amgen; Baker Heart and Diabetes Institute; University of Groningen; University of Erlangen Nuremberg; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); University of Glasgow; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Rigshospitalet; University of Copenhagen; Aarhus University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pfeffer, MA (corresponding author), Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Dept Med,Med Sch, 75 Francis St, Boston, MA 02115 USA.	mpfeffer@rics.bwh.harvard.edu	Ponikowski, Piotr/O-6454-2015; mcmurray, John/B-2467-2013; Colussi, Giacomo/AFV-2812-2022; Salgado Filho, Natalino/P-2276-2014; Singh, Ajay/AAF-4414-2020; Johnson, David/F-2897-2011; Solomon, Scott/I-5789-2013; Saudek, František/E-1975-2018; de Zeeuw, Dick/E-9080-2014; Burdmann, Emmanuel/AAY-1966-2020; ALMEIDA, FERNANDO/S-1880-2019; Ferreira-Filho, S R/G-2354-2012; Kesari, Santosh/E-8461-2013; Burdmann, Emmanuel/B-7023-2009; Cooper, Mark/AAC-5326-2020; Wilson, Matthew H/K-3193-2013; Cooper, Mark E/E-8680-2010; de Jesus Falcão Pestana Vasconcelos, Manuel/AGX-6239-2022; de Jesus Falcão Pestana Vasconcelos, Manuel/E-9226-2013; Schäffler, Andreas/W-2384-2019; Remuzzi, Giuseppe/V-9766-2017	Ponikowski, Piotr/0000-0002-3391-7064; mcmurray, John/0000-0002-6317-3975; Colussi, Giacomo/0000-0001-6133-1899; Johnson, David/0000-0001-5491-3460; Saudek, František/0000-0002-0448-4351; de Zeeuw, Dick/0000-0003-3434-7777; ALMEIDA, FERNANDO/0000-0002-9404-9707; Ferreira-Filho, S R/0000-0003-4176-9572; Burdmann, Emmanuel/0000-0002-7644-8579; Cooper, Mark E/0000-0002-5953-642X; de Jesus Falcão Pestana Vasconcelos, Manuel/0000-0003-1482-2024; de Jesus Falcão Pestana Vasconcelos, Manuel/0000-0003-1482-2024; Hojs, Radovan/0000-0001-9735-6959; Busnach, Ghil/0000-0002-4013-050X; rossing, peter/0000-0002-1531-4294; Liang, Chang-seng/0000-0002-0328-0277; Shilo, Valeriy/0000-0001-9025-8061; Grzeszczak, Wladyslaw/0000-0003-1947-3783; Capasso, Giovambattista/0000-0003-3469-8614; BICHET, DANIEL-G/0000-0003-2856-6850; Remuzzi, Giuseppe/0000-0002-6194-3446	Amgen; Baxter; Celladon; Novartis; Sanofi-Aventis; Roche; Robert Wood Johnson Foundation; Boehringer Ingelheim; BMS; AstraZeneca; Cytokinetics; Hoffmann-La Roche; Pfizer; Scios; GlaxoSmithKline; Johnson & Johnson; AMAG Pharmaceuticals; Watson; Reata; Abbott; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	Amgen(Amgen); Baxter; Celladon; Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Boehringer Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Cytokinetics; Hoffmann-La Roche(Hoffmann-La Roche); Pfizer(Pfizer); Scios; GlaxoSmithKline(GlaxoSmithKline); Johnson & Johnson(Johnson & JohnsonJohnson & Johnson USA); AMAG Pharmaceuticals; Watson; Reata; Abbott(Abbott Laboratories); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by Amgen, which provided independent statistical support through a contract with the board of regents for the University of Wisconsin System for data analysis for the TREAT Data and Safety Monitoring Committee as well as for the study.; Dr. Pfeffer reports receiving consulting fees from Abbott, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Centocor, CVRx, Genentech, Cytokinetics, Daiichi Sankyo, Genzyme, Medtronic, Novartis, Roche, Sanofi-Aventis, Servier, and VIA Pharmaceutics and grant support from Amgen, Baxter, Celladon, Novartis, and Sanofi-Aventis, and being named coinventor on a patent for the use of inhibitors of the renin-angiotensin system in selected survivors of myocardial infarction; Dr. Burdmann, receiving consulting fees from Amgen and Sigma Pharma and grant support from Amgen and Roche; Drs. Chen and Kewalramani, being employees of and owning stock in Amgen; Dr. Cooper, receiving consulting fees from Amgen; Dr. de Zeeuw, receiving consulting fees from Amgen and Novartis and lecture fees from Amgen; Dr. Eckardt, receiving consulting fees from Amgen, Ortho Biotech, Roche, Affymax, Stada, and Sandoz-Hexal and lecture fees from Amgen, Ortho Biotech, and Roche; Dr. Ivanovich, receiving consulting fees from Amgen, Baxter, Biogen, and Reata; Dr. Levey, receiving grant support from Amgen; Dr. Lewis, receiving consulting fees from Amgen and grant support from Amgen and the Robert Wood Johnson Foundation; Dr. McGill, receiving consulting fees from Amgen and Boehringer Ingelheim, lecture fees from Novartis, and grant support from Novartis and Boehringer Ingelheim; Dr. McMurray, receiving consulting fees from Menarini, Bristol- Myers Squibb, Roche, Novocardia, Boehringer Ingelheim, Novartis, BioMerieux, and Boston Scientific, lecture fees from AstraZeneca, Solvay, Takeda, Novartis, BMS Sanofi, and Vox Media, and grant support from BMS, Novartis, Amgen, AstraZeneca, Cytokinetics, Hoffmann-La Roche, Pfizer, Scios, and GlaxoSmithKline; Dr. Parfrey, receiving consulting and lecture fees from Amgen and lecture fees from Ortho Biotech; Dr. Parving, receiving consulting fees from Amgen and Novartis and lecture fees from Novartis; Dr. Singh, receiving consulting fees from Johnson & Johnson and Watson, lecture fees from Johnson & Johnson, Amgen, and Watson, and grant support from Johnson & Johnson, Amgen, Roche, AMAG Pharmaceuticals, and Watson; Dr. Solomon, receiving grant support from Amgen; and Dr. Toto, receiving consulting and lecture fees from Amgen and grant support from Novartis, Reata, and Abbott. No other potential conflict of interest relevant to this article was reported.	Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bohlius J, 2009, LANCET, V374, P28; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Califf RM, 2002, CIRCULATION, V106, P1015, DOI 10.1161/01.CIR.0000023260.78078.BB; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; EHRENREICH H, 2009, STROKE          1015; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; *FOOD DRUG ADM, FDA BLOCK BOX WARN A; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1666, DOI 10.1093/ndt/gfh314; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Mozzicato P, 2007, DRUG SAFETY, V30, P617, DOI 10.2165/00002018-200730070-00009; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; PFEFFER MA, 2005, REV CARDIOVASC MED S, V3, pS35; Pfeffer MA, 2008, AM J KIDNEY DIS, V51, P366, DOI 10.1053/j.ajkd.2008.01.003; Pfeffer MA, 2007, NEW ENGL J MED, V356, P959, DOI 10.1056/NEJMc066568; Pfeffer MA, 2009, AM J KIDNEY DIS, V54, P59, DOI 10.1053/j.ajkd.2009.04.008; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; Strippoli GFM, 2007, LANCET, V369, P346, DOI 10.1016/S0140-6736(07)60165-2; Tonelli M, 2005, CIRCULATION, V112, P171, DOI 10.1161/CIRCULATIONAHA.104.517565; Tong PCY, 2006, DIABETES CARE, V29, P2439, DOI 10.2337/dc06-0887; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226	35	1464	1517	2	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2019	2032		10.1056/NEJMoa0907845	http://dx.doi.org/10.1056/NEJMoa0907845			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19880844				2022-12-28	WOS:000271898600007
J	Stockinger, ZT				Stockinger, Zsolt T.			Death and Life in Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												zsolt.stockinger@med.navy.mil						Stockinger ZT, 2005, JAMA-J AM MED ASSOC, V294, P17, DOI 10.1001/jama.294.1.17	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1947	1947		10.1001/jama.2009.1541	http://dx.doi.org/10.1001/jama.2009.1541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903907				2022-12-28	WOS:000271619700001
J	Elser, JJ; Andersen, T; Baron, JS; Bergstrom, AK; Jansson, M; Kyle, M; Nydick, KR; Steger, L; Hessen, DO				Elser, James J.; Andersen, Tom; Baron, Jill S.; Bergstroem, Ann-Kristin; Jansson, Mats; Kyle, Marcia; Nydick, Koren R.; Steger, Laura; Hessen, Dag O.			Shifts in Lake N:P Stoichiometry and Nutrient Limitation Driven by Atmospheric Nitrogen Deposition	SCIENCE			English	Article							PHOSPHORUS LIMITATION; PHYTOPLANKTON; EUTROPHICATION; ENRICHMENT; DIVERSITY; GRADIENT; CYCLE	Human activities have more than doubled the amount of nitrogen (N) circulating in the biosphere. One major pathway of this anthropogenic N input into ecosystems has been increased regional deposition from the atmosphere. Here we show that atmospheric N deposition increased the stoichiometric ratio of N and phosphorus (P) in lakes in Norway, Sweden, and Colorado, United States, and, as a result, patterns of ecological nutrient limitation were shifted. Under low N deposition, phytoplankton growth is generally N-limited; however, in high-N deposition lakes, phytoplankton growth is consistently P-limited. Continued anthropogenic amplification of the global N cycle will further alter ecological processes, such as biogeochemical cycling, trophic dynamics, and biological diversity, in the world's lakes, even in lakes far from direct human disturbance.	[Elser, James J.; Kyle, Marcia; Steger, Laura] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Andersen, Tom; Hessen, Dag O.] Univ Oslo, Dept Biol, N-0316 Oslo, Norway; [Baron, Jill S.] Colorado State Univ, US Geol Survey, Ft Collins, CO 80523 USA; [Baron, Jill S.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Bergstroem, Ann-Kristin; Jansson, Mats] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [Nydick, Koren R.] Mt Studies Inst, Silverton, CO 81433 USA	Arizona State University; Arizona State University-Tempe; University of Oslo; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; Umea University	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Baron, Jill/C-5270-2016; Elser, James J/AAL-6199-2020; Elser, James/A-7082-2008; Hessen, Dag/F-4039-2011	Baron, Jill/0000-0002-5902-6251; Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; 	NSF; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning	NSF(National Science Foundation (NSF)); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas)	We are grateful to all those who helped with the field and laboratory work, including staff of the Mountain Research Station, the Rocky Mountain Biological Station, and the Mountain Studies Institute; the U. S. National Park Service; the U. S. Geological Survey; and the Norwegian Institute for Water Research. We also thank S. Fisher, M. McCrackin, and A. Jonsson for useful comments and discussion. Funding was provided by NSF and the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning.	Bergstrom AK, 2008, AQUAT BIOL, V4, P55, DOI 10.3354/ab00099; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, ECOLOGY, V90, P3062, DOI 10.1890/08-1742.1; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grover J. P., 1997, RESOURCE COMPETITION; Hessen DO, 2009, LIMNOL OCEANOGR, V54, P2520, DOI 10.4319/lo.2009.54.6_part_2.2520; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; MullerNavarra DC, 1995, LIMNOL OCEANOGR, V40, P1209; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573	23	544	592	29	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					835	837		10.1126/science.1176199	http://dx.doi.org/10.1126/science.1176199			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892979				2022-12-28	WOS:000271468000039
J	Bonneau, F; Basquin, J; Ebert, J; Lorentzen, E; Conti, E				Bonneau, Fabien; Basquin, Jerome; Ebert, Judith; Lorentzen, Esben; Conti, Elena			The Yeast Exosome Functions as a Macromolecular Cage to Channel RNA Substrates for Degradation	CELL			English	Article							ARCHAEAL EXOSOME; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; STRUCTURAL BASIS; COMPLEX; CORE; SUBUNIT; RECOGNITION; EXORIBONUCLEASE	The exosome is a conserved macromolecular complex essential for RNA degradation. The nine-subunit core of the eukaryotic exosome shares a similar barrel-like architecture with prokaryotic complexes, but is catalytically inert. Here, we investigate how the Rrp44 nuclease functions in the active ten-subunit exosome. The 3.0 A resolution crystal structure of the yeast Rrp44-Rrp41-Rrp45 complex shows how the nuclease interacts with the exosome core and the relative accessibility of its endoribonuclease and exoribonuclease sites. Biochemical studies indicate that RNAs thread through the central channel of the core to reach the Rrp44 exoribonuclease site. This channeling mechanism involves evolutionary conserved residues. It allows the processive unwinding and degradation of RNA duplexes containing a sufficiently long single-stranded 30 extension, without the requirement for helicase activities. Although the catalytic function of the exosome core has been lost during evolution, the substrate recruitment and binding properties have been conserved from prokaryotes to eukaryotes.	[Bonneau, Fabien; Basquin, Jerome; Ebert, Judith; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Lorentzen, Esben] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	Max Planck Society; University of London; Birkbeck University London	Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de	Lorentzen, Esben/AAX-8077-2020	Lorentzen, Esben/0000-0001-6493-7220; Conti, Elena/0000-0003-1254-5588; Bonneau, Fabien/0000-0001-8787-7662	Max Planck Gesellschaft; European Union [LSHG-CT-2005-512028]; Sonderforschungsbereich [SFB646]; Deutsche Forschungsgemeinschaft; Federation of European Biochemical Societies and Human Frontier Science	Max Planck Gesellschaft(Max Planck Society); European Union(European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federation of European Biochemical Societies and Human Frontier Science	We would like to thank Petra Birle and Tatjana Krywcun for mutagenesis, Mark Baumgartner, Markus Mittelhauser, and Uma Jayachandran for help in producing individual exosome components, and Karina Valer Saldana and Sabine Pleyer at the MPI crystallization facility. We also thank Herve Le Hir for advice on biochemical assays, Berndt Haas for RNA synthesis, Chris Lima for the kind gift of Sumo-tagged vectors and Senp2 protease, and the staff of the PXII beamline at the Swiss Light Source (Villigen, Switzerland) for assistance during data collection. We thank Peter Brick and members of our laboratory for discussions and critical reading of the manuscript and Atlanta Cook for the drawing in Figure 3A. This study was supported by the Max Planck Gesellschaft, the European Union grant 3D Repertoire contract number LSHG-CT-2005-512028, the Sonderforschungsbereich SFB646, and the Leibniz Program of the Deutsche Forschungsgemeinschaft. E. L. was supported by Federation of European Biochemical Societies and Human Frontier Science Program postdoctoral fellowships.	Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lorentzen E, 2008, CURR OPIN STRUC BIOL, V18, P709, DOI 10.1016/j.sbi.2008.10.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	40	188	193	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					547	559		10.1016/j.cell.2009.08.042	http://dx.doi.org/10.1016/j.cell.2009.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879841	Bronze			2022-12-28	WOS:000271259600019
J	Sharif-Naeini, R; Folgering, JHA; Bichet, D; Duprat, F; Lauritzen, I; Arhatte, M; Jodar, M; Dedman, A; Chatelain, FC; Schulte, U; Retailleau, K; Loufrani, L; Patel, A; Sachs, F; Delmas, P; Peters, DJM; Honore, E				Sharif-Naeini, Reza; Folgering, Joost H. A.; Bichet, Delphine; Duprat, Fabrice; Lauritzen, Inger; Arhatte, Malika; Jodar, Martine; Dedman, Alexandra; Chatelain, Franck C.; Schulte, Uwe; Retailleau, Kevin; Loufrani, Laurent; Patel, Amanda; Sachs, Frederick; Delmas, Patrick; Peters, Dorien J. M.; Honore, Eric			Polycystin-1 and-2 Dosage Regulates Pressure Sensing	CELL			English	Article							KIDNEY-DISEASE; CATION CHANNEL; TRP CHANNELS; FILAMIN-A; MECHANOSENSATION; CELLS; ACTIVATION; MEMBRANE; PROTEIN; GENE	Autosomal-dominant polycystic kidney disease, the most frequent monogenic cause of kidney failure, is induced by mutations in the PKD1 or PKD2 genes, encoding polycystins TRPP1 and TRPP2, respectively. Polycystins are proposed to form a flow-sensitive ion channel complex in the primary cilium of both epithelial and endothelial cells. However, how polycystins contribute to cellular mechanosensitivity remains obscure. Here, we show that TRPP2 inhibits stretch-activated ion channels (SACs). This specific effect is reversed by coexpression with TRPP1, indicating that the TRPP1/TRPP2 ratio regulates pressure sensing. Moreover, deletion of TRPP1 in smooth muscle cells reduces SAC activity and the arterial myogenic tone. Inversely, depletion of TRPP2 in TRPP1-deficient arteries rescues both SAC opening and the myogenic response. Finally, we show that TRPP2 interacts with filamin A and demonstrate that this actin crosslinking protein is critical for SAC regulation. This work uncovers a role for polycystins in regulating pressure sensing.	[Sharif-Naeini, Reza; Folgering, Joost H. A.; Bichet, Delphine; Duprat, Fabrice; Lauritzen, Inger; Arhatte, Malika; Jodar, Martine; Dedman, Alexandra; Chatelain, Franck C.; Patel, Amanda; Honore, Eric] Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Schulte, Uwe] Logopharm, D-79232 March, Germany; [Retailleau, Kevin; Loufrani, Laurent] Inst Natl Sante & Rech Med 771, UMR CNRS 6214, Fac Med, F-49045 Angers, France; [Sachs, Frederick] SUNY Buffalo, Buffalo, NY 14214 USA; [Delmas, Patrick] Univ Aix Marseille 2, Ctr Rech Neurophysiol & Neurobiol Marseille, UMR CNRS 6231, Fac Med,CS80011, F-13344 Marseille 15, France; [Peters, Dorien J. M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Honore, E (corresponding author), Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	honore@ipmc.cnrs.fr	loufrani, laurent/K-1713-2015; DUPRAT, Fabrice/D-1221-2013	DUPRAT, Fabrice/0000-0001-8774-1220; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893; HONORE, Eric/0000-0002-8007-0919; lauritzen, inger/0000-0002-2011-1387	ANR 2005 cardiovasculaire-obesite-diabete; ANR 2008 du gene a la physiopathologie; Association for information and research on genetic kidney disease France; Fondation del Duca; Fondation de la recherche medicale; Fondation de France; EEC Marie-Curie [039328]; Fondation de recherche sur l'hypertension arterielle; Fondation de la recherche sur le cerveau; Human Frontier Science [LT-00555]; Societe Generale AM; Universite de Nice Sophia Antipolis; Centre National de la Recherche Scientifique; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	ANR 2005 cardiovasculaire-obesite-diabete(French National Research Agency (ANR)); ANR 2008 du gene a la physiopathologie(French National Research Agency (ANR)); Association for information and research on genetic kidney disease France; Fondation del Duca; Fondation de la recherche medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); EEC Marie-Curie(European Commission); Fondation de recherche sur l'hypertension arterielle; Fondation de la recherche sur le cerveau; Human Frontier Science(Human Frontier Science Program); Societe Generale AM; Universite de Nice Sophia Antipolis; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the ANR 2005 cardiovasculaire-obesite-diabete, to the ANR 2008 du gene a la physiopathologie, to the Association for information and research on genetic kidney disease France, to the Fondation del Duca, to the Fondation de la recherche medicale, to the Fondation de France, to EEC Marie-Curie fellowship 039328 (J. H. A. F.), to the Fondation de recherche sur l'hypertension arterielle, to the Fondation de la recherche sur le cerveau, to the Human Frontier Science Program long-term fellowship LT-00555 (R.S.N.), to the Societe Generale AM, to the Universite de Nice Sophia Antipolis, and to the Centre National de la Recherche Scientifique for financial support. We are grateful to T. P. Stossel for providing the M2 and A7 cell lines and FLNa constructs and to L. Tsokias for providing the human and mouse Pkd2 clones. We are grateful to G. Romey and J. Barhanin for valuable discussions.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 2001, J BIOL CHEM, V276, P31969, DOI 10.1074/jbc.M102715200; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; HALPERN W, 1991, BLOOD VESSELS, V28, P245; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee BY, 2007, BIOCHIP J, V1, P76; Lee HA, 2007, CARDIOVASC RES, V76, P224, DOI 10.1016/j.cardiores.2007.06.021; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Morel N, 2009, PFLUG ARCH EUR J PHY, V457, P845, DOI 10.1007/s00424-008-0561-y; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Voets T, 2009, EMBO J, V28, P4, DOI 10.1038/emboj.2008.261; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	49	221	224	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					587	596		10.1016/j.cell.2009.08.045	http://dx.doi.org/10.1016/j.cell.2009.08.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879844	Green Submitted, Bronze			2022-12-28	WOS:000271259600022
J	Custers, IM; Flierman, PA; Maas, P; Cox, T; Van Dessel, TJHM; Gerards, MH; Mochtar, MH; Janssen, CAH; van der Veen, F; Mol, BWJ				Custers, Inge M.; Flierman, Paul A.; Maas, Pettie; Cox, Tessa; Van Dessel, Thierry J. H. M.; Gerards, Mariette H.; Mochtar, Monique H.; Janssen, Catharina A. H.; van der Veen, Fulco; Mol, Ben Willem J.			Immobilisation versus immediate mobilisation after intrauterine insemination: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							SPERM TRANSPORT; HYSTEROSALPINGOSCINTIGRAPHY; TRACT	Objective To evaluate the effectiveness of 15 minutes of immobilisation versus immediate mobilisation after intrauterine insemination. Design Randomised controlled trial. Setting One academic teaching hospital and six non-academic teaching hospitals. Participants Women having intrauterine insemination for unexplained, cervical factor, or male subfertility. Interventions 15 minutes of immobilisation or immediate mobilisation after insemination. Main outcome measure Ongoing pregnancy per couple. Results 391 couples were randomised; 199 couples were allocated to 15 minutes of immobilisation after intrauterine insemination, and 192 couples were allocated to immediate mobilisation (control). The ongoing pregnancy rate per couple was significantly higher in the immobilisation group than in the control group: 27% (n= 54) versus 18% ( 34); relative risk 1.5, 95% confidence interval 1.1 to 2.2 (crude difference in ongoing pregnancy rates: 9.4%, 1.2% to 17%). Live birth rates were 27% (53) in the immobilisation group and 17% ( 32) in the control group: relative risk 1.6, 1.1 to 2.4 (crude difference for live birth rates: 10%, 1.8% to 18%). In the immobilisation group, the ongoing pregnancy rates in the first, second, and third treatment cycles were 10%, 10%, and 7%. The corresponding rates in the mobilisation group were 7%, 5%, and 5%. Conclusion In treatment with intrauterine insemination, 15 minutes' immobilisation after insemination is an effective modification. Immobilisation for 15 minutes should be offered to all women treated with intrauterine insemination. Trial registration Current Controlled Trials ISRCTN53294431 [controlled-trials.com].	[Custers, Inge M.; Mochtar, Monique H.; van der Veen, Fulco] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Maas, Pettie; Mol, Ben Willem J.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Flierman, Paul A.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Cox, Tessa] Antonius Ziekenhuis, Dept Obstet & Gynaecol, Nieuwegein, Netherlands; [Van Dessel, Thierry J. H. M.] TweeSteden Ziekenhuis, Dept Obstet & Gynaecol, Tilburg, Netherlands; [Gerards, Mariette H.] Martini Ziekenhuis, Dept Obstet & Gynaecol, Groningen, Netherlands; [Janssen, Catharina A. H.] Groene Hart Ziekenhuis, Dept Obstet & Gynaecol, Gouda, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Martini Hospital	Custers, IM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.m.custers@amc.uva.nl	Mol, Ben/I-4526-2012					*DUTCH SOC OBST GY, 2004, GUID BAS FERT WORK U; Hafez E S, 1979, Acta Eur Fertil, V10, P41; Kissler S, 2004, ACTA OBSTET GYN SCAN, V83, P369, DOI 10.1111/j.0001-6349.2004.00412.x; Kunz G, 1996, HUM REPROD, V11, P627, DOI 10.1093/HUMREP/11.3.627; Saleh A, 2000, FERTIL STERIL, V74, P509, DOI 10.1016/S0015-0282(00)00702-0; SETTLAGE DS, 1973, FERTIL STERIL, V24, P655; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047	7	27	27	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 29	2009	339								b4080	10.1136/bmj.b4080	http://dx.doi.org/10.1136/bmj.b4080			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AO	19875843	Green Published, hybrid			2022-12-28	WOS:000271365900001
J	Nakanishi, K; Bonnefond, L; Kimura, S; Suzuki, T; Ishitani, R; Nureki, O				Nakanishi, Kotaro; Bonnefond, Luc; Kimura, Satoshi; Suzuki, Tsutomu; Ishitani, Ryuichiro; Nureki, Osamu			Structural basis for translational fidelity ensured by transfer RNA lysidine synthetase	NATURE			English	Article							ISOLEUCINE TRANSFER-RNA; AMINO-ACID SPECIFICITIES; CRYSTAL-STRUCTURE; ANTICODON; RECOGNITION; CODON; REFINEMENT; RESOLUTION; COMPLEX; GENE	Maturation of precursor transfer RNA (pre-tRNA) includes excision of the 5' leader and 3' trailer sequences, removal of introns and addition of the CCA terminus(1-3). Nucleotide modifications are incorporated at different stages of tRNA processing, after the RNA molecule adopts the proper conformation. In bacteria, tRNA(Ile2) lysidine synthetase (TilS) modifies cytidine into lysidine (L; 2-lysyl-cytidine) at the first anticodon of tRNA(Ile2) (refs 4-9). This modification switches tRNA(Ile2) from a methionine-specific to an isoleucine-specific tRNA(9). However, the aminoacylation of tRNA(Ile2) by methionyl-tRNA synthetase (MetRS), before the modification by TilS, might lead to the misincorporation of methionine in response to isoleucine codons. The mechanism used by bacteria to avoid this pitfall is unknown. Here we show that the TilS enzyme specifically recognizes and modifies tRNA(Ile2) in its precursor form, thereby avoiding translation errors. We identified the lysidine modification in pre-tRNA(Ile2) isolated from RNase-Edeficient Escherichia coli and did not detect mature tRNA(Ile2) lacking this modification. Our kinetic analyses revealed that TilS can modify both types of RNA molecule with comparable efficiencies. X-ray crystallography and mutational analyses revealed that TilS specifically recognizes the entire L-shape structure in pre-tRNA(Ile2) through extensive interactions coupled with sequential domain movements. Our results demonstrate how TilS prevents the recognition of tRNA(Ile2) by MetRS and achieves high specificity for its substrate. These two key points form the basis for maintaining the fidelity of isoleucine codon translation in bacteria. Our findings also provide a rationale for the necessity of incorporating specific modifications at the precursor level during tRNA biogenesis.	[Nakanishi, Kotaro; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2258501, Japan; [Bonnefond, Luc; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan; [Kimura, Satoshi; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Tokyo Institute of Technology; University of Tokyo; University of Tokyo	Nureki, O (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2258501, Japan.	nureki@ims.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015; NUREKI, OSAMU/G-4960-2014; Bonnefond, Luc/P-3926-2016	Suzuki, Tsutomu/0000-0002-9731-1731; Bonnefond, Luc/0000-0002-1164-742X; Kimura, Satoshi/0000-0003-3555-5877; Nakanishi, Kotaro/0000-0002-9857-6010	SORST program grant from Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Society for the Promotion of Science	SORST program grant from Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NW12 of PF-AR (Tsukuba, Japan) for help during data collection. We thank H. Aiba for providing the temperature- sensitive E. coli strain of RNase E, A. Soma and Y. Sekine for discussions, and T. Suzuki and Y. Sakaguchi for support with mass spectrometry. This work was supported by a SORST program grant from Japan Science and Technology to O. N., by a grant for the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to O. N. and T. S., by grants from MEXT to R. I. and O. N., and by Mitsubishi Foundation and Kurata Memorial Hitachi Science and Technology Foundation grants to O. N. L. B. and K. N. were supported by a postdoctoral fellowship for foreign researchers and a young scientist fellowship, respectively, from the Japan Society for the Promotion of Science.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ETCHEVERRY T, 1979, CELL, V18, P11, DOI 10.1016/0092-8674(79)90349-0; HARADA F, 1974, BIOCHEMISTRY-US, V13, P300, DOI 10.1021/bi00699a011; Hendrickson TL, 2003, MOL B INT U, P34; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Matsugi J, 1996, J BIOCHEM, V119, P811; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; Nakanishi K, 2005, MOL CELLS, V19, P157; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SAKANO H, 1978, J MOL BIOL, V123, P287, DOI 10.1016/0022-2836(78)90082-7; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Sugiura I, 2000, STRUCTURE, V8, P197, DOI 10.1016/S0969-2126(00)00095-2; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WEBER F, 1990, NUCLEIC ACIDS RES, V18, P5027, DOI 10.1093/nar/18.17.5027; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976	39	45	45	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1144	U249		10.1038/nature08474	http://dx.doi.org/10.1038/nature08474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847269				2022-12-28	WOS:000270987600049
J	Putensen, C; Theuerkauf, N; Zinserling, J; Wrigge, H; Pelosi, P				Putensen, Christian; Theuerkauf, Nils; Zinserling, Joerg; Wrigge, Hermann; Pelosi, Paolo			Meta-analysis: Ventilation Strategies and Outcomes of the Acute Respiratory Distress Syndrome and Acute Lung Injury	ANNALS OF INTERNAL MEDICINE			English	Review							END-EXPIRATORY PRESSURE; TIDAL VOLUME VENTILATION; MECHANICAL VENTILATION; RECRUITMENT; TRIALS; REDUCTION; COLLAPSE; BENCH	Background: Trials have provided conflicting results regarding the effect of different ventilatory strategies on the outcomes of patients with the acute respiratory distress syndrome (ARDS) and acute lung injury. Purpose: To determine whether ventilation with low tidal volume (VT) and limited airway pressure or higher positive end-expiratory pressure (PEEP) improves outcomes for patients with ARDS or acute lung injury. Data Sources: Multiple computerized databases (through March 2009), reference lists of identified articles, and queries of principal investigators. No language restrictions were applied. Study Selection: Randomized, controlled trials (RCTs) reporting mortality and comparing lower versus higher VT ventilation, lower versus higher PEEP, or a combination of both in adults with ARDS or acute lung injury. Data Extraction: Using a standard protocol, 2 reviewer teams assessed trial eligibility and abstracted data on quality of study design and conduct, population characteristics, intervention, co-interventions, and confounding variables. Data Synthesis: 4 RCTs tested lower versus higher VT ventilation at similar PEEP in 1149 patients, 3 RCTs compared lower versus higher PEEP at low VT ventilation in 2299 patients, and 2 RCTs compared a combination of higher VT and lower PEEP ventilation versus lower VT and higher PEEP ventilation in 148 patients. Lower VT ventilation reduced hospital mortality (odds ratio, 0.75 [95% CI, 0.58 to 0.96]; P = 0.02) compared with higher VT ventilation at similar PEEP. Higher PEEP did not reduce hospital mortality ( odds ratio, 0.86 [CI, 0.72 to 1.02]; P = 0.08) compared with lower PEEP using low VT ventilation. Higher PEEP reduced the need for rescue therapy to prevent life-threatening hypoxemia (odds ratio, 0.51 [CI, 0.36 to 0.71]; P < 0.001) and death (odds ratio, 0.51 [CI, 0.36 to 0.71]; P < 0.001) in patients receiving rescue therapies. Limitations: Pooling according to similar ventilatory strategies resulted in few RCTs analyzed in each group. The benefit of low VT is derived from only 1 study. Conclusion: Available evidence from a limited number of RCTs shows better outcomes with routine use of low VT but not high PEEP ventilation in unselected patients with ARDS or acute lung injury. High PEEP may help to prevent life-threatening hypoxemia in selected patients.	Univ Hosp Bonn, Bonn, Germany; Univ Insubria, Varese, Italy	University of Bonn; University of Insubria	Putensen, C (corresponding author), Univ Bonn, Dept Anaesthesiol & Intens Care Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	putensen@buni-bonn.de; joerg.zinserling@ukb.uni-bonn.de	Rocco, Patricia/I-7460-2012; Wrigge, Hermann/AAJ-8985-2021	Rocco, Patricia/0000-0003-1412-7136; Wrigge, Hermann/0000-0002-9035-6822; Pelosi, Paolo/0000-0001-5055-3023				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DENZIN NK, 1995, J COMMUN, V45, P177, DOI 10.1111/j.1460-2466.1995.tb00735.x; Dixon-Woods M, 2004, QUAL SAF HEALTH CARE, V13, P223, DOI 10.1136/qshc.2003.008714; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; FEIHL F, 1994, AM J RESP CRIT CARE, V150, P1722, DOI 10.1164/ajrccm.150.6.7952641; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Gattinoni L, 2008, JAMA-J AM MED ASSOC, V299, P691, DOI 10.1001/jama.299.6.691; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; LENNON M, 2005, CRIT CARE RESUSC, V7, P60; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Marini JJ, 2003, CRIT CARE, V7, P435, DOI 10.1186/cc2392; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Moran JL, 2005, INTENS CARE MED, V31, P227, DOI 10.1007/s00134-004-2506-z; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Pelosi P, 2001, AM J RESP CRIT CARE, V164, P122, DOI 10.1164/ajrccm.164.1.2007010; Petrucci N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003844.pub3; Petrucci N, 2004, ANESTH ANALG, V99, P193, DOI 10.1213/01.ANE.0000118102.93688.97; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Routly JJ, 2003, CRIT CARE MED, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Tremblay LN, 2005, AM J PHYSIOL-LUNG C, V288, pL596, DOI 10.1152/ajplung.00438.2004; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	44	255	270	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					566	U96		10.7326/0003-4819-151-8-200910200-00011	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00011			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19841457	Green Published			2022-12-28	WOS:000271386200006
J	Boysen, G; Krarup, LH; Zeng, XR; Oskedra, A; Korv, J; Andersen, G; Gluud, C; Pedersen, A; Lindahl, M; Hansen, L; Winkel, P; Truelsen, T				Boysen, Gudrun; Krarup, Lars-Henrik; Zeng, Xianrong; Oskedra, Adam; Korv, Janika; Andersen, Grethe; Gluud, Christian; Pedersen, Anders; Lindahl, Marianne; Hansen, Lotte; Winkel, Per; Truelsen, Thomas		ExStroke Pilot Trial Grp	ExStroke Pilot Trial of the effect of repeated instructions to improve physical activity after ischaemic stroke: a multinational randomised controlled clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVITY SCALE; ELDERLY PASE; GENERAL-PRACTICE; FOLLOW-UP; RISK; EXERCISE; ASSOCIATION; VALIDITY; PROMOTE; ADVICE	Objectives To investigate if repeated verbal instructions about physical activity to patients with ischaemic stroke could increase long term physical activity. Design Multicentre, multinational, randomised clinical trial with masked outcome assessment. Setting Stroke units in Denmark, China, Poland, and Estonia. Participants 314 patients with ischaemic stroke aged >= 40 years who were able to walk-157 ( mean age 69. 7 years) randomised to the intervention, 157 (mean age 69.4 years) in the control group. Interventions Patients randomised to the intervention were instructed in a detailed training programme before discharge and at five follow-up visits during 24 months. Control patients had follow-up visits with the same frequency but without instructions in physical activity. Main outcome measures Physical activity assessed with the Physical Activity Scale for the Elderly (PASE) at each visit. Secondary outcomes were clinical events. Results The estimated mean PASE scores were 69.1 in the intervention group and 64.0 in the control group (difference 5.0 (95% confidence interval -5.8 to 15.9), P=0.36. The intervention had no significant effect on mortality, recurrent stroke, myocardial infarction, or falls and fractures. Conclusion Repeated encouragement and verbal instruction in being physically active did not lead to a significant increase in physical activity measured by the PASE score. More intensive strategies seem to be needed to promote physical activity after ischaemic stroke.	[Boysen, Gudrun; Krarup, Lars-Henrik; Pedersen, Anders; Lindahl, Marianne; Hansen, Lotte; Truelsen, Thomas] Univ Copenhagen Hosp, Bispebjerg Hosp, Dept Neurol, DK-2400 Copenhagen NV, Denmark; [Zeng, Xianrong] Sichuan Prov Peoples Hosp, Dept Neurol, Chengdu, Peoples R China; [Oskedra, Adam] Inst Psychiat & Neurol, Dept Neurol, Warsaw, Poland; [Korv, Janika] Univ Tartu, Dept Neurol & Neurosurg, Tartu, Estonia; [Andersen, Grethe] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Krarup, Lars-Henrik; Gluud, Christian; Winkel, Per] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2400 Copenhagen NV, Denmark	University of Copenhagen; Bispebjerg Hospital; Sichuan Provincial People's Hospital; Institute of Psychiatry & Neurology; University of Tartu; Aarhus University; Rigshospitalet; University of Copenhagen	Boysen, G (corresponding author), Univ Copenhagen Hosp, Bispebjerg Hosp, Dept Neurol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	gb01@bbh.regionh.dk	Gluud, Christian/AAY-1027-2021; Kõrv, Janika/I-4395-2015; Lindahl, Marianne/AAF-9142-2020; Gluud, Christian/HGB-3191-2022; Krarup, Lars-Henrik/K-7199-2019; Truelsen, Thomas/AAY-1549-2020; krarup, lh/K-8404-2019	Gluud, Christian/0000-0002-8861-0799; Kõrv, Janika/0000-0002-6074-0727; Andersen, Grethe/0000-0001-6807-2500; Iversen, Helle Klingenberg/0000-0002-5880-6352	Ludvig and Sara Elsass' Foundation; Hede Nielsen Foundation; Eva and Henry Fraenkel's Foundation; Soren and Helene Hempel's Foundation; King Christian X Foundation	Ludvig and Sara Elsass' Foundation; Hede Nielsen Foundation; Eva and Henry Fraenkel's Foundation; Soren and Helene Hempel's Foundation; King Christian X Foundation	The ExStroke Pilot Trial was funded by the Ludvig and Sara Elsass' Foundation, Hede Nielsen Foundation, Eva and Henry Fraenkel's Foundation, Soren and Helene Hempel's Foundation, and King Christian X Foundation. The funding sources had no involvement in the design of the trial; data collection, management, analysis, interpretation, and reporting; writing of the paper; or submission of the article for publication.	ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; Calfas KJ, 1996, PREV MED, V25, P225, DOI 10.1006/pmed.1996.0050; Dinger MK, 2004, J SPORT MED PHYS FIT, V44, P186; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Eden KB, 2002, ANN INTERN MED, V137, P208, DOI 10.7326/0003-4819-137-3-200208060-00015; Ellekjaer H, 2000, STROKE, V31, P14, DOI 10.1161/01.STR.31.1.14; Foster C., 2005, COCHRANE DB SYST REV, V1, P1, DOI 10.1002/14651858.cd003180.pub2; Gillum RF, 1996, AM J EPIDEMIOL, V143, P860, DOI 10.1093/oxfordjournals.aje.a008829; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hudon C, 2008, CAN FAM PHYSICIAN, V54, P1130; Krarup LH, 2008, CONTEMP CLIN TRIALS, V29, P410, DOI 10.1016/j.cct.2007.09.008; Krarup LH, 2007, CEREBROVASC DIS, V24, P296, DOI 10.1159/000105683; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lawlor DA, 2001, J PUBLIC HEALTH MED, V23, P219, DOI 10.1093/pubmed/23.3.219; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee IM, 1999, STROKE, V30, P1, DOI 10.1161/01.STR.30.1.1; Lindahl M, 2008, EUR J PHYSIOTHER, V10, P188, DOI 10.1080/14038190802490025; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Martin KA, 1999, MED SCI SPORT EXER, V31, P627, DOI 10.1097/00005768-199905000-00001; Mead GE, 2007, J AM GERIATR SOC, V55, P892, DOI 10.1111/j.1532-5415.2007.01185.x; Molenberghs G, 2007, STAT PRACTICE; POTEMPA K, 1995, STROKE, V26, P101, DOI 10.1161/01.STR.26.1.101; RANKIN J, 1957, Scott Med J, V2, P200; RIKLI R, 2001, SENIOR FITNESS TEST, P13; Saunders DH, 2008, ARCH PHYS MED REHAB, V89, P677, DOI 10.1016/j.apmr.2007.09.034; Saunders DH, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003316.PUB2; Schuit AJ, 1997, J CLIN EPIDEMIOL, V50, P541, DOI 10.1016/S0895-4356(97)00010-3; Smith BJ, 2000, BRIT J SPORT MED, V34, P262, DOI 10.1136/bjsm.34.4.262; Steptoe A, 1999, BRIT MED J, V319, P943, DOI 10.1136/bmj.319.7215.943; Teixeira-Salmela LF, 2001, J REHABIL MED, V33, P53; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9	36	83	83	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2009	339								b2810	10.1136/bmj.b2810	http://dx.doi.org/10.1136/bmj.b2810			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475IL	19900934	Green Published, hybrid			2022-12-28	WOS:000268351700008
J	Remus, D; Beuron, F; Tolun, G; Griffith, JD; Morris, EP; Diffley, JFX				Remus, Dirk; Beuron, Fabienne; Tolun, Goekhan; Griffith, Jack D.; Morris, Edward P.; Diffley, John F. X.			Concerted Loading of Mcm2-7 Double Hexamers around DNA during DNA Replication Origin Licensing	CELL			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; RECOGNITION COMPLEX INTERACTS; SACCHAROMYCES-CEREVISIAE; HELICASE ACTIVITY; STRUCTURAL-CHANGES; DORMANT ORIGINS; ATP-HYDROLYSIS; EXCESS MCM2-7; BINDING SITE; ORC	The licensing of eukaryotic DNA replication origins, which ensures once-per-cell-cycle replication, involves the loading of six related minichromosome maintenance proteins (Mcm2-7) into prereplicative complexes (pre-RCs). Mcm2-7 forms the core of the replicative DNA helicase, which is inactive in the pre-RC. The loading of Mcm2-7 onto DNA requires the origin recognition complex (ORC), Cdc6, and Cdt1, and depends on ATP. We have reconstituted Mcm2-7 loading with purified budding yeast proteins. Using biochemical approaches and electron microscopy, we show that single heptamers of Cdt1 center dot Mcm2-7 are loaded cooperatively and result in association of stable, head-to-head Mcm2-7 double hexamers connected via their N-terminal rings. DNA runs through a central channel in the double hexamer, and, once loaded, Mcm2-7 can slide passively along double-stranded DNA. Our work has significant implications for understanding how eukaryotic DNA replication origins are chosen and licensed, how replisomes assemble during initiation, and how unwinding occurs during DNA replication.	[Remus, Dirk; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Beuron, Fabienne; Morris, Edward P.] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of North Carolina; University of North Carolina Chapel Hill	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451; Remus, Dirk/0000-0002-5155-181X; Morris, Edward/0000-0003-3544-0041; Diffley, John/0000-0001-5184-7680	Cancer Research UK; Institute of Cancer Research; National Institutes of Health [GM31819, ES13773]; European Molecular Biology Organization long-term fellowship; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Institute of Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Cancer Research UK (D. R., J.F. X. D., F. B., and E. P. M.), the Institute of Cancer Research (F. B. and E. P. M.), and National Institutes of Health grants to J.D.G. (GM31819 and ES13773). D. R. was supported by European Molecular Biology Organization long-term fellowship. We are grateful to Dale Wigley for help and advice in the early stages of this project and to Paula da Fonseca for advice on image processing. We thank Mark Skehel and colleagues for mass spectrometry and Karim Labib for antibodies. We are also grateful to members of the Diffley laboratory for helpful discussions.	Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; DEAN FB, 1992, J BIOL CHEM, V267, P14129; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VanLoock MS, 2002, CURR BIOL, V12, P472, DOI 10.1016/S0960-9822(02)00696-6; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wigley DB, 2009, CURR OPIN STRUC BIOL, V19, P72, DOI 10.1016/j.sbi.2008.12.010; Wilmes GM, 2002, P NATL ACAD SCI USA, V99, P101, DOI 10.1073/pnas.012578499; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	74	438	449	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					719	730		10.1016/j.cell.2009.10.015	http://dx.doi.org/10.1016/j.cell.2009.10.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19896182	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000271747200016
J	Shaw, K; Cassel, CK; Black, C; Levinson, W				Shaw, Kirstyn; Cassel, Christine K.; Black, Carol; Levinson, Wendy			Shared Medical Regulation in a Time of Increasing Calls for Accountability and Transparency Comparison of Recertification in the United States, Canada, and the United Kingdom	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE REFORM; QUALITY-OF-CARE; CONSULTANT APPRAISAL; BOARD CERTIFICATION; EXAMINATION SCORES; PHYSICIANS; MAINTENANCE; ASSOCIATION; COMPETENCE; SYSTEM	In the United States, Canada, and the United Kingdom, the medical profession is accountable to the public for the delivery and quality of care provided to patients. Traditionally, this accountability has been achieved through the development and maintenance of professional standards established by the profession itself-self-regulation. Medical self-regulation is being re-examined by regulators, government, and the profession in response to a range of drivers including payers seeking ways to hold physicians accountable for cost-effective care; patients seeking more information about their physician's qualifications; and the emergence of a number of high-profile cases of unacceptable medical practice. This article outlines the current state of medical regulation in the United States, Canada, and the United Kingdom and highlights the increasing external pressure on the self-regulatory framework that is leading to a shift toward shared regulation between the profession and other stakeholders. JAMA. 2009; 302(18): 2008-2014	[Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Shaw, Kirstyn; Black, Carol] Acad Med Royal Coll, London, England; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	University of Toronto; American Board of Internal Medicine	Levinson, W (corresponding author), Univ Toronto, Dept Med, Ste 3-805,R Fraser Elliot Bldg,190 Elizabeth St, Toronto, ON M5G 2C4, Canada.	wendy.levinson@utoronto.ca						Accreditation Council for Graduate Medical Education, COMM PROGR REQ GEN C; AKSHOM J, 2005, BRIT MED J, V330, P1144; [Anonymous], 2001, BRIST ROYAL INF INQ; Batmangelich Sorush, 2004, J Contin Educ Health Prof, V24, P134, DOI 10.1002/chp.1340240303; Black C, 2009, JAMA-J AM MED ASSOC, V301, P2156, DOI 10.1001/jama.2009.735; Bloom BS, 2005, INT J TECHNOL ASSESS, V21, P380, DOI 10.1017/S026646230505049X; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Cassel C, 2007, LANCET, V369, P906; Cassel CK, 2006, LANCET, V368, P1557, DOI 10.1016/S0140-6736(06)69609-8; CAYTON H, 2009, ASSURING PATIENT SAF; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Corrigan J, 2000, ERR IS HUMAN BUILDIN; Darzi A, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0905707; *DEP HLTH, 2006, NHS APPR TOOLK CONS; Department of Health, 1999, SUPP DOCT PROT PAT; Department of Health, 2007, WHIT PAP TRUST ASS S; Department of Health, 2008, MED REV PRINC NEXT S; Department of Health, 2006, GOOD DOCT SAF PAT PR; Emanuel LL, 1996, ANN INTERN MED, V124, P240, DOI 10.7326/0003-4819-124-2-199601150-00008; Evans CC, 2003, CLIN MED, V3, P495, DOI 10.7861/clinmedicine.3-6-495; Federation of Medical Regulatory Authorities of Canada Revalidation Working Group, 2007, PHYS REV MAINT COMP; *GEN MED COUNC, 2005, DEV MED REG VIS FUT; General Medical Council, 2004, POL FRAM REV POS PAP; GODLEE F, 2006, BMJ-BRIT MED J, V333, DOI DOI 10.1136/BMJ.333.7567.0-F; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Holmboe ES, 2008, JAMA-J AM MED ASSOC, V299, P338, DOI 10.1001/jama.299.3.338; Institute of Medicine (US) Committee on Quality of Health Care in America, 2014, CROSSING QUALITY CHA; Lelliott P, 2008, BRIT J PSYCHIAT, V193, P156, DOI 10.1192/bjp.bp.107.041681; Levinson W, 2008, CAN MED ASSOC J, V179, P979, DOI 10.1503/cmaj.081342; Lockyer J, 2006, MED EDUC, V40, P340, DOI 10.1111/j.1365-2929.2006.02410.x; *MERR COMM, 1975, REP COMM INQ REG MED; Miller SH, 2006, CLIN ORTHOP RELAT R, P155, DOI 10.1097/01.blo.0000229289.75979.6f; Norcini JJ, 1999, BRIT MED J, V319, P1183, DOI 10.1136/bmj.319.7218.1183; Norcini JJ, 2000, ACAD MED, V75, P1193, DOI 10.1097/00001888-200012000-00016; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; *ROYAL COLL PHYS S, CANMEDS PHYS COMP FR; Shaw K, 2007, CLIN GOVERNANCE INT, V12, P170; Smith J. Dame, 2005, SHIPMAN INQUIRY; Tamblyn R, 2002, JAMA-J AM MED ASSOC, V288, P3019, DOI 10.1001/jama.288.23.3019; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; Weinberg NS, 1998, INT J QUAL HEALTH C, V10, P295, DOI 10.1093/intqhc/10.4.295; Winearls CG, 2001, QJM-MON J ASSOC PHYS, V94, P235, DOI 10.1093/qjmed/94.5.235; 2008, CMAJ, V179, P979	45	56	56	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2008	2014		10.1001/jama.2009.1620	http://dx.doi.org/10.1001/jama.2009.1620			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903922				2022-12-28	WOS:000271619700028
J	de Vos, P; Van der Stuyft, P				de Vos, Pol; Van der Stuyft, Patrick			The right to health in times of economic crisis: Cuba's way	LANCET			English	Editorial Material									[de Vos, Pol; Van der Stuyft, Patrick] Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	de Vos, P (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	pdevos@itg.be	De Vos, Pol/D-3370-2009					CASTRO R, 2009, COMMUNICATION   0801; Cooper RS, 2006, INT J EPIDEMIOL, V35, P817, DOI 10.1093/ije/dyl175; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; De Vos P, 2005, SOC SCI MED, V60, P609, DOI 10.1016/j.socscimed.2004.05.022; De Vos P, 2007, INT J HEALTH SERV, V37, P761, DOI 10.2190/HS.37.4.k; EISEN G, 1996, REV CUBANA SALUD PUB, V22, P117; Jenkins TM, 2008, QUAL HEALTH RES, V18, P1384, DOI 10.1177/1049732308322601; Lage A, 2008, NAT IMMUNOL, V9, P109, DOI 10.1038/ni0208-109; *PAN AM HLTH ORG H, HLTH SIT AM BAS IND; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; WHO, 2008, PHARMAFORUM 0121; WORLD BANK, 2009, CRIS HITT POOR HARD	12	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1575	1576		10.1016/S0140-6736(09)61920-6	http://dx.doi.org/10.1016/S0140-6736(09)61920-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518EZ	19897114				2022-12-28	WOS:000271674600008
J	Wade, CM; Giulotto, E; Sigurdsson, S; Zoli, M; Gnerre, S; Imsland, F; Lear, TL; Adelson, DL; Bailey, E; Bellone, RR; Blocker, H; Distl, O; Edgar, RC; Garber, M; Leeb, T; Mauceli, E; MacLeod, JN; Penedo, MCT; Raison, JM; Sharpe, T; Vogel, J; Andersson, L; Antczak, DF; Biagi, T; Binns, MM; Chowdhary, BP; Coleman, SJ; Della Valle, G; Fryc, S; Guerin, G; Hasegawa, T; Hill, EW; Jurka, J; Kiialainen, A; Lindgren, G; Liu, J; Magnani, E; Mickelson, JR; Murray, J; Nergadze, SG; Onofrio, R; Pedroni, S; Piras, MF; Raudsepp, T; Rocchi, M; Roed, KH; Ryder, OA; Searle, S; Skow, L; Swinburne, JE; Syvanen, AC; Tozaki, T; Valberg, SJ; Vaudin, M; White, JR; Zody, MC; Lander, ES; Lindblad-Toh, K				Wade, C. M.; Giulotto, E.; Sigurdsson, S.; Zoli, M.; Gnerre, S.; Imsland, F.; Lear, T. L.; Adelson, D. L.; Bailey, E.; Bellone, R. R.; Bloecker, H.; Distl, O.; Edgar, R. C.; Garber, M.; Leeb, T.; Mauceli, E.; MacLeod, J. N.; Penedo, M. C. T.; Raison, J. M.; Sharpe, T.; Vogel, J.; Andersson, L.; Antczak, D. F.; Biagi, T.; Binns, M. M.; Chowdhary, B. P.; Coleman, S. J.; Della Valle, G.; Fryc, S.; Guerin, G.; Hasegawa, T.; Hill, E. W.; Jurka, J.; Kiialainen, A.; Lindgren, G.; Liu, J.; Magnani, E.; Mickelson, J. R.; Murray, J.; Nergadze, S. G.; Onofrio, R.; Pedroni, S.; Piras, M. F.; Raudsepp, T.; Rocchi, M.; Roed, K. H.; Ryder, O. A.; Searle, S.; Skow, L.; Swinburne, J. E.; Syvanen, A. C.; Tozaki, T.; Valberg, S. J.; Vaudin, M.; White, J. R.; Zody, M. C.; Lander, E. S.; Lindblad-Toh, K.		Broad Inst Genome Sequencing Perfo; Broad Inst Whole Genome Assembly T	Genome Sequence, Comparative Analysis, and Population Genetics of the Domestic Horse	SCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; CENTROMERES; APPALOOSA; EVOLUTION; CATTLE	We report a high-quality draft sequence of the genome of the horse ( Equus caballus). The genome is relatively repetitive but has little segmental duplication. Chromosomes appear to have undergone few historical rearrangements: 53% of equine chromosomes show conserved synteny to a single human chromosome. Equine chromosome 11 is shown to have an evolutionary new centromere devoid of centromeric satellite DNA, suggesting that centromeric function may arise before satellite repeat accumulation. Linkage disequilibrium, showing the influences of early domestication of large herds of female horses, is intermediate in length between dog and human, and there is long-range haplotype sharing among breeds.	[Wade, C. M.; Sigurdsson, S.; Gnerre, S.; Garber, M.; Mauceli, E.; Sharpe, T.; Biagi, T.; Fryc, S.; Onofrio, R.; White, J. R.; Zody, M. C.; Lander, E. S.; Lindblad-Toh, K.; Broad Inst Genome Sequencing Perfo; Broad Inst Whole Genome Assembly T] Broad Inst, Cambridge, MA 02142 USA; [Wade, C. M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Wade, C. M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Giulotto, E.; Magnani, E.; Nergadze, S. G.; Piras, M. F.] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Sigurdsson, S.; Imsland, F.; Andersson, L.; Zody, M. C.; Lindblad-Toh, K.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Zoli, M.; Della Valle, G.] Univ Bologna, Dipartimento Biol, I-40126 Bologna, Italy; [Lear, T. L.; Bailey, E.; MacLeod, J. N.; Coleman, S. J.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY 40546 USA; [Adelson, D. L.; Raison, J. M.; Chowdhary, B. P.; Raudsepp, T.] Univ Adelaide, Adelaide, SA 5005, Australia; [Bellone, R. R.; Roed, K. H.] Univ Tampa, Tampa, FL 33606 USA; [Bloecker, H.] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Distl, O.; Leeb, T.] Univ Vet Med Hannover, Inst Genet & Anim Breeding, D-30559 Hannover, Germany; [Leeb, T.] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland; [Penedo, M. C. T.; Pedroni, S.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Vogel, J.; Searle, S.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Antczak, D. F.] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Binns, M. M.] Univ London Royal Vet Coll, London NW1 0TU, England; [Skow, L.] Texas A&M Univ, Coll Vet Med, College Stn, TX 77843 USA; [Guerin, G.] INRA, UMR 1313, F-44078350 Jouy En Josas, France; [Hasegawa, T.] Japan Racing Assoc, Equine Res Inst, Utsunomiya, Tochigi 3200856, Japan; [Hill, E. W.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 4, Ireland; [Jurka, J.] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kiialainen, A.; Syvanen, A. C.] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Lindgren, G.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Liu, J.] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Mickelson, J. R.; Valberg, S. J.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Murray, J.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Rocchi, M.] Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Ryder, O. A.] San Diego Zoos Inst Conservat Res, Escondido, CA 92029 USA; [Swinburne, J. E.; Vaudin, M.] Anim Hlth Trust, Newmarket CB8 7UU, Suffolk, England; [Tozaki, T.] Lab Racing Chem, Dept Mol Genet, Utsunomiya, Tochigi 3200851, Japan; [Lander, E. S.] MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Sydney; University of Pavia; Uppsala University; University of Bologna; University of Kentucky; University of Adelaide; University of Tampa; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Bern; University of California System; University of California Davis; Wellcome Trust Sanger Institute; Cornell University; University of London; University of London Royal Veterinary College; Texas A&M University System; Texas A&M University College Station; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University College Dublin; Uppsala University; Swedish University of Agricultural Sciences; University of Kentucky; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; Universita degli Studi di Bari Aldo Moro; Norwegian University of Life Sciences; Zoological Society of San Diego; Animal Health Trust; Massachusetts Institute of Technology (MIT)	Wade, CM (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	c.wade@usyd.edu.au; kersli@broadinstitute.org	Ferrier, David E.K./D-7595-2013; Leeb, Tosso/G-3187-2014; Bailey, Ernest/M-1859-2018; Garcia-Fernandez, Jordi/B-3839-2013; Terry, Astrid Y/A-2538-2011; Schmutz, Jeremy/N-3173-2013; Robinson-Rechavi, Marc/E-9727-2011; Tozaki, Teruaki/ABD-9286-2021; Satoh, Nori/C-4123-2009; Adelson, David L/E-5506-2011	Ferrier, David E.K./0000-0003-3247-6233; Leeb, Tosso/0000-0003-0553-4880; Bailey, Ernest/0000-0001-8246-9117; Garcia-Fernandez, Jordi/0000-0001-5677-5970; Terry, Astrid Y/0000-0002-5234-1224; Schmutz, Jeremy/0000-0001-8062-9172; Robinson-Rechavi, Marc/0000-0002-3437-3329; Tozaki, Teruaki/0000-0001-8797-6644; Satoh, Nori/0000-0002-4480-3572; Adelson, David L/0000-0003-2404-5636; GIULOTTO, ELENA/0000-0002-4705-2049; Antczak, Douglas/0000-0003-3336-5818; Skow, Loren/0000-0001-8998-359X; Mickelson, James/0000-0001-6951-0234; Lindgren, Gabriella/0000-0001-6046-9669; Coleman, Stephen/0000-0001-7686-4866; Bellone, Rebecca/0000-0001-8838-7227; Wade, Claire/0000-0003-3413-4771; Sigurdsson, Snaevar/0000-0003-4860-6311; Piras, Maria Francesca/0000-0002-7418-3976; Imsland, Freyja/0000-0002-9452-5566; Hill, Emmeline/0000-0002-1805-2250; NERGADZE, SOLOMON/0000-0001-8121-0189	National Human Genome Research Institute; Dorothy Russell Havemeyer Foundation; Volkswagen Foundation; Morris Animal Foundation; Centro di Eccellenza di Genomica in Campo Biomedico e Agrario; Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale [PRIN-2006]; European Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Dorothy Russell Havemeyer Foundation; Volkswagen Foundation(Volkswagen); Morris Animal Foundation; Centro di Eccellenza di Genomica in Campo Biomedico e Agrario; Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale; European Science Foundation(European Science Foundation (ESF)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Kentucky Horse Park and L. Chemnick for samples, L. Gaffney for graphics, and M. Daly for useful discussions. Supported by the National Human Genome Research Institute, the Dorothy Russell Havemeyer Foundation, the Volkswagen Foundation, the Morris Animal Foundation, the Centro di Eccellenza di Genomica in Campo Biomedico e Agrario, and the Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN-2006). K. L. T. is the recipient of a European Young Investigator award funded by the European Science Foundation. Sequences have GenBank accession numbers AAWR02000001 to AAWR02055316. 1,163,466 discovery SNPs have accession numbers rs6844103 to rs69617090 in dbSNP 130.	Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Carbone L, 2006, GENOMICS, V87, P777, DOI 10.1016/j.ygeno.2005.11.012; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Chowdhary BP, 2008, ANIM REPROD SCI, V107, P208, DOI 10.1016/j.anireprosci.2008.04.010; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lau AN, 2009, MOL BIOL EVOL, V26, P199, DOI 10.1093/molbev/msn239; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Sandmeyer LS, 2007, VET OPHTHALMOL, V10, P368, DOI 10.1111/j.1463-5224.2007.00572.x; Trifonov VA, 2008, CHROMOSOME RES, V16, P89, DOI 10.1007/s10577-007-1201-7; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wu JW, 2009, J EUR ACAD DERMATOL, V23, P174, DOI 10.1111/j.1468-3083.2008.02752.x	17	528	594	0	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					865	867		10.1126/science.1178158	http://dx.doi.org/10.1126/science.1178158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892987	Green Accepted			2022-12-28	WOS:000271468000047
J	Wang, BM; Primeau, TM; Myers, N; Rohrs, HW; Gross, ML; Lybarger, L; Hansen, TH; Connolly, JM				Wang, Baomei; Primeau, Tina M.; Myers, Nancy; Rohrs, Henry W.; Gross, Michael L.; Lybarger, Lonnie; Hansen, Ted H.; Connolly, Janet M.			A Single Peptide-MHC Complex Positively Selects a Diverse and Specific CD8 T Cell Repertoire	SCIENCE			English	Article							SELF-PEPTIDES; NEGATIVE SELECTION; MICE; THYMUS; LYMPHOCYTES; SEQUENCE	Pathogen recognition by T cells is dependent on their exquisite specificity for self-major histocompatibility complex (MHC) molecules presenting a bound peptide. Although this specificity results from positive and negative selection of developing T cells in the thymus, the relative contribution of these two processes remains controversial. To address the relation between the selecting peptide-MHC complex and the specificity of mature T cells, we generated transgenic mice that express a single peptide-MHC class I complex. We demonstrate that positive selection of CD8 T cells in these mice results in an MHC-specific repertoire. Although selection on a single complex is peptide promiscuous, mature T cells are highly peptide specific. Thus, positive selection imparts MHC and peptide specificity on the peripheral CD8 T cell repertoire.	[Wang, Baomei; Primeau, Tina M.; Myers, Nancy; Hansen, Ted H.; Connolly, Janet M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Rohrs, Henry W.; Gross, Michael L.] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [Lybarger, Lonnie] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	Washington University (WUSTL); Washington University (WUSTL); University of Arizona	Connolly, JM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	connolly@wustl.edu			National Center for Research Resources MS Resource [2P41RR000954]; NIH [AI 027568, AI 055849]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055849, R01AI055849, R01AI027568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Center for Research Resources MS Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Allen, C.-S. Hsieh, Y. Huang, K. Murphy, E. Unanue, and A. Singer for critical comments, and Y. Y. Yu for making the transgene constructs. Mass spectrometry was performed at the Washington University National Center for Research Resources MS Resource ( grant 2P41RR000954). This work was supported by NIH grants AI 027568 and AI 055849.	APASOV SG, 1994, J IMMUNOL, V152, P2087; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Barton GM, 2002, P NATL ACAD SCI USA, V99, P6937, DOI 10.1073/pnas.102645699; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; BEVAN MJ, 1981, P NATL ACAD SCI-BIOL, V78, P1843, DOI 10.1073/pnas.78.3.1843; Chmielowski B, 1999, J IMMUNOL, V162, P95; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	29	37	38	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					871	874		10.1126/science.1177627	http://dx.doi.org/10.1126/science.1177627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892989	Green Accepted			2022-12-28	WOS:000271468000049
J	Park, AW; Daly, JM; Lewis, NS; Smith, DJ; Wood, JLN; Grenfell, BT				Park, Andrew W.; Daly, Janet M.; Lewis, Nicola S.; Smith, Derek J.; Wood, James L. N.; Grenfell, Bryan T.			Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza	SCIENCE			English	Article							EQUINE INFLUENZA; PANDEMIC INFLUENZA; INFECTION; VIRUS; EVOLUTION	Influenza virus evades prevailing natural and vaccine-induced immunity by accumulating antigenic change in the haemagglutinin surface protein. Linking amino acid substitutions in haemagglutinin epitopes to epidemiology has been problematic because of the scarcity of data connecting these scales. We use experiments on equine influenza virus to address this issue, quantifying how key parameters of viral establishment and shedding increase the probability of transmission with genetic distance between previously immunizing virus and challenge virus. Qualitatively similar patterns emerge from analyses based on antigenic distance and from a published human influenza study. Combination of the equine data and epidemiological models allows us to calculate the effective reproductive number of transmission as a function of relevant genetic change in the virus, illuminating the probability of influenza epidemics as a function of immunity.	[Park, Andrew W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Park, Andrew W.] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Daly, Janet M.; Lewis, Nicola S.] Anim Hlth Trust, Newmarket CB8 7UU, Suffolk, England; [Daly, Janet M.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lewis, Nicola S.; Wood, James L. N.] Cambridge Infect Dis Consortium, Dept Vet Med, Cambridge CB3 0ES, England; [Smith, Derek J.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Smith, Derek J.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Animal Health Trust; University of Nottingham; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Princeton University; Princeton University	Park, AW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	awpark@uga.edu	Smith, Derek/Z-3075-2019; Wood, James/A-1626-2008; Daly, Janet/G-9797-2011	Smith, Derek/0000-0002-2393-1890; Wood, James/0000-0002-0258-3188; Daly, Janet/0000-0002-1912-4500	Horserace Betting Levy Board; University of Georgia; Cambridge Infectious Diseases Consortium; NIH [DP1-OD000490-01, R01GM083983-02]; European Union [223498]; Human Frontiers Science Program; Defra [VT0105]; Alborada Trust; Department of Homeland Security; NSF [0742373]; Fogarty International Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	Horserace Betting Levy Board; University of Georgia; Cambridge Infectious Diseases Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Alborada Trust; Department of Homeland Security(United States Department of Homeland Security (DHS)); NSF(National Science Foundation (NSF)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to R. Pyhala, National Public Health Institute, Finland, for providing the HA1 sequence for A/Finland/74 (H3N2) and L. Yipu, National Institute for Medical Research, UK, for providing a sample of A/Scotland/74 (H3N2) from which we obtained the HA1 sequence. We also thank J. Gog, S. Gandon, J. Drake, P. Rohani, and Y. Michalakis for helpful discussions. Financial support came from Horserace Betting Levy Board (A. P. and J. D.), University of Georgia (A. P.), Cambridge Infectious Diseases Consortium (N. L.), NIH Director's pioneer award DP1-OD000490-01 (D. S.), European Union 223498 (D. S.), Human Frontiers Science Program (D. S.), Defra grant VT0105 (J. W.), Alborada Trust (J. W.), Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security (J. W. and B. G.), NIH grant R01GM083983-02 (B. G.), NSF grant 0742373 (B. G.), Fogarty International Center, and NIH (B. G., D. S., J. W.). The authors declare no competing financial interests.	ANDERSON R M, 1991; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Daly JM, 2004, VACCINE, V22, P4101, DOI 10.1016/j.vaccine.2004.02.048; DANIELS RS, 1985, J GEN VIROL, V66, P457, DOI 10.1099/0022-1317-66-3-457; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; Nasell I., 1995, EPIDEMIC MODELS THEI; Newton JR, 1999, VET REC, V145, P449, DOI 10.1136/vr.145.16.449; POTTER CW, 1977, J HYG-CAMBRIDGE, V79, P321, DOI 10.1017/S0022172400053158; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Satou K, 2006, J EQUINE VET SCI, V26, P310, DOI 10.1016/j.jevs.2006.05.003; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; STUDDERT MJ, 1996, VIRUS INFECT INVERTE; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	24	77	78	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					726	728		10.1126/science.1175980	http://dx.doi.org/10.1126/science.1175980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900931	Green Accepted			2022-12-28	WOS:000271233200037
J	Shi, YG				Shi, Yigong			Serine/Threonine Phosphatases: Mechanism through Structure	CELL			English	Review							RNA-POLYMERASE-II; PP2A CATALYTIC SUBUNIT; RABBIT SKELETAL-MUSCLE; SER/THR PROTEIN PHOSPHATASE; TERMINAL LEUCINE RESIDUE; MIDDLE TUMOR-ANTIGEN; SMALL T-ANTIGEN; CRYSTAL-STRUCTURE; REGULATORY SUBUNITS; IN-VIVO		[Shi, Yigong] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn		Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801]; Tsinghua University 985 Phase II funds; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University 985 Phase II funds; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918801), Tsinghua University 985 Phase II funds, the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bennett KP., 2000, ACM SIGKDD EXPLOR NE, V2, P1, DOI [10.1145/380995.380999, DOI 10.1145/380995.380999]; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CARDENAS ME, 1995, EMBO J, V14, P2772, DOI 10.1002/j.1460-2075.1995.tb07277.x; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Cohen PTW, 2002, J CELL SCI, V115, P241; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Cori GT, 1943, J BIOL CHEM, V151, P31; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; DeLano W.L, PYMOL MOL GRAPHICS S; DESDOUITS F, 1995, BIOCHEM BIOPH RES CO, V206, P652, DOI 10.1006/bbrc.1995.1092; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; FISCHER EH, 1955, J BIOL CHEM, V216, P121; FOULKES JG, 1980, EUR J BIOCHEM, V105, P195, DOI 10.1111/j.1432-1033.1980.tb04489.x; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gentile S, 2006, P NATL ACAD SCI USA, V103, P5202, DOI 10.1073/pnas.0600080103; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Gregan J, 2008, TRENDS GENET, V24, P205, DOI 10.1016/j.tig.2008.02.001; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hausmann S, 2004, J BIOL CHEM, V279, P10892, DOI 10.1074/jbc.M312513200; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Hirano K, 1997, J BIOL CHEM, V272, P3683, DOI 10.1074/jbc.272.6.3683; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kins S, 2001, J BIOL CHEM, V276, P38193; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; KREBS EG, 1956, BIOCHIM BIOPHYS ACTA, V20, P150, DOI 10.1016/0006-3002(56)90273-6; KREBS EG, 1958, J BIOL CHEM, V231, P73; Kutuzov MA, 2002, CELL SIGNAL, V14, P745, DOI 10.1016/S0898-6568(02)00018-9; Kutuzov MA, 2001, BIOCHEM BIOPH RES CO, V289, P634, DOI 10.1006/bbrc.2001.6020; Kutuzov MA, 1998, FEBS LETT, V440, P147, DOI 10.1016/S0014-5793(98)01428-8; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Leulliot N, 2006, MOL CELL, V23, P413, DOI 10.1016/j.molcel.2006.07.008; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; NIMMO GA, 1978, EUR J BIOCHEM, V87, P353, DOI 10.1111/j.1432-1033.1978.tb12384.x; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Ridder IS, 1999, J BIOL CHEM, V274, P30672, DOI 10.1074/jbc.274.43.30672; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; SUTHERLAND EW, 1955, NATURE, V175, P169, DOI 10.1038/175169a0; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; VANHOOF C, 1994, EUR J BIOCHEM, V226, P899; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; XU Z, 2009, MOL CELL IN PRESS; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhang CC, 2005, J MOL MICROB BIOTECH, V9, P154, DOI 10.1159/000089644; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhu DH, 1996, MOL PHARMACOL, V50, P506	160	1016	1053	16	420	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					468	484		10.1016/j.cell.2009.10.006	http://dx.doi.org/10.1016/j.cell.2009.10.006			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879837	Bronze			2022-12-28	WOS:000271259600013
J	Reubi, O; Blundy, J				Reubi, Olivier; Blundy, Jon			A dearth of intermediate melts at subduction zone volcanoes and the petrogenesis of arc andesites	NATURE			English	Article							MEDICINE LAKE VOLCANO; OLIVINE PHENOCRYSTS; GRANITIC MAGMAS; PLUTONIC ROOTS; INCLUSIONS; CRYSTALLIZATION; GENESIS; CRUSTAL; EVOLUTION; DIFFERENTIATION	Andesites represent a large proportion of the magmas erupted at continental arc volcanoes and are regarded as a major component in the formation of continental crust(1). Andesite petrogenesis is therefore fundamental in terms of both volcanic hazard and differentiation of the Earth. Andesites typically contain a significant proportion of crystals showing disequilibrium petrographic characteristics indicative of mixing or mingling between silicic and mafic magmas, which fuels a long-standing debate regarding the significance of these processes in andesite petrogenesis(2) and ultimately questions the abundance of true liquids with andesitic composition. Central to this debate is the distinction between liquids (or melts) and magmas, mixtures of liquids with crystals, which may or may not be co-genetic. With this distinction comes the realization that bulk-rock chemical analyses of petrologically complex andesites can lead to a blurred picture of the fundamental processes behind arc magmatism. Here we present an alternative view of andesite petrogenesis, based on a review of quenched glassy melt inclusions trapped in phenocrysts, whole-rock chemistry, and high-pressure and high-temperature experiments. We argue that true liquids of intermediate composition (59 to 66 wt% SiO2) are far less common in the sub-volcanic reservoirs of arc volcanoes than is suggested by the abundance of erupted magma within this compositional range. Effective mingling within upper crustal magmatic reservoirs obscures a compositional bimodality of melts ascending from the lower crust, and masks the fundamental role of silicic melts (>= 66 wt% SiO2) beneath intermediate arc volcanoes. This alternative view resolves several puzzling aspects of arc volcanism and provides important clues to the integration of plutonic and volcanic records.	[Reubi, Olivier; Blundy, Jon] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Reubi, O (corresponding author), ETH, Inst Isotope Geochem & Mineral Resources, CH-8092 Zurich, Switzerland.	olivier.reubi@erdw.ethz.ch	Facility, Edinburgh Ion Microprobe/AAD-8512-2020	Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657; Reubi, Olivier/0000-0003-1121-914X	Marie Curie Fellowship; NERC; Natural Environment Research Council [IMF010001] Funding Source: researchfish; NERC [IMF010001] Funding Source: UKRI	Marie Curie Fellowship(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Marie Curie Fellowship (O. R.) and an NERC Senior Research Fellowship (J. B.). We thank S. Sparks, K. Kelley and K. Roggensack for comments on an early draft of this manuscript, and P. Wallace and M. Pichavant for critical reviews. Weare grateful to V. C. Smith for unpublished data and discussions.	Alonso-Perez R, 2009, CONTRIB MINERAL PETR, V157, P541, DOI 10.1007/s00410-008-0351-8; ANDERSON AT, 1976, J VOLCANOL GEOTH RES, V1, P3, DOI 10.1016/0377-0273(76)90016-0; Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; ARCULUS RJ, 2007, STATE ARC C EXTENDED, P1; Blundy J, 2005, GEOLOGY, V33, P793, DOI 10.1130/G21668.1; BLUNDY JD, 1992, J PETROL, V33, P1039, DOI 10.1093/petrology/33.5.1039; Blundy J, 2006, NATURE, V443, P76, DOI 10.1038/nature05100; Chappell BW, 2001, AUST J EARTH SCI, V48, P489, DOI 10.1046/j.1440-0952.2001.00882.x; Cottrell E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000205; Danyushevsky LV, 2004, J PETROL, V45, P2531, DOI 10.1093/petrology/egh080; Danyushevsky LV, 2002, CHEM GEOL, V183, P5, DOI 10.1016/S0009-2541(01)00369-2; Danyushevsky LV, 2000, CONTRIB MINERAL PETR, V138, P68, DOI 10.1007/PL00007664; DEPAOLO DJ, 1992, T ROY SOC EDIN-EARTH, V83, P439, DOI 10.1017/S0263593300008117; Dungan MA, 2004, GEOLOGY, V32, P773, DOI 10.1130/G20735.1; Gill J., 1981, OROGENIC ANDESITES P; GLAZNER AF, 2007, STATE ARC C EXTENDED, P79; GROVE TL, 1986, CONTRIB MINERAL PETR, V92, P281, DOI 10.1007/BF00572157; Grove TL, 1997, CONTRIB MINERAL PETR, V127, P205, DOI 10.1007/s004100050276; HILDRETH W, 1988, CONTRIB MINERAL PETR, V98, P455, DOI 10.1007/BF00372365; HILDRETH W, 2007, PROF PAP US GEOL SUR, V1744; Humphreys MCS, 2008, CONTRIB MINERAL PETR, V155, P45, DOI 10.1007/s00410-007-0223-7; Humphreys MCS, 2006, J PETROL, V47, P2303, DOI 10.1093/petrology/egl045; Johnson ER, 2008, EARTH PLANET SC LETT, V269, P477, DOI 10.1016/j.epsl.2008.03.004; Martin VM, 2006, J VOLCANOL GEOTH RES, V154, P89, DOI 10.1016/j.jvolgeores.2005.09.021; Muntener O, 2001, CONTRIB MINERAL PETR, V141, P643; NARANJO JA, 1992, GEOL MAG, V129, P657, DOI 10.1017/S0016756800008426; Naumov BV, 1997, PETROLOGY+, V5, P586; Pichavant M, 2007, CONTRIB MINERAL PETR, V154, P535, DOI 10.1007/s00410-007-0208-6; Reubi O, 2008, J PETROL, V49, P2221, DOI 10.1093/petrology/egn066; Roedder E., 1984, FLUID INCLUSIONS; Roggensack K, 2001, GEOLOGY, V29, P911, DOI 10.1130/0091-7613(2001)029<0911:UTEOFV>2.0.CO;2; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Sisson TW, 2005, CONTRIB MINERAL PETR, V148, P635, DOI 10.1007/s00410-004-0632-9; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; Ulmer P, 2007, PERIOD MINERAL, V76, P309, DOI 10.2451/2007PM0030; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Wright IC, 1999, MAR GEOL, V161, P207, DOI 10.1016/S0025-3227(99)00040-7	37	279	294	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1269	U103		10.1038/nature08510	http://dx.doi.org/10.1038/nature08510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865169				2022-12-28	WOS:000271190800046
J	Jackson, SP; Bartek, J				Jackson, Stephen P.; Bartek, Jiri			The DNA-damage response in human biology and disease	NATURE			English	Review							DOUBLE-STRAND BREAKS; HEMATOPOIETIC STEM-CELLS; CELLULAR SENESCENCE; HOMOLOGOUS RECOMBINATION; REPAIR PATHWAYS; EXCISION-REPAIR; CANCER; GENOME; ATM; P53	The prime objective for every life form is to deliver its genetic material, intact and unchanged, to the next generation. This must be achieved despite constant assaults by endogenous and environmental agents on the DNA. To counter this threat, life has evolved several systems to detect DNA damage, signal its presence and mediate its repair. Such responses, which have an impact on a wide range of cellular events, are biologically significant because they prevent diverse human diseases. Our improving understanding of DNA-damage responses is providing new avenues for disease management.	[Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Inst Mol Genet, CZ-14220 Prague, Czech Republic	University of Cambridge; University of Cambridge; Danish Cancer Society; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Bartek, Jiri/G-5870-2014; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937	Cancer Research UK; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Danish Cancer Society; Danish National Research Foundation	Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank S. Polo and P. Huertas for advice, and K. Dry for expert help with the text and figures. The S.P.J. laboratory is supported by grants from Cancer Research UK, the European Commission ( projects GENICA and DNA Repair), the Wellcome Trust and the Biotechnology and Biological Sciences Research Council. The J.B. laboratory is supported by grants from the Danish Cancer Society, the Danish National Research Foundation and the European Commission ( projects GENICA, Active p53, TRIREME and DNA Repair).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2007, INT J ANDROL, V30, P282, DOI 10.1111/j.1365-2605.2007.00772.x; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Espinosa E, 2003, CANCER TREAT REV, V29, P515, DOI 10.1016/S0305-7372(03)00116-6; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jackson SP, 2009, BIOCHEM SOC T, V37, P483, DOI 10.1042/BST0370483; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lebwohl M, 2005, ANN RHEUM DIS, V64, P83, DOI 10.1136/ard.2004.030791; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li H, 2008, VIROLOGY, V375, P13, DOI 10.1016/j.virol.2008.01.038; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mercer J, 2007, MUTAT RES-FUND MOL M, V621, P75, DOI 10.1016/j.mrfmmm.2007.02.011; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mocanu MM, 2003, FEBS LETT, V555, P302, DOI 10.1016/S0014-5793(03)01260-2; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nouspikel TP, 2006, MOL CELL BIOL, V26, P8722, DOI 10.1128/MCB.01263-06; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Richardson C, 2004, DNA REPAIR, V3, P1149, DOI 10.1016/j.dnarep.2004.05.007; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schlissel MS, 2006, GENE DEV, V20, P1539, DOI 10.1101/gad.1446506; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith H, 2008, PAIN PHYSICIAN, V11, P1; Smith JA, 2006, ACS CHEM BIOL, V1, P217, DOI 10.1021/cb600131q; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yang JL, 2008, DNA REPAIR, V7, P1110, DOI 10.1016/j.dnarep.2008.03.012; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	101	3658	3761	28	843	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1071	1078		10.1038/nature08467	http://dx.doi.org/10.1038/nature08467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847258	Green Accepted			2022-12-28	WOS:000270987600034
J	Domian, IJ; Chiravuri, M; van der Meer, P; Feinberg, AW; Shi, X; Shao, Y; Wu, SM; Parker, KK; Chien, KR				Domian, Ibrahim J.; Chiravuri, Murali; van der Meer, Peter; Feinberg, Adam W.; Shi, Xi; Shao, Ying; Wu, Sean M.; Parker, Kevin Kit; Chien, Kenneth R.			Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells	SCIENCE			English	Article							SMOOTH-MUSCLE; ISL1; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; MEF2C	The mammalian heart is formed from distinct sets of first and second heart field (FHF and SHF, respectively) progenitors. Although multipotent progenitors have previously been shown to give rise to cardiomyocytes, smooth muscle, and endothelial cells, the mechanism governing the generation of large numbers of differentiated progeny remains poorly understood. We have employed a two-colored fluorescent reporter system to isolate FHF and SHF progenitors from developing mouse embryos and embryonic stem cells. Genome-wide profiling of coding and noncoding transcripts revealed distinct molecular signatures of these progenitor populations. We further identify a committed ventricular progenitor cell in the Islet 1 lineage that is capable of limited in vitro expansion, differentiation, and assembly into functional ventricular muscle tissue, representing a combination of tissue engineering and stem cell biology.	[Domian, Ibrahim J.; Chiravuri, Murali; van der Meer, Peter; Shi, Xi; Shao, Ying; Wu, Sean M.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Domian, Ibrahim J.; Wu, Sean M.; Parker, Kevin Kit; Chien, Kenneth R.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Feinberg, Adam W.; Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Dis Biophys Grp, Cambridge, MA 02138 USA; [Parker, Kevin Kit] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Groningen; Harvard University; Harvard University; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Plaza,CPZN 3200,185 Cambridge St, Boston, MA 02114 USA.	krchien@partners.org	Feinberg, Adam W/A-7103-2009; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Wu, Sean/0000-0002-0000-3821	NHLBI NIH HHS [K08 HL081086-01, K08 HL091209, R01 HL079126, K08 HL081086, T32 HL002807, R01 HL079126-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079126, K08HL081086, K08HL091209] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lien CL, 1999, DEVELOPMENT, V126, P75; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	21	161	170	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					426	429		10.1126/science.1177350	http://dx.doi.org/10.1126/science.1177350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833966	Green Accepted, Green Submitted			2022-12-28	WOS:000270818600053
J	Reichhardt, CJO; Lopatina, LM				Reichhardt, C. J. Olson; Lopatina, L. M.			A Ball-and-Chain Polymer Model	SCIENCE			English	Editorial Material									[Reichhardt, C. J. Olson; Lopatina, L. M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Lopatina, L. M.] Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Reichhardt, CJO (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	cjrx@lanl.gov		Reichhardt, Cynthia/0000-0002-3487-5089				De Gennes P.-G., 1979, SCALING CONCEPTS POL; Drocco JA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.088001; FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; Rubenstein MC, 2003, POLYM PHYS; Zou LN, 2009, SCIENCE, V326, P408, DOI 10.1126/science.1177114	7	10	10	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					374	375		10.1126/science.1180973	http://dx.doi.org/10.1126/science.1180973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833947				2022-12-28	WOS:000270818600032
J	Brun, R; Blum, J; Chappuis, F; Burri, C				Brun, Reto; Blum, Johannes; Chappuis, Francois; Burri, Christian			Human African trypanosomiasis	LANCET			English	Article							GAMBIENSE SLEEPING SICKNESS; CARD-AGGLUTINATION-TEST; OF-THE-CONGO; CATT/TRYPANOSOMA-BRUCEI-GAMBIENSE; INTRATHECAL IMMUNE-RESPONSE; NERVOUS-SYSTEM INVOLVEMENT; POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; LATE-STAGE; COTE-DIVOIRE	Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies. Almost all cases are due to Trypanosoma brucei gambiense, which is indigenous to west and central Africa. Prevalence is strongly dependent on control measures, which are often neglected during periods of political instability, thus leading to resurgence. With fewer than 12000 cases of this disabling and fatal disease reported per year, trypanosomiasis belongs to the most neglected tropical diseases. The clinical presentation is complex, and diagnosis and treatment difficult. The available drugs are old, complicated to administer, and can cause severe adverse reactions. New diagnostic methods and safe and effective drugs are urgently needed. Vector control, to reduce the number of flies in existing foci, needs to be organised on a pan-African basis. WHO has stated that if national control programmes, international organisations, research institutes, and philanthropic partners engage in concerted action, elimination of this disease might even be possible.	[Brun, Reto; Blum, Johannes; Burri, Christian] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Chappuis, Francois] Univ Geneva, Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; Med Sans Frontieres, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Geneva; Doctors Without Borders	Brun, R (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	reto.brun@unibas.ch		Burri, Christian/0000-0001-5418-1984				Abel PM, 2004, TROP MED INT HEALTH, V9, P141, DOI 10.1046/j.1365-3156.2003.01152.x; *AFR UN, 2002, AHP DFID SPEC WORKSH; Agranoff D, 2005, TRENDS PARASITOL, V21, P154, DOI 10.1016/j.pt.2005.02.003; Ancelle T, 1997, Med Trop (Mars), V57, P245; [Anonymous], MANSONS TROPICAL DIS; [Anonymous], 1998, CONTR SURV AFR TRYP; Ayed Z, 1997, AM J TROP MED HYG, V57, P1; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P783, DOI 10.2471/BLT.06.031955; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P777, DOI 10.2471/BLT.05.028399; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; BAYER AG, 2004, BAYER SUSTAINABLE DE; Bedat-Millet AL, 2000, REV NEUROL, V156, P505; Bisoffi Z, 2005, EMERG INFECT DIS, V11, P1745, DOI 10.3201/eid1111.050649; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum J, 2005, T ROY SOC TROP MED H, V99, P795, DOI 10.1016/j.trstmh.2005.04.010; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; Blum JA, 2008, LANCET INFECT DIS, V8, P631, DOI 10.1016/S1473-3099(08)70230-5; Blum JA, 2007, TROP MED INT HEALTH, V12, P1422, DOI 10.1111/j.1365-3156.2007.01948.x; Blum JA, 2007, ACTA TROP, V104, P16, DOI 10.1016/j.actatropica.2007.07.004; BRONNER U, 1991, T ROY SOC TROP MED H, V85, P608, DOI 10.1016/0035-9203(91)90364-5; Bronner U., 1994, THESIS KAROLINSKA I; Brun R, 2006, CURR OPIN INFECT DIS, V19, P415, DOI 10.1097/01.qco.0000244045.93016.b1; Buguet A, 2001, Med Trop (Mars), V61, P328; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Chappuis F, 2004, AM J TROP MED HYG, V71, P313, DOI 10.4269/ajtmh.2004.71.313; Chappuis F, 2002, TROP MED INT HEALTH, V7, P942, DOI 10.1046/j.1365-3156.2002.00956.x; CHAPPUIS F, 2004, DEV SANTE, V171, P41; Chappuis F, 2007, CLIN INFECT DIS, V45, P1443, DOI 10.1086/522983; Checchi F, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000064; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Courtioux B, 2005, J CLIN MICROBIOL, V43, P4789, DOI 10.1128/JCM.43.9.4789-4795.2005; de Raadt P, 1968, East Afr Med J, V45, P128; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; *DNDI, 2008, DNDI NEWSL; Dorlo TPC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000225; Doua F, 1996, AM J TROP MED HYG, V55, P586, DOI 10.4269/ajtmh.1996.55.586; DUGGAN AJ, 1966, J TROP MED HYG, V69, P124; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Ekwanzala M, 1996, LANCET, V348, P1427, DOI 10.1016/S0140-6736(96)06088-6; Enyaru JCK, 2006, ANN NY ACAD SCI, V1081, P311, DOI 10.1196/annals.1373.041; Ezzedine K, 2007, J TRAVEL MED, V14, P192, DOI 10.1111/j.1708-8305.2007.00114.x; Fevre EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-96; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; GREENWOOD BM, 1973, LANCET, V2, P525; Gustafsson LL, 1987, HDB DRUGS TROPICAL P, P160; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; Iborra C, 1999, CLIN INFECT DIS, V28, P679, DOI 10.1086/517213; Inojosa WO, 2006, BMJ-BRIT MED J, V332, P1479, DOI 10.1136/bmj.38859.531354.7C; *INT FED PHARM MAN, HLTH PARTN DEV WORLD; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Jamonneau V, 2004, ANN TROP MED PARASIT, V98, P329, DOI 10.1179/000349804225003406; Jamonneau V, 2003, TROP MED INT HEALTH, V8, P589, DOI 10.1046/j.1365-3156.2003.01079.x; Jamonneau V, 2002, TROP MED INT HEALTH, V7, P610, DOI 10.1046/j.1365-3156.2002.00905.x; Jamonneau V, 2000, ANN TROP MED PARASIT, V94, P831, DOI 10.1080/00034980020028004; Jamonneau V, 2000, ACTA TROP, V76, P175, DOI 10.1016/S0001-706X(00)00095-4; Jansson R, 2008, ANTIMICROB AGENTS CH, V52, P2842, DOI 10.1128/AAC.00050-08; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; Jordan A. M., 1993, P333; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kennedy PGE, 2008, T ROY SOC TROP MED H, V102, P306, DOI 10.1016/j.trstmh.2007.11.011; Kennedy PGE, 2006, J NEUROL, V253, P411, DOI 10.1007/s00415-006-0093-3; KOTEN JW, 1969, T ROY SOC TROP MED H, V63, P485, DOI 10.1016/0035-9203(69)90036-4; Lejon V, 2005, TROP MED INT HEALTH, V10, P395, DOI 10.1111/j.1365-3156.2005.01403.x; Lejon V, 1999, AM J TROP MED HYG, V60, P94, DOI 10.4269/ajtmh.1999.60.94; Lejon V, 2003, LANCET INFECT DIS, V3, P804, DOI 10.1016/S1473-3099(03)00834-X; Lejon V, 2003, J NEUROIMMUNOL, V144, P132, DOI 10.1016/j.jneuroim.2003.08.033; Lejon V, 2003, EUR J NEUROL, V10, P711, DOI 10.1046/j.1468-1331.2003.00660.x; Lejon V, 2003, J INFECT DIS, V187, P1475, DOI 10.1086/374645; Lejon V, 2002, TROP MED INT HEALTH, V7, P685, DOI 10.1046/j.1365-3156.2002.00917.x; Lejon V, 1998, ACTA TROP, V69, P151, DOI 10.1016/S0001-706X(97)00137-X; Louis F J, 2005, Med Trop (Mars), V65, P251; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; Lundkvist GB, 2004, PHYSIOLOGY, V19, P198, DOI 10.1152/physiol.00006.2004; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; Lutumba P, 2007, EMERG INFECT DIS, V13, P1484, DOI 10.3201/eid1310.060358; MacLean L, 2004, INFECT IMMUN, V72, P7040, DOI 10.1128/IAI.72.12.7040-7044.2004; Macleod ET, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000239; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Marcello L, 2007, J EUKARYOT MICROBIOL, V54, P14, DOI 10.1111/j.1550-7408.2006.00227.x; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; Maudlin I, 2006, ANN TROP MED PARASIT, V100, P679, DOI 10.1179/136485906X112211; *MED SANS FRONT, 2007, CLIN GUID; Mendonca Melo M, 2002, Ned Tijdschr Geneeskd, V146, P2552; Moore A, 2001, TROP MED INT HEALTH, V6, P342, DOI 10.1046/j.1365-3156.2001.00714.x; Moore AC, 2002, NEW ENGL J MED, V346, P2069, DOI 10.1056/NEJMcpc010056; Moore DAJ, 2002, EMERG INFECT DIS, V8, P74, DOI 10.3201/eid0801.010130; Na-Bangchang K, 2004, EUR J CLIN PHARMACOL, V60, P269, DOI 10.1007/s00228-004-0759-7; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; NOIREAU F, 1991, B WORLD HEALTH ORGAN, V69, P607; NOIREAU F, 1988, T ROY SOC TROP MED H, V82, P237, DOI 10.1016/0035-9203(88)90430-0; Odiit M, 2005, TROP MED INT HEALTH, V10, P840, DOI 10.1111/j.1365-3156.2005.01470.x; Odiit M, 1997, E AFR MED J, V74, P792; Oscherwitz SL, 2003, J TRAVEL MED, V10, P141, DOI 10.2310/7060.2003.31743; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38; Penchenier L, 2003, ACTA TROP, V85, P31, DOI 10.1016/S0001-706X(02)00232-2; PEPIN J, 1992, T ROY SOC TROP MED H, V86, P254, DOI 10.1016/0035-9203(92)90298-Q; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Pohlig G, 2008, 57 M AM SOC TROP MED; POHLIG G, 2005, 28 M INT SCI COUNC T; Priotto G, 2008, BMJ-BRIT MED J, V336, P679; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Reincke M, 1998, ANN NY ACAD SCI, V840, P809, DOI 10.1111/j.1749-6632.1998.tb09619.x; Ripamonti D, 2002, CLIN INFECT DIS, V34, pE18, DOI 10.1086/338157; Robays J, 2004, TROP MED INT HEALTH, V9, P869, DOI 10.1111/j.1365-3156.2004.01266.x; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Ruiz JA, 2002, B WORLD HEALTH ORGAN, V80, P738; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; SEIXAS J, 2004, THESIS U NOVA LISBOA; Shiflett AM, 2007, J EUKARYOT MICROBIOL, V54, P18, DOI 10.1111/j.1550-7408.2006.00228.x; Simarro P P, 2003, Med Trop (Mars), V63, P231; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; SPENCER HC, 1975, ANN INTERN MED, V82, P633, DOI 10.7326/0003-4819-82-5-633; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Steverding Dietmar, 2006, Kinetoplastid Biol Dis, V5, P1, DOI 10.1186/1475-9292-5-1; Stijemans B, 2007, VET PARASITOL, V148, P3, DOI 10.1016/j.vetpar.2007.05.005; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Truc P, 1998, T ROY SOC TROP MED H, V92, P537, DOI 10.1016/S0035-9203(98)90904-X; Truc P, 1999, B WORLD HEALTH ORGAN, V77, P745; Truc P, 2002, B WORLD HEALTH ORGAN, V80, P882; Truc P, 1998, T ROY SOC TROP MED H, V92, P288, DOI 10.1016/S0035-9203(98)91014-8; Van Nieuwenhove S, 2001, TROP MED INT HEALTH, V6, P335, DOI 10.1046/j.1365-3156.2001.00731.x; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; VANMEIRVENNE N, 1999, PROGR HUMAN AFRICAN, P235; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; *WHO, 1986, WHO TECH REP SER, V739; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P71; Woo P. T. K., 1970, Acta trop., V27, P384; World Health Organization, 2002, WHO PROGR EL SLEEP S; 2008, ARZNEIMITTELKOMPENDI	153	550	559	8	228	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					148	159		10.1016/S0140-6736(09)60829-1	http://dx.doi.org/10.1016/S0140-6736(09)60829-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	19833383				2022-12-28	WOS:000273664500032
J	Ginsburg, PB				Ginsburg, Paul B.			Getting to the Real Issues in Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Studying Hlth Syst Change, Washington, DC USA		Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2107	2109		10.1056/NEJMp0910678	http://dx.doi.org/10.1056/NEJMp0910678			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	524BC	19907036				2022-12-28	WOS:000272117800002
J	Abdo, AA; Ackermann, M; Ajello, M; Asano, K; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Bechtol, K; Bellazzini, R; Berenji, B; Bhat, PN; Bissaldi, E; Bloom, ED; Bonamente, E; Bonnell, J; Borgland, AW; Bouvier, A; Bregeon, J; Brez, A; Briggs, MS; Brigida, M; Bruel, P; Burgess, JM; Burnett, TH; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Chaplin, V; Charles, E; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Connaughton, V; Conrad, J; Cutini, S; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Dingus, BL; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Farnier, C; Favuzzi, C; Fegan, SJ; Finke, J; Fishman, G; Focke, WB; Foschini, L; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Gibby, L; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Granot, J; Greiner, J; Grenier, IA; Grondin, MH; Grove, JE; Grupe, D; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hoversten, EA; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Kawai, N; Kerr, M; Kippen, RM; Knodlseder, J; Kocevski, D; Kouveliotou, C; Kuehn, F; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Mazziotta, MN; McBreen, S; McEnery, JE; McGlynn, S; Meszaros, P; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Moretti, E; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nolan, PL; Norris, JP; Nuss, E; Ohno, M; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Ozaki, M; Paciesas, WS; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Petrosian, V; Piron, F; Porter, TA; Preece, R; Raino, S; Ramirez-Ruiz, E; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, LS; Rodriguez, AY; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Schalk, TL; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Stamatikos, M; Stecker, FW; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Toma, K; Torres, DF; Tosti, G; Troja, E; Uchiyama, Y; Uehara, T; Usher, TL; van der Horst, AJ; Vasileiou, V; Vilchez, N; Vitale, V; von Kienlin, A; Waite, AP; Wang, P; Wilson-Hodge, C; Winer, BL; Wood, KS; Wu, XF; Yamazaki, R; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Asano, K.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Bhat, P. N.; Bissaldi, E.; Bloom, E. D.; Bonamente, E.; Bonnell, J.; Borgland, A. W.; Bouvier, A.; Bregeon, J.; Brez, A.; Briggs, M. S.; Brigida, M.; Bruel, P.; Burgess, J. M.; Burnett, T. H.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Chaplin, V.; Charles, E.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Connaughton, V.; Conrad, J.; Cutini, S.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; Dingus, B. L.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Finke, J.; Fishman, G.; Focke, W. B.; Foschini, L.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Gibby, L.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Granot, J.; Greiner, J.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Grupe, D.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hoversten, E. A.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kawai, N.; Kerr, M.; Kippen, R. M.; Knoedlseder, J.; Kocevski, D.; Kouveliotou, C.; Kuehn, F.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Mazziotta, M. N.; McBreen, S.; McEnery, J. E.; McGlynn, S.; Meszaros, P.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Moretti, E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohno, M.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Ozaki, M.; Paciesas, W. S.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Petrosian, V.; Piron, F.; Porter, T. A.; Preece, R.; Raino, S.; Ramirez-Ruiz, E.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Schalk, T. L.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Stamatikos, M.; Stecker, F. W.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Toma, K.; Torres, D. F.; Tosti, G.; Troja, E.; Uchiyama, Y.; Uehara, T.; Usher, T. L.; van der Horst, A. J.; Vasileiou, V.; Vilchez, N.; Vitale, V.; von Kienlin, A.; Waite, A. P.; Wang, P.; Wilson-Hodge, C.; Winer, B. L.; Wood, K. S.; Wu, X. F.; Yamazaki, R.; Ylinen, T.; Ziegler, M.			A limit on the variation of the speed of light arising from quantum gravity effects	NATURE			English	Article							GAMMA-RAY BURSTS; HIGH-ENERGY; VIOLATION; EMISSION; PHOTONS; LORENTZ; TESTS; FOAM	A cornerstone of Einstein's special relativity is Lorentz invariance-the postulate that all observers measure exactly the same speed of light in vacuum, independent of photon-energy. While special relativity assumes that there is no fundamental length-scale associated with such invariance, there is a fundamental scale (the Planck scale, l(Planck) approximate to 1.62 x 10(-33) cm or E-Planck = M(Planck)c(2) approximate to 1.22 x 10(19) GeV), at which quantum effects are expected to strongly affect the nature of space-time. There is great interest in the (not yet validated) idea that Lorentz invariance might break near the Planck scale. A key test of such violation of Lorentz invariance is a possible variation of photon speed with energy(1-7). Even a tiny variation in photon speed, when accumulated over cosmological light-travel times, may be revealed by observing sharp features in gamma-ray burst (GRB) light-curves(2). Here we report the detection of emission up to similar to 31GeV from the distant and short GRB090510. We find no evidence for the violation of Lorentz invariance, and place a lower limit of 1.2E(Planck) on the scale of a linear energy dependence (or an inverse wavelength dependence), subject to reasonable assumptions about the emission (equivalently we have an upper limit of l(Planck)/1.2 on the length scale of the effect). Our results disfavour quantum-gravity theories(3,6,7) in which the quantum nature of space-time on a very small scale linearly alters the speed of light.	[Granot, J.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Abdo, A. A.; Cheung, C. C.; Dermer, C. D.; Finke, J.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Razzaque, S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Abdo, A. A.; Cheung, C. C.; Finke, J.; Razzaque, S.] Natl Acad Sci, Natl Res Council Res Associate, Washington, DC 20001 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocevski, D.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Petrosian, V.; Reimer, A.; Reimer, O.; Rochester, L. S.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, Dept Phys, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocevski, D.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Petrosian, V.; Reimer, A.; Reimer, O.; Rochester, L. S.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Asano, K.; Kataoka, J.; Kawai, N.; Nakamori, T.; Troja, E.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Asano, K.] Tokyo Inst Technol, Interact Res Ctr Sci, Meguro, Tokyo 1528551, Japan; [Atwood, W. B.; Johnson, R. P.; Porter, T. A.; Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Ziegler, M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Dept Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Johnson, R. P.; Porter, T. A.; Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Ramirez-Ruiz, E.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Axelsson, M.; Conrad, J.; McGlynn, S.; Meurer, C.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; McGlynn, S.; Meurer, C.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Tibaldo, L.] Univ Paris Diderot, CEA Saclay, Lab AIM,CEA IRFU,CNRS, Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.; Moretti, E.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.; Moretti, E.] Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Bhat, P. N.; Briggs, M. S.; Burgess, J. M.; Chaplin, V.; Connaughton, V.; Guiriec, S.; Paciesas, W. S.; Preece, R.] Univ Alabama, CSPAR, Huntsville, AL 35899 USA; [Bissaldi, E.; Greiner, J.; McBreen, S.; Orlando, E.; von Kienlin, A.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Bonnell, J.; Celik, Oe; Cheung, C. C.; Gehrels, N.; Harding, A. K.; Hays, E.; McEnery, J. E.; Stamatikos, M.; Stecker, F. W.; Thompson, D. J.; Troja, E.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bonnell, J.; Gehrels, N.; Moiseev, A. A.; Spinelli, P.] Univ Maryland, College Pk, MD 20742 USA; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.] Univ & Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Celik, Oe; Vasileiou, V.] Univ Maryland, Baltimore, MD 21250 USA; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier 5, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Cutini, S.; Gasparrini, D.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dingus, B. L.; Kippen, R. M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, F-33175 Gradignan, France; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, UMR 5797, IN2P3, F-33175 Gradignan, France; [Fishman, G.; Kouveliotou, C.; van der Horst, A. J.; Wilson-Hodge, C.] NASA, George C Marshall Space Flight Ctr, Space Sci Off, VP62, Huntsville, AL 35812 USA; [Foschini, L.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy; [Fukazawa, Y.; Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Uehara, T.; Yamazaki, R.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gibby, L.] Jacobs Technol, Huntsville, AL 35806 USA; [Grupe, D.; Hoversten, E. A.; Meszaros, P.; Toma, K.; Wu, X. F.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Guillemot, L.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Hughes, R. E.; Kuehn, F.; Sander, A.; Smith, P. D.; Stamatikos, M.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Kataoka, J.] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Knoedlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [McBreen, S.] Natl Univ Ireland Univ Coll Dublin, Dublin 4, Ireland; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Ohno, M.; Ozaki, M.; Takahashi, T.; Uchiyama, Y.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Rodriguez, A. Y.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, Barcelona 08193, Spain; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] ICREA, Barcelona 08193, Spain; [Wu, X. F.] Chinese Acad Sci, Joint Ctr Particle Nucl Phys & Cosmol, Nanjing 210008, Peoples R China; [Wu, X. F.] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	University of Hertfordshire; United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Tokyo Institute of Technology; Tokyo Institute of Technology; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Stockholm University; Oskar Klein Centre; Royal Institute of Technology; Royal Institute of Technology; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of Alabama System; University of Alabama Huntsville; Max Planck Society; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Agenzia Spaziale Italiana (ASI); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Energy (DOE); Los Alamos National Laboratory; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Istituto Nazionale Astrofisica (INAF); Hiroshima University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; University System of Ohio; Ohio State University; Waseda University; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; George Mason University; University College Dublin; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; University of Denver; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Innsbruck; University of Innsbruck; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; ICREA; Chinese Academy of Sciences; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Linnaeus University; University of Kalmar	Granot, J (corresponding author), Univ Hertfordshire, Ctr Astrophys Res, Coll Lane, Hatfield AL10 9AB, Herts, England.	j.granot@herts.ac.uk; sylvain.guiriec@nasa.gov; ohno@astro.isas.jaxa.jp; pelassa@lpta.in2p3.fr	Torres, Diego F./O-9422-2016; Gasparrini, Dario/X-6699-2019; Troja, Eleonora/AAB-3604-2020; Sgrò, Carmelo/K-3395-2016; Baldini, Luca/E-5396-2012; Morselli, Aldo/G-6769-2011; McEnery, Julie E/D-6612-2012; Torres, Diego F/ABD-7940-2020; Fukazawa, Yasushi/G-2081-2017; Tosti, Gino/E-9976-2013; Cutini, Sara/ABB-1787-2020; Ozaki, Masanobu/K-1165-2013; Kuss, Michael W/H-8959-2012; Hays, Elizabeth/D-3257-2012; Foschini, Luigi/H-3833-2012; Bissaldi, Elisabetta/AAB-2443-2021; Reimer, Anita/K-5822-2015; Wu, Xuefeng/G-5316-2015; Troja, Eleonora/I-5282-2017; Giglietto, Nicola/Y-2425-2019; Moskalenko, Igor V/A-1301-2007; Funk, Stefan/AAI-1568-2021; Caraveo, Patrizia/AAL-5708-2020; Reimer, Olaf/A-3117-2013; Stecker, Floyd W/D-3169-2012; Mazziotta, Mario N/O-8867-2015; Takahashi, Hiromitsu H/T-2713-2017; Rando, Riccardo/O-1302-2019; Nolan, Patrick L/A-5582-2009; Torres, Diego F./AAF-7931-2019; Harding, Alice K/D-3160-2012; Jóhannesson, Guðlaugur/O-8741-2015; Chaplin, Vandiver/AAN-6228-2021; Jóhannesson, Guðlaugur/ABC-7216-2020; Loparco, Francesco/O-8847-2015; cohen-tanugi, Johann/ABB-1481-2021; Thompson, David J/D-2939-2012; Gargano, Fabio/AAD-5121-2021; Funk, Stefan/B-7629-2015; Bissaldi, Elisabetta/K-7911-2016; Gehrels, Neil/D-2971-2012; Rando, Riccardo/M-7179-2013; Gargano, Fabio/O-8934-2015; Johnson, Neil/G-3309-2014; Bastieri, Denis/AAC-5917-2020; Tajima, Hiroyasu/I-6228-2014; lubrano, pasquale/F-7269-2012; giglietto, nicola/I-8951-2012; Orlando, Elena/R-5594-2016	Torres, Diego F./0000-0002-1522-9065; Gasparrini, Dario/0000-0002-5064-9495; Troja, Eleonora/0000-0002-1869-7817; Morselli, Aldo/0000-0002-7704-9553; Fukazawa, Yasushi/0000-0002-0921-8837; Cutini, Sara/0000-0002-1271-2924; Foschini, Luigi/0000-0001-8678-0324; Bissaldi, Elisabetta/0000-0001-9935-8106; Reimer, Anita/0000-0001-8604-7077; Wu, Xuefeng/0000-0002-6299-1263; Troja, Eleonora/0000-0002-1869-7817; Giglietto, Nicola/0000-0002-9021-2888; Moskalenko, Igor V/0000-0001-6141-458X; Funk, Stefan/0000-0002-2012-0080; Caraveo, Patrizia/0000-0003-2478-8018; Reimer, Olaf/0000-0001-6953-1385; Mazziotta, Mario N/0000-0001-9325-4672; Takahashi, Hiromitsu H/0000-0001-6314-5897; Rando, Riccardo/0000-0001-6992-818X; Torres, Diego F./0000-0002-1522-9065; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Chaplin, Vandiver/0000-0002-4074-0391; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Loparco, Francesco/0000-0002-1173-5673; cohen-tanugi, Johann/0000-0001-9022-4232; Thompson, David J/0000-0001-5217-9135; Gargano, Fabio/0000-0002-5055-6395; Funk, Stefan/0000-0002-2012-0080; Bissaldi, Elisabetta/0000-0001-9935-8106; Gargano, Fabio/0000-0002-5055-6395; Bastieri, Denis/0000-0002-6954-8862; Tajima, Hiroyasu/0000-0002-1721-7252; lubrano, pasquale/0000-0003-0221-4806; giglietto, nicola/0000-0002-9021-2888; Omodei, Nicola/0000-0002-5448-7577; McBreen, Sheila/0000-0002-1477-618X; Charles, Eric/0000-0002-3925-7802; van der Horst, Alexander/0000-0001-9149-6707; Giordano, Francesco/0000-0002-8651-2394; Sadrozinski, Hartmut/0000-0003-0019-5410; Grenier, Isabelle/0000-0003-3274-674X; Ciprini, Stefano/0000-0002-0712-2479; De Angelis, Alessandro/0000-0002-3288-2517; Granot, Jonathan/0000-0001-8530-8941; Murgia, Simona/0000-0003-0516-9422; Fusco, Piergiorgio/0000-0002-9383-2425; Porter, Troy/0000-0002-2621-4440; Kerr, Matthew/0000-0002-0893-4073; Orlando, Elena/0000-0001-6406-9910; Preece, Robert/0000-0003-1626-7335; Cameron, Robert/0000-0003-0942-2747; Sgro', Carmelo/0000-0001-5676-6214; Tanaka, Takaaki/0000-0002-4383-0368; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Katagiri, Hideaki/0000-0003-2347-8819; Berenji, Bijan/0000-0002-4551-772X; Razzaque, Soebur/0000-0002-0130-2460; Pesce-Rollins, Melissa/0000-0003-1790-8018; Tibaldo, Luigi/0000-0001-7523-570X; Moretti, Elena/0000-0001-5477-9097; Ackermann, Markus/0000-0001-8952-588X; Burgess, James/0000-0003-3345-9515; Pepe, Monica/0000-0001-5624-4010; Cecchi, Claudia/0000-0002-2192-8233; SPINELLI, Paolo/0000-0001-6688-8864; Baldini, Luca/0000-0002-9785-7726; de Palma, Francesco/0000-0001-5898-2834; Dingus, Brenda/0000-0001-8451-7450; Meszaros, Peter/0000-0002-4132-1746; Cheung, Chi (Teddy)/0000-0002-4377-0174; Monzani, Maria Elena/0000-0002-8254-5308; Petrosian, Vahe'/0000-0002-2670-8942; Spandre, Gloria/0000-0003-0802-3453; Casandjian, Jean-Marc/0000-0003-1404-0524	Royal Society Wolfson Research Merit Award; NASA United States; DRL Germany; Royal Swedish Academy of Sciences; K. A. Wallenberg Foundation; Canon Foundation in Europe; Science and Technology Facilities Council [ST/G002630/1] Funding Source: researchfish; STFC [ST/G002630/1] Funding Source: UKRI; ICREA Funding Source: Custom	Royal Society Wolfson Research Merit Award(Royal Society of London); NASA United States(National Aeronautics & Space Administration (NASA)); DRL Germany; Royal Swedish Academy of Sciences; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Canon Foundation in Europe(Canon Foundation); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA)	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both the development and the operation of the LAT as well as scientific data analysis. These include NASA and DOE in the United States, CEA/Irfu and IN2P3/CNRS in France, ASI and INFN in Italy, MEXT, KEK, and JAXA in Japan, and the K. A. Wallenberg Foundation, the Swedish Research Council and the National Space Board in Sweden. Additional support from INAF in Italy for science analysis during the operations phase is also acknowledged. J. Granot gratefully acknowledges a Royal Society Wolfson Research Merit Award. The Fermi GBM Collaboration acknowledges the support of NASA in the United States and DRL in Germany. J. Conrad is a Royal Swedish Academy of Sciences Research Fellow, funded by a grant from the K. A. Wallenberg Foundation. E. T. is a NASA Postdoctoral Program Fellow and a Canon Foundation in Europe Fellow. A. J. v. d. H. is a NASA Postdoctoral Program Fellow. We thank J. Ellis for comments.	Albert J, 2008, PHYS LETT B, V668, P253, DOI 10.1016/j.physletb.2008.08.053; Amelino-Camelia G, 1998, NATURE, V393, P763, DOI 10.1038/31647; AMELINOCAMELIA G, 2008, QUANTUM GRAVITY PHEN; AMELINOCAMELIA G, 2009, PROSPECTS CONSTRAINI; Christiansen WA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.051301; Efron B., 1994, MONOGRAPHS STAT APPL; Ellis J, 2008, PHYS LETT B, V665, P412, DOI 10.1016/j.physletb.2008.06.029; GUIRIEC S, 2009, 9336 GCN; Jacob U, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.124010; Jacobson T, 2006, ANN PHYS-NEW YORK, V321, P150, DOI 10.1016/j.aop.2005.06.004; Kifune T, 1999, ASTROPHYS J, V518, pL21, DOI 10.1086/312057; Kostelecky VA, 2008, ASTROPHYS J LETT, V689, pL1, DOI 10.1086/595815; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; MARTINEZ MR, 2006, J COSMOL ASTROPART P; Mattingly D, 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-5; Ng YJ, 2009, AIP CONF PROC, V1115, P74, DOI 10.1063/1.3131531; NG YJ, 2008, SPACETIME FOAM ENTRO; Norris JP, 2006, ASTROPHYS J, V643, P266, DOI 10.1086/502796; NORRIS JP, 1986, ADV SPACE RES, V6, P19; OHNO M, 2009, 9334 GCN; Scargle JD, 2008, ASTROPHYS J, V673, P972, DOI 10.1086/524396; Wheeler J.A., 1998, GEONS BLACK HOLES QU; ZLOSHCHASTIEV KG, 2009, LOGARITHMIC NONLINEA; [No title captured]	25	424	431	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					331	334		10.1038/nature08574	http://dx.doi.org/10.1038/nature08574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19865083	Green Submitted			2022-12-28	WOS:000271899300039
J	Wardlaw, JM; Sandercock, PAG; Murray, V				Wardlaw, Joanna M.; Sandercock, Peter A. G.; Murray, Veronica			Uncertainties Page Should more patients with acute ischaemic stroke receive thrombolytic treatment?	BRITISH MEDICAL JOURNAL			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; ALTEPLASE; THERAPY; ECASS		[Wardlaw, Joanna M.; Sandercock, Peter A. G.] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Murray, Veronica] Karolinska Inst, Danderyd Hosp, Div Med, SE-18288 Stockholm, Sweden	University of Edinburgh; Danderyds Hospital; Karolinska Institutet	Wardlaw, JM (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019	Wardlaw, Joanna M/0000-0002-9812-6642; Sandercock, Peter/0000-0001-8484-0135				Cocho D, 2005, NEUROLOGY, V64, P719, DOI 10.1212/01.WNL.0000152041.20486.2F; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heuschmann PU, 2003, STROKE, V34, P1106, DOI 10.1161/01.STR.0000065198.80347.C5; Kapral MK, 2004, STROKE, V35, P1756, DOI 10.1161/01.STR.0000130423.50191.9f; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Qureshi AI, 2005, NEUROLOGY, V64, P2115, DOI 10.1212/01.WNL.0000165951.03373.25; SANDERCOCK P, 2008, 3 INT STROK TRIAL IS; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	15	16	16	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2009	339								b4584	10.1136/bmj.b4584	http://dx.doi.org/10.1136/bmj.b4584			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906748				2022-12-28	WOS:000271833900004
J	McCalley, CK; Sparks, JP				McCalley, Carmody K.; Sparks, Jed P.			Abiotic Gas Formation Drives Nitrogen Loss from a Desert Ecosystem	SCIENCE			English	Article							NITRIC-OXIDE EMISSIONS; SOIL EMISSIONS; MINERALIZATION; MECHANISMS; PATTERN; NO	In arid environments such as deserts, nitrogen is often the most limiting nutrient for biological activity. The majority of the ecosystem nitrogen flux is typically thought to be driven by production and loss of reactive nitrogen species by microorganisms in the soil. We found that high soil-surface temperatures (greater than 50 degrees C), driven by solar radiation, are the primary cause of nitrogen loss in Mojave Desert soils. This abiotic pathway not only enables the balancing of arid ecosystem nitrogen budgets, but also changes our view of global nitrogen cycling and the predicted impact of climate change and increased temperatures on nitrogen bioavailability.	[McCalley, Carmody K.; Sparks, Jed P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	McCalley, CK (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Corson Hall,Room E149, Ithaca, NY 14853 USA.	ckm27@cornell.edu			NSF [DEB-0709642, DEB-0237674]; Cornell University's NSF Integrative Graduate Education and Research Traineeship; Cornell University's Andrew Mellon Student Research	NSF(National Science Foundation (NSF)); Cornell University's NSF Integrative Graduate Education and Research Traineeship; Cornell University's Andrew Mellon Student Research	Funding for this project was provided by the NSF Doctoral Dissertation Improvement Award DEB-0709642, NSF Award DEB-0237674, Cornell University's NSF Integrative Graduate Education and Research Traineeship program in Biogeochemistry and Environmental Biocomplexity Student Research Grants, and Cornell University's Andrew Mellon Student Research Grants.	Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Barger NN, 2005, BIOGEOCHEMISTRY, V75, P373, DOI 10.1007/s10533-005-1378-9; Belnap J, 2001, ECOL STU AN, V150, P241; Billings SA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002137; Billings SA, 2002, SOIL BIOL BIOCHEM, V34, P1777, DOI 10.1016/S0038-0717(02)00166-9; Davidson EA, 1997, NUTR CYCL AGROECOSYS, V48, P37, DOI 10.1023/A:1009738715891; DAVIDSON EA, 1991, J GEOPHYS RES-ATMOS, V96, P15439, DOI 10.1029/91JD01476; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; Feig GT, 2008, BIOGEOSCIENCES, V5, P1723, DOI 10.5194/bg-5-1723-2008; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Grannas AM, 2007, ATMOS CHEM PHYS, V7, P4329, DOI 10.5194/acp-7-4329-2007; Honrath RE, 2000, GEOPHYS RES LETT, V27, P2237, DOI 10.1029/1999GL011286; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Jacob D. J., 1999, INTRO ATMOSPHERIC CH, DOI [10.1515/9781400841547, DOI 1001852/INTRODUCTION-TOATMOSPHERIC-CHEMISTRY, DOI 10.1515/9781400841547]; Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x; Luxhoi J, 2008, AUST J SOIL RES, V46, P710, DOI 10.1071/SR08044; McCalley CK, 2008, OECOLOGIA, V156, P871, DOI 10.1007/s00442-008-1031-0; *NV DES RES CTR, NEV DES FACE LONG TE; Passianoto CC, 2004, PLANT SOIL, V258, P21, DOI 10.1023/B:PLSO.0000016500.47714.30; PETERJOHN WT, 1990, BIOGEOCHEMISTRY, V10, P67; PHILLIPS L, 1947, NATURE, V160, P753, DOI 10.1038/160753a0; Rosentreter R, 2001, ECOL STU AN, V150, P31; Rundel PW, 1996, ECOLOGICAL COMMUNITI; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Sierra J, 2000, SOIL SCI SOC AM J, V64, P2002, DOI 10.2136/sssaj2000.6462002x; Solomon S., 2007, PHYS SCI BASIS WORKI; STERN KH, 2001, HIGH TEMPERATURE PRO, P135; Venterea RT, 2000, GLOBAL CHANGE BIOL, V6, P303, DOI 10.1046/j.1365-2486.2000.00309.x; West NE, 1978, NITROGEN DESERT ECOS, P1; Whitford W., 2002, ECOLOGY DESERT SYSTE	30	99	105	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					837	840		10.1126/science.1178984	http://dx.doi.org/10.1126/science.1178984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892980				2022-12-28	WOS:000271468000040
J	Shroyer, AL; Grover, FL; Hattler, B; Collins, JF; McDonald, GO; Kozora, E; Lucke, JC; Baltz, JH; Novitzky, D				Shroyer, A. Laurie; Grover, Frederick L.; Hattler, Brack; Collins, Joseph F.; McDonald, Gerald O.; Kozora, Elizabeth; Lucke, John C.; Baltz, Janet H.; Novitzky, Dimitri		Vet Affairs (ROOBY) Study Grp	On-Pump versus Off-Pump Coronary-Artery Bypass Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOPULMONARY BYPASS; VETERANS-AFFAIRS; LIFE OUTCOMES; GRAFT PATENCY; METAANALYSIS; REVASCULARIZATION; EXPERIENCE; MORTALITY; IMPROVEMENT; MORBIDITY	Background: Coronary-artery bypass grafting (CABG) has traditionally been performed with the use of cardiopulmonary bypass (on-pump CABG). CABG without cardiopulmonary bypass (off-pump CABG) might reduce the number of complications related to the heart-lung machine. Methods: We randomly assigned 2203 patients scheduled for urgent or elective CABG to either on-pump or off-pump procedures. The primary short-term end point was a composite of death or complications (reoperation, new mechanical support, cardiac arrest, coma, stroke, or renal failure) before discharge or within 30 days after surgery. The primary long-term end point was a composite of death from any cause, a repeat revascularization procedure, or a nonfatal myocardial infarction within 1 year after surgery. Secondary end points included the completeness of revascularization, graft patency at 1 year, neuropsychological outcomes, and the use of major resources. Results: There was no significant difference between off-pump and on-pump CABG in the rate of the 30-day composite outcome (7.0% and 5.6%, respectively; P=0.19). The rate of the 1-year composite outcome was higher for off-pump than for on-pump CABG (9.9% vs. 7.4%, P=0.04). The proportion of patients with fewer grafts completed than originally planned was higher with off-pump CABG than with on-pump CABG (17.8% vs. 11.1%, P<0.001). Follow-up angiograms in 1371 patients who underwent 4093 grafts revealed that the overall rate of graft patency was lower in the off-pump group than in the on-pump group (82.6% vs. 87.8%, P<0.01). There were no treatment-based differences in neuropsychological outcomes or short-term use of major resources. Conclusions: At 1 year of follow-up, patients in the off-pump group had worse composite outcomes and poorer graft patency than did patients in the on-pump group. No significant differences between the techniques were found in neuropsychological outcomes or use of major resources. (ClinicalTrials.gov number, NCT00032630.) N Engl J Med 2009;361:1827-37.	[Shroyer, A. Laurie] Northport Vet Affairs VA, Med Ctr, Northport, NY USA; [Shroyer, A. Laurie; Grover, Frederick L.; Hattler, Brack; Baltz, Janet H.] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Denver, CO USA; [Kozora, Elizabeth] Natl Jewish Hlth, Denver, CO USA; [Grover, Frederick L.] Univ Colorado Denver, Dept Surg, Sch Med, Aurora, CO USA; [Hattler, Brack; Kozora, Elizabeth] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO USA; [Collins, Joseph F.] VA Med Ctr, Cooperat Studies Program Coordinat Ctr, Perry Point, MD USA; [McDonald, Gerald O.] Off Patient Care Serv, Dept Vet Affairs, Washington, DC USA; [Lucke, John C.] Charles George VA Med Ctr, Asheville, NC USA; [Novitzky, Dimitri] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Novitzky, Dimitri] Univ S Florida, Dept Surg, Tampa, FL 33620 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Collins, JF (corresponding author), CSPCC 151E, Boiler House Rd,Bldg 362T, Perry Point, MD 21902 USA.	joseph.collins2@va.gov	Shroyer, Annie Laurie/B-8836-2016	Shroyer, Annie Laurie/0000-0001-6461-0623	Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development; VA Central Office, Office of Patient Care Services; Offices of Research and Development at the Eastern Colorado Health Care System VA Medical Center, Denver; Northport VA Medical Center, Northport, NY.	Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development(US Department of Veterans Affairs); VA Central Office, Office of Patient Care Services; Offices of Research and Development at the Eastern Colorado Health Care System VA Medical Center, Denver; Northport VA Medical Center, Northport, NY.	Supported by the Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development and the VA Central Office, Office of Patient Care Services, and in part by the Offices of Research and Development at the Eastern Colorado Health Care System VA Medical Center, Denver, and the Northport VA Medical Center, Northport, NY.	Al-Ruzzeh S, 2006, BMJ-BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C; Balacumaraswami L, 2004, J THORAC CARDIOV SUR, V128, P238, DOI 10.1016/j.jtcvs.2003.11.072; BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312; Caputo M, 2005, ANN THORAC SURG, V80, P2141, DOI 10.1016/j.athoracsur.2005.05.077; Chang WK, 2004, ANN THORAC SURG, V78, P2057, DOI 10.1016/j.athoracsur.2004.05.059; Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; FITZGIBBON GM, 1978, CIRCULATION, V57, P1070, DOI 10.1161/01.CIR.57.6.1070; Gill IS, 2000, ANN THORAC SURG, V69, P56, DOI 10.1016/S0003-4975(99)00861-9; Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kobayashi J, 2005, CIRCULATION, V112, pI338, DOI 10.1161/CIRCULATIONAHA.104.524504; Kozora E, 2007, CLIN NEUROPSYCHOL, V21, P653, DOI 10.1080/13803390600674615; Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022; Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859; Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4; Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841; Puskas J, 2005, INNOVATIONS, V1, P3, DOI 10.1097/01243895-200500110-00002; SAVAGEAU JA, 1982, J THORAC CARDIOV SUR, V84, P595; Selnes OA, 2005, ANN THORAC SURG, V79, P1201, DOI 10.1016/j.athoracsur.2004.10.011; SMITH PL, 1988, ANN ROY COLL SURG, V70, P212; Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090; Taylor KM, 1998, ANN THORAC SURG, V65, pS20, DOI 10.1016/S0003-4975(98)00072-1; van Dijk D, 2006, SEMIN CARDIOTHORAC V, V10, P167, DOI 10.1177/1089253206288999; Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0; Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X; WEILAND AP, 1986, HEART LUNG, V15, P34; Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36; Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064; Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268	33	799	865	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1827	1837		10.1056/NEJMoa0902905	http://dx.doi.org/10.1056/NEJMoa0902905			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890125				2022-12-28	WOS:000271405800007
J	Pyle, AM				Pyle, Anna Marie			How to Drive Your Helicase in a Straight Line	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; TRANSLOCATION; MECHANISM		Yale Univ, Dept Mol Biophys & Biochem, Howard Hughes Med Inst, New Haven, CT 06511 USA	Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Howard Hughes Med Inst, New Haven, CT 06511 USA.	anna.pyle@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8	9	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					458	459		10.1016/j.cell.2009.10.016	http://dx.doi.org/10.1016/j.cell.2009.10.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879832	Bronze			2022-12-28	WOS:000271259600008
J	Tanvir, NR; Fox, DB; Levan, AJ; Berger, E; Wiersema, K; Fynbo, JPU; Cucchiara, A; Kruhler, T; Gehrels, N; Bloom, JS; Greiner, J; Evans, PA; Rol, E; Olivares, F; Hjorth, J; Jakobsson, P; Farihi, J; Willingale, R; Starling, RLC; Cenko, SB; Perley, D; Maund, JR; Duke, J; Wijers, RAMJ; Adamson, AJ; Allan, A; Bremer, MN; Burrows, DN; Castro-Tirado, AJ; Cavanagh, B; Postigo, AD; Dopita, MA; Fatkhullin, TA; Fruchter, AS; Foley, RJ; Gorosabel, J; Kennea, J; Kerr, T; Klose, S; Krimm, HA; Komarova, VN; Kulkarni, SR; Moskvitin, AS; Mundell, CG; Naylor, T; Page, K; Penprase, BE; Perri, M; Podsiadlowski, P; Roth, K; Rutledge, RE; Sakamoto, T; Schady, P; Schmidt, BP; Soderberg, AM; Sollerman, J; Stephens, AW; Stratta, G; Ukwatta, TN; Watson, D; Westra, E; Wold, T; Wolf, C				Tanvir, N. R.; Fox, D. B.; Levan, A. J.; Berger, E.; Wiersema, K.; Fynbo, J. P. U.; Cucchiara, A.; Kruehler, T.; Gehrels, N.; Bloom, J. S.; Greiner, J.; Evans, P. A.; Rol, E.; Olivares, F.; Hjorth, J.; Jakobsson, P.; Farihi, J.; Willingale, R.; Starling, R. L. C.; Cenko, S. B.; Perley, D.; Maund, J. R.; Duke, J.; Wijers, R. A. M. J.; Adamson, A. J.; Allan, A.; Bremer, M. N.; Burrows, D. N.; Castro-Tirado, A. J.; Cavanagh, B.; de Ugarte Postigo, A.; Dopita, M. A.; Fatkhullin, T. A.; Fruchter, A. S.; Foley, R. J.; Gorosabel, J.; Kennea, J.; Kerr, T.; Klose, S.; Krimm, H. A.; Komarova, V. N.; Kulkarni, S. R.; Moskvitin, A. S.; Mundell, C. G.; Naylor, T.; Page, K.; Penprase, B. E.; Perri, M.; Podsiadlowski, P.; Roth, K.; Rutledge, R. E.; Sakamoto, T.; Schady, P.; Schmidt, B. P.; Soderberg, A. M.; Sollerman, J.; Stephens, A. W.; Stratta, G.; Ukwatta, T. N.; Watson, D.; Westra, E.; Wold, T.; Wolf, C.			A gamma-ray burst at a redshift of z approximate to 8.2	NATURE			English	Article							REIONIZATION; AFTERGLOW; EVOLUTION; FRACTION; GALAXY; PROBE; GRBS	Long-duration gamma-ray bursts (GRBs) are thought to result from the explosions of certain massive stars(1), and some are bright enough that they should be observable out to redshifts of z > 20 using current technology(2-4). Hitherto, the highest redshift measured for any object was z = 6.96, for a Lyman-alpha emitting galaxy(5). Here we report that GRB 090423 lies at a redshift of z approximate to 8.2, implying that massive stars were being produced and dying as GRBs similar to 630 Myr after the Big Bang. The burst also pinpoints the location of its host galaxy.	[Tanvir, N. R.; Wiersema, K.; Evans, P. A.; Farihi, J.; Willingale, R.; Starling, R. L. C.; Duke, J.; Page, K.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Fox, D. B.; Cucchiara, A.; Burrows, D. N.; Kennea, J.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Levan, A. J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Berger, E.; Foley, R. J.; Soderberg, A. M.; Westra, E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fynbo, J. P. U.; Hjorth, J.; Maund, J. R.; Sollerman, J.; Watson, D.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; [Kruehler, T.; Greiner, J.; Olivares, F.] Max Planck Inst Extraterr Phys, D-85740 Garching, Germany; [Kruehler, T.] Tech Univ Munich, D-85748 Garching, Germany; [Gehrels, N.; Krimm, H. A.; Sakamoto, T.; Ukwatta, T. N.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bloom, J. S.; Cenko, S. B.; Perley, D.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Rol, E.; Wijers, R. A. M. J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Jakobsson, P.] Univ Iceland, Inst Sci, Ctr Astrophys & Cosmol, IS-107 Reykjavik, Iceland; [Adamson, A. J.; Cavanagh, B.; Kerr, T.; Wold, T.] Joint Astron Ctr, Hilo, HI 96720 USA; [Allan, A.; Naylor, T.] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Bremer, M. N.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Castro-Tirado, A. J.; Gorosabel, J.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [de Ugarte Postigo, A.] European So Observ, Santiago 19, Chile; [Dopita, M. A.; Schmidt, B. P.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Fatkhullin, T. A.; Komarova, V. N.; Moskvitin, A. S.] Special Astrophys Observ, Nizhnii Arkhyz 369167, Russia; [Fruchter, A. S.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Klose, S.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Krimm, H. A.; Sakamoto, T.] CRESST, Greenbelt, MD 20771 USA; [Krimm, H. A.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Kulkarni, S. R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Mundell, C. G.] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Penprase, B. E.] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Perri, M.; Stratta, G.] ASI Sci Data Ctr, I-00044 Frascati, Italy; [Podsiadlowski, P.; Wolf, C.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Roth, K.; Stephens, A. W.] Gemini Observ, Hilo, HI 96720 USA; [Rutledge, R. E.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Schady, P.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Sollerman, J.] Stockholm Univ, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Ukwatta, T. N.] George Washington Univ, Washington, DC 20052 USA	University of Leicester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Warwick; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Copenhagen; Niels Bohr Institute; Max Planck Society; Technical University of Munich; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; University of Amsterdam; University of Iceland; University of Exeter; University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); European Southern Observatory; Australian National University; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Space Telescope Science Institute; Universities Space Research Association (USRA); California Institute of Technology; Liverpool John Moores University; Claremont Colleges; Pomona College; Agenzia Spaziale Italiana (ASI); University of Oxford; McGill University; University of London; University College London; Oskar Klein Centre; Stockholm University; George Washington University	Tanvir, NR (corresponding author), Univ Leicester, Dept Phys & Astron, Univ Rd, Leicester LE1 7RH, Leics, England.	nrt3@star.le.ac.uk	Dopita, Michael A/P-5413-2014; Фатхуллин, Тимур/AAO-5319-2021; Kennea, Jamie/AAF-2090-2019; Komarova, Victoria/AAO-7832-2021; Jakobsson, Pall/L-9950-2015; Fynbo, Johan P. U./L-8496-2014; Gehrels, Neil/D-2971-2012; Komarova, Victoria/AAD-2137-2022; Stratta, Maria Giuliana/L-3045-2016; Olivares E., Felipe/Y-4641-2018; Naylor, Tim/A-9465-2015; Hjorth, Jens/M-5787-2014; Watson, Darach/E-4521-2015; Levan, Andrew/F-6179-2014	Dopita, Michael A/0000-0003-0922-4986; Kennea, Jamie/0000-0002-6745-4790; Jakobsson, Pall/0000-0002-9404-5650; Fynbo, Johan P. U./0000-0002-8149-8298; Komarova, Victoria/0000-0002-6327-5816; Stratta, Maria Giuliana/0000-0003-1055-7980; Hjorth, Jens/0000-0002-4571-2306; Watson, Darach/0000-0002-4465-8264; Farihi, Jay/0000-0003-1748-602X; Wolf, Christian/0000-0002-4569-016X; Levan, Andrew/0000-0001-7821-9369; Castro-Tirado, A. J./0000-0003-2999-3563; de Ugarte Postigo, Antonio/0000-0001-7717-5085; Bloom, Joshua/0000-0002-7777-216X; Kruehler, Thomas/0000-0002-8682-2384; Schmidt, Brian/0000-0001-6589-1287; Perri, Matteo/0000-0003-3613-4409; Wijers, Ralph/0000-0002-3101-1808; Naylor, Tim/0000-0002-0506-8501; Foley, Ryan/0000-0002-2445-5275	Clay Fellowship; STFC [PP/E002137/1, ST/G001049/1, ST/F002599/1, ST/F002742/1, ST/F003277/1, PP/E002064/1, PP/E001149/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E001149/1, PP/E002064/1, ST/F002742/1, PP/E002137/1, ST/G001049/1, ST/F003277/1, ST/F002599/1] Funding Source: researchfish; UK Space Agency [ST/G008655/1] Funding Source: researchfish	Clay Fellowship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We thank Ph. Yock, B. Allen, P. Kubanek, M. Jelinek and S. Guziy for their assistance with the BOOTES-3 YA telescope observations (Supplementary Information). This work was partly based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the US National Science Foundation on behalf of the Gemini partnership: the National Science Foundation (United States), the Science and Technology Facilities Council (United Kingdom), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), the Ministerio da Ciencia e Tecnologia (Brazil) and SECYT (Argentina). This work was also partly based on observations made using ESO telescopes at the La Silla or Paranal observatories by G. Carraro, L. Schmidtobreick, G. Marconi, J. Smoker, V. Ivanov, E. Mason and M. Huertas-Company. The UKIRT is operated by the Joint Astronomy Centre on behalf of the UK Science and Technology Facilities Council. R. J. F. acknowledges a Clay Fellowship.	Barkana R, 2004, ASTROPHYS J, V601, P64, DOI 10.1086/380435; Becker GD, 2007, ASTROPHYS J, V662, P72, DOI 10.1086/517866; Berger E, 2007, ASTROPHYS J, V665, P102, DOI 10.1086/519511; Bloom JS, 2009, ASTROPHYS J, V691, P723, DOI 10.1088/0004-637X/691/1/723; Bromm V, 2006, ASTROPHYS J, V642, P382, DOI 10.1086/500799; Chen HW, 2007, ASTROPHYS J, V667, pL125, DOI 10.1086/522306; Faucher-Giguere CA, 2008, ASTROPHYS J, V688, P85, DOI 10.1086/592289; FYNBO JPU, 2009, LOW RESOLUTION SPECT; Greiner J, 2009, ASTROPHYS J, V693, P1610, DOI 10.1088/0004-637X/693/2/1610; Grindlay J, 2009, AIP CONF PROC, V1133, P18, DOI 10.1063/1.3155875; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; Jakobsson P, 2006, ASTRON ASTROPHYS, V460, pL13, DOI 10.1051/0004-6361:20066405; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Malhotra S, 2004, ASTROPHYS J, V617, pL5, DOI 10.1086/427182; McQuinn M, 2008, MON NOT R ASTRON SOC, V388, P1101, DOI [10.1111/j.1365-2966.2008.13271.x, 10.1111/j.l365-2966.2008.13271.x]; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Racusin JL, 2008, NATURE, V455, P183, DOI 10.1038/nature07270; Tanvir NR, 2007, PHILOS T R SOC A, V365, P1377, DOI 10.1098/rsta.2006.1992; Totani T, 2006, PUBL ASTRON SOC JPN, V58, P485, DOI 10.1093/pasj/58.3.485; VONKIENLIN A, 2009, 9251 GCN; Wijers RAMJ, 1998, MON NOT R ASTRON SOC, V294, pL13, DOI 10.1046/j.1365-8711.1998.01328.x; Willingale R, 2007, ASTROPHYS J, V662, P1093, DOI 10.1086/517989; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; ZHANG B, 2009, ASTROPHYS J IN PRESS; ZHANG BB, 2009, 9279 GCN	27	467	471	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1254	1257		10.1038/nature08459	http://dx.doi.org/10.1038/nature08459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865165	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000271190800042
J	Ross, JS; Detsky, AS				Ross, Joseph S.; Detsky, Allan S.			Health Care Choices and Decisions in the United States and Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Management, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Evaluat & Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr, New York, NY USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Palliat Care & Med, New York, NY USA; [Ross, Joseph S.] James J Peters Vet Adm Med Ctr, Hlth Serv Res & Dev Res Enhancement Award Program, Bronx, NY USA; [Ross, Joseph S.] James J Peters Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 429-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca		Ross, Joseph/0000-0002-9218-3320	NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG032886, K08 AG032886-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM MED ASS, 2007, COMP HLTH INS COMPR; BILES B, 2009, PAYING MED ADVANTAGE; Blendon RJ, 2004, HEALTH AFFAIR, V23, P119, DOI 10.1377/hlthaff.23.3.119; Blendon RJ, 2003, HEALTH AFFAIR, V22, P106, DOI 10.1377/hlthaff.22.3.106; Davis K, 2007, MIRROR MIRROR WALL I; Katz SJ, 2002, HEALTH AFFAIR, V21, P19, DOI 10.1377/hlthaff.21.3.19; TAM P, 2008, OTTAWA CITIZEN  1126, pC1; 2009, CURRENT SATISFACTION	8	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1803	1804		10.1001/jama.2009.1566	http://dx.doi.org/10.1001/jama.2009.1566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511FW	19861673	Green Accepted			2022-12-28	WOS:000271150300024
J	Martin, A; Troadec, C; Boualem, A; Rajab, M; Fernandez, R; Morin, H; Pitrat, M; Dogimont, C; Bendahmane, A				Martin, Antoine; Troadec, Christelle; Boualem, Adnane; Rajab, Mazen; Fernandez, Ronan; Morin, Halima; Pitrat, Michel; Dogimont, Catherine; Bendahmane, Abdelhafid			A transposon-induced epigenetic change leads to sex determination in melon	NATURE			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; MUTATION; PLANTS; GENE; CIS	Sex determination in plants leads to the development of unisexual flowers from an originally bisexual floral meristem(1,2). This mechanism results in the enhancement of outcrossing and promotes genetic variability, the consequences of which are advantageous to the evolution of a species(3). In melon, sexual forms are controlled by identity of the alleles at the andromonoecious (a) and gynoecious (g) loci(4). We previously showed that the a gene encodes an ethylene biosynthesis enzyme, CmACS-7, that represses stamen development in female flowers(5). Here we show that the transition from male to female flowers in gynoecious lines results from epigenetic changes in the promoter of a transcription factor, CmWIP1. This natural and heritable epigenetic change resulted from the insertion of a transposon, which is required for initiation and maintenance of the spreading of DNA methylation to the CmWIP1 promoter. Expression of CmWIP1 leads to carpel abortion, resulting in the development of unisexual male flowers. Moreover, we show that CmWIP1 indirectly represses the expression of the andromonoecious gene, CmACS-7, to allow stamen development. Together our data indicate a model in which CmACS-7 and CmWIP1 interact to control the development of male, female and hermaphrodite flowers in melon.	[Martin, Antoine; Troadec, Christelle; Boualem, Adnane; Rajab, Mazen; Fernandez, Ronan; Bendahmane, Abdelhafid] INRA, CNRS, UMR1165, Unite Rech Genom Vegetale, F-91057 Evry, France; [Morin, Halima] INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Pitrat, Michel; Dogimont, Catherine] INRA, UR 1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Bendahmane, A (corresponding author), INRA, CNRS, UMR1165, Unite Rech Genom Vegetale, 2 Rue Gaston Cremieux, F-91057 Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021	Boualem, Adnane/0000-0003-4428-6496; Bendahmane, Abdelhafid/0000-0003-3246-868X; Catherine, DOGIMONT/0000-0001-7399-768X; Martin, Antoine/0000-0002-6956-2904; TROADEC, Christelle/0000-0003-1927-7352	GAP department	GAP department	We thank D. Bradley, M. Purugganan, P. Laufs, J. C. Palauqui and colleagues from Unite de Recherche en Genomique Vegetale (URGV) for discussions and comments on the manuscript, and F. Teixeira and V. Colot for helpful assistance on DNA methylation assays. This work was supported by GAP department in INRA and by a grant from Genopole (A.M.).	Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Staden R, 2000, Methods Mol Biol, V132, P115; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Weil C, 2008, CURR OPIN GENET DEV, V18, P188, DOI 10.1016/j.gde.2008.01.015	27	401	434	14	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1135	U237		10.1038/nature08498	http://dx.doi.org/10.1038/nature08498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847267				2022-12-28	WOS:000270987600047
J	Kharbanda, RK; Nielsen, TT; Redington, AN				Kharbanda, Rajesh K.; Nielsen, Torsten Toftgard; Redington, Andrew N.			Translation of remote ischaemic preconditioning into clinical practice	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; CHANNEL-DEPENDENT MECHANISM; RANDOMIZED CONTROLLED-TRIAL; GENE-RELATED PEPTIDE; CORONARY BLOOD-FLOW; K-ATP CHANNELS; REPERFUSION INJURY; LIMB ISCHEMIA; ADENOSINE RECEPTORS; CARDIAC-SURGERY	Reduction of the burden of ischaemia-reperfusion injury is the aim of most treatments for cardiovascular and cerebrovascular disease. Although many strategies have proven benefit in the experimental arena, few have translated to clinical practice. Scientific and practical reasons might explain this finding, but the unpredictability of acute ischaemic syndromes is one of the biggest obstacles to timely application of novel treatments. Remote ischaemic preconditioning-which is a powerful innate mechanism of multiorgan protection that can be induced by transient occlusion of blood flow to a limb with a blood-pressure cuff-could be close to becoming a clinical technique. Several proof-of-principle and clinical trials have been reported, suggesting that the technique has remarkable promise. We examine the history, development, and present state of remote preconditioning in cardiovascular disease.	[Redington, Andrew N.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada; [Redington, Andrew N.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Kharbanda, Rajesh K.] Univ Oxford, Oxford, England; [Kharbanda, Rajesh K.] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; [Nielsen, Torsten Toftgard] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Oxford; University of Oxford; Aarhus University	Redington, AN (corresponding author), Hosp Sick Children, Div Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.redington@sickkids.ca		Kharbanda, Rajesh/0000-0002-5356-2395	Leducq Foundation; Canadian Institutes of Health Research; Heart and Stroke foundation of Canada; NIHR Oxford Biomedical Research Centre; Danish Research Agency; Danish Heart Foundation	Leducq Foundation(Leducq Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke foundation of Canada(Heart & Stroke Foundation of Canada); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Danish Research Agency; Danish Heart Foundation	We thank Tatiana Petrinic for her assistance with the search of published work. RK, TTN, and AN R are all supported by Transatlantic Networks of Research Excellence grants from the Leducq Foundation. ANR is supported by the Canadian Institutes of Health Research, and the Heart and Stroke foundation of Canada. RKK is supported by NIHR Oxford Biomedical Research Centre. TTN is supported by the Danish Research Agency and the Danish Heart Foundation.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Andersen HR, 2003, AM HEART J, V146, P234, DOI 10.1016/S0002-8703(03)00316-8; Andreka G, 2007, HEART, V93, P749, DOI 10.1136/hrt.2006.114504; Ates E, 2002, TRANSPLANTATION, V74, P1247, DOI 10.1097/01.TP.0000032752.61372.36; Baxter GF, 2001, BASIC RES CARDIOL, V96, P329, DOI 10.1007/s003950170041; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; BOTKER HE, 2009, 58 ANN SCI SESS AM C; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Darling CE, 2007, BASIC RES CARDIOL, V102, P274, DOI 10.1007/s00395-007-0643-6; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Ding Yan-Feng, 2001, Shengli Xuebao, V53, P7; Dirksen MT, 2007, CARDIOVASC RES, V74, P343, DOI 10.1016/j.cardiores.2007.01.014; Dong Jing-Hui, 2004, Shengli Xuebao, V56, P41; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gunaydin B, 2000, PHARMACOL RES, V41, P493, DOI 10.1006/phrs.1999.0611; Hajrasouliha AR, 2008, EUR J PHARMACOL, V579, P246, DOI 10.1016/j.ejphar.2007.09.034; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Heidbreder M, 2008, CARDIOVASC RES, V78, P108, DOI 10.1093/cvr/cvm114; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Jenkins PO, 2008, CLIN MED, V8, P253, DOI 10.7861/clinmedicine.8-3-253; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Kharbanda RK, 2006, HEART, V92, P1506, DOI 10.1136/hrt.2004.042366; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, J THORAC CARDIOV SUR, V130, P1326, DOI 10.1016/j.jtcvs.2005.03.050; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kristiansen SB, 2005, AM J PHYSIOL-HEART C, V288, pH1252, DOI 10.1152/ajpheart.00207.2004; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Laskey WK, 2008, CATHETER CARDIO INTE, V72, P212, DOI 10.1002/ccd.21583; Li GH, 2004, EUR J CARDIO-THORAC, V26, P968, DOI 10.1016/j.ejcts.2004.06.015; Liem DA, 2005, AM J PHYSIOL-HEART C, V288, pH1165, DOI 10.1152/ajpheart.00899.2004; Liem DA, 2002, AM J PHYSIOL-HEART C, V283, pH29, DOI 10.1152/ajpheart.01031.2001; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Loukogeorgakis SP, 2007, CIRCULATION, V116, P1386, DOI 10.1161/CIRCULATIONAHA.106.653782; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; Miura T, 2008, BASIC RES CARDIOL, V103, P501, DOI 10.1007/s00395-008-0743-y; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OXMAN T, 1997, AM J PHYSIOL-HEART C, V273, pH1707; Patel HH, 2002, J MOL CELL CARDIOL, V34, P1317, DOI 10.1006/jmcc.2002.2072; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Petrishchev N N., 2001, Pathophysiology, V7, P271, DOI 10.1016/S0928-4680(00)00058-4; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Shimizu M, 2007, ACTA PHYSIOL, V190, P103, DOI 10.1111/j.1748-1716.2007.01667.x; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Singh D, 2004, METHOD FIND EXP CLIN, V26, P117, DOI 10.1358/mf.2004.26.2.800064; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Takaoka A, 1999, J AM COLL CARDIOL, V33, P556, DOI 10.1016/S0735-1097(98)00559-2; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Tissier R, 2008, FRONT BIOSCI-LANDMRK, V13, P284, DOI 10.2741/2679; Tokuno S, 2002, ARTERIOSCL THROM VAS, V22, P995, DOI 10.1161/01.ATV.0000017703.87741.12; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Verdouw PD, 1996, ANN NY ACAD SCI, V793, P27, DOI 10.1111/j.1749-6632.1996.tb33502.x; Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062; Wang LX, 2008, J THORAC CARDIOV SUR, V136, P335, DOI 10.1016/j.jtcvs.2007.12.055; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Wolfrum S, 2005, REGUL PEPTIDES, V127, P217, DOI 10.1016/j.regpep.2004.12.008; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Xiao L, 2001, EUR J PHARMACOL, V427, P131, DOI 10.1016/S0014-2999(01)01231-6; Yang Xin-Chun, 2007, J Invasive Cardiol, V19, P424; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Zhou K, 2007, INT J CARDIOL, V122, P250, DOI 10.1016/j.ijcard.2006.11.079	79	183	198	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1557	1565		10.1016/S0140-6736(09)61421-5	http://dx.doi.org/10.1016/S0140-6736(09)61421-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19880021				2022-12-28	WOS:000271591300034
J	Miyazono, K; Miyakawa, T; Sawano, Y; Kubota, K; Kang, HJ; Asano, A; Miyauchi, Y; Takahashi, M; Zhi, YH; Fujita, Y; Yoshida, T; Kodaira, KS; Yamaguchi-Shinozaki, K; Tanokura, M				Miyazono, Ken-ichi; Miyakawa, Takuya; Sawano, Yoriko; Kubota, Keiko; Kang, Hee-Jin; Asano, Atsuko; Miyauchi, Yumiko; Takahashi, Mihoko; Zhi, Yuehua; Fujita, Yasunari; Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko; Tanokura, Masaru			Structural basis of abscisic acid signalling	NATURE			English	Article							PROTEIN-KINASES; STRESS; IDENTIFICATION; TRANSDUCTION; CALMODULIN; FAMILY; GROWTH	The phytohormone abscisic acid (ABA) mediates the adaptation of plants to environmental stresses such as drought and regulates developmental signals such as seed maturation. Within plants, the PYR/PYL/RCAR family of START proteins receives ABA to inhibit the phosphatase activity of the group-A protein phosphatases 2C (PP2Cs), which are major negative regulators in ABA signalling. Here we present the crystal structures of the ABA receptor PYL1 bound with (+)-ABA, and the complex formed by the further binding of (+)-ABA-bound PYL1 with the PP2C protein ABI1. PYL1 binds (+)-ABA using the START-protein-specific ligand-binding site, thereby forming a hydrophobic pocket on the surface of the closed lid. (+)-ABA-bound PYL1 tightly interacts with a PP2C domain of ABI1 by using the hydrophobic pocket to cover the active site of ABI1 like a plug. Our results reveal the structural basis of the mechanism of (+)-ABA-dependent inhibition of ABI1 by PYL1 in ABA signalling.	[Miyazono, Ken-ichi; Miyakawa, Takuya; Sawano, Yoriko; Kubota, Keiko; Kang, Hee-Jin; Asano, Atsuko; Miyauchi, Yumiko; Takahashi, Mihoko; Zhi, Yuehua; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Fujita, Yasunari; Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources Div, Tsukuba 3058686, Japan; [Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Yoshida, Takuya/AAX-6352-2020; Miyazono, Kenichi/P-9654-2019; Fujita, Yasunari/P-9861-2018	Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Yoshida, Takuya/0000-0003-0514-6941; Miyazono, Kenichi/0000-0002-9354-2604; Fujita, Yasunari/0000-0002-5036-8319; Tanokura, Masaru/0000-0001-5072-2480	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [2008S2-001]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	The synchrotron-radiation experiments were performed at BL5A in the Photon Factory (2008S2-001). This work was supported by the Targeted Proteins Research Program ( TPRP) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. We thank Y. Sakaguchi (DKSH Japan K. K.) and Y. Asami ( TA Instruments Japan Inc.) for the ITC measurements and T. Mitani (GE Healthcare Japan Corp.) for the SPR experiments.	Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; TANOKURA M, 1993, J BIOL CHEM, V268, P7090; TANOKURA M, 1984, J BIOCHEM-TOKYO, V95, P643, DOI 10.1093/oxfordjournals.jbchem.a134653; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188	29	385	418	2	141	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					609	U79		10.1038/nature08583	http://dx.doi.org/10.1038/nature08583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19855379				2022-12-28	WOS:000272277900032
J	Black, S; Eskola, J; Siegrist, CA; Halsey, N; MacDonald, N; Law, B; Miller, E; Andrews, N; Stowe, J; Salmon, D; Vannice, K; Izurieta, HS; Akhtar, A; Gold, M; Oselka, G; Zuber, P; Pfeifer, D; Vellozzi, C				Black, Steven; Eskola, Juhani; Siegrist, Claire-Anne; Halsey, Neal; MacDonald, Noni; Law, Barbara; Miller, Elizabeth; Andrews, Nick; Stowe, Julia; Salmon, Daniel; Vannice, Kirsten; Izurieta, Hector S.; Akhtar, Aysha; Gold, Mike; Oselka, Gabriel; Zuber, Patrick; Pfeifer, Dina; Vellozzi, Claudia			Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines	LANCET			English	Article							GUILLAIN-BARRE-SYNDROME; MULTIPLE-SCLEROSIS; OPTIC NEURITIS; SUDDEN-DEATH; RISK; POPULATION; EPIDEMIOLOGY; ANAPHYLAXIS; PREVALENCE; STATES	Because of the advent of a new influenza A H1N1. strain, many countries have begun mass immunisation programmes. Awareness of the background rates of possible adverse events will be a crucial part of assessment of possible vaccine safety concerns and will help to separate legitimate safety concerns from events that are temporally associated with but not caused by vaccination. We identified background rates of selected medical events for several countries. Rates of disease events varied by age, sex, method of ascertainment, and geography. Highly visible health conditions, such as Guillain-Barre syndrome, spontaneous abortion, or even death, will occur in coincident temporal association with novel influenza vaccination. On the basis of the reviewed data, if a cohort of 10 million individuals was vaccinated in the UK, 21.5 cases of Guillain-Barre syndrome and 5.75 cases of sudden death would be expected to occur within 6 weeks of vaccination as coincident background cases. In female vaccinees in the USA, 86.3 cases of optic neuritis per 10 million population would be expected within 6 weeks of vaccination. 397 per 1 million vaccinated pregnant women would be predicted to have a spontaneous abortion within 1 day of vaccination.	[Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH 45229 USA; [Black, Steven] Cincinnati Childrens Hosp, Div Infect Dis, Cincinnati, OH 45229 USA; [Eskola, Juhani] Natl Inst Hlth & Welf, Helsinki, Finland; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Dept Pediat, Geneva, Switzerland; [Halsey, Neal] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Vaccine Safety, Baltimore, MD USA; [MacDonald, Noni] Dalhousie Univ, Dept Pediat, Div Infect Dis, Halifax, NS, Canada; [Law, Barbara] Publ Hlth Agcy Canada, Vaccine Safety Sect, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada; [Miller, Elizabeth; Andrews, Nick; Stowe, Julia] Hlth Protect Agcy, Ctr Infect, London, England; [Salmon, Daniel; Vannice, Kirsten] Dept Hlth & Human Serv, Natl Vaccine Program Off, Washington, DC USA; [Izurieta, Hector S.; Akhtar, Aysha] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Gold, Mike] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Oselka, Gabriel] Univ Sao Paulo, Dept Pediat, Fac Med, Sao Paulo, Brazil; [Zuber, Patrick; Pfeifer, Dina] WHO, Qual Safety & Stand Team, CH-1211 Geneva, Switzerland; [Vellozzi, Claudia] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Finland National Institute for Health & Welfare; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Dalhousie University; Public Health Agency of Canada; Health Protection Agency; US Food & Drug Administration (FDA); University of Adelaide; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); World Health Organization; Centers for Disease Control & Prevention - USA	Black, S (corresponding author), Cincinnati Childrens Hosp, Ctr Global Hlth, 3333 Burnet Ave,MLC 2048, Cincinnati, OH 45229 USA.	Steven.Black1@cchmc.org		Stowe, Julia/0000-0002-3999-6461; salmon, daniel/0000-0002-1035-4422	Centers for Disease Control and Prevention; Department of Health and Human Services; WHO; US Food and Drug Administration; UK Health Protection Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046405] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Health and Human Services; WHO(World Health Organization); US Food and Drug Administration; UK Health Protection Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the Department of Health and Human Services, WHO, the US Food and Drug Administration, or the UK Health Protection Agency.	Banwell B, 2009, NEUROLOGY, V72, P232, DOI 10.1212/01.wnl.0000339482.84392.bd; BERMAN M, 1981, NEUROLOGY, V31, P969; BHAN V, 2005, AM AC NEUR 57 ANN M; Bodnar LM, 2008, PAEDIATR PERINAT EP, V22, P538, DOI 10.1111/j.1365-3016.2008.00971.x; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; Bowker TJ, 2003, QJM-INT J MED, V96, P269, DOI 10.1093/qjmed/hcg038; Brotherton JML, 2008, CAN MED ASSOC J, V179, P525, DOI 10.1503/cmaj.080916; *CDC, PREGN WOM NOV INFL A; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; D'Souza RM, 2002, AUST NZ J PUBL HEAL, V26, P45, DOI 10.1111/j.1467-842X.2002.tb00269.x; Dias-Tosta E, 2002, ARQ NEURO-PSIQUIAT, V60, P367, DOI 10.1590/S0004-282X2002000300005; Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005; FORSGREN L, 1990, ACTA PAEDIATR SCAND, V79, P550, DOI 10.1111/j.1651-2227.1990.tb11510.x; Gray RH, 2000, AM J PUBLIC HEALTH, V90, P1452, DOI 10.2105/AJPH.90.9.1452; HALSEY NA, 2002, SEMIN PEDIAT INFECT, V12, P205; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; Hemminki E, 1999, AM J OBSTET GYNECOL, V181, P396, DOI 10.1016/S0002-9378(99)70568-5; Herbert D, 2009, WOMEN HEALTH ISS, V19, P21, DOI 10.1016/j.whi.2008.08.007; Iskander JK, 2004, PEDIATR ANN, V33, P599, DOI 10.3928/0090-4481-20040901-11; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; JEFFERY DR, 1993, ARCH NEUROL-CHICAGO, V50, P532, DOI 10.1001/archneur.1993.00540050074019; Jin YP, 1998, J NEUROL SCI, V159, P107, DOI 10.1016/S0022-510X(98)00141-5; Kapp C, 2004, LANCET, V363, P709, DOI 10.1016/S0140-6736(04)15665-1; KLEIN N, 2009, NAT FDN INF DIS M BA; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; LASKY T, INFLUENZA VACCINE GB; Lim SA, 2009, OPHTHAL EPIDEMIOL, V16, P65, DOI 10.1080/09286580902737516; Lower Johannes, 2008, MMW Fortschr Med, V150, P6; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; Morken Nils-Halvdan, 2008, BMC Womens Health, V8, P16, DOI 10.1186/1472-6874-8-16; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; NEUTRA RR, 1990, AM J EPIDEMIOL, V132, P1; Papiernik E, 2004, CLIN OBSTET GYNECOL, V47, P755, DOI 10.1097/01.grf.0000141409.92711.11; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RODRIGUEZ M, 1995, NEUROLOGY, V45, P244, DOI 10.1212/WNL.45.2.244; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Warren SA, 2008, MULT SCLER J, V14, P872, DOI 10.1177/1352458508089226; WILCOX AJ, 1981, AM J EPIDEMIOL, V114, P548, DOI 10.1093/oxfordjournals.aje.a113220; World Health Organization, WORLD HLTH STAT 2009; Zeller B, 2005, ACTA PAEDIATR, V94, P178, DOI 10.1080/08035250410025294	44	178	180	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2115	2122		10.1016/S0140-6736(09)61877-8	http://dx.doi.org/10.1016/S0140-6736(09)61877-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19880172	Green Accepted, Green Submitted			2022-12-28	WOS:000273122900035
J	Iglehart, JK				Iglehart, John K.			Narrowly Clearing the Next Hurdle - Passage of the House Reform Bill	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22								10.1056/NEJMp0910927	http://dx.doi.org/10.1056/NEJMp0910927			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	524BC	19907033				2022-12-28	WOS:000272117800004
J	Hejblum, G; Chalumeau-Lemoine, L; Ioos, V; Boelle, PY; Salomon, L; Simon, T; Vibert, JF; Guidet, B				Hejblum, Gilles; Chalumeau-Lemoine, Ludivine; Ioos, Vincent; Boelle, Pierre-Yves; Salomon, Laurence; Simon, Tabossome; Vibert, Jean-Francois; Guidet, Bertrand			Comparison of routine and on-demand prescription of chest radiographs in mechanically ventilated adults: a multicentre, cluster-randomised, two-period crossover study	LANCET			English	Article							INTENSIVE-CARE-UNIT; SURGICAL ICU; ELIMINATION; UTILITY; EFFICACY; DELPHI	Background Present guidelines recommend routine daily chest radiographs for mechanically ventilated patients in intensive care units. However, some units use an on-demand strategy, in which chest radiographs are done only if warranted by the patient's clinical status. By comparison between routine and on-demand strategies, we aimed to establish which strategy was more efficient and effective for optimum patient care. Methods In a cluster-randomised, open-label crossover study, we randomly assigned 21 intensive care units at 18 hospitals in France to use a routine or an on-demand strategy for prescription of chest radiographs during the first of two treatment periods. Units used the alternative strategy in the second period. Each treatment period lasted for the time taken for enrolment and study of 20 consecutive patients per intensive care unit; patients were monitored until discharge from the unit or for up to 30 days' mechanical ventilation, whichever was first. Units enrolled 967 patients, but 118 were excluded because they had been receiving mechanical ventilation for less than 2 days. The primary outcome measure was the mean number of chest radiographs per patient-day of mechanical ventilation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00893672. Findings 11 intensive care units were randomly allocated to use a routine strategy to order chest radiographs in the first treatment period, and 10 units to use an on-demand strategy. Overall, 424 patients had 4607 routine chest radiographs (mean per patient-day of mechanical ventilation 1.09, 95% CI 1.05-1.14), and 425 had 3148 on-demand chest radiographs (mean 0.75, 0.67-0.83), which corresponded to a reduction of 32% (95% CI 25-38) with the on-demand strategy (p<0.0001). Interpretation Our results strongly support adoption of an on-demand strategy in preference to a routine strategy to decrease use of chest radiographs in mechanically ventilated patients without a reduction in patients' quality of care or safety.	[Hejblum, Gilles; Boelle, Pierre-Yves; Vibert, Jean-Francois; Guidet, Bertrand] INSERM, U707, F-75571 Paris 12, France; [Hejblum, Gilles; Boelle, Pierre-Yves; Vibert, Jean-Francois; Guidet, Bertrand] Univ Paris 06, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France; [Simon, Tabossome] Univ Paris 06, Fac Med Pierre & Marie Curie, Serv Pharmacol, Paris, France; [Hejblum, Gilles; Boelle, Pierre-Yves] Hop St Antoine, Assistance Publ Hop Paris, Unite Sante Publ, F-75571 Paris, France; [Chalumeau-Lemoine, Ludivine; Ioos, Vincent; Guidet, Bertrand] Hop St Antoine, Assistance Publ Hop Paris, Serv Reanimat, F-75571 Paris, France; [Simon, Tabossome] Hop St Antoine, Assistance Publ Hop Paris, Unite Rech Clin Est Parisien, F-75571 Paris, France; [Vibert, Jean-Francois] Hop St Antoine, Assistance Publ Hop Paris, Serv Physiol, F-75571 Paris, France; [Salomon, Laurence] Hop Louis Mourier, Assistance Publ Hop Paris, Dept Sante Publ, F-92701 Colombes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hejblum, G (corresponding author), INSERM, U707, 27 Rue Chaligny, F-75571 Paris 12, France.	gilles.hejblum@inserm.fr	Hejblum, Gilles/N-6337-2017	Hejblum, Gilles/0000-0003-0127-1964; Ioos, Vincent/0000-0001-6959-5602; Boelle, Pierre-Yves/0000-0002-5367-8232; SIMON, Tabassome/0000-0002-4550-0450	Assistance Publique-Hopitaux de Paris (Direction Regionale de la Recherche Clinique Ile de France) [SCR06006]	Assistance Publique-Hopitaux de Paris (Direction Regionale de la Recherche Clinique Ile de France)	We thank the research clinical assistants, and especially Louise Anemet, Linda Gimeno, Xavier Lepage; the radiology departments of the 18 hospitals participating in the study; and David Young for editorial assistance. This study was funded by a grant (SCR06006) devoted to research on standard care procedures from Assistance Publique-Hopitaux de Paris (Direction Regionale de la Recherche Clinique Ile de France).	*AM COLL RAD, 2006, APPR CRIT ROUT CHEST; BEKEMEYER WB, 1985, CHEST, V88, P691, DOI 10.1378/chest.88.5.691; Bhagwanjee S, 1996, INTENS CARE MED, V22, P1335, DOI 10.1007/s001340050260; Brainsky A, 1997, CRIT CARE MED, V25, P801, DOI 10.1097/00003246-199705000-00015; Chahine-Malus N, 2001, CRIT CARE, V5, P271, DOI 10.1186/cc1045; Clec'h C, 2008, INTENS CARE MED, V34, P264, DOI 10.1007/s00134-007-0919-1; FONG YM, 1995, ARCH SURG-CHICAGO, V130, P764; Good P. I, 2004, PERMUTATION PARAMETR; Graat ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3955; Graat Marleen E, 2006, BMC Med Imaging, V6, P8, DOI 10.1186/1471-2342-6-8; Graat ME, 2007, INTENS CARE MED, V33, P639, DOI 10.1007/s00134-007-0542-1; GREENBAUM DM, 1982, CRIT CARE MED, V10, P29, DOI 10.1097/00003246-198201000-00007; HALL JB, 1991, CRIT CARE MED, V19, P689, DOI 10.1097/00003246-199105000-00015; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; Hendrikse KA, 2007, CHEST, V132, P823, DOI 10.1378/chest.07-1162; Henschke CI, 1997, CLIN IMAG, V21, P90, DOI 10.1016/0899-7071(95)00097-6; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Krivopal M, 2003, CHEST, V123, P1607, DOI 10.1378/chest.123.5.1607; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lemaire F, 2007, PRESSE MED, V36, P1167, DOI 10.1016/j.lpm.2007.02.033; Lessnau KD, 2008, CHEST, V133, P1060, DOI 10.1378/chest.07-2337; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Marik P E, 1997, Am J Crit Care, V6, P95; Mets O, 2007, J THORAC CARDIOV SUR, V134, P139, DOI 10.1016/j.jtcvs.2007.02.029; Price MB, 1999, CRIT CARE MED, V27, P1588, DOI 10.1097/00003246-199908000-00033; Team RC., 2022, LANG ENV STAT COMP; Turner RM, 2007, STAT MED, V26, P274, DOI 10.1002/sim.2537	28	95	95	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 14	2009	374	9702					1687	1693		10.1016/S0140-6736(09)61459-8	http://dx.doi.org/10.1016/S0140-6736(09)61459-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19896184				2022-12-28	WOS:000271999700024
J	Fuselier, SA; Allegrini, F; Funsten, HO; Ghielmetti, AG; Heirtzler, D; Kucharek, H; Lennartsson, OW; McComas, DJ; Mobius, E; Moore, TE; Petrinec, SM; Saul, LA; Scheer, JA; Schwadron, N; Wurz, P				Fuselier, S. A.; Allegrini, F.; Funsten, H. O.; Ghielmetti, A. G.; Heirtzler, D.; Kucharek, H.; Lennartsson, O. W.; McComas, D. J.; Moebius, E.; Moore, T. E.; Petrinec, S. M.; Saul, L. A.; Scheer, J. A.; Schwadron, N.; Wurz, P.			Width and Variation of the ENA Flux Ribbon Observed by the Interstellar Boundary Explorer	SCIENCE			English	Article								The dominant feature in Interstellar Boundary Explorer ( IBEX) sky maps of heliospheric energetic neutral atom (ENA) flux is a ribbon of enhanced flux that extends over a broad range of ecliptic latitudes and longitudes. It is narrow (similar to 20 degrees average width) but long ( extending over 300 in the sky) and is observed at energies from 0.2 to 6 kilo-electron volts. We demonstrate that the flux in the ribbon is a factor of 2 to 3 times higher than that of the more diffuse, globally distributed heliospheric ENA flux. The ribbon is most pronounced at similar to 1 kilo-electron volt. The average width of the ribbon is nearly constant, independent of energy. The ribbon is likely the result of an enhancement in the combined solar wind and pickup ion populations in the heliosheath.	[Fuselier, S. A.; Ghielmetti, A. G.; Lennartsson, O. W.; Petrinec, S. M.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA; [Allegrini, F.; McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Allegrini, F.; McComas, D. J.] SW Res Inst, San Antonio, TX 78228 USA; [Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Heirtzler, D.; Kucharek, H.; Moebius, E.] Univ New Hampshire, Durham, NH 03824 USA; [Moore, T. E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Saul, L. A.; Scheer, J. A.; Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Schwadron, N.] Boston Univ, Boston, MA 02215 USA	Lockheed Martin; University of Texas System; University of Texas at San Antonio (UTSA); Southwest Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; University System Of New Hampshire; University of New Hampshire; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Bern; Boston University	Fuselier, SA (corresponding author), Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA.	stephen.a.fuselier@lmco.com	Funsten, Herbert O/A-5702-2015; McComas, David J/H-6202-2011; Wurz, Peter/R-2273-2017; Moore, Thomas Earle/D-4675-2012	Funsten, Herbert O/0000-0002-6817-1039; McComas, David J/0000-0001-6160-1158; Wurz, Peter/0000-0002-2603-1169; Moore, Thomas Earle/0000-0002-3150-1137; Moebius, Eberhard/0000-0002-2745-6978; Allegrini, Frederic/0000-0003-0696-4380	NASA through sub-contract from Southwest Research Institute	NASA through sub-contract from Southwest Research Institute	These results from the IBEX mission are a tribute to the hard work of many scientists and engineers. Work at Lockheed Martin was funded by NASA through sub-contract from Southwest Research Institute.	Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Fuselier SA, 2009, SPACE SCI REV, V146, P117, DOI 10.1007/s11214-009-9495-8; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; McComas DJ, 2009, SPACE SCI REV, V146, P11, DOI 10.1007/s11214-009-9499-4; Mobius E, 2009, SCIENCE, V326, P969, DOI 10.1126/science.1180971; Schwadron NA, 2009, SCIENCE, V326, P966, DOI 10.1126/science.1180986	6	152	154	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					962	964		10.1126/science.1180981	http://dx.doi.org/10.1126/science.1180981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833916				2022-12-28	WOS:000271712300029
J	Danchin, MH; Bines, JE				Danchin, Margaret H.; Bines, Julie E.			Global Health: Defeating Rotavirus? The Global Recommendation for Rotavirus Vaccination.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Danchin, Margaret H.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Danchin, MH (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.		Danchin, Margie/ABE-3391-2020	Bines, Julie/0000-0002-5452-6601				Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Clark HF, 2009, CLIN VACCINE IMMUNOL, V16, P382, DOI 10.1128/CVI.00382-08; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Parashar UD, 2009, NEW ENGL J MED, V360, P1063, DOI 10.1056/NEJMp0810154; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6	5	20	20	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1919	1921		10.1056/NEJMp0905091	http://dx.doi.org/10.1056/NEJMp0905091			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907040				2022-12-28	WOS:000271660500002
J	Clarke, NMP; Kendrick, T				Clarke, N. M. P.; Kendrick, Tony			Easily missed? Slipped capital femoral epiphysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarke, N. M. P.; Kendrick, Tony] Southampton Gen Hosp, Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Clarke, NMP (corresponding author), Southampton Gen Hosp, Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England.	ortho@soton.ac.uk	Kendrick, Tony/H-8558-2014	Kendrick, Tony/0000-0003-1618-9381				Aronsson DD, 2006, J AM ACAD ORTHOP SUR, V14, P666, DOI 10.5435/00124635-200611000-00010; Bhatia NN, 2006, J PEDIATR ORTHOPED, V26, P197, DOI 10.1097/01.bpo.0000218526.36362.3f; CARNEY BT, 1991, J BONE JOINT SURG AM, V73A, P667, DOI 10.2106/00004623-199173050-00004; Green Daniel W, 2005, HSS J, V1, P103, DOI 10.1007/s11420-005-0118-y; JONES JR, 1990, J BONE JOINT SURG BR, V72, P568; KALLIO P, 1995, J BONE JOINT SURG BR, V77, P752, DOI 10.1302/0301-620X.77B5.7559704; KLEIN A, 1951, AM J ROENTGENOL, V66, P361; Lehmann CL, 2006, J PEDIATR ORTHOPED, V26, P286, DOI 10.1097/01.bpo.0000217718.10728.70; LODER RT, 2007, PEDIAT ORTHOPAEDIC S, P353; Matava MJ, 1999, J PEDIATR ORTHOPED, V19, P455, DOI 10.1097/00004694-199907000-00007; Rahme D, 2006, J PEDIATR ORTHOP B, V15, P93, DOI 10.1097/01.bpb.0000188251.24771.c9	11	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2009	339								b4457	10.1136/bmj.b4457	http://dx.doi.org/10.1136/bmj.b4457			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UE	19897664				2022-12-28	WOS:000271568000001
J	Meylan, E; Dooley, AL; Feldser, DM; Shen, L; Turk, E; Ouyang, C; Jacks, T				Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler			Requirement for NF-kappa B signalling in a mouse model of lung adenocarcinoma	NATURE			English	Article							IKK-BETA; CELLULAR-TRANSFORMATION; KINASE COMPLEX; K-RAS; CANCER; P53; ACTIVATION; INFLAMMATION; INTEGRATOR; INHIBITION	NF-kappa B transcription factors function as crucial regulators of inflammatory and immune responses as well as of cell survival(1). They have also been implicated in cellular transformation and tumorigenesis(2-6). However, despite extensive biochemical characterization of NF-kappa B signalling during the past twenty years, the requirement for NF-kappa B in tumour development in vivo, particularly in solid tumours, is not completely understood. Here we show that the NF-kappa B pathway is required for the development of tumours in a mouse model of lung adenocarcinoma. Concomitant loss of p53 (also known as Trp53) and expression of oncogenic Kras(G12D) resulted in NF-kappa B activation in primary mouse embryonic fibroblasts. Conversely, in lung tumour cell lines expressing Kras(G12D) and lacking p53, p53 restoration led to NF-kappa B inhibition. Furthermore, the inhibition of NF-kappa B signalling induced apoptosis in p53-null lung cancer cell lines. Inhibition of the pathway in lung tumours in vivo, from the time of tumour initiation or after tumour progression, resulted in significantly reduced tumour development. Together, these results indicate a critical function for NF-kappa B signalling in lung tumour development and, further, that this requirement depends on p53 status. These findings also provide support for the development of NF-kappa B inhibitory drugs as targeted therapies for the treatment of patients with defined mutations in Kras and p53.	[Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu		Meylan, Etienne/0000-0002-0899-2230; Piazza, Erin/0000-0002-3263-5946	Howard Hughes Medical Institute; NCI [P30-CA14051]; International Human Frontier Science Program Organization; Swiss National Science Foundation; Leukemia & Lymphoma Society Fellow Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leukemia & Lymphoma Society Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. McFadden, T. Oliver, M. DuPage, K. Lane, A. Cheung, M. Kumar and E. Snyder for discussions and for sharing various reagents, A. Deconinck for critical reading of the manuscript, D. Crowley for preparation of tissue sections, and the entire Jacks laboratory for discussions. This work was supported by the Howard Hughes Medical Institute (T. J.) and partially by a Cancer Center Support grant from the NCI (P30-CA14051). T. J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. E. M. is a recipient of fellowships from the International Human Frontier Science Program Organization and the Swiss National Science Foundation. D. M. F. is a recipient of a Leukemia & Lymphoma Society Fellow Award.	DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ravi R, 1998, CANCER RES, V58, P4531; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	416	431	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					104	U115		10.1038/nature08462	http://dx.doi.org/10.1038/nature08462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19847165	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000271419200041
J	SteelFisher, GK; Blendon, RJ; Sussman, T; Connolly, JM; Benson, JM; Herrmann, MJ				SteelFisher, Gillian K.; Blendon, Robert J.; Sussman, Tara; Connolly, John M.; Benson, John M.; Herrmann, Melissa J.			Physicians' Views of the Massachusetts Health Care Reform Law -- A Poll.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[SteelFisher, Gillian K.; Blendon, Robert J.; Sussman, Tara; Connolly, John M.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Herrmann, Melissa J.] Social Sci Res Solut, Media, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	SteelFisher, GK (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							*AM COLL EM PHYS, 2009, ACEP MASS EM PHYS SU; Blendon RJ, 2008, HEALTH AFFAIR, V27, pW556, DOI 10.1377/hlthaff.27.6.w556; CHEPLICK T, 2009, HLTH CARE NEWS   SEP; Holahan J, 2006, HEALTH AFFAIR, V25, pW432, DOI 10.1377/hlthaff.25.w432; Long SK, 2009, ESTIMATES HLTH INSUR	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19								10.1056/NEJMp0909851	http://dx.doi.org/10.1056/NEJMp0909851			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19846839				2022-12-28	WOS:000271405800006
J	Sharma, M; Ansari, MT; Abou-Setta, AM; Soares-Weiser, K; Ooi, TC; Sears, M; Yazdi, F; Tsertsvadze, A; Moher, D				Sharma, Mukul; Ansari, Mohammed T.; Abou-Setta, Ahmed M.; Soares-Weiser, Karla; Ooi, Teik Chye; Sears, Margaret; Yazdi, Fatemeh; Tsertsvadze, Alexander; Moher, David			Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; EXTENDED-RELEASE NIACIN; DENSITY-LIPOPROTEIN CHOLESTEROL; LIPID-ALTERING EFFICACY; TYPE-2 DIABETES-MELLITUS; C GOAL ATTAINMENT; EZETIMIBE AND/OR SIMVASTATIN; LOW-DOSE COLESTIPOL; DOUBLE-BLIND TRIAL; ATORVASTATIN 20 MG	Background: Statin therapy effectively prevents vascular disease, but treatment targets are often not achieved. Purpose: To compare the benefits and harms of high-dose statin monotherapy with those of combination therapy in adults at high risk for coronary disease. Data Sources: English-language records from MEDLINE (1966 to 2009), EMBASE (1980 to 2009), and the Cochrane Library (third quarter of 2008). Study Selection: A reviewer screened records, and a second reviewer verified selection of randomized, controlled trials in adult patients that compared combinations of statins and bile-acid sequestrants, fibrates, ezetimibe, niacin, or omega-3 fatty acids with statin monotherapy, as well as nonrandomized comparative studies that were longer than 24 weeks and reported clinical and harms outcomes. Data Extraction: Data were abstracted for studies by using standardized forms, and study quality was rated with a standardized scale and strength of evidence by using the Grading of Recommendations Assessment, Development, and Evaluation approach. Data Synthesis: 102 studies met eligibility criteria. The main analysis compared combination therapy with high-dose statin monotherapy in high-risk patients. Very-low-strength evidence showed that statin-ezetimibe (2 trials; n = 439) and statin-fibrate (1 trial; n = 166) combinations did not reduce mortality more than high-dose statin monotherapy. No trials compared the effect of combination therapy versus high-dose statin monotherapy on the incidence of myocardial infarction, stroke, or revascularization procedures. Two statin-ezetimibe trials (n = 295) demonstrated higher low-density lipoprotein cholesterol goal attainment with combination therapy (odds ratio, 7.21 [95% CI, 4.30 to 12.08]). Trials in lower-risk patients did not show a difference in mortality. Limitations: Studies were generally short, focused on surrogate outcomes, and were heterogeneous in the sample's risk for coronary disease. Few studies examined treatment combinations other than statin-ezetimibe. Conclusion: Limited evidence suggests that combinations of lipid-lowering agents do not improve clinical outcomes more than high-dose statin monotherapy. Very-low-quality evidence favors statinezetimibe treatment for attainment of low-density lipoprotein cholesterol goals.	Univ Ottawa, Clin Epidemiol Program, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; Enhance Reviews, Kefar Sava, Israel	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alberta	Sharma, M (corresponding author), Ottawa Hosp, Reg Stroke Program, Canadian Stroke Network, Civ Campus,C2,Room 2182,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.			Moher, David/0000-0003-2434-4206	AHRQ, U.S. Department of Health and Human Services [290-02-0021]	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ, U.S. Department of Health and Human Services ( contract 290-02-0021).	Airan-Javia SL, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2009.01.001; *AM SOC HOSP PHARM, 1990, AM HOSP FORM SERV AF; Amarenco P, 2006, NEW ENGL J MED, V355, P549; American Heart Association, 2008, HEART DIS STROK STAT; Athyros VG, 2005, METABOLISM, V54, P1065, DOI 10.1016/j.metabol.2005.03.010; Athyros VG, 2002, J CARDIOVASC RISK, V9, P33, DOI 10.1097/00043798-200202000-00005; Athyros VG, 2002, DIABETES CARE, V25, P1198, DOI 10.2337/diacare.25.7.1198; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2008, J CLIN LIPIDOL, V2, P79, DOI 10.1016/j.jacl.2008.02.004; Ballantyne CM, 2008, AM J CARDIOL, V101, P1428, DOI 10.1016/j.amjcard.2008.02.092; Ballantyne CM, 2007, AM J CARDIOL, V99, P673, DOI 10.1016/j.amjcard.2006.10.022; Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023; Ballantyne CM, 2004, CLIN THER, V26, P1855, DOI 10.1016/j.clinthera.2004.11.001; Ballantyne CM, 2004, AM J CARDIOL, V93, P1487, DOI 10.1016/j.amjcard.2004.02.060; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; BARBI G, 1992, DRUG DEVELOP RES, V27, P297, DOI 10.1002/ddr.430270309; Barrios V, 2005, INT J CLIN PRACT, V59, P1377, DOI 10.1111/j.1368-5031.2005.00714.x; Bays HE, 2004, CLIN THER, V26, P1758, DOI 10.1016/j.clinthera.2004.11.016; Bays HE, 2003, AM J CARDIOL, V91, P667, DOI 10.1016/S0002-9149(03)00007-9; Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007; Blagden MD, 2007, CURR MED RES OPIN, V23, P767, DOI 10.1185/030079907X182059; Brohet C, 2005, CURR MED RES OPIN, V21, P571, DOI 10.1185/030079905X382004; Brown BG, 2008, NEW ENGL J MED, V358, P1504, DOI 10.1056/NEJMe0801608; Capuzzi DM, 2003, AM J CARDIOL, V91, P1304, DOI 10.1016/S0002-9149(03)00318-7; Catapano AL, 2006, CURR MED RES OPIN, V22, P2041, DOI 10.1185/030079906X132721; Chan DC, 2002, EUR J CLIN INVEST, V32, P429, DOI 10.1046/j.1365-2362.2002.01001.x; Chenot F, 2007, EUR J CLIN INVEST, V37, P357, DOI 10.1111/j.1365-2362.2007.01797.x; Conard SE, 2008, AM J CARDIOL, V102, P1489, DOI 10.1016/j.amjcard.2008.09.075; Constance C, 2007, DIABETES OBES METAB, V9, P575, DOI 10.1111/j.1463-1326.2007.00725.x; Cruz-Fernandez JM, 2005, INT J CLIN PRACT, V59, P619, DOI 10.1111/j.1368-5031.2005.00565.x; Dagli N, 2007, INFLAMMATION, V30, P230, DOI 10.1007/s10753-007-9041-3; Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4; Davidson MH, 1997, AM J CARDIOL, V80, P797, DOI 10.1016/S0002-9149(97)00522-5; Davidson MH, 2001, CLIN CARDIOL, V24, P467, DOI 10.1002/clc.4960240610; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Derosa G, 2004, CLIN THER, V26, P1599, DOI 10.1016/j.clinthera.2004.10.008; Dobs AS, 2003, J AM COLL CARDIOL, V41, p227A; Durrington PN, 2004, DIABETES RES CLIN PR, V64, P137, DOI 10.1016/j.diabres.2003.11.012; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; Eriksson M, 1998, J INTERN MED, V243, P373; Farnier M, 2005, INT J CARDIOL, V102, P327, DOI 10.1016/j.ijcard.2005.01.022; Feldman T, 2004, AM J CARDIOL, V93, P1481, DOI 10.1016/j.amjcard.2004.02.059; Gagne C, 2002, CIRCULATION, V105, P2469, DOI 10.1161/01.CIR.0000018744.58460.62; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gardner SF, 1996, PHARMACOTHERAPY, V16, P419; Gaudiani LM, 2005, DIABETES OBES METAB, V7, P88, DOI 10.1111/j.1463-1326.2004.00420.x; Geiss HC, 2005, ATHEROSCLEROSIS, V180, P107, DOI 10.1016/j.atherosclerosis.2004.11.007; Goldberg AC, 2004, MAYO CLIN PROC, V79, P620, DOI 10.4065/79.5.620; Goldberg RB, 2006, MAYO CLIN PROC, V81, P1579, DOI 10.4065/81.12.1579; Gouni-Berthold I, 2008, ATHEROSCLEROSIS, V198, P198, DOI 10.1016/j.atherosclerosis.2007.09.034; Grundy SM, 2005, AM J CARDIOL, V95, P462, DOI 10.1016/j.amjcard.2004.10.012; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Heinonen, 1996, J Cardiovasc Pharmacol Ther, V1, P117; Hong Heng, 2004, Chinese Medical Sciences Journal, V19, P145; Hunninghake D, 2001, ATHEROSCLEROSIS, V158, P407, DOI 10.1016/S0021-9150(01)00437-3; Hunninghake DB, 2003, CLIN CARDIOL, V26, P112, DOI 10.1002/clc.4960260304; Insull W, 2004, ARCH INTERN MED, V164, P1121, DOI 10.1001/archinte.164.10.1121; Isaacsohn, 1997, J Cardiovasc Pharmacol Ther, V2, P243, DOI 10.1177/107424849700200402; ISMAIL F, 1990, CLIN THER, V12, P427; Ito MK, 1997, AM J CARDIOL, V80, P799, DOI 10.1016/S0002-9149(97)00523-7; JOHANSSON J, 1995, NUTR METAB CARDIOVAS, V5, P39; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kerzner B, 2003, AM J CARDIOL, V91, P418, DOI 10.1016/S0002-9149(02)03236-8; Knapp HH, 2001, AM J MED, V110, P352, DOI 10.1016/S0002-9343(01)00638-6; KNOPP RH, 1993, ARCH INTERN MED, V153, P1321, DOI 10.1001/archinte.153.11.1321; Kosoglou T, 2004, CURR MED RES OPIN, V20, P1185, DOI 10.1185/030079904125004213; Kosoglou T, 2004, CURR MED RES OPIN, V20, P955, DOI 10.1185/030079904125003872; Kosoglou T, 2002, BRIT J CLIN PHARMACO, V54, P309, DOI 10.1046/j.1365-2125.2002.01633.x; Kuvin JT, 2006, AM J CARDIOL, V98, P743, DOI 10.1016/j.amjcard.2006.04.011; Landray M, 2006, AM J KIDNEY DIS, V47, P385, DOI 10.1053/j.ajkd.2005.11.018; Leiter LA, 2008, AM J CARDIOL, V102, P1495, DOI 10.1016/j.amjcard.2008.09.076; Liu ML, 2003, NUTR RES, V23, P1027, DOI 10.1016/S0271-5317(03)00102-7; Mackay J, 2004, ATLAS HEART DIS STRO; Masana L, 2005, CLIN THER, V27, P174, DOI 10.1016/j.clinthera.2005.02.011; McKenney JM, 2007, ATHEROSCLEROSIS, V192, P432, DOI 10.1016/j.atherosclerosis.2006.11.037; *MED EC, 1993, PHYS DESK REF; Melani L, 2003, EUR HEART J, V24, P717, DOI 10.1016/S0195-668X(02)00803-5; Meyer BJ, 2007, LIPIDS, V42, P109, DOI 10.1007/s11745-006-3014-4; MININO AM, 2006, NATL VITAL STAT REP, V51, P1; MOL MJTM, 1990, NETH J MED, V36, P182; Moore A, 2007, J CLIN LIPIDOL, V1, P620, DOI 10.1016/j.jacl.2007.09.001; Muhlestein JB, 2006, J AM COLL CARDIOL, V48, P396, DOI 10.1016/j.jacc.2006.05.009; Napoli, 1997, J Cardiovasc Pharmacol Ther, V2, P17, DOI 10.1177/107424849700200103; Nordoy A, 2001, NUTR METAB CARDIOVAS, V11, P7; Nordoy A, 1998, J INTERN MED, V243, P163; OBRIEN RC, 1990, MED J AUSTRALIA, V152, P480, DOI 10.5694/j.1326-5377.1990.tb125308.x; OJALA JP, 1990, ATHEROSCLEROSIS, V82, P85, DOI 10.1016/0021-9150(90)90147-B; OKEEFE JH, 1995, AM J CARDIOL, V76, P480, DOI 10.1016/S0002-9149(99)80134-9; Patel JV, 2006, INT J CLIN PRACT, V60, P914, DOI 10.1111/j.1742-1241.2006.01023.x; Pearson TA, 2005, MAYO CLIN PROC, V80, P587, DOI 10.4065/80.5.587; Piorkowski M, 2007, J AM COLL CARDIOL, V49, P1035, DOI 10.1016/j.jacc.2006.10.064; Reckless JPD, 2008, INT J CLIN PRACT, V62, P539, DOI 10.1111/j.1742-1241.2008.01697.x; Rodney RA, 2006, J NATL MED ASSOC, V98, P772; Sakai T, 2001, ARTERIOSCL THROM VAS, V21, P1783, DOI 10.1161/hq1001.096624; SCHROTT HG, 1995, AM J CARDIOL, V75, P34, DOI 10.1016/S0002-9149(99)80523-2; Shah Hetal D, 2007, Exp Clin Cardiol, V12, P91; Shankar PK, 2007, J CLIN LIPIDOL, V1, P264, DOI 10.1016/j.jacl.2007.07.009; SHARMA M, 2009, 09EHC0241 AHRQ; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; Simons LA, 1998, AUST NZ J MED, V28, P327, DOI 10.1111/j.1445-5994.1998.tb01957.x; SIMONS LA, 1992, MED J AUSTRALIA, V157, P455, DOI 10.5694/j.1326-5377.1992.tb137306.x; Smit Jan W. A., 1995, American Journal of Cardiology, V76, p126A; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; SPRECHER DL, 1994, ANN INTERN MED, V120, P537, DOI 10.7326/0003-4819-120-7-199404010-00002; Stein, 1996, J Cardiovasc Pharmacol Ther, V1, P107; Stein E, 2004, AM HEART J, V148, P447, DOI 10.1016/j.ahj.2004.03.052; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Turk TR, 2008, NEPHROL DIAL TRANSPL, V23, P369, DOI 10.1093/ndt/gfm620; *US FDA, 2008, EV SAF EFF ADV COMB; *US FDA, 1992, APPR DRUG PROD THER; VACEK JL, 1995, AM J CARDIOL, V76, P182, DOI 10.1016/S0002-9149(99)80056-3; van Dam M, 2001, CLIN DRUG INVEST, V21, P477, DOI 10.2165/00044011-200121070-00003; van Lennep HWOR, 2008, CURR MED RES OPIN, V24, P685, DOI [10.1185/030079908X273273, 10.1185/03007990SX273273]; WIKLUND O, 1993, AM J MED, V94, P13, DOI 10.1016/0002-9343(93)90114-5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	119	64	69	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					622	W200		10.7326/0003-4819-151-9-200911030-00144	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00144			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884623				2022-12-28	WOS:000271387700004
J	Kastrinos, F; Mukherjee, B; Tayob, N; Wang, F; Sparr, J; Raymond, VM; Bandipalliam, P; Stoffel, EM; Gruber, SB; Syngal, S				Kastrinos, Fay; Mukherjee, Bhramar; Tayob, Nabihah; Wang, Fei; Sparr, Jennifer; Raymond, Victoria M.; Bandipalliam, Prathap; Stoffel, Elena M.; Gruber, Stephen B.; Syngal, Sapna			Risk of Pancreatic Cancer in Families With Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MSH2 MUTATION CARRIERS; DNA-MISMATCH-REPAIR; MEDULLARY CARCINOMA; ENDOMETRIAL CANCER; HISTORY; ACCURACY; INDIVIDUALS; PATIENT; GENE	Context Lynch syndrome is an inherited cause of colorectal cancer caused by mutations of DNA mismatch repair (MMR) genes. A number of extracolonic tumors have been associated with the disorder, including pancreatic cancer; however, the risk of pancreatic cancer in Lynch syndrome is uncertain and not quantified. Objective To estimate pancreatic cancer risk in families with germline MMR gene mutations. Design, Setting, and Patients Cancer histories of probands and their relatives were evaluated in MMR gene mutation carriers in the familial cancer registries of the Dana-Farber Cancer Institute (n=80), Boston, Massachusetts, and University of Michigan Comprehensive Cancer Center (n=67), Ann Arbor, Michigan. Families enrolled before the study start date ( June 2008) were eligible. Age-specific cumulative risks and hazard ratio estimates of pancreatic cancer risk were calculated and compared with the general population using modified segregation analysis, with correction for ascertainment. Main Outcome Measures Age-specific cumulative risks and hazard ratio estimates of pancreatic cancer risk. Results Data on 6342 individuals from 147 families with MMR gene mutations were analyzed. Thirty-one families (21.1%) reported at least 1 case of pancreatic cancer. Forty-seven pancreatic cancers were reported ( 21 men and 26 women), with no sex-related difference in age of diagnosis (51.5 vs 56.5 years for men and women, respectively). The cumulative risk of pancreatic cancer in these families with gene mutations was 1.31% (95% confidence interval [CI], 0.31%-2.32%) up to age 50 years and 3.68% ( 95% CI, 1.45%-5.88%) up to age 70 years, which represents an 8.6-fold increase ( 95% CI, 4.7-15.7) compared with the general population. Conclusions Among 147 families with germline MMR gene mutations, the risk of pancreatic cancer was increased compared with the US population. Individuals with MMR gene mutations and a family history of pancreatic cancer are appropriate to include in studies to further define the risk of premalignant and malignant pancreatic neoplasms and potential benefits and limitations of surveillance. JAMA. 2009; 302(16):1790-1795 www.jama.com	[Sparr, Jennifer; Bandipalliam, Prathap; Stoffel, Elena M.; Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Kastrinos, Fay; Stoffel, Elena M.; Syngal, Sapna] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Kastrinos, Fay] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Mukherjee, Bhramar; Tayob, Nabihah; Wang, Fei] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Raymond, Victoria M.; Gruber, Stephen B.] Univ Michigan, Sch Publ Hlth, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gruber, Stephen B.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol & Human Genet, Ann Arbor, MI 48109 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Columbia University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 1 Jimmy Fund Way,SM 209, Boston, MA 02115 USA.	sgruber@med.umich.edu; ssyngal@partners.org			National Cancer Institute [R01CA81488, K24CA113433, R01CA97075, 5P30CA46592]; The Karp Family; H. H. & M. Metals Inc Fund; Leake Gift for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA097075, K24CA113433, P30CA046592, R01CA081488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Karp Family; H. H. & M. Metals Inc Fund; Leake Gift for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants R01CA81488, K24CA113433, R01CA97075, and 5P30CA46592 from the National Cancer Institute, The Karp Family, H. H. & M. Metals Inc Fund, and the Leake Gift for Pancreatic Cancer Research.	Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Banville N, 2006, HUM PATHOL, V37, P1498, DOI 10.1016/j.humpath.2006.06.024; Brand RE, 2000, MED CLIN N AM, V84, P665, DOI 10.1016/S0025-7125(05)70249-2; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Canto MI, 2004, CLIN GASTROENTEROL H, V2, P606, DOI 10.1016/S1542-3565(04)00244-7; Douglas FS, 1999, J MED GENET, V36, P309; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Geary J, 2008, FAM CANCER, V7, P163, DOI 10.1007/s10689-007-9164-6; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Goecke T, 2006, J CLIN ONCOL, V24, P4285, DOI 10.1200/JCO.2005.03.7333; Hruban RH, 2001, DIGEST DIS, V19, P76, DOI 10.1159/000050656; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Lynch HT, 1996, SEMIN ONCOL, V23, P251; LYNCH HT, 1967, AM J MED SCI, V254, P322, DOI 10.1097/00000441-196709000-00007; Maple JT, 2005, PANCREATOLOGY, V5, P220, DOI 10.1159/000085275; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Petersen GM, 2006, CANCER EPIDEM BIOMAR, V15, P704, DOI 10.1158/1055-9965.EPI-05-0734; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Rulyak SJ, 2001, PANCREATOLOGY, V1, P477, DOI 10.1159/000055851; Sijmons RH, 2000, EUR J HUM GENET, V8, P181, DOI 10.1038/sj.ejhg.5200441; Sparr JA, 2009, AM J SURG PATHOL, V33, P309, DOI 10.1097/PAS.0b013e3181882c3d; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Wang WY, 2007, J CLIN ONCOL, V25, P1417, DOI 10.1200/JCO.2006.09.2452; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Wilentz RE, 2000, AM J PATHOL, V156, P1641, DOI 10.1016/S0002-9440(10)65035-3	38	310	316	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1790	1795		10.1001/jama.2009.1529	http://dx.doi.org/10.1001/jama.2009.1529			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861671	Green Accepted, Bronze			2022-12-28	WOS:000271150300022
J	Giessen, H; Vogelgesang, R				Giessen, Harald; Vogelgesang, Ralf			Glimpsing the Weak Magnetic Field of Light	SCIENCE			English	Editorial Material							OPTICAL MICROSCOPY; RESOLUTION; PROBE		[Giessen, Harald] Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany; [Vogelgesang, Ralf] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	University of Stuttgart; Max Planck Society	Giessen, H (corresponding author), Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany.	giessen@physik.uni-stuttgart.de; r.vogelgesang@fkf.mpg.de	Vogelgesang, Ralf/B-4460-2009; Giessen, Harald/AAG-7586-2019	Vogelgesang, Ralf/0000-0002-1026-3205; Giessen, Harald/0000-0002-4270-3850				BINNIG G, 1985, SCI AM, V253, P50, DOI 10.1038/scientificamerican0885-50; Burresi M, 2009, SCIENCE, V326, P550, DOI 10.1126/science.1177096; FISCHER UC, 1994, J MICROSC-OXFORD, V176, P231, DOI 10.1111/j.1365-2818.1994.tb03520.x; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Kalkbrenner T, 2001, J MICROSC-OXFORD, V202, P72, DOI 10.1046/j.1365-2818.2001.00817.x; Knoll B, 1999, J MICROSC-OXFORD, V194, P512, DOI 10.1046/j.1365-2818.1999.00496.x; Landau L. D., 1960, ELECTRODYNAMICS CONT, P251; Lee KG, 2007, NAT PHOTONICS, V1, P53, DOI 10.1038/nphoton.2006.37; LEWIS A, 1984, ULTRAMICROSCOPY, V13, P227, DOI 10.1016/0304-3991(84)90201-8; Liu N, 2009, NAT PHOTONICS, V3, P157, DOI 10.1038/NPHOTON.2009.4; Merlin R, 2009, P NATL ACAD SCI USA, V106, P1693, DOI 10.1073/pnas.0808478106; NOVOTNY L, 1995, OPT LETT, V20, P970, DOI 10.1364/OL.20.000970; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865	13	28	28	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					529	530		10.1126/science.1181552	http://dx.doi.org/10.1126/science.1181552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900886				2022-12-28	WOS:000271019400025
J	Jackson, SC				Jackson, Stacy C.			Parallel Pursuit of Near-Term and Long-Term Climate Mitigation	SCIENCE			English	Editorial Material							CARBON; LIFETIME		Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Jackson, SC (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	stacyjackson@berkeley.edu		Jackson, Stacy/0000-0001-5276-502X				Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Bond TC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002840; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; Jacobson MZ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002044; Koch D, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD007024; Koch D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028360; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; McMullen C., 2009, CLIMATE CHANGE SCI C; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moore FC, 2009, INT J CLIM CHANG STR, V1, P42, DOI 10.1108/17568690910934390; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Quinn PK, 2008, ATMOS CHEM PHYS, V8, P1723, DOI 10.5194/acp-8-1723-2008; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Stohl A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007216; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235	25	43	43	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					526	527		10.1126/science.1177042	http://dx.doi.org/10.1126/science.1177042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19900884				2022-12-28	WOS:000271019400023
J	Saunders, J				Saunders, John			Should healthy volunteers in clinical trials be paid according to risk? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEATH		Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Saunders, J (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	John.Saunders3@wales.nhs.uk						DARRAGH A, 1985, LANCET, V1, P93; *DOH, 2006, EXP GROUP PHAS ON CL; *INV, 2006, GUID REIMB PAYING ME; JONAS H, 1969, DAEDALUS, V98, P219; KOLATA GB, 1980, HASTINGS CENT REP, V10, P5, DOI 10.2307/3560443; Royal College of Physicians, 2007, GUID PRACT ETH COMM; *US DEP HHS, INF CONS FREQ ASK QU	7	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 22	2009	339								b4145	10.1136/bmj.b4145	http://dx.doi.org/10.1136/bmj.b4145			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510PN	19850610				2022-12-28	WOS:000271102500002
J	Klassen, TP; Harding, L; Hamm, M; van der Lee, JH; Ursum, J; Offringa, M				Klassen, Terry P.; Harding, Lisa; Hamm, Michele; van der Lee, Johanna H.; Ursum, Jennie; Offringa, Martin			StaR Child Health: an initiative for RCTs in children	LANCET			English	Editorial Material							CLINICAL-TRIALS; PLACEBO		[van der Lee, Johanna H.; Ursum, Jennie; Offringa, Martin] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands; [Klassen, Terry P.; Harding, Lisa; Hamm, Michele] Univ Alberta, Edmonton, AB, Canada; [Klassen, Terry P.; Harding, Lisa; Hamm, Michele] Stollery Childrens Hosp, Womens & Childrens Hlth Res Inst, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Alberta; Stollery Children's Hospital	Offringa, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Clin Epidemiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.offringa@amc.uva.nl		Offringa, Martin/0000-0002-4402-5299; Klassen, Terry/0000-0002-5309-7091				Bosch X, 2005, SCIENCE, V309, P1799; Cohen E, 2007, J CLIN EPIDEMIOL, V60, P118, DOI 10.1016/j.jclinepi.2006.03.015; Cramer Kristie, 2005, BMC Pediatr, V5, P38, DOI 10.1186/1471-2431-5-38; Fernandes R, 2008, J PEDIATR-US, V152, P527, DOI 10.1016/j.jpeds.2007.09.024; FRAKKING FNJ, 2009, STAR CHILD HLTH GROU; Gimpel C, 2009, J HYPERTENS, V27, P1568, DOI 10.1097/HJH.0b013e32832cb2a8; HARTLING L, 2009, BRIT MED J, V339, pB4006; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Smyth RL, 2007, ARCH DIS CHILD, V92, P835, DOI 10.1136/adc.2006.113357; *STAR CHILD HLTH, 2009, STAND RES CHILD HLTH; THOMSON D, 2008, Z EVIDENZ FORTBIL S6, V102, P80; van der Lee JH, 2008, J CLIN EPIDEMIOL, V61, P324, DOI 10.1016/j.jclinepi.2007.07.008; Weber Elske H, 2009, Paediatr Drugs, V11, P161, DOI 10.2165/00148581-200911030-00001	15	47	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1310	1312		10.1016/S0140-6736(09)61803-1	http://dx.doi.org/10.1016/S0140-6736(09)61803-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19837237				2022-12-28	WOS:000271254600008
J	Dean, T; Sehgal, A				Dean, Terry; Sehgal, Amita			New Routes for Memory Retrieval and Reinforcement	CELL			English	Editorial Material							DROSOPHILA		[Dean, Terry; Sehgal, Amita] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Gruninger TR, 2007, MOL NEUROBIOL, V35, P1; KIM YC, 2007, NEURON, V53, P103; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	7	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 16	2009	139	2					225	227		10.1016/j.cell.2009.09.031	http://dx.doi.org/10.1016/j.cell.2009.09.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837025	Bronze			2022-12-28	WOS:000270857500006
J	Bolmers, MDM; Linthorst, GE; Soeters, MR; Nio, YC; van Lieshout, JJ				Bolmers, Mattheus D. M.; Linthorst, Gabor E.; Soeters, Maarten R.; Nio, Yung C.; van Lieshout, Johannes J.			Green urine, but no infection	LANCET			English	Editorial Material									[Linthorst, Gabor E.; Soeters, Maarten R.] Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Bolmers, Mattheus D. M.; van Lieshout, Johannes J.] Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Nio, Yung C.] Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Linthorst, GE (corresponding author), Acad Med Ctr, Dept Endocrinol & Metab, Room F4-119, NL-1105 AZ Amsterdam, Netherlands.	g.e.linthorst@amc.nl	van Lieshout, Johannes J/B-6674-2011; Van Lieshout, Johannes/P-5499-2019	van Lieshout, Johannes J/0000-0002-3646-2122; Van Lieshout, Johannes/0000-0002-3646-2122; Soeters, Maarten/0000-0001-5008-6752				KARAMCHANDANI MC, 1984, AM J SURG, V147, P681, DOI 10.1016/0002-9610(84)90141-7; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Murakami Kazutaka, 2007, Clin Exp Nephrol, V11, P225, DOI 10.1007/s10157-007-0475-6; Saxena R, 1997, AM J KIDNEY DIS, V30, P131, DOI 10.1016/S0272-6386(97)90576-X	4	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1566	1566		10.1016/S0140-6736(09)61295-2	http://dx.doi.org/10.1016/S0140-6736(09)61295-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19880022				2022-12-28	WOS:000271591300035
J	Baucus, SM				Baucus, Senator Max			Doctors, Patients, and the Need for Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*AAMC, 2008 GRAD STUD SURV; *BUR CENS, HLTH INS COV 2008; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012	3	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1817	1819		10.1056/NEJMp0910001	http://dx.doi.org/10.1056/NEJMp0910001			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19846842				2022-12-28	WOS:000271405800001
J	Stein, S; Liu, M				Stein, Seth; Liu, Mian			Long aftershock sequences within continents and implications for earthquake hazard assessment	NATURE			English	Article							SEISMIC-HAZARD; FAULT; DEFORMATION	One of the most powerful features of plate tectonics is that the known plate motions give insight into both the locations and average recurrence interval of future large earthquakes on plate boundaries. Plate tectonics gives no insight, however, into where and when earthquakes will occur within plates, because the interiors of ideal plates should not deform. As a result, within plate interiors, assessments of earthquake hazards rely heavily on the assumption that the locations of small earthquakes shown by the short historical record reflect continuing deformation that will cause future large earthquakes(1). Here, however, we show that many of these recent earthquakes are probably aftershocks of large earthquakes that occurred hundreds of years ago. We present a simple model predicting that the length of aftershock sequences varies inversely with the rate at which faults are loaded. Aftershock sequences within the slowly deforming continents are predicted to be significantly longer than the decade typically observed at rapidly loaded plate boundaries. These predictions are in accord with observations. So the common practice of treating continental earthquakes as steady-state seismicity overestimates the hazard in presently active areas and underestimates it elsewhere.	[Stein, Seth] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Liu, Mian] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA	Northwestern University; University of Missouri System; University of Missouri Columbia	Stein, S (corresponding author), Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA.	seth@earth.northwestern.edu			NSF/OISE [0730154]; Chinese Academy of Sciences	NSF/OISE(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Y. Yang for assistance in preparing the figures and Supplementary Information, and H. Wang for providing the Chinese earthquake catalogue. M. L.'s research is supported by NSF/OISE grant 0730154 and a grant from the Chinese Academy of Sciences. We also thank E. Calais, A. Friedrich, R. Smith and R. Stein for discussions, and T. Parsons and Y. Kagan for reviews.	Calais E, 2009, SCIENCE, V323, P1442, DOI 10.1126/science.1168122; Camelbeeck T, 2007, GEOL SOC AM SPEC PAP, V425, P193, DOI 10.1130/2007.2425(14); Chang WL, 2002, B SEISMOL SOC AM, V92, P1904, DOI 10.1785/0120010181; CRONE AJ, 1990, GEOL SOC AM BULL, V102, P1, DOI 10.1130/0016-7606(1990)102<0001:SATOHS>2.3.CO;2; Crone AJ, 2003, B SEISMOL SOC AM, V93, P1913, DOI 10.1785/0120000094; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Ebel J. E., 2000, SEISMOL RES LETT, V71, P283, DOI [DOI 10.1785/GSSRL.71.2.283, 10.1785/gssrl.71.2.283]; Hammond WC, 2009, GEOL SOC AM SPEC PAP, V447, P33, DOI 10.1130/2009.2447(03); Hearn EH, 2002, B SEISMOL SOC AM, V92, P172, DOI 10.1785/0120000832; Holbrook J, 2006, TECTONOPHYSICS, V420, P431, DOI 10.1016/j.tecto.2006.04.002; Kafka AL, 2007, GEOL SOC AM SPEC PAP, V425, P35, DOI 10.1130/2007.2425(03); Kagan YY, 1999, B SEISMOL SOC AM, V89, P1147; Li QS, 2009, B SEISMOL SOC AM, V99, P52, DOI 10.1785/0120080005; MAZZOTTI S, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2004JB0035900; Newman A, 1999, SCIENCE, V284, P619, DOI 10.1126/science.284.5414.619; OGATA Y, 1984, B SEISMOL SOC AM, V74, P1757; Parsons T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000646; RYALL A, 1977, B SEISMOL SOC AM, V67, P517; SAVAGE JC, 1973, J GEOPHYS RES, V78, P832, DOI 10.1029/JB078i005p00832; Shedlock K., 2000, SEISMOL RES LETT, V71, P679; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Stein S, 2004, SEISMOL RES LETT, V75, P173, DOI 10.1785/gssrl.75.2.173; Stein S, 2009, SEISMOL RES LETT, V80, P551, DOI 10.1785/gssrl.80.4.551; Toda S, 1998, J GEOPHYS RES-SOL EA, V103, P24543, DOI 10.1029/98JB00765; Toda S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000172; Tuttle MP, 2006, SEISMOL RES LETT, V77, P755, DOI 10.1785/gssrl.77.6.755; Tuttle MP, 2002, B SEISMOL SOC AM, V92, P2080, DOI 10.1785/0120010227; WESNOUSKY SG, 1986, J GEOPHYS RES-SOLID, V91, P2587, DOI 10.1029/JB091iB12p12587; Ziv A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027141; Zoller G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021871	30	150	158	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					87	89		10.1038/nature08502	http://dx.doi.org/10.1038/nature08502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890328				2022-12-28	WOS:000271419200037
J	Wang, CJ; Conroy, KN; Zuckerman, B				Wang, C. Jason; Conroy, Kathleen N.; Zuckerman, Barry			Payment Reform for Safety-Net Institutions -- Improving Quality and Outcomes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, C. Jason; Conroy, Kathleen N.; Zuckerman, Barry] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Wang, C. Jason; Conroy, Kathleen N.; Zuckerman, Barry] Boston Univ, Sch Med, Boston, MA 02118 USA; [Wang, C. Jason; Zuckerman, Barry] Boston Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA USA	Boston Medical Center; Boston University; Boston University	Wang, CJ (corresponding author), Boston Med Ctr, Dept Pediat, Boston, MA USA.			Zuckerman, Barry/0000-0002-0044-2592				Fisher E.S., 2008, DISPARITIES HLTH HLT; GAWANDE A, 2009, NEW YORKER      0601; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; Smith LA, 2008, PEDIATRICS, V122, P760, DOI 10.1542/peds.2007-2750; Zuckerman B, 2008, LANCET, V372, P1615, DOI 10.1016/S0140-6736(08)61670-0	5	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1821	1823		10.1056/NEJMp0907656	http://dx.doi.org/10.1056/NEJMp0907656			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19890124				2022-12-28	WOS:000271405800003
J	Tonks, NK				Tonks, Nicholas K.			Pseudophosphatases: Grab and Hold on	CELL			English	Editorial Material							PROTEIN-TYROSINE PHOSPHATASES		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tonks, NK (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu						Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Govindan JA, 2007, CURR BIOL, V17, pR890, DOI 10.1016/j.cub.2007.08.019; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021	9	26	29	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					464	465		10.1016/j.cell.2009.10.008	http://dx.doi.org/10.1016/j.cell.2009.10.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879835	Bronze			2022-12-28	WOS:000271259600011
J	Craig, JC; Simpson, JM; Williams, GJ; Lowe, A; Reynolds, GJ; McTaggart, SJ; Hodson, EM; Carapetis, JR; Cranswick, NE; Smith, G; Irwig, LM; Caldwell, PHY; Hamilton, S; Roy, LP				Craig, Jonathan C.; Simpson, Judy M.; Williams, Gabrielle J.; Lowe, Alison; Reynolds, Graham J.; McTaggart, Steven J.; Hodson, Elisabeth M.; Carapetis, Jonathan R.; Cranswick, Noel E.; Smith, Grahame; Irwig, Les M.; Caldwell, Patrina H. Y.; Hamilton, Sana; Roy, Leslie P.		Prevention Recurrent Urinary Tract	Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY VESICOURETERAL REFLUX; CONTROLLED-TRIAL; RISK-FACTORS; RENAL SCARS; PREVENTION; PYELONEPHRITIS; ASSOCIATION; MULTICENTER; THERAPY; OLD	BACKGROUND Antibiotics are widely administered to children with the intention of preventing urinary tract infection, but adequately powered, placebo-controlled trials regarding efficacy are lacking. This study from four Australian centers examined whether low-dose, continuous oral antibiotic therapy prevents urinary tract infection in predisposed children. METHODS We randomly assigned children under the age of 18 years who had had one or more microbiologically proven urinary tract infections to receive either daily trimethoprim-sulfamethoxazole suspension (as 2 mg of trimethoprim plus 10 mg of sulfamethoxazole per kilogram of body weight) or placebo for 12 months. The primary outcome was microbiologically confirmed symptomatic urinary tract infection. Intention-to-treat analyses were performed with the use of time-to-event data. RESULTS From December 1998 to March 2007, a total of 576 children (of 780 planned) underwent randomization. The median age at entry was 14 months; 64% of the patients were girls, 42% had known vesicoureteral reflux (at least grade III in 53% of these patients), and 71% were enrolled after the first diagnosis of urinary tract infection. During the study, urinary tract infection developed in 36 of 288 patients (13%) in the group receiving trimethoprim-sulfamethoxazole (antibiotic group) and in 55 of 288 patients (19%) in the placebo group (hazard ratio in the antibiotic group, 0.61; 95% confidence interval, 0.40 to 0.93; P = 0.02 by the log-rank test). In the antibiotic group, the reduction in the absolute risk of urinary tract infection (6 percentage points) appeared to be consistent across all subgroups of patients (P >= 0.20 for all interactions). CONCLUSIONS Long-term, low-dose trimethoprim-sulfamethoxazole was associated with a decreased number of urinary tract infections in predisposed children. The treatment effect appeared to be consistent but modest across subgroups. (Australian New Zealand Clinical Trials Registry number, ACTRN12608000470392.)	[Craig, Jonathan C.; Williams, Gabrielle J.; Lowe, Alison; Hodson, Elisabeth M.; Caldwell, Patrina H. Y.; Hamilton, Sana; Roy, Leslie P.] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW 2145, Australia; [Craig, Jonathan C.; Williams, Gabrielle J.; Irwig, Les M.] Univ Sydney, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Craig, Jonathan C.; Simpson, Judy M.; Hodson, Elisabeth M.; Irwig, Les M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Smith, Grahame] Childrens Hosp Westmead, Dept Urol & Surg, Sydney, NSW 2145, Australia; [Reynolds, Graham J.] Australian Natl Univ, Dept Paediat & Child Hlth, Sch Med, Canberra, ACT, Australia; [McTaggart, Steven J.] Queensland Child & Adolescent Renal Serv, Brisbane, Qld, Australia; [McTaggart, Steven J.] Univ Queensland, Brisbane, Qld, Australia; [Carapetis, Jonathan R.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Cranswick, Noel E.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cranswick, Noel E.] Univ Melbourne, Royal Childrens Hosp, Melbourne, Vic, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Australian National University; University of Queensland; Charles Darwin University; Menzies School of Health Research; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Craig, JC (corresponding author), Childrens Hosp Westmead, Ctr Kidney Res, Locked Bag 4001, Sydney, NSW 2145, Australia.		Carapetis, Jonathan R/H-8933-2014; Craig, Jonathan/E-2813-2013; Caldwell, Patrina/C-4211-2013	Carapetis, Jonathan R/0000-0002-1182-9792; Craig, Jonathan/0000-0002-2548-4035; Smith, Grahame/0000-0002-2911-6520; Caldwell, Patrina/0000-0003-1124-6578; Simpson, Judy M/0000-0001-5172-3004	National Health and Medical Research Council of Australia [990735, 301999, 402764]; Financial Markets Foundation for Children of Australia [058-2003]; Manildra Group	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Financial Markets Foundation for Children of Australia; Manildra Group	Supported by grants from the National Health and Medical Research Council of Australia (990735, 301999, and 402764) and from the Financial Markets Foundation for Children of Australia (058-2003) and by a private donation by J.T. Honan of the Manildra Group.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; *AM AC PED COMM QU, 2000, PEDIATRICS, V105, P141; American Academy of Pediatrics, 1999, PEDIATRICS, V103, P1052; [Anonymous], 1991, J R Coll Physicians Lond, V25, P36; ARANT BS, 1991, AM J KIDNEY DIS, V17, P491, DOI 10.1016/S0272-6386(12)80490-2; Bailey R R, 1973, Clin Nephrol, V1, P132; Bergman DA, 1999, PEDIATRICS, V103, P843; Bergman DA, 1999, PEDIATRICS, V104, P118; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; Coulthard MG, 1997, BMJ-BRIT MED J, V315, P918; Craig JC, 2001, CURR OPIN INFECT DIS, V14, P309, DOI 10.1097/00001432-200106000-00011; Disney APS, 1991, P 2 CJ HODS S REFL N, P53; Elder JS, 1997, J UROLOGY, V157, P1846, DOI 10.1016/S0022-5347(01)64882-1; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; GOLDRAICH NP, 1989, PEDIATR NEPHROL, V3, P1, DOI 10.1007/BF00859614; Hellerstein S, 1995, PEDIATR CLIN N AM, V42, P1433; HELLSTROM A, 1991, ARCH DIS CHILD, V66, P232, DOI 10.1136/adc.66.2.232; Hoberman A, 1999, PEDIATR INFECT DIS J, V18, P1020, DOI 10.1097/00006454-199911000-00018; Hodson EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001532.pub3; JONES KV, 1990, ARCH DIS CHILD, V65, P327, DOI 10.1136/adc.65.3.327; Keren R, 2007, CURR OPIN PEDIATR, V19, P705, DOI 10.1097/MOP.0b013e3282f1dcd7; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; LOHR JA, 1977, PEDIATRICS, V59, P562; Montini G, 2008, PEDIATRICS, V122, P1064, DOI 10.1542/peds.2007-3770; Myers MW, 1997, BRIT J CLIN PHARMACO, V43, P446, DOI 10.1046/j.1365-2125.1997.00584.x; Panaretto KS, 1999, J PAEDIATR CHILD H, V35, P454, DOI 10.1046/j.1440-1754.1999.355417.x; Pennesi M, 2008, PEDIATRICS, V121, pE1489, DOI 10.1542/peds.2007-2652; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Reddy PP, 1997, PEDIATRICS, V100, P555; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; SAVAGE DCL, 1975, LANCET, V1, P358; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; SMELLIE JM, 1978, LANCET, V2, P175; STANSFELD JM, 1975, BRIT MED J, V3, P65, DOI 10.1136/bmj.3.5975.65; *U NC, RAND INT CHILDR VES; Westwood Marie E, 2005, BMC Pediatr, V5, P2, DOI 10.1186/1471-2431-5-2; Williams G, 2009, CURR OPIN INFECT DIS, V22, P72, DOI 10.1097/QCO.0b013e328320a885; WILLIAMS GJ, 2006, COCHRANE DB SYST REV, V3	40	249	260	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1748	1759		10.1056/NEJMoa0902295	http://dx.doi.org/10.1056/NEJMoa0902295			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864673				2022-12-28	WOS:000271185600007
J	Holman, RR; Farmer, AJ; Davies, MJ; Levy, JC; Darbyshire, JL; Keenan, JF; Paul, SK				Holman, Rury R.; Farmer, Andrew J.; Davies, Melanie J.; Levy, Jonathan C.; Darbyshire, Julie L.; Keenan, Joanne F.; Paul, Sanjoy K.		4-T Study Grp	Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN NPH INSULIN; TO-TARGET TRIAL; HYPOGLYCEMIC AGENTS; GLUCOSE CONTROL; BASAL INSULIN; ORAL-THERAPY; GLARGINE; PEOPLE; TREAT; COMPLICATIONS	BACKGROUND Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited. METHODS In this 3-year open-label, multicenter trial, we evaluated 708 patients who had suboptimal glycated hemoglobin levels while taking metformin and sulfonylurea therapy. Patients were randomly assigned to receive biphasic insulin aspart twice daily, prandial insulin aspart three times daily, or basal insulin detemir once daily (twice if required). Sulfonylurea therapy was replaced by a second type of insulin if hyperglycemia became unacceptable during the first year of the study or subsequently if glycated hemoglobin levels were more than 6.5%. Outcome measures were glycated hemoglobin levels, the proportion of patients with a glycated hemoglobin level of 6.5% or less, the rate of hypoglycemia, and weight gain. RESULTS Median glycated hemoglobin levels were similar for patients receiving biphasic (7.1%), prandial (6.8%), and basal (6.9%) insulin-based regimens (P = 0.28). However, fewer patients had a level of 6.5% or less in the biphasic group (31.9%) than in the prandial group (44.7%, P = 0.006) or in the basal group (43.2%, P = 0.03), with 67.7%, 73.6%, and 81.6%, respectively, taking a second type of insulin (P = 0.002). Median rates of hypoglycemia per patient per year were lowest in the basal group (1.7), higher in the biphasic group (3.0), and highest in the prandial group (5.7) (P<0.001 for the overall comparison). The mean weight gain was higher in the prandial group than in either the biphasic group or the basal group. Other adverse event rates were similar in the three groups. CONCLUSIONS Patients who added a basal or prandial insulin-based regimen to oral therapy had better glycated hemoglobin control than patients who added a biphasic insulin-based regimen. Fewer hypoglycemic episodes and less weight gain occurred in patients adding basal insulin. (Current Controlled Trials number, ISRCTN51125379.)	[Holman, Rury R.; Darbyshire, Julie L.; Keenan, Joanne F.; Paul, Sanjoy K.] Univ Oxford, Diabet Trials Unit, Oxford, England; [Holman, Rury R.; Farmer, Andrew J.; Levy, Jonathan C.; Darbyshire, Julie L.; Keenan, Joanne F.; Paul, Sanjoy K.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Farmer, Andrew J.] Univ Oxford, Sch Primary Care Res, Dept Primary Hlth Care, Oxford, England; [Farmer, Andrew J.] Univ Oxford, Sch Primary Care Res, Natl Inst Hlth Res, Oxford, England; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Leicester	Holman, RR (corresponding author), Churchill Hosp Headington, OCDEM, Diabet Trials Unit, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Del Prato, Stefano/K-3405-2016; Darbyshire, Julie/O-7932-2019; Paul, Sanjoy K/F-8199-2010	Del Prato, Stefano/0000-0002-5388-0270; Darbyshire, Julie/0000-0002-7655-1963; Paul, Sanjoy K/0000-0003-0848-7194; Keenan, Joanne/0000-0003-2558-6688; Hills, Robert/0000-0003-0166-0062; Jaap, Alan/0000-0001-8289-704X; Davies, Melanie/0000-0002-9987-9371; Levy, Jonathan/0000-0002-9486-1885; stratton, irene/0000-0003-1172-7865	Novo Nordisk; Diabetes UK; MRC [MC_U137686861, G0800808] Funding Source: UKRI; Medical Research Council [G0800808, MC_U137686861] Funding Source: researchfish	Novo Nordisk(Novo Nordisk); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Novo Nordisk and Diabetes UK.	Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Bretzel RG, 2008, LANCET, V372, P718; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; Calvert MJ, 2007, FAM PRACT, V24, P224, DOI 10.1093/fampra/cmm008; Davies M, 2008, DIABETES OBES METAB, V10, P387, DOI 10.1111/j.1463-1326.2008.00873.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hermansen K, 2007, DIABETES CARE, V30, P1035; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jones GC, 2003, BMJ-BRIT MED J, V326, P4, DOI 10.1136/bmj.326.7379.4; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Lasserson DS, 2009, DIABETOLOGIA, V52, P1990, DOI 10.1007/s00125-009-1468-7; McMahon GT, 2007, NEW ENGL J MED, V357, P1759, DOI 10.1056/NEJMe078196; Moritz T, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc096250; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; Siebenhofer A, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/1465158.CD003287.PUB4; TURNBULL FM, 2009, DIABETOLOGIA    0805; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; *WORLD MED ASS, 2000, DECL HELS ETH PRINC; Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0	31	481	506	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1736	1747		10.1056/NEJMoa0905479	http://dx.doi.org/10.1056/NEJMoa0905479			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19850703	Green Published			2022-12-28	WOS:000271185600006
J	Maslowski, KM; Vieira, AT; Ng, A; Kranich, J; Sierro, F; Yu, D; Schilter, HC; Rolph, MS; Mackay, F; Artis, D; Xavier, RJ; Teixeira, MM; Mackay, CR				Maslowski, Kendle M.; Vieira, Angelica T.; Ng, Aylwin; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Fabienne; Artis, David; Xavier, Ramnik J.; Teixeira, Mauro M.; Mackay, Charles R.			Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43	NATURE			English	Article							CHAIN FATTY-ACIDS; DISTAL ULCERATIVE-COLITIS; NF-KAPPA-B; FUNCTIONAL-CHARACTERIZATION; INTESTINAL MICROBIOTA; BOWEL-DISEASE; MICE; EOSINOPHILS; IRRIGATION; INHIBITION	The immune system responds to pathogens by a variety of pattern recognition molecules such as the Toll-like receptors (TLRs), which promote recognition of dangerous foreign pathogens. However, recent evidence indicates that normal intestinal microbiota might also positively influence immune responses, and protect against the development of inflammatory diseases(1,2). One of these elements may be short-chain fatty acids (SCFAs), which are produced by fermentation of dietary fibre by intestinal microbiota. A feature of human ulcerative colitis and other colitic diseases is a change in 'healthy' microbiota such as Bifidobacterium and Bacteriodes(3), and a concurrent reduction in SCFAs4. Moreover, increased intake of fermentable dietary fibre, or SCFAs, seems to be clinically beneficial in the treatment of colitis(5-9). SCFAs bind the G-protein-coupled receptor 43 (GPR43, also known as FFAR2)(10,11), and here we show that SCFA-GPR43 interactions profoundly affect inflammatory responses. Stimulation of GPR43 by SCFAs was necessary for the normal resolution of certain inflammatory responses, because GPR43-deficient (Gpr43(-/-)) mice showed exacerbated or unresolving inflammation in models of colitis, arthritis and asthma. This seemed to relate to increased production of inflammatory mediators by Gpr43(-/-) immune cells, and increased immune cell recruitment. Germ-free mice, which are devoid of bacteria and express little or no SCFAs, showed a similar dysregulation of certain inflammatory responses. GPR43 binding of SCFAs potentially provides a molecular link between diet, gastrointestinal bacterial metabolism, and immune and inflammatory responses.	[Maslowski, Kendle M.; Vieira, Angelica T.; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Fabienne; Mackay, Charles R.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Maslowski, Kendle M.; Kranich, Jan; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Charles R.] Cooperat Res Ctr Asthma & Airways, Camperdown, NSW 2050, Australia; [Maslowski, Kendle M.; Schilter, Heidi C.; Mackay, Charles R.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Vieira, Angelica T.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Ng, Aylwin; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Mackay, Fabienne; Mackay, Charles R.] Monash Univ, Fac Med, Clayton, Vic 3800, Australia; [Artis, David] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Xavier, Ramnik J.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Univ, Cambridge, MA 02142 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Universidade Federal de Minas Gerais; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Monash University; University of Pennsylvania; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Mackay, CR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	charles.mackay@med.monash.edu.au	Eckhardt, Erik/G-1567-2010; Sierro, Frederic/B-9742-2009; Mackay, Charles R/A-9673-2008; Maslowski, Kendle M/R-9331-2018; Mackay, Fabienne/B-7440-2008; Teixeira, Mauro M/A-4587-2008; Ng, Aylwin/AAQ-6478-2020; Vieira, Angelica T/A-6227-2015; Yu, Di/C-2163-2009	Sierro, Frederic/0000-0001-5004-8414; Mackay, Charles R/0000-0002-6338-7340; Maslowski, Kendle M/0000-0003-1995-5424; Mackay, Fabienne/0000-0002-6074-2693; Teixeira, Mauro M/0000-0002-6944-3008; Vieira, Angelica T/0000-0002-4556-7671; Yu, Di/0000-0003-1721-8922; Artis, David/0000-0002-1753-4100; Kranich, Jan/0000-0002-9928-4132; Schilter, Heidi/0000-0003-3709-1631	Australian NHMRC; CRC for Asthma and Airways; Crohn's and Colitis Foundation of America; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R01AI061570, R01AI095466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CRC for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Crohn's and Colitis Foundation of America; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P. Silvera and S. Tangye for supply of certain Genechip data sets, L. Tsai for help with heatmaps, and D. Kobuley, J. Nicoli and M. Abt for help in the germ-free animal facilities. K. M. M. and C. R. M. are supported by the Australian NHMRC, and the CRC for Asthma and Airways. A. N. is a recipient of a Fellowship award from the Crohn's and Colitis Foundation of America. F. S. and D. Y. are Cancer Institute NSW Fellows.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BREUER RI, 1991, DIGEST DIS SCI, V36, P185, DOI 10.1007/BF01300754; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; COOPER HS, 1993, LAB INVEST, V69, P238; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kanauchi O, 2002, J GASTROENTEROL, V37, P67, DOI 10.1007/BF03326417; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Luhrs H, 2002, ANTICANCER RES, V22, P1561; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; MORLAND B, 1984, INFECT IMMUN, V44, P750; POMARE EW, 1985, J CLIN INVEST, V75, P1448, DOI 10.1172/JCI111847; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scheppach W, 1996, DIGEST DIS SCI, V41, P2254, DOI 10.1007/BF02071409; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shreiner A, 2008, ADV EXP MED BIOL, V635, P113, DOI 10.1007/978-0-387-09550-9_10; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; TREEM WR, 1994, J PEDIATR GASTR NUTR, V18, P159, DOI 10.1097/00005176-199402000-00007; VERNIA P, 1995, ALIMENT PHARM THERAP, V9, P309; Vieira AT, 2005, BRIT J PHARMACOL, V146, P244, DOI 10.1038/sj.bjp.0706321; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720	44	1977	2084	21	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1282	U119		10.1038/nature08530	http://dx.doi.org/10.1038/nature08530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865172	Green Accepted			2022-12-28	WOS:000271190800049
J	Schwartz, LM; Woloshin, S				Schwartz, Lisa M.; Woloshin, Steven			Lost in Transmission - FDA Drug Information That Never Reaches Clinicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIALS		[Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; VA Med Ctr, VA Outcomes Grp, White River Jct, VT USA	Dartmouth College; VA Outcomes Group	Schwartz, LM (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA.							*DRUGS FDA, APPR HIST NDA 021223; *DRUGS FDA, APPR HIST NDA 021782; *DRUGS FDA, APPR HIST NDA 021476; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106	5	33	33	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1717	1720		10.1056/NEJMp0907708	http://dx.doi.org/10.1056/NEJMp0907708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511RY	19846841				2022-12-28	WOS:000271185600001
J	Shipton, D; Tappin, DM; Vadiveloo, T; Crossley, JA; Aitken, DA; Chalmers, J				Shipton, Deborah; Tappin, David M.; Vadiveloo, Thenmalar; Crossley, Jennifer A.; Aitken, David A.; Chalmers, Jim			Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE-SMOKING; SERUM COTININE; EXPOSURE; SMOKERS; CESSATION; NICOTINE	Objective To determine what impact reliance on self reported smoking status during pregnancy has on both the accuracy of smoking prevalence figures and access to smoking cessation services for pregnant women in Scotland. Design Retrospective, cross sectional study of cotinine measurements in stored blood samples. Participants Random sample (n=3475) of the 21 029 pregnant women in the West of Scotland who opted for second trimester prenatal screening over a one year period. Main outcome measure Smoking status validated with cotinine measurement by maternal area deprivation category ( Scottish Index of Multiple Deprivation). Results Reliance on self reported smoking status underestimated true smoking by 25% (1046/3475 (30%) from cotinine measurement v 839/3475 (24%) from self reporting, z score 8.27, P<0.001). Projected figures suggest that in Scotland more than 2400 pregnant smokers go undetected each year. A greater proportion of smokers in the least deprived areas ( deprivation categories 1+2) did not report their smoking (39%) compared with women in the most deprived areas (22% in deprivation categories 4+5), but, because smoking was far more common in the most deprived areas (706(40%) in deprived areas compared with 142 (14%) in affluent areas), projected figures for Scotland suggest that twice as many women in the most deprived areas are undetected (n=1196) than in the least deprived areas (n=642). Conclusion Reliance on self reporting to identify pregnant smokers significantly underestimates the number of pregnant smokers in Scotland and results in a failure to detect over 2400 smokers each year who are therefore not offered smoking cessation services.	[Tappin, David M.] Univ Glasgow, Yorkhill Hosp, PEACH Unit, Glasgow G3 8SJ, Lanark, Scotland; [Vadiveloo, Thenmalar; Crossley, Jennifer A.; Aitken, David A.] Yorkhill Hosp, Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; [Chalmers, Jim] NHS Natl Serv Scotland, ISD, Edinburgh EH12 9EB, Midlothian, Scotland	University of Glasgow; University of Glasgow; NHS National Services Scotland	Tappin, DM (corresponding author), Univ Glasgow, Yorkhill Hosp, PEACH Unit, Glasgow G3 8SJ, Lanark, Scotland.	goda11@udcf.gla.ac.uk		Vadiveloo, Thenmalar/0000-0001-5531-6289	Glasgow Centre for Population Health	Glasgow Centre for Population Health	This was provided by a Glasgow Centre for Population Health Grant. All authors are independent of the funding body.	AITKEN DA, 2007, PRINCIPLES PRACTICE, P636; Boyd N R, 1998, Matern Child Health J, V2, P77, DOI 10.1023/A:1022936705438; Bryce A, 2009, MIDWIFERY, V25, P473, DOI 10.1016/j.midw.2007.10.006; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; CORBET J, 2006, SCOTLANDS PEOPLE RES; D'Souza L, 2004, CHILD CARE HLTH DEV, V30, P599, DOI 10.1111/j.1365-2214.2004.00471.x; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; *DEP HLTH, 1998, CM4177; *DEP HLTH, 2009, TACKL HLTH IN TARG R; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Ford RPK, 1997, J EPIDEMIOL COMMUN H, V51, P246, DOI 10.1136/jech.51.3.246; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Giovino GA, 2007, AM J PREV MED, V33, pS318, DOI 10.1016/j.amepre.2007.09.008; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; *INF SERV DIV NHS, 2009, BIRTHS BAB BIRTHW GE; Information Services Division NHS National Services Scotland, 2009, BIRTHS BAB SMOK PREG; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; JARVIS MJ, 1992, BRIT J ADDICT, V87, P111; Kendall R.A., 1993, CONTEMP MUSIC REV, V9, P51, DOI DOI 10.1080/07494469300640341; KENDRICK JS, 1995, AM J PUBLIC HEALTH, V85, P217, DOI 10.2105/AJPH.85.2.217; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Lindqvist R, 2002, ACTA OBSTET GYN SCAN, V81, P240; LUMLEY J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001055.PUB2; McDonald SD, 2005, ADDICT BEHAV, V30, P853, DOI 10.1016/j.addbeh.2004.08.016; MCGOWAN A, 2008, MIDWIFERY       0807; *NHS HLTH SCOTL, 2008, SMOK CESS SUPP PREGN; O'Gorman C, 2008, BRIT MED J, V336, P330, DOI 10.1136/bmj.39479.677188.BD; Owen L, 2001, ADDICTION, V96, P1001, DOI 10.1046/j.1360-0443.2001.96710019.x; Parna K, 2005, MATERN CHILD HLTH J, V9, P385, DOI 10.1007/s10995-005-0022-6; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; *SCI ADV COMM NUTR, 2009, INF FEED SURV 2005 C; *SCOTT GOV, 2003, NHS NAT TARG REL NHS; Tappin DM, 2005, BMJ-BRIT MED J, V331, P373, DOI 10.1136/bmj.331.7513.373; Usmani ZC, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-4; Webb David A, 2003, J Public Health Manag Pract, V9, P322; WINDSOR RA, 1993, AM J PUBLIC HEALTH, V83, P201, DOI 10.2105/AJPH.83.2.201	37	249	250	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2009	339								b4347	10.1136/bmj.b4347	http://dx.doi.org/10.1136/bmj.b4347			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AO	19875845	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000271365900007
J	Bramwell, ST; Giblin, SR; Calder, S; Aldus, R; Prabhakaran, D; Fennell, T				Bramwell, S. T.; Giblin, S. R.; Calder, S.; Aldus, R.; Prabhakaran, D.; Fennell, T.			Measurement of the charge and current of magnetic monopoles in spin ice	NATURE			English	Article							WIEN DISSOCIATION; FRUSTRATION; LATTICE	The transport of electrically charged quasiparticles (based on electrons or ions) plays a pivotal role in modern technology as well as in determining the essential functions of biological organisms. In contrast, the transport of magnetic charges has barely been explored experimentally, mainly because magnetic charges, in contrast to electric ones, are generally considered at best to be convenient macroscopic parameters(1,2), rather than well-defined quasiparticles. However, it was recently proposed that magnetic charges can exist in certain materials in the form of emergent excitations that manifest like point charges, or magnetic monopoles(3). Here we address the question of whether such magnetic charges and their associated currents-'magnetricity'-can be measured directly in experiment, without recourse to any material-specific theory. By mapping the problem onto Onsager's theory of electrolytes(4), we show that this is indeed possible, and devise an appropriate method for the measurement of magnetic charges and their dynamics. Using muon spin rotation as a suitable local probe, we apply the method to a real material, the 'spin ice' Dy(2)Ti(2)O(7) (refs 5-8). Our experimental measurements prove that magnetic charges exist in this material, interact via a Coulomb potential, and have measurable currents. We further characterize deviations from Ohm's law, and determine the elementary unit of magnetic charge to be 5 mu(B) angstrom(-1), which is equal to that recently predicted using the microscopic theory of spin ice(3). Our measurement of magnetic charge and magnetic current establishes an instance of a perfect symmetry between electricity and magnetism.	[Bramwell, S. T.; Calder, S.; Aldus, R.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Bramwell, S. T.; Calder, S.; Aldus, R.] UCL, Dept Phys & Astron, London WC1H 0AH, England; [Giblin, S. R.] Rutherford Appleton Lab, ISIS Facil, Chilton OX11 0QX, Oxon, England; [Prabhakaran, D.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Fennell, T.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	University of London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; Institut Laue-Langevin (ILL)	Bramwell, ST (corresponding author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.	s.t.bramwell@ucl.ac.uk	Fennell, Tom/D-1912-2014	Fennell, Tom/0000-0002-0063-7517; Giblin, Sean/0000-0003-1876-8619; Calder, Stuart/0000-0001-8402-3741	Engineering and Physical Sciences Research Council [EP/C534654/1] Funding Source: researchfish; EPSRC [EP/C534654/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BASS L, 1968, T FARADAY SOC, V64, P2153, DOI 10.1039/tf9686402153; Bertin E, 2002, EUR PHYS J B, V27, P347, DOI 10.1140/epjb/e2002-00165-2; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Bramwell ST, 1998, J PHYS-CONDENS MAT, V10, pL215, DOI 10.1088/0953-8984/10/14/002; Burnell FJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144432; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; den Hertog BC, 2000, PHYS REV LETT, V84, P3430, DOI 10.1103/PhysRevLett.84.3430; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; FENNELL T, 2009, SCIENCE         0826, DOI DOI 10.1126/SCIENCE.1177582; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Hermele M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064404; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Jaubert LDC, 2009, NAT PHYS, V5, P258, DOI 10.1038/NPHYS1227; KADOWAKI H, 2009, OBSERVATION MAGNETIC; Keren A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107204; Lago J, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/326210; Lee SH, 2002, NATURE, V418, P856, DOI 10.1038/nature00964; MASON DP, 1978, P ROY SOC LOND A MAT, V359, P303, DOI 10.1098/rspa.1978.0044; Moessner R, 1998, PHYS REV LETT, V80, P2929, DOI 10.1103/PhysRevLett.80.2929; Moore W.J, 1978, PHYS CHEM; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Morrish A. H., 1965, PHYS PRINCIPLES MAGN; Onsager L, 1934, J CHEM PHYS, V2, DOI 10.1063/1.1749541; Orendac M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104425; Preskill J, 1984, ANNU REV NUCL PART S, V34, P461, DOI 10.1146/annurev.ns.34.120184.002333; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Ryzhkin IA, 2005, J EXP THEOR PHYS+, V101, P481, DOI 10.1134/1.2103216; Snyder J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064414; Uemura Y. J., 1998, MUON SCI MUONS PHYS, P85; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447	30	267	268	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	2009	461	7266					956	U211		10.1038/nature08500	http://dx.doi.org/10.1038/nature08500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829376	Green Submitted			2022-12-28	WOS:000270817700041
J	Diaz, C; Pijper, E; Olsen, RA; Busnengo, HF; Auerbach, DJ; Kroes, GJ				Diaz, C.; Pijper, E.; Olsen, R. A.; Busnengo, H. F.; Auerbach, D. J.; Kroes, G. J.			Chemically Accurate Simulation of a Prototypical Surface Reaction: H-2 Dissociation on Cu(111)	SCIENCE			English	Article							6-DIMENSIONAL QUANTUM DYNAMICS; POTENTIAL-ENERGY SURFACE; METAL-SURFACES; ADSORPTION; SCATTERING; CU(100); APPROXIMATION; FUNCTIONALS; MOLECULES; CHEMISTRY	Methods for accurately computing the interaction of molecules with metal surfaces are critical to understanding and thereby improving heterogeneous catalysis. We introduce an implementation of the specific reaction parameter (SRP) approach to density functional theory (DFT) that carries the method forward from a semiquantitative to a quantitative description of the molecule-surface interaction. Dynamics calculations on reactive scattering of hydrogen from the copper (111) surface using an SRP-DFT potential energy surface reproduce data on the dissociative adsorption probability as a function of incidence energy and reactant state and data on rotationally inelastic scattering with chemical accuracy (within similar to 4.2 kilojoules per mole).	[Diaz, C.; Pijper, E.; Olsen, R. A.; Kroes, G. J.] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands; [Busnengo, H. F.] Univ Nacl Rosario, CONICET, Inst Fis Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Auerbach, D. J.] GRT, Santa Barbara, CA 93111 USA; [Auerbach, D. J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	Leiden University; Leiden University - Excl LUMC; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of California System; University of California Santa Barbara	Kroes, GJ (corresponding author), Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, POB 9502, NL-2300 RA Leiden, Netherlands.	g.j.kroes@chem.leidenuniv.nl	Busnengo, Heriberto/C-3772-2011; Blanco, Cristina Díaz/D-4532-2012; Auerbach, Daniel J/J-7109-2014	Blanco, Cristina Díaz/0000-0002-9318-5846; Auerbach, Daniel J/0000-0001-9494-3066	NCF; CW/NWO PIONIER; MICIIN (Spain); DGI [FIS2007-60064]	NCF; CW/NWO PIONIER; MICIIN (Spain)(Spanish Government); DGI	This research was supported by a Dutch Computing Challenge Project from NCF, a CW/NWO PIONIER-grant, a Juan de la Cierva fellowship from MICIIN (Spain) and DGI Project N. FIS2007-60064. We thank K. D. Rendulic, A. Winkler, A. Hodgson, G. O. Sitz, L. B. F. Juurlink, A. C. Luntz, F. Martin, A. W. Kleyn, and D. G. Truhlar for useful discussions.	BERGER HF, 1990, CHEM PHYS LETT, V175, P425, DOI 10.1016/0009-2614(90)85558-T; Carbogno C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096104; Chuang YY, 1999, J PHYS CHEM A, V103, P4893, DOI 10.1021/jp990969d; Clary DC, 2008, SCIENCE, V321, P789, DOI 10.1126/science.1157718; Dai JQ, 1997, J CHEM PHYS, V107, P1676, DOI 10.1063/1.474520; Dai JQ, 1998, J CHEM PHYS, V108, P7816, DOI 10.1063/1.476217; ERTL G, 1983, J VAC SCI TECHNOL A, V1, P1247, DOI 10.1116/1.572299; Filippi C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.166102; Groot IMN, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2813413; Gross A, 1998, SURF SCI REP, V32, P291, DOI 10.1016/S0167-5729(98)00008-9; Gross A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206107; Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413; HAMMER B, 1994, PHYS REV LETT, V73, P1400, DOI 10.1103/PhysRevLett.73.1400; Hodgson A, 1997, PHYS REV LETT, V78, P963, DOI 10.1103/PhysRevLett.78.963; HODGSON A, 1992, NATURE, V356, P501, DOI 10.1038/356501a0; HODGSON A, COMMUNICATION; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Hou H, 1997, SCIENCE, V277, P80, DOI 10.1126/science.277.5322.80; Janesko BG, 2009, PHYS CHEM CHEM PHYS, V11, P443, DOI 10.1039/b812838c; Kroes GJ, 2008, SCIENCE, V321, P794, DOI 10.1126/science.1157717; Kroes GJ, 2005, J THEOR COMPUT CHEM, V4, P493, DOI 10.1142/S0219633605001647; Luntz AC, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2000249; MICHELSEN HA, 1993, J CHEM PHYS, V98, P8294, DOI 10.1063/1.464535; Mosch C, 2008, J PHYS CHEM C, V112, P6924, DOI 10.1021/jp711991b; Nave S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173003; Nieto P, 2006, SCIENCE, V312, P86, DOI 10.1126/science.1123057; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; RETTNER CT, 1995, J CHEM PHYS, V102, P4625, DOI 10.1063/1.469511; RETTNER CT, 1993, CHEM PHYS, V175, P157, DOI 10.1016/0301-0104(93)80235-2; RETTNER CT, 1993, FARADAY DISCUSS, V96, P17, DOI 10.1039/fd9939600017; Shenvi N, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357740; Somers MF, 2004, J CHEM PHYS, V121, P11379, DOI 10.1063/1.1812743; Somers MF, 2002, CHEM PHYS LETT, V360, P390, DOI 10.1016/S0009-2614(02)00869-2; Stroppa A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063020; Watts E, 2001, J CHEM PHYS, V114, P4171, DOI 10.1063/1.1344233; WHITE JA, 1994, PHYS REV LETT, V73, P1404, DOI 10.1103/PhysRevLett.73.1404; Wodtke AM, 2004, INT REV PHYS CHEM, V23, P513, DOI 10.1080/01442350500037521; Zheng JJ, 2009, J CHEM THEORY COMPUT, V5, P808, DOI 10.1021/ct800568m	38	268	270	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					832	834		10.1126/science.1178722	http://dx.doi.org/10.1126/science.1178722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892978				2022-12-28	WOS:000271468000038
J	Dise, NB				Dise, Nancy B.			Peatland Response to Global Change	SCIENCE			English	Editorial Material							CARBON; GROWTH		Manchester Metropolitan Univ, Dept Geog & Environm Sci, Manchester M1 5GD, Lancs, England	Manchester Metropolitan University	Dise, NB (corresponding author), Manchester Metropolitan Univ, Dept Geog & Environm Sci, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England.	n.dise@mmu.ac.uk			NERC [NE/G002363/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002363/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Bridgham SD, 2008, ECOLOGY, V89, P3041, DOI 10.1890/08-0279.1; Frolking S, 2007, GLOBAL CHANGE BIOL, V13, P1079, DOI 10.1111/j.1365-2486.2007.01339.x; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Solomon S., 2007, PHYS SCI BASIS WORKI; Strack M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002715; SVENSSON G, 1988, BOREAS, V17, P89; Tomassen HBM, 2003, J ECOL, V91, P357, DOI 10.1046/j.1365-2745.2003.00771.x; Turetsky MR, 2007, GLOBAL CHANGE BIOL, V13, P1922, DOI 10.1111/j.1365-2486.2007.01381.x	11	225	235	13	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					810	811		10.1126/science.1174268	http://dx.doi.org/10.1126/science.1174268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892972				2022-12-28	WOS:000271468000030
J	Achard, C; Courtillot, C; Lahuna, O; Meduri, G; Soufir, JC; Liere, P; Bachelot, A; Benyounes, H; Schumacher, M; Kuttenn, F; Touraine, P; Misrahi, M				Achard, Caroline; Courtillot, Carine; Lahuna, Olivier; Meduri, Geri; Soufir, Jean-Claude; Liere, Philippe; Bachelot, Anne; Benyounes, Hassani; Schumacher, Michael; Kuttenn, Frederique; Touraine, Philippe; Misrahi, Micheline			Brief Report: Normal Spermatogenesis in a Man with Mutant Luteinizing Hormone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLICLE-STIMULATING-HORMONE; MALE CONTRACEPTION; BETA-SUBUNIT; HYPOGONADISM; TESTOSTERONE; GONADOTROPIN; MEN; SUFFICIENT; INSIGHTS; MUTATION	Men with mutations in LHB, the gene encoding the beta subunit of luteinizing hormone (LHB), have azoospermia with absent or few fetal Leydig cells. We report a mutation in LHB in a man and his sister. The man presented with absence of virilization, undetectable luteinizing hormone, and a low serum testosterone level. He had complete spermatogenesis with a normal sperm count. The mutant luteinizing hormone had a low level of partial activity in vitro. We concluded that the residual luteinizing hormone activity, resulting in the expression of steroidogenic enzymes in few mature Leydig cells producing small amounts of intratesticular testosterone (20.2 ng per gram), was sufficient for complete and quantitatively normal spermatogenesis.	[Misrahi, Micheline] Hop Bicetre, AP HP, Lab Mol Genet Pharmacol & Hormonol, INSERM,U854, F-94275 Le Kremlin Bicetre, France; [Soufir, Jean-Claude] Hop Bicetre, Lab Biol Androl, F-94275 Le Kremlin Bicetre, France; [Liere, Philippe; Schumacher, Michael] Hop Bicetre, INSERM, U788, F-94275 Le Kremlin Bicetre, France; [Achard, Caroline; Lahuna, Olivier; Misrahi, Micheline] Univ Paris S 11, INSERM, Bicetre Hosp, U854, Le Kremlin Bicetre, France; [Courtillot, Carine; Bachelot, Anne; Kuttenn, Frederique; Touraine, Philippe] Univ Paris 06, Dept Endocrinol & Reprod Med, Pitie Salpetriere Hosp, Paris, France; [Courtillot, Carine; Bachelot, Anne; Kuttenn, Frederique; Touraine, Philippe] Ctr Malad Endocriniennes Rares Croissance, Paris, France; [Lahuna, Olivier; Soufir, Jean-Claude; Misrahi, Micheline] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Misrahi, M (corresponding author), Hop Bicetre, AP HP, Lab Mol Genet Pharmacol & Hormonol, INSERM,U854, F-94275 Le Kremlin Bicetre, France.	micheline.misrahi@bct.aphp.fr	Schumacher, Michael/G-3581-2013; lahuna, olivier/O-7840-2017; Bachelot, Anne/GQZ-0551-2022	Schumacher, Michael/0000-0001-6117-5371; lahuna, olivier/0000-0002-6286-3923; 	INSERM; Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris; French Ministry of Health (DHOS)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris; French Ministry of Health (DHOS)	Supported by grants from INSERM, the Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris, and the French Ministry of Health (DHOS).	Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bougneres P, 2008, J CLIN ENDOCR METAB, V93, P2202, DOI 10.1210/jc.2008-0121; Coviello AD, 2004, J ANDROL, V25, P931; DALY AF, 2006, ANN M END SOC BOST J; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Huhtaniemi IT, 2005, ENDOCRINE, V26, P207, DOI 10.1385/ENDO:26:3:207; Kamischke A, 2004, TRENDS PHARMACOL SCI, V25, P49, DOI 10.1016/j.tips.2003.11.009; Lewis G, 2009, EUR J WOMENS STUD, V16, P5, DOI 10.1177/1350506808098531; Lofrano-Porto A, 2007, NEW ENGL J MED, V357, P897, DOI 10.1056/NEJMoa071999; Lombardo F, 2005, J Endocrinol Invest, V28, P51; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; McLachlan RI, 2002, J ANDROL, V23, P149; Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Page ST, 2008, ENDOCR REV, V29, P465, DOI 10.1210/er.2007-0041; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Valdes-Socin H, 2004, NEW ENGL J MED, V351, P2619, DOI 10.1056/NEJMoa040326; Valdes-Socin H, 2009, J CLIN ENDOCR METAB, V94, P3, DOI 10.1210/jc.2008-1584; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Wu XF, 2007, J CELL PHYSIOL, V213, P429, DOI 10.1002/jcp.21231; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100	24	41	44	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1856	1863		10.1056/NEJMoa0805792	http://dx.doi.org/10.1056/NEJMoa0805792			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890128				2022-12-28	WOS:000271405800010
J	Hensley, SE; Das, SR; Bailey, AL; Schmidt, LM; Hickman, HD; Jayaraman, A; Viswanathan, K; Raman, R; Sasisekharan, R; Bennink, JR; Yewdell, JW				Hensley, Scott E.; Das, Suman R.; Bailey, Adam L.; Schmidt, Loren M.; Hickman, Heather D.; Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram; Bennink, Jack R.; Yewdell, Jonathan W.			Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift	SCIENCE			English	Article							VARIANTS; NEUTRALIZATION; RECOGNITION; ANTIBODIES	Rapid antigenic evolution in the influenza A virus hemagglutinin precludes effective vaccination with existing vaccines. To understand this phenomenon, we passaged virus in mice immunized with influenza vaccine. Neutralizing antibodies selected mutants with single-amino acid hemagglutinin substitutions that increased virus binding to cell surface glycan receptors. Passaging these high-avidity binding mutants in naive mice, but not immune mice, selected for additional hemagglutinin substitutions that decreased cellular receptor binding avidity. Analyzing a panel of monoclonal antibody hemagglutinin escape mutants revealed a positive correlation between receptor binding avidity and escape from polyclonal antibodies. We propose that in response to variation in neutralizing antibody pressure between individuals, influenza A virus evolves by adjusting receptor binding avidity via amino acid substitutions throughout the hemagglutinin globular domain, many of which simultaneously alter antigenicity.	[Hensley, Scott E.; Das, Suman R.; Bailey, Adam L.; Schmidt, Loren M.; Hickman, Heather D.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@mail.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020; Das, Suman R/C-8760-2009	Das, Suman/0000-0003-2496-9724; Hickman, Heather/0000-0003-4168-4894	Division of Intramural Research, NIAID; Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; National Institute of General Medical Sciences [GM 57073, U54 GM62116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001014, ZIAAI001014, ZIAAI001055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the National Institute of Allergy and Infectious Diseases (NIAID) Comparative Medical Branch for assistance with animal studies, G. Reynoso for technical assistance, the Consortium for Functional Glycomics for glycan standards, and S. Epstein (U. S. Food and Drug Administration) for insightful reading of the manuscript. This work was supported by Division of Intramural Research, NIAID (J.R.B. and J.W.Y.), the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (R. S.), and the National Institute of General Medical Sciences (GM 57073 and U54 GM62116) (R. S.).	Air G M, 1987, Contrib Microbiol Immunol, V8, P20; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; DESTGROTH SF, 1977, TOPICS INFECTIOUS DI, V3, P25; DIMMOCK NJ, 1984, J GEN VIROL, V65, P1015, DOI 10.1099/0022-1317-65-6-1015; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; GERBER P, 1955, J EXP MED, V101, P627, DOI 10.1084/jem.101.6.627; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; UNDERWOOD PA, 1987, J VIROL, V61, P206, DOI 10.1128/JVI.61.1.206-208.1987; WANG ML, 1986, J VIROL, V57, P124, DOI 10.1128/JVI.57.1.124-128.1986; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986; YEWDELL JW, 1979, NATURE, V279, P246, DOI 10.1038/279246a0	18	340	356	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					734	736		10.1126/science.1178258	http://dx.doi.org/10.1126/science.1178258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900932	Green Published, Green Accepted			2022-12-28	WOS:000271233200039
J	Logvenov, G; Gozar, A; Bozovic, I				Logvenov, G.; Gozar, A.; Bozovic, I.			High-Temperature Superconductivity in a Single Copper-Oxygen Plane	SCIENCE			English	Article							2-DIMENSIONAL SYSTEMS; OXIDES; FILMS; SUPERLATTICES; HETEROSTRUCTURES; INTERFACE; PHYSICS; PHASE	The question of how thin cuprate layers can be while still retaining high-temperature superconductivity (HTS) has been challenging to address, in part because experimental studies require the synthesis of near-perfect ultrathin HTS layers and ways to profile the superconducting properties such as the critical temperature and the superfluid density across interfaces with atomic resolution. We used atomic-layer molecular beam epitaxy to synthesize bilayers of a cuprate metal (La1.65Sr0.45CuO4) and a cuprate insulator (La2CuO4) in which each layer is just three unit cells thick. We selectively doped layers with isovalent Zn atoms, which suppress superconductivity and act as markers, to show that this interface HTS occurs within a single CuO2 plane. This approach may also be useful in fabricating HTS devices.	[Logvenov, G.; Gozar, A.; Bozovic, I.] Brookhaven Natl Lab, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.	bozovic@bnl.gov			U. S. Department of Energy [MA-509-MACA]	U. S. Department of Energy(United States Department of Energy (DOE))	We thank V. L. Ginzburg, D. Schlom, B. Halperin, and S. Kivelson for useful discussions. Supported by the U. S. Department of Energy under contract MA-509-MACA.	ALLOUL H, 1991, PHYS REV LETT, V67, P3140, DOI 10.1103/PhysRevLett.67.3140; Basletic M, 2008, NAT MATER, V7, P621, DOI 10.1038/nmat2223; BEREZINSKII VL, 1971, SOV PHYS JETP-USSR, V32, P493; Bernhard C, 1996, PHYS REV LETT, V77, P2304, DOI 10.1103/PhysRevLett.77.2304; BOZOVIC I, 1994, PHYSICA C, V235, P178, DOI 10.1016/0921-4534(94)91342-0; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; BOZOVIC I, 1996, PHYSICAL PROPERTIES, V5, P99; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Calame M, 2001, PHYS REV LETT, V86, P3630, DOI 10.1103/PhysRevLett.86.3630; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; GINZBURG VL, 1989, PHYS SCRIPTA, VT27, P76, DOI 10.1088/0031-8949/1989/T27/011; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Hetel I, 2007, NAT PHYS, V3, P700, DOI 10.1038/nphys707; Karpinska K, 2000, PHYS REV LETT, V84, P155, DOI 10.1103/PhysRevLett.84.155; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; LORAM JW, 1990, PHYSICA C, V171, P243, DOI 10.1016/0921-4534(90)90137-4; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Rufenacht A, 2003, SOLID STATE ELECTRON, V47, P2167, DOI 10.1016/S0038-1101(03)00191-6; Smadici S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107004; SUGIMOTO T, 1991, APPL PHYS LETT, V58, P1103, DOI 10.1063/1.104385; TERASHIMA T, 1991, PHYS REV LETT, V67, P1362, DOI 10.1103/PhysRevLett.67.1362; Triscone JM, 1997, REP PROG PHYS, V60, P1673, DOI 10.1088/0034-4885/60/12/004; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430	27	189	193	4	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					699	702		10.1126/science.1178863	http://dx.doi.org/10.1126/science.1178863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900926				2022-12-28	WOS:000271233200029
J	Shindell, DT; Faluvegi, G; Koch, DM; Schmidt, GA; Unger, N; Bauer, SE				Shindell, Drew T.; Faluvegi, Greg; Koch, Dorothy M.; Schmidt, Gavin A.; Unger, Nadine; Bauer, Susanne E.			Improved Attribution of Climate Forcing to Emissions	SCIENCE			English	Article							TROPOSPHERIC OZONE; AIR-QUALITY; REGIONAL EMISSIONS; AEROSOLS; IMPACT; PREINDUSTRIAL; PRECURSORS; RADIATION; ISSUES; CTM	Evaluating multicomponent climate change mitigation strategies requires knowledge of the diverse direct and indirect effects of emissions. Methane, ozone, and aerosols are linked through atmospheric chemistry so that emissions of a single pollutant can affect several species. We calculated atmospheric composition changes, historical radiative forcing, and forcing per unit of emission due to aerosol and tropospheric ozone precursor emissions in a coupled composition-climate model. We found that gas-aerosol interactions substantially alter the relative importance of the various emissions. In particular, methane emissions have a larger impact than that used in current carbon-trading schemes or in the Kyoto Protocol. Thus, assessments of multigas mitigation policies, as well as any separate efforts to mitigate warming from short-lived pollutants, should include gas-aerosol interactions.	[Shindell, Drew T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Columbia Univ, New York, NY 10025 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University	Shindell, DT (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	drew.t.shindell@nasa.gov	Bauer, Susanne/P-3082-2014; Unger, Nadine/M-9360-2015; Schmidt, Gavin/D-4427-2012; Shindell, Drew/D-4636-2012; Unger, Nadine/AAI-4462-2021	Schmidt, Gavin/0000-0002-2258-0486; Shindell, Drew/0000-0003-1552-4715; Unger, Nadine/0000-0001-7739-2290; Faluvegi, Gregory/0000-0001-9011-3663	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank the NASA Atmospheric Chemistry Modeling and Analysis Program for supporting this work.	Ambrosi P., 2009, STATE TRENDS CARBON; Bauer SE, 2007, ATMOS CHEM PHYS, V7, P5043, DOI 10.5194/acp-7-5043-2007; Berglen TF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003948; Berntsen TK, 2005, TELLUS B, V57, P283, DOI 10.1111/j.1600-0889.2005.00152.x; Bond TC, 2005, ENVIRON SCI TECHNOL, V39, P5921, DOI 10.1021/es0480421; Collins WJ, 2002, CLIMATIC CHANGE, V52, P453, DOI 10.1023/A:1014221225434; Dentener F, 2005, ATMOS CHEM PHYS, V5, P1731, DOI 10.5194/acp-5-1731-2005; Derwent RG, 2001, CLIMATIC CHANGE, V49, P463, DOI 10.1023/A:1010648913655; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Godal O, 2003, CLIMATIC CHANGE, V58, P243, DOI 10.1023/A:1023935918891; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Henze DK, 2009, ATMOS CHEM PHYS, V9, P5877, DOI 10.5194/acp-9-5877-2009; JENSEN J, 2001, WHAT ARE GAINS MULTI; Koch D, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2004JD005550; Kvalevag MM, 2007, J CLIMATE, V20, P4874, DOI 10.1175/JCLI4277.1; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Ming Y, 2009, J CLIMATE, V22, P1329, DOI [10.1175/2008JCLI2362.1, 10.1175/2008JCL12362.1]; Penner JE, 2006, ATMOS CHEM PHYS, V6, P3391, DOI 10.5194/acp-6-3391-2006; Pye HOT, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010701; Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069; Rypdal K, 2005, ENVIRON SCI POLICY, V8, P29, DOI 10.1016/j.envsci.2004.09.003; Shindell D, 2008, ATMOS CHEM PHYS, V8, P7101, DOI 10.5194/acp-8-7101-2008; Shindell DT, 2006, ATMOS CHEM PHYS, V6, P4427, DOI 10.5194/acp-6-4427-2006; Shindell D, 2009, NAT GEOSCI, V2, P294, DOI 10.1038/NGEO473; Shindell DT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021900; Shine KP, 2005, P NATL ACAD SCI USA, V102, P15768, DOI 10.1073/pnas.0506865102; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Tsigaridis K, 2006, ATMOS CHEM PHYS, V6, P5143, DOI 10.5194/acp-6-5143-2006; Unger N, 2006, P NATL ACAD SCI USA, V103, P4377, DOI 10.1073/pnas.0508769103; Wild O, 2001, GEOPHYS RES LETT, V28, P1719, DOI 10.1029/2000GL012573	30	569	593	13	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					716	718		10.1126/science.1174760	http://dx.doi.org/10.1126/science.1174760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900930	Green Published			2022-12-28	WOS:000271233200034
J	Cerf, VG				Cerf, Vinton G.			The day the Internet age began	NATURE			English	Editorial Material									[Cerf, Vinton G.] Google, Mountain View, CA 94043 USA	Google Incorporated	Cerf, VG (corresponding author), Google, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA.	vint@google.com							0	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1202	1203		10.1038/4611202a	http://dx.doi.org/10.1038/4611202a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511TF	19865146				2022-12-28	WOS:000271190800021
J	Daley, L; Gordon, J; Weston, C; Webb-Peploe, K				Daley, Liana; Gordon, Jackie; Weston, Charlotte; Webb-Peploe, Kathy			A Patient's Journey Cardiomyopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gordon, Jackie; Weston, Charlotte] Worthing Dist Hosp, Mental Hlth Liaison Team, Worthing BN11 2DH, England		Gordon, J (corresponding author), Worthing Dist Hosp, Mental Hlth Liaison Team, Worthing BN11 2DH, England.	Jackie.Gordon@sussexpartnership.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2009	339								b4210	10.1136/bmj.b4210	http://dx.doi.org/10.1136/bmj.b4210			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AI	19858173				2022-12-28	WOS:000271365300004
J	Aldeco-Perez, E; Rosenthal, AJ; Donnadieu, B; Parameswaran, P; Frenking, G; Bertrand, G				Aldeco-Perez, Eugenia; Rosenthal, Amos J.; Donnadieu, Bruno; Parameswaran, Pattiyil; Frenking, Gernot; Bertrand, Guy			Isolation of a C5-Deprotonated Imidazolium, a Crystalline "Abnormal" N-Heterocyclic Carbene	SCIENCE			English	Article							OLEFIN-METATHESIS CATALYSTS; ORGANIC-SYNTHESIS; STABLE CARBENES; LIGANDS; COMPLEXES; POLYMERIZATION; BINDING; SALT	The discovery two decades ago of metal-free stable carbenes, especially imidazol-2-ylidenes [N-heterocyclic carbenes (NHCs)], has led to numerous breakthroughs in organic and organometallic catalysis. More recently, a small range of complexes has been prepared in which alternative NHC isomers, namely imidazol-5-ylidenes ( also termed abnormal NHCs or aNHCs, because the carbene center is no longer located between the two nitrogens), coordinate to a transition metal. Here we report the synthesis of a metal-free aNHC that is stable at room temperature, both in the solid state and in solution. Calculations show that the aNHC is more basic than its normal NHC isomer. Because the substituent at the carbon next to the carbene center is a nonbulky phenyl group, a variety of substitution patterns should be tolerated without precluding the isolation of the corresponding aNHC.	[Aldeco-Perez, Eugenia; Rosenthal, Amos J.; Donnadieu, Bruno; Bertrand, Guy] Univ Calif Riverside, CNRS, Joint Res Chem Lab, Dept Chem,UMI 2957, Riverside, CA 92521 USA; [Parameswaran, Pattiyil; Frenking, Gernot] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	University of California System; University of California Riverside; Philipps University Marburg	Bertrand, G (corresponding author), Univ Calif Riverside, CNRS, Joint Res Chem Lab, Dept Chem,UMI 2957, Riverside, CA 92521 USA.	guy.bertrand@ucr.edu	Parameswaran, Pattiyil/H-8134-2013	Parameswaran, Pattiyil/0000-0003-2065-2463	NIH [R01 GM 68825]; Deutsche Forschungsgemeinschaft; Consejo Nacional de Ciencia y Tecnologia; Alexander von Humboldt Foundation;  [CCDC-735754];  [CCDC-735755];  [CCDC-735756];  [CCDC-744123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NIH ( grant R01 GM 68825) and the Deutsche Forschungsgemeinschaft for financial support of this work and the Consejo Nacional de Ciencia y Tecnologia ( E. A. P.) and Alexander von Humboldt Foundation ( P. P.) for postdoctoral fellowships. Metrical data for the solid-state structures of 6 (Br-), 8, 9, and 10 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-735754, CCDC-735755, CCDC-735756, and CCDC-744123, respectively.	Albrecht M, 2008, CHEM COMMUN, P3601, DOI 10.1039/b806924g; Alcarazo M, 2005, J AM CHEM SOC, V127, P3290, DOI 10.1021/ja0423769; Alder RW, 2004, ANGEW CHEM INT EDIT, V43, P5896, DOI 10.1002/anie.200400654; Appelhans LN, 2005, J AM CHEM SOC, V127, P16299, DOI 10.1021/ja055317j; Arduengo AJ, 1999, ACCOUNTS CHEM RES, V32, P913, DOI 10.1021/ar980126p; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P3122; Arnold PL, 2007, COORDIN CHEM REV, V251, P596, DOI 10.1016/j.ccr.2006.08.006; Bambirra S, 2003, CHEM COMMUN, P522, DOI 10.1039/b208502j; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Delaude L, 2009, EUR J INORG CHEM, P1681, DOI 10.1002/ejic.200801227; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Grundemann S, 2001, CHEM COMMUN, P2274, DOI 10.1039/b107881j; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Heckenroth M, 2007, ANGEW CHEM INT EDIT, V46, P6293, DOI 10.1002/anie.200702199; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kamber NE, 2007, CHEM REV, V107, P5813, DOI 10.1021/cr068415b; KOROTKIKH MI, 2001, UKRAINSKII KHIM Z, V67, P97; Lavallo V, 2006, SCIENCE, V312, P722, DOI 10.1126/science.1126675; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P6652, DOI 10.1002/anie.200602701; Lebel H, 2004, J AM CHEM SOC, V126, P5046, DOI 10.1021/ja049759r; Lin JCY, 2009, CHEM REV, V109, P3561, DOI 10.1021/cr8005153; Lipshutz BH, 2008, CHEM REV, V108, P2793, DOI 10.1021/cr800415x; Magill AM, 2004, AUST J CHEM, V57, P1205, DOI 10.1071/CH04159; Magill AM, 2004, J AM CHEM SOC, V126, P8717, DOI 10.1021/ja038973x; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Prades A, 2008, ORGANOMETALLICS, V27, P4254, DOI 10.1021/om800377m; Riduan SN, 2009, ANGEW CHEM INT EDIT, V48, P3322, DOI 10.1002/anie.200806058; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sini G, 2002, INORG CHEM, V41, P602, DOI 10.1021/ic010714q; Tonner R, 2008, CHEMPHYSCHEM, V9, P1474, DOI 10.1002/cphc.200800208; Tonner R, 2007, CHEM-ASIAN J, V2, P1555, DOI 10.1002/asia.200700235	37	333	335	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					556	559		10.1126/science.1178206	http://dx.doi.org/10.1126/science.1178206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	509LN	19900893	Green Accepted			2022-12-28	WOS:000271019400036
J	Lavallo, V; Grubbs, RH				Lavallo, Vincent; Grubbs, Robert H.			Carbenes As Catalysts for Transformations of Organometallic Iron Complexes	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; OLEFIN-METATHESIS CATALYSTS; STABLE COMPOUND; ACTIVATION; CHEMISTRY; BOND; NHC	Compared with the enormous arsenal of catalysts used to produce organic compounds, complementary species that are able to mediate sophisticated organometallic transformations are virtually nonexistent. We found that stable N-heterocyclic carbenes (NHCs) can mediate unusual organometallic transformations in solution at room temperature. Depending on the choice of NHC initiator, stoichiometric or catalytic reactions of bis(cyclooctatetraene) iron [Fe(COT)(2)] ensue. The stoichiometric reaction leads to the isolation of a previously unknown mixed-valent species, featuring distinct and directly bonded Fe(0) and Fe(1) centers. In the catalytic process, three iron atoms are fused to afford the tri-iron cluster Fe-3(COT)(3), which is a hydrocarbon analog of Dewar's classic Fe-3(CO)(12) complex. The key step in both of these processes is proposed to involve the NHC's ability to induce metal-metal bond formation. These NHC-mediated reactions provide a foundation on which to develop future organometallic transformations that are catalyzed by organic species.	[Lavallo, Vincent; Grubbs, Robert H.] CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Grubbs, RH (corresponding author), CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	rhg@caltech.edu	grubbs, robert h/D-4293-2009	grubbs, robert h/0000-0002-0057-7817	NIH [5RO1 GM31332]; National Research Service Award Postdoctoral Fellowship; NSF [CHE-0639094];  [CCDC-724011];  [CCDC-728138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085916, R01GM031332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge financial support from NIH for grant 5RO1 GM31332 and a National Research Service Award Postdoctoral Fellowship ( to V. L.). We thank L. M. Henling and M. W. Day ( California Institute of Technology) for x- ray crystallographic analysis. The Bruker KAPPA APEX II x-ray diffractometer was purchased via an NSF Chemistry Research Instrumentation and Facilities: Multi-User award to the California Institute of Technology, CHE-0639094. Crystallographic data for complexes 3 and 8 are available free of charge from the Cambridge Crystallographic Data Center under reference numbers CCDC-724011 and CCDC-728138, respectively.	Alcarazo M, 2009, NAT CHEM, V1, P295, DOI [10.1038/NCHEM.248, 10.1038/nchem.248]; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h; BRESLOW R, 1959, J AM CHEM SOC, V81, P3080, DOI 10.1021/ja01521a042; CARBONARO A, 1969, J ORGANOMET CHEM, V20, P177, DOI 10.1016/S0022-328X(00)80103-5; Clement ND, 2006, ORGANOMETALLICS, V25, P4155, DOI 10.1021/om0602759; Crabtree RH, 2007, COORDIN CHEM REV, V251, P595, DOI 10.1016/j.ccr.2006.08.005; Culkin DA, 2007, ANGEW CHEM INT EDIT, V46, P2627, DOI 10.1002/anie.200604740; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; DESIDERATO R, 1982, J CHEM EDUC, V59, P752, DOI 10.1021/ed059p752; Dorta R, 2005, J AM CHEM SOC, V127, P2485, DOI 10.1021/ja0438821; Dyson P. J., 2000, TRANSITION METAL CAR; ENDERS D, 1995, ANGEW CHEM INT EDIT, V34, P1021, DOI 10.1002/anie.199510211; Enders D, 2008, J ORG CHEM, V73, P7857, DOI 10.1021/jo801374j; FELKIN H, 1978, J ORGANOMET CHEM, V157, pC64, DOI 10.1016/S0022-328X(00)94034-8; Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474; Furstner A, 2009, ANGEW CHEM INT EDIT, V48, P1364, DOI 10.1002/anie.200805728; GERLACH DH, 1974, INORG SYNTH, V15, P2; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Hess CR, 2009, ANGEW CHEM INT EDIT, V48, P3703, DOI 10.1002/anie.200900725; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kaufhold O, 2008, ANGEW CHEM INT EDIT, V47, P4057, DOI 10.1002/anie.200800846; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P3488, DOI 10.1002/anie.200600987; Le Floch P, 1998, EUR J INORG CHEM, P119; MACKENZI.R, 1974, J CHEM SOC CHEM COMM, P650, DOI 10.1039/c39740000650; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; Masuda JD, 2007, ANGEW CHEM INT EDIT, V46, P7052, DOI 10.1002/anie.200703055; Nguyen T, 2005, SCIENCE, V310, P844, DOI 10.1126/science.1116789; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Resa I, 2004, SCIENCE, V305, P1136, DOI 10.1126/science.1101356; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sherry BD, 2008, ACCOUNTS CHEM RES, V41, P1500, DOI 10.1021/ar800039x; Vignolle J, 2009, CHEM REV, V109, P3333, DOI 10.1021/cr800549j; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768	38	86	86	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					559	562		10.1126/science.1178919	http://dx.doi.org/10.1126/science.1178919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	509LN	19900894	Green Accepted			2022-12-28	WOS:000271019400037
J	Li, WKW; McLaughlin, FA; Lovejoy, C; Carmack, EC				Li, William K. W.; McLaughlin, Fiona A.; Lovejoy, Connie; Carmack, Eddy C.			Smallest Algae Thrive As the Arctic Ocean Freshens	SCIENCE			English	Article									[Li, William K. W.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [McLaughlin, Fiona A.; Carmack, Eddy C.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Lovejoy, Connie] Univ Laval, Dept Biol, Quebec Ocean & Inst Biol Integrat & Syst, Quebec City, PQ G1V 0A6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Laval University	Li, WKW (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	LiB@mar.dfo-mpo.gc.ca	Lovejoy, Connie/A-3756-2008	Lovejoy, Connie/0000-0001-8027-2281	Fisheries and Oceans Canada; International Polar Year Program Canada's Three Oceans project; U. S. NSF Beaufort Gyre Exploration Project; Japan Agency for Marine-Earth Science and Technology	Fisheries and Oceans Canada; International Polar Year Program Canada's Three Oceans project; U. S. NSF Beaufort Gyre Exploration Project; Japan Agency for Marine-Earth Science and Technology	Financial and ship time support were provided by Fisheries and Oceans Canada, International Polar Year Program Canada's Three Oceans project, U. S. NSF Beaufort Gyre Exploration Project, and the Japan Agency for Marine-Earth Science and Technology. We thank S. Zimmermann, J. Eert, K. Scarcella, D. Horn, T. Perry, and the men and women of Canadian Coast Guard Ship Louis S. St-Laurent.	Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Tremblay G, 2009, AQUAT MICROB ECOL, V54, P55, DOI 10.3354/ame01257; Tremblay JE, 2009, NATO SCI PEACE SECUR, P73, DOI 10.1007/978-1-4020-9460-6_7; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000	9	524	563	4	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					539	539		10.1126/science.1179798	http://dx.doi.org/10.1126/science.1179798			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900890				2022-12-28	WOS:000271019400031
J	Sawicki, PT				Sawicki, Peter T.			Communal Responsibility for Health Care -- The Example of Benefit Assessment in Germany.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Inst Qual & Efficiency Hlth Care, Cologne, Germany		Sawicki, PT (corresponding author), Inst Qual & Efficiency Hlth Care, Cologne, Germany.							Antiel RM, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0907876; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; *GEM BUND FED JOIN, 2007, GERM HLTH CAR SYTS F; Hennock EP, 2007, ORIGIN OF THE WELFARE STATE IN ENGLAND AND GERMANY, 1850-1914: SOCIAL POLICIES COMPARED, P1; Sawicki PT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1997	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20								10.1056/NEJMp0908797	http://dx.doi.org/10.1056/NEJMp0908797			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518AI	19864646				2022-12-28	WOS:000271660500004
J	Maguire, AM; High, KA; Auricchio, A; Wright, JF; Pierce, EA; Testa, F; Mingozzi, F; Bennicelli, JL; Ying, GS; Rossi, S; Fulton, A; Marshall, KA; Banfi, S; Chung, DC; Morgan, JIW; Hauck, B; Zelenaia, O; Zhu, XS; Raffini, L; Coppieters, F; De Baere, E; Shindler, KS; Volpe, NJ; Surace, EM; Acerra, C; Lyubarsky, A; Redmond, TM; Stone, E; Sun, JW; McDonnell, JW; Leroy, BP; Simonelli, F; Bennett, J				Maguire, Albert M.; High, Katherine A.; Auricchio, Alberta; Wright, J. Fraser; Pierce, Eric A.; Testa, Francesco; Mingozzi, Federico; Bennicelli, Jeannette L.; Ying, Gui-shuang; Rossi, Settimio; Fulton, Ann; Marshall, Kathleen A.; Banfi, Sandra; Chung, Daniel C.; Morgan, Jessica I. W.; Hauck, Bernd; Zelenaia, Olga; Zhu, Xiaosong; Raffini, Leslie; Coppieters, Frauke; De Baere, Elfride; Shindler, Kenneth S.; Volpe, Nicholas J.; Surace, Enrico M.; Acerra, Carmela; Lyubarsky, Arkady; Redmond, T. Michael; Stone, Edwin; Sun, Junwei; McDonnell, Jennifer Wellman; Leroy, Bart P.; Simonelli, Francesca; Bennett, Jean			Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial	LANCET			English	Article							VISUAL CYCLE; RETINITIS-PIGMENTOSA; VISION; MUTATIONS; BLINDNESS; ROD; ISOMEROHYDROLASE; ISOMERASE; KINETICS; SAFETY	Background Gene therapy has the potential to reverse disease or prevent further deterioration of vision in patients with incurable inherited retinal degeneration. We therefore did a phase 1 trial to assess the effect of gene therapy on retinal and visual function in children and adults with Leber's congenital amaurosis. Methods We assessed the retinal and visual function in 12 patients (aged 8-44 years) with RPE65-associated Leber's congenital amaurosis given one subretinal injection of adeno-associated virus (AAV) containing a gene encoding a protein needed for the isomerohydrolase activity of the retinal pigment epithelium (AAV2-hRPE65v2) in the worst eye at low (1.5x10(10) vector genomes), medium (4.8x10(10) vector genomes), or high dose (1.5x10(11) vector genomes) for up to 2 years. Findings AAV2-hRPE65v2 was well tolerated and all patients showed sustained improvement in subjective and objective measurements of vision (ie, dark adaptometry, pupillometry, electroretinography, nystagmus, and ambulatory behaviour). Patients had at least a 2 log unit increase in pupillary light responses, and an 8-year-old child had nearly the same level of light sensitivity as that in age-matched normal-sighted individuals. The greatest improvement was noted in children, all of whom gained ambulatory vision. The study is registered with ClinicalTrials.gov, number NCT00516477. Interpretation The safety, extent, and stability of improvement in vision in all patients support the use of AAV mediated gene therapy for treatment of inherited retinal diseases, with early intervention resulting in the best potential gain.	[Bennett, Jean] Univ Penn, Stellar Chance Labs 309C, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Maguire, Albert M.; High, Katherine A.; Wright, J. Fraser; Mingozzi, Federico; Marshall, Kathleen A.; Hauck, Bernd; Zelenaia, Olga; Sun, Junwei; McDonnell, Jennifer Wellman; Bennett, Jean] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Abramson Pediat Res Ctr, Philadelphia, PA 19104 USA; [Maguire, Albert M.; Pierce, Eric A.; Zhu, Xiaosong] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; [High, Katherine A.; Raffini, Leslie] Univ Penn, Childrens Hosp Philadelphia, Dept Hematol, Dept Pediat, Philadelphia, PA 19104 USA; [High, Katherine A.; Stone, Edwin] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [High, Katherine A.; Stone, Edwin] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Auricchio, Alberta; Banfi, Sandra; Surace, Enrico M.] TIGEM, Naples, Italy; [Auricchio, Alberta] Univ Naples Federico 2, Dept Pediat, Naples, Italy; [Testa, Francesco; Rossi, Settimio; Acerra, Carmela; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Ying, Gui-shuang; Volpe, Nicholas J.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Ctr Prevent Ophthalmol & Biostat, Philadelphia, PA 19104 USA; [Fulton, Ann] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA; [Coppieters, Frauke; De Baere, Elfride; Leroy, Bart P.] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; Univ Penn, Scheie Eye Inst, Neuroophthalmol Serv, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Stone, Edwin] Univ Iowa, Coll Med, Dept Ophthalmol, Carver Ctr, Iowa City, IA 52242 USA; [Wright, J. Fraser] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Leroy, Bart P.] Univ Ghent, Dept Ophthalmol, B-9000 Ghent, Belgium; [Leroy, Bart P.] Ghent Univ Hosp, B-9000 Ghent, Belgium	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; University of Pennsylvania; Howard Hughes Medical Institute; University of Iowa; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Universita della Campania Vanvitelli; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Ghent University; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Iowa; University of Pennsylvania; Ghent University; Ghent University; Ghent University Hospital	Bennett, J (corresponding author), Univ Penn, Stellar Chance Labs 309C, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu	Shindler, Kenneth/D-2095-2009; Banfi, Sandro/K-3963-2018; Rossi, Settimio/AHI-1119-2022; Rossi, Settimio/J-4922-2012; Simonelli, Francesca/AHE-7571-2022; De Baere, Elfride/E-7405-2017; Testa, Francesco/J-3185-2012; AURICCHIO, Alberto/AHE-7979-2022; High, Katherine A./AAB-9322-2020	Banfi, Sandro/0000-0002-6541-8833; Simonelli, Francesca/0000-0001-8520-6769; De Baere, Elfride/0000-0002-5609-6895; AURICCHIO, Alberto/0000-0002-0832-2472; Coppieters, Frauke/0000-0001-7224-0992; Stone, Edwin M./0000-0003-3343-4414; Pierce, Eric/0000-0002-2354-4102; Surace, Enrico Maria/0000-0002-2975-942X; High, Katherine/0000-0002-0805-6223; Redmond, T. Michael/0000-0002-1813-5291; Testa, Francesco/0000-0002-1482-1577	Funding Center for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia; Foundation Fighting Blindness; Telethon; Research to Prevent Blindness; F M Kirby Foundation; Mackall Foundation Trust; Regione Campania Convenzione; European Union; Associazione Italiana Amaurosi Congenita di Leber; Fund for Scientific Research; Fund for Research in Ophthalmology; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY013729, R01EY010820, ZIAEY000260] Funding Source: NIH RePORTER	Funding Center for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia; Foundation Fighting Blindness(European Commission); Telethon(Fondazione Telethon); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); F M Kirby Foundation; Mackall Foundation Trust; Regione Campania Convenzione; European Union(European Commission); Associazione Italiana Amaurosi Congenita di Leber; Fund for Scientific Research; Fund for Research in Ophthalmology; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding Center for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, Foundation Fighting Blindness, Telethon, Research to Prevent Blindness, F M Kirby Foundation, Mackall Foundation Trust, Regione Campania Convenzione, European Union, Associazione Italiana Amaurosi Congenita di Leber, Fund for Scientific Research, Fund for Research in Ophthalmology, and National Center for Research Resources.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BENNICELLI J, 2008, MOL THER, V358, P2282; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; BERGAMIN O, 2004, INVEST OPHTH VIS SCI, V45, P1259; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; LORENZ B, 2003, INVEST OPHTH VIS SCI, V44, P1546; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Seiple W, 2004, DOC OPHTHALMOL, V109, P255, DOI 10.1007/s10633-005-0567-0; SIMONELLI F, MOL THER IN PRESS; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068	26	623	666	1	72	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1597	1605		10.1016/S0140-6736(09)61836-5	http://dx.doi.org/10.1016/S0140-6736(09)61836-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19854499	Green Accepted			2022-12-28	WOS:000271674600033
J	Aziz, A; Soucie, E; Sarrazin, S; Sieweke, MH				Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.			MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated Functional Macrophages	SCIENCE			English	Article							CELL-CYCLE EXIT; STEM-CELLS; MONOCYTIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; DENDRITIC CELLS; BONE-MARROW; IMMORTALIZATION; TRANSFORMATION; PLURIPOTENCY; MECHANISM	In metazoan organisms, terminal differentiation is generally tightly linked to cell cycle exit, whereas the undifferentiated state of pluripotent stem cells is associated with unlimited self-renewal. Here, we report that combined deficiency for the transcription factors MafB and c-Maf enables extended expansion of mature monocytes and macrophages in culture without loss of differentiated phenotype and function. Upon transplantation, the expanded cells are nontumorigenic and contribute to functional macrophage populations in vivo. Small hairpin RNA inactivation shows that continuous proliferation of MafB/c-Maf deficient macrophages requires concomitant up-regulation of two pluripotent stem cell-inducing factors, KLF4 and c-Myc. Our results indicate that MafB/c-MafB deficiency renders self-renewal compatible with terminal differentiation. It thus appears possible to amplify functional differentiated cells without malignant transformation or stem cell intermediates.	[Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] Univ Aix Marseille, CIML, F-13288 Marseille 09, France; [Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] INSERM, U631, F-13258 Marseille, France; [Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] CNRS, UMR6102, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020; Soucie, Erinn L/R-1731-2016	Sieweke, Michael/0000-0002-3228-9537; Soucie, Erinn L/0000-0001-6347-3954	Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH); E. S. from the Leukemia and Lymphoma Society of America [5204-06]; Fondation de France (FdF) [2004004150]; SFH; Association for International Cancer Research [05-0079]; Association pour la Recherche sur le Cancer [3857, 3422]; Agence Biomedecine. M. S. directs an Equipe FRM (Fondation pour la Recherche Medicale) [20071210559]	Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH); E. S. from the Leukemia and Lymphoma Society of America; Fondation de France (FdF)(Fondation de France); SFH; Association for International Cancer Research; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Biomedecine. M. S. directs an Equipe FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	We thank L. Chasson for immunofluorescence staining; E. Bertosio for leukocyte counts; C. Otto for communication of preliminary results; T. Benoukraf for microarray analysis; P. Grenot, M. Barad, N. Brun, and A. Zouine for cell sorting; L. Glimcher, A.-M. Schmitt-Verhulst, and F. Maina for c-Maf+/-, Ink4a-/-,and p53-/- mice; and J.-P. Gorvel and S. Meresse for FP-expressing S. typhimurium. Histological analyses were performed in the mouse functional genomics platform Reunion Interorganisme/ Marseille-Nice Genopole with support from the Institut National du Cancer. Miame (minimum information about a microarray experiment)-compliant gene expression data have been deposited at the European Bioinformatics Institute ArrayExpress database under accession no. E-MEXP-2419. A. A. received fellowships from the Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH), E. S. from the Leukemia and Lymphoma Society of America (5204-06), and S. S. from the Fondation de France (FdF) and SFH. We gratefully acknowledge grants from FdF ( 2004004150), the Association for International Cancer Research (05-0079), the Association pour la Recherche sur le Cancer (3857, 3422), and the Agence Biomedecine. M. S. directs an Equipe FRM ( Fondation pour la Recherche Medicale, Deq 20071210559).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Auffray C, 2008, NAT IMMUNOL, V9, P584, DOI 10.1038/ni0608-584; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Buttitta LA, 2007, DEV CELL, V12, P631, DOI 10.1016/j.devcel.2007.02.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2007, NAT IMMUNOL, V8, P558, DOI 10.1038/ni0607-558; GRAF T, 1981, EXP CELL RES, V131, P331, DOI 10.1016/0014-4827(81)90236-6; Hegde SP, 1999, BLOOD, V94, P1578, DOI 10.1182/blood.V94.5.1578.417k18_1578_1589; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Khan SA, 2001, MICROB PATHOGENESIS, V30, P29, DOI 10.1006/mpat.2000.0405; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; ROUSSEL MF, 1994, J CELL SCI, P105; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	29	179	186	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					867	871		10.1126/science.1176056	http://dx.doi.org/10.1126/science.1176056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892988				2022-12-28	WOS:000271468000048
J	Keel, SB; Abkowitz, JL				Keel, Sioban B.; Abkowitz, Janis L.			The Microcytic Red Cell and the Anemia of Inflammation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IRON; FERROPORTIN		[Keel, Sioban B.; Abkowitz, Janis L.] Univ Washington, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Keel, SB (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL031823] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; MCANS R, 2006, CLIN HEMATOLOGY; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	5	36	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1904	1906		10.1056/NEJMcibr0906391	http://dx.doi.org/10.1056/NEJMcibr0906391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890136	Green Accepted			2022-12-28	WOS:000271405800021
J	Bartels, A; Heinecke, D; Diddams, SA				Bartels, Albrecht; Heinecke, Dirk; Diddams, Scott A.			10-GHz Self-Referenced Optical Frequency Comb	SCIENCE			English	Article							LASER		[Bartels, Albrecht; Heinecke, Dirk] Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany; [Heinecke, Dirk; Diddams, Scott A.] NIST, Boulder, CO 80305 USA	University of Konstanz; National Institute of Standards & Technology (NIST) - USA	Bartels, A (corresponding author), Univ Konstanz, Ctr Appl Photon, Univ Str 10, D-78457 Constance, Germany.	albrecht.bartels@uni-konstanz.de; scott.diddams@nist.gov	Heinecke, Dirk C./E-2952-2012; Diddams, Scott A/L-2819-2013; Bartels, Albrecht O/B-3456-2009; Bartels, Albrecht/N-5801-2019	Heinecke, Dirk C./0000-0001-7894-3066; Diddams, Scott A/0000-0002-2144-0764; 	Center for Applied Photonics at the University of Konstanz; NIST	Center for Applied Photonics at the University of Konstanz; NIST(National Institute of Standards & Technology (NIST) - USA)	We thank T. Fortier and C. Oates for thoughtful comments on this manuscript. A. B. is chief executive officer and partial owner of Gigaoptics GmbH. NIST and Gigaoptics hold patents (6,618,423 and 6,850,543) relating to some of the technologies used in the present submission. This work is supported by the Center for Applied Photonics at the University of Konstanz and NIST.	Bartels A, 2008, OPT LETT, V33, P1905, DOI 10.1364/OL.33.001905; Jiang Z, 2007, NAT PHOTONICS, V1, P463, DOI 10.1038/nphoton.2007.139; Li CH, 2008, NATURE, V452, P610, DOI 10.1038/nature06854; Steinmetz T, 2008, SCIENCE, V321, P1335, DOI 10.1126/science.1161030; STOWE MC, 2007, ADV ATOMIC MOL OPTIC, V55, P51101; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a	6	166	171	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					681	681		10.1126/science.1179112	http://dx.doi.org/10.1126/science.1179112			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900924	Green Submitted			2022-12-28	WOS:000271233200025
J	Klein, JP; Ryther, RC				Klein, Joshua P.; Ryther, Robin C.			Central Nervous System Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klein, Joshua P.; Ryther, Robin C.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Klein, JP (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1786	1786		10.1056/NEJMicm0900232	http://dx.doi.org/10.1056/NEJMicm0900232			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864677				2022-12-28	WOS:000271185600011
J	Thyme, SB; Jarjour, J; Takeuchi, R; Havranek, JJ; Ashworth, J; Scharenberg, AM; Stoddard, BL; Baker, D				Thyme, Summer B.; Jarjour, Jordan; Takeuchi, Ryo; Havranek, James J.; Ashworth, Justin; Scharenberg, Andrew M.; Stoddard, Barry L.; Baker, David			Exploitation of binding energy for catalysis and design	NATURE			English	Article							HOMING ENDONUCLEASE; PROTEIN; DNA; MUTAGENESIS; SPECIFICITY; PREDICTION	Enzymes use substrate-binding energy both to promote ground-state association and to stabilize the reaction transition state selectively1. The monomeric homing endonuclease I-AniI cleaves with high sequence specificity in the centre of a 20-base-pair ( bp) DNA target site, with the amino (N)-terminal domain of the enzyme making extensive binding interactions with the left (-) side of the target site and the similarly structured carboxy (C)-terminal domain interacting with the right (+) side(2). Here we show that, despite the approximate twofold symmetry of the enzyme-DNA complex, there is almost complete segregation of interactions responsible for substrate binding to the (-) side of the interface and interactions responsible for transition-state stabilization to the (+) side. Although single base-pair substitutions throughout the entire DNA target site reduce catalytic efficiency, mutations in the (-) DNA half-site almost exclusively increase the dissociation constant (K-D) and the Michaelis constant under single-turnover conditions (K-M*), and those in the (+) half-site primarily decrease the turnover number (k(cat)*). The reduction of activity produced by mutations on the (-) side, but not mutations on the (+) side, can be suppressed by tethering the substrate to the endonuclease displayed on the surface of yeast. This dramatic asymmetry in the use of enzyme-substrate binding energy for catalysis has direct relevance to the redesign of endonucleases to cleave genomic target sites for gene therapy and other applications. Computationally redesigned enzymes that achieve new specificities on the (-) side do so by modulating K-M*, whereas redesigns with altered specificities on the (+) side modulate k(cat)*. Our results illustrate how classical enzymology and modern protein design can each inform the other.	[Thyme, Summer B.; Ashworth, Justin; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Jarjour, Jordan; Scharenberg, Andrew M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Thyme, Summer B.; Ashworth, Justin; Stoddard, Barry L.; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Jarjour, Jordan; Scharenberg, Andrew M.] Seattle Childrens Hosp Res Inst, Seattle, WA 98177 USA; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Havranek, James J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Fred Hutchinson Cancer Center; Washington University (WUSTL)	Thyme, SB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	sthyme@u.washington.edu; dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Thyme, Summer/0000-0003-3593-4148; Ashworth, Justin/0000-0003-4835-6551	National Science Foundation; US National Institutes of Health [GM084433, RL1CA133832]; Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [RL1CA133832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation graduate research fellowship to S. B. T., the US National Institutes of Health (GM084433 and RL1CA133832), the Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative, and the Howard Hughes Medical Institute. We thank A. Quadri for help with plasmid substrate preparation and M. Scalley-Kim for I-AniI cleavage data collected in the presence of Mn<SUP>2+</SUP>.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Collins CH, 2003, CURR OPIN BIOTECH, V14, P371, DOI 10.1016/S0958-1669(03)00091-0; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Fersht A., 1999, STRUCTURE MECH PROTE; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Geese WJ, 2003, EUR J BIOCHEM, V270, P1543, DOI 10.1046/j.1432-1033.2003.03518.x; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; JENCKS WP, 1963, ANNU REV BIOCHEM, V32, P639, DOI 10.1146/annurev.bi.32.070163.003231; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Mitchell M, 1998, INTRO GENETIC ALGORI; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; Zhao L, 2009, J MOL BIOL, V385, P1498, DOI 10.1016/j.jmb.2008.10.096	28	76	76	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1300	U142		10.1038/nature08508	http://dx.doi.org/10.1038/nature08508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865174	Green Accepted			2022-12-28	WOS:000271190800053
J	Schapira, L				Schapira, Lidia			A Gift of Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lschapira@partners.org	Schapira, Lidia/AAA-1293-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1738	1738		10.1001/jama.2009.1447	http://dx.doi.org/10.1001/jama.2009.1447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861660				2022-12-28	WOS:000271150300001
J	Albrecht, M				Albrecht, Martin			Carbenes in Action	SCIENCE			English	Editorial Material							IMPACT		Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 4, Ireland	University College Dublin	Albrecht, M (corresponding author), Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 4, Ireland.	martin.albrecht@ucd.ie	albrecht, martin/B-4141-2014	albrecht, martin/0000-0001-7403-2329				Albrecht M, 2008, CHEM COMMUN, P3601, DOI 10.1039/b806924g; Aldeco-Perez E, 2009, SCIENCE, V326, P556, DOI 10.1126/science.1178206; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P3122; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Heckenroth M, 2009, CHEM-EUR J, V15, P9375, DOI 10.1002/chem.200900249; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Lavallo V, 2008, ANGEW CHEM INT EDIT, V47, P5411, DOI 10.1002/anie.200801176; Lavallo V, 2009, SCIENCE, V326, P559, DOI 10.1126/science.1178919; Schreiner PR, 2008, NATURE, V453, P906, DOI 10.1038/nature07010	10	30	30	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					532	533		10.1126/science.1181553	http://dx.doi.org/10.1126/science.1181553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900887	Green Submitted			2022-12-28	WOS:000271019400028
J	Bellomo, R; Cass, A; Norton, R; Gallagher, M; Lo, S; Su, S; Cole, L; Finfer, S; McArthur, C; McGuinness, S; Myburgh, J; Scheinkestel, C; Bellomo, R; Lee, J; Ali, D; Cass, A; Cole, L; Finfer, S; Gallagher, M; Goldsmith, D; McGuinness, S; Myburgh, J; Norton, R; Scheinkestel, C; Banerjee, A; Bhonagiri, D; Blythe, D; Botha, J; Cade, J; Cole, L; Dobb, G; Eddington, J; Finfer, S; Flabouris, A; French, C; Garrett, P; Henderson, S; Ihle, B; Joyce, C; Kalkoff, M; Lipman, J; McArthur, C; McGuinness, S; Milliss, D; Mitchell, I; Morgan, J; Myburgh, J; Nair, P; Orford, N; Raza, A; Scheinkestel, C; Shehabi, Y; Tobin, A; Totaro, R; Turner, A; Wright, C; Ali, D; Lee, J; Little, L; Morrison, A; Regaglia, G; Shukla, R; Baigent, C; Emberson, J; Wheeler, D; Young, D; Billot, L; Bompoint, S; Heritier, S; Lo, SN; Pillai, A; Su, S; Pandey, S; Ryan, S; Schmidt, M; Starzec, G; Vijayan, B; Mitchell, I; Ashley, R; Gissane, J; Malchukova, K; Ranse, J; Raza, A; Nand, K; Sara, T; Cheung, W; Fugaccia, E; Lawrence, P; Millis, D; Tan, J; Thankrishnan, G; Wong, H; Harrigan, P; Crowfoot, E; Hardie, M; Bhonagiri, D; Micallef, S; Brieva, J; Lintott, M; Cole, L; Seppelt, I; Gresham, R; Nikas, M; Weisbrodt, L; Shehabi, Y; Bass, F; Boyle, M; Campbell, M; Hammond, N; Finfer, S; Ankers, S; O'Connor, A; Potter, J; Totaro, R; Rajbhandari, D; Myburgh, J; Dhiacou, V; Jovanovska, A; Munster, F; Nair, P; Breeding, J; Burns, C; Banerjee, A; Morrison, M; Pfeffercorn, C; Ritchie, A; McGuinness, S; Buhr, H; Eccleston, M; Parke, R; McArthur, C; Bell, J; Newby, L; Henderson, S; Mehrtens, J; Kalkoff, M; West, C; Morgan, J; Rudder, L; Sutton, J; Garrett, P; Groves, N; McDonald, S; Jaspers, J; Joyce, C; Harwood, M; Helyar, J; Mackie, B; Lipman, J; Boots, R; Bertenshaw, C; Deans, R; Fourie, C; Lassig-Smith, M; Stuart, J; Flabouris, A; Edwards, J; O'Connor, S; Lewis, K; Rivett, J; Turner, A; Field, T; McAllister, R; Marsden, K; Bellomo, R; Mathlin, C; Goldsmith, D; Mercer, I; O'Sullivan, K; Edington, J; Boschert, C; Smith, J; Ihle, B; Graan, M; Ho, S; Botha, J; Fowler, N; McInness, J; Pratt, N; Orford, N; Elderkin, T; Fraser, M; Kinmonth, A; Wright, C; Barrett, J; Wilson, S; Galt, P; Burton, S; Culhane, C; Ioannidis, R; Roberston, M; Barge, D; Caf, T; Howe, B; Low, P; Tobin, A; Groves, N; Holmes, J; Smith, R; Scheinkestel, C; Davies, A; Murray, L; Nevill, R; Vallance, S; Varley, S; White, V; French, C; Little, L; Raunow, H; Blythe, D; Palermo, A; Dobb, G; Boardman, M; Chamberlain, J; Gould, A; McEntaggart, G; Perryman, S; Thomas, L				Bellomo, R.; Cass, A.; Norton, R.; Gallagher, M.; Lo, S.; Su, S.; Cole, L.; Finfer, S.; McArthur, C.; McGuinness, S.; Myburgh, J.; Scheinkestel, C.; Bellomo, R.; Lee, J.; Ali, D.; Cass, A.; Cole, L.; Finfer, S.; Gallagher, M.; Goldsmith, D.; McGuinness, S.; Myburgh, J.; Norton, R.; Scheinkestel, C.; Banerjee, A.; Bhonagiri, D.; Blythe, D.; Botha, J.; Cade, J.; Cole, L.; Dobb, G.; Eddington, J.; Finfer, S.; Flabouris, A.; French, C.; Garrett, P.; Henderson, S.; Ihle, B.; Joyce, C.; Kalkoff, M.; Lipman, J.; McArthur, C.; McGuinness, S.; Milliss, D.; Mitchell, I.; Morgan, J.; Myburgh, J.; Nair, P.; Orford, N.; Raza, A.; Scheinkestel, C.; Shehabi, Y.; Tobin, A.; Totaro, R.; Turner, A.; Wright, C.; Ali, D.; Lee, J.; Little, L.; Morrison, A.; Regaglia, G.; Shukla, R.; Baigent, C.; Emberson, J.; Wheeler, D.; Young, D.; Billot, L.; Bompoint, S.; Heritier, S.; Lo, S. N.; Pillai, A.; Su, S.; Pandey, S.; Ryan, S.; Schmidt, M.; Starzec, G.; Vijayan, B.; Mitchell, I.; Ashley, R.; Gissane, J.; Malchukova, K.; Ranse, J.; Raza, A.; Nand, K.; Sara, T.; Cheung, W.; Fugaccia, E.; Lawrence, P.; Millis, D.; Tan, J.; Thankrishnan, G.; Wong, H.; Harrigan, P.; Crowfoot, E.; Hardie, M.; Bhonagiri, D.; Micallef, S.; Brieva, J.; Lintott, M.; Cole, L.; Seppelt, I.; Gresham, R.; Nikas, M.; Weisbrodt, L.; Shehabi, Y.; Bass, F.; Boyle, M.; Campbell, M.; Hammond, N.; Finfer, S.; Ankers, S.; O'Connor, A.; Potter, Julie; Totaro, R.; Rajbhandari, D.; Myburgh, J.; Dhiacou, V.; Jovanovska, A.; Munster, F.; Nair, P.; Breeding, J.; Burns, C.; Banerjee, A.; Morrison, M.; Pfeffercorn, C.; Ritchie, A.; McGuinness, S.; Buhr, H.; Eccleston, M.; Parke, R.; McArthur, C.; Bell, J.; Newby, L.; Henderson, S.; Mehrtens, J.; Kalkoff, M.; West, C.; Morgan, J.; Rudder, L.; Sutton, J.; Garrett, P.; Groves, N.; McDonald, S.; Jaspers, J.; Joyce, C.; Harwood, M.; Helyar, J.; Mackie, B.; Lipman, J.; Boots, R.; Bertenshaw, C.; Deans, R.; Fourie, C.; Lassig-Smith, M.; Stuart, J.; Flabouris, A.; Edwards, J.; O'Connor, S.; Lewis, K.; Rivett, J.; Turner, A.; Field, T.; McAllister, R.; Marsden, K.; Bellomo, R.; Mathlin, C.; Goldsmith, D.; Mercer, I.; O'Sullivan, K.; Edington, J.; Boschert, C.; Smith, J.; Ihle, B.; Graan, M.; Ho, S.; Botha, J.; Fowler, N.; McInness, J.; Pratt, N.; Orford, N.; Elderkin, T.; Fraser, M.; Kinmonth, A.; Wright, C.; Barrett, J.; Wilson, S.; Galt, P.; Burton, S.; Culhane, C.; Ioannidis, R.; Roberston, M.; Barge, D.; Caf, T.; Howe, B.; Low, P.; Tobin, A.; Groves, N.; Holmes, J.; Smith, R.; Scheinkestel, C.; Davies, A.; Murray, L.; Nevill, R.; Vallance, S.; Varley, S.; White, V.; French, C.; Little, L.; Raunow, H.; Blythe, D.; Palermo, A.; Dobb, G.; Boardman, M.; Chamberlain, J.; Gould, A.; McEntaggart, G.; Perryman, S.; Thomas, L.		RENAL Replacement Therapy Study In	Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE KIDNEY INJURY; RIFLE CRITERIA; FAILURE; HEMOFILTRATION; SURVIVAL; DIALYSIS; COHORT	Background The optimal intensity of continuous renal-replacement therapy remains unclear. We conducted a multicenter, randomized trial to compare the effect of this therapy, delivered at two different levels of intensity, on 90-day mortality among critically ill patients with acute kidney injury. Methods We randomly assigned critically ill adults with acute kidney injury to continuous renal-replacement therapy in the form of postdilution continuous venovenous hemodiafiltration with an effluent flow of either 40 ml per kilogram of body weight per hour (higher intensity) or 25 ml per kilogram per hour (lower intensity). The primary outcome measure was death within 90 days after randomization. Results Of the 1508 enrolled patients, 747 were randomly assigned to higher-intensity therapy, and 761 to lower-intensity therapy with continuous venovenous hemodiafiltration. Data on primary outcomes were available for 1464 patients (97.1%): 721 in the higher-intensity group and 743 in the lower-intensity group. The two study groups had similar baseline characteristics and received the study treatment for an average of 6.3 and 5.9 days, respectively (P = 0.35). At 90 days after randomization, 322 deaths had occurred in the higher-intensity group and 332 deaths in the lower-intensity group, for a mortality of 44.7% in each group (odds ratio, 1.00; 95% confidence interval [CI], 0.81 to 1.23; P = 0.99). At 90 days, 6.8% of survivors in the higher-intensity group (27 of 399), as compared with 4.4% of survivors in the lower-intensity group (18 of 411), were still receiving renal-replacement therapy (odds ratio, 1.59; 95% CI, 0.86 to 2.92; P = 0.14). Hypophosphatemia was more common in the higher-intensity group than in the lower-intensity group (65% vs. 54%, P< 0.001). Conclusions In critically ill patients with acute kidney injury, treatment with higher-intensity continuous renal-replacement therapy did not reduce mortality at 90 days. (ClinicalTrials.gov number, NCT00221013.)	[Cole, L.; Seppelt, I.; Gresham, R.; Nikas, M.; Weisbrodt, L.] Nepean Hosp, Kingswood, NSW, Australia; [Finfer, S.] Royal N Shore Hosp, Sydney, NSW, Australia; [McArthur, C.; McGuinness, S.] Auckland City Hosp, Auckland, New Zealand; [Myburgh, J.] St George Hosp Sydney, Sydney, NSW, Australia; [Scheinkestel, C.; Davies, A.; Murray, L.; Nevill, R.; Vallance, S.; Varley, S.; White, V.] Alfred Hosp, Melbourne, Vic, Australia; [Raza, A.; Nand, K.; Sara, T.] New S Wales Blacktown Hosp, Blacktown, NSW, Australia; [Mitchell, I.; Ashley, R.; Gissane, J.; Malchukova, K.; Ranse, J.] Australian Capital Terr Canberra Hosp, Canberra, ACT, Australia; [Harrigan, P.; Crowfoot, E.; Hardie, M.] John Hunter Hosp, New Lambton Hts, NSW, Australia; [Bhonagiri, D.; Micallef, S.] Liverpool Hosp, Liverpool, Merseyside, England; [Brieva, J.; Lintott, M.] Newcastle Mater Calvary Hosp, Newcastle, NSW, Australia; [Shehabi, Y.; Bass, F.; Boyle, M.; Campbell, M.; Hammond, N.] Prince Wales Hosp, Sydney, NSW, Australia; [Totaro, R.; Rajbhandari, D.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Nair, P.; Breeding, J.; Burns, C.] St Vincents Hosp, Sydney, NSW, Australia; [Banerjee, A.; Morrison, M.; Pfeffercorn, C.; Ritchie, A.] Westmead Hosp, Westmead, NSW, Australia; [McGuinness, S.; Buhr, H.; Eccleston, M.; Parke, R.] New Zealand Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand; [McArthur, C.; Bell, J.; Newby, L.] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Henderson, S.; Mehrtens, J.] Christchurch Hosp, Christchurch, New Zealand; [Kalkoff, M.; West, C.] Whangarei Hosp, Whangarei, New Zealand; [Garrett, P.; Groves, N.; McDonald, S.; Jaspers, J.] Nambour Gen Hosp, Nambour, Qld, Australia; [Joyce, C.; Harwood, M.; Helyar, J.; Mackie, B.] Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Lipman, J.; Boots, R.; Bertenshaw, C.; Deans, R.; Fourie, C.; Lassig-Smith, M.; Stuart, J.] Royal Brisbane Hosp, Brisbane, Qld, Australia; [Flabouris, A.; Edwards, J.; O'Connor, S.; Lewis, K.; Rivett, J.] S Australia Royal Adelaide Hosp, Adelaide, SA, Australia; [Turner, A.; Field, T.; McAllister, R.; Marsden, K.] Tasmania Royal Hobart Hosp, Hobart, Tas, Australia; [Bellomo, R.; Goldsmith, D.; Mathlin, C.; Mercer, I.; O'Sullivan, K.] Victoria Austin Hosp, Melbourne, Vic, Australia; [Edington, J.; Boschert, C.; Smith, J.] Bendigo Hosp, Bendigo, Vic, Australia; [Botha, J.; Fowler, N.; McInness, J.; Pratt, N.] Frankston Hosp, Melbourne, Vic, Australia; [Orford, N.; Elderkin, T.; Fraser, M.; Kinmonth, A.] Geelong Hosp, Geelong, Vic, Australia; [Roberston, M.; Barge, D.; Caf, T.; Howe, B.; Low, P.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Tobin, A.; Groves, N.; Holmes, J.; Smith, R.] St Vincents Hosp Mellbourne, Melbourne, Vic, Australia; [French, C.; Little, L.; Raunow, H.] Western Hosp, Toronto, ON, Canada; [Blythe, D.; Palermo, A.] Western Australia Fremantle Hosp, Fremantle, WA, Australia; [Dobb, G.; Boardman, M.; Chamberlain, J.; Gould, A.; McEntaggart, G.; Perryman, S.; Thomas, L.] Royal Perth Hosp, Perth, WA, Australia	Nepean Hospital; Royal North Shore Hospital; University of Sydney; Auckland City Hospital; St George Hospital; Florey Institute of Neuroscience & Mental Health; Blacktown & Mount Druitt Hospital; John Hunter Hospital; University of Sydney; St Vincents Hospital Sydney; University of Sydney; Auckland City Hospital; Auckland City Hospital; Christchurch Hospital New Zealand; Royal Brisbane & Women's Hospital; Royal Adelaide Hospital; Royal Hobart Hospital; Frankston Hospital; Geelong Hospital; Royal Melbourne Hospital; St Vincent's Hospital Melbourne; Royal Perth Hospital; University of Western Australia	Bellomo, R (corresponding author), ANZICS CTG, Level 3,10 Levers St, Carlton, Vic 3053, Australia.	ctg@anzics.com.au	French, Craig/ABF-5087-2020; Boots, Robert/K-1159-2013; Lo, Serigne/L-6220-2018; Flabouris, Arthas/AAF-9477-2019; Flabouris, Arthas/L-1347-2019; FRENCH, CRAIG/HGA-5299-2022; Billot, Laurent/Y-1241-2019; Goldsmith, David J A/H-6965-2018; Parke, Rachael/AAX-4004-2021; Joyce, Christopher/B-7437-2013	French, Craig/0000-0003-1363-9711; Boots, Robert/0000-0002-2436-7654; Lo, Serigne/0000-0001-5092-5544; Flabouris, Arthas/0000-0002-1535-9441; Billot, Laurent/0000-0002-4975-9793; Goldsmith, David J A/0000-0002-4349-9193; Parke, Rachael/0000-0003-4209-0334; Hammond, Naomi/0000-0002-6559-7747; Micallef, Sharon/0000-0002-8496-2324; Finfer, Simon/0000-0002-2785-5864; Bellomo, Rinaldo/0000-0002-1650-8939; Myburgh, John/0000-0003-4088-7016; Cass, Alan/0000-0002-3923-3173; SHEHABI, Yahya/0000-0003-4707-7462; Bompoint, Severine/0000-0001-5226-4321; McGuinness, Shay/0000-0003-0620-4787; Gallagher, Martin/0000-0001-9187-6187; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Emberson, Jonathan/0000-0001-7792-9422	National Health and Medical Research Council of Australia [352550]; Health Research Council of New Zealand [06-357]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand)	Supported by grants from the National Health and Medical Research Council of Australia (352550) and the Health Research Council of New Zealand (06-357).	Bagshaw SM, 2007, CRIT CARE, V11, DOI 10.1186/cc5949; Bellomo R, 2008, BLOOD PURIFICAT, V26, P407, DOI 10.1159/000148400; Bellomo R, 2009, BLOOD PURIFICAT, V27, P199, DOI 10.1159/000195091; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Finfer S, 2009, CRIT CARE RESUSC, V11, P5; Finfer S, 2009, CRIT CARE RESUSC, V11, P58; Gatward JJ, 2008, ANAESTHESIA, V63, P959, DOI 10.1111/j.1365-2044.2008.05514.x; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; RENAL Study Investigators, 2008, CRIT CARE RESUSC, V10, P225; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705; Tolwani AJ, 2008, J AM SOC NEPHROL, V19, P1233, DOI 10.1681/ASN.2007111173; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-1672-8; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Venkataraman R, 2002, J CRIT CARE, V17, P246, DOI 10.1053/jcrc.2002.36757; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	20	892	935	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1627	1638						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846848				2022-12-28	WOS:000270977400005
J	Simioni, P; Tormene, D; Tognin, G; Gavasso, S; Bulato, C; Iacobelli, NP; Finn, JD; Spiezia, L; Radu, C; Arruda, VR				Simioni, Paolo; Tormene, Daniela; Tognin, Giulio; Gavasso, Sabrina; Bulato, Cristiana; Iacobelli, Nicholas P.; Finn, Jonathan D.; Spiezia, Luca; Radu, Claudia; Arruda, Valder R.			X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; FACTOR-V; RISK; GENE; MUTATION; DETERMINANTS; VARIANTS; INCREASE; CARRIERS	We report a case of juvenile thrombophilia associated with a substitution of leucine for arginine at position 338 (R338L) in the factor IX gene (factor IX-R338L). The level of the mutant factor IX protein in plasma was normal, but the clotting activity of factor IX from the proband was approximately eight times the normal level. In vitro, recombinant factor IX-R338L had a specific activity that was 5 to 10 times as high as that in the recombinant wild-type factor IX. The R338 substitution causes a gain-of-function mutation, resulting in factor IX that is hyperfunctional.	[Simioni, Paolo; Tormene, Daniela; Tognin, Giulio; Gavasso, Sabrina; Bulato, Cristiana; Spiezia, Luca; Radu, Claudia] Univ Padua, Sch Med, Chair Internal Med 2, Dept Cardiol Thorac & Vasc Sci, I-35100 Padua, Italy; [Iacobelli, Nicholas P.; Finn, Jonathan D.; Arruda, Valder R.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Arruda, Valder R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Padua; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Simioni, P (corresponding author), Univ Padua, Sch Med, Chair Internal Med 2, Dept Cardiol Thorac & Vasc Sci, Via Giustiniani 2, I-35100 Padua, Italy.		SIMIONI, PAOLO/AAC-5438-2022; Radu, Claudia/AAO-2738-2021; Simioni, Paolo/AAC-5416-2022; Bulato, Cristiana/AAY-1950-2020	SIMIONI, PAOLO/0000-0002-6744-383X; Radu, Claudia/0000-0002-5548-9785; Spiezia, Luca/0000-0003-4339-8525; Bulato, Cristiana/0000-0002-3062-1268	Ministero dell'Istruzione, dell'Universita e della Ricerca [A07-3130/07]; National Institutes of Health [P01 HL64910]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (A07-3130/07, to Dr. Simioni), and the National Institutes of Health (P01 HL64910, to Dr. Arruda).	ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Arruda VR, 2001, BLOOD, V97, P130, DOI 10.1182/blood.V97.1.130; Bezemer ID, 2009, HAEMATOL-HEMATOL J, V94, P693, DOI 10.3324/haematol.2008.003020; BOTTEMA CDK, 1993, HUM GENET, V91, P496; Chang JL, 1998, J BIOL CHEM, V273, P12089, DOI 10.1074/jbc.273.20.12089; Cooper DN, 2002, J INHERIT METAB DIS, V25, P157, DOI 10.1023/A:1015621710660; Czapinska H, 1999, EUR J BIOCHEM, V260, P571, DOI 10.1046/j.1432-1327.1999.00160.x; Giannelli F, 1998, NUCLEIC ACIDS RES, V26, P265, DOI 10.1093/nar/26.1.265; Khachidze M, 2006, J THROMB HAEMOST, V4, P1537, DOI 10.1111/j.1538-7836.2006.02024.x; Lowe G, 2000, THROMB HAEMOSTASIS, V83, P530; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 2005, BLOOD, V106, P2363, DOI 10.1182/blood-2005-04-1461; Simioni P, 2002, BLOOD, V99, P1938, DOI 10.1182/blood.V99.6.1938; Tormene D, 2005, J THROMB HAEMOST, V3, P1414, DOI 10.1111/j.1538-7836.2005.01308.x; Van Minkelen R, 2008, J THROMB HAEMOST, V6, P1610, DOI 10.1111/j.1538-7836.2008.03066.x; Vlieg AV, 2000, BLOOD, V95, P3678; Wojcik EGC, 1996, THROMB HAEMOSTASIS, V75, P70; Yang BY, 2008, BLOOD, V112, P3234, DOI 10.1182/blood-2008-01-136820; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200	23	217	260	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1671	1675		10.1056/NEJMoa0904377	http://dx.doi.org/10.1056/NEJMoa0904377			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846852				2022-12-28	WOS:000270977400009
J	Trimboli, AJ; Cantemir-Stone, CZ; Li, F; Wallace, JA; Merchant, A; Creasap, N; Thompson, JC; Caserta, E; Wang, H; Chong, JL; Naidu, S; Wei, G; Sharma, SM; Stephens, JA; Fernandez, SA; Gurcan, MN; Weinstein, MB; Barsky, SH; Yee, L; Rosol, TJ; Stromberg, PC; Robinson, ML; Pepin, F; Hallett, M; Park, M; Ostrowski, MC; Leone, G				Trimboli, Anthony J.; Cantemir-Stone, Carmen Z.; Li, Fu; Wallace, Julie A.; Merchant, Anand; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Wei, Guo; Sharma, Sudarshana M.; Stephens, Julie A.; Fernandez, Soledad A.; Gurcan, Metin N.; Weinstein, Michael B.; Barsky, Sanford H.; Yee, Lisa; Rosol, Thomas J.; Stromberg, Paul C.; Robinson, Michael L.; Pepin, Francois; Hallett, Michael; Park, Morag; Ostrowski, Michael C.; Leone, Gustavo			Pten in stromal fibroblasts suppresses mammary epithelial tumours	NATURE			English	Article							BREAST-CANCER; GENE-EXPRESSION; ETS-2 PHOSPHORYLATION; EXTRACELLULAR-MATRIX; NEGATIVE REGULATION; CELL-SURVIVAL; PI3K PATHWAY; GROWTH; ACTIVATION; SIGNATURE	The tumour stroma is believed to contribute to some of the most malignant characteristics of epithelial tumours. However, signalling between stromal and tumour cells is complex and remains poorly understood. Here we show that the genetic inactivation of Pten in stromal fibroblasts of mouse mammary glands accelerated the initiation, progression and malignant transformation of mammary epithelial tumours. This was associated with the massive remodelling of the extracellular matrix (ECM), innate immune cell infiltration and increased angiogenesis. Loss of Pten in stromal fibroblasts led to increased expression, phosphorylation (T72) and recruitment of Ets2 to target promoters known to be involved in these processes. Remarkably, Ets2 inactivation in Pten stroma-deleted tumours ameliorated disruption of the tumour microenvironment and was sufficient to decrease tumour growth and progression. Global gene expression profiling of mammary stromal cells identified a Pten-specific signature that was highly represented in the tumour stroma of patients with breast cancer. These findings identify the Pten-Ets2 axis as a critical stroma-specific signalling pathway that suppresses mammary epithelial tumours.	[Cantemir-Stone, Carmen Z.; Li, Fu; Wallace, Julie A.; Merchant, Anand; Wei, Guo; Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Trimboli, Anthony J.; Li, Fu; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Wei, Guo; Weinstein, Michael B.; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Trimboli, Anthony J.; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Weinstein, Michael B.; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Naidu, Shan; Rosol, Thomas J.; Stromberg, Paul C.] Ohio State Univ, Dept Vet Biosci, Coll Vet Med, Columbus, OH 43210 USA; [Stephens, Julie A.; Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Off Hlth Sci, Columbus, OH 43210 USA; [Gurcan, Metin N.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Barsky, Sanford H.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Yee, Lisa] Ohio State Univ, Dept Surg, Sch Med, Columbus, OH 43210 USA; [Robinson, Michael L.] Columbus Childrens Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Pepin, Francois; Hallett, Michael; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Pepin, Francois; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Ostrowski, Michael C.; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; McGill University; McGill University; McGill University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu; gustavo.leone@osumc.edu	Rosol, Thomas/G-9585-2011; Li, Fu/E-7072-2011; Sharma, Sudarshana Mangalore/AAI-2475-2019; Merchant, Anand/B-3467-2010; Peng, Chunwei/F-6788-2010; Ostrowski, Michael/H-3108-2011	Rosol, Thomas/0000-0003-3737-1190; Hallett, Michael/0000-0001-6738-6786; Sharma, Sudarshana/0000-0002-9745-0061; Gurcan, Metin/0000-0002-2421-8229; Ostrowski, Michael/0000-0003-2948-6297	National Institutes of Health [R01CA85619, R01HD47470, P01CA097189, R01CA053271]; Komen Breast Cancer Foundation; Evelyn Simmers Charitable Trust; Terry Fox New Frontiers Group Grant; Natural Science and Engineering Research Council of Canada Discovery Grants Program; Department of Defense Pre- doctoral Fellowships; Department of Defense Postdoctoral Fellowship; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award; Diane and Sal Guerrera Chair in Cancer Genetics at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA053271, R01CA085619, R01CA121275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Evelyn Simmers Charitable Trust; Terry Fox New Frontiers Group Grant; Natural Science and Engineering Research Council of Canada Discovery Grants Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Defense Pre- doctoral Fellowships(United States Department of Defense); Department of Defense Postdoctoral Fellowship(United States Department of Defense); Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Diane and Sal Guerrera Chair in Cancer Genetics at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Rawahneh and J. Moffitt for histotechnical assistance, K. Kornacker, S. Cory and I. Vasudeva Murthy for bioinformatics assistance, P. Gulati for statistics assistance, the Ohio State University Human Tissue Resource Network and the Ohio State University Comprehensive Cancer Center Microarray, Nucleic Acids, Trangenics and Flow Cytometry Shared Facilities for technical assistance. MMTV-ErbB2 mice were provided by W. Muller. This work was funded by the National Institutes of Health to G. L. (R01CA85619, R01HD47470, P01CA097189) and to M. C. O. (R01CA053271, P01CA097189), by the Komen Breast Cancer Foundation and Evelyn Simmers Charitable Trust to M. C. O., by the Terry Fox New Frontiers Group Grant to M. P., and by the Natural Science and Engineering Research Council of Canada Discovery Grants Program grant to M. H. F. L. and F. P. were funded by Department of Defense Pre- doctoral Fellowships and J.-L. C. was funded by a Department of Defense Postdoctoral Fellowship. G. L. is the recipient of the Pew Charitable Trusts Scholar Award and the Leukemia and Lymphoma Society Scholar Award. M. P. holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University.	Allred DC, 1998, MODERN PATHOL, V11, P155; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Auer H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-111; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Park ES, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000145; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tynan JA, 2005, ONCOGENE, V24, P6870, DOI 10.1038/sj.onc.1208856; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; WESTALL PH, 1993, RESAMPLING BASED MUL; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	54	410	422	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1084	U181		10.1038/nature08486	http://dx.doi.org/10.1038/nature08486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847259	Green Accepted			2022-12-28	WOS:000270987600036
J	Davies, AP; Chalmers, RM				Davies, A. P.; Chalmers, R. M.			Cryptosporidiosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PERUVIAN CHILDREN; DIARRHEA; INFECTION; MALNUTRITION; PAROMOMYCIN; ENGLAND; PARVUM; AIDS; EPIDEMIOLOGY		[Davies, A. P.] Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales; [Chalmers, R. M.] Natl Publ Hlth Serv Wales, UK Cryptosporidium Reference Unit, Swansea, W Glam, Wales	Swansea University	Davies, AP (corresponding author), Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales.	angharad.p.davies@swansea.ac.uk		Davies, Angharad/0000-0003-4190-8894				Abubakar I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004932.pub2; Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; BISSUEL F, 1994, CLIN INFECT DIS, V18, P447, DOI 10.1093/clinids/18.3.447; BOUCHIER I, 1998, CRYPTOSPORIDIUM WATE, P1; Chalmers R M, 2002, Commun Dis Public Health, V5, P114; Chalmers R. M., 2009, EURO SURVEILL, V14; Chappell CL, 1999, AM J TROP MED HYG, V60, P157, DOI 10.4269/ajtmh.1999.60.157; Checkley W, 1997, AM J EPIDEMIOL, V145, P156, DOI 10.1093/oxfordjournals.aje.a009086; *CMO UPD 23, 1999, CRYPT WAT ADV IMM CO; CRON RQ, 1995, J RHEUMATOL, V22, P1962; Davies AP, 2009, PEDIATR INFECT DIS J, V28, P838, DOI 10.1097/INF.0b013e31819d646d; Dunand VA, 1997, CLIN INFECT DIS, V25, P267, DOI 10.1086/514536; *FORM PHLS ADV COM, 2004, COMMUN DIS PUBLIC HL, V7, P362; HAY EM, 1987, BRIT MED J, V295, P248, DOI 10.1136/bmj.295.6592.248; Hewitt RG, 2000, CLIN INFECT DIS, V31, P1084, DOI 10.1086/318155; *HLTH PROT AG, 2007, 31 BSOP HLTH PROT AG; Hunter PR, 2004, CLIN INFECT DIS, V39, P504, DOI 10.1086/422649; Hunter PR, 2004, EMERG INFECT DIS, V10, P1241, DOI 10.3201/eid1007.030582; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Lake IR, 2007, EMERG INFECT DIS, V13, P623, DOI 10.3201/eid1304.060890; LIMA AAM, 1992, ACTA PAEDIATR, V81, P39, DOI 10.1111/j.1651-2227.1992.tb12370.x; Manthey MW, 1997, DIGEST DIS SCI, V42, P1580, DOI 10.1023/A:1018828507990; Ozgul A, 1999, RHEUMATOLOGY, V38, P288, DOI 10.1093/rheumatology/38.3.288; Rossignol JF, 1998, T ROY SOC TROP MED H, V92, P663, DOI 10.1016/S0035-9203(98)90804-5; SALLON S, 1988, AM J DIS CHILD, V142, P312, DOI 10.1001/archpedi.1988.02150030086027; SARABIAARCE S, 1990, PEDIATR INFECT DIS J, V9, P627; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; SHEPHERD RC, 1989, ARCH DIS CHILD, V64, P743, DOI 10.1136/adc.64.5.743; Sopwith W, 2005, EPIDEMIOL INFECT, V133, P785, DOI 10.1017/S0950268805004772; WHITE AC, 1994, J INFECT DIS, V170, P419, DOI 10.1093/infdis/170.2.419	31	44	45	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2009	339								b4168	10.1136/bmj.b4168	http://dx.doi.org/10.1136/bmj.b4168			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PI	19841008				2022-12-28	WOS:000271101900004
J	Fujita, M; Maeda, Y; Ra, M; Yamaguchi, Y; Taguchi, R; Kinoshita, T				Fujita, Morihisa; Maeda, Yusuke; Ra, Moonjin; Yamaguchi, Yoshiki; Taguchi, Ryo; Kinoshita, Taroh			GPI Glycan Remodeling by PGAP5 Regulates Transport of GPI-Anchored Proteins from the ER to the Golgi	CELL			English	Article							COPII-COATED VESICLES; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; INOSITOL DEACYLATION; RECYCLING PATHWAY; MDCK CELLS; GLYCOSYLPHOSPHATIDYLINOSITOL; YEAST; MEMBRANE	Many eukaryotic proteins are attached to the cell surface via glycosylphosphatidylinositol (GPI) anchors. How GPI-anchored proteins (GPI-APs) are trafficked from the endoplasmic reticulum (ER) to the cell surface is poorly understood, but the GPI moiety has been postulated to function as a signal for sorting and transport. Here, we established mutant cells that were selectively defective in transport of GPI-APs from the ER to the Golgi. We identified a responsible gene, designated PGAP5 (post-GPI-attachment to proteins 5). PGAP5 belongs to a dimetal-containing phosphoesterase family and catalyzed the remodeling of the glycan moiety on GPI-APs. PGAP5 catalytic activity is a prerequisite for the efficient exit of GPI-APs from the ER. Our data demonstrate that GPI glycan acts as an ER-exit signal and suggest that glycan remodeling mediated by PGAP5 regulates GPI-AP transport in the early secretory pathway.	[Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Yamaguchi, Yoshiki] RIKEN ASI, Struct Glycobiol Team, Saitama 3510198, Japan; [Fujita, Morihisa; Taguchi, Ryo; Kinoshita, Taroh] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	Osaka University; Osaka University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Fujita, Morihisa/AAM-4142-2020; Kinoshita, Taroh/C-7353-2009; ra, moonjin/AAK-3816-2021; Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Osaka University Global COE program	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to Yasu Morita for critical reading and helpful discussion. We thank Ikuo Wada for plasmids, Felix Wieland and Irene Schulz for antibodies, Keiko Kinoshita, Noriyuki Kanzawa, Satoshi Takida, and Fumiko Mori for technical help, Kohjiro Nakamura for cell sorting, Katsuichiro Komatsu for homology modeling, Tadashi Satoh, Shinya Hanashima, and Masaki Kato for evaluation of 3D structural model, Yoshiko Murakami and Tamotsu Yoshimori for helpful discussion, and Yoshifumi Jigami for initial support of this work. This work was supported by grants from Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology of Japan. M.F. was supported by the Osaka University Global COE program.	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Ferguson M. A., 2008, ESSENTIALS GLYCOBIOL, P143; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Guddat LW, 1999, STRUCT FOLD DES, V7, P757, DOI 10.1016/S0969-2126(99)80100-2; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hauri HP, 2000, J CELL SCI, V113, P587; HIROSE S, 1992, J BIOL CHEM, V267, P16968; Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783; Klumperman J, 1998, J CELL SCI, V111, P3411; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nagaya H, 2008, J CELL BIOL, V180, P129, DOI 10.1083/jcb.200704078; Ogata K, 2000, J MOL GRAPH MODEL, V18, P258, DOI 10.1016/S1093-3263(00)00037-1; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paidhungat M, 1998, GENETICS, V148, P1787; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Shishioh N, 2005, J BIOL CHEM, V280, P9728, DOI 10.1074/jbc.M413755200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Tavassoli K, 1997, HUM GENET, V100, P508, DOI 10.1007/s004390050543	48	100	104	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					352	365		10.1016/j.cell.2009.08.040	http://dx.doi.org/10.1016/j.cell.2009.08.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837036	Bronze			2022-12-28	WOS:000270857500018
J	Suter, DM; Schibler, U				Suter, David M.; Schibler, Ueli			Feeding the Clock	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; METABOLIC CYCLE; CRYPTOCHROME		[Suter, David M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Suter, DM (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	david.suter@unige.ch; ueli.schibler@unige.ch	Suter, David/S-9210-2019	Suter, David/0000-0001-5644-4899				Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499	10	6	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					378	379		10.1126/science.1181278	http://dx.doi.org/10.1126/science.1181278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833950				2022-12-28	WOS:000270818600035
J	Talapin, DV; Shevchenko, EV; Bodnarchuk, MI; Ye, XC; Chen, J; Murray, CB				Talapin, Dmitri V.; Shevchenko, Elena V.; Bodnarchuk, Maryna I.; Ye, Xingchen; Chen, Jun; Murray, Christopher B.			Quasicrystalline order in self-assembled binary nanoparticle superlattices	NATURE			English	Article							NANOCRYSTALS; PHASE; MODEL	The discovery of quasicrystals in 1984 changed our view of ordered solids as periodic structures(1,2) and introduced new long-range-ordered phases lacking any translational symmetry(3-5). Quasi-crystals permit symmetry operations forbidden in classical crystallography, for example five-, eight-, ten-and 12-fold rotations, yet have sharp diffraction peaks. Intermetallic compounds have been observed to form both metastable and energetically stabilized quasicrystals(1,3,5); quasicrystalline order has also been reported for the tantalum telluride phase with an approximate Ta1.6Te composition(6). Later, quasicrystals were discovered in soft matter, namely supramolecular structures of organic dendrimers(7) and tri-block copolymers(8), and micrometre-sized colloidal spheres have been arranged into quasicrystalline arrays by using intense laser beams that create quasi-periodic optical standing-wave patterns(9). Here we show that colloidal inorganic nanoparticles can self-assemble into binary aperiodic superlattices. We observe formation of assemblies with dodecagonal quasicrystalline order in different binary nanoparticle systems: 13.4-nm Fe2O3 and 5-nm Au nanocrystals, 12.6-nm Fe3O4 and 4.7-nm Au nanocrystals, and 9-nm PbS and 3-nm Pd nanocrystals. Such compositional flexibility indicates that the formation of quasicrystalline nanoparticle assemblies does not require a unique combination of interparticle interactions, but is a general sphere-packing phenomenon governed by the entropy and simple interparticle potentials. We also find that dodecagonal quasicrystalline superlattices can form low-defect interfaces with ordinary crystalline binary superlattices, using fragments of (3(3).4(2)) Archimedean tiling as the 'wetting layer' between the periodic and aperiodic phases.	[Talapin, Dmitri V.; Bodnarchuk, Maryna I.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Talapin, Dmitri V.; Shevchenko, Elena V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Ye, Xingchen; Murray, Christopher B.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Chen, Jun; Murray, Christopher B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Pennsylvania; University of Pennsylvania	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	dvtalapin@uchicago.edu; eshevchenko@anl.gov	Ye, Xingchen/AAN-4494-2020; Ye, Xingchen/D-3202-2017; Liu, Xin/I-7709-2015; Chen, Jun/F-7103-2014	Ye, Xingchen/0000-0001-6851-2721; Ye, Xingchen/0000-0001-6851-2721; Bodnarchuk, Maryna/0000-0001-6597-3266	US National Science Foundation (NSF) [DMR-0847535, DMR-0213745]; Austrian Nanoinitiative; Center for Nanoscale Materials; Argonne National Laboratory; US Department of Energy [DE-AC02-06CH11357]; Direct For Mathematical & Physical Scien [0847535] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); Austrian Nanoinitiative; Center for Nanoscale Materials; Argonne National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. O'Brien, W. Heiss, A. P. Alivisatos, T. Witten, W. Green and J. Urban for discussions and V. Altoe for help with analytical TEM studies. D. V. T. acknowledges support from the US National Science Foundation (NSF) CAREER Program under award number DMR-0847535 and the NSF MRSEC Program under award number DMR-0213745. M. I. B. acknowledges financial support from the Austrian Nanoinitiative. The work at the Center for Nanoscale Materials, Argonne National Laboratory, was supported by the US Department of Energy under contract number DE-AC02-06CH11357.	Abe E, 2004, NAT MATER, V3, P759, DOI 10.1038/nmat1244; Chen Z, 2008, ACS NANO, V2, P1219, DOI 10.1021/nn800129s; Conrad M, 1998, ANGEW CHEM INT EDIT, V37, P1384, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R; DiVincenzo D. P, 1999, QUASICRYSTALS STATE; ELDRIDGE MD, 1993, NATURE, V365, P35, DOI 10.1038/365035a0; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Glotzer SC, 2008, NATURE, V454, P420, DOI 10.1038/454420a; Grunbaum B., 1986, TILINGS PATTERNS; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s; ISHIMASA T, 1985, PHYS REV LETT, V55, P511, DOI 10.1103/PhysRevLett.55.511; Joseph D, 1997, PHYS REV LETT, V79, P1066, DOI 10.1103/PhysRevLett.79.1066; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Keys AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235503; LEUNG PW, 1989, PHYS REV B, V39, P446, DOI 10.1103/PhysRevB.39.446; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; Mikhael J, 2008, NATURE, V454, P501, DOI 10.1038/nature07074; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Shevchenko EV, 2006, J AM CHEM SOC, V128, P3620, DOI 10.1021/ja0564261; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Sopousek J, 1996, SCRIPTA MATER, V35, P689, DOI 10.1016/1359-6462(96)00202-3; Ueda K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195122; WIDOM M, 1993, PHYS REV LETT, V70, P2094, DOI 10.1103/PhysRevLett.70.2094; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zoorob ME, 2000, NATURE, V404, P740, DOI 10.1038/35008023	30	469	475	15	512	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					964	967		10.1038/nature08439	http://dx.doi.org/10.1038/nature08439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829378				2022-12-28	WOS:000270817700043
J	Ramachandran, A; Ma, RCW; Snehalatha, C				Ramachandran, Ambady; Ma, Ronald Ching Wan; Snehalatha, Chamukuttan			Diabetes in Asia	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK-FACTORS; GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; HIGH PREVALENCE; INSULIN-RESISTANCE; TCF7L2 GENE; HONG-KONG; PREVENTION PROGRAM; URBAN-POPULATION	Prevalence of type 2 diabetes has rapidly increased in native and migrant Asian populations. Diabetes develops at a younger age in Asian populations than in white populations, hence the morbidity and mortality associated with the disease and its complications are also common in young Asian people. The young age of these populations and the high rates of cardiovascular risk factors seen in Asian people substantially increase lifetime risk of cardiovascular disease. Several distinctive features are apparent in pathogenetic factors for diabetes and their thresholds in Asian populations. The economic burden due to diabetes at personal, societal, and national levels is huge. National strategies to raise public awareness about the disease and to improve standard of care and implementation of programmes for primary prevention are urgently needed.	[Ramachandran, Ambady; Snehalatha, Chamukuttan] India Diabet Res Fdn, Madras 600008, Tamil Nadu, India; [Ramachandran, Ambady; Snehalatha, Chamukuttan] Dr A Ramachandrans Diabet Hosp, Madras 600008, Tamil Nadu, India; [Ma, Ronald Ching Wan] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ramachandran, A (corresponding author), India Diabet Res Fdn, Madras 600008, Tamil Nadu, India.	ramachandran@vsnl.com	Ma, Ronald/C-2788-2009	Ma, Ronald/0000-0002-1227-803X	Department of Medicine and Therapeutics, Chinese University of Hong Kong; Research Grants Council of Hong Kong [CUHK4724/07M]; Government of the Hong Kong Special Administrative Region [ITS/088/08]	Department of Medicine and Therapeutics, Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Government of the Hong Kong Special Administrative Region	We drank S Selvam and C J Thirupurasundari for help with compiling the references, L Vijaya and A Bobby for secretarial assistance, I Chan for her helpful comments, and J C Florez for permission to reproduce figure 2. RM acknowledges research funding support from the research fund of the Department of Medicine and Therapeutics, Chinese University of Hong Kong, the Research Grants Council of Hong Kong (CUHK4724/07M), and the Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region (ITS/088/08).	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Abate N, 2007, INDIAN J MED RES, V125, P251; AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Aekplakorn W, 2003, DIABETES CARE, V26, P2758, DOI 10.2337/diacare.26.10.2758; Aekplakorn W, 2007, DIABETES CARE, V30, P2007, DOI 10.2337/dc06-2319; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; Baltazar JC, 2004, DIABETES RES CLIN PR, V64, P107, DOI 10.1016/j.diabres.2003.10.013; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; CHAN JC, 2008, EPIDEMIOLOGY DIABETE, P179; Chan JCN, 1997, DIABETES CARE, V20, P1785, DOI 10.2337/diacare.20.11.1785; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chang C, 2009, BIOMARK MED, V3, P33, DOI 10.2217/17520363.3.1.33; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chi ZS, 2001, DIABETOLOGIA, V44, pS82, DOI 10.1007/PL00002944; Chin K, 1996, CIRCULATION, V100, P706; COCKRAM CS, 1993, DIABETES RES CLIN PR, V21, P67, DOI 10.1016/0168-8227(93)90099-Q; de Courten M, 1997, INT TXB DIABETES MEL, P143; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Florez JC, 2008, J CLIN ENDOCR METAB, V93, P4633, DOI 10.1210/jc.2008-1345; Forouhi NG, 1999, DIABETOLOGIA, V42, P932, DOI 10.1007/s001250051250; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gill T, 2007, DIABETES VOICE, V52, P20; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; International Diabetes Federation (IDF), 2006, DEF DIAGN DIAB MELL; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; JARVINEN HY, 2002, J ROY SOC MED, V95, P39; Joshi Shashank R, 2003, J Assoc Physicians India, V51, P445; Kapur A, 2007, INDIAN J MED RES, V125, P473; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Ko GTC, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-10; Lee WRW, 2000, DIABETES RES CLIN PR, V50, pS35, DOI 10.1016/S0168-8227(00)00184-4; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 1996, CHINESE MED J-PEKING, V109, P599; Li Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240802376389; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Ma RCW, 2009, INT J GYNECOL OBSTET, V104, pS42, DOI 10.1016/j.ijgo.2008.11.032; Mafauzy M, 1999, Asia Pac J Public Health, V11, P16, DOI 10.1177/101053959901100104; MARGUERITE J, 2008, EPIDEMIOLOGY DIABETE, P323; Martin M, 2008, DIABETES CARE, V31, P798, DOI 10.2337/dc07-1781; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; *MIN HLTH MAL, 1985, NAT HLTH MORB SURV, V1; *MIN HLTH MAL, 1996, NAT HLTH MORB SURV, V2; Misra A, 2006, DIABETES RES CLIN PR, V71, P101, DOI 10.1016/j.diabres.2005.06.006; Misra A, 2009, J Assoc Physicians India, V57, P163; MISRA A, 2001, INT J OBESITY, V125, P1722; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; MOHAN V, 1985, DIABETES CARE, V8, P371, DOI 10.2337/diacare.8.4.371; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Murugesan N, 2007, DIABETES RES CLIN PR, V77, P433, DOI 10.1016/j.diabres.2007.01.004; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Ng MCY, 2001, DIABETES CARE, V24, P663, DOI 10.2337/diacare.24.4.663; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Radha V, 2006, DIABETES CARE, V29, P1046, DOI 10.2337/dc05-1473; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Ramachandran A, 2003, DIABETES CARE, V26, P1022, DOI 10.2337/diacare.26.4.1022; RAMACHANDRAN A, 1988, BRIT MED J, V297, P587, DOI 10.1136/bmj.297.6648.587; RAMACHANDRAN A, 1992, DIABETES CARE, V15, P1348, DOI 10.2337/diacare.15.10.1348; Ramachandran A, 2002, DIABETIC MED, V19, P130, DOI 10.1046/j.1464-5491.2002.00656.x; Ramachandran A, 1997, DIABETOLOGIA, V40, P232, DOI 10.1007/s001250050668; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ramachandran A, 1998, DIABETES CARE, V21, P666, DOI 10.2337/diacare.21.4.666; RAMACHANDRAN A, 1987, J MED ASS THAI, V2, P180; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Ramachandran A, 2007, DIABETES CARE, V30, P1828, DOI 10.2337/dc06-2097; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Retnakaran R, 2006, DIABETES CARE, V29, P1950, DOI 10.2337/dc06-0867; Sakamoto Y, 2007, J HUM GENET, V52, P781, DOI 10.1007/s10038-007-0190-x; SAMRAGE SM, 1995, THESIS U COLOMBO; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Sicree R, 2006, DIABETES ATLAS, V3, P16; Sicree R, 2003, DIABETES ATLAS; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Snehalatha C, 2000, DIABETES RES CLIN PR, V47, P129, DOI 10.1016/S0168-8227(99)00109-6; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Snehalatha C, 1997, METABOLISM, V46, P1220, DOI 10.1016/S0026-0495(97)90221-3; Snehalatha C, 2000, DIABETES RES CLIN PR, V48, P57, DOI 10.1016/S0168-8227(99)00136-9; Snehalatha C, 1998, DIABETES CARE, V21, P76, DOI 10.2337/diacare.21.1.76; Snehalatha C, 2008, DIABETES CARE, V31, P2374, DOI 10.2337/dc08-1083; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tam WH, 2008, PEDIATRICS, V122, P1229, DOI 10.1542/peds.2008-0158; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Tian HG, 2009, DIABETES RES CLIN PR, V84, P273, DOI 10.1016/j.diabres.2009.03.015; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; UN, WORLD POP PROSP 2007; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Viswanathan M, 1996, DIABETIC MED, V13, P232, DOI 10.1002/(SICI)1096-9136(199603)13:3<232::AID-DIA27>3.0.CO;2-7; Wang K, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P282; Wei JN, 2003, JAMA-J AM MED ASSOC, V290, P1345, DOI 10.1001/jama.290.10.1345; WHO, 2004, LANCET, V363, P902; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolk R, 2007, EXP PHYSIOL, V92, P67, DOI 10.1113/expphysiol.2006.033787; World Health Organization, 2004, WORLD HLTH REP 2004; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Wu DM, 2001, INT J OBESITY, V25, P1189, DOI 10.1038/sj.ijo.0801679; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhai F, 2008, OBES REV, V9, P107, DOI 10.1111/j.1467-789X.2007.00450.x; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; 1996, P 3 INT DIAB FED W P, P91	140	512	521	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					408	418		10.1016/S0140-6736(09)60937-5	http://dx.doi.org/10.1016/S0140-6736(09)60937-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	19875164				2022-12-28	WOS:000274305500028
J	Wilson, BJ; Qureshi, N; Santaguida, P; Little, J; Carroll, JC; Allanson, J; Raina, P				Wilson, Brenda J.; Qureshi, Nadeem; Santaguida, Pasqualina; Little, Julian; Carroll, June C.; Allanson, Judith; Raina, Parminder			Systematic Review: Family History in Risk Assessment for Common Diseases	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; PROSTATE-CANCER RISK; LIFE-STYLE FACTORS; BREAST-CANCER; MYOCARDIAL-INFARCTION; PARENTAL HISTORY; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; OVARIAN-CANCER; COLORECTAL-CANCER	Background: The usefulness of routinely examining family history in primary care practice is uncertain. Purpose: To assess the beneficial and adverse effects of collecting family history in primary care populations; how well family history predicts individual disease risk; and how accurately patients report it. Data Sources: English-language studies in MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, and PsycINFO from 1995 to 2 March 2009. Study Selection: Two independent reviewers selected studies that met question-specific eligibility criteria. These included controlled and uncontrolled intervention studies of systematic family history collection and uptake of preventive interventions or adverse effects, longitudinal and cross-sectional studies that examined family history and disease frequency, and studies in which reported family history was validated against relatives' true disease status. Data Extraction: Information about study quality, setting, and findings was extracted using standardized protocols. Data Synthesis: Two uncontrolled studies provided insufficient evidence to assess whether querying about family history improves any outcomes. One randomized, controlled trial and 2 uncontrolled studies provided weak evidence that some patients experienced a reversible, short-term increase in anxiety associated with family history taking. In 41 studies, different family history definitions were associated with sensitivities of 0 to 0.51 and specificities of 0.66 to 1.00 for detection of disease risk, and 0 to 0.83 and 0.48 to 1.00, respectively, for detection of prevalent disease. Twenty-three studies suggested that absence of disease in relatives was more accurately reported than presence of disease and that reporting accuracy was higher for information related to first-degree relatives than more distant relatives. Limitation: Few studies were designed to address the specific questions of interest. Conclusion: Insufficient evidence evaluates how to collect family history information accurately in the primary care setting and the effects of taking family history on patient outcomes. Patients seem to correctly report the absence of disease in relatives more often than the presence of disease.	[Wilson, Brenda J.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; Univ Nottingham, Nottingham NG7 2UH, England; McMaster Univ, Evidence Based Practice Ctr, Hamilton, ON L8S 4L8, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Nottingham; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Wilson, BJ (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	bwilson@uottawa.ca	Little, Julian/AAR-6117-2020; Carroll, June C/K-2096-2017	Little, Julian/0000-0001-5026-5531; Carroll, June C/0000-0002-5893-4194; Qureshi, Nadeem/0000-0003-4909-0644	Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services [290-020020]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract 290-020020).	Ahn J, 2008, INT J CANCER, V123, P1154, DOI 10.1002/ijc.23591; AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; Aitken JF, 1996, MELANOMA RES, V6, P313, DOI 10.1097/00008390-199608000-00006; Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004; Andersen MR, 2002, GYNECOL ONCOL, V85, P3, DOI 10.1006/gyno.2001.6556; Annis Ann M, 2005, Prev Chronic Dis, V2, pA19; AntonCulver H, 1996, GENET EPIDEMIOL, V13, P193, DOI 10.1002/(SICI)1098-2272(1996)13:2<193::AID-GEPI5>3.0.CO;2-9; BENNETT R, 2004, GENETIC FAMILY HIST, V2, P1; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Bjornholt JV, 2000, DIABETES CARE, V23, P1255, DOI 10.2337/diacare.23.9.1255; Bochud M, 2004, J CLIN EPIDEMIOL, V57, P497, DOI 10.1016/j.jclinepi.2003.10.008; Boer JMA, 1996, INT J EPIDEMIOL, V25, P394, DOI 10.1093/ije/25.2.394; BOYKO EJ, 1990, J CLIN EPIDEMIOL, V43, P851, DOI 10.1016/0895-4356(90)90068-Z; Byeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065; Carlsson S, 2007, DIABETES CARE, V30, P3040, DOI 10.2337/dc07-0718; Cauley JA, 2007, BREAST CANCER RES TR, V102, P181, DOI 10.1007/s10549-006-9326-5; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; Denic S, 2001, BRIT J CANCER, V85, P1675, DOI 10.1054/bjoc.2001.2131; Djousse L, 2008, EUR J CLIN INVEST, V38, P896, DOI 10.1111/j.1365-2362.2008.02046.x; Dodani S, 2005, ETHNIC DIS, V15, P429; Ebbesson SOK, 1998, DIABETES CARE, V21, P563, DOI 10.2337/diacare.21.4.563; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; France CR, 1998, PSYCHOPHYSIOLOGY, V35, P341, DOI 10.1017/S0048577298000833; Gikas A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-2; Giles JT, 2001, PHARMACOTHERAPY, V21, P243, DOI 10.1592/phco.21.2.243.34100; Halapy E, 2005, BREAST CANCER RES TR, V90, P299, DOI 10.1007/s10549-004-5168-1; Hariri S, 2006, GENET MED, V8, P102, DOI 10.1097/01.gim.0000200949.52795.df; Haron Y, 2006, ISR MED ASSOC J, V8, P622; Hawe E, 2003, ANN HUM GENET, V67, P97, DOI 10.1046/j.1469-1809.2003.00017.x; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Hippe M, 1999, J EPIDEMIOL COMMUN H, V53, P269, DOI 10.1136/jech.53.5.269; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; Jousilahti P, 1997, STROKE, V28, P1361, DOI 10.1161/01.STR.28.7.1361; Kadison P, 1998, PREV MED, V27, P493, DOI 10.1006/pmed.1998.0313; Kadota A, 2008, HYPERTENS RES, V31, P1525, DOI 10.1291/hypres.31.1525; Kalish LA, 2000, UROLOGY, V56, P803, DOI 10.1016/S0090-4295(00)00780-9; Karter AJ, 1999, DIABETES CARE, V22, P938, DOI 10.2337/diacare.22.6.938; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; Kerlikowske K, 1997, JNCI-J NATL CANCER I, V89, P76, DOI 10.1093/jnci/89.1.76; King TM, 2002, UROLOGY, V59, P546, DOI 10.1016/S0090-4295(01)01598-9; Klungel OH, 1999, NETH J MED, V55, P177, DOI 10.1016/S0300-2977(99)00045-5; Leggatt V, 2000, J MED GENET, V37, P470, DOI 10.1136/jmg.37.6.470; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Magno CP, 2008, ETHNIC DIS, V18, P458; Makinen T, 2002, J CLIN ONCOL, V20, P2658, DOI 10.1200/JCO.2002.05.006; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Melbostad E, 1998, SCAND J WORK ENV HEA, V24, P262, DOI 10.5271/sjweh.319; Millar RP, 2003, TRENDS ENDOCRIN MET, V14, P35, DOI 10.1016/S1043-2760(02)00016-4; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Mohan V, 2003, J Assoc Physicians India, V51, P771; Molyneaux L, 2004, DIABETES OBES METAB, V6, P187, DOI 10.1111/j.1462-8902.2004.00330.x; Morrison AC, 2000, STROKE, V31, P2098, DOI 10.1161/01.STR.31.9.2098; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Mussio P, 1998, ANTICANCER RES, V18, P2811; Nakanishi S, 2003, DIABETES RES CLIN PR, V61, P109, DOI 10.1016/S0168-8227(03)00104-9; Novakovic B, 1996, JNCI-J NATL CANCER I, V88, P1492, DOI 10.1093/jnci/88.20.1492; Nyenwe EA, 2003, DIABETES RES CLIN PR, V62, P177, DOI 10.1016/j.diabres.2003.07.002; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; PARENT ME, 1995, EPIDEMIOLOGY, V6, P184, DOI 10.1097/00001648-199503000-00018; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Piros S, 2000, J CARDIOVASC RISK, V7, P395; Qureshi N, 2001, FAM PRACT, V18, P78, DOI 10.1093/fampra/18.1.78; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rodriguez C, 1997, EPIDEMIOLOGY, V8, P653, DOI 10.1097/00001648-199710000-00007; Rose P, 1999, FAM PRACT, V16, P78, DOI 10.1093/fampra/16.1.78; Sandhu MS, 2001, J MED SCREEN, V8, P69, DOI 10.1136/jms.8.2.69; Scheuner MT, 2006, GENET MED, V8, P491, DOI 10.1097/01.gim.0000232582.91028.03; Schneider KA, 2004, GENET TEST, V8, P222, DOI 10.1089/gte.2004.8.222; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Sijmons RH, 2000, EUR J HUM GENET, V8, P181, DOI 10.1038/sj.ejhg.5200441; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1123; Soegaard M, 2008, CANCER CAUSE CONTROL, V19, P469, DOI 10.1007/s10552-007-9108-3; Wattendorf DJ, 2005, AM FAM PHYSICIAN, V72, P441; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Werness BA, 1999, HUM PATHOL, V30, P151, DOI 10.1016/S0046-8177(99)90269-1; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009; Zhu KM, 1999, INT J EPIDEMIOL, V28, P409, DOI 10.1093/ije/28.3.409; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7	85	92	93	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					878	U11		10.7326/0000605-200912150-00177	http://dx.doi.org/10.7326/0000605-200912150-00177			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532ET	19884616				2022-12-28	WOS:000272728900006
J	Fernald, LCH; Gertler, PJ; Neufeld, LM				Fernald, Lia C. H.; Gertler, Paul J.; Neufeld, Lynnette M.			10-year effect of Oportunidades, Mexico's conditional cash transfer programme, on child growth, cognition, language, and behaviour: a longitudinal follow-up study	LANCET			English	Article							INTELLECTUAL-DEVELOPMENT; DEVELOPING-COUNTRIES; HEALTH; POVERTY; STRATEGIES; IMPACT	Background Mexico's conditional cash transfer programme, Oportunidades, was started to improve the lives of poor families through interventions in health, nutrition, and education. We investigated the effect of Oportunidades on children almost 10 years after the programme began. Methods From April, 1998, to October, 1999, low-income communities were randomly assigned to be enrolled in Oportunidades immediately (early treatment, n=320) or 18 months later (late treatment, n=186). In 2007, when 1093 children receiving early treatment and 700 late treatment in these communities were aged 8-10 years, they were assessed for outcomes including physical growth, cognitive and language development, and socioemotional development. The primary objective was to investigate outcomes associated with an additional 18 months in the programme. We used cluster-adjusted t tests and multivariate regressions to compare effects of programme participation for height-for-age, body-mass index (BMI), and cognitive language and behavioural assessment scores in early versus late treatment groups. Findings Early enrolment reduced behavioural problems for all children in the early versus late treatment group (mean behaviour problem score -0.09 [SD 0.97] vs 0.13 [1.03]; p=0.0024), but we identified no difference between groups for mean height-for-age Z scores (-1.12 [0.96] vs -1.14 [0.97]; p=0.88), BMI-for-age Z scores (0.14 [0.99] vs 0.17 [1.06]; p=0.58), or assessment scores for language (98.8 [13.8] vs 98.4 [14.6] p=0.90) or cognition (98.8 [12.9] vs 100.2 [13.2]; p=0.26). An additional 18 months of the programme before age 3 years for children aged 8-10 years whose mothers had no education resulted in improved child growth of about 1.5 cm assessed as height-for-weight Z score (beta 0.23 [0.023-0.44] p=0.029), independently of cash received. Interpretation An additional 18 months in the Oportunidades programme has independent beneficial effects other than money, especially for women with no formal education. The money itself also has significant effects on most outcomes, adding to existing evidence for interventions in early childhood.	[Fernald, Lia C. H.; Gertler, Paul J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Neufeld, Lynnette M.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Neufeld, Lynnette M.] Micronutrient Initiat, Ottawa, ON, Canada	University of California System; University of California Berkeley; Instituto Nacional de Salud Publica	Fernald, LCH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall, Berkeley, CA 94720 USA.	fernald@berkeley.edu		Fernald, Lia C.H./0000-0003-1555-4607	Mexican Ministry of Social Development; National Institutes of Child Health and Human Development	Mexican Ministry of Social Development; National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Mexican Ministry of Social Development and the National Institutes of Child Health and Human Development.	BECKER GS, 1986, J LABOR ECON, V4, pS1, DOI 10.1086/298118; BEHRMAN JR, 1999, RANDOMNESS EXPT SAMP; Das J, 2005, WORLD BANK RES OBSER, V20, P57, DOI 10.1093/wbro/lki005; de Janvry A, 2006, WORLD BANK ECON REV, V20, P1, DOI 10.1093/wber/lhj002; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; FERNALD LCH, EXAMINING C IN PRESS; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; GERTLER PJ, INVESTING CASH TRANS; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Guo G, 2000, DEMOGRAPHY, V37, P431, DOI 10.2307/2648070; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; Handa S, 2006, DEV POLICY REV, V24, P513, DOI 10.1111/j.1467-7679.2006.00345.x; Heckman J., 2005, PRODUCTIVITY ARGUMEN; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leroy JL, 2008, J NUTR, V138, P793, DOI 10.1093/jn/138.4.793; LEROY JL, 2009, J DEV EFFECTIVENESS, V1, P1; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Macours K, 2008, CAN CONDITIONAL CASH; MALUCCIO J, 2005, 141 INT FOOD POL RES; MCGEE R, 2001, POVERTY ASSESSMENT P; Moore C., 2008, ASSESSING HONDURAS C; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; Moser CON, 1998, WORLD DEV, V26, P1, DOI 10.1016/S0305-750X(97)10015-8; Ozer EJ, 2009, PEDIATRICS, V123, pE630, DOI 10.1542/peds.2008-2882; PAXSON C, 2008, DOES MONEY MAT UNPUB; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Skoufias E., 1999, EVALUATION SELECTION; Wechsler D., 2007, WASI 2 WECHSLER ABBR; WHO, WHO CHILD GROWTH STA; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P47, DOI 10.1007/s00787-004-2008-0; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511	35	149	154	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1997	2005		10.1016/S0140-6736(09)61676-7	http://dx.doi.org/10.1016/S0140-6736(09)61676-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19892392				2022-12-28	WOS:000272727000023
J	Cohen, J; Rau, A; Bruning, K				Cohen, Jeff; Rau, Alex; Bruning, Kristian			Bridging the Montreal-Kyoto Gap	SCIENCE			English	Editorial Material									[Cohen, Jeff] EOS Climate, San Francisco, CA 94080 USA; [Rau, Alex; Bruning, Kristian] Climate Wedge Ltd, San Francisco, CA 94080 USA; [Rau, Alex; Bruning, Kristian] Climate Wedge Ltd, Helsinki 00120, Finland		Cohen, J (corresponding author), EOS Climate, San Francisco, CA 94080 USA.							*INT PAN CLIM CHAN, 2005, IPCC TEAP SPEC REP S; Kintisch E, 2009, SCIENCE, V324, P323, DOI 10.1126/science.324.5925.323a; Kolankiewicz L.J., 2008, IMMIGRATION US WORLD; McKinsey & Company, 2009, PATHW LOW CARB EC VE; Ravishankara A. R., 2008, TRENDS EMISSIONS OZO; *UNEP TEAP, 2009, TASK FORC DEC 20 7 R; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104	7	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					940	941		10.1126/science.1176958	http://dx.doi.org/10.1126/science.1176958			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518SB	19892945				2022-12-28	WOS:000271712300019
J	Bakr, WS; Gillen, JI; Peng, A; Folling, S; Greiner, M				Bakr, Waseem S.; Gillen, Jonathon I.; Peng, Amy; Foelling, Simon; Greiner, Markus			A quantum gas microscope for detecting single atoms in a Hubbard-regime optical lattice	NATURE			English	Article							ULTRACOLD ATOMS; MOTT INSULATOR	Recent years have seen tremendous progress in creating complex atomicmany-body quantum systems. One approach is to use macroscopic, effectively thermodynamic ensembles of ultracold atoms to create quantum gases and strongly correlated states of matter, and to analyse the bulk properties of the ensemble. For example, bosonic and fermionic atoms in a Hubbard-regime optical lattice(1-5) can be used for quantum simulations of solid-state models(6). The opposite approach is to build up microscopic quantum systems atom-by-atom, with complete control over all degrees of freedom(7-9). The atoms or ions act as qubits and allow the realization of quantum gates, with the goal of creating highly controllable quantum information systems. Until now, the macroscopic and microscopic strategies have been fairly disconnected. Here we present a quantum gas 'microscope' that bridges the two approaches, realizing a system in which atoms of a macroscopic ensemble are detected individually and a complete set of degrees of freedom for each of them is determined through preparation and measurement. By implementing a high-resolution optical imaging system, single atoms are detected with near-unity fidelity on individual sites of a Hubbard-regime optical lattice. The lattice itself is generated by projecting a holographic mask through the imaging system. It has an arbitrary geometry, chosen to support both strong tunnel coupling between lattice sites and strong on-site confinement. Our approach can be used to directly detect strongly correlated states of matter; in the context of condensed matter simulation, this corresponds to the detection of individual electrons in the simulated crystal. Also, the quantum gas microscope may enable addressing and read-out of large-scale quantum information systems based on ultracold atoms.	[Bakr, Waseem S.; Gillen, Jonathon I.; Peng, Amy; Foelling, Simon; Greiner, Markus] Harvard Univ, Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA; [Bakr, Waseem S.; Gillen, Jonathon I.; Peng, Amy; Foelling, Simon; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Greiner, M (corresponding author), Harvard Univ, Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Greiner, Markus/E-9512-2017; Greiner, Markus/A-8502-2010	Folling, Simon/0000-0002-6951-3651	NSF; AFOSR MURI; DARPA; Alfred P. Sloan Fellowship	NSF(National Science Foundation (NSF)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation)	We are grateful for discussions with D. Weiss and V. Vuletic and thank P. Unterwaditzer, E. Su and J. Brachmann for experimental assistance during the early stage of the experiment. We thank D. Weiss for sharing the lens design of the objective lens. This work was funded by grants from the NSF, AFOSR MURI, DARPA, an Alfred P. Sloan Fellowship to M. G., and an NSF Fellowship to J. I. G.	Bergamini S, 2004, J OPT SOC AM B, V21, P1889, DOI 10.1364/JOSAB.21.001889; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Gericke T, 2008, NAT PHYS, V4, P949, DOI 10.1038/nphys1102; Gillen JI, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.021602; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; ITAH A, 2009, DIRECT OBSERVATION N; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Karski M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053001; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; MANSFIELD SM, 1990, APPL PHYS LETT, V57, P2615, DOI 10.1063/1.103828; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Newell R, 2003, OPT LETT, V28, P1266, DOI 10.1364/OL.28.001266; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Schrader D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150501; Soderberg KAB, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055022; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; WINELAND DJ, 1992, J OPT SOC AM B, V9, P32, DOI 10.1364/JOSAB.9.000032; Winoto SL, 1999, PHYS REV A, V59, pR19, DOI 10.1103/PhysRevA.59.R19; Wurtz P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.080404	30	1001	1002	7	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					74	U80		10.1038/nature08482	http://dx.doi.org/10.1038/nature08482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890326	Green Submitted			2022-12-28	WOS:000271419200034
J	Cuker, A; Connors, JM; Katz, JT; Levy, BD; Loscalzo, J				Cuker, Adam; Connors, Jean M.; Katz, Joel T.; Levy, Bruce D.; Loscalzo, Joseph			A Bloody Mystery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VON-WILLEBRAND-SYNDROME; MULTIPLE-MYELOMA; PLASMA-CELLS; DISEASE		[Connors, Jean M.; Katz, Joel T.; Levy, Bruce D.; Loscalzo, Joseph] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cuker, Adam] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania	Loscalzo, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jloscalzo@partners.org	Loscalzo, Joseph/ABD-8980-2021					Bowen DJ, 2006, BRIT J HAEMATOL, V133, P457, DOI 10.1111/j.1365-2141.2006.06096.x; Casonato A, 2002, BRIT J HAEMATOL, V116, P899, DOI 10.1046/j.0007-1048.2002.03341.x; Federici AB, 2006, SEMIN HEMATOL, V43, pS48, DOI 10.1053/j.seminhematol.2005.11.003; Federici AB, 1998, BLOOD, V92, P2707, DOI 10.1182/blood.V92.8.2707.420k25_2707_2711; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; MOHRI H, 1995, BLOOD COAGUL FIBRIN, V6, P561, DOI 10.1097/00001721-199509000-00010; Mohri H, 2006, AM J HEMATOL, V81, P616, DOI 10.1002/ajh.20455; RICHARD C, 1990, AM J HEMATOL, V35, P114, DOI 10.1002/ajh.2830350210; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SCROBOHACI ML, 1993, BRIT J HAEMATOL, V84, P471, DOI 10.1111/j.1365-2141.1993.tb03103.x	10	12	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1887	1894		10.1056/NEJMcps066546	http://dx.doi.org/10.1056/NEJMcps066546			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890132				2022-12-28	WOS:000271405800016
J	Spite, M; Norling, LV; Summers, L; Yang, R; Cooper, D; Petasis, NA; Flower, RJ; Perretti, M; Serhan, CN				Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Cooper, Dianne; Petasis, Nicos A.; Flower, Roderick J.; Perretti, Mauro; Serhan, Charles N.			Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis	NATURE			English	Article							NITRIC-OXIDE; LIPID MEDIATORS; ACUTE-INFLAMMATION; ENDOTOXIC-SHOCK; IN-VIVO; MACROPHAGES; ACTIVATION; RESOLUTION; RECEPTORS; MORTALITY	A growing body of evidence indicates that resolution of acute inflammation is an active process(1,2). Resolvins are a new family of lipid mediators enzymatically generated within resolution networks that possess unique and specific functions to orchestrate catabasis, the phase in which disease declines(2,3). Resolvin D2 (RvD2) was originally identified in resolving exudates, yet its individual contribution in resolution remained to be elucidated. Here, we establish RvD2's potent stereoselective actions in reducing excessive neutrophil trafficking to inflammatory loci. RvD2 decreased leukocyte-endothelial interactions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leukocyte adhesion receptor expression. In mice with microbial sepsis initiated by caecal ligation and puncture, RvD2 sharply decreased both local and systemic bacterial burden, excessive cytokine production and neutrophil recruitment, while increasing peritoneal mononuclear cells and macrophage phagocytosis. These multi-level pro-resolving actions of RvD2 translate to increased survival from sepsis induced by caecal ligation and puncture and surgery. Together, these results identify RvD2 as a potent endogenous regulator of excessive inflammatory responses that acts via multiple cellular targets to stimulate resolution and preserve immune vigilance.	[Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Norling, Lucy V.; Cooper, Dianne; Flower, Roderick J.; Perretti, Mauro] Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, London EC1M 6BQ, England; [Petasis, Nicos A.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA; [Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of London; Queen Mary University London; University of Southern California; University of Southern California	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Spite, Matthew/B-3337-2010; Norling, Lucy/W-9523-2019; Petasis, Nicos/B-3162-2009; Norling, Lucy/AAO-4645-2020; Yang, Rong/ABA-7587-2021	Petasis, Nicos/0000-0002-8864-4446; Norling, Lucy/0000-0001-5316-9115; Yang, Rong/0000-0001-8837-0089	National Institutes of Health [GM-38765, P50-DE016191]; Welcome Trust [086867/Z/08/Z, 085903/Z/08]; Arthritis Research Campaign UK [18445, 18103]; NHLBI [HL087526]; Versus Arthritis [18103] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL087526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038765, R37GM038765, R01GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welcome Trust(Wellcome Trust); Arthritis Research Campaign UK(Versus Arthritis); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from National Institutes of Health grants GM-38765 and P50-DE016191 (C. N. S.), Welcome Trust Programme grant 086867/Z/08/Z (R. J. F. and M. P.) and Project grant 085903/Z/08 (R. J. F.) and Arthritis Research Campaign UK fellowships 18445 and 18103 (to L. V. N. and D. C., respectively). M. S. received a National Research Service Award from the NHLBI (HL087526). We thank J. W. Winkler and J. Uddin for work related to RvD2 synthesis, P. Pillai, K. Martinod, G. Fredman and J. Dalli for technical assistance, and M. H. Small for assistance with the manuscript. We also thank B. Schmidt for histopathology, Children's Hospital Boston.	Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Farolan LR, 1996, SHOCK, V6, P263, DOI 10.1097/00024382-199610000-00007; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Pluess TT, 2007, INTENS CARE MED, V33, P789, DOI 10.1007/s00134-007-0591-5; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rodriguez AR, 2004, TETRAHEDRON LETT, V45, P8717, DOI 10.1016/j.tetlet.2004.09.129; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, METHOD ENZYMOL, V432, P275, DOI 10.1016/S0076-6879(07)32012-0; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Singer P, 2008, INTENS CARE MED, V34, P1580, DOI 10.1007/s00134-008-1142-4; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415	32	489	507	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1287	U125		10.1038/nature08541	http://dx.doi.org/10.1038/nature08541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	511TF	19865173	Green Accepted, Green Submitted			2022-12-28	WOS:000271190800050
J	Ma, SM; Li, JWH; Choi, JW; Zhou, H; Lee, KKM; Moorthie, VA; Xie, XK; Kealey, JT; Da Silva, NA; Vederas, JC; Tang, Y				Ma, Suzanne M.; Li, Jesse W. -H.; Choi, Jin W.; Zhou, Hui; Lee, K. K. Michael; Moorthie, Vijayalakshmi A.; Xie, Xinkai; Kealey, James T.; Da Silva, Nancy A.; Vederas, John C.; Tang, Yi			Complete Reconstitution of a Highly Reducing Iterative Polyketide Synthase	SCIENCE			English	Article							LOVASTATIN NONAKETIDE SYNTHASE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CRYSTAL-STRUCTURE; ADH2 PROMOTER; GENE-CLUSTER; BIOSYNTHESIS; EXPRESSION; PROTEINS; VERSATILITY; CLONING	Highly reducing iterative polyketide synthases are large, multifunctional enzymes that make important metabolites in fungi, such as lovastatin, a cholesterol-lowering drug from Aspergillus terreus. We report efficient expression of the lovastatin nonaketide synthase (LovB) from an engineered strain of Saccharomyces cerevisiae, as well as complete reconstitution of its catalytic function in the presence and absence of cofactors ( the reduced form of nicotinamide adenine dinucleotide phosphate and S-adenosylmethionine) and its partner enzyme, the enoyl reductase LovC. Our results demonstrate that LovB retains correct intermediates until completion of synthesis of dihydromonacolin L, but off-loads incorrectly processed compounds as pyrones or hydrolytic products. Experiments replacing LovC with analogous MlcG from compactin biosynthesis demonstrate a gate-keeping function for this partner enzyme. This study represents a key step in the understanding of the functions and structures of this family of enzymes.	[Li, Jesse W. -H.; Moorthie, Vijayalakshmi A.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Ma, Suzanne M.; Zhou, Hui; Xie, Xinkai; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Choi, Jin W.; Lee, K. K. Michael; Da Silva, Nancy A.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92697 USA; [Kealey, James T.] Amyris Biotechnol, Emeryville, CA 94608 USA	University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca; yitang@ucla.edu		Vederas, John/0000-0002-2996-0326	NIH [1R21GM077264, 1R01GM085128]; David and Lucile Packard Fellowship in Science and Engineering; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NSF [BES0432307]; Kosan Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128, R21GM077264] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NSF(National Science Foundation (NSF)); Kosan Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Khosla for plasmid pRSG33 and L. Du for LovC cDNA. This work was supported in part by NIH ( grants 1R21GM077264 and 1R01GM085128) and a David and Lucile Packard Fellowship in Science and Engineering to Y. T. These studies were also supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chair in Bioorganic and Medicinal Chemistry, NSF ( Grant Opportunities for Academic Liaison with Industry program, grant BES0432307 to N. A. D. S.), and Kosan Biosciences. J. T. K. was formerly affiliated with Kosan Biosciences.	Abe Y, 2002, MOL GENET GENOMICS, V267, P636, DOI 10.1007/s00438-002-0697-y; An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Burr DA, 2007, ORG LETT, V9, P161, DOI 10.1021/ol062763i; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Halo LM, 2008, CHEMBIOCHEM, V9, P585, DOI 10.1002/cbic.200700390; HUTCHINSON CR, 2005, HDB IND MYCOLOGY, pCH17; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Lee KM, 2005, YEAST, V22, P431, DOI 10.1002/yea.1221; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma SM, 2007, FEBS J, V274, P2854, DOI 10.1111/j.1742-4658.2007.05818.x; Maggon K, 2005, DRUG DISCOV TODAY, V10, P739, DOI 10.1016/S1359-6446(05)03468-9; MOORE RN, 1985, J AM CHEM SOC, V107, P3694, DOI 10.1021/ja00298a046; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; PRICE VL, 1990, METHOD ENZYMOL, V185, P308; Sims JW, 2005, CHEM COMMUN, P186, DOI 10.1039/b413523g; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	23	252	273	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					589	592		10.1126/science.1175602	http://dx.doi.org/10.1126/science.1175602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900898	Green Accepted			2022-12-28	WOS:000271019400046
J	Wittkopp, PJ; Stewart, EE; Arnold, LL; Neidert, AH; Haerum, BK; Thompson, EM; Akhras, S; Smith-Winberry, G; Shefner, L				Wittkopp, Patricia J.; Stewart, Emma E.; Arnold, Lisa L.; Neidert, Adam H.; Haerum, Belinda K.; Thompson, Elizabeth M.; Akhras, Saleh; Smith-Winberry, Gabriel; Shefner, Laura			Intraspecific Polymorphism to Interspecific Divergence: Genetics of Pigmentation in Drosophila	SCIENCE			English	Article							EVOLUTIONARY HISTORY; AMERICANA; PATTERNS; GENOMES; GENES	Genetic changes contributing to phenotypic differences within or between species have been identified for a handful of traits, but the relationship between alleles underlying intraspecific polymorphism and interspecific divergence is largely unknown. We found that noncoding changes in the tan gene, as well as changes linked to the ebony gene, contribute to pigmentation divergence between closely related Drosophila species. Moreover, we found that alleles linked to tan and ebony fixed in one Drosophila species also contribute to variation within another species, and that multiple genotypes underlie similar phenotypes even within the same population. These alleles appear to predate speciation, which suggests that standing genetic variation present in the common ancestor gave rise to both intraspecific polymorphism and interspecific divergence.	[Wittkopp, Patricia J.; Stewart, Emma E.; Neidert, Adam H.; Haerum, Belinda K.; Akhras, Saleh; Smith-Winberry, Gabriel; Shefner, Laura] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Wittkopp, Patricia J.; Arnold, Lisa L.; Thompson, Elizabeth M.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	wittkopp@umich.edu			NSF [DEB140640485]; Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects; University of Michigan; Alfred P. Sloan Research Fellow	NSF(National Science Foundation (NSF)); Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects; University of Michigan(University of Michigan System); Alfred P. Sloan Research Fellow	We thank G. Kalay, X. Heng, M. Weisel, A. Ratnala, and E. Larimore for technical assistance; P. Mena and B. McAllister for sharing unpublished data ( including the images shown in fig. S7) and lines of D. americana; C. Dick for use of the Mixer Mill, M. Rebeiz for sharing an unpublished in situ protocol; N. Rosenberg, G. Coop, and other colleagues for discussions of incomplete lineage sorting and introgression; and J. Gruber, J. Coolon, A. Cooley, G. Kalay, D. Yuan, B. McAllister, A. Kopp, B. Prud'homme, and N. Gompel for comments on the manuscript. Supported by NSF grant DEB140640485, the Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects, and the University of Michigan. P. J. W. is an Alfred P. Sloan Research Fellow. DNA sequences are available from GenBank ( accession numbers GQ457336 to GQ457453).	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BRIDGES CB, 1923, PUBL CARNEGIE I, V327; Caletka BC, 2004, MOL PHYLOGENET EVOL, V33, P664, DOI 10.1016/j.ympev.2004.08.007; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HSU TC, 1951, THESIS U TEXAS AUSTI; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; LAURIE CC, 1994, GENETICS, V138, P379; Maside XL, 2004, CURR BIOL, V14, P150, DOI 10.1016/j.cub.2003.12.055; McAllister BF, 2003, GENETICS, V165, P1317; McAllister BF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000112; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; MENA P, COMMUNICATION; Morales-Hojas R, 2008, MOL ECOL, V17, P2910, DOI 10.1111/j.1365-294X.2008.03796.x; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Schafer MA, 2006, HEREDITY, V97, P291, DOI 10.1038/sj.hdy.6800860; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Vieira CP, 2003, GENETICS, V164, P1459; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849	28	110	113	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					540	544		10.1126/science.1176980	http://dx.doi.org/10.1126/science.1176980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900891				2022-12-28	WOS:000271019400032
J	Harris, LJ				Harris, Loren J.			Bronchial Obstruction after Pneumonectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Harris, LJ (corresponding author), Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1688	1688		10.1056/NEJMicm0707911	http://dx.doi.org/10.1056/NEJMicm0707911			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846854				2022-12-28	WOS:000270977400011
J	Pan, JH				Pan, Jiahua			China expects leadership from rich nations	NATURE			English	Editorial Material									Chinese Acad Social Sci, Inst Urban & Environm Studies, Beijing 100005, Peoples R China	Chinese Academy of Social Sciences	Pan, JH (corresponding author), Chinese Acad Social Sci, Inst Urban & Environm Studies, 10 Xianxiao Hutong, Beijing 100005, Peoples R China.	jiahuapan@163.com							0	5	6	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1055	1055		10.1038/4611055a	http://dx.doi.org/10.1038/4611055a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847244	Bronze			2022-12-28	WOS:000270987600019
J	Chew, EY				Chew, Emily Y.			Laser Photocoagulation and Intravitreal Injection of Triamcinolone for Retinal Vein Occlusions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MACULAR EDEMA SECONDARY; STANDARD-CARE; EFFICACY; SAFETY; EYE	Objective: To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone with observation for eyes with vision loss associated with macular edema secondary to perfused central retinal vein occlusion (CRVO). Methods: Multicenter, randomized, clinical trial of 271 participants. Main Outcome Measure: Gain in visual acuity letter score of 15 or more from baseline to month 12. Results: Seven percent, 27%, and 26% of participants achieved the primary outcome in the observation, 1-mg, and 4-mg groups, respectively. The odds of achieving the primary outcome were 5.0 times greater in the 1-mg group than the observation group (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.8-14.1; P=.001) and 5.0 times greater in 4-mg group than the observation group (OR, 5.0; 95% CI, 1.8-14.4; P=.001); there was no difference identified between the 1-mg and 4-mg groups (OR, 1.0, 95% CI, 0.5-2.1; P=.97). The rates of elevated intraocular pressure and cataract were similar for the observation and 1-mg groups, but higher in the 4-mg group. Conclusions: Intravitreal triamcinolone is superior to observation for treating vision loss associated with macular edema secondary to CRVO in patients who have characteristics similar to those in the SCORE-CRVO trial. The 1-mg dose has a safety profile superior to that of the 4-mg dose. Application to Clinical Practice: Intravitreal triamcinolone in a 1-mg dose, following the retreatment criteria applied in the SCORE Study, should be considered for up to 1 year, and possibly 2 years, for patients with characteristics similar to those in the SCORE-CRVO trial.	NEI, NIH, CRC, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, NIH, CRC, Bldg 10,Room 3-2531,10 Ctr Dr,MSC 1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov			Intramural NIH HHS [Z99 EY999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1101, DOI 10.1001/archophthalmol.2009.234; Iturralde D, 2006, RETINA-J RET VIT DIS, V26, P279, DOI 10.1097/00006982-200603000-00005; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Lee HBH, 2007, CAN J OPHTHALMOL, V42, P131, DOI 10.3129/canjophthalmol.06-101; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1115, DOI 10.1001/archophthalmol.2009.233	10	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1693	1695		10.1001/jama.2009.1523	http://dx.doi.org/10.1001/jama.2009.1523			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19856489				2022-12-28	WOS:000270941200025
J	Mulley, AG				Mulley, Albert G.			Inconvenient truths about supplier induced demand and unwarranted variation in medical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGIONAL-VARIATIONS; HEALTH OUTCOMES; DECISION AIDS; PRIMARY-CARE; QUALITY; PROSTATECTOMY; INTENSITY; PROGRAM; TRIAL		[Mulley, Albert G.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Mulley, Albert G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mulley, AG (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St, Boston, MA 02114 USA.	amulley@partners.org						BARRY MJ, 1995, MED CARE, V33, P771, DOI 10.1097/00005650-199508000-00003; Burton MJ, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym259; Cabot R.C., 1903, AM MED, V5, P344; Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; Eddy D M, 1984, Health Aff (Millwood), V3, P74, DOI 10.1377/hlthaff.3.2.74; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FOWLER FJ, 1995, UROLOGY, V45, P1007, DOI 10.1016/S0090-4295(99)80122-8; Glover J A, 1938, Proc R Soc Med, V31, P1219; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Mulley A. G., 1995, OUTCOMES CLIN PRACTI; MULLEY AG, 1989, MILBANK Q, V67, P257, DOI 10.2307/3350140; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; RICHARDSON JR, 2006, RECONSIDERING THEORI; Schon D.A, 2017, REFLECTIVE PRACTITIO; SEPUCHA KR, 2004, HLTH AFF MILLWOOD S, pVAR54; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; WENNBERG JE, 1988, JAMA-J AM MED ASSOC, V259, P3027, DOI 10.1001/jama.259.20.3027	26	62	62	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2009	339								b4073	10.1136/bmj.b4073	http://dx.doi.org/10.1136/bmj.b4073			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510PJ	19843566				2022-12-28	WOS:000271102100002
J	Jefferson, T; Jones, M; Doshi, P; Del Mar, C				Jefferson, Tom; Jones, Mark; Doshi, Peter; Del Mar, Chris			Possible harms of oseltarnivir-a call for urgent action	LANCET			English	Editorial Material							OSELTAMIVIR		[Del Mar, Chris] Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia; [Jefferson, Tom] Cochrane Acute Resp Infect Grp, Anguillara Sabazia, Italy; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Doshi, Peter] MIT, Cambridge, MA 02139 USA	Bond University; University of Queensland; Massachusetts Institute of Technology (MIT)	Del Mar, C (corresponding author), Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia.	cdelmar@bond.edu.au	Del Mar, Chris/B-1136-2008; Jones, Mark/I-2720-2016	Del Mar, Chris/0000-0003-3821-8163; Jones, Mark/0000-0001-6858-9710				Hama R., 2008, INT J RISK SAF MED, V20, P5, DOI [DOI 10.3233/JRS-2008-0431, 10.3233/JRS-2008-0431]; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Nicholson K G, 1992, Semin Respir Infect, V7, P26; Ortiz JR, 2008, EMERG INFECT DIS, V14, P1280, DOI 10.3201/eid1408.080074; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; *US FDA, 2009, ADV EV REP SYST AERS; Yorifuji T, 2009, EPIDEMIOLOGY, V20, P188, DOI 10.1097/EDE.0b013e318190e73f	7	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1312	1313		10.1016/S0140-6736(09)61804-3	http://dx.doi.org/10.1016/S0140-6736(09)61804-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19837238	Green Submitted			2022-12-28	WOS:000271254600009
J	Fulweiler, RW				Fulweiler, Robinson W.			Fantastic Fixers	SCIENCE			English	Editorial Material							NITROGEN-FIXATION; METHANE		Boston Univ, Dept Earth Sci, Boston, MA 02215 USA	Boston University	Fulweiler, RW (corresponding author), Boston Univ, Dept Earth Sci, Boston, MA 02215 USA.	rwf@bu.edu	Fulweiler, Robinson W./A-3806-2010	Fulweiler, Robinson W./0000-0003-0871-4246				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; Fulweiler RW, 2007, NATURE, V448, P180, DOI 10.1038/nature05963; Gardner WS, 2006, LIMNOL OCEANOGR, V51, P558, DOI 10.4319/lo.2006.51.1_part_2.0558; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; McCarthy MJ, 2008, ESTUAR COAST, V31, P521, DOI 10.1007/s12237-008-9041-z; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Postgate J. R, 1982, FUNDAMENTALS NITROGE; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	14	6	6	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					377	378		10.1126/science.1181129	http://dx.doi.org/10.1126/science.1181129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833949				2022-12-28	WOS:000270818600034
J	Taccone, P; Pesenti, A; Latini, R; Polli, F; Vagginelli, F; Mietto, C; Caspani, L; Raimondi, F; Bordone, G; Iapichino, G; Mancebo, J; Guerin, C; Ayzac, L; Blanch, L; Fumagalli, R; Tognoni, G; Gattinoni, L				Taccone, Paolo; Pesenti, Antonio; Latini, Roberto; Polli, Federico; Vagginelli, Federica; Mietto, Cristina; Caspani, Luisa; Raimondi, Ferdinando; Bordone, Giovanni; Iapichino, Gaetano; Mancebo, Jordi; Guerin, Claude; Ayzac, Louis; Blanch, Lluis; Fumagalli, Roberto; Tognoni, Gianni; Gattinoni, Luciano		Prone-Supine II Study Grp	Prone Positioning in Patients With Moderate and Severe Acute Respiratory Distress Syndrome A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED LUNG INJURY; MECHANICAL VENTILATION; CLINICAL-TRIALS; FAILURE; METAANALYSIS; MULTICENTER; GUIDELINES; OUTCOMES; SEPSIS; STRAIN	Context Post hoc analysis of a previous trial has suggested that prone positioning may improve survival in patients with severe hypoxemia and with acute respiratory distress syndrome (ARDS). Objective To assess possible outcome benefits of prone positioning in patients with moderate and severe hypoxemia who are affected by ARDS. Design, Setting, and Patients The Prone-Supine II Study, a multicenter, unblinded, randomized controlled trial conducted in 23 centers in Italy and 2 in Spain. Patients were 342 adults with ARDS receiving mechanical ventilation, enrolled from February 2004 through June 2008 and prospectively stratified into subgroups with moderate (n=192) and severe (n=150) hypoxemia. Interventions Patients were randomized to undergo supine (n=174) or prone (20 hours per day; n=168) positioning during ventilation. Main Outcome Measures The primary outcome was 28-day all-cause mortality. Secondary outcomes were 6-month mortality and mortality at intensive care unit discharge, organ dysfunctions, and the complication rate related to prone positioning. Results Prone and supine patients from the entire study population had similar 28-day (31.0% vs 32.8%; relative risk [RR], 0.97; 95% confidence interval [CI], 0.84-1.13; P=.72) and 6-month (47.0% vs 52.3%; RR, 0.90; 95% CI, 0.73-1.11; P=.33) mortality rates, despite significantly higher complication rates in the prone group. Outcomes were also similar for patients with moderate hypoxemia in the prone and supine groups at 28 days (25.5% vs 22.5%; RR, 1.04; 95% CI, 0.89-1.22; P=.62) and at 6 months (42.6% vs 43.9%; RR, 0.98; 95% CI, 0.76-1.25; P=.85). The 28-day mortality of patients with severe hypoxemia was 37.8% in the prone and 46.1% in the supine group (RR, 0.87; 95% CI, 0.66-1.14; P=.31), while their 6-month mortality was 52.7% and 63.2%, respectively (RR, 0.78; 95% CI, 0.53-1.14; P=.19). Conclusion Data from this study indicate that prone positioning does not provide significant survival benefit in patients with ARDS or in subgroups of patients with moderate and severe hypoxemia. Trial Registration clinicaltrials.gov Identifier: NCT00159939 JAMA. 2009;302(18):1977-1984	[Taccone, Paolo; Vagginelli, Federica; Caspani, Luisa; Gattinoni, Luciano] Fdn IRCCS Osped Maggiore Policlin Mangiagalli Reg, Dipartimento Anestesia & Rianimaz, I-20122 Milan, Italy; [Pesenti, Antonio; Fumagalli, Roberto] Azienda Osped San Gerardo Monza, Dipartimento Med Perioperatoria & Terapie Intens, Monza, Italy; [Latini, Roberto] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Polli, Federico; Mietto, Cristina; Iapichino, Gaetano; Gattinoni, Luciano] Univ Milan, Ist Anestesiol & Rianimaz, Milan, Italy; [Iapichino, Gaetano] Azienda Osped Polo Univ San Paolo, UO Anestesia & Rianimaz, Milan, Italy; [Pesenti, Antonio; Fumagalli, Roberto] Univ Milano Bicocca, Dipartimento Med Sperimentale, Milan, Italy; [Raimondi, Ferdinando] Polo Univ Luigi Sacco, UO Anestesia & Rianimaz, Milan, Italy; [Bordone, Giovanni] Ist Clin Humanitas, Dipartimento Anestesia & Rianimaz Gen, Rozzano, Italy; [Mancebo, Jordi] Hosp Sant Pau, Serv Med Intens, Barcelona, Spain; [Guerin, Claude] Hop Croix Rousse, Serv Reanimat Med & Assistance Resp, F-69317 Lyon, France; [Ayzac, Louis] Hosp Henry Gabrielle, Ctr Coordinat Lutte Infect Nosocomi Sud Est, St Genis Laval, France; [Blanch, Lluis] Univ Autonoma Barcelona, Crit Care Ctr, CIBER Enfermedades Resp, Corp Sanitaria Parc Tauli, Sabadell, Spain; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milano-Bicocca; IRCCS Humanitas Research Hospital; Hospital of Santa Creu i Sant Pau; CHU Lyon; CHU Lyon; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gattinoni, L (corresponding author), Fdn IRCCS Osped Maggiore Policlin Mangiagalli Reg, Dipartimento Anestesia & Rianimaz, Via F Sforza 35, I-20122 Milan, Italy.	gattinon@policlinico.mi.it	Pesenti, Antonio/H-7483-2012; Polli, Federico/AAB-9868-2022; Fumagalli, Roberto/AAB-9746-2019; Rialp, Gemma/I-3353-2016; Rossi, Sandra/AHH-8015-2022; Latini, Roberto/AAB-1410-2020; guerin, claude/H-5692-2014	Pesenti, Antonio/0000-0003-2593-729X; Fumagalli, Roberto/0000-0003-0398-1329; Rialp, Gemma/0000-0003-3614-3639; Rossi, Sandra/0000-0002-9963-8121; Latini, Roberto/0000-0002-3729-4650; guerin, claude/0000-0003-4700-6672; Gattinoni, Luciano/0000-0001-5380-2494				Abroug F, 2008, INTENS CARE MED, V34, P1002, DOI 10.1007/s00134-008-1062-3; Alsaghir AH, 2008, CRIT CARE MED, V36, P603, DOI 10.1097/01.CCM.0000299739.98236.05; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; PIEHL MA, 1976, CRIT CARE MED, V4, P13, DOI 10.1097/00003246-197601000-00003; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Slutsky AS, 2001, NEW ENGL J MED, V345, P610, DOI 10.1056/NEJM200108233450811; Sud S, 2008, CAN MED ASSOC J, V178, P1153, DOI 10.1503/cmaj.071802; Valenza F, 2005, CRIT CARE MED, V33, P361, DOI 10.1097/01.CCM.0000150660.45376.7C; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	20	316	362	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1977	1984		10.1001/jama.2009.1614	http://dx.doi.org/10.1001/jama.2009.1614			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903918	Bronze			2022-12-28	WOS:000271619700024
J	Naldini, L				Naldini, Luigi			A Comeback for Gene Therapy	SCIENCE			English	Editorial Material							STABLE TRANSDUCTION; HEMATOPOIETIC-CELLS; LENTIVIRAL VECTORS; CD34(+) CELLS; INTEGRATION; HIV; TRANSPLANTATION		Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University	Naldini, L (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy, Via Olgettina 58, I-20132 Milan, Italy.	naldini.luigi@hsr.it	Naldini, Luigi/E-9083-2012	NALDINI, Luigi/0000-0002-7835-527X	Telethon [TGT06D03] Funding Source: Medline	Telethon(Fondazione Telethon)		Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; AUBOURG P, 1990, NEW ENGL J MED, V322, P1860, DOI 10.1056/NEJM199006283222607; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Fischer A, 2008, LANCET, V371, P2044, DOI 10.1016/S0140-6736(08)60874-0; Kim YJ, 2009, BLOOD, V113, P5434, DOI 10.1182/blood-2008-10-185199; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; Miller JW, 2008, NEW ENGL J MED, V358, P2282, DOI 10.1056/NEJMe0803081; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939	18	47	52	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					805	806		10.1126/science.1181937	http://dx.doi.org/10.1126/science.1181937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892968	Green Published			2022-12-28	WOS:000271468000026
J	Ayala, E; Kagawa, FT; Wehner, JH; Tam, J; Upadhyay, D				Ayala, Estela; Kagawa, Frank T.; Wehner, John H.; Tam, James; Upadhyay, Daya			Rhabdomyolysis Associated With 2009 Influenza A(H1N1)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ayala, Estela; Upadhyay, Daya] Stanford Univ, Med Ctr, Pulm & Crit Care Div, Stanford, CA 94305 USA; [Kagawa, Frank T.; Wehner, John H.] Santa Clara Valley Med Ctr, Div Resp & Crit Care Med, San Jose, CA 95128 USA; [Tam, James] Santa Clara Valley Med Ctr, Dept Med, San Jose, CA 95128 USA	Stanford University; Santa Clara Valley Medical Center; Santa Clara Valley Medical Center	Ayala, E (corresponding author), Stanford Univ, Med Ctr, Pulm & Crit Care Div, Stanford, CA 94305 USA.	frank.kagawa@hhs.co.santa-clara.ca.us						Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Singh U, 1996, CLIN INFECT DIS, V22, P642, DOI 10.1093/clinids/22.4.642; Takayanagi Noboru, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P731; *WHO, 2009, CDC PROT REALT RTPCR	5	59	59	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1863	1864		10.1001/jama.2009.1582	http://dx.doi.org/10.1001/jama.2009.1582			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19887664	Bronze			2022-12-28	WOS:000271375300014
J	Campbell, EG; Rosenthal, M				Campbell, Eric G.; Rosenthal, Meredith			Reform of Continuing Medical Education Investments in Physician Human Capital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Campbell, Eric G.] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Rosenthal, Meredith] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Campbell, EG (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, 50 Stanford St,9th Floor, Boston, MA 02114 USA.	ecampbell@partners.org		Rosenthal, Meredith/0000-0003-3410-0184				*ACCR COUNC CONT M, 2007, ACCME ANN REP DAT 20; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Horowitz SD, 2004, MED EDUC, V38, P10, DOI 10.1046/j.1365-2923.2004.01702.x; Institute of Medicine, 2009, CONFL INT MED RES ED; Marinopoulos S. S., 2007, AHRQ PUBLICATION; Newhouse JP, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.2.136; Steinbrook R, 2008, JAMA-J AM MED ASSOC, V299, P1060, DOI 10.1001/jama.299.9.1060; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200	8	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1807	1808		10.1001/jama.2009.1560	http://dx.doi.org/10.1001/jama.2009.1560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861675				2022-12-28	WOS:000271150300026
J	Madden, JM; Graves, AJ; Ross-Degnan, D; Briesacher, BA; Soumerai, SB				Madden, Jeanne M.; Graves, Amy J.; Ross-Degnan, Dennis; Briesacher, Becky A.; Soumerai, Stephen B.			Cost-Related Medication Nonadherence After Implementation of Medicare Part D, 2006-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Madden, Jeanne M.; Ross-Degnan, Dennis; Soumerai, Stephen B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Graves, Amy J.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Briesacher, Becky A.] Univ Massachusetts, Sch Med, Worcester, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester	Madden, JM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jeanne_madden@hphc.org			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028745, K01AG031836, R01AG022362] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS010391, 2U18HS010391] Funding Source: Medline; NIA NIH HHS [R01AG028745, R01 AG022362, K01 AG031836, K01 AG031836-02, R01AG022362, R01 AG028745] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; *CTR MED MED SERV, 2002, SOURC SER HLTH HLTH; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; The Henry J. Kaiser Family Foundation, 2009, MED PRESCR DRUG BEN	6	43	43	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1755	1756						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861666	Green Published, Green Accepted			2022-12-28	WOS:000271150300017
J	Gornall, J				Gornall, Jonathan			NHS An eye on profit	BRITISH MEDICAL JOURNAL			English	Editorial Material												Jgornall@mac.com						BOFFEY D, 2007, DAILY MAIL      0113; GAINSBURY S, 2008, HLTH SERVICE J  0724; *MON, NHS FDN TRUST FIN RE; *MOORF EYE HOSP NH, ANN REP ACC 2008 09	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2009	339								b4294	10.1136/bmj.b4294	http://dx.doi.org/10.1136/bmj.b4294			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AK	19861371				2022-12-28	WOS:000271365500007
J	Voyles, J; Young, S; Berger, L; Campbell, C; Voyles, WF; Dinudom, A; Cook, D; Webb, R; Alford, RA; Skerratt, LF; Speare, R				Voyles, Jamie; Young, Sam; Berger, Lee; Campbell, Craig; Voyles, Wyatt F.; Dinudom, Anuwat; Cook, David; Webb, Rebecca; Alford, Ross A.; Skerratt, Lee F.; Speare, Rick			Pathogenesis of Chytridiomycosis, a Cause of Catastrophic Amphibian Declines	SCIENCE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; INFECTIOUS-DISEASE; RANA-PIPIENS; EXTINCTION; SKIN; FROG; SODIUM; VARIES	The pathogen Batrachochytrium dendrobatidis (Bd), which causes the skin disease chytridiomycosis, is one of the few highly virulent fungi in vertebrates and has been implicated in worldwide amphibian declines. However, the mechanism by which Bd causes death has not been determined. We show that Bd infection is associated with pathophysiological changes that lead to mortality in green tree frogs (Litoria caerulea). In diseased individuals, electrolyte transport across the epidermis was inhibited by > 50%, plasma sodium and potassium concentrations were respectively reduced by similar to 20% and similar to 50%, and asystolic cardiac arrest resulted in death. Because the skin is critical in maintaining amphibian homeostasis, disruption to cutaneous function may be the mechanism by which Bd produces morbidity and mortality across a wide range of phylogenetically distant amphibian taxa.	[Voyles, Jamie; Young, Sam; Berger, Lee; Webb, Rebecca; Skerratt, Lee F.; Speare, Rick] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia; [Campbell, Craig; Dinudom, Anuwat; Cook, David] Univ Sydney, Fac Med, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia; [Voyles, Wyatt F.] Univ New Mexico, Div Cardiol, Sch Med, Albuquerque, NM 87131 USA; [Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia	James Cook University; University of Sydney; University of New Mexico; James Cook University	Voyles, J (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia.	jamie.voyles@gmail.com	webb, rebecca/A-7458-2012; Skerratt, Lee Francis/L-2797-2013; Campbell, Craig R/B-5983-2012; Alford, Ross A/H-1577-2011	Campbell, Craig R/0000-0002-0843-7579; Alford, Ross A/0000-0002-3010-6768; Webb, Rebecca/0000-0002-2539-2755; Speare, Rick/0000-0002-9993-1213; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	Australian Research Council Discovery Project [DP0452826]; Australian Government Department of Environment and Heritage [RFT 43/2004]; Wildlife Preservation Society of Australia; Queensland Parks and Wildlife Service [WISP03866106, WISP04143907, WIWM04381507]; New South Wales Parks and Wildlife Service [IE0705693]	Australian Research Council Discovery Project(Australian Research Council); Australian Government Department of Environment and Heritage(Australian Government); Wildlife Preservation Society of Australia; Queensland Parks and Wildlife Service; New South Wales Parks and Wildlife Service	We thank A. Hyatt and V. Olsen for assistance with PCR and S. Bell, J. Browne, S. Cashins, S. Garland, M. Holdsworth, C. Manicom, L. Owens, R. Puschendorf, K. Rose, E. Rosenblum, D. Rudd, A. Storfer, J. VanDerwal, B. Voyles, and J. Warner for project assistance and editing. Supported by Australian Research Council Discovery Project grant DP0452826, Australian Government Department of Environment and Heritage grant RFT 43/2004, and the Wildlife Preservation Society of Australia. Animals were collected with permission from Queensland Parks and Wildlife Service ( scientific permits WISP03866106 and WISP04143907; movement permit WIWM04381507) and New South Wales Parks and Wildlife Service ( import license IE0705693).	ALVARADO RH, 1975, AM J PHYSIOL, V229, P869, DOI 10.1152/ajplegacy.1975.229.3.869; BENOS DJ, 1979, J GEN PHYSIOL, V73, P307, DOI 10.1085/jgp.73.3.307; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boutilier Robert G., 1992, P81; Castillo GA, 1997, COMP BIOCHEM PHYS A, V118, P1145, DOI 10.1016/S0300-9629(97)86799-0; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DEYRUP IJ, 1964, PHYSL AMPHIBIA, V1, P251; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; HEATWOLE H, 1994, AMPHIBIAN BIOL, V1, P98; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; PARADIS NA, 1996, CARDIAC ARREST SCI P, P621; ROBERTSON DR, 1978, COMP BIOCHEM PHYS A, V60, P387, DOI 10.1016/0300-9629(78)90005-1; Rosenman S, 2008, AUSTRALAS PSYCHIATRY, V16, P1, DOI 10.1080/10398560701760219; SCHAECHTER M, 1998, MECH MICROBIAL DIS, P419; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; WRIGHT KM, 2001, AMPHIBIAN MED CAPTIV, P318	27	446	462	2	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					582	585		10.1126/science.1176765	http://dx.doi.org/10.1126/science.1176765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900897				2022-12-28	WOS:000271019400044
J	Lapperre, TS; Snoeck-Stroband, JB; Gosman, MME; Jansen, DF; van Schadewijk, A; Thiadens, HA; Vonk, JM; Boezen, HM; ten Hacken, NHT; Sont, JK; Rabe, KF; Kerstjens, HAM; Hiemstra, PS; Timens, W; Postma, DS; Sterk, PJ				Lapperre, Therese S.; Snoeck-Stroband, Jiska B.; Gosman, Margot M. E.; Jansen, Desiree F.; van Schadewijk, Annemarie; Thiadens, Henk A.; Vonk, Judith M.; Boezen, H. Marike; ten Hacken, Nick H. T.; Sont, Jacob K.; Rabe, Klaus F.; Kerstjens, Huib A. M.; Hiemstra, Pieter S.; Timens, Wim; Postma, Dirkje S.; Sterk, Peter J.		GLUCOLD Study Grp	Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							AIR-FLOW LIMITATION; INHALED CORTICOSTEROIDS; LUNG-FUNCTION; DOUBLE-BLIND; SALMETEROL/FLUTICASONE PROPIONATE; INFLAMMATORY CELLS; SMOKING-CESSATION; COPD PATIENTS; HEALTH-STATUS; METAANALYSIS	Background: Inhaled corticosteroids (ICSs) and long-acting beta(2)-agonists (LABAs) are used to treat moderate to severe chronic obstructive pulmonary disease (COPD). Objective: To determine whether long-term ICS therapy, with and without LABAs, reduces inflammation and improves pulmonary function in COPD. Design: Randomized, placebo-controlled trial. (ClinicalTrials.gov registration number: NCT00158847) Setting: 2 university medical centers in The Netherlands. Patients: 114 steroid-naive current or former smokers with moderate to severe COPD. Measurements: Cell counts in bronchial biopsies and sputum (primary outcome); methacholine responsiveness at baseline, 6, and 30 months; and clinical outcomes every 3 months. Intervention: Random assignment by minimization method to receive fluticasone propionate, 500 mu g twice daily, for 6 months (n = 31) or 30 months (n = 26); fluticasone, 500 mu g twice daily, and salmeterol, 50 mu g twice daily, for 30 months (single inhaler; n = 28); or placebo twice daily (n = 29). Results: 101 patients were greater than 70% adherent to therapy. Fluticasone therapy decreased counts of mucosal CD3(+) cells (-55% [95% CI, -74% to -22%]; P = 0.004), CD4(+) cells (-78% [CI, -88% to 60%]; P < 0.001), CD8(+) cells (-57% [CI, -77% to -18%]; P = 0.010), and mast cells (-38% [CI, -60% to -2%]; P = 0.039) and reduced hyperresponsiveness (P = 0.036) versus placebo at 6 months, with effects maintained after 30 months. Fluticasone therapy for 30 months reduced mast cell count and increased eosinophil count and percentage of intact epithelium, with accompanying reductions in sputum neutrophil, macrophage, and lymphocyte counts and improvements in FEV1 decline, dyspnea, and quality of life. Reductions in inflammatory cells correlated with clinical improvements. Discontinuing fluticasone therapy at 6 months increased counts of CD3(+) cells (120% [CI, 24% to 289%]; P = 0.007), mast cells (218% [CI, 99% to 407%]; P < 0.001), and plasma cells (118% [CI, 9% to 336%]; P = 0.028) and worsened clinical outcome. Adding salmeterol improved FEV1 level. Limitations: The study was not designed to evaluate clinical outcomes. Measurement of primary outcome was not available for 24% of patients at 30 months. Conclusion: ICS therapy decreases inflammation and can attenuate decline in lung function in steroid-naive patients with moderate to severe COPD. Adding LABAs does not enhance these effects.	[Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, NL-9700 RB Groningen, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Amsterdam Med Ctr, Amsterdam, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Postma, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Box 30-001, NL-9700 RB Groningen, Netherlands.	j.k.sont@lumc.nl; d.s.postma@int.umcg.nl; p.j.sterk@amc.nl	Sterk, P.J./AAK-8175-2020; Sont, Jacob K/J-8071-2015; Vonk, Judith/K-8477-2019; Rabe, Klaus F./AAW-6296-2021; Kerstjens, Huib/N-4754-2017; Vonk, Judith M/ABA-3009-2020; Timens, Wim/K-5570-2013; Hiemstra, Pieter S/K-8587-2018	Sont, Jacob K/0000-0002-5840-0651; Vonk, Judith/0000-0001-7531-4547; Rabe, Klaus F./0000-0002-7020-1401; Kerstjens, Huib/0000-0001-7705-7927; Vonk, Judith M/0000-0001-7531-4547; Timens, Wim/0000-0002-4146-6363; Hiemstra, Pieter S/0000-0002-0238-5982; Lapperre, Therese/0000-0002-5176-0101	Netherlands Organization for Scientific Research; Netherlands Asthma Foundation [3.4.93.96.3]; GlaxoSmithKline of The Netherlands; University Medical Center Groningen; Leiden University Medical Center	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation; GlaxoSmithKline of The Netherlands(GlaxoSmithKline); University Medical Center Groningen; Leiden University Medical Center	Grant Support: By the Netherlands Asthma Foundation (grant 3.4.93.96.3), GlaxoSmithKline of The Netherlands, University Medical Center Groningen, and Leiden University Medical Center.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; BATTAGLIA S, 2003, AM J RESP CRIT CARE, V167, pA873; Battaglia S, 2007, J CLIN PATHOL, V60, P907, DOI 10.1136/jcp.2006.037002; Belvisi Maria G, 2004, Proc Am Thorac Soc, V1, P207, DOI 10.1513/pats.200402-002MS; Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; *EUR AG EV MED PRO, 1999, POINTS CONS CLIN INV; *EUR AG EV MED PRO, 1999, POINTS CONS MULT ISS; Gan Wen Qi, 2005, BMC Pulm Med, V5, P3, DOI 10.1186/1471-2466-5-3; Gizycki MJ, 2002, THORAX, V57, P799, DOI 10.1136/thorax.57.9.799; *GLOB IN CHRON OBS, 2008, NHLBI WHO WORKSH REP; Grashoff WFH, 1997, AM J PATHOL, V151, P1785; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Highland KB, 2003, ANN INTERN MED, V138, P969, DOI 10.7326/0003-4819-138-12-200306170-00008; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kocks JWH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-62; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; POSTMA DS, 1986, AM REV RESPIR DIS, V134, P276; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Rennard SI, 2008, CHEST, V134, P623, DOI 10.1378/chest.07-3059; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Sont JK, 2003, AM J RESP CRIT CARE, V167, P1496, DOI 10.1164/rccm.2205003; Soriano JB, 2007, CHEST, V131, P682, DOI 10.1378/chest.06-1696; Sutherland ER, 2003, THORAX, V58, P937, DOI 10.1136/thorax.58.11.937; Tashkin DP, 2008, EUR RESPIR J, V31, P742, DOI 10.1183/09031936.00129607; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; van Grunsven PM, 1999, THORAX, V54, P7, DOI 10.1136/thx.54.1.7; Verhoeven GT, 2002, THORAX, V57, P694, DOI 10.1136/thorax.57.8.694; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280	45	152	157	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					517	U20		10.7326/0003-4819-151-8-200910200-00004	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19841453				2022-12-28	WOS:000271386200001
J	Eippert, F; Finsterbusch, J; Bingel, U; Buchel, C				Eippert, Falk; Finsterbusch, Juergen; Bingel, Ulrike; Buechel, Christian			Direct Evidence for Spinal Cord Involvement in Placebo Analgesia	SCIENCE			English	Article							MECHANISMS		[Eippert, Falk; Finsterbusch, Juergen; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany; [Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Eippert, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany.	f.eippert@uke.uni-hamburg.de	Finsterbusch, Jürgen/M-2969-2016; Eippert, Falk/M-6188-2013	Eippert, Falk/0000-0002-3986-1719				Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Fields HL, 2006, WALL MELZACKS TXB PA, P125; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Matre D, 2006, J NEUROSCI, V26, P559, DOI 10.1523/JNEUROSCI.4218-05.2006; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176	6	298	304	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					404	404		10.1126/science.1180142	http://dx.doi.org/10.1126/science.1180142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833962				2022-12-28	WOS:000270818600046
J	Gerstner, W; Naud, R				Gerstner, Wulfram; Naud, Richard			How Good Are Neuron Models?	SCIENCE			English	Editorial Material							DENDRITES; FRAMEWORK		[Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne, Switzerland; Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gerstner, W (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne, Switzerland.	wulfram.gerstner@epfl.ch	Naud, Richard/V-2586-2019	Naud, Richard/0000-0001-7383-3095				Boucsein C, 2005, J NEUROPHYSIOL, V94, P2948, DOI 10.1152/jn.00245.2005; Carandini M, 2007, J VISION, V7, DOI 10.1167/7.14.20; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Huys QJM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000379; Jolivet R, 2008, BIOL CYBERN, V99, P417, DOI 10.1007/s00422-008-0261-x; Kobayashi R, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.009.2009; Koch Christof, 1999, P1; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Meunier C, 2002, TRENDS NEUROSCI, V25, P558, DOI 10.1016/S0166-2236(02)02278-6; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104	15	146	146	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					379	380		10.1126/science.1181936	http://dx.doi.org/10.1126/science.1181936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833951	Green Submitted			2022-12-28	WOS:000270818600036
J	Ye, X; Wang, YS; Cahill, H; Yu, MZ; Badea, TC; Smallwood, PM; Peachey, NS; Nathans, J				Ye, Xin; Wang, Yanshu; Cahill, Hugh; Yu, Minzhong; Badea, Tudor C.; Smallwood, Philip M.; Peachey, Neal S.; Nathans, Jeremy			Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization	CELL			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; VENOUS INSUFFICIENCY; REDUNDANT ROLES; DISEASE MICE; ANGIOGENESIS; MUTATIONS; MOUSE; VASCULATURE; MODEL; SOX17	Disorders of vascular structure and function play a central role in a wide variety of CNS diseases. Mutations in the Frizzled-4 (Fz4) receptor, Lrp5 coreceptor, or Norrin ligand cause retinal hypovascularization, but the mechanisms by which Norrin/Fz4/Lrp signaling controls vascular development have not been defined. Using mouse genetic and cell culture models, we show that loss of Fz4 signaling in endothelial cells causes defective vascular growth, which leads to chronic but reversible silencing of retinal neurons. Loss of Fz4 in all endothelial cells disrupts the blood brain barrier in the cerebellum, whereas excessive Fz4 signaling disrupts embryonic angiogenesis. Sox17, a transcription factor that is upregulated by Norrin/Fz4/Lrp signaling, plays a central role in inducing the angiogenic program controlled by Norrin/Fz4/Lrp. These experiments establish a cellular basis for retinal hypovascularization diseases due to insufficient Frizzled signaling, and they suggest a broader role for Frizzled signaling in vascular growth, remodeling, maintenance, and disease.	[Ye, Xin; Wang, Yanshu; Badea, Tudor C.; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wang, Yanshu; Badea, Tudor C.; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland VA Med Ctr, Res Serv, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu	Badea, Tudor Constantin/B-1654-2018; Peachey, Neal/G-5533-2010	Badea, Tudor Constantin/0000-0003-3086-6713; Peachey, Neal/0000-0002-4419-7226; Nathans, Jeremy/0000-0001-8106-5460	National Eye Institute; Howard Hughes Medical Institute; Foundation Fighting Blindness; Veterans Administration; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation Fighting Blindness(European Commission); Veterans Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Elke Stein, Shin Kang, and Dwight Bergles for helpful discussions; Chip Hawkins and the JHMI transgenic core for blastocyst injection; Lawrence Chan, Milan Jamrich, Eric Swindell, Ralf Adams, and Masashi Yanagisawa for mouse lines; Se-Jin Lee for the mouse ES cell genomic library; Huimin Yu for the Norrin-expressing 293 cell line; Corrinne Lobe for the Z/AP plasmid; Tom Rotolo for the Z/AP targeting vector; William Guggino for the use of his fluorescent microscope; Hongjun Song for advice on producing the lentivirus; Linda Orzolek, Ira Maine, Haiping Hao, and Connie Talbot for microarray support; Yifeng Zhang and Markus Meister for advice on microelectrode array recording; and David Ginty, Stewart Hendry, Se-Jin Lee, Amir Rattner, and Randy Reed for helpful comments on the manuscript. This work was supported by the National Eye Institute, the Howard Hughes Medical Institute, the Foundation Fighting Blindness, and the Veterans Administration.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alm A., 1992, ADLERS PHYSL EYE, P198; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7; BERGER W, 2001, METABOLIC MOL BASES, P5977; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Girard JP, 1996, J BIOL CHEM, V271, P4511; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kondo H, 2007, OPHTHALMIC GENET, V28, P220, DOI 10.1080/13816810701663543; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Luhmann UFO, 2005, GENESIS, V42, P253, DOI 10.1002/gene.20141; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Matsubara T, 2000, CURR EYE RES, V20, P1, DOI 10.1076/0271-3683(200001)20:1;1-H;FT001; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P1475, DOI 10.1136/bjo.2004.042556; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Rehm HL, 1997, HUM MUTAT, V9, P402; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Su XJ, 2003, MOL VIS, V9, P171; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	48	294	304	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					285	298		10.1016/j.cell.2009.07.047	http://dx.doi.org/10.1016/j.cell.2009.07.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837032	Green Accepted, Bronze			2022-12-28	WOS:000270857500013
J	DeStefano, F; Tokars, J				DeStefano, Frank; Tokars, Jerome			H1N1 vaccine safety monitoring: beyond background rates	LANCET			English	Editorial Material									[DeStefano, Frank; Tokars, Jerome] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	DeStefano, F (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA.	fdestefano@cdc.gov						BLACK S, 2009, LANCET; Centers for Disease Control and Prevention, EM INF PROGR; DeStefano F, 2001, PHARMACOEPIDEM DR S, V10, P403, DOI 10.1002/pds.613; Iskander JK, 2004, PEDIATR ANN, V33, P599, DOI 10.3928/0090-4481-20040901-11; Lieu TA, 2007, MED CARE, V45, pS89, DOI 10.1097/MLR.0b013e3180616c0a	5	11	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 3	2010	375	9721					1146	1147		10.1016/S0140-6736(09)61917-6	http://dx.doi.org/10.1016/S0140-6736(09)61917-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VL	19880171				2022-12-28	WOS:000276858200009
J	D'Haens, G; Rutgeerts, P				D'Haens, Geert; Rutgeerts, Paul			Immunosuppression-associated lymphoma in IBD	LANCET			English	Editorial Material									[D'Haens, Geert] Imelda GI Clin Res Ctr, B-2820 Bonheiden, Belgium; [D'Haens, Geert; Rutgeerts, Paul] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium	Imeldaziekenhuis; KU Leuven; University Hospital Leuven	D'Haens, G (corresponding author), Imelda GI Clin Res Ctr, B-2820 Bonheiden, Belgium.	geert.dhaens@imelda.be						Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Caprilli R, 2006, GUT, V55, DOI 10.1136/gut.2005.081950c; Colombel JF, 2009, GASTROENTEROLOGY, V136, pA651; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; OPELZ G, 1993, LANCET, V342, P1514, DOI 10.1016/S0140-6736(05)80084-4; Sandborn W., 2000, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000545; *SEER, NONH LYMPH STAT; Siegel CA, 2009, CLIN GASTROENTEROL H, V7, P874, DOI 10.1016/j.cgh.2009.01.004; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; *US FDA, 2009, INF HEALTHC PROF TUM	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1572	1573		10.1016/S0140-6736(09)61487-2	http://dx.doi.org/10.1016/S0140-6736(09)61487-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19837454				2022-12-28	WOS:000271674600006
J	Barbie, DA; Tamayo, P; Boehm, JS; Kim, SY; Moody, SE; Dunn, IF; Schinzel, AC; Sandy, P; Meylan, E; Scholl, C; Frohling, S; Chan, EM; Sos, ML; Michel, K; Mermel, C; Silver, SJ; Weir, BA; Reiling, JH; Sheng, Q; Gupta, PB; Wadlow, RC; Le, H; Hoersch, S; Wittner, BS; Ramaswamy, S; Livingston, DM; Sabatini, DM; Meyerson, M; Thomas, RK; Lander, ES; Mesirov, JP; Root, DE; Gilliland, DG; Jacks, T; Hahn, WC				Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.			Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1	NATURE			English	Article							NF-KAPPA-B; TUMOR-CELL SURVIVAL; LUNG ADENOCARCINOMA; ESSENTIAL GENES; K-RAS; ACTIVATION; SCREEN; PHOSPHORYLATION; CLASSIFICATION; APOPTOSIS	The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele(1,2). Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical I kappa B kinase TBK1 was selectively essential in cells that contain mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappa B anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations indicate that TBK1 and NF-kappa B signalling are essential in KRAS mutant tumours, and establish a general approach for the rational identification of co-dependent pathways in cancer.	[Barbie, David A.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Mermel, Craig; Sheng, Qing; Livingston, David M.; Meyerson, Matthew; Gilliland, D. Gary; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, So Young; Meyerson, Matthew; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Chan, Edmond M.; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Wittner, Ben S.; Ramaswamy, Sridhar; Sabatini, David M.; Meyerson, Matthew; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Chan, Edmond M.; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Wittner, Ben S.; Ramaswamy, Sridhar; Sabatini, David M.; Meyerson, Matthew; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.] MIT, Cambridge, MA 02142 USA; [Barbie, David A.; Wadlow, Raymond C.; Wittner, Ben S.; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Scholl, Claudia; Froehling, Stefan; Gilliland, D. Gary; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Sandy, Peter; Meylan, Etienne; Reiling, Jan H.; Sabatini, David M.; Lander, Eric S.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sandy, Peter; Meylan, Etienne; Hoersch, Sebastian; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sos, Martin L.; Michel, Kathrin; Thomas, Roman K.] Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; [Sos, Martin L.; Michel, Kathrin; Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Reiling, Jan H.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sabatini, David M.; Gilliland, D. Gary; Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, D-44227 Dortmund, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Max Planck Society; University of Cologne; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Cologne; University of Cologne; Max Planck Society	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Sos, Martin L/I-1852-2014; Mermel, Craig/AAZ-7322-2020; Meyerson, Matthew L/E-7123-2012; Mesirov, Jill/AGF-7626-2022	Mermel, Craig/0000-0002-0816-3395; Wadlow, Raymond/0000-0003-1959-5406; /0000-0002-1446-7256; Chan, Edmond/0000-0002-7460-2560; Boehm, Jesse/0000-0002-6795-6336; Meylan, Etienne/0000-0002-0899-2230	US National Cancer Institute [R33 CA128625, R01 CA130988]; NIH [T32 CA09172-33]; Starr Cancer Consortium [I1-A11]; Susan Madden Fund; ASCO YIA; Department of Defense Prostate Cancer Postdoctoral Fellowship; Brain Science Foundation Fellowship; Deutsche Krebshilfe [107954]; Fritz-Thyssen-Stiftung [10.08.2.175]; German Ministry of Science and Education [01GS08100]; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA130988, R33CA128625, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Susan Madden Fund; ASCO YIA; Department of Defense Prostate Cancer Postdoctoral Fellowship(United States Department of Defense); Brain Science Foundation Fellowship; Deutsche Krebshilfe(Deutsche Krebshilfe); Fritz-Thyssen-Stiftung; German Ministry of Science and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the US National Cancer Institute (R33 CA128625, R01 CA130988) (W. C. H.) and NIH T32 CA09172-33 (D. A. B., S. E. M.), the Starr Cancer Consortium (I1-A11; W. C. H., D. G. G.), the Susan Madden Fund and an ASCO YIA (D. A. B.), a Department of Defense Prostate Cancer Postdoctoral Fellowship (S. Y. K.), a Brain Science Foundation Fellowship (I. F. D.), the Deutsche Krebshilfe (grant 107954) (R. K. T.), the Fritz-Thyssen-Stiftung (grant 10.08.2.175; R. K. T.) and the NGFNplus-program of the German Ministry of Science and Education (BMBF, grant 01GS08100; R. K. T.). We thank C. Yu, G. Wei and members of the Hahn laboratory for discussions. High-throughput RNAi screening was conducted at the RNAi Platform of the Broad Institute of MIT and Harvard.	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zhang J, 2002, J ROY STAT SOC B, V64, P281, DOI 10.1111/1467-9868.00337	31	1764	1828	7	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					108	U122		10.1038/nature08460	http://dx.doi.org/10.1038/nature08460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19847166	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000271419200042
J	Clutton-Brock, T				Clutton-Brock, Tim			Cooperation between non-kin in animal societies	NATURE			English	Review							LONG-TAILED MACAQUES; RECIPROCAL ALTRUISM; KIN SELECTION; GROOMING RECIPROCITY; SOCIAL RELATIONSHIPS; EVOLUTION; MUTUALISM; BEHAVIOR; STRATEGIES; PUNISHMENT	Explanations of cooperation between non-kin in animal societies often suggest that individuals exchange resources or services and that cooperation is maintained by reciprocity. But do cooperative interactions between unrelated individuals in non-human animals really resemble exchanges or are they a consequence of simpler mechanisms? Firm evidence of reciprocity in animal societies is rare and many examples of cooperation between non-kin probably represent cases of intra-specific mutualism or manipulation.	Univ Cambridge, Dept Zool, Cambridge CB3 9EJ, England	University of Cambridge	Clutton-Brock, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB3 9EJ, England.	thcb@cam.ac.uk			Natural Environment Research Council [NE/C511348/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AURELI F, 1992, BEHAV ECOL SOCIOBIOL, V31, P329; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barras C, 2008, NEW SCI, V197, P6, DOI 10.1016/S0262-4079(08)60003-2; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; Bercovitch FB, 2001, FOUND HUM B, P369; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Boncoraglio G, 2008, J EVOLUTION BIOL, V21, P256, DOI 10.1111/j.1420-9101.2007.01441.x; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bourke Andrew F.G., 1997, P203; Bowles S, 2003, DAHL WS ENV, P429; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Brown J.L., 1987, HELPING COMMUNAL BRE; Brown JS, 2008, P ROY SOC B-BIOL SCI, V275, P1985, DOI 10.1098/rspb.2007.1685; Bshary R, 2006, PLOS BIOL, V4, P2393, DOI 10.1371/journal.pbio.0040431; Cant MA, 2006, J EVOLUTION BIOL, V19, P1383, DOI 10.1111/j.1420-9101.2006.01151.x; Cheney Dorothy L., 2007, BABOON METAPHYSICS; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P173, DOI 10.1007/3-540-28277-7_10; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; CONNOR RC, 1995, ANIM BEHAV, V49, P528, DOI 10.1006/anbe.1995.0070; CONNOR RC, 1986, ANIM BEHAV, V34, P1562, DOI 10.1016/S0003-3472(86)80225-1; DARWIN C, 1859, ORIGIN SPECIES, pCH8; Dawkins R., 2008, GOD DELUSION; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DUGATKIN LA, 1997, COOPERATION AMONG AN; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; GRAFEN A, 1982, NATURE, V298, P425, DOI 10.1038/298425a0; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammerstein P, 2003, DAHL WS ENV, P83; HART BL, 1992, ANIM BEHAV, V44, P1073, DOI 10.1016/S0003-3472(05)80319-7; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; HAUSER MD, 1992, P NATL ACAD SCI USA, V89, P12137, DOI 10.1073/pnas.89.24.12137; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; KROPOTKIN P, 1908, MUTUAL AID; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Leimar O, 2003, DAHL WS ENV, P203; MCMAHON BF, 1992, BEHAVIOUR, V120, P69, DOI 10.1163/156853992X00219; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; MILINSKI M, 1990, ANIM BEHAV, V39, P989, DOI 10.1016/S0003-3472(05)80966-2; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Packer C., 1988, P363; PACKER C, 1977, NATURE, V265, P441, DOI 10.1038/265441a0; Paxton M., 1988, GABAR, V3, P82; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Richerson P. J., 2005, NOT GENES ALONE CULT; Roberts G, 2008, P R SOC B, V275, P173, DOI 10.1098/rspb.2007.1134; ROOD JP, 1983, ANIM BEHAV, V31, P1261, DOI 10.1016/S0003-3472(83)80036-0; Russell Andrew F., 2004, P210, DOI 10.1017/CBO9780511606816.014; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Smith EA, 2003, DAHL WS ENV, P401; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; SMUTS BB, 1990, INT J PRIMATOL, V11, P147, DOI 10.1007/BF02192786; Solomon N. G., 1997, COOPERATIVE BREEDING; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Suzuki S, 2007, J THEOR BIOL, V245, P539, DOI 10.1016/j.jtbi.2006.11.002; Taborsky M, 2007, BEHAV PROCESS, V76, P95, DOI 10.1016/j.beproc.2007.01.013; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turchin P, 2005, WAR PEACE WAR RISE F; von Neumann J., 1953, THEORY GAMES EC BEHA; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2008, J EVOLUTION BIOL, V21, P374, DOI 10.1111/j.1420-9101.2007.01458.x; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON GS, 1988, ETHOL SOCIOBIOL, V9, P85, DOI 10.1016/0162-3095(88)90015-5; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wright J, 2001, ANIM BEHAV, V62, P973, DOI 10.1006/anbe.2001.1838; Wynne-Edwards V. C., 1962, pUnpaginated; YOUNG P, 2003, GENETIC CULTURAL EVO; Zahavi A, 1997, HANDICAP PRINCIPLE M; [No title captured]	101	517	527	8	562	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					51	57		10.1038/nature08366	http://dx.doi.org/10.1038/nature08366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890322				2022-12-28	WOS:000271419200030
J	Todes, D				Todes, Daniel			Global Darwin: Contempt for competition	NATURE			English	Editorial Material									Johns Hopkins Univ, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Todes, D (corresponding author), Johns Hopkins Univ, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.	dtodes@jhmi.edu							0	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 5	2009	462	7269					36	37		10.1038/462036a	http://dx.doi.org/10.1038/462036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514TT	19890312				2022-12-28	WOS:000271419200021
J	Ahmed, T; Ahmed, AMS				Ahmed, Tahmeed; Ahmed, A. M. Shamsir			Reducing the burden of malnutrition in Bangladesh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tahmeed@icddrb.org						AHMED T, 2007, POLICY BRIEF CHILD M; *BANGL BUR STAT, 2005, HOUS INC EXP SURV 20; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Shekar M, 2006, REPOSITIONING NUTR C	6	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2009	339								b4490	10.1136/bmj.b4490	http://dx.doi.org/10.1136/bmj.b4490			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889736				2022-12-28	WOS:000271567800004
J	Tsertsvadze, A; Fink, HA; Yazdi, F; MacDonald, R; Bella, AJ; Ansari, MT; Garritty, C; Soares-Weiser, K; Daniel, R; Sampson, M; Fox, S; Moher, D; Wilt, TJ				Tsertsvadze, Alexander; Fink, Howard A.; Yazdi, Fatemeh; MacDonald, Roderick; Bella, Anthony J.; Ansari, Mohammed T.; Garritty, Chantelle; Soares-Weiser, Karla; Daniel, Raymond; Sampson, Margaret; Fox, Steven; Moher, David; Wilt, Timothy J.			Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ISCHEMIC OPTIC NEUROPATHY; PLACEBO-CONTROLLED TRIAL; SILDENAFIL CITRATE VIAGRA((R)); RANDOMIZED DOUBLE-BLIND; ON-DEMAND TADALAFIL; SPARING RADICAL PROSTATECTOMY; INCREASES PENILE RIGIDITY; SERUM TESTOSTERONE LEVELS; FLEXIBLE-DOSE VARDENAFIL; IMPROVES SEXUAL FUNCTION	Background: Erectile dysfunction (ED) is a common male sexual disorder. The relative benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal testing in men with ED, are uncertain. Purpose: To evaluate the efficacy and harms of oral phosphodiesterase-5 (PDE-5) inhibitors and hormonal treatments for ED and assess the effect of measuring serum hormone levels on treatment outcomes for ED. Data Sources: English-language studies from MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, PsycINFO, AMED, and SCOPUS through April 2009. Trial reference lists also were scanned. Study Selection: Randomized, controlled trials (RCTs) of oral PDE-5 inhibitors and hormonal treatment for ED, and observational studies reporting measurement of serum hormone levels, prevalence of hormonal abnormalities, or both in men with ED. Data Extraction: Two independent reviewers abstracted data on study, participant, and treatment characteristics; efficacy and harms outcomes; and prevalence of hormonal abnormalities. Data Synthesis: Data, primarily from short-term trials (<= 12 weeks), indicate that PDE-5 inhibitors were more effective than placebo in improving sexual intercourse success (69.0% vs. 35.0%). The proportion of men with improved erections was significantly greater among those treated with PDE-5 inhibitors (range, 67.0% to 89.0%) than with placebo (range, 27.0% to 35.0%). The PDE-5 inhibitors were associated with increased risk for any adverse events compared with placebo (for example, relative risk with sildenafil, 1.72 [95% CI, 1.53 to 1.93]). In 4 head-to-head RCTs comparing sildenafil, vardenafil, and tadalafil, improvement of ED and adverse events did not differ among treatments. Results from 15 RCTs evaluating hormonal treatment of ED were inconsistent on whether treatment improved outcomes. Evidence was insufficient regarding whether men with ED had a higher prevalence of hypogonadism than men without ED. Limitations: Many RCTs were of low methodological and reporting quality, particularly those involving hormonal treatments or directly comparing different PDE-5 inhibitors. Most RCTs provided only short-term efficacy and harms data. Conclusion: Oral PDE-5 inhibitors improved erectile functioning and had similar efficacy and safety profiles. Results on the efficacy of hormonal treatments and the value of hormone testing in men with ED were inconclusive. Primary Funding Source: Agency for Healthcare Research and Quality.	Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; Minneapolis Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA; Minneapolis Evidence Based Practice Ctr, Minneapolis, MN USA; Enhance Reviews, Kefar Sava, Israel; Agcy Healthcare Res & Qual, Rockville, MD USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Agency for Healthcare Research & Quality	Fink, HA (corresponding author), Vet Affairs Med Ctr 11 G, 1 Vet Dr, Minneapolis, MN 55417 USA.	howard.fink@va.gov	Fink, Howard/F-3933-2012; Garritty, Chantelle/ABG-7790-2020; Garritty, Chantelle Marie/AAC-4136-2022	Moher, David/0000-0003-2434-4206; Sampson, Margaret/0000-0003-2550-9893; Daniel, Raymond/0000-0002-1753-6683	Agency for Healthcare Research and Quality; Pfizer, Lilly, Bayer	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Pfizer, Lilly, Bayer(Eli LillyBayer AGPfizer)	Agency for Healthcare Research and Quality.; Honoraria: A. J. Bella (Pfizer, Lilly, Bayer).	Abdel-Naser MB, 2004, INT J IMPOT RES, V16, P552, DOI 10.1038/sj.ijir.3901245; Acar D, 2004, ARCH ANDROLOGY, V50, P247, DOI 10.1080/01485010490448769; Akash R, 2005, J OCUL PHARMACOL TH, V21, P315, DOI 10.1089/jop.2005.21.315; AKPUNONU BE, 1994, J GEN INTERN MED, V9, P336, DOI 10.1007/BF02599183; ALBUQUERQUE DC, 2005, INT BRAZ J UROL, V31, P354; Albuquerque Denilson C., 2005, Int. braz j urol., V31, P342, DOI 10.1590/S1677-55382005000400008; Althof SE, 2006, J SEX MED, V3, P521, DOI 10.1111/j.1743-6109.2006.00234.x; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Aversa A, 2007, INT J IMPOT RES, V19, P200, DOI 10.1038/sj.ijir.3901513; Aversa A, 2003, CLIN ENDOCRINOL, V58, P632, DOI 10.1046/j.1365-2265.2003.01764.x; Aversa A, 2000, CLIN ENDOCRINOL, V53, P517, DOI 10.1046/j.1365-2265.2000.01118.x; BANCROFT J, 1983, ARCH SEX BEHAV, V12, P59, DOI 10.1007/BF01542116; Bannowsky A, 2008, BJU INT, V101, P1279, DOI 10.1111/j.1464-410X.2008.07515.x; *BAYER AG, 2006, BAY ANN REP 2005; Becher E, 2002, INT J IMPOT RES, V14, pS33, DOI 10.1038/sj.ijir.3900896; Bocchio M, 2008, ATHEROSCLEROSIS, V196, P313, DOI 10.1016/j.atherosclerosis.2006.09.035; Boolell M, 1996, BRIT J UROL, V78, P257, DOI 10.1046/j.1464-410X.1996.10220.x; Boulton AJM, 2001, DIABETOLOGIA, V44, P1296, DOI 10.1007/s001250100656; Boyanov M A, 2003, Aging Male, V6, P1; Bunch T J, 2002, Aging Male, V5, P38, DOI 10.1080/713604648; Buranakitjaroen Peera, 2007, Journal of the Medical Association of Thailand, V90, P1100; Burnett AL, 1998, NAT MED, V4, P84, DOI 10.1038/nm0198-084; Burnett AL, 2009, J UROLOGY, V181, P245, DOI 10.1016/j.juro.2008.09.005; Buvat J, 1997, J UROLOGY, V158, P1764, DOI 10.1016/S0022-5347(01)64123-5; Buvat J, 2008, BJU INT, V102, P1645, DOI 10.1111/j.1464-410X.2008.07908.x; Cappelleri JC, 2000, UROLOGY, V56, P477, DOI 10.1016/S0090-4295(00)00697-X; Carrier S, 2005, J SEX MED, V2, P685, DOI 10.1111/j.1743-6109.2005.00097.x; Carson C, 2005, UROLOGY, V65, P353, DOI 10.1016/j.urology.2004.09.056; Carson CC, 2004, BJU INT, V94, P1301, DOI 10.1111/j.1464-410X.2004.05161.x; Cavallini G, 2005, UROLOGY, V66, P1080, DOI 10.1016/j.urology.2005.05.014; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; Chen KK, 2001, INT J IMPOT RES, V13, P221, DOI 10.1038/sj.ijir.3900685; Chen KK, 2004, J SEX MED, V1, P201, DOI 10.1111/j.1743-6109.2004.04029.x; Chiang HS, 2007, INT J IMPOT RES, V19, P411, DOI 10.1038/sj.ijir.3901562; Choi HK, 2003, INT J IMPOT RES, V15, P80, DOI 10.1038/sj.ijir.3900944; CHOI HK, 2006, TAEHAN PINYOGIKWA HA, V47, P852; Christiansen E, 2000, INT J IMPOT RES, V12, P177, DOI 10.1038/sj.ijir.3900527; Citron JT, 1996, J UROLOGY, V155, P529, DOI 10.1016/S0022-5347(01)66441-3; CLOPPER RR, 1993, PSYCHONEUROENDOCRINO, V18, P149, DOI 10.1016/0306-4530(93)90066-T; Corona G, 2008, J SEX MED, V5, P2454, DOI 10.1111/j.1743-6109.2008.00856.x; Cunningham AV, 2001, J NEURO-OPHTHALMOL, V21, P22, DOI 10.1097/00041327-200103000-00006; De Rose AF, 2005, INT J IMPOT RES, V17, P76, DOI 10.1038/sj.ijir.3901265; de Tejada IS, 2002, DIABETES CARE, V25, P2159; DeBusk RF, 2004, AM J CARDIOL, V93, P147, DOI 10.1016/j.amjcard.2003.09.030; Demir E, 2006, TRANSPL P, V38, P1379, DOI 10.1016/j.transproceed.2006.02.076; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dheer Somna, 2002, J Assoc Physicians India, V50, P265; Dinsmore WW, 1999, UROLOGY, V53, P800, DOI 10.1016/S0090-4295(98)00586-X; DRINKA PJ, 1993, SOUTHERN MED J, V86, P1264, DOI 10.1097/00007611-199311000-00017; Eardley I, 2002, BRIT J CLIN PHARMACO, V53, p61S, DOI 10.1046/j.0306-5251.2001.00034.x; Eardley I, 2005, BJU INT, V96, P1323, DOI 10.1111/j.1464-410X.2005.05892.x; Eardley I, 2004, BJU INT, V94, P871, DOI 10.1111/j.1464-410X.2004.05049.x; Eardley I, 2001, BRIT J PSYCHIAT, V178, P325, DOI 10.1192/bjp.178.4.325; Earle CM, 2003, UROLOGY, V62, P727, DOI 10.1016/S0090-4295(03)00508-9; Edwards D, 2006, J SEX MED, V3, P1028, DOI 10.1111/j.1743-6109.2006.00329.x; Egan R, 2000, ARCH OPHTHALMOL-CHIC, V118, P291; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Sakka AI, 2007, J SEX MED, V4, P1691, DOI 10.1111/j.1743-6109.2006.00342.x; El-Sakka AI, 2006, J UROLOGY, V176, P2589, DOI 10.1016/j.juro.2006.08.005; El-Sakka AI, 2005, J SEX MED, V2, P551, DOI 10.1111/j.1743-6109.2005.00082.x; Fahmy AK, 1999, BJU INT, V84, P482; Fava M, 2006, J CLIN PSYCHIAT, V67, P240, DOI 10.4088/JCP.v67n0210; Fazio L, 2004, CAN MED ASSOC J, V170, P1429, DOI 10.1503/cmaj.1020049; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FORSBERG L, 1990, SCAND J UROL NEPHROL, V24, P83, DOI 10.3109/00365599009180368; Fowler CJ, 2005, J NEUROL NEUROSUR PS, V76, P700, DOI 10.1136/jnnp.2004.038695; Gedik S, 2007, EYE, V21, P129, DOI 10.1038/sj.eye.6702445; GLINA S, 2001, BRAZ J UROL, V27, P148; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Goldstein I, 2005, J SEX MED, V2, P819, DOI 10.1111/j.1743-6109.2005.00147.x; Goldstein I, 2003, DIABETES CARE, V26, P777, DOI 10.2337/diacare.26.3.777; GOMAA AA, 2006, J MENS HLTH GEND, V3, P47; Gomez F, 2002, INT J IMPOT RES, V14, pS42, DOI 10.1038/sj.ijir.3900897; Gopalakrishnan R, 2006, AM J PSYCHIAT, V163, P494, DOI 10.1176/appi.ajp.163.3.494; Govier F, 2003, CLIN THER, V25, P2709, DOI 10.1016/S0149-2918(03)80328-4; Gruhn N, 2005, ACTA OPHTHALMOL SCAN, V83, P131, DOI 10.1111/j.1600-0420.2005.00374.x; Guay A, 2007, J SEX MED, V4, P1046, DOI 10.1111/j.1743-6109.2007.00530.x; GUAY AT, 1991, UROLOGY, V38, P317, DOI 10.1016/0090-4295(91)80143-U; Guo YL, 2006, INT J UROL, V13, P721, DOI 10.1111/j.1442-2042.2006.01393.x; Gupta B, 2008, ACTA OPHTHALMOL, V86, P924, DOI 10.1111/j.1600-0420.2007.01115.x; Haren M, 2005, AGE AGEING, V34, P125, DOI 10.1093/ageing/afi003; Hatzichristou D, 2004, EUR UROL, V45, P634, DOI 10.1016/j.eururo.2004.01.014; Hatzichristou D, 2008, DIABETIC MED, V25, P138, DOI 10.1111/j.1464-5491.2007.02338.x; Hatzichristou D, 2002, J UROLOGY, V168, P615, DOI 10.1016/S0022-5347(05)64690-3; Heiman JR, 2007, BJOG-INT J OBSTET GY, V114, P437, DOI 10.1111/j.1471-0528.2006.01228.x; Hellstrom WJG, 2002, J ANDROL, V23, P763; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hong SK, 2007, J UROLOGY, V178, P613, DOI 10.1016/j.juro.2007.03.132; Hundertmark J, 2007, J SEX MED, V4, P1126, DOI 10.1111/j.1743-6109.2007.00536.x; Hussain IF, 2001, J NEUROL NEUROSUR PS, V71, P371, DOI 10.1136/jnnp.71.3.371; Incrocci L, 2001, INT J RADIAT ONCOL, V51, P1190, DOI 10.1016/S0360-3016(01)01767-9; Incrocci L, 2006, INT J RADIAT ONCOL, V66, P439, DOI 10.1016/j.ijrobp.2006.04.047; Ishii N, 2006, INT J UROL, V13, P1066, DOI 10.1111/j.1442-2042.2006.01480.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; JOHNSON AR, 1992, J UROLOGY, V147, P1542, DOI 10.1016/S0022-5347(17)37620-6; Jones LA, 2008, J SEX MED, V5, P1955, DOI 10.1111/j.1743-6109.2008.00879.x; Kadioglu A, 2008, J SEX MED, V5, P726, DOI 10.1111/j.1743-6109.2007.00701.x; Katz SD, 2005, AM J CARDIOL, V95, P36, DOI 10.1016/j.amjcard.2004.08.060; Klotz T, 2001, WORLD J UROL, V19, P32, DOI 10.1007/s003450000168; Kohler Tobias S, 2008, Urology, V71, P693, DOI 10.1016/j.urology.2007.11.073; Kongkanand Apichat, 2003, J Med Assoc Thai, V86, P195; Koulikov D, 2007, J UROLOGY, V177, P2267, DOI 10.1016/j.juro.2007.01.123; Kupelian V, 2006, J UROLOGY, V176, P2584, DOI 10.1016/j.juro.2006.08.020; Levinson IP, 2003, INT J IMPOT RES, V15, pS25, DOI 10.1038/sj.ijir.3900970; Light R.J., 1984, SUMMING SCI REV RES; Lindsey I, 2002, DIS COLON RECTUM, V45, P727, DOI 10.1007/s10350-004-6287-9; LOW WY, 2006, J MENS HLTH GEND, V3, P263; Lue TF, 1998, CAMPBELLS UROLOGY, P1181; Mahon A, 2005, AM J KIDNEY DIS, V45, P381, DOI 10.1053/j.ajkd.2004.10.012; Makhlouf AA, 2008, INT J IMPOT RES, V20, P157, DOI 10.1038/sj.ijir.3901576; Margo CE, 2007, AM J OPHTHALMOL, V143, P538, DOI 10.1016/j.ajo.2006.10.006; Martin-Morales A, 2007, J SEX MED, V4, P440, DOI 10.1111/j.1743-6109.2006.00426.x; Martinez-Jabaloyas JM, 2006, BJU INT, V97, P1278, DOI 10.1111/j.1464-410X.2006.06154.x; Mazo E, 2006, INT J IMPOT RES, V18, P464, DOI 10.1038/sj.ijir.3901454; McCullough AR, 2008, INT J IMPOT RES, V20, P388, DOI 10.1038/ijir.2008.21; McCullough AR, 2008, UROLOGY, V71, P686, DOI 10.1016/j.urology.2007.12.025; McCullough AR, 2008, J SEX MED, V5, P476, DOI 10.1111/j.1743-6109.2007.00700.x; MCEVOY GK, 2008, ATENOLOL AHFS DRUG I; McMahon C, 2005, J SEX MED, V2, P415, DOI 10.1111/j.1743-6109.2005.20360.x; McMahon CG, 2005, INT J CLIN PRACT, V59, P143, DOI 10.1111/j.1742-1241.2005.00451.x; McNicholas TA, 2003, BJU INT, V91, P69, DOI 10.1046/j.1464-410X.2003.04016.x; McVary KT, 2007, J UROLOGY, V177, P1401, DOI 10.1016/j.juro.2006.11.037; McVary KT, 2007, J UROLOGY, V177, P1071, DOI 10.1016/j.juro.2006.10.055; Merza Z, 2006, INT J ANDROL, V29, P381, DOI 10.1111/j.1365-2605.2005.00612.x; Meuleman E, 2001, BJU INT, V87, P75, DOI 10.1046/j.1464-410x.2001.00998.x; Miller TA, 2000, AM FAM PHYSICIAN, V61, P95; Miner M, 2008, J SEX MED, V5, P1455, DOI 10.1111/j.1743-6109.2008.00820.x; Mirone V, 2005, EUR UROL, V47, P846, DOI 10.1016/j.eururo.2005.02.019; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Montague DK, 2005, J UROLOGY, V174, P230, DOI 10.1097/01.ju.0000164463.19239.19; Montorsi F, 2004, J UROLOGY, V172, P1036, DOI 10.1097/01.ju.0000136448.71773.2b; Montorsi F, 1999, UROLOGY, V53, P1011, DOI 10.1016/S0090-4295(98)00643-8; Montorsi F, 2000, UROLOGY, V56, P906, DOI 10.1016/S0090-4295(00)00841-4; Montorsi F, 2008, EUR UROL, V54, P924, DOI 10.1016/j.eururo.2008.06.083; Montorsi F, 2004, J SEX MED, V1, P168, DOI 10.1111/j.1743-6109.2004.04025.x; Morano S, 2007, EUR UROL, V52, P1768, DOI 10.1016/j.eururo.2007.04.042; Morelli A, 2004, ENDOCRINOLOGY, V145, P2253, DOI 10.1210/en.2003-1699; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; Nagao K, 2004, INT J UROL, V11, P515, DOI 10.1111/j.1442-2042.2004.00833.x; Nagao K, 2006, UROLOGY, V68, P845, DOI 10.1016/j.urology.2006.05.001; Nehra A, 2005, J UROLOGY, V173, P2067, DOI 10.1097/01.ju.0000158456.41788.93; Netto Junior N R, 1993, Rev Paul Med, V111, P454; NOLDUS J, 1994, UROLOGE A, V33, P73; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; O'Leary MP, 2006, J UROLOGY, V175, P1058, DOI 10.1016/S0022-5347(05)00418-0; Olsson AM, 2001, INT J CLIN PRACT, V55, P171; Olsson AM, 2000, INT J CLIN PRACT, V54, P561; Orr G, 2006, J CLIN PSYCHOPHARM, V26, P426, DOI 10.1097/01.jcp.0000227701.33999.b3; Padma-Nathan H, 2003, UROLOGY, V62, P400, DOI 10.1016/S0090-4295(03)00567-3; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Paick JS, 2008, J SEX MED, V5, P2672, DOI 10.1111/j.1743-6109.2008.00945.x; Paick JS, 2008, ASIAN J ANDROL, V10, P791, DOI 10.1111/j.1745-7262.2008.00422.x; Paick JS, 2008, J SEX MED, V5, P946, DOI 10.1111/j.1743-6109.2007.00723.x; Palmer JS, 2000, J UROLOGY, V164, P958, DOI 10.1016/S0022-5347(05)67225-4; Pepin S, 2008, J NEURO-OPHTHALMOL, V28, P76, DOI 10.1097/WNO.0b013e31816743da; *PFIZ, 2006, PFIZ ANN REP 2005; Pickering TG, 2004, AM J HYPERTENS, V17, P1135, DOI 10.1016/j.amjhyper.2004.07.004; Pomeranz HD, 2005, J NEURO-OPHTHALMOL, V25, P9, DOI 10.1097/00041327-200503000-00003; Pomeranz HD, 2002, OPHTHALMOLOGY, V109, P584, DOI 10.1016/S0161-6420(01)00976-9; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Porst H, 1996, J UROLOGY, V155, P802, DOI 10.1016/S0022-5347(01)66315-8; Porst H, 2003, UROLOGY, V62, P121, DOI 10.1016/S0090-4295(03)00359-5; Porst H, 2006, EUR UROL, V50, P1086, DOI 10.1016/j.eururo.2006.05.036; Price DE, 1998, DIABETIC MED, V15, P821, DOI 10.1002/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P; Rabkin JG, 2000, ARCH GEN PSYCHIAT, V57, P141, DOI 10.1001/archpsyc.57.2.141; Rajfer J, 2007, INT J IMPOT RES, V19, P95, DOI 10.1038/sj.ijir.3901496; Ralph D, 2007, BJU INT, V100, P130, DOI 10.1111/j.1464-410X.2007.06900.x; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Reyes-Vallejo L, 2007, J SEX MED, V4, P1757, DOI 10.1111/j.1743-6109.2006.00381.x; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Tolra JR, 2006, J SEX MED, V3, P901, DOI 10.1111/j.1743-6109.2006.00297.x; Rosanoa GMC, 2005, EUR UROL, V47, P214, DOI 10.1016/j.eururo.2004.10.002; Rosen R, 2006, AM J PSYCHIAT, V163, P79, DOI 10.1176/appi.ajp.163.1.79; Rosen RC, 2004, J SEX MED, V1, P193, DOI 10.1111/j.1743-6109.2004.04028.x; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Safarinejad MR, 2009, J UROLOGY, V181, P252, DOI 10.1016/j.juro.2008.09.003; Safarinejad MR, 2004, J DIABETES COMPLICAT, V18, P205, DOI 10.1016/S1056-8727(03)00056-4; Saylan M, 2006, INT J CLIN PRACT, V60, P812, DOI 10.1111/j.1742-1241.2006.00993.x; Schiavi RC, 1997, ARCH SEX BEHAV, V26, P231, DOI 10.1023/A:1024518730222; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Seftel AD, 2004, J UROLOGY, V172, P652, DOI 10.1097/01.ju.0000132857.39680.ce; Seftel AD, 2004, J ANDROL, V25, P963; Seibel I, 2002, J AM SOC NEPHROL, V13, P2770, DOI 10.1097/01.ASN.0000034201.97937.3E; Seidman SN, 2006, J SEX MARITAL THER, V32, P267, DOI 10.1080/00926230600575355; Seidman SN, 2001, AM J PSYCHIAT, V158, P1623, DOI 10.1176/appi.ajp.158.10.1623; Shabsigh R, 2004, J UROLOGY, V172, P658, DOI 10.1097/01.ju.0000132389.97804.d7; Shamloul R, 2005, J SEX MED, V2, P559, DOI 10.1111/j.1743-6109.2005.00071.x; Sharma RK, 2006, AM J KIDNEY DIS, V48, P128, DOI 10.1053/j.ajkd.2006.04.061; Sinha S, 2004, EYE, V18, P446, DOI 10.1038/sj.eye.6700697; Skoumal R, 2004, EUR UROL, V46, P362, DOI 10.1016/j.eururo.2004.04.026; Sommer F, 2007, ASIAN J ANDROL, V9, P134, DOI 10.1111/j.1745-7262.2007.00233.x; Staab A, 2004, PHARM RES-DORDR, V21, P1463, DOI 10.1023/B:PHAM.0000036922.03519.40; Stark S, 2001, EUR UROL, V40, P181, DOI 10.1159/000049770; Stief C, 2004, INT J CLIN PRACT, V58, P230, DOI 10.1111/j.1368-5031.2004.00128.x; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Su DHW, 2008, J NEURO-OPHTHALMOL, V28, P75, DOI 10.1097/WNO.0b013e318167554a; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; Tan HM, 2000, UROLOGY, V56, P635, DOI 10.1016/S0090-4295(00)00688-9; Tan HM, 2008, ASIAN J ANDROL, V10, P495, DOI 10.1111/j.1745-7262.2008.00388.x; Tignol J, 2004, INT CLIN PSYCHOPHARM, V19, P191, DOI 10.1097/01.yic.0000117902.43995.b0; Tsertsvadze A, 2009, EVID REP TECHNOL ASS, V171, P98; Tsujimura A, 2005, INT J IMPOT RES, V17, P259, DOI 10.1038/sj.ijir.3901300; Umrani Dhananjay N., 1999, Indian Journal of Physiology and Pharmacology, V43, P160; Valiquette L, 2005, MAYO CLIN PROC, V80, P1291, DOI 10.4065/80.10.1291; van Ahlen H, 2005, J SEX MED, V2, P856, DOI 10.1111/j.1743-6109.2005.00150.x; Virag R, 1999, UROLOGY, V54, P1073, DOI 10.1016/S0090-4295(99)00310-6; von Keitz A, 2004, EUR UROL, V45, P499, DOI 10.1016/j.eururo.2003.11.030; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Warburton I, 2004, J SEX MED, V1, P179, DOI 10.1111/j.1743-6109.2004.04026.x; Webster LJ, 2004, ARCH INTERN MED, V164, P514, DOI 10.1001/archinte.164.5.514; Wespes E, 2006, EUR UROL, V49, P806, DOI 10.1016/j.eururo.2006.01.028; Wessells H, 2007, J UROLOGY, V177, P1675, DOI 10.1016/j.juro.2007.01.057; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yassin AA, 2006, ANDROLOGIA, V38, P61, DOI 10.1111/j.1439-0272.2006.00712.x; Yip WCA, 2006, ASIAN J ANDROL, V8, P685, DOI 10.1111/j.1745-7262.2006.00213.x; Young JM, 2005, J ANDROL, V26, P310, DOI 10.2164/jandrol.04126; Young JM, 2002, UROLOGY, V60, P39, DOI 10.1016/S0090-4295(02)01689-8; Ziegler D, 2006, J SEX MED, V3, P883, DOI 10.1111/j.1743-6109.2006.00295.x; Zinner N, 2007, J SEX MED, V4, P137, DOI 10.1111/j.1743-6109.2006.00400.x; Zohdy W, 2007, J SEX MED, V4, P797, DOI 10.1111/j.1743-6109.2007.00499.x; Zumbe J, 2008, EUR UROL, V54, P204, DOI 10.1016/j.eururo.2008.03.056; 1993, JAMA, V270, P83	226	113	121	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					650	W218		10.7326/0003-4819-151-9-200911030-00150	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00150			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884626				2022-12-28	WOS:000271387700007
J	Dioum, EM; Wauson, EM; Cobb, MH				Dioum, Elhadji M.; Wauson, Eric M.; Cobb, Melanie H.			MAP-ping Unconventional Protein-DNA Interactions	CELL			English	Editorial Material							TRANSCRIPTION COMPLEXES; KINASES; BINDING		[Dioum, Elhadji M.; Wauson, Eric M.; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	melanie.cobb@utsouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473				Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Vincent T, 2008, ONCOGENE, V27, P5254, DOI 10.1038/onc.2008.152; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200	9	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					462	463		10.1016/j.cell.2009.10.007	http://dx.doi.org/10.1016/j.cell.2009.10.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879834	Bronze			2022-12-28	WOS:000271259600010
J	Liljas, A				Liljas, Anders			Leaps in Translational Elongation	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; EF-P; RIBOSOME; TU		Lund Univ, S-79333 Se, Leksand, Sweden	Lund University	Liljas, A (corresponding author), Lund Univ, S-79333 Se, Leksand, Sweden.	anders.liljas@mbfys.lu.se						Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	13	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					677	678		10.1126/science.1181511	http://dx.doi.org/10.1126/science.1181511			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19833922				2022-12-28	WOS:000271233200023
J	Siegenthaler, JA; Ashique, AM; Zarbalis, K; Patterson, KP; Hecht, JH; Kane, MA; Folias, AE; Choe, Y; May, SR; Kume, T; Napoli, JL; Peterson, AS; Pleasure, SJ				Siegenthaler, Julie A.; Ashique, Amir M.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Kane, Maureen A.; Folias, Alexandra E.; Choe, Youngshik; May, Scott R.; Kume, Tsutomu; Napoli, Joseph L.; Peterson, Andrew S.; Pleasure, Samuel J.			Retinoic Acid from the Meninges Regulates Cortical Neuron Generation	CELL			English	Article							CAJAL-RETZIUS CELLS; FOREBRAIN DEVELOPMENT; BINDING PROTEINS; PROGENITOR CELLS; STEM-CELLS; MOUSE; EXPRESSION; RECEPTORS; DEFECTS; CREST	Extrinsic signals controlling generation of neocortical neurons during embryonic life have been difficult to identify. In this study we demonstrate that the dorsal forebrain meninges communicate with the adjacent radial glial endfeet and influence cortical development. We took advantage of Foxc1 mutant mice with defects in forebrain meningeal formation. Foxc1 dosage and loss of meninges correlated with a dramatic reduction in both neuron and intermediate progenitor production and elongation of the neuroepithelium. Several types of experiments demonstrate that retinoic acid (RA) is the key component of this secreted activity. In addition, Rdh10- and Raldh2-expressing cells in the dorsal meninges were either reduced or absent in the Foxc1 mutants, and Rdh10 mutants had a cortical phenotype similar to the Foxc1 null mutants. Lastly, in utero RA treatment rescued the cortical phenotype in Foxc1 mutants. These results establish RA as a potent, meningeal-derived cue required for successful corticogenesis.	[Siegenthaler, Julie A.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, Program Neurosci, Inst Regenerat Med, San Francisco, CA 94158 USA; [Siegenthaler, Julie A.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, Program Dev Biol, Inst Regenerat Med, San Francisco, CA 94158 USA; [Hecht, Jonathan H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ashique, Amir M.; Peterson, Andrew S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kane, Maureen A.; Folias, Alexandra E.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA; [May, Scott R.] Salk Inst Biol Studies, San Diego, CA 92186 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; University of California System; University of California Berkeley; Vanderbilt University; Salk Institute	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, Inst Regenerat Med, San Francisco, CA 94158 USA.	sam.pleasure@ucsf.edu		, Julie/0000-0003-3700-6441	NIH [R01DA017627]; Autism Speaks; AHA/AAN; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA017627, R01DA017627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; AHA/AAN(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Grant Li for technical assistance and helpful discussions, Dr. Brad Pawlikowski for critical review of the manuscript, and Drs. John Rubenstein and Arturo Alvarez-Buylla for helpful discussion. This work was supported by grants from the NIH (R01DA017627), Autism Speaks, and the AHA/AAN.	Anchan RM, 1997, J COMP NEUROL, V379, P171; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Dickman ED, 1997, DEVELOPMENT, V124, P3111; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; Folkers GE, 1998, J BIOL CHEM, V273, P32200, DOI 10.1074/jbc.273.48.32200; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi A, 2004, J NEUROSCI RES, V78, P784, DOI 10.1002/jnr.20347; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li WW, 1998, J NEUROSCI, V18, P8853; Liao WL, 2005, DEV DYNAM, V232, P887, DOI 10.1002/dvdy.20281; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Luo TL, 2004, J COMP NEUROL, V470, P297, DOI 10.1002/cne.20013; Maden M, 2001, INT REV CYTOL, V209, P1; Mehrara BJ, 1999, PLAST RECONSTR SURG, V104, P435, DOI 10.1097/00006534-199908000-00017; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NAPOLI JL, 2004, VITAMIN A RETINOIDS, V4; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Romand R, 2008, J COMP NEUROL, V508, P879, DOI 10.1002/cne.21707; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1993, DEVELOPMENT, V118, P267; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Vivatbutsiri P, 2008, J ANAT, V212, P603, DOI 10.1111/j.1469-7580.2008.00893.x; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zarbalis K, 2000, MECH DEVELOP, V93, P165, DOI 10.1016/S0925-4773(00)00252-5; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104; Zhang JH, 2003, J NEUROSCI, V23, P7610	51	286	292	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					597	609		10.1016/j.cell.2009.10.004	http://dx.doi.org/10.1016/j.cell.2009.10.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879845	Bronze, Green Accepted			2022-12-28	WOS:000271259600023
J	Lerner, BH				Lerner, Barron H.			When Diseases Disappear - The Case of Familial Dysautonomia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.							Axelrod FB, 2006, CLIN AUTON RES, V16, P90, DOI 10.1007/s10286-006-0326-7; GESSEN M, 2008, BLOOD MATTERS; Harmon Amy, 2004, NY TIMES        0214, pA1; LINDEE S, 2005, MOMENTS TRUTH GENETI, P156; Rosenberg C. E., 1992, FRAMING DIS STUDIES, pxiii	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1622	1625		10.1056/NEJMp0809587	http://dx.doi.org/10.1056/NEJMp0809587			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508YW	19846847				2022-12-28	WOS:000270977400003
J	Gillick, MR				Gillick, Muriel R.			Medicine as Ecoculture	ANNALS OF INTERNAL MEDICINE			English	Article							DECISION-MAKING; PHYSICIAN; OUTCOMES; CARE	The use of diagnostic tests, especially imaging studies, varies markedly across the United States-with higher costs but no better patient outcomes associated with the highest-use regions. A proposed new model of the health care system draws on an analogy with the ecosystem to explain the geographic variations in physician test ordering. This framework emphasizes the adaptability and interdependence of the components of the system. Patients and physicians are influenced by the health care organizations in their community, including the practice site in which the physician works, local hospitals, malpractice lawyers, and imaging centers. These are in turn influenced by institutions in society at large, including the media, health care plans, and the government. Further adaptations to the explanatory model account for the psychologic and sociologic aspects of physician behavior. Understanding the medical ecoculture is essential for effective health care reform because widely touted changes, such as the introduction of an electronic medical record or comparative effectiveness studies, do not address the adaptability and interdependence that characterize the medical ecoculture.	[Gillick, Muriel R.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA; [Gillick, Muriel R.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mgillick@partners.org						ALBERT M, 2004, USE MRI PET CLIN DIA; Chatterji AK, 2008, HEALTH AFFAIR, V27, P1532, DOI 10.1377/hlthaff.27.6.1532; Cohen AB, 2003, TECHNOLOGY IN AMERICAN HEALTH CARE: POLICY DIRECTIONS FOR EFFECTIVE EVALUATION AND MANAGEMENT, P79; Fisher E.S., 2008, TRACKING CARE PATIEN; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; *FLOR HOSP IM SERV, 2009, PET ALZH; HING E, 2005, 365 NAT CTR HLTH STA; Iansiti M, 2004, HARVARD BUS REV, V82, P132; Iansiti M, 2004, HARVARD BUS REV, V82, P68; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Illes J, 2004, ARCH INTERN MED, V164, P2415, DOI 10.1001/archinte.164.22.2415; Ketcham JD, 2007, HEALTH AFFAIR, V26, P195, DOI 10.1377/hlthaff.26.1.195; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KOLATA G, 2003, NY TIMES        0311, pA1; Kouri BE, 2002, AM J ROENTGENOL, V179, P843, DOI 10.2214/ajr.179.4.1790843; Levin David C, 2008, J Am Coll Radiol, V5, P806, DOI 10.1016/j.jacr.2008.01.025; Lo B, 2009, CONFLICT INTEREST ME; Mitchell JM, 2007, HEALTH AFFAIR, V26, pW415, DOI 10.1377/hlthaff.26.3.w415; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P1985, DOI 10.1001/jama.2008.528; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491	21	5	6	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					577	580		10.7326/0003-4819-151-8-200910200-00012	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514HY	19841458				2022-12-28	WOS:000271386200007
J	Kee, K; Angeles, VT; Flores, M; Nguyen, HN; Pera, RAR				Kee, Kehkooi; Angeles, Vanessa T.; Flores, Martha; Nguyen, Ha Nam; Pera, Renee A. Reijo			Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation	NATURE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; PROTEIN GENE; Y-CHROMOSOME; DERIVATION; MOUSE; LINEAGE; SPERMATOGENESIS; DIFFERENTIATION; ESTABLISHMENT	The leading cause of infertility in men and women is quantitative and qualitative defects in human germ-cell (oocyte and sperm) development. Yet, it has not been possible to examine the unique developmental genetics of human germ-cell formation and differentiation owing to inaccessibility of germ cells during fetal development. Although several studies have shown that germ cells can be differentiated from mouse and human embryonic stem cells, human germ cells differentiated in these studies generally did not develop beyond the earliest stages(1-8). Here we used a germ-cell reporter to quantify and isolate primordial germ cells derived from both male and female human embryonic stem cells. By silencing and overexpressing genes that encode germ-cell-specific cytoplasmic RNA-binding proteins (not transcription factors), we modulated human germ-cell formation and developmental progression. We observed that human DAZL (deleted in azoospermia-like) functions in primordial germ cell formation, whereas closely related genes DAZ and BOULE (also called BOLL) promote later stages of meiosis and development of haploid gametes. These results are significant to the generation of gametes for future basic science and potential clinical applications.	[Kee, Kehkooi; Angeles, Vanessa T.; Flores, Martha; Nguyen, Ha Nam; Pera, Renee A. Reijo] Stanford Univ, Sch Med,Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94305 USA	Stanford University	Pera, RAR (corresponding author), Stanford Univ, Sch Med,Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94305 USA.	reneer@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329; KEE, KEHKOOI/0000-0001-6926-7203	California TRDRP [14RT0159]; National Institutes of Health [RO1HD047721, U54HD055764]; California Institute for Regenerative Medicine [RC1-00137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047721] Funding Source: NIH RePORTER	California TRDRP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Suter for the p2k7 vectors, B. Behr for procurement of clinical samples, C. Nicholas for assistance with SCP3 staining, and S. Jiang and P. Lovelace for FACS expertise. K. K. was supported by a California TRDRP postdoctoral fellowship; V. T. A. was supported by an NIH fellowship. This work was supported by the National Institutes of Health (RO1HD047721, U54HD055764 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research), the California TRDRP (14RT0159) and the California Institute for Regenerative Medicine (RC1-00137) to R. A. R. P.	Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Darzynkiewicz Z, 2001, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0705s00; FLORKEGERLOFF S, 1983, HUM GENET, V65, P61, DOI 10.1007/BF00285030; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miyamoto T, 2002, J ASSIST REPROD GEN, V19, P531, DOI 10.1023/A:1020963919596; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	33	362	409	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					222	U95		10.1038/nature08562	http://dx.doi.org/10.1038/nature08562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19865085	Green Accepted			2022-12-28	WOS:000271655100043
J	Lorusso, R; Gelsomino, S				Lorusso, Roberto; Gelsomino, Sandro			El corazon espinado	LANCET			English	Editorial Material									[Lorusso, Roberto] Civ Hosp, Cardiac Surg Unit, I-25125 Brescia, Italy; [Gelsomino, Sandro] Careggi Hosp, Heart & Vessels Dept, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi	Lorusso, R (corresponding author), Civ Hosp, Cardiac Surg Unit, Piazzale Spedali Civili 1, I-25125 Brescia, Italy.	roberto_lorusso@iol.it	Gelsomino, Sandro/AAK-9824-2020; Lorusso, Roberto/ABB-9275-2020	Gelsomino, Sandro/0000-0002-7746-989X; Lorusso, Roberto/0000-0002-1777-2045					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 7	2009	374	9701					1626	1626		10.1016/S0140-6736(09)60292-0	http://dx.doi.org/10.1016/S0140-6736(09)60292-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19897129				2022-12-28	WOS:000271674600036
J	Bonetta, L				Bonetta, Laura			Should You Be Tweeting?	CELL			English	Editorial Material																			0	29	31	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					452	453		10.1016/j.cell.2009.10.017	http://dx.doi.org/10.1016/j.cell.2009.10.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879830	Bronze			2022-12-28	WOS:000271259600006
J	Schmeing, TM; Ramakrishnan, V				Schmeing, T. Martin; Ramakrishnan, V.			What recent ribosome structures have revealed about the mechanism of translation	NATURE			English	Review							PEPTIDE-BOND FORMATION; ELONGATION-FACTOR-G; AMINOACYL-TRANSFER-RNA; COLI 70S RIBOSOME; SUBSTRATE-ASSISTED CATALYSIS; STOP CODON RECOGNITION; SITE TRANSFER-RNA; FACTOR EF-TU; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE	The high-resolution structures of ribosomal subunits published in 2000 have revolutionized the field of protein translation. They facilitated the determination and interpretation of functional complexes of the ribosome by crystallography and electron microscopy. Knowledge of the precise positions of residues in the ribosome in various states has facilitated increasingly sophisticated biochemical and genetic experiments, as well as the use of new methods such as single-molecule kinetics. In this review, we discuss how the interaction between structural and functional studies over the last decade has led to a deeper understanding of the complex mechanisms underlying translation.	[Schmeing, T. Martin; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	schmeing@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council (UK); Wellcome Trust; Louis-Jeantet Foundation; Agouron Institute; Human Frontiers Science Program and Emmanuel College, Cambridge; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Louis-Jeantet Foundation; Agouron Institute(Pfizer); Human Frontiers Science Program and Emmanuel College, Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Voorhees for a critical reading of this manuscript, and J. Frank and X. Aggirrezabala for providing coordinates of a hybrid state complex. Work in V. R.'s laboratory is supported by the Medical Research Council (UK), the Wellcome Trust, the Louis-Jeantet Foundation and the Agouron Institute. T. M. S. was supported by fellowships from the Human Frontiers Science Program and Emmanuel College, Cambridge. Part of this review was written when V. R. was a G. N. Ramachandran Visiting Professor at the Indian Institute of Science, Bangalore, where he thanks U. Varshney for his hospitality and useful discussions.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Antoun A, 2003, EMBO J, V22, P5593, DOI 10.1093/emboj/cdg525; Antoun A, 2006, MOL CELL, V23, P183, DOI 10.1016/j.molcel.2006.05.030; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Beringer M, 2003, RNA, V9, P919, DOI 10.1261/rna.5600503; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Dorner S, 2003, NUCLEIC ACIDS RES, V31, P6536, DOI 10.1093/nar/gkg842; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; GAO YG, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1179709; GAVRILOVA LP, 1974, FEBS LETT, V45, P324, DOI 10.1016/0014-5793(74)80872-0; Gregory ST, 2009, RNA, V15, P208, DOI 10.1261/rna.1355709; Grigoriadou C, 2007, J MOL BIOL, V373, P551, DOI 10.1016/j.jmb.2007.07.031; Grigoriadou C, 2007, J MOL BIOL, V373, P562, DOI 10.1016/j.jmb.2007.07.032; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; HECHT SM, 1974, P NATL ACAD SCI USA, V71, P4317, DOI 10.1073/pnas.71.11.4317; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; KAZEMIE M, 1976, EUR J BIOCHEM, V67, P373, DOI 10.1111/j.1432-1033.1976.tb10701.x; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Koch M, 2008, ANGEW CHEM INT EDIT, V47, P7242, DOI 10.1002/anie.200801511; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lang K, 2008, CHEM BIOL, V15, P485, DOI 10.1016/j.chembiol.2008.03.014; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; MOORE VG, 1975, P NATL ACAD SCI USA, V72, P844, DOI 10.1073/pnas.72.3.844; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; NIERHAUS KH, 1980, BIOCHEM INT, V1, P185; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; Poole ES, 1998, NUCLEIC ACIDS RES, V26, P954, DOI 10.1093/nar/26.4.954; QUIGGLE K, 1981, BIOCHEMISTRY-US, V20, P3480, DOI 10.1021/bi00515a027; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; SCHMEING TM, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma PK, 2005, BIOCHEMISTRY-US, V44, P11307, DOI 10.1021/bi0509806; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Trobro S, 2005, P NATL ACAD SCI USA, V102, P12395, DOI 10.1073/pnas.0504043102; Trobro S, 2008, BIOCHEMISTRY-US, V47, P4898, DOI 10.1021/bi8001874; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; VESTERGAARD B, 2001, MOL CELL; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wohlgemuth I, 2006, EMBO REP, V7, P699, DOI 10.1038/sj.embor.7400732; WOWER J, 1989, P NATL ACAD SCI USA, V86, P5232, DOI 10.1073/pnas.86.14.5232; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	134	484	496	1	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1234	1242		10.1038/nature08403	http://dx.doi.org/10.1038/nature08403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19838167				2022-12-28	WOS:000271190800039
J	Porter, M				Porter, Mark			BMA view on whistleblowing	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA, London, England		Porter, M (corresponding author), BMA, London, England.	mporter@bma.org.uk						BMA, 2009, BMA SURV SPEAK PAT; *BMA, 2009, RAIS CONC WHISTL	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2009	339								b4405	10.1136/bmj.b4405	http://dx.doi.org/10.1136/bmj.b4405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AK	19861380				2022-12-28	WOS:000271365500010
J	Aita, K				Aita, Kaoruko			Japan approves brain death to increase donors: will it work?	LANCET			English	Editorial Material							DEFINITIONS		Univ Tokyo, Global Ctr Excellence Program Death & Life Studie, Grad Sch Humanities & Sociol, Tokyo 1130033, Japan	University of Tokyo	Aita, K (corresponding author), Univ Tokyo, Global Ctr Excellence Program Death & Life Studie, Grad Sch Humanities & Sociol, Tokyo 1130033, Japan.	aitak-tky@umin.ac.jp						AITA K, 2000, JAPAN TIMES     1025; AITA K, 1997, JAPAN TIMES     0618; Chiong W, 2005, HASTINGS CENT REP, V35, P20; HALEVY A, 1993, ANN INTERN MED, V119, P519, DOI 10.7326/0003-4819-119-6-199309150-00013; KATO M, 2009, JAPAN TIMES     0619; MARTIN A, 2009, JAPAN TIMES     0619; Morioka M, 2001, HASTINGS CENT REP, V31, P41, DOI 10.2307/3527955; Powner DJ, 2009, LANCET, V373, P1587, DOI 10.1016/S0140-6736(09)60887-4; President's Council on Bioethics, 2008, CONTR DET DEATH; Shewmon DA, 2009, HASTINGS CENT REP, V39, P18; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; Truog RD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528024; Veatch RM, 1999, DEFINITION OF DEATH, P137; 2009, ASAHI SHIMBUN   0723, P38	14	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 24	2009	374	9699					1403	1404		10.1016/S0140-6736(09)61842-0	http://dx.doi.org/10.1016/S0140-6736(09)61842-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19854358				2022-12-28	WOS:000271255000009
J	Khurana, V; Gambhir, IS; Srivastava, A; Kishore, D				Khurana, Vishal; Gambhir, Inderjeet Singh; Srivastava, Arvind; Kishore, Dhiraj			Dizziness and collapse? It's a steal!	LANCET			English	Editorial Material									[Khurana, Vishal; Gambhir, Inderjeet Singh; Kishore, Dhiraj] Banaras Hindu Univ, Dept Gen Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Srivastava, Arvind] Banaras Hindu Univ, Dept Radiodiol, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Khurana, V (corresponding author), Banaras Hindu Univ, Dept Gen Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	vishdoc24@gmail.com						BRANCHEREAU A, 1991, J CARDIOVASC SURG, V32, P604; Kaneko A, 1998, INTERNAL MED, V37, P259, DOI 10.2169/internalmedicine.37.259; Lum Cindy F, 2004, Optometry, V75, P147, DOI 10.1016/S1529-1839(04)70034-2; Pollard H, 1998, Australas Chiropr Osteopathy, V7, P20; VOLLMAR J, 1965, DEUT MED WOCHENSCHR, V90, P8, DOI 10.1055/s-0028-1111287	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1472	1472		10.1016/S0140-6736(09)61200-9	http://dx.doi.org/10.1016/S0140-6736(09)61200-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19854374				2022-12-28	WOS:000271255000036
J	Shen, YJ; Tenney, AP; Busch, SA; Horn, KP; Cuascut, FX; Liu, K; He, ZG; Silver, J; Flanagan, JG				Shen, Yingjie; Tenney, Alan P.; Busch, Sarah A.; Horn, Kevin P.; Cuascut, Fernando X.; Liu, Kai; He, Zhigang; Silver, Jerry; Flanagan, John G.			PTP sigma Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-SIGMA; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; GLIAL SCAR; AXONAL REGENERATION; FUNCTIONAL RECOVERY; IN-VIVO; GROWTH; CNS; LAR	Chondroitin sulfate proteoglycans (CSPGs) present a barrier to axon regeneration. However, no specific receptor for the inhibitory effect of CSPGs has been identified. We showed that a transmembrane protein tyrosine phosphatase, PTP sigma, binds with high affinity to neural CSPGs. Binding involves the chondroitin sulfate chains and a specific site on the first immunoglobulin-like domain of PTP sigma. In culture, PTP sigma(-/-) neurons show reduced inhibition by CSPG. A PTP sigma fusion protein probe can detect cognate ligands that are up-regulated specifically at neural lesion sites. After spinal cord injury, PTP sigma gene disruption enhanced the ability of axons to penetrate regions containing CSPG. These results indicate that PTP sigma can act as a receptor for CSPGs and may provide new therapeutic approaches to neural regeneration.	[Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Busch, Sarah A.; Horn, Kevin P.; Cuascut, Fernando X.; Silver, Jerry] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Liu, Kai; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020	Horn, Kevin/0000-0002-8799-6941	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025713, R37NS025713] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011559] Funding Source: Medline; NICHD NIH HHS [R37 HD029417] Funding Source: Medline; NINDS NIH HHS [R37 NS025713, R01 NS025713, R37 NS025713-22] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Asher RA, 2000, J NEUROSCI, V20, P2427; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cafferty WBJ, 2008, J NEUROSCI, V28, P11998, DOI 10.1523/JNEUROSCI.3877-08.2008; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chan CCM, 2007, GLIA, V55, P369, DOI 10.1002/glia.20466; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; FRY EJ, 2009, GLIA, DOI DOI 10.1002/GLIA.20934; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Haworth K, 1998, MOL CELL NEUROSCI, V12, P93, DOI 10.1006/mcne.1998.0707; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; McLean J, 2002, J NEUROSCI, V22, P5481; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tester NJ, 2008, EXP NEUROL, V209, P483, DOI 10.1016/j.expneurol.2007.07.019; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	35	480	502	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					592	596		10.1126/science.1178310	http://dx.doi.org/10.1126/science.1178310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19833921	Green Accepted			2022-12-28	WOS:000271019400047
J	Jones, E; Liddell, K				Jones, Eleri; Liddell, Kathleen			Should healthy volunteers in clinical trials be paid according to risk? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jones, Eleri] Middle Temple, London EC4Y 9AT, England; [Liddell, Kathleen] Univ Cambridge, Fac Law, Cambridge CB3 9DZ, England	University of Cambridge	Jones, E (corresponding author), Middle Temple, London EC4Y 9AT, England.	eleri.jones@cantab.net						*ASS BRIT PHARM IN, 2007, GUID PHAS 1 CLIN TRI, P19; Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Ferguson Pamela R, 2008, Med Law Rev, V16, P23, DOI 10.1093/medlaw/fwm020; Fortun P, 2008, QJM-INT J MED, V101, P625, DOI 10.1093/qjmed/hcn067; Grady Christine, 2001, American Journal of Bioethics, V1, P40, DOI 10.1162/152651601300169031; LAURANCE J, 2006, INDEPENDENT     0316; Phillips TB, 2007, AM J BIOETHICS, V7, P88, DOI 10.1080/15265160601112170; Royal College of Physicians, 2007, GUID PRACT ETH COMM; MED HUMAN USE CLIN T	9	5	5	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 22	2009	339								b4142	10.1136/bmj.b4142	http://dx.doi.org/10.1136/bmj.b4142			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PN	19850609				2022-12-28	WOS:000271102500001
J	Psaty, BM; Prentice, RL				Psaty, Bruce M.; Prentice, Ross L.			Variation in Event Rates in Trials of Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE CONTROL		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Prentice, Ross L.] Univ Washington, Div Publ Hlth Sci, Fred Hutchinson Canc Res Ctr, Seattle, WA 98101 USA; [Prentice, Ross L.] Univ Washington, Dept Biostat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Grp Hlth, Grp Hlth Res Inst, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL CANCER INSTITUTE [P01CA053996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, U01HL080295, R01HL085251, R01HL080295, R01HL087652] Funding Source: NIH RePORTER; NCI NIH HHS [CA53996] Funding Source: Medline; NHLBI NIH HHS [HL74745, HL087652, HL085251, HL080295] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ARIC, ARIC INC TABL; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; Davis BR, 2009, NEW ENGL J MED, V360, P1148; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prentice RL, 2009, JNCI-J NATL CANCER I, V101, P216, DOI 10.1093/jnci/djn515	10	17	17	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1698	1700		10.1001/jama.2009.1497	http://dx.doi.org/10.1001/jama.2009.1497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843906				2022-12-28	WOS:000270941200027
J	Sennerby, U; Melhus, H; Gedeborg, R; Byberg, L; Garmo, H; Ahlbom, A; Pedersen, NL; Michaelsson, K				Sennerby, Ulf; Melhus, Hakan; Gedeborg, Rolf; Byberg, Liisa; Garmo, Hans; Ahlbom, Anders; Pedersen, Nancy L.; Michaelsson, Karl			Cardiovascular Diseases and Risk of Hip Fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-FAILURE; BONE LOSS; VASCULAR CALCIFICATION; MYOCARDIAL-INFARCTION; LIFETIME RISK; OSTEOPOROSIS; STROKE; WOMEN; HOSPITALIZATION; MORTALITY	Context Recent studies indicate common etiologies for cardiovascular disease (CVD) and osteoporotic fractures. Objectives To examine the relation between CVD and risk of hip fracture in twins and evaluate the relative importance of genetics and lifestyle factors in this association. Design, Setting, and Participants A cohort of all 31 936 Swedish twins born from 1914-1944 was followed up from the age of 50 years. The National Patient Registry identified twins with CVDs and fractures from 1964 through 2005. Time-dependent exposures using Cox proportional hazard regression models were evaluated. Main Outcome Measure Time to hip fracture after diagnosis of CVD. Results The crude absolute rate of hip fractures was 12.6 per 1000 person-years after a diagnosis of heart failure, 12.6 per 1000 person-years after a stroke, 6.6 per 1000 person-years after a diagnosis of peripheral atherosclerosis, and 5.2 per 1000 person-years after a diagnosis of ischemic heart disease compared with 1.2 per 1000 person-years for those without a CVD diagnosis. The multivariable-adjusted hazard ratio (HR) of hip fracture after a diagnosis of heart failure was 4.40 (95% confidence interval [CI], 3.43-5.63); after a stroke, the HR was 5.09 (95% CI, 4.18-6.20); after a diagnosis of peripheral atherosclerosis, the HR was 3.20 (95% CI, 2.28-4.50); and after an ischemic heart disease event, the HR was 2.32 (95% CI, 1.91-2.84). Identical twins without heart failure and stroke also had, after their co-twins had been exposed to these respective diseases, an increased rate of hip fracture. These sibling twins pseudoexposed for heart failure had a multivariable-adjusted HR of 3.74 (95% CI, 1.97-7.10) for hip fracture, whereas pseudoexposure for stroke had an HR of 2.29 (95% CI, 1.20-4.35). Conclusions A diagnosis of CVD was significantly associated with risk of subsequent hip fracture. Increased risks in co-twins without an index diagnosis suggest genetic factors in the association between CVD and osteoporotic fractures. JAMA. 2009;302(15):1666-1673	[Melhus, Hakan; Gedeborg, Rolf; Byberg, Liisa; Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Sennerby, Ulf; Byberg, Liisa; Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, SE-75185 Uppsala, Sweden; [Gedeborg, Rolf] Uppsala Univ, Sect Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Clin Pharmacol Sect, SE-75185 Uppsala, Sweden; [Garmo, Hans] Uppsala Univ, Reg Oncol Ctr, SE-75185 Uppsala, Sweden; [Garmo, Hans] Kings Coll London, Sch Med, Div Canc Studies, London WC2R 2LS, England; [Ahlbom, Anders] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-10401 Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; University of London; King's College London; Karolinska Institutet; Karolinska Institutet	Michaelsson, K (corresponding author), Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Gedeborg, Rolf/AAV-6702-2020; Michaelsson, Karl/AAM-9094-2021	Gedeborg, Rolf/0000-0002-8850-7863; Michaelsson, Karl/0000-0003-2815-1217; Garmo, Hans/0000-0001-7181-7083	National Institutes of Health [AG 08754]; Swedish Research Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant AG 08754 from the National Institutes of Health and another from the Swedish Research Council.	Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Baldini V, 2005, J Endocrinol Invest, V28, P69; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Dennison E, 2006, RHEUM DIS CLIN N AM, V32, P617, DOI 10.1016/j.rdc.2006.08.003; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Farhat GN, 2006, CALCIFIED TISSUE INT, V79, P102, DOI 10.1007/s00223-006-0052-0; Heaney RP, 2006, OSTEOPOROSIS INT, V17, P212, DOI 10.1007/s00198-005-1975-4; Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Merlo J, 2000, EUR J EPIDEMIOL, V16, P235, DOI 10.1023/A:1007634722658; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Myint PK, 2007, QJM-INT J MED, V100, P539, DOI 10.1093/qjmed/hcm067; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Nyberg L, 1997, STROKE, V28, P716, DOI 10.1161/01.STR.28.4.716; Oden A, 1998, OSTEOPOROSIS INT, V8, P599, DOI 10.1007/s001980050105; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Rejnmark L, 2004, OSTEOPOROSIS INT, V15, P452, DOI 10.1007/s00198-003-1568-z; Samelson EJ, 2007, J BONE MINER RES, V22, P1449, DOI 10.1359/JBMR.070519; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Valdes AM, 2007, OSTEOPOROSIS INT, V18, P1203, DOI 10.1007/s00198-007-0357-5; Wiens M, 2006, J INTERN MED, V260, P350, DOI 10.1111/j.1365-2796.2006.01695.x; Wong LSM, 2008, EUR J HEART FAIL, V10, P1049, DOI 10.1016/j.ejheart.2008.08.007	36	241	251	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1666	1673		10.1001/jama.2009.1463	http://dx.doi.org/10.1001/jama.2009.1463			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843901	Bronze, Green Published			2022-12-28	WOS:000270941200021
J	Hartling, L; Ospina, M; Liang, YY; Dryden, DM; Hooton, N; Seida, JK; Klassen, TP				Hartling, Lisa; Ospina, Maria; Liang, Yuanyuan; Dryden, Donna M.; Hooton, Nicola; Seida, Jennifer Krebs; Klassen, Terry P.			Risk of bias versus quality assessment of randomised controlled trials: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; METAANALYSIS; OUTCOMES	Objectives To evaluate the risk of bias tool, introduced by the Cochrane Collaboration for assessing the internal validity of randomised trials, for inter-rater agreement, concurrent validity compared with the Jadad scale and Schulz approach to allocation concealment, and the relation between risk of bias and effect estimates. Design Cross sectional study. Study sample 163 trials in children. Main outcome measures Inter-rater agreement between reviewers assessing trials using the risk of bias tool (weighted K), time to apply the risk of bias tool compared with other approaches to quality assessment (paired t test), degree of correlation for overall risk compared with overall quality scores (Kendall's t statistic), and magnitude of effect estimates for studies classified as being at high, unclear, or low risk of bias (metaregression). Results Inter-rater agreement on individual domains of the risk of bias tool ranged from slight (K = 0.13) to substantial (K = 0.74). The mean time to complete the risk of bias tool was significantly longer than for the Jadad scale and Schulz approach, individually or combined (8.8 minutes (SD 2.2) per study v 2.0 (SD 0.8), P<0.001). There was low correlation between risk of bias overall compared with the Jadad scores (P=0.395) and Schulz approach (P=0.064). Effect sizes differed between studies assessed as being at high or unclear risk of bias (0.52) compared with those at low risk (0.23). Conclusions Inter-rater agreement varied across domains of the risk of bias tool. Generally, agreement was poorer for those items that required more judgment. There was low correlation between assessments of overall risk of bias and two common approaches to quality assessment: the Jadad scale and Schulz approach to allocation concealment. Overall risk of bias as assessed by the risk of bias tool differentiated effect estimates, with more conservative estimates for studies at low risk.	[Hartling, Lisa; Ospina, Maria; Liang, Yuanyuan; Dryden, Donna M.; Hooton, Nicola; Seida, Jennifer Krebs; Klassen, Terry P.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB T6G 2J3, Canada	University of Alberta	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Aberhart Ctr 1, Edmonton, AB T6G 2J3, Canada.	hartling@ualberta.ca		Ospina, Maria/0000-0001-9305-7521; Ospina, Maria/0000-0002-1627-4781; Klassen, Terry/0000-0002-5309-7091				ALSNIELSEN B, 2004, ARE TRIAL SIZE REPOR; [Anonymous], 47 AG HEALTHC RES QU; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cicchetti DV., 1971, AM J EEG TECHNOL, V11, P101, DOI [10.1080/00029238.1971.11080840, DOI 10.1080/00029238.1971.11080840]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 2003, Health Technol Assess, V7, P1; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Klassen TP, 2002, ARCH PEDIAT ADOL MED, V156, P474, DOI 10.1001/archpedi.156.5.474; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Schulz K F, 2001, Evid Based Nurs, V4, P4, DOI 10.1136/ebn.4.1.4; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SEIGEL DG, 1992, AM J EPIDEMIOL, V135, P571, DOI 10.1093/oxfordjournals.aje.a116324; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Verhagen AP, 2001, J CLIN EPIDEMIOL, V54, P651, DOI 10.1016/S0895-4356(00)00360-7; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	34	227	238	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2009	339								b4012	10.1136/bmj.b4012	http://dx.doi.org/10.1136/bmj.b4012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PI	19841007	Green Published, hybrid			2022-12-28	WOS:000271101900001
J	Dekas, AE; Poretsky, RS; Orphan, VJ				Dekas, Anne E.; Poretsky, Rachel S.; Orphan, Victoria J.			Deep-Sea Archaea Fix and Share Nitrogen in Methane-Consuming Microbial Consortia	SCIENCE			English	Article							ANAEROBIC OXIDATION; FIXATION; EVOLUTION; SEDIMENTS; BIOGEOCHEMISTRY; BACTERIA; DIVERSE; CARBON; FISH	Nitrogen-fixing (diazotrophic) microorganisms regulate productivity in diverse ecosystems; however, the identities of diazotrophs are unknown in many oceanic environments. Using single-cell-resolution nanometer secondary ion mass spectrometry images of (15)N incorporation, we showed that deep-sea anaerobic methane-oxidizing archaea fix N(2), as well as structurally similar CN(-), and share the products with sulfate-reducing bacterial symbionts. These archaeal/bacterial consortia are already recognized as the major sink of methane in benthic ecosystems, and we now identify them as a source of bioavailable nitrogen as well. The archaea maintain their methane oxidation rates while fixing N(2) but reduce their growth, probably in compensation for the energetic burden of diazotrophy. This finding extends the demonstrated lower limits of respiratory energy capable of fueling N(2) fixation and reveals a link between the global carbon, nitrogen, and sulfur cycles.	[Dekas, Anne E.; Poretsky, Rachel S.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Dekas, AE (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dekas@gps.caltech.edu; vorphan@gps.caltech.edu	Orphan, Victoria/AAS-5989-2020; Orphan, Victoria J/K-1002-2014	Orphan, Victoria/0000-0002-5374-6178; Orphan, Victoria J/0000-0002-5374-6178	NSF [MCB-0348492]; Gordon and Betty Moore Foundation; NSF Graduate Research Fellowship	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Graduate Research Fellowship(National Science Foundation (NSF))	We thank C. House, A. Schmitt, K. McKeegan, Y. Guan, J. Eiler, and L. Remusat for assistance with the ion microprobe data collection; S. Joye, M. Boyles, M. Walton, J. Howard, N. Dalleska, O. Mason, A. Green, P. Tavormina, S. Goffredi, C. Gammon, and the shipboard party and crew of the R/V Atlantis and DSSV Alvin for support in the field and laboratory; and J. Howard, W. Fischer, J. Amend, C. Anderson, D. Fike, D. Sigman, V. Rich, J. Bailey, D. Newman, J. Grotzinger, T. Hoehler, J. Delacruz, and three anonymous reviewers for helpful suggestions regarding this manuscript. Funding was provided by NSF (grant MCB-0348492), the Gordon and Betty Moore Foundation, and an NSF Graduate Research Fellowship (A. E. D.). The Caltech Center for Microanalysis and nanoSIMS 50L are funded by the Gordon and Betty Moore Foundation, and the University of California Los Angeles ion microprobe is partially supported by the NSF Instrumentation and Facilities Program.	Behrens S, 2008, APPL ENVIRON MICROB, V74, P3143, DOI 10.1128/AEM.00191-08; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Buckley DH, 2008, SOIL BIOL BIOCHEM, V40, P1272, DOI 10.1016/j.soilbio.2007.05.006; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dang HY, 2009, APPL ENVIRON MICROB, V75, P2238, DOI 10.1128/AEM.02556-08; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Fulweiler RW, 2007, NATURE, V448, P180, DOI 10.1038/nature05963; Horner-Devine MC, 2008, SCIENCE, V320, P757, DOI 10.1126/science.1147012; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kessler PS, 2001, J BACTERIOL, V183, P882, DOI 10.1128/JB.183.3.882-889.2001; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Liu Jong-Kaing, 1997, Proceedings of the National Science Council Republic of China Part B Life Sciences, V21, P37; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; MURRAY PA, 1984, NATURE, V312, P284, DOI 10.1038/312284a0; Orphan VJ, 2009, ENVIRON MICROBIOL, V11, P1777, DOI 10.1111/j.1462-2920.2009.01903.x; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Raymond J, 2005, REV MINERAL GEOCHEM, V59, P211, DOI 10.2138/rmg.2005.59.9; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; SILVER WS, 1973, J THEOR BIOL, V40, P1, DOI 10.1016/0022-5193(73)90160-4; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	29	222	234	8	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					422	426		10.1126/science.1178223	http://dx.doi.org/10.1126/science.1178223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833965	Green Accepted			2022-12-28	WOS:000270818600052
J	Gingras, MJP				Gingras, Michel J. P.			Observing Monopoles in a Magnetic Analog of Ice	SCIENCE			English	Editorial Material							SPIN ICE; ENTROPY; WATER		[Gingras, Michel J. P.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Gingras, Michel J. P.] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON MSG 1Z8, Canada	University of Waterloo; Canadian Institute for Advanced Research (CIFAR)	Gingras, MJP (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	gingras@gandalf.uwaterloo.ca						Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Fennell T, 2007, NAT PHYS, V3, P566, DOI 10.1038/nphys632; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Giauque WF, 1933, PHYS REV, V43, P81, DOI 10.1103/PhysRev.43.81.2; Giauque WF, 1936, J AM CHEM SOC, V58, P1144, DOI 10.1021/ja01298a023; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Hermele M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064404; JACKSON RJ, 1998, CLASSICAL ELECTRODYN, P273; Jaubert LDC, 2009, NAT PHYS, V5, P258, DOI 10.1038/NPHYS1227; Molavian HR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157204; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Yavors'kii T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037204	16	36	37	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					375	376		10.1126/science.1181510	http://dx.doi.org/10.1126/science.1181510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833948	Green Submitted			2022-12-28	WOS:000270818600033
J	Silverstein, SC; Dubner, J; Miller, J; Glied, S; Loike, JD				Silverstein, Samuel C.; Dubner, Jay; Miller, Jon; Glied, Sherry; Loike, John D.			Teachers' Participation in Research Programs Improves Their Students' Achievement in Science	SCIENCE			English	Article								Research experience programs engage teachers in the hands-on practice of science. Program advocates assert that program participation enhances teachers' skills in communicating science to students. We measured the impact of New York City public high-school science teachers' participation in Columbia University's Summer Research Program on their students' academic performance in science. In the year before program entry, students of participating and nonparticipating teachers passed a New York State Regents science examination at the same rate. In years three and four after program entry, participating teachers' students passed Regents science exams at a rate that was 10.1% higher ( P = 0.049) than that of nonparticipating teachers' students. Other program benefits include decreased teacher attrition from classroom teaching and school cost savings of U. S. $1.14 per $1 invested in the program.	[Silverstein, Samuel C.; Dubner, Jay; Loike, John D.] Columbia Univ, Dept Physiol, New York, NY 10032 USA; [Silverstein, Samuel C.; Dubner, Jay; Loike, John D.] Columbia Univ, Dept Cellular Biophys, New York, NY 10032 USA; [Miller, Jon] Michigan State Univ, Int Ctr Adv Sci Literacy, E Lansing, MI 48824 USA; [Glied, Sherry] Columbia Univ, Dept Hlth Policy & Management, New York, NY 10032 USA	Columbia University; Columbia University; Michigan State University; Columbia University	Silverstein, SC (corresponding author), Columbia Univ, Dept Physiol, 630 W 168th St, New York, NY 10032 USA.	scs3@columbia.edu			Howard Hughes Medical Institute; Ambrose Monell, Braitmayer, Bristol Myers Squibb, Camile and Henry Dreyfus, Greenwald, Mellam Family, J. P. Morgan, and NY Times Company Foundations; Charles Edison Fund; Hebrew Technical Institute; National Institutes of Health; NSF's Division of Engineering Education and Human Resource Development; Columbia University's Materials Research Science and Engineering Center and Nanoscale Science and Engineering Center; M. J. Murdock Charitable Trust; Columbia University faculty, staff, and program alumni who have participated in CUSRP's Advisory Committee; 200 Columbia faculty	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ambrose Monell, Braitmayer, Bristol Myers Squibb, Camile and Henry Dreyfus, Greenwald, Mellam Family, J. P. Morgan, and NY Times Company Foundations(Bristol-Myers Squibb); Charles Edison Fund; Hebrew Technical Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF's Division of Engineering Education and Human Resource Development; Columbia University's Materials Research Science and Engineering Center and Nanoscale Science and Engineering Center; M. J. Murdock Charitable Trust; Columbia University faculty, staff, and program alumni who have participated in CUSRP's Advisory Committee; 200 Columbia faculty	The authors gratefully acknowledge support from the Howard Hughes Medical Institute; the Ambrose Monell, Braitmayer, Bristol Myers Squibb, Camile and Henry Dreyfus, Greenwald, Mellam Family, J. P. Morgan, and NY Times Company Foundations; the Charles Edison Fund; the Hebrew Technical Institute; the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources-Science Education Partnership Award of the National Institutes of Health; NSF's Division of Engineering Education and Human Resource Development; Columbia University's Materials Research Science and Engineering Center and Nanoscale Science and Engineering Center; the M. J. Murdock Charitable Trust; Columbia University faculty, staff, and program alumni who have participated in CUSRP's Advisory Committee; the 200 Columbia faculty who have mentored teachers; the 250 teachers who have participated in the program to date; and the anonymous reviewer who made many helpful suggestions that have clarified and strengthened this manuscript.	[Anonymous], 1983, SOUTHWARK SPARROW; BLALOCK HM, 1960, SOC STAT, P242; Braun H., 2009, EXPLORING WHAT WORKS; DUFOUR R, 2004, SOLUTION TREE; FRAZIER WM, 2001, THESIS COLUMBIA U NE; GRIGG WS, 2006, TRENDS INT MATH SCI; Levin H., 2006, COSTS BENEFITS EXCEL; *NAT COMM TEACH FU, 1996, WHAT MATT MOST TEACH; National Research Council, 2007, RISING GATHERING STO; POGASH C, 2008, NY TIMES        0301; SILVERSTEIN SC, EFFECTS TEACHER PART; SUPOVITZ JA, 2000, CAPITOL CLASSROOM ST, P81; *US DEP ED, 2005, 2006466 NCES US DEP; Weisbaum KS, 2001, IISME TEACHER RETENT; Wenglinsky H., 2000, TEACHING MATTERS	15	55	56	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					440	442		10.1126/science.1177344	http://dx.doi.org/10.1126/science.1177344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833969				2022-12-28	WOS:000270818600057
J	Marshall, JC; Abraham, E; Adikhari, N; Aikawa, N; al Rahma, HN; Amin, P; Angus, DC; Annane, D; Argent, A; Bernard, GR; Bertolini, G; Bhagwanjee, S; Burns, KA; Calandra, T; Ceraso, D; Chan, K; Chiche, JD; Cobb, JP; Cook, DJ; Cuthbertson, BH; da Silva, E; de Backer, D; Dellinger, RP; Divatia, JV; Fedson, D; Festa, M; Ferguson, ND; Finfer, S; Fowler, R; Gomerall, C; Granton, J; Hammer, B; Hudson, LD; Jimenez, E; Kissoon, N; Koh, Y; Kumar, A; Langer, M; Latronico, N; Levy, MM; Lowry, S; Mamdani, M; Marsh, B; McAuley, DF; Meduri, GU; Menon, D; Mira, JP; Morales-Alava, F; Moreno, R; Morrison, L; Myburgh, J; Opal, S; Perkins, G; Perner, A; Randolph, A; Reinhart, K; Rello, J; Rice, T; Rowan, K; Sanchez-Nava, VM; Schuettler, J; Shukri, K; Slutsky, AS; Sprung, C; Sybrecht, GW; Taylor, BI; Thompson, AE; Thompson, BT; Tomicic, V; Ugarte, S; van der Poll, T; Vernon, DD; Vincent, JL; Walsh, T; Webb, S; Welte, T; Yung, M				Marshall, John C.; Abraham, Edward; Adikhari, Neill; Aikawa, Naoki; al Rahma, Hussain Nasser; Amin, Pravin; Angus, Derek C.; Annane, Djillali; Argent, Andrew; Bernard, Gordon R.; Bertolini, Guido; Bhagwanjee, Satish; Burns, Karen A.; Calandra, Thierry; Ceraso, Daniel; Chan, Kenneth; Chiche, Jean-Daniel; Cobb, J. Perren; Cook, Deborah J.; Cuthbertson, Brian H.; da Silva, Eliezer; de Backer, Daniel; Dellinger, R. Phillip; Divatia, Jigeeshu V.; Fedson, David; Festa, Marino; Ferguson, Niall D.; Finfer, Simon; Fowler, Robert; Gomerall, Charles; Granton, John; Hammer, Beth; Hudson, Leonard D.; Jimenez, Edgar; Kissoon, Niranjan; Koh, Younsuck; Kumar, Anand; Langer, Martin; Latronico, Nicola; Levy, Mitchell M.; Lowry, Stephen; Mamdani, Muhammad; Marsh, Brian; McAuley, Daniel F.; Meduri, G. Umberto; Menon, David; Mira, Jean-Paul; Morales-Alava, Freddy; Moreno, Rui; Morrison, Laurie; Myburgh, John; Opal, Steven; Perkins, Gavin; Perner, Anders; Randolph, Adrienne; Reinhart, Konrad; Rello, Jordi; Rice, Todd; Rowan, Kathy; Sanchez-Nava, Victor M.; Schuettler, Juergen; Shukri, Khalid; Slutsky, Arthur S.; Sprung, Charles; Sybrecht, Gerhard W.; Taylor, Bruce I.; Thompson, Ann E.; Thompson, B. Taylor; Tomicic, Vinko; Ugarte, Sebastian; van der Poll, Tom; Vernon, Donald D.; Vincent, Jean-Louis; Walsh, Timothy; Webb, Steven; Welte, Tobias; Yung, Michael		InFACT Global H1N1 Collaboration	InFACT: a global critical care research response to H1N1	LANCET			English	Editorial Material									[Annane, Djillali] Sch Med Paris Ile France Ouest, Paris, France; [Chan, Kenneth] SICM Singapore, Singapore, Singapore; [Finfer, Simon; Myburgh, John] George Inst Int Hlth, Sydney, NSW, Australia; [Gomerall, Charles] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [InFACT Global H1N1 Collaboration] St Michaels Hosp, Toronto, ON M5B 1W8, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; University of Sydney; Chinese University of Hong Kong; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto		marshallj@smh.toronto.on.ca	Kissoon, Niranjan/AAC-6140-2021; De Backer, Daniel/AAF-4177-2020; Annane, Djillali/R-7947-2019; Slutsky, Arthur/M-3325-2019; Gomersall, Charles D/J-1540-2012; Angus, Derek C/E-9671-2012; Rice, Todd/X-7853-2019; Rello, Jordi/P-2402-2019; Chiche, Jean-Daniel/P-5220-2017; Calandra, Thierry/D-9017-2015; Argent, Andrew/J-1605-2019; Latronico, Nicola/F-1557-2010; Perkins, Gavin/E-7613-2010; Ferguson, Niall/D-7619-2019	De Backer, Daniel/0000-0001-9841-5762; Gomersall, Charles D/0000-0002-8494-8063; Rello, Jordi/0000-0003-0676-6210; Chiche, Jean-Daniel/0000-0002-6433-6254; Calandra, Thierry/0000-0003-3051-1285; Argent, Andrew/0000-0001-9333-2036; Latronico, Nicola/0000-0002-2521-5871; Ferguson, Niall/0000-0002-6213-5264; Finfer, Simon/0000-0002-2785-5864; Randolph, Adrienne/0000-0002-3084-3071; Kissoon, Niranjan/0000-0001-8847-9973; Perner, Anders/0000-0002-4668-0123; Vincent, Jean-Louis/0000-0001-6011-6951				Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lynn J., 2009, REUTERS         0804; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2009, PAND H1N1 2009 UPD 6	9	38	38	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					11	13		10.1016/S0140-6736(09)61792-X	http://dx.doi.org/10.1016/S0140-6736(09)61792-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539BZ	19906418				2022-12-28	WOS:000273229700008
J	Drmanac, R; Sparks, AB; Callow, MJ; Halpern, AL; Burns, NL; Kermani, BG; Carnevali, P; Nazarenko, I; Nilsen, GB; Yeung, G; Dahl, F; Fernandez, A; Staker, B; Pant, KP; Baccash, J; Borcherding, AP; Brownley, A; Cedeno, R; Chen, LS; Chernikoff, D; Cheung, A; Chirita, R; Curson, B; Ebert, JC; Hacker, CR; Hartlage, R; Hauser, B; Huang, S; Jiang, Y; Karpinchyk, V; Koenig, M; Kong, C; Landers, T; Le, C; Liu, J; McBride, CE; Morenzoni, M; Morey, RE; Mutch, K; Perazich, H; Perry, K; Peters, BA; Peterson, J; Pethiyagoda, CL; Pothuraju, K; Richter, C; Rosenbaum, AM; Roy, S; Shafto, J; Sharanhovich, U; Shannon, KW; Sheppy, CG; Sun, M; Thakuria, JV; Tran, A; Vu, D; Zaranek, AW; Wu, XD; Drmanac, S; Oliphant, AR; Banyai, WC; Martin, B; Ballinger, DG; Church, GM; Reid, CA				Drmanac, Radoje; Sparks, Andrew B.; Callow, Matthew J.; Halpern, Aaron L.; Burns, Norman L.; Kermani, Bahram G.; Carnevali, Paolo; Nazarenko, Igor; Nilsen, Geoffrey B.; Yeung, George; Dahl, Fredrik; Fernandez, Andres; Staker, Bryan; Pant, Krishna P.; Baccash, Jonathan; Borcherding, Adam P.; Brownley, Anushka; Cedeno, Ryan; Chen, Linsu; Chernikoff, Dan; Cheung, Alex; Chirita, Razvan; Curson, Benjamin; Ebert, Jessica C.; Hacker, Coleen R.; Hartlage, Robert; Hauser, Brian; Huang, Steve; Jiang, Yuan; Karpinchyk, Vitali; Koenig, Mark; Kong, Calvin; Landers, Tom; Le, Catherine; Liu, Jia; McBride, Celeste E.; Morenzoni, Matt; Morey, Robert E.; Mutch, Karl; Perazich, Helena; Perry, Kimberly; Peters, Brock A.; Peterson, Joe; Pethiyagoda, Charit L.; Pothuraju, Kaliprasad; Richter, Claudia; Rosenbaum, Abraham M.; Roy, Shaunak; Shafto, Jay; Sharanhovich, Uladzislau; Shannon, Karen W.; Sheppy, Conrad G.; Sun, Michel; Thakuria, Joseph V.; Tran, Anne; Vu, Dylan; Zaranek, Alexander Wait; Wu, Xiaodi; Drmanac, Snezana; Oliphant, Arnold R.; Banyai, William C.; Martin, Bruce; Ballinger, Dennis G.; Church, George M.; Reid, Clifford A.			Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays	SCIENCE			English	Article							GENE-EXPRESSION; HYBRIDIZATION; POLYMERASE	Genome sequencing of large numbers of individuals promises to advance the understanding, treatment, and prevention of human diseases, among other applications. We describe a genome sequencing platform that achieves efficient imaging and low reagent consumption with combinatorial probe anchor ligation chemistry to independently assay each base from patterned nanoarrays of self-assembling DNA nanoballs. We sequenced three human genomes with this platform, generating an average of 45- to 87-fold coverage per genome and identifying 3.2 to 4.5 million sequence variants per genome. Validation of one genome data set demonstrates a sequence accuracy of about 1 false variant per 100 kilobases. The high accuracy, affordable cost of $4400 for sequencing consumables, and scalability of this platform enable complete human genome sequencing for the detection of rare variants in large-scale genetic studies.	[Drmanac, Radoje; Sparks, Andrew B.; Callow, Matthew J.; Halpern, Aaron L.; Burns, Norman L.; Kermani, Bahram G.; Carnevali, Paolo; Nazarenko, Igor; Nilsen, Geoffrey B.; Yeung, George; Dahl, Fredrik; Fernandez, Andres; Staker, Bryan; Pant, Krishna P.; Baccash, Jonathan; Borcherding, Adam P.; Brownley, Anushka; Cedeno, Ryan; Chen, Linsu; Chernikoff, Dan; Cheung, Alex; Chirita, Razvan; Curson, Benjamin; Ebert, Jessica C.; Hacker, Coleen R.; Hartlage, Robert; Hauser, Brian; Huang, Steve; Jiang, Yuan; Karpinchyk, Vitali; Koenig, Mark; Kong, Calvin; Landers, Tom; Le, Catherine; Liu, Jia; McBride, Celeste E.; Morenzoni, Matt; Morey, Robert E.; Mutch, Karl; Perazich, Helena; Perry, Kimberly; Peters, Brock A.; Peterson, Joe; Pethiyagoda, Charit L.; Pothuraju, Kaliprasad; Richter, Claudia; Roy, Shaunak; Shafto, Jay; Sharanhovich, Uladzislau; Shannon, Karen W.; Sheppy, Conrad G.; Sun, Michel; Tran, Anne; Vu, Dylan; Drmanac, Snezana; Oliphant, Arnold R.; Banyai, William C.; Martin, Bruce; Ballinger, Dennis G.; Reid, Clifford A.] Complete Genom Inc, Mountain View, CA 94043 USA; [Rosenbaum, Abraham M.; Thakuria, Joseph V.; Zaranek, Alexander Wait; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02115 USA; [Wu, Xiaodi] Washington Univ, Sch Med, St Louis, MO 63110 USA	Harvard University; Washington University (WUSTL)	Drmanac, R (corresponding author), Complete Genom Inc, 2071 Stierlin Court, Mountain View, CA 94043 USA.	rdrmanac@completegenomics.com; dballinger@completegenomics.com		church, george/0000-0001-6232-9969; Peters, Brock/0000-0002-5137-3902; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655				ADAMS CP, 1997, Patent No. 5641658; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CHEESMAN PC, 1994, Patent No. 5302509; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1989, GENOMICS, V4, P114; DRMANAC R, 1995, Patent No. 1995009248; DRMANAC R, 1990, SCI YUGOSL, V16, P97; DRMANAC R, 2004, Patent No. 2004076683; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; MACEVICZ SC, 1998, Patent No. 5750341; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pihlak A, 2008, NAT BIOTECHNOL, V26, P676, DOI 10.1038/nbt1405; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	37	835	992	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					78	81		10.1126/science.1181498	http://dx.doi.org/10.1126/science.1181498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19892942				2022-12-28	WOS:000273395400034
J	Rerks-Ngarm, S; Pitisuttithum, P; Nitayaphan, S; Kaewkungwal, J; Chiu, J; Paris, R; Premsri, N; Namwat, C; de Souza, M; Adams, E; Benenson, M; Gurunathan, S; Tartaglia, J; McNeil, JG; Francis, DP; Stablein, D; Birx, DL; Chunsuttiwat, S; Khamboonruang, C; Thongcharoen, P; Robb, ML; Michael, NL; Kunasol, P; Kim, JH				Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Chiu, Joseph; Paris, Robert; Premsri, Nakorn; Namwat, Chawetsan; de Souza, Mark; Adams, Elizabeth; Benenson, Michael; Gurunathan, Sanjay; Tartaglia, Jim; McNeil, John G.; Francis, Donald P.; Stablein, Donald; Birx, Deborah L.; Chunsuttiwat, Supamit; Khamboonruang, Chirasak; Thongcharoen, Prasert; Robb, Merlin L.; Michael, Nelson L.; Kunasol, Prayura; Kim, Jerome H.		MOPH-TAVEG Investigators	Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; IMMUNE-RESPONSES; CANARYPOX VACCINE; PHASE-I/II; SUBTYPE-E; NEUTRALIZING ANTIBODIES; SIMIAN IMMUNODEFICIENCY; HIV-1-UNINFECTED ADULTS; CANDIDATE VACCINE	BACKGROUND The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control. METHODS In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, we evaluated four priming injections of a recombinant canarypox vector vaccine (ALVAC-HIV [vCP1521]) plus two booster injections of a recombinant glycoprotein 120 subunit vaccine (AIDSVAX B/E). The vaccine and placebo injections were administered to 16,402 healthy men and women between the ages of 18 and 30 years in Rayong and Chon Buri provinces in Thailand. The volunteers, primarily at heterosexual risk for HIV infection, were monitored for the coprimary end points: HIV-1 infection and early HIV-1 viremia, at the end of the 6-month vaccination series and every 6 months thereafter for 3 years. RESULTS In the intention-to-treat analysis involving 16,402 subjects, there was a trend toward the prevention of HIV-1 infection among the vaccine recipients, with a vaccine efficacy of 26.4% (95% confidence interval [CI], -4.0 to 47.9; P = 0.08). In the per-protocol analysis involving 12,542 subjects, the vaccine efficacy was 26.2% (95% CI, -13.3 to 51.9; P = 0.16). In the modified intention-to-treat analysis involving 16,395 subjects (with the exclusion of 7 subjects who were found to have had HIV-1 infection at baseline), the vaccine efficacy was 31.2% (95% CI, 1.1 to 52.1; P = 0.04). Vaccination did not affect the degree of viremia or the CD4+ T-cell count in subjects in whom HIV-1 infection was subsequently diagnosed. CONCLUSIONS This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk. Vaccination did not affect the viral load or CD4+ count in subjects with HIV infection. Although the results show only a modest benefit, they offer insight for future research. (ClinicalTrials.gov number, NCT00223080.)	[Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD 20850 USA; [Rerks-Ngarm, Supachai; Paris, Robert; Namwat, Chawetsan; Chunsuttiwat, Supamit; Khamboonruang, Chirasak; Thongcharoen, Prasert; Kunasol, Prayura] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Vaccine Trials Ctr, Bangkok 10700, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Data Management Unit, Bangkok, Thailand; [Chiu, Joseph; Paris, Robert; de Souza, Mark; Benenson, Michael] Armed Forces Res Inst Med Sci, US Army Med Component, Bangkok 10400, Thailand; [Adams, Elizabeth] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Gurunathan, Sanjay; Tartaglia, Jim; McNeil, John G.] Sanofi Pasteur, Swiftwater, PA USA; [Francis, Donald P.] Global Solut Infect Dis, San Francisco, CA USA; [Stablein, Donald] Emmes Corp, Rockville, MD USA; [Birx, Deborah L.] Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA; [Kim, Jerome H.] US Army Med Mat Dev Act, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Public Health - Thailand; Mahidol University; Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanofi-Aventis; Emmes Corporation; Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army	Kim, JH (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, 1600 E Gude Dr, Rockville, MD 20850 USA.	jkim@hivresearch.org		Kaewkungwal, Jaranit/0000-0001-7916-8460	U. S. Army Medical Research and Materiel Command [Y1-AI-2642-12]; National Institute of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation [W81XWH-07-2-0067]; U. S. Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642] Funding Source: NIH RePORTER	U. S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation; U. S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by an Interagency Agreement (Y1-AI-2642-12) between the U. S. Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U. S. Department of Defense. Sanofi Pasteur provided the ALVAC-HIV vaccine, and Global Solutions for Infectious Diseases (VaxGen) provided the reagents for the immunogenicity assays.	Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; BROWN T, 2004, SEXUALLY TRANSMITTED, V80, P19; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Corey L, 2001, J INFECT DIS, V183, P563, DOI 10.1086/318523; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Fu TM, 2007, AIDS RES HUM RETROV, V23, P67, DOI 10.1089/aid.2006.0114; Gilbert PB, 2005, J INFECT DIS, V192, P974, DOI 10.1086/432734; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gilbert PB, 2003, BIOMETRICS, V59, P531, DOI 10.1111/1541-0420.00063; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gupta K, 2002, J ACQ IMMUN DEF SYND, V29, P254, DOI 10.1097/00126334-200203010-00005; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; KIBUUKA H, J INFECT DI IN PRESS; Lee D, 2004, J INFECT DIS, V190, P903, DOI 10.1086/423284; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; National AIDS Prevention and Alleviation Committee, UNGASS COUNTR PROGR; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; NELSON KE, 1993, JAMA-J AM MED ASSOC, V270, P955, DOI 10.1001/jama.270.8.955; Nitayaphan S, 2000, VACCINE, V18, P1448, DOI 10.1016/S0264-410X(99)00421-1; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; NITAYAPHAN S, 1998, AIDS S, pS155; Pal R, 2006, J VIROL, V80, P3732, DOI 10.1128/JVI.80.8.3732-3742.2006; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Phoolcharoen W, 1998, SCIENCE, V280, P1873, DOI 10.1126/science.280.5371.1873; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1669; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Ratto-Kim S, 2003, JAIDS-J ACQ IMM DEF, V32, P9, DOI 10.1097/00126334-200301010-00003; Rerks-Ngarm S, 2006, AIDS, V20, P1471, DOI 10.1097/01.aids.0000237362.26370.f8; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Thongcharoen P, 2007, JAIDS-J ACQ IMM DEF, V46, P48; Van Rompay KKA, 2005, JAIDS-J ACQ IMM DEF, V38, P124, DOI 10.1097/00126334-200502010-00002; Verrier F, 2000, J VIROL, V74, P10025, DOI 10.1128/JVI.74.21.10025-10033.2000; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; WENIGER BG, 1993, AIDS, V7, P147; Zolla-Pazner S, 1998, J INFECT DIS, V178, P1502, DOI 10.1086/314452	48	2229	2322	5	262	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2209	2220		10.1056/NEJMoa0908492	http://dx.doi.org/10.1056/NEJMoa0908492			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19843557				2022-12-28	WOS:000272257100004
J	Santiago, J; Dupeux, F; Round, A; Antoni, R; Park, SY; Jamin, M; Cutler, SR; Rodriguez, PL; Marquez, JA				Santiago, Julia; Dupeux, Florine; Round, Adam; Antoni, Regina; Park, Sang-Youl; Jamin, Marc; Cutler, Sean R.; Luis Rodriguez, Pedro; Marquez, Jose Antonio			The abscisic acid receptor PYR1 in complex with abscisic acid	NATURE			English	Article							PROTEIN PHOSPHATASES; ARABIDOPSIS; BINDING; START; SCATTERING; PROGRAM; DOMAIN; FOLD	The plant hormone abscisic acid (ABA) has a central role in coordinating the adaptive response in situations of decreased water availability as well as the regulation of plant growth and development. Recently, a 14-member family of intracellular ABA receptors, named PYR/PYL/RCAR(1-3), has been identified. These proteins inhibit in an ABA-dependent manner the activity of a family of key negative regulators of the ABA signalling pathway: the group-A protein phosphatases type 2C (PP2Cs)(4-6). Here we present the crystal structure of Arabidopsis thaliana PYR1, which consists of a dimer in which one of the subunits is bound to ABA. In the ligand-bound subunit, the loops surrounding the entry to the binding cavity fold over the ABA molecule, enclosing it inside, whereas in the empty subunit they form a channel leaving an open access to the cavity, indicating that conformational changes in these loops have a critical role in the stabilization of the hormone-receptor complex. By providing structural details on the ABA-binding pocket, this work paves the way for the development of new small molecules able to activate the plant stress response.	[Dupeux, Florine; Round, Adam; Marquez, Jose Antonio] UJF, EMBL, CNRS, European Mol Biol Lab,Grenoble Outstn, F-38042 Grenoble 9, France; [Dupeux, Florine; Round, Adam; Marquez, Jose Antonio] UJF, EMBL, CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Santiago, Julia; Antoni, Regina; Luis Rodriguez, Pedro] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Park, Sang-Youl; Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Jamin, Marc] Univ Grenoble 1, CNRS, EMBL, Virus Host Cell Interact UVHCI UMI 3265, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Marquez, JA (corresponding author), UJF, EMBL, CNRS, European Mol Biol Lab,Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	marquez@embl.fr	Cutler, Sean R/D-6617-2011; Rodriguez, Pedro L./K-4605-2014; Marquez, Jose/C-5826-2015	Rodriguez, Pedro L./0000-0002-5886-9425; Santiago, Julia/0000-0002-5765-6495; Round, Adam/0000-0002-0723-8228; Jamin, Marc/0000-0002-8677-2110	Ministerio de Educacion y Ciencia [BIO2008-00221]; Fondo Europeo de Desarrollo Regional; Consejo Superior de Investigaciones Cientificas; European Community-Research Infrastructure Action PCUBE	Ministerio de Educacion y Ciencia(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Consejo Superior de Investigaciones Cientificas; European Community-Research Infrastructure Action PCUBE	We thank A. McArthy and S. Brockhauser for support during X- ray data collection and R. Serrano and S. Cusack for critical reading of the manuscript. We are grateful to the European Synchrotron radiation facility ( ESRF) and the EMBL for access to the macromolecular crystallography and BioSAXS beamlines. This work was supported by grant BIO2008-00221 from Ministerio de Educacion y Ciencia and Fondo Europeo de Desarrollo Regional and Consejo Superior de Investigaciones Cientificas (fellowships to J. S. and R. A.). Access to the high throughput crystallization facility of the Partnership for Structural Biology in Grenoble (PSB) (https://htxlab.embl.fr) was supported by the European Community-Research Infrastructure Action PCUBE under the FP7 'Capacities' specific programme.	Christmann A, 2009, CELL, V136, P21, DOI 10.1016/j.cell.2008.12.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; MILBORROW BV, 1974, ANNU REV PLANT PHYS, V25, P259, DOI 10.1146/annurev.pp.25.060174.001355; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2008, PLANT CELL, V20, P2972, DOI 10.1105/tpc.107.056705; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; UEDA H, 1977, B CHEM SOC JPN, V50, P1506, DOI 10.1246/bcsj.50.1506; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	23	363	395	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					665	U143		10.1038/nature08591	http://dx.doi.org/10.1038/nature08591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898494				2022-12-28	WOS:000272277900044
J	Mattson-DiCecca, AA; Reynolds, EE; Cummings, SR				Mattson-DiCecca, Anna A.; Reynolds, Eileen E.; Cummings, Steven R.			Update: A 55-Year-Old Woman With Osteopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VITAMIN-D; FRACTURES											Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cummings SR, 2006, JAMA-J AM MED ASSOC, V296, P2601, DOI 10.1001/jama.296.21.2601; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2023	2024		10.1001/jama.2009.1647	http://dx.doi.org/10.1001/jama.2009.1647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903923				2022-12-28	WOS:000271619700030
J	Marquez, M				Marquez, Miguel			Health-workforce development in the Cuban health system	LANCET			English	Editorial Material									[Marquez, Miguel] Miramar, Havana, Cuba; [Marquez, Miguel] PAHO WHO, Havana, Cuba		Marquez, M (corresponding author), Miramar, Havana, Cuba.	marcere@infomed.sld.cu						DELATORRE EE, 2005, HLTH ALL IS POSSIBLE; HERNANDEZ E, 1976, ED MED SALUD, V10, P1; *PAN AM HLTH ORG, 2007, HLTH SIT AM BAS IND; Pan American Health Organization, 2007, HLTH AM, V2; VUJICI M, 2009, WORKING HLTH FINANCI; WHO, 2008, WORLD HLTH REP PRIM; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]; World Health Organization, 2006, WORLD HLTH REP WORK; 2009, MEDICC REV INT J CUB, V11, P3	9	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1574	1575		10.1016/S0140-6736(09)61919-X	http://dx.doi.org/10.1016/S0140-6736(09)61919-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518EZ	19897113				2022-12-28	WOS:000271674600007
J	Vardi, A; Van Mooy, BAS; Fredricks, HF; Popendorf, KJ; Ossolinski, JE; Haramaty, L; Bidle, KD				Vardi, Assaf; Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Popendorf, Kimberly J.; Ossolinski, Justin E.; Haramaty, Liti; Bidle, Kay D.			Viral Glycosphingolipids Induce Lytic Infection and Cell Death in Marine Phytoplankton	SCIENCE			English	Article							EMILIANIA-HUXLEYI; SERINE PALMITOYLTRANSFERASE; NITRIC-OXIDE; ALGAL VIRUS; COCCOLITHOPHORE; PHYCODNAVIRIDAE; METABOLISM; EXPRESSION; STRATEGY; STRESS	Marine viruses that infect phytoplankton are recognized as a major ecological and evolutionary driving force, shaping community structure and nutrient cycling in the marine environment. Little is known about the signal transduction pathways mediating viral infection. We show that viral glycosphingolipids regulate infection of Emiliania huxleyi, a cosmopolitan coccolithophore that plays a major role in the global carbon cycle. These sphingolipids derive from an unprecedented cluster of biosynthetic genes in Coccolithovirus genomes, are synthesized de novo during lytic infection, and are enriched in virion membranes. Purified glycosphingolipids induced biochemical hallmarks of programmed cell death in an uninfected host. These lipids were detected in coccolithophore populations in the North Atlantic, which highlights their potential as biomarkers for viral infection in the oceans.	[Vardi, Assaf; Haramaty, Liti; Bidle, Kay D.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Popendorf, Kimberly J.; Ossolinski, Justin E.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution	Bidle, KD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	bidle@marine.rutgers.edu		Vardi, Assaf/0000-0002-7079-0234; Popendorf, Kimberly/0000-0002-5581-9043	NSF's [OCE-0619608, IOS-0717494, OCE-0646944]; Gordon and Betty Moore Foundation	NSF's(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The authors acknowledge M. Soule and E. Kujawinski and the funding sources of the Woods Hole Oceanographic Institution Fourier-Transform Mass Spectrometry Facility (NSF's Major Research Instrumentation Program OCE-0619608 and the Gordon and Betty Moore Foundation) for assistance with MS data acquisition. We thank D. Repeta for assistance and advice on pigment analysis, V. Starovoytov for TEM analysis, and C. Brown and M. Frada for helpful discussions and valuable feedback. This work was supported by NSF grant IOS-0717494 to K. D. B. and A. V., as well as NSF grant OCE-0646944 to B. V.M.	Allen MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-11; Allen MJ, 2006, J VIROL, V80, P7699, DOI 10.1128/JVI.00491-06; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; MONIER A, 2009, GENOME BIOL, DOI DOI 10.1101/GR.091686.109; PAGARETE A, 2009, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Turkoglu M, 2008, J MAR BIOL ASSOC UK, V88, P433, DOI 10.1017/S0025315408000866; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109	27	153	165	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					861	865		10.1126/science.1177322	http://dx.doi.org/10.1126/science.1177322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892986				2022-12-28	WOS:000271468000046
J	Beaumont, HJE; Gallie, J; Kost, C; Ferguson, GC; Rainey, PB				Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.			Experimental evolution of bet hedging	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE; ESCHERICHIA-COLI; FLUCTUATING ENVIRONMENTS; DIVERSITY; STRATEGY	Bet hedging-stochastic switching between phenotypic states(1-3)-is a canonical example of an evolutionary adaptation that facilitates persistence in the face of fluctuating environmental conditions. Although bet hedging is found in organisms ranging from bacteria to humans(4-10), direct evidence for an adaptive origin of this behaviour is lacking(11). Here we report the de novo evolution of bet hedging in experimental bacterial populations. Bacteria were subjected to an environment that continually favoured new phenotypic states. Initially, our regime drove the successive evolution of novel phenotypes by mutation and selection; however, in two (of 12) replicates this trend was broken by the evolution of bet-hedging genotypes that persisted because of rapid stochastic phenotype switching. Genome re-sequencing of one of these switching types revealed nine mutations that distinguished it from the ancestor. The final mutation was both necessary and sufficient for rapid phenotype switching; nonetheless, the evolution of bet hedging was contingent upon earlier mutations that altered the relative fitness effect of the final mutation. These findings capture the adaptive evolution of bet hedging in the simplest of organisms, and suggest that risk-spreading strategies may have been among the earliest evolutionary solutions to life in fluctuating environments.	[Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, N Shore Mail Ctr, North Shore 0745, Auckland, New Zealand; [Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, N Shore Mail Ctr, N Shore City 0745, Auckland, New Zealand; [Beaumont, Hubertus J. E.] Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands	Massey University; Massey University; Leiden University; Leiden University - Excl LUMC	Beaumont, HJE (corresponding author), Leiden Univ, Inst Biol Leiden, POB 9505, NL-2300 RA Leiden, Netherlands.	h.j.e.beaumont@biology.leidenuniv.nl	Kost, Christian/N-1553-2014; Gallie, Jenna/ABH-7516-2020; Rainey, Paul/A-3207-2008	Kost, Christian/0000-0002-7870-7343; Rainey, Paul/0000-0003-0879-5795; Ferguson, Gayle/0000-0002-7858-6190	Royal Society of New Zealand; Netherlands Organisation for Scientific Research(NWO); New Zealand Foundation for Research, Science and Technology; Alexander von Humboldt Foundation, Germany	Royal Society of New Zealand(Royal Society of New Zealand); Netherlands Organisation for Scientific Research(NWO)(Netherlands Organization for Scientific Research (NWO)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	We thank T. F. Cooper, M. R. Goddard and D. Refardt for discussion; M. Gray, A. Hurman and G. E. M. Lamers for technical assistance; M. Ackermann, P. M. Brakefield, T. Fukami, S. Rossell and B. J. Zwaan for comments on the manuscript; T. J. M. Van Dooren for statistical advice; F. Bertels for computational analysis of Solexa data; and E. Libby for theoretical insight. This work was supported by the Marsden Fund Council from government funding administered by the Royal Society of New Zealand. H. J. E. B. is supported by a Veni Fellowship from The Netherlands Organisation for Scientific Research(NWO). J. G. was supported by a Bright Futures Scholarship from the New Zealand Foundation for Research, Science and Technology. C. K. was supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation, Germany. G. C. F. is supported by a Postdoctoral Fellowship from the New Zealand Foundation for Research, Science and Technology.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Danforth BN, 1999, P ROY SOC B-BIOL SCI, V266, P1985, DOI 10.1098/rspb.1999.0876; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; HAIRSTON NG, 1984, AM NAT, V123, P733, DOI 10.1086/284236; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MCDONALD MJ, GENETICS IN PRESS; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; Spiers AJ, 2002, GENETICS, V161, P33; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Zhang XX, 2007, J MICROBIOL METH, V71, P78, DOI 10.1016/j.mimet.2007.07.001	30	406	413	1	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 5	2009	462	7269					90	U97		10.1038/nature08504	http://dx.doi.org/10.1038/nature08504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890329	Green Published			2022-12-28	WOS:000271419200038
J	Iglehart, JK				Iglehart, John K.			Reform and the Health Care Workforce -- Current Capacity, Future Demand.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; GARSON A, 2009, HLTH AFFAIRS BL 0928; *GOV ACC OFF, 2009, GAO09559 GOV ACC OFF; *MASS MED SOC, 2009, MMS PHYS WORKF STUD; Whitcomb M, 2009, NEW DEV MED SCH MOTI	5	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19								10.1056/NEJMp0909521	http://dx.doi.org/10.1056/NEJMp0909521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19846840				2022-12-28	WOS:000271405800005
J	Jackson, GP; Tarpley, JL				Jackson, Gretchen Purcell; Tarpley, John L.			How long does it take to train a surgeon?	BRITISH MEDICAL JOURNAL			English	Editorial Material							80-HOUR WORK WEEK; OPERATIVE EXPERIENCE; HOUR RESTRICTIONS; PATIENT SAFETY; RESIDENTS; EDUCATION; IMPACT; PERFORMANCE; LIMITS; TIME		[Jackson, Gretchen Purcell; Tarpley, John L.] Vanderbilt Childrens Hosp, Nashville, TN 37232 USA	Vanderbilt University	Jackson, GP (corresponding author), Vanderbilt Childrens Hosp, 220 Childrens Way, Nashville, TN 37232 USA.	gretchen.jackson@vanderbilt.edu						Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Bollschweiler E, 2001, LANGENBECK ARCH SURG, V386, P104, DOI 10.1007/s004230000188; BOSK CL, 1979, FORGIVE REMEMBER; Carlin AM, 2007, AM J SURG, V193, P326, DOI 10.1016/j.amjsurg.2006.09.014; Carpenter RO, 2006, AM J SURG, V191, P527, DOI 10.1016/j.amjsurg.2006.01.002; Chung RS, 2005, AM J SURG, V190, P351, DOI 10.1016/j.amjsurg.2005.06.035; COLEMAN RM, 1986, WIDE AWAKE 3 00 AM C; Curet MJ, 2008, J AM COLL SURGEONS, V207, P767, DOI 10.1016/j.jamcollsurg.2008.07.010; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Feanny MA, 2005, AM J SURG, V190, P947, DOI 10.1016/j.amjsurg.2005.08.025; Gladwell Malcolm, 2008, OUTLIERS; Hassett JM, 2002, SURGERY, V132, P635, DOI 10.1067/msy.2002.127542; Iglehart JK, 2008, NEW ENGL J MED, V359, P2633, DOI 10.1056/NEJMp0808736; Pappas TN, 2009, ANN SURG, V249, P706, DOI 10.1097/01.sla.0000348650.20314.5a; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Richards T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1507; Salim A, 2007, ARCH SURG-CHICAGO, V142, P708, DOI 10.1001/archsurg.142.8.708; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Vetto JT, 2005, J CANCER EDUC, V20, P23, DOI 10.1207/s15430154jce2001_9	20	55	57	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2009	339								b4260	10.1136/bmj.b4260	http://dx.doi.org/10.1136/bmj.b4260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UD	19892790				2022-12-28	WOS:000271567900001
J	Parmet, WE				Parmet, Wendy E.			Litigation Amidst Reform -- The Boston Medical Center Case.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northeastern Univ, Sch Law, Boston, MA 02115 USA	Northeastern University	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							Kingsdale J, 2009, HEALTH AFFAIR, V28, pW588, DOI 10.1377/hlthaff.28.4.w588	1	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1819	1821		10.1056/NEJMp0906587	http://dx.doi.org/10.1056/NEJMp0906587			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19890123				2022-12-28	WOS:000271405800002
J	Zinzen, RP; Girardot, C; Gagneur, J; Braun, M; Furlong, EEM				Zinzen, Robert P.; Girardot, Charles; Gagneur, Julien; Braun, Martina; Furlong, Eileen E. M.			Combinatorial binding predicts spatio-temporal cis-regulatory activity	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; MUSCLE-CELL LINEAGES; GENOME-WIDE ANALYSIS; MESODERM DEVELOPMENT; GENE MEF2; DROSOPHILA; INTEGRATION; ELEMENTS; TINMAN; TWIST	Development requires the establishment of precise patterns of gene expression, which are primarily controlled by transcription factors binding to cis-regulatory modules. Although transcription factor occupancy can now be identified at genome-wide scales, decoding this regulatory landscape remains a daunting challenge. Here we used a novel approach to predict spatio-temporal cis-regulatory activity based only on in vivo transcription factor binding and enhancer activity data. We generated a high-resolution atlas of cis-regulatory modules describing their temporal and combinatorial occupancy during Drosophila mesoderm development. The binding profiles of cis-regulatory modules with characterized expression were used to train support vector machines to predict five spatio-temporal expression patterns. In vivo transgenic reporter assays demonstrate the high accuracy of these predictions and reveal an unanticipated plasticity in transcription factor binding leading to similar expression. This data-driven approach does not require previous knowledge of transcription factor sequence affinity, function or expression, making it widely applicable.	[Zinzen, Robert P.; Girardot, Charles; Gagneur, Julien; Braun, Martina; Furlong, Eileen E. M.] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	furlong@embl.de	Zinzen, Robert P/A-3130-2015; Girardot, Charles/AAF-2417-2020; Zinzen, Robert/AAG-2784-2020	Zinzen, Robert P/0000-0002-8638-5102; Girardot, Charles/0000-0003-4301-3920; Furlong, Eileen/0000-0002-9544-8339; Gagneur, Julien/0000-0002-8924-8365	Human Frontiers Science Program	Human Frontiers Science Program(Human Frontier Science Program)	We are grateful to M. Leptin for providing an independent assessment of the expression patterns driven by tested CRMs. We thank H. Gustafson for fly work, J. de Graaf for array hybridizations, S. Muller for embryo injections, and R. Bourgon for sharing code on signal peak identification. We thank all members of the Furlong laboratory for discussions and comments on the manuscript. This work was supported by a grant to E. E. M. F. and by a fellowship to R. P. Z. from the Human Frontiers Science Program.	Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Arnosti DN, 1996, DEVELOPMENT, V122, P205; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Davidson EH, 2006, REG GEN GEN REG; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Knirr S, 2001, DEV BIOL, V238, P13, DOI 10.1006/dbio.2001.0397; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li LP, 2007, BIOINFORMATICS, V23, P1188, DOI 10.1093/bioinformatics/btm080; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Lloyd CJ, 1998, J AM STAT ASSOC, V93, P1356, DOI 10.2307/2670051; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sink H., 2006, MUSCLE DEV DROSOPHIL; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zaffran S, 2001, GENE DEV, V15, P2900; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	57	283	286	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					65	U72		10.1038/nature08531	http://dx.doi.org/10.1038/nature08531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890324				2022-12-28	WOS:000271419200032
J	Zoungas, S; Ninomiya, T; Huxley, R; Cass, A; Jardine, M; Gallagher, M; Patel, A; Vasheghani-Farahani, A; Sadigh, G; Perkovic, V				Zoungas, Sophia; Ninomiya, Toshiharu; Huxley, Rachel; Cass, Alan; Jardine, Meg; Gallagher, Martin; Patel, Anushka; Vasheghani-Farahani, Ali; Sadigh, Gelareh; Perkovic, Vlado			Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; RADIOCONTRAST-INDUCED NEPHROPATHY; RANDOMIZED CLINICAL-TRIALS; ACUTE-RENAL-FAILURE; N-ACETYLCYSTEINE; METAANALYSIS; INSUFFICIENCY; HYDRATION; CONSENSUS; CHLORIDE	Background: Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). Purpose: To determine the effect of sodium bicarbonate on the risk for CIN. Data Sources: MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to December 2008; conference proceedings; and ClinicalTrials.gov, without language restriction. Study Selection: Randomized, controlled trials of intravenous sodium bicarbonate that prespecified the outcome of CIN as a 25% increase in baseline serum creatinine level or an absolute increase of 44 mu mol/L (0.5 mg/dL) after radiocontrast administration. Data Extraction: Using standardized protocols, 2 reviewers serially abstracted data for each study. Data Synthesis: 23 published and unpublished trials with information on 3563 patients and 396 CIN events were included. The pooled relative risk was 0.62 (95% CI, 0.45 to 0.86), with evidence of significant heterogeneity across studies (I-2 = 49.1%; P = 0.004). Some heterogeneity was due to the difference in the estimates between published and unpublished studies: relative risk, 0.43 (CI, 0.25 to 0.75) versus 0.78 (CI, 0.52 to 1.17), respectively. Meta-regression showed that small, poor-quality studies that assessed outcomes soon after radiocontrast administration were more likely to suggest benefit (P < 0.05 for all). No clear effects of treatment on the risk for dialysis, heart failure, and total mortality were identified. Limitation: Power to assess clinical end points was limited. Conclusion: The effectiveness of sodium bicarbonate treatment to prevent CIN in high-risk patients remains uncertain. Earlier reports probably overestimated the magnitude of any benefit, whereas larger, more recent trials have had neutral results. Large multicenter trials are required to clarify whether sodium bicarbonate has value for prevention of CIN before routine use can be recommended.	[Zoungas, Sophia] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; Monash Univ, Melbourne, Vic 3004, Australia; Univ Tehran Med Sci, Tehran, Iran	University of Sydney; Monash University; Tehran University of Medical Sciences	Zoungas, S (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	szoungas@george.org.au	Farahani, Ali Vasheghani/L-6076-2018; Sadigh, Gelareh/GNW-5641-2022; Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013; Jardine, Meg/AAS-1864-2020; Jardine, Meg/AFR-1699-2022; Perkovic, Vlado/AAY-1933-2021	Farahani, Ali Vasheghani/0000-0003-3346-2124; Sadigh, Gelareh/0000-0003-3233-1878; Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Patel, Anushka/0000-0003-3825-4092; Perkovic, Vlado/0000-0002-4257-7620; Cass, Alan/0000-0002-3923-3173; Gallagher, Martin/0000-0001-9187-6187; Zoungas, Sophia/0000-0003-2672-0949	National Health and Medical Research Council of Australia Health Professional Research Fellowship; National Heart Foundation of Australia AstraZeneca research fellowship; National Health and Medical Research Council of Australia Senior Research Fellowship; National Heart Foundation of Australia Career Development awards	National Health and Medical Research Council of Australia Health Professional Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia AstraZeneca research fellowship(National Heart Foundation of Australia); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia Career Development awards(National Heart Foundation of Australia)	Dr. Zoungas was supported by a National Health and Medical Research Council of Australia Health Professional Research Fellowship. Dr. Perkovic was supported by a National Heart Foundation of Australia AstraZeneca research fellowship. Dr. Cass was supported by a National Health and Medical Research Council of Australia Senior Research Fellowship. Drs. Huxley and Patel are supported by National Heart Foundation of Australia Career Development awards.	Addad F, 2006, EUR HEART J, V27, P246; Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6; ATKINS JL, 1986, NEPHRON, V44, P70, DOI 10.1159/000183915; Bagshaw SM, 2005, ARCH INTERN MED, V165, P1087, DOI 10.1001/archinte.165.10.1087; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; CHEN H, 2007, J AM SOC NEPHROL, V18, P817; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fischereder M, 2008, NAT CLIN PRACT NEPHR, V4, P296, DOI 10.1038/ncpneph0805; From AM, 2008, CLIN J AM SOC NEPHRO, V3, P10, DOI 10.2215/CJN.03100707; Heguilen R, 2007, NEPHROL DIAL TRANSPL, V22, P54; HENGEL C, 2006, CAN CARD C VANC BRIT; Ho KM, 2008, ANAESTH INTENS CARE, V36, P646, DOI 10.1177/0310057X0803600503; Hogan SE, 2008, AM HEART J, V156, P414, DOI 10.1016/j.ahj.2008.05.014; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joannidis M, 2008, WIEN KLIN WOCHENSCHR, V120, P742, DOI 10.1007/s00508-008-1117-z; Kanbay M, 2009, INT UROL NEPHROL, V41, P617, DOI 10.1007/s11255-009-9569-2; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kim GH, 2007, NEPHROL DIAL TRANSPL, V22, P49; LIN M, 2008, J AM SOC NEPHROL, V19, pA788; Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026; MALPICA EM, 2008, TRANSC CARD THER M W; Masuda M, 2007, AM J CARDIOL, V100, P781, DOI 10.1016/j.amjcard.2007.03.098; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, REV CARDIOVASC MED, V7, P177; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; MORA JA, 2007, WORLD C NEPHR RIO DE; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Navaneethan SD, 2009, AM J KIDNEY DIS, V53, P617, DOI 10.1053/j.ajkd.2008.08.033; Newhouse JH, 2008, AM J ROENTGENOL, V191, P376, DOI 10.2214/AJR.07.3280; Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ahj.2007.05.012; Pakfetrat M, 2009, INT UROL NEPHROL, V41, P629, DOI 10.1007/s11255-008-9520-y; Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; SAIDIN R, 2006, J AM SOC NEPHROL, V17, pA766; SHAIKH F, 2007, TRANSCATHETER CARDIO, V100, pS122; SHAVIT L, 2008, J AM SOC NEPHROL, V19, pA788; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Sinert Richard, 2009, Ann Emerg Med, V54, pe1, DOI 10.1016/j.annemergmed.2008.08.014; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tamura A, 2008, CIRCULATION, V118, pS658; VASHEGHANIFARAH.A, 2009, AM J KIDNEY DIS; VASHEGHANIFARAH.A, 2009, J NEPHROL IN PRESS; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Woodward M., 2013, EPIDEMIOLOGY STUDY D	49	122	124	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					631	W207		10.7326/0003-4819-151-9-200911030-00008	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00008			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884624				2022-12-28	WOS:000271387700005
J	Odeh, B; Bareford, D				Odeh, Bassam; Bareford, David			Lesson of the Week Colonic carcinoma presenting as repeated episodes of enterobacter septicaemia during induction of remission in acute myeloblastic leukaemia	BRITISH MEDICAL JOURNAL			English	Article							STREPTOCOCCUS-BOVIS SEPTICEMIA; BACTEREMIA; NEOPLASIA; ENDOCARDITIS		[Bareford, David] Russells Hall Hosp, Dept Haematol, Dudley DY1 2HQ, England; [Odeh, Bassam] City Hosp, Dept Haematol, Birmingham B18 7QH, W Midlands, England	Russells Hall Hospital; University of Birmingham	Bareford, D (corresponding author), Russells Hall Hosp, Dept Haematol, Dudley DY1 2HQ, England.	d.bareford@bham.ac.uk						BEECHING NJ, 1985, Q J MED, V56, P439; FRIEDRICH IA, 1982, AM J GASTROENTEROL, V77, P82; Karthaus M, 2002, CHEMOTHERAPY, V48, P154, DOI 10.1159/000064922; LEPORT C, 1987, LANCET, V1, P748; MCMAHON AJ, 1991, BRIT J SURG, V78, P883, DOI 10.1002/bjs.1800780734; RUBIO M, 1994, INFECT CONT HOSP EP, V15, P101; TABIBIAN N, 1989, AM FAM PHYSICIAN, V39, P227; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Varghese GM, 2004, J INTERN MED, V255, P692, DOI 10.1111/j.1365-2796.2004.01333.x; Waisberg Jaques, 2002, Arq. Gastroenterol., V39, P177, DOI 10.1590/S0004-28032002000300008	10	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2009	339								b4027	10.1136/bmj.b4027	http://dx.doi.org/10.1136/bmj.b4027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UA	19884200				2022-12-28	WOS:000271567600001
J	Acemoglu, D; Robinson, J				Acemoglu, Daron; Robinson, James			Foundations of Societal Inequality	SCIENCE			English	Editorial Material							INCOME		[Acemoglu, Daron] MIT, Dept Econ, Cambridge, MA 02142 USA; [Robinson, James] Harvard Univ, Dept Govt, Boston, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	Acemoglu, D (corresponding author), MIT, Dept Econ, Cambridge, MA 02142 USA.	daron@mit.edu; jrobinson@gov.harvard.edu						Acemoglu D, 2002, Q J ECON, V117, P1231, DOI 10.1162/003355302320935025; Acemoglu D., 2005, HDB EC GROWTH, V1A, P386, DOI DOI 10.1016/S1574-0684(05)01006-3; BECKER GS, 1979, J POLIT ECON, V87, P1153, DOI 10.1086/260831; BENDER B, 1978, WORLD ARCHAEOL, V10, P204, DOI 10.1080/00438243.1978.9979731; Diamond J., 2010, RUZHYA MIKROBY STALI; Hillman G.C., 2000, VILLAGE EUPHRATES FO; Maddison Angus, 2001, WORLD EC MILLENNIAL; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Smith B. D., 1998, EMERGENCE AGR	9	16	17	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					678	679		10.1126/science.1181939	http://dx.doi.org/10.1126/science.1181939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	512GB	19900923				2022-12-28	WOS:000271233200024
J	Lyle, K; Dent, L; Bailey, S; Kerridge, L; Roberts, I; Milne, R				Lyle, Katy; Dent, Louise; Bailey, Sally; Kerridge, Lynn; Roberts, Ian; Milne, Ruairidh			Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials	BRITISH MEDICAL JOURNAL			English	Article								Objective To calculate the global warming potential, in carbon dioxide (CO(2)) equivalent emissions, from a sample of pragmatic randomised controlled trials. Design Retrospective analysis. Data source Internal data held by NIHR Evaluation, Trials and Studies Coordinating Centre. Studies included All eligible pragmatic randomised controlled trials funded by the NIHR Health Technology Assessment programme during 2002 and 2003. Main outcome measure CO(2) equivalents for trial activities calculated with standard conversion factors. Results 12 pragmatic randomised controlled trials involving more than 4800 participants and a wide range of technologies were included. The average CO(2) emission generated by the trials was 78.4 (range 42.1-112.7) tonnes. This is equivalent to that produced in one year by approximately nine people in the United Kingdom. Commuting to work by the trial team generated the most emissions (average 21 (11.5-35.0) tonnes per trial), followed by study centres' fuel use (18(9.3-32.2) tonnes per trial), trial team related travel (15(2.0-29.0) tonnes per trial), and participant related travel (13(0-46.7) tonnes per trial). Conclusions CO(2) emissions from pragmatic randomised controlled trials are generated in areas where steps could be taken to reduce them. A large proportion of the CO(2) emissions come from travel related to various aspects of a trial. The results of this research are likely to underestimate the total CO(2) emissions associated with the trials studied, because of the sources of information available. Further research is needed to explore the additional CO(2) emissions generated by clinical trials, over and above those generated by routine care. The results from this project will feed into NIHR guidelines that will advise researchers on how to reduce CO(2) emissions.	[Bailey, Sally; Kerridge, Lynn; Milne, Ruairidh] Univ Southampton, NIHR Evaluat Trials & Studies Coordinating Ctr, Southampton SO16 7NS, Hants, England; [Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Southampton; University of London; London School of Hygiene & Tropical Medicine		k.lyle@southamtpon.ac.uk		Milne, Ruairidh/0000-0002-5117-4380; Lyle, Kate/0000-0001-9265-7648; Stanton, Louise/0000-0001-8181-840X				Burnett J, 2007, BMJ-BRIT MED J, V334, P671; *CHART I PERS DEV, 2008, ABS MAN SURV POL PRA; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; *DEP FOOD ENV RUR, 2008, GUID DEFR GHG CONV F; *DEP TRANSP, 2007, TRANSP STAT B; Department of Trade and Industry, 2006, EN ITS IMP ENV SOC; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH N; PROPPER C, 2006, DISTANCE TRAVELLED N; Richardson Katherine, 2009, CLIMATE CHANGE GLOBA; *SUST DEV COMM, 2008, NHS ENGL CARB EMM CA; World Business Council for Sustainable Development World Resources Institute., 2004, GREENH GAS PROT CORP; [No title captured]	12	17	17	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 30	2009	339								b4187	10.1136/bmj.b4187	http://dx.doi.org/10.1136/bmj.b4187			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AQ	19880529	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000271366100002
J	Yurtsever, A; Zewail, AH				Yurtsever, Aycan; Zewail, Ahmed H.			4D Nanoscale Diffraction Observed by Convergent-Beam Ultrafast Electron Microscopy	SCIENCE			English	Article							CRYSTALLOGRAPHY; DYNAMICS; SILICON	Diffraction with focused electron probes is among the most powerful tools for the study of time-averaged nanoscale structures in condensed matter. Here, we report four-dimensional (4D) nanoscale diffraction, probing specific site dynamics with 10 orders of magnitude improvement in time resolution, in convergent-beam ultrafast electron microscopy (CB-UEM). As an application, we measured the change of diffraction intensities in laser-heated crystalline silicon as a function of time and fluence. The structural dynamics (change in 7.3 +/- 3.5 picoseconds), the temperatures (up to 366 kelvin), and the amplitudes of atomic vibrations (up to 0.084 angstroms) are determined for atoms strictly localized within the confined probe area (10 to 300 nanometers in diameter). We anticipate a broad range of applications for CB-UEM and its variants, especially in the studies of single particles and heterogeneous structures.	[Yurtsever, Aycan; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu		gaber, sarah/0000-0002-5995-7291	NSF; Air Force Office of Scientific Research in the Gordon; Betty Moore Center for Physical Biology at CalTech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Betty Moore Center for Physical Biology at CalTech	This work was supported by the NSF and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at CalTech. We thank O.-H. Kwon and H. S. Park for the experimental aid in UEM-2 laboratory and acknowledge the helpful use of the Cornell TEM sample preparation facility. Caltech has filed a provisional patent application for variants of 4D microscopy.	ALDRED PJE, 1973, PROC R SOC LON SER-A, V332, P239, DOI 10.1098/rspa.1973.0023; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Carbone F, 2009, SCIENCE, V325, P181, DOI 10.1126/science.1175005; Cowley J.M., 1995, DIFFRACTION PHYS; ELSAYEDALI HE, 1987, PHYS REV LETT, V58, P1212, DOI 10.1103/PhysRevLett.58.1212; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; GOLDMAN JR, 1994, PHYS REV LETT, V72, P1364, DOI 10.1103/PhysRevLett.72.1364; Harb M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155504; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; LOANE RF, 1991, ACTA CRYSTALLOGR A, V47, P267, DOI 10.1107/S0108767391000375; MIDGLEY PA, 1995, ULTRAMICROSCOPY, V59, P1, DOI 10.1016/0304-3991(95)00014-R; Midgley PA, 2007, CHEM SOC REV, V36, P1477, DOI 10.1039/b701569k; Mkhoyan KA, 2006, SCIENCE, V312, P1354, DOI 10.1126/science.1124511; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Muller DA, 2001, ULTRAMICROSCOPY, V86, P371, DOI 10.1016/S0304-3991(00)00128-5; Nie SH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.025901; OKADA Y, 1984, J APPL PHYS, V56, P314, DOI 10.1063/1.333965; Raman RK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077401; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Sjodin T, 1998, PHYS REV LETT, V81, P5664, DOI 10.1103/PhysRevLett.81.5664; Spence JCH., 1992, ELECT MICRODIFFRACTI; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P2606, DOI 10.1002/anie.200301746; WANG ZL, 1995, ELASTIC INELASTIC DI, P51161; Williams D. B., 1996, TRANSMISSION ELECT M, VII; XU PR, 1991, ULTRAMICROSCOPY, V38, P127, DOI 10.1016/0304-3991(91)90113-K; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Zewail A H, 2009, 4D ELECT MICROSCOPY; Zhang P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362978; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403	32	70	72	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					708	712		10.1126/science.1179314	http://dx.doi.org/10.1126/science.1179314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900928				2022-12-28	WOS:000271233200032
J	Albarede, F				Albarede, Francis			Volatile accretion history of the terrestrial planets and dynamic implications	NATURE			English	Article							ISOTOPIC VARIATIONS; PLATE-TECTONICS; TRACE-ELEMENTS; SOLAR-SYSTEM; RIDGE BASALT; NOBLE-GASES; WATER; MANTLE; ORIGIN; EVOLUTION	Accretion left the terrestrial planets depleted in volatile components. Here I examine evidence for the hypothesis that the Moon and the Earth were essentially dry immediately after the formation of the Moon-by a giant impact on the proto-Earth-and only much later gained volatiles through accretion of wet material delivered from beyond the asteroid belt. This view is supported by U-Pb and I-Xe chronologies, which show that water delivery peaked similar to 100 million years after the isolation of the Solar System. Introduction of water into the terrestrial mantle triggered plate tectonics, which may have been crucial for the emergence of life. This mechanism may also have worked for the young Venus, but seems to have failed for Mars.	[Albarede, Francis] Univ Lyon 1, Ecole Normale Super, F-69007 Lyon, France; [Albarede, Francis] CNRS, F-69007 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS)	Albarede, F (corresponding author), Univ Lyon 1, Ecole Normale Super, 46 Allee Italie, F-69007 Lyon, France.	albarede@ens-lyon.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428	Agence Nationale de la Recherche; Programme National de Planetologie (INSU-CEA)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme National de Planetologie (INSU-CEA)	I am grateful to J. Blichert-Toft, S. Labrosse and H. Ohmoto for suggestions on the manuscript. Reviews by A. Morbidelli, M. Humayun and M. Drake were particularly helpful. Thanks to A. Levander and C.-T. Lee, I was able to spend enough quiet time at Rice University to bring this work to completion. This work was supported by the Agence Nationale de la Recherche and the Programme National de Planetologie (INSU-CEA).	Albarede F, 2005, GEOPHYS MONOGR SER, V160, P27, DOI 10.1029/160GM04; Albarede F, 2009, ORIGINS OF LIFE: SELF-ORGANIZATION AND/OR BIOLOGICAL EVOLUTION?, P1, DOI 10.1051/orvie/2009001; ALBAREDE F, 1984, GEOCHIM COSMOCHIM AC, V48, P207, DOI 10.1016/0016-7037(84)90364-8; ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; Barabash S, 2007, NATURE, V450, P650, DOI 10.1038/nature06434; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Bouvier A, 2005, EARTH PLANET SC LETT, V240, P221, DOI 10.1016/j.epsl.2005.09.007; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; CARR MH, 1992, ICARUS, V98, P61, DOI 10.1016/0019-1035(92)90207-N; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Davis AM, 2005, TREATISE GEOCHEM, V1, P407; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; Fromang S, 2002, MON NOT R ASTRON SOC, V329, P18, DOI 10.1046/j.1365-8711.2002.04940.x; Galer S. J. G., 1996, GEOPHYS MONOGR SER, V95, P75, DOI DOI 10.1029/GM095; Ganapathy R., 1974, P 5 LUN C HOST TX, V2, P1181; GAST PW, 1960, J GEOPHYS RES, V65, P1287, DOI 10.1029/JZ065i004p01287; GURNIS M, 1986, GEOPHYS RES LETT, V13, P541, DOI 10.1029/GL013i006p00541; Harper CL, 1996, SCIENCE, V273, P1814, DOI 10.1126/science.273.5283.1814; Hauck SA, 1998, J GEOPHYS RES-PLANET, V103, P13635, DOI 10.1029/98JE00400; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; Huebner WF, 2002, EARTH MOON PLANETS, V89, P179; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; Ingrin J, 2006, REV MINERAL GEOCHEM, V62, P291, DOI 10.2138/rmg.2006.62.13; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; JOCHUM KP, 1983, NATURE, V306, P431, DOI 10.1038/306431a0; Kawamoto T, 2006, REV MINERAL GEOCHEM, V62, P273, DOI 10.2138/rmg.2006.62.12; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Kunz J, 1999, NATURE, V399, P649, DOI 10.1038/21352; Lahaye Y, 2001, CAN MINERAL, V39, P473, DOI 10.2113/gscanmin.39.2.473; LARIMER JW, 1967, GEOCHIM COSMOCHIM AC, V31, P1215, DOI 10.1016/S0016-7037(67)80013-9; Lawrence JF, 2006, GEOPHYS MONOGR SER, V168, P251, DOI 10.1029/168GM19; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lodders K, 1998, METEORIT PLANET SCI, V33, pA183, DOI 10.1111/j.1945-5100.1998.tb01331.x; Luck JM, 2005, GEOCHIM COSMOCHIM AC, V69, P5351, DOI 10.1016/j.gca.2005.06.018; Lunine JI, 2003, ICARUS, V165, P1, DOI 10.1016/S0019-1035(03)00172-6; MCDONOUGH WF, 1992, GEOCHIM COSMOCHIM AC, V56, P1001, DOI 10.1016/0016-7037(92)90043-I; MCDONOUGH WF, 1993, NATURE, V365, P432, DOI 10.1038/365432a0; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; Medard E, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002742; MICHAEL P, 1995, EARTH PLANET SC LETT, V131, P301, DOI 10.1016/0012-821X(95)00023-6; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P6103, DOI 10.1016/j.gca.2006.02.030; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P4287, DOI 10.1016/j.gca.2006.06.1371; Muralidharan K, 2008, ICARUS, V198, P400, DOI 10.1016/j.icarus.2008.07.017; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; O'Brien DP, 2006, ICARUS, V184, P39, DOI 10.1016/j.icarus.2006.04.005; O'Neill C, 2007, EARTH PLANET SC LETT, V261, P20, DOI 10.1016/j.epsl.2007.05.038; O'Neill H.S.C., 1998, EARTHS MANTLE COMPOS, P3; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; Ozima M, 1999, J GEOPHYS RES-SOL EA, V104, P25493, DOI 10.1029/1999JB900257; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Palme H, 2005, TREATISE GEOCHEM, V1, P41; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; PEPIN RO, 1976, LUNAR PLANET SCI, V7, P683; PHILLIPS RJ, 1992, J GEOPHYS RES-PLANET, V97, P15923, DOI 10.1029/92JE01696; PREMO WR, 1999, INT BK SERIES, V2, P207; Raymond SN, 2006, ICARUS, V183, P265, DOI 10.1016/j.icarus.2006.03.011; Richter FM, 2004, GEOCHIM COSMOCHIM AC, V68, P4971, DOI 10.1016/j.gca.2004.06.008; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; ROSENBLATT P, 1994, GEOPHYS RES LETT, V21, P465, DOI 10.1029/94GL00419; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Shieh SR, 1998, EARTH PLANET SC LETT, V159, P13, DOI 10.1016/S0012-821X(98)00062-4; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Smyth JR, 2006, REV MINERAL GEOCHEM, V62, P85, DOI 10.2138/rmg.2006.62.5; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; TATSUMOTO M, 1973, SCIENCE, V180, P1279, DOI 10.1126/science.180.4092.1279; TAYLOR SR, 1984, ORIGIN MOON, P125; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Trieloff M, 2002, EARTH PLANET SC LETT, V200, P297, DOI 10.1016/S0012-821X(02)00639-8; WANKE H, 1981, PHILOS T R SOC A, V303, P287, DOI 10.1098/rsta.1981.0203; Warren PH, 2005, TREATISE GEOCHEM, V1, P559; WASSERBURG GJ, 1964, SCIENCE, V143, P465, DOI 10.1126/science.143.3605.465; Wetherill G. W, 1986, ORIGIN MOON, P519; Wulfsberg G, 2000, INORGANIC CHEM; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	89	301	310	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1227	1233		10.1038/nature08477	http://dx.doi.org/10.1038/nature08477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865163				2022-12-28	WOS:000271190800038
J	Kapoor, JR; McConnell, MV				Kapoor, John R.; McConnell, Michael V.			A Swinging Heart	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kapoor, John R.; McConnell, Michael V.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Kapoor, JR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.			McConnell, Michael/0000-0001-8743-0932					0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					E37	E37		10.1056/NEJMicm0802946	http://dx.doi.org/10.1056/NEJMicm0802946			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864670				2022-12-28	WOS:000271185600012
J	Walsh, DA; Zaikova, E; Howes, CG; Song, YC; Wright, JJ; Tringe, SG; Tortell, PD; Hallam, SJ				Walsh, David A.; Zaikova, Elena; Howes, Charles G.; Song, Young C.; Wright, Jody J.; Tringe, Susannah G.; Tortell, Philippe D.; Hallam, Steven J.			Metagenome of a Versatile Chemolithoautotroph from Expanding Oceanic Dead Zones	SCIENCE			English	Article							SULFIDE OXIDATION; ESCHERICHIA-COLI; WATERS; NITRATE; SULFUR; DIVERSITY; BACTERIAL; SYMBIONT	Oxygen minimum zones, also known as oceanic "dead zones," are widespread oceanographic features currently expanding because of global warming. Although inhospitable to metazoan life, they support a cryptic microbiota whose metabolic activities affect nutrient and trace gas cycling within the global ocean. Here, we report metagenomic analyses of a ubiquitous and abundant but uncultivated oxygen minimum zone microbe (SUP05) related to chemoautotrophic gill symbionts of deep-sea clams and mussels. The SUP05 metagenome harbors a versatile repertoire of genes mediating autotrophic carbon assimilation, sulfur oxidation, and nitrate respiration responsive to a wide range of water-column redox states. Our analysis provides a genomic foundation for understanding the ecological and biogeochemical role of pelagic SUP05 in oxygen-deficient oceanic waters and its potential sensitivity to environmental changes.	[Walsh, David A.; Zaikova, Elena; Howes, Charles G.; Song, Young C.; Wright, Jody J.; Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Tringe, Susannah G.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Tortell, Philippe D.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Tortell, Philippe D.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of British Columbia; University of British Columbia; University of British Columbia	Hallam, SJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada.	shallam@interchange.ubc.ca		Tortell, Philippe/0000-0003-0212-2151; Walsh, David/0000-0002-9951-5447	U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory [DE-AC02-05CH11231, DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Natural Sciences and Engineering Research Council (NSERC) of Canada [328256-07, STPSC 356988]; Canada Foundation for Innovation (CFI) [Canada Foundation for Innovation (CFI) 17444]; Canadian Institute for Advanced Research ( CIFAR); Center for Bioinorganic Chemistry (CEBIC); NSERC; Killam Trust; Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE); DNA DataBank of Japan and European Molecular Biology Laboratory;  [ACSG00000000]	U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory(University of California System); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Advanced Research ( CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Center for Bioinorganic Chemistry (CEBIC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Trust; Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE); DNA DataBank of Japan and European Molecular Biology Laboratory; 	This work was performed under the auspices of the U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. This work was also supported by grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada 328256-07 and STPSC 356988, Canada Foundation for Innovation (CFI) 17444; Canadian Institute for Advanced Research ( CIFAR), and the Center for Bioinorganic Chemistry (CEBIC). D. A. W. was supported by NSERC, Killam Trust, and the Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE). We thank M. Robert ( Institute of Ocean Sciences, Sidney, BC, Canada), C. Payne, L. Pakhomova, and J. Granger (UBC) for help in sampling and chemical analyses and the captains and crews of the CCGS John P. Tulley and HMS John Strickland for logistical support. We thank the Joint Genome Institute, including K. Barry, S. Pitluck, and E. Kirton, for technical assistance and A. Page, K. Mitchell, and S. Lee in the Hallam laboratory for reading the manuscript. This metagenome project has been deposited at the DNA DataBank of Japan and European Molecular Biology Laboratory, and GenBank, under the project accession ACSG00000000. The version described in this paper is the first version, ACSG01000000. SSU rRNA gene sequences were deposited at GenBank under the accession numbers GQ345343-GQ351265, and fosmid sequences were deposited under the accession numbers GQ351266 to GQ351269 and GQ369726.	ANDERSON J J, 1973, Estuarine and Coastal Marine Science, V1, P1, DOI 10.1016/0302-3524(73)90052-2; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fuchs BM, 2005, AQUAT MICROB ECOL, V39, P145, DOI 10.3354/ame039145; Jost G, 2008, LIMNOL OCEANOGR, V53, P14, DOI 10.4319/lo.2008.53.1.0014; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Wang HN, 1999, J BACTERIOL, V181, P5303, DOI 10.1128/JB.181.17.5303-5308.1999; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zopfi J, 2001, MAR CHEM, V74, P29, DOI 10.1016/S0304-4203(00)00091-8	29	236	243	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					578	582		10.1126/science.1175309	http://dx.doi.org/10.1126/science.1175309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900896	Green Submitted			2022-12-28	WOS:000271019400043
J	Crawford, JM; Korman, TP; Labonte, JW; Vagstad, AL; Hill, EA; Kamari-Bidkorpeh, O; Tsai, SC; Townsend, CA				Crawford, Jason M.; Korman, Tyler P.; Labonte, Jason W.; Vagstad, Anna L.; Hill, Eric A.; Kamari-Bidkorpeh, Oliver; Tsai, Shiou-Chuan; Townsend, Craig A.			Structural basis for biosynthetic programming of fungal aromatic polyketide cyclization	NATURE			English	Article							CRYSTAL-STRUCTURE; CRYSTALLOGRAPHY	Polyketides are a class of natural products with diverse structures and biological activities. The structural variability of aromatic products of fungal nonreducing, multidomain iterative polyketide synthases (NR-PKS group of IPKSs) results from regiospecific cyclizations of reactive poly-beta-keto intermediates(1-3). How poly-beta-keto species are synthesized and stabilized, how their chain lengths are determined, and, in particular, how specific cyclization patterns are controlled have been largely inaccessible and functionally unknown until recently(4). A product template (PT) domain is responsible for controlling specific aldol cyclization and aromatization of these mature polyketide precursors, but the mechanistic basis is unknown. Here we present the 1.8 angstrom crystal structure and mutational studies of a dissected PT monodomain from PksA, the NR-PKS that initiates the biosynthesis of the potent hepatocarcinogen aflatoxin B-1 in Aspergillus parasiticus. Despite having minimal sequence similarity to known enzymes, the structure displays a distinct `double hot dog' (DHD) fold. Co-crystal structures with palmitate or a bicyclic substrate mimic illustrate that PT can bind both linear and bicyclic polyketides. Docking and mutagenesis studies reveal residues important for substrate binding and catalysis, and identify a phosphopantetheine localization channel and a deep two-part interior binding pocket and reaction chamber. Sequence similarity and extensive conservation of active site residues in PT domains suggest that the mechanistic insights gleaned from these studies will prove general for this class of IPKSs, and lay a foundation for defining the molecular rules controlling NR-PKS cyclization specificity.	[Crawford, Jason M.; Labonte, Jason W.; Vagstad, Anna L.; Hill, Eric A.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Townsend, Craig A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Townsend, Craig A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Korman, Tyler P.; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Kamari-Bidkorpeh, Oliver; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Townsend, CA (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	sctsai@uci.edu; ctownsend@jhu.edu	Tsai, Shiou-Chuan/C-1188-2010	Vagstad, Anna Lisa/0000-0001-8074-0137	US National Institutes of Health [ES001670]; Pew Foundation; Stanford Synchrotron Radiation Laboratory (SSRL); Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences; Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Damon Runyon Cancer Research Foundation [DRG-2002-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES001670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM100305, R01GM076330] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Stanford Synchrotron Radiation Laboratory (SSRL); Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Harris for his gift of HC8. The work at Johns Hopkins was supported by the US National Institutes of Health grant ES001670 awarded to C. A. T. S.-C. T. is supported by the Pew Foundation. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. J. M. C. is currently a fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2002-09, Harvard Medical School).	Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hibbert F., 1990, ADV PHYS ORG CHEM, V26, P255, DOI DOI 10.1016/S0065-3160(08)60047-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jordan DB, 2000, BIOCHEMISTRY-US, V39, P2276, DOI 10.1021/bi991839y; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; MILLS SG, 1985, J ORG CHEM, V50, P1216, DOI 10.1021/jo00208a014; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thomas R, 2001, CHEMBIOCHEM, V2, P612, DOI 10.1002/1439-7633(20010903)2:9<612::AID-CBIC612>3.0.CO;2-Z; TOWNSEND CA, 1999, COMPREHENSIVE NATURA, V1, P443; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465	30	132	136	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1139	U243		10.1038/nature08475	http://dx.doi.org/10.1038/nature08475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847268	Green Accepted			2022-12-28	WOS:000270987600048
J	Albert, NM; Yancy, CW; Liang, L; Zhao, X; Hernandez, AF; Peterson, ED; Cannon, CP; Fonarow, GC				Albert, Nancy M.; Yancy, Clyde W.; Liang, Li; Zhao, Xin; Hernandez, Adrian F.; Peterson, Eric D.; Cannon, Christopher P.; Fonarow, Gregg C.			Use of Aldosterone Antagonists in Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-INSUFFICIENCY; SPIRONOLACTONE; HYPERKALEMIA; GUIDELINES; DYSFUNCTION; ASSOCIATION; MANAGEMENT; POTASSIUM; DIAGNOSIS; UPDATE	Context Aldosterone antagonists are recommended for patients with moderate to severe heart failure (HF) and systolic dysfunction. Prior studies suggest underuse of aldosterone antagonists in eligible patients as well as overuse in settings in which therapy may be harmful. Objective To examine aldosterone antagonist prescription based on HF management guideline criteria, investigator-defined appropriateness criteria, and trends over time in patients hospitalized with heart failure. Design, Setting, and Patients Observational analysis of 43 625 patients admitted with HF and discharged home from 241 hospitals participating in the Get With The Guidelines-HF quality improvement registry between January 2005 and December 2007. Main Outcome Measures Prescription and predictors of use of aldosterone antagonists, based on guideline criteria. Results Among 12 565 patients eligible for aldosterone antagonist therapy, 4087 (32.5%) received an aldosterone antagonist at discharge, and treatment increased modestly from 28% to 34% over the study period. There was also wide variation in aldosterone antagonist use among hospitals (0%-90.6%). Aldosterone antagonist use in eligible patients was associated with younger age (adjusted odds ratio [OR], 0.85; 95% confidence interval [CI], 0.82-0.88), African American race/ethnicity (adjusted OR, 1.17; 95% CI, 1.04-1.32), lower systolic blood pressure (adjusted OR, 0.94; 95% CI, 0.92-0.95), history of implantable cardioverter-defibrillator use (adjusted OR, 1.51; 95% CI, 1.34-1.69), depression (adjusted OR, 1.15; 95% CI, 1.01-1.30), alcohol use (adjusted OR, 1.23; 95% CI, 1.02-1.50), and pacemaker implantation (adjusted OR, 1.21; 95% CI, 1.06-1.38), and with having no history of renal insufficiency (adjusted OR, 0.85; 95% CI, 0.75-0.96). Applying serum creatinine and potassium appropriateness criteria, inappropriate and potentially inappropriate use of aldosterone antagonist therapy was low and did not change over the 3-year study period. Conclusions Less than one-third of eligible patients hospitalized for HF and participating in a quality improvement registry received HF guideline-recommended aldosterone antagonist therapy. Use of aldosterone antagonist therapy among patients with documented contraindications was low. JAMA. 2009;302(15):1658-1665	[Albert, Nancy M.] Cleveland Clin, Nursing Inst, Cleveland, OH 44106 USA; [Albert, Nancy M.] Cleveland Clin, Kaufman Ctr Heart Failure, Cleveland, OH 44106 USA; [Yancy, Clyde W.] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA; [Liang, Li; Zhao, Xin; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Baylor University; Baylor University Medical Center; Duke University; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles	Albert, NM (corresponding author), 9500 Euclid Ave,Mail Code J3-4, Cleveland, OH 44195 USA.	albertn@ccf.org	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021; Cannon, Christopher P/AAY-7644-2020; Fonarow, Gregg C/D-5988-2014	Hernandez, Adrian F/0000-0003-3387-9616; Cannon, Christopher P/0000-0003-4596-2791; Fonarow, Gregg C/0000-0002-3192-8093	American Heart Association; GlaxoSmithKline; Medtronic	American Heart Association(American Heart Association); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic)	The Get With The GuidelinesHeart Failure program is sponsored by the American Heart Association and receives funding in part from GlaxoSmithKline and Medtronic.	Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Erhardt L, 2008, EUR J HEART FAIL, V10, P1020, DOI 10.1016/j.ejheart.2008.08.001; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1097/00000539-200207000-00006; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1116, DOI [DOI 10.1016/j.jacc.2005.08.023, DOI 10.1016/J.JACC.2005.08.023]; HUNT SA, 2006, CIRCULATION, V113, pE684; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Krantz MJ, 2008, AM J CARDIOL, V102, P1693, DOI 10.1016/j.amjcard.2008.08.015; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Raebel MA, 2007, ANN PHARMACOTHER, V41, P193, DOI 10.1345/aph.1H520; Saito M, 2005, J CLIN PHARM THER, V30, P603, DOI 10.1111/j.1365-2710.2005.00694.x; Shah KB, 2005, J AM COLL CARDIOL, V46, P845, DOI 10.1016/j.jacc.2005.06.010; Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Williams EM, 2006, CLIN CARDIOL, V29, P149, DOI 10.1002/clc.4960290405; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	25	203	206	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1658	1665		10.1001/jama.2009.1493	http://dx.doi.org/10.1001/jama.2009.1493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843900	Bronze			2022-12-28	WOS:000270941200020
J	van Linschoten, R; van Middelkoop, M; Berger, MY; Heintjes, EM; Verhaar, JAN; Willemsen, SP; Koes, BW; Bierma-Zeinstra, SM				van Linschoten, R.; van Middelkoop, M.; Berger, M. Y.; Heintjes, E. M.; Verhaar, J. A. N.; Willemsen, S. P.; Koes, B. W.; Bierma-Zeinstra, S. M.			Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTERIOR KNEE PAIN; CLOSED KINETIC CHAIN; CLINICAL-TRIAL; PHYSIOTHERAPY; MANAGEMENT; DISORDERS; TESTS	Objective To assess the effectiveness of supervised exercise therapy compared with usual care with respect to recovery, pain, and function in patients with patellofemoral pain syndrome. Design Open label randomised controlled trial. Setting General practice and sport physician practice. Participants Patients with a new episode of patellofemoral pain syndrome recruited by their general practitioner or sport physician. Interventions The intervention group received a standardised exercise programme for 6 weeks tailored to individual performance and supervised by a physical therapist, and were instructed to practise the tailored exercises at home for 3 months. The control group were assigned usual care, which comprised a "wait and see" approach of rest during periods of pain and refraining from pain provoking activities. Both the intervention group and the control group received written information about patellofemoral pain syndrome and general instructions for home exercises. Main outcome measures The primary outcomes were self reported recovery (7 point Likert scale), pain at rest and pain on activity (0-10 point numerical rating scale), and function (0-100 point Kujala patellofemoral score) at 3 months and 12 months follow-up. Results A total of 131 participants were included in the study: 65 in the intervention group and 66 in the control group. After 3 months, the intervention group showed better outcomes than the control group with regard to pain at rest (adjusted difference -1.07, 95% confidence interval -1.92 to -0.22; effect size 0.47), pain on activity (-1.00, -1.91 to -0.08; 0.45), and function (4.92, 0.14 to 9.72; 0.34). At 12 months, the intervention group continued to show better outcomes than the control group with regard to pain (adjusted difference in pain at rest -1.29, -2.16 to -0.42; effect size 0.56; pain on activity -1.19, -2.22 to -0.16; effect size 0.54), but not function (4.52, -0.73 to 9.76). A higher proportion of patients in the exercise group than in the control group reported recovery (41.9% v 35.0% at 3 months and 62.1% v 50.8% at 12 months), although the differences in self reported recovery between the two groups were not statistically significant. Predefined subgroup analyses revealed that patients recruited by sport physicians (n=30) did not benefit from the intervention, whereas those recruited by general practitioners (n=101) showed significant and clinically relevant differences in pain and function in favour of the intervention group. Conclusion Supervised exercise therapy resulted in less pain and better function at short term and long term follow-up compared with usual care in patients with patellofemoral pain syndrome in general practice. Exercise therapy did not produce a significant difference in the rate of self reported recovery.	[van Linschoten, R.; van Middelkoop, M.; Berger, M. Y.; Willemsen, S. P.; Koes, B. W.; Bierma-Zeinstra, S. M.] Erasmus Univ, Med Ctr, Dept Gen Practice, Rotterdam, Netherlands; [Verhaar, J. A. N.] Erasmus Univ, Med Ctr, Dept Orthopaed, Rotterdam, Netherlands; [Willemsen, S. P.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Heintjes, E. M.] PHARMO Inst, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Linschoten, R (corresponding author), Erasmus Univ, Med Ctr, Dept Gen Practice, Rotterdam, Netherlands.	r.v.linschoten@hccnet.nl	Verhaar, Jan/AAH-1372-2020; Bierma-Zeinstra, Sita/AAF-2122-2019; Koes, Bart w/K-4614-2016	Koes, Bart w/0000-0002-0450-9969; van Middelkoop, Marienke/0000-0001-6926-0618; Verhaar, Jan/0000-0003-3016-9600	ZON-MW (The Netherlands organisation for health research and development)	ZON-MW (The Netherlands organisation for health research and development)(Netherlands Organization for Health Research and Development)	This study was supported by ZON-MW (The Netherlands organisation for health research and development).	Bizzini M, 2003, J ORTHOP SPORT PHYS, V33, P4, DOI 10.2519/jospt.2003.33.1.4; CIRKEL JW, 1998, HUISARTS WET, V41, P246; Clark DI, 2000, ANN RHEUM DIS, V59, P700, DOI 10.1136/ard.59.9.700; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Crossley K, 2002, AM J SPORT MED, V30, P857, DOI 10.1177/03635465020300061701; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; Cutbill JW, 1997, CLIN J SPORT MED, V7, P40, DOI 10.1097/00042752-199701000-00008; Dehaven K E, 1979, Am J Sports Med, V7, P5, DOI 10.1177/036354657900700102; DENHERTOG PC, 2003, ONGEVALLEN BEWEGEN N; Dixit S, 2007, AM FAM PHYSICIAN, V75, P194; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Dursun N, 2001, ARCH PHYS MED REHAB, V82, P1692, DOI 10.1053/apmr.2001.26253; GOBELET C, 1992, REV RHUM, V59, P23; Hartung J., 2008, STAT METAANALYSIS AP; Heintjes EM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003472, DOI 10.1002/14651858.CD003472]; KUJALA UM, 1993, ARTHROSCOPY, V9, P159, DOI 10.1016/S0749-8063(05)80366-4; Lun VMY, 2005, CLIN J SPORT MED, V15, P233; Malanga GA, 2003, ARCH PHYS MED REHAB, V84, P592, DOI 10.1053/apmr.2003.50026; Mayo E., 1949, HAWTHORNE W ELECT CO; McConnell J, 2002, CLIN SPORT MED, V21, P363, DOI 10.1016/S0278-5919(02)00027-3; Nijs J, 2006, MANUAL THER, V11, P69, DOI 10.1016/j.math.2005.04.002; Nimon G, 1998, J PEDIATR ORTHOPED, V18, P118, DOI 10.1097/00004694-199801000-00021; SANCHISALFONSO V, 2006, ANTERIOR KNEE PAIN P; Stiene HA, 1996, J ORTHOP SPORT PHYS, V24, P136, DOI 10.2519/jospt.1996.24.3.136; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Thomee R, 1999, SPORTS MED, V28, P245, DOI 10.2165/00007256-199928040-00003; Timm KE, 1998, MED SCI SPORT EXER, V30, P665, DOI 10.1097/00005768-199805000-00004; van der Velden J, 1991, NATL STUDIE NAAR ZIE; van Linschoten R, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-31; WHITELAW GP, 1989, CLIN ORTHOP RELAT R, P234; Witvrouw E, 2000, AM J SPORT MED, V28, P687, DOI 10.1177/03635465000280051201; Witvrouw E, 2005, KNEE SURG SPORT TR A, V13, P122, DOI 10.1007/s00167-004-0577-6; Witvrouw E, 2004, AM J SPORT MED, V32, P1122, DOI 10.1177/0363546503262187	33	90	92	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2009	339								b4074	10.1136/bmj.b4074	http://dx.doi.org/10.1136/bmj.b4074			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PJ	19843565	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000271102100003
J	Yarmolinsky, DA; Zuker, CS; Ryba, NJP				Yarmolinsky, David A.; Zuker, Charles S.; Ryba, Nicholas J. P.			Common Sense about Taste: From Mammals to Insects	CELL			English	Article							GUSTATORY RECEPTOR NEURONS; BITTER TASTE; OLFACTORY RECEPTORS; CELL COMMUNICATION; CAFFEINE RESPONSE; DROSOPHILA; SWEET; FAMILY; BUDS; IDENTIFICATION		[Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Ryba, Nicholas J. P.] NIDCR, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	cz2195@columbia.edu		Ryba, Nicholas/0000-0002-2060-8393	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Bachmanov AA, 2002, BEHAV GENET, V32, P445, DOI 10.1023/A:1020832327983; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; BRESLIN PA, 1993, AM J PHYSIOL, V264, pR12; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Herness S, 2005, CHEM SENSES, V30, pI37, DOI 10.1093/chemse/bjh101; Herness S, 2009, PHYSIOL BEHAV, V97, P581, DOI 10.1016/j.physbeh.2009.02.043; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002610; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YJ, 2005, ARCH ITAL BIOL, V143, P87; Ikeda Kikunae, 1909, J TOKYO CHEM SOC JAP, V30, P820, DOI DOI 10.1093/CHEMSE/27.9.847; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; IWASAKI K, 1985, PHYSIOL BEHAV, V34, P531, DOI 10.1016/0031-9384(85)90045-9; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KINNAMON JC, 1993, MICROSC RES TECHNIQ, V26, P142, DOI 10.1002/jemt.1070260207; KOMAI M, 1994, OLFACTION TASTE, V11, P92; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meyerhof W, 2005, CHEM SENSES, V30, pI14, DOI 10.1093/chemse/bjh089; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Roper SD, 2009, PHYSIOL BEHAV, V97, P604, DOI 10.1016/j.physbeh.2009.04.003; ROYER SM, 1988, J COMP NEUROL, V270, P11, DOI 10.1002/cne.902700103; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Siddiqi O, 1980, Basic Life Sci, V16, P347; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Spector AC, 1996, J NEUROSCI, V16, P8115; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Thorne N, 2005, CHEM SENSES, V30, pI270, DOI 10.1093/chemse/bjh219; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yasuoka A, 2009, RESULTS PROBL CELL D, V47, P239, DOI 10.1007/400_2008_6; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	89	506	521	11	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					234	244		10.1016/j.cell.2009.10.001	http://dx.doi.org/10.1016/j.cell.2009.10.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837029	Green Accepted, Bronze			2022-12-28	WOS:000270857500010
J	Lange, A; Wickstrom, SA; Jakobson, M; Zent, R; Sainio, K; Fassler, R				Lange, Anika; Wickstroem, Sara A.; Jakobson, Madis; Zent, Roy; Sainio, Kirsi; Faessler, Reinhard			Integrin-linked kinase is an adaptor with essential functions during mouse development	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; NEUROTROPHIC FACTOR; PROTEIN-KINASE; CELL-ADHESION; ILK; ACTIN; INACTIVATION; CYTOSKELETON; EXPRESSION; PARVIN	The development of multicellular organisms requires integrin-mediated interactions between cells and their extracellular environment. Integrin binding to extracellular matrix catalyses assembly of multiprotein complexes, which transduce mechanical and chemical signals that regulate many aspects of cell physiology(1,2). Integrin-linked kinase (Ilk) is a multifunctional protein that binds beta-integrin cytoplasmic domains and regulates actin dynamics by recruiting actin binding regulatory proteins such as alpha-and beta-parvin(3). Ilk has also been shown to possess serine/threonine kinase activity(4) and to phosphorylate signalling proteins such as Akt1 and glycogen synthase kinase 3 beta (Gsk3 beta) in mammalian cells(5); however, these functions have been shown by genetic studies(6,7) not to occur in flies and worms. Here we show that mice carrying point mutations in the proposed autophosphorylation site of the putative kinase domain and in the pleckstrin homology domain are normal. In contrast, mice with point mutations in the conserved lysine residue of the potential ATP-binding site of the kinase domain, which mediates Ilk binding to alpha-parvin, die owing to renal agenesis. Similar renal defects occur in alpha-parvin-null mice. Thus, we provide genetic evidence that the kinase activity of Ilk is dispensable for mammalian development; however, an interaction between Ilk and alpha-parvin is critical for kidney development.	[Lange, Anika; Wickstroem, Sara A.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Jakobson, Madis; Sainio, Kirsi] Univ Helsinki, Inst Biomed Med Biochem & Dev Biol, FIN-00014 Helsinki, Finland; [Zent, Roy] Vanderbilt Univ Sch Med, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Zent, Roy] Vet Affairs Hosp, Nashville, TN 37232 USA	Max Planck Society; University of Helsinki; Vanderbilt University	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	Faessler@biochem.mpg.de		Wickstrom, Sara/0000-0001-6383-6292	Sigrid Juselius Foundation; Academy of Finland; Finnish Cultural Foundation; NIDDK [DK065123, DK075594, DK65123]; AHA; Department of Veterans Affairs; Austrian Science Funds [SFB021]; Max Planck Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, R01DK075594] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); Austrian Science Funds(Austrian Science Fund (FWF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bosl and M. Moser for help with the generation of the mutant mice, E. Montanez for help with the analysis of the alpha-parvin-null mice, M. Grzejszczyk and S. Bach for technical assistance, O. Kudlacek for help with initial vector construction, M. Aumailley (Univ. Cologne) for laminin322, A. A. Noegel (Univ. Cologne) for alpha-parvin cDNA, A. Miettinen (Univ. Helsinki) for the brush border antibody, and R. Bottcher for careful reading of the manuscript. This work was supported by the Sigrid Juselius Foundation (to S. A. W. and M. J.), the Academy of Finland (to S. A. W., M. J. and K. S.), the Finnish Cultural Foundation (to S. A. W.), NIDDK DK065123, DK075594, DK65123, an AHA established investigator award and a Merit award from the Department of Veterans Affairs (to R. Z.), the Austrian Science Funds (grant SFB021) and the Max Planck Society (to R. F.).	Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chu HY, 2006, MOL CELL BIOL, V26, P1817, DOI 10.1128/MCB.26.5.1817-1825.2006; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kuure S, 2005, MECH DEVELOP, V122, P765, DOI 10.1016/j.mod.2005.03.006; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; MONTANEZ E, EMBO J IN PRESS; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	33	100	101	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					1002	U269		10.1038/nature08468	http://dx.doi.org/10.1038/nature08468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829382				2022-12-28	WOS:000270817700052
J	Lund, SS; Tarnow, L; Frandsen, M; Nielsen, BB; Hansen, BV; Pedersen, O; Parving, HH; Vaag, AA				Lund, Soren S.; Tarnow, Lise; Frandsen, Merete; Nielsen, Bente B.; Hansen, Birgitte V.; Pedersen, Oluf; Parving, Hans-Henrik; Vaag, Allan A.			Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIPHASIC HUMAN INSULIN; 10-YEAR FOLLOW-UP; PREMIXED INSULIN; BASAL INSULIN; GLYCEMIC CONTROL; STARTING INSULIN; DAILY INJECTIONS; RISK-FACTORS; ASPART 70/30; THERAPY	Objectives To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. Design Randomised, double blind, double dummy, parallel trial. Setting Secondary care in Denmark between 2003 and 2006. Participants Non-obese patients (BMI <= 27) with preserved beta cell function. Interventions After a four month run-in period with repaglinide plus metformin combination therapy, patients with a glycated haemoglobin (HbA(1c)) concentration of 6.5% or more were randomised to repaglinide 6 mg or metformin 2000 mg. All patients also received biphasic insulin aspart 70/30 (30% soluble insulin aspart and 70% intermediate acting insulin aspart) 6 units once a day before dinner for 12 months. Insulin dose was adjusted aiming for a fasting plasma glucose concentration of 4.0-6.0 mmol/l. The target of HbA(1c) concentration was less than 6.5%. Treatment was intensified to two or three insulin injections a day if glycaemic targets were not reached. Main outcome measure HbA(1c) concentration. Results Of the 459 patients who were eligible, 102 were randomised, and 97 completed the trial. Patients had had type 2 diabetes for approximately 10 years. At the end of treatment, HbA(1c) concentration was reduced by a similar amount in the two treatment groups (insulin plus metformin: mean (standard deviation) HbA(1c) 8.15% (1.32) v 6.72% (0.66); insulin plus repaglinide: 8.07% (1.49) v 6.90% (0.68); P=0.177). Total daily insulin dose and risk of hypoglycaemia were also similar in the two treatment groups. Weight gain was less with metformin plus biphasic insulin aspart 70/30 than with repaglinide plus biphasic insulin aspart 70/30 (difference in mean body weight between treatments -2.51 kg, 95% confidence interval -4.07 to -0.95). Conclusions In non-obese patients with type 2 diabetes and poor glycaemic regulation on oral hypoglycaemic agents, overall glycaemic regulation with insulin in combination with metformin was equivalent to that with insulin plus repaglinide. Weight gain seemed less with insulin plus metformin than with insulin plus repaglinide.	[Lund, Soren S.; Tarnow, Lise; Frandsen, Merete; Nielsen, Bente B.; Hansen, Birgitte V.; Vaag, Allan A.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf; Parving, Hans-Henrik] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Vaag, Allan A.] Lund Univ, Dept Endocrinol, Malmo, Sweden	Steno Diabetes Center; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; Rigshospitalet; University of Copenhagen; Lund University	Lund, SS (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	sqrl@steno.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Tarnow, Lise/0000-0002-8735-966X; Vaag, Allan Arthur/0000-0002-3690-2191	Novo Nordisk A/S; Novo Nordisk Scandinavia A/S; Clinical Development Foundation	Novo Nordisk A/S(Novo Nordisk); Novo Nordisk Scandinavia A/S(Novo Nordisk); Clinical Development Foundation	Novo Nordisk A/S, Novo Nordisk Scandinavia A/S, and the Clinical Development Foundation at Steno Diabetes Center co-sponsored the study financially. Novo Nordisk A/S and Novo Nordisk Scandinavia A/S supplied biphasic insulin aspart 70/30, repaglinide, and repaglinide placebo tablets. Hexal A/S supplied metformin and metformin placebo tablets. Medisense Danmark supplied blood glucose hand measurement devices and test strips. Steno Diabetes Center housed the database and Novo Nordisk A/S performed the statistical analyses. Otherwise, the sponsors had no role in design and conduct of the study; collection, management, and interpretation of the data; or preparation, review, and approval of the manuscript.	ARNER P, 1991, DIABETOLOGIA, V34, P483, DOI 10.1007/BF00403284; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Boehm Bernhard O, 2004, Eur J Intern Med, V15, P496, DOI 10.1016/j.ejim.2004.10.001; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Cozma LS, 2005, DIABETES CARE, V28, P1001, DOI 10.2337/diacare.28.5.1001; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Davies MJ, 2007, DIABETIC MED, V24, P714, DOI 10.1111/j.1464-5491.2007.02128.x; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Douek IF, 2005, DIABETIC MED, V22, P634, DOI 10.1111/j.1464-5491.2005.01475.x; ELDRUP E, 2009, DIABETOLOGIA S, V51; *EMA, 1998, CPMPICH36396137; *EMEA, 2005, EMEACPMPEWP215899111; Esposito K, 2004, CIRCULATION, V110, P214, DOI 10.1161/01.CIR.0000134501.57864.66; Furlong MJ, 2002, DIABETES CARE, V25, P1685, DOI 10.2337/diacare.25.10.1685; GARANCINI MP, 1995, DIABETOLOGIA, V38, P306, DOI 10.1007/BF00400635; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Garber AJ, 2006, DRUGS, V66, P31, DOI 10.2165/00003495-200666010-00003; Garber AJ, 2006, DIABETES OBES METAB, V8, P58, DOI 10.1111/j.1463-1326.2005.00563.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hermansen K, 2002, DIABETES CARE, V25, P883, DOI 10.2337/diacare.25.5.883; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Jang HC, 2008, INT J CLIN PRACT, V62, P1013, DOI 10.1111/j.1742-1241.2008.01792.x; Janka HU, 2005, DIABETES CARE, V28, P254, DOI 10.2337/diacare.28.2.254; Jovanovic L, 2000, J CLIN PHARMACOL, V40, P49, DOI 10.1177/00912700022008694; Kann PH, 2006, EXP CLIN ENDOCR DIAB, V114, P527, DOI 10.1055/s-2006-949655; Kilo C, 2003, J DIABETES COMPLICAT, V17, P307, DOI 10.1016/S1056-8727(03)00076-X; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Kvapil A, 2006, DIABETES OBES METAB, V8, P39, DOI 10.1111/j.1463-1326.2005.00492.x; Ligthelm RJ, 2006, EXP CLIN ENDOCR DIAB, V114, P511, DOI 10.1055/s-2006-924424; Lund SS, 2007, DIABETES OBES METAB, V9, P394, DOI 10.1111/j.1463-1326.2007.00713.x; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Manzella D, 2005, DIABETES CARE, V28, P366, DOI 10.2337/diacare.28.2.366; Massi-Benedetti M, 2000, EXPERT OPIN INV DRUG, V9, P885, DOI 10.1517/13543784.9.4.885; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; Metropolitan Life Foundation New weight standards for men and women, 1959, STAT B, V40, P1; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Ong CR, 2006, DIABETES CARE, V29, P2361, DOI 10.2337/dc06-0827; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Qayyum R, 2008, ANN INTERN MED, V149, P549, DOI 10.7326/0003-4819-149-8-200810210-00242; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; SCHRAMM TK, 2009, DIABETES S117, V58; Sharma SK, 2008, CURR MED RES OPIN, V24, P645, DOI 10.1185/030079908X260952; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1995, DIABETES, V44, P1249; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002; Yki-Jarvinen H, 2001, DIABETES CARE, V24, P758, DOI 10.2337/diacare.24.4.758; Yoshioka N, 2009, DIABETES RES CLIN PR, V85, P47, DOI 10.1016/j.diabres.2009.04.012	57	29	30	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2009	339								b4324	10.1136/bmj.b4324	http://dx.doi.org/10.1136/bmj.b4324			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HK	19900993	hybrid, Green Published			2022-12-28	WOS:000271833700002
J	Hasselbrink, E				Hasselbrink, Eckart			Capturing the Complexities of Molecule-Surface Interactions	SCIENCE			English	Editorial Material							SCATTERING; EXCITATION		[Hasselbrink, Eckart] Univ Duisburg Essen, Fak Chem, D-45117 Essen, Germany; [Hasselbrink, Eckart] Univ Duisburg Essen, Ctr NanoIntegrat, D-45117 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Hasselbrink, E (corresponding author), Univ Duisburg Essen, Fak Chem, D-45117 Essen, Germany.	eckart.hasselbrink@uni-due.de	Hasselbrink, Eckart/C-1933-2009	Hasselbrink, Eckart/0000-0002-9374-2868				ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Born M, 1927, ANN PHYS-BERLIN, V84, P0457; Diaz C, 2009, SCIENCE, V326, P832, DOI 10.1126/science.1178722; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Hasselbrink E, 2008, HBK SURF SCI, V3, P1; Hasselbrink E, 2006, CURR OPIN SOLID ST M, V10, P192, DOI 10.1016/j.cossms.2007.04.003; Huang YH, 2000, SCIENCE, V290, P111, DOI 10.1126/science.290.5489.111; MULLERHA.E, 1971, PHYS REV B, V3, P1102, DOI 10.1103/PhysRevB.3.1102; Shenvi N, 2009, SCIENCE, V326, P829, DOI 10.1126/science.1179240; White JD, 2005, NATURE, V433, P503, DOI 10.1038/nature03213	10	10	10	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					809	810		10.1126/science.1181275	http://dx.doi.org/10.1126/science.1181275			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892971				2022-12-28	WOS:000271468000029
J	Lee, SW; Han, SW; Sririyanum, M; Park, CJ; Seo, YS; Ronald, PC				Lee, Sang-Won; Han, Sang-Wook; Sririyanum, Malinee; Park, Chang-Jin; Seo, Young-Su; Ronald, Pamela C.			RETRACTED: A Type I-Secreted, Sulfated Peptide Triggers XA21-Mediated Innate Immunity (Retracted article. See vol. 342, pg. 191, 2013)	SCIENCE			English	Article; Retracted Publication							DISEASE RESISTANCE; GENE; FLAGELLIN; PERCEPTION; CAMPESTRIS; ACYLATION; ELICITOR; PATTERN; IMPACT; PLANTS	The rice Xa21 gene confers immunity to most strains of the bacterium Xanthomonas oryzae pv. oryzae (Xoo). Liquid chromatography-tandem mass spectrometry analysis of biologically active fractions from Xoo supernatants led to the identification of a 194-amino acid protein designated Ax21 (activator of XA21-mediated immunity). A sulfated, 17-amino acid synthetic peptide (axY(S)22) derived from the N-terminal region of Ax21 is sufficient for activity, whereas peptides lacking tyrosine sulfation are biologically inactive. Using coimmunoprecipitation, we found that XA21 is required for axY(S)22 binding and recognition. axY(S)22 is 100% conserved in all analyzed Xanthomonas species, confirming that Ax21 is a pathogen-associated molecular pattern and that XA21 is a pattern recognition receptor.	[Lee, Sang-Won; Han, Sang-Wook; Sririyanum, Malinee; Park, Chang-Jin; Seo, Young-Su; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Ronald, Pamela/AAK-7664-2020; poinssot, benoit/B-2569-2009; Sriariyanun, Malinee/AEX-7648-2022; Sriariyanun, Malinee/B-6767-2016	poinssot, benoit/0000-0001-5890-4318; Sriariyanun, Malinee/0000-0002-3088-9256	KOSEF through PMRC of Kyung-Hee Univ., Korea; USDA Cooperative State Research, Education and Extension Service [006-01888, 2007-35319-18397]; NIH [GM55962]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	KOSEF through PMRC of Kyung-Hee Univ., Korea; USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Macek, M. Mann, C. Bertozzi, andD. Kliebenstein for technical assistance and discussions; R. Eigenheer and B. Phinney for LC-MS/MS service and HPLC equipment; and M. S. Chern, X. Chen, L. Bartley, A. Bent, J. Dangl, J. Dubcovsky, and B. Tyler for helpful comments and critical reading of the manuscript. S.-W. Lee was partially supported by KOSEF through PMRC of Kyung-Hee Univ., Korea. Supported by the USDA Cooperative State Research, Education and Extension Service ( National Research Initiative grants 006-01888 and 2007-35319-18397) and by NIH grant GM55962.	Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Carneiro LAM, 2004, MICROBES INFECT, V6, P609, DOI 10.1016/j.micinf.2004.01.012; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Panstruga R, 2009, CELL, V136, P978, DOI 10.1016/j.cell.2009.02.020; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Wang GL, 1996, MOL PLANT MICROBE IN, V9, P850, DOI 10.1094/MPMI-9-0850; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	31	193	224	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					850	853		10.1126/science.1173438	http://dx.doi.org/10.1126/science.1173438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892983				2022-12-28	WOS:000271468000043
J	Goldston, D				Goldston, David			In which we say goodbye	NATURE			English	Editorial Material												partyofonecolumn@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					25	25		10.1038/462025a	http://dx.doi.org/10.1038/462025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514TT	19890302	Bronze			2022-12-28	WOS:000271419200011
J	Louie, JK; Acosta, M; Winter, K; Jean, C; Gavali, S; Schechter, R; Vugia, D; Harriman, K; Matyas, B; Glaser, CA; Samuel, MC; Rosenberg, J; Talarico, J; Hatch, D				Louie, Janice K.; Acosta, Meileen; Winter, Kathleen; Jean, Cynthia; Gavali, Shilpa; Schechter, Robert; Vugia, Duc; Harriman, Kathleen; Matyas, Bela; Glaser, Carol A.; Samuel, Michael C.; Rosenberg, Jon; Talarico, John; Hatch, Douglas		Calif Pandemic (H1N1) Working Grp	Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEASONAL INFLUENZA; OBESE-PATIENTS; OUTCOMES; COMPLICATIONS; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; MORTALITY; CHILDREN; INFANTS	Context Pandemic influenza A(H1N1) emerged rapidly in California in April 2009. Preliminary comparisons with seasonal influenza suggest that pandemic 2009 influenza A(H1N1) disproportionately affects younger ages and causes generally mild disease. Objective To describe the clinical and epidemiologic features of pandemic 2009 influenza A(H1N1) cases that led to hospitalization or death. Design, Setting, and Participants Statewide enhanced public health surveillance of California residents who were hospitalized or died with laboratory evidence of pandemic 2009 influenza A(H1N1) infection reported to the California Department of Public Health between April 23 and August 11, 2009. Main Outcome Measure Characteristics of hospitalized and fatal cases. Results During the study period there were 1088 cases of hospitalization or death due to pandemic 2009 influenza A(H1N1) infection reported in California. The median age was 27 years (range, <1-92 years) and 68% (741/1088) had risk factors for seasonal influenza complications. Sixty-six percent (547/833) of those with chest radiographs performed had infiltrates and 31% (340/1088) required intensive care. Rapid antigen tests were falsely negative in 34% (208/618) of cases evaluated. Secondary bacterial infection was identified in 4% (46/1088). Twenty-one percent (183/884) received no antiviral treatment. Overall fatality was 11% (118/1088) and was highest (18%-20%) in persons aged 50 years or older. The most common causes of death were viral pneumonia and acute respiratory distress syndrome. Conclusions In the first 16 weeks of the current pandemic, the median age of hospitalized infected cases was younger than is common with seasonal influenza. Infants had the highest hospitalization rates and persons aged 50 years or older had the highest mortality rates once hospitalized. Most cases had established risk factors for complications of seasonal influenza. JAMA. 2009;302(17):1896-1902	[Louie, Janice K.; Acosta, Meileen; Winter, Kathleen; Jean, Cynthia; Gavali, Shilpa; Schechter, Robert; Vugia, Duc; Harriman, Kathleen; Matyas, Bela; Glaser, Carol A.; Samuel, Michael C.; Rosenberg, Jon; Talarico, John; Hatch, Douglas; Calif Pandemic (H1N1) Working Grp] Calif Dept Publ Hlth, Richmond, CA 94804 USA	California Department of Public Health	Louie, JK (corresponding author), Calif Dept Publ Hlth, 850 Marina Bay Pkwy, Richmond, CA 94804 USA.	Janice.Louie@cdph.ca.gov		Pan, Chao-Yang/0000-0003-1584-4233	CDPH	CDPH	This study was fully sponsored by the CDPH.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], UPD INT REC US ANT M; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Duarte AG, 2007, CRIT CARE MED, V35, P732, DOI 10.1097/01.CCM.0000256842.39767.41; El-Solh A, 2001, CHEST, V120, P1989, DOI 10.1378/chest.120.6.1989; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Koenig SM, 2001, AM J MED SCI, V321, P249, DOI 10.1097/00000441-200104000-00006; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poirier P, 2009, CIRCULATION, V120, P86, DOI 10.1161/CIRCULATIONAHA.109.192575; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; VGONTZAS AN, 1994, ARCH INTERN MED, V154, P1705, DOI 10.1001/archinte.154.15.1705; World Health Organization, 2010, GLOB AL RESP PAND H1; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P301	33	771	824	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1896	1902		10.1001/jama.2009.1583	http://dx.doi.org/10.1001/jama.2009.1583			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19887665	Bronze			2022-12-28	WOS:000271375300021
J	Jelinek, M; Barraclough, K				Jelinek, Michael; Barraclough, Kevin			Diagnosis in General Practice Chest pain	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY DISEASE; EXERCISE TEST		[Jelinek, Michael] St Vincents Hosp, Melbourne, Vic, Australia; [Jelinek, Michael] Univ Melbourne, Melbourne, Vic, Australia	St Vincent's Hospital Melbourne; University of Melbourne	Jelinek, M (corresponding author), St Vincents Hosp, Melbourne, Vic, Australia.	michael.jelinek@svhm.org.au						Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Doust J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3823; ELLESTAD MH, 1975, CIRCULATION, V51, P363, DOI 10.1161/01.CIR.51.2.363; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Glasziou P., 2001, EVID BASED MED, V6, P164, DOI DOI 10.1136/EBM.6.6.164; GOLDMAN L, 1982, CIRCULATION, V66, P945, DOI 10.1161/01.CIR.66.5.945; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; RIFKIN RD, 1977, NEW ENGL J MED, V297, P686; Williams SV, 2001, ANN INTERN MED, V135, P530, DOI 10.7326/0003-4819-135-7-200110020-00014	10	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2009	339								b4117	10.1136/bmj.b4117	http://dx.doi.org/10.1136/bmj.b4117			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UB	19887529				2022-12-28	WOS:000271567700002
J	Yau, KW; Hardie, RC				Yau, King-Wai; Hardie, Roger C.			Phototransduction Motifs and Variations	CELL			English	Review							GANGLION-CELL PHOTORECEPTORS; G-PROTEIN; LIGHT RESPONSE; PARIETAL-EYE; VISUAL CYCLE; HYPERPOLARIZING PHOTORECEPTORS; FUNCTIONAL EXPRESSION; RETINAL DEGENERATION; CRYSTAL-STRUCTURE; TRP CHANNELS		[Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Johns Hopkins University; Johns Hopkins University; University of Cambridge	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kwyau@mail.jhmi.edu; rch14@cam.ac.uk		Hardie, Roger/0000-0001-5531-3264	NATIONAL EYE INSTITUTE [R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; BBSRC [BB/G006865/1, BB/D007585/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006865/1, BB/D007585/1] Funding Source: Medline; NEI NIH HHS [R01 EY006837-20A1, R01 EY006837-16A1, R01 EY006837-21, R01 EY014596-05, R01 EY014596-07, R01 EY006837-19, R01 EY006837-22, R01 EY014596-01, R01 EY014596-03, R01 EY014596, R01 EY006837, R01 EY006837-18, R01 EY014596-02, R01 EY014596-06, R01 EY014596-07S1] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-04, R01 DC006904-05, R01 DC006904-03, R01 DC006904-02, R01 DC006904-01, R01 DC006904-06A1, R01 DC006904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arendt D, 2003, INT J DEV BIOL, V47, P563; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Ashmore LJ, 2003, J BIOL RHYTHM, V18, P206, DOI [10.1177/0748730403018003003, 10.1177/0748730403253385]; Bandyopadhyay BC, 2004, J NEUROCHEM, V91, P825, DOI 10.1111/j.1471-4159.2004.02773.x; BARLOW HB, 1957, J PHYSIOL-LONDON, V136, P469, DOI 10.1113/jphysiol.1957.sp005774; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; Beech DJ, 2009, CELL CALCIUM, V45, P583, DOI 10.1016/j.ceca.2009.02.006; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Chen FH, 2001, VISUAL NEUROSCI, V18, P517, DOI 10.1017/S0952523801184026; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cowan CW, 2001, PROG NUCLEIC ACID RE, V65, P341; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Gomez MD, 2009, P NATL ACAD SCI USA, V106, P9081, DOI 10.1073/pnas.0900708106; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dorlochter M, 1997, PROG NEUROBIOL, V53, P451, DOI 10.1016/S0301-0082(97)00046-4; DRYER SE, 1991, NATURE, V353, P756, DOI 10.1038/353756a0; EAKIN RM, 1973, 3 EYE; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Galindo BE, 2007, BIOCHEM BIOPH RES CO, V354, P668, DOI 10.1016/j.bbrc.2007.01.035; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FERREIRA PA, 1994, J BIOL CHEM, V269, P3129; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Garger A, 2001, VISUAL NEUROSCI, V18, P625, DOI 10.1017/S0952523801184129; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Gomez MD, 2005, J BIOL CHEM, V280, P16784, DOI 10.1074/jbc.M414538200; Gomez MD, 2005, J NEUROSCI, V25, P2042, DOI 10.1523/JNEUROSCI.5129-04.2005; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hofmann F, 2005, PHARMACOL REV, V57, P455, DOI 10.1124/pr.57.4.8; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kawamura S, 2002, ADV EXP MED BIOL, V514, P61; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; Kojima D, 2000, J NEUROSCI, V20, P2845; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Korenbrot JI, 2002, ADV EXP MED BIOL, V514, P179; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Linder JU, 2002, MOL CELL BIOCHEM, V230, P149, DOI 10.1023/A:1014200325422; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Lott JS, 1999, MOL NEUROBIOL, V20, P61, DOI 10.1007/BF02741365; LUO DG, 2008, SENSES COMPREHENSIVE, V1, P269; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mano H, 2007, PHOTOCHEM PHOTOBIOL, V83, P11, DOI 10.1562/2006-02-24-IR-813; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Mayeenuddin LH, 2003, J NEUROCHEM, V85, P592, DOI 10.1046/j.1471-4159.2003.01726.x; MCREYNOLDS JS, 1975, VISION RES, V15, P1181, DOI 10.1016/0042-6989(75)90160-1; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; NASI E, 2000, HDB BIOL PHYS, V0003, P00389; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PU GA, 1981, J NEUROPHYSIOL, V46, P1018, DOI 10.1152/jn.1981.46.5.1018; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Raghu P, 2009, CELL CALCIUM, V45, P566, DOI 10.1016/j.ceca.2009.03.005; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; Soni BG, 1998, NATURE, V394, P27, DOI 10.1038/27794; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; SUZUKI E, 1993, J ELECTRON MICROSC, V42, P178; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsunoda S, 1998, CURR OPIN GENET DEV, V8, P419, DOI 10.1016/S0959-437X(98)80112-3; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; von Salvini-Plawen L, 2008, AM MALACOL BULL, V26, P83, DOI 10.4003/006.026.0209; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Warren R, 2002, ADV EXP MED BIOL, V514, P205; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	151	270	281	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					246	264		10.1016/j.cell.2009.09.029	http://dx.doi.org/10.1016/j.cell.2009.09.029			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837030	Bronze, Green Accepted			2022-12-28	WOS:000270857500011
J	Hofstetter, L; Csonka, S; Nygard, J; Schonenberger, C				Hofstetter, L.; Csonka, S.; Nygard, J.; Schoenenberger, C.			Cooper pair splitter realized in a two-quantum-dot Y-junction	NATURE			English	Article							DOUBLE-QUANTUM DOTS; SUPERCONDUCTOR; ENTANGLEMENT	Non-locality is a fundamental property of quantum mechanics that manifests itself as correlations between spatially separated parts of a quantum system. A fundamental route for the exploration of such phenomena is the generation of Einstein-Podolsky-Rosen (EPR) pairs(1) of quantum-entangled objects for the test of so-called Bell inequalities(2). Whereas such experimental tests of non-locality have been successfully conducted with pairwise entangled photons, it has not yet been possible to realize an electronic analogue of it in the solid state, where spin-1/2 mobile electrons are the natural quantum objects(3). The difficulty stems from the fact that electrons are immersed in a macroscopic ground state-the Fermi sea-which prevents the straightforward generation and splitting of entangled pairs of electrons on demand. A superconductor, however, could act as a source of EPR pairs of electrons, because its ground-state is composed of Cooper pairs in a spin-singlet state(4). These Cooper pairs can be extracted from a superconductor by tunnelling, but, to obtain an efficient EPR source of entangled electrons, the splitting of the Cooper pairs into separate electrons has to be enforced. This can be achieved by having the electrons 'repel' each other by Coulomb interaction(5). Controlled Cooper pair splitting can thereby be realized by coupling of the superconductor to two normal metal drain contacts by means of individually tunable quantum dots. Here we demonstrate the first experimental realization of such a tunable Cooper pair splitter, which shows a surprisingly high efficiency. Our findings open a route towards a first test of the EPR paradox and Bell inequalities in the solid state.	[Hofstetter, L.; Csonka, S.; Schoenenberger, C.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Csonka, S.] Budapest Univ Technol & Econ, Dept Phys, H-1111 Budapest, Hungary; [Nygard, J.] Univ Copenhagen, Niels Bohr Inst, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Basel; Budapest University of Technology & Economics; University of Copenhagen; Niels Bohr Institute	Schonenberger, C (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	csonka@dept.phy.bme.hu; christian.schoenenberger@unibas.ch	Nygård, Jesper/F-5113-2014; Schönenberger, Christian/N-3187-2017; Csonka, Szabolcs/A-5348-2013	Nygård, Jesper/0000-0002-4639-5314; Schönenberger, Christian/0000-0002-5652-460X; 	Swiss National Science Foundation; Swiss National Center of Competence in Research on Nanoscale Science; Danish Natural Science Research Council; Hungarian Scientific Research Fund [NNF 78842]; European Union [41139]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research on Nanoscale Science(Swiss National Science Foundation (SNSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission)	We thank G. Zarand, P. Moca and C. W. J. Beenakker for discussions, and C. B. Srensen and M. Aagesen for Molecular Beam Epitaxy growth. This work was supported by the Swiss National Science Foundation, the Swiss National Center of Competence in Research on Nanoscale Science, the Danish Natural Science Research Council, Hungarian Scientific Research Fund (OTKA) project NNF 78842 and Marie Curie project 41139 of the European Union. S. C. is a grantee of the Bolyai Janos Scholarship.	ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Beckmann D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.197003; Bena C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037901; Bjork MT, 2004, NANO LETT, V4, P1621, DOI 10.1021/nl049230s; Bouchiat V, 2003, NANOTECHNOLOGY, V14, P77, DOI 10.1088/0957-4484/14/1/318; Burkard G, 2000, PHYS REV B, V61, P16303, DOI 10.1103/PhysRevB.61.R16303; Choi MS, 2000, PHYS REV B, V62, P13569, DOI 10.1103/PhysRevB.62.13569; Chtchelkatchev NM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.161320; Crepieux A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.205408; Csonka S, 2008, NANO LETT, V8, P3932, DOI 10.1021/nl802418w; Deutscher G, 2002, J SUPERCOND, V15, P43, DOI 10.1023/A:1014075110249; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Falci G, 2001, EUROPHYS LETT, V54, P255, DOI 10.1209/epl/i2001-00303-0; Fasth C, 2005, NANO LETT, V5, P1487, DOI 10.1021/nl050850i; Feinberg D, 2003, EUR PHYS J B, V36, P419, DOI 10.1140/epjb/e2003-00361-6; Golubev DS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.184510; HERRMANN LG, 2009, CARBON NANOTUBES COO; Kurtsiefer C, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023802; Lesovik GB, 2001, EUR PHYS J B, V24, P287, DOI 10.1007/s10051-001-8675-4; Loss D, 2000, PHYS REV LETT, V84, P1035, DOI 10.1103/PhysRevLett.84.1035; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Morten JP, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214510; Recher P, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165327; Recher P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165314; Russo S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.027002; Samuelsson P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115330; Samuelsson P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157002; Samuelsson P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.046601; Sauret O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245313; Torres J, 1999, EUR PHYS J B, V12, P319, DOI 10.1007/s100510051010	31	375	375	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					960	963		10.1038/nature08432	http://dx.doi.org/10.1038/nature08432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829377				2022-12-28	WOS:000270817700042
J	Kilama, W; Ntoumi, F				Kilama, Wen; Ntoumi, Francine			Malaria: a research agenda for the eradication era	LANCET			English	Editorial Material							RESISTANCE		[Kilama, Wen] African Malaria Network Trust AMANET, Dar Es Salaam, Tanzania; [Ntoumi, Francine] Multilateral Initiat Malaria Secretariat, Dar Es Salaam, Tanzania; [Ntoumi, Francine] Cent African Network TB HIV AIDS & Malaria CANTAM, Brazzaville, Rep Congo		Kilama, W (corresponding author), African Malaria Network Trust AMANET, Dar Es Salaam, Tanzania.	wlkilama@amanet-trust.org						Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2008, MAL RAP DIAGN TEST P; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], UND ANT MARK UG 2007; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; *GLOB FUND, 2008, GLOB FUND FIGHT AIDS; Nantulya FN, 2007, AM J TROP MED HYG, V77, P303; Rugemalila JB, 2007, AM J TROP MED HYG, V77, P296, DOI 10.4269/ajtmh.2007.77.296; SUDHAKAR M, 2009, 5 MIM PAN AFR MAL C; WELLS T, 2008, COMMUNICATION    OCT; GSK BIOL PATH MVI FA	13	24	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1480	1482		10.1016/S0140-6736(09)61884-5	http://dx.doi.org/10.1016/S0140-6736(09)61884-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19880004				2022-12-28	WOS:000271591300007
J	Oeffinger, KC; Bhatia, S				Oeffinger, Kevin C.; Bhatia, Smita			Second primary cancers in survivors of childhood cancer	LANCET			English	Editorial Material							MALIGNANT NEOPLASMS; 5-YEAR SURVIVORS; RISK		[Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Bhatia, Smita] City Hope Natl Med Ctr, Duarte, CA 91010 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City of Hope	Oeffinger, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	oeffingk@mskcc.org			NCI NIH HHS [R01 CA139633] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bhatia S, 2002, NAT REV CANCER, V2, P124, DOI 10.1038/nrc722; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; KREMER LCM, 2006, TIJDSCHRIFT KINDERGE, V6, P214; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; *NAT CANC I, RISK PRED MOD; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Scottish Intercollegiate Guidelines Network (SIGN), 2004, LONG TERM FOLL SURV; United KingdomChildren's Cancer Study Group late effects group, 2005, THER BAS LONG TERM F	16	30	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1484	1485		10.1016/S0140-6736(09)61885-7	http://dx.doi.org/10.1016/S0140-6736(09)61885-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19880005				2022-12-28	WOS:000271591300009
J	Morran, LT; Parmenter, MD; Phillips, PC				Morran, Levi T.; Parmenter, Michelle D.; Phillips, Patrick C.			Mutation load and rapid adaptation favour outcrossing over self-fertilization	NATURE			English	Article							CAENORHABDITIS-ELEGANS; INBREEDING DEPRESSION; SEX DETERMINATION; SELECTION; ADVANTAGE; GENE; EXTINCTION; EVOLUTION; MALES	The tendency of organisms to reproduce by cross-fertilization despite numerous disadvantages relative to self-fertilization is one of the oldest puzzles in evolutionary biology. For many species, the primary obstacle to the evolution of outcrossing is the cost of production of males(1), individuals that do not directly contribute offspring and thus diminish the long-term reproductive output of a lineage. Self-fertilizing ('selfing') organisms do not incur the cost of males and therefore should possess at least a twofold numerical advantage over most outcrossing organisms(2). Two competing explanations for the widespread prevalence of outcrossing in nature despite this inherent disadvantage are the avoidance of inbreeding depression generated by selfing(3-5) and the ability of outcrossing populations to adapt more rapidly to environmental change(1,6,7). Here we show that outcrossing is favoured in populations of Caenorhabditis elegans subject to experimental evolution both under conditions of increased mutation rate and during adaptation to a novel environment. In general, fitness increased with increasing rates of outcrossing. Thus, each of the standard explanations for the maintenance of outcrossing are correct, and it is likely that outcrossing is the predominant mode of reproduction inmost species because it is favoured under ecological conditions that are ubiquitous in natural environments.	[Morran, Levi T.; Parmenter, Michelle D.; Phillips, Patrick C.] 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Phillips, PC (corresponding author), 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	pphil@uoregon.edu		Phillips, Patrick/0000-0001-7271-342X	NSF [DEB-0236180, DEB-0710386, DEB-0641066]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank S. Scholz, A. Ohdera and J. Chiem for logistical help, S. Katz for providing the S. marcescens 2170 strain, and J. Thornton for use of laboratory space and equipment. We also thank B. Cresko, C. Lively, J. Thornton and the members of the Phillips and Cresko laboratories for comments and discussion pertaining to this work. Funding was provided by NSF grants DEB-0236180, DEB-0710386 and DEB-0641066, and an NIH Genetics Fellowship awarded to L. T. M. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; BARTON NH, 1995, GENETICS, V140, P821; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chasnov JR, 2002, GENETICS, V160, P983; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW JF, 1992, J HERED, V83, P169, DOI 10.1093/oxfordjournals.jhered.a111187; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; Estes S, 2004, GENETICS, V166, P1269, DOI 10.1534/genetics.166.3.1269; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Heller J., 1979, GENET RES, V8, P269; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LIVELY CM, 1990, AM NAT, V135, P489, DOI 10.1086/285058; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-125; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; MAYNARD SMITH J., 1978, EVOLUTION SEX; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; SCHEDL T, 1988, GENETICS, V119, P43; Schultz ST, 1997, EVOLUTION, V51, P1363, DOI [10.1111/j.1558-5646.1997.tb01459.x, 10.2307/2411188]; Sivasundar A, 2003, GENETICS, V163, P147; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stewart AD, 2002, GENETICS, V160, P975; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	30	150	152	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					350	352		10.1038/nature08496	http://dx.doi.org/10.1038/nature08496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19847164	Green Accepted			2022-12-28	WOS:000271899300044
J	Cremers, FPM; Collin, RWJ				Cremers, Frans P. M.; Collin, Rob W. J.			Promises and challenges of genetic therapy for blindness	LANCET			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; VISION; MUTATIONS; SCID-X1; MODEL; ROD		[Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	F.Cremers@antrg.umcn.nl	Cremers, Frans/A-5625-2014; Collin, Rob/N-3575-2014	Cremers, Frans/0000-0002-4954-5592; 				Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Yzer S, 2003, J MED GENET, V40, P709, DOI 10.1136/jmg.40.9.709	12	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 7	2009	374	9701					1569	1570		10.1016/S0140-6736(09)61869-9	http://dx.doi.org/10.1016/S0140-6736(09)61869-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19854500				2022-12-28	WOS:000271674600004
J	Kenter, GG; Welters, MJP; Valentijn, ARPM; Lowik, MJG; Berends-van der Meer, DMA; Vloon, APG; Essahsah, F; Fathers, LM; Offringa, R; Drijfhout, JW; Wafelman, AR; Oostendorp, J; Fleuren, GJ; van der Burg, SH; Melief, CJM				Kenter, Gemma G.; Welters, Marij J. P.; Valentijn, A. Rob P. M.; Lowik, Margriet J. G.; Berends-van der Meer, Dorien M. A.; Vloon, Annelies P. G.; Essahsah, Farah; Fathers, Lorraine M.; Offringa, Rienk; Drijfhout, Jan Wouter; Wafelman, Amon R.; Oostendorp, Jaap; Fleuren, Gert Jan; van der Burg, Sjoerd H.; Melief, Cornelis J. M.			Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER PATIENTS; CHRONIC VIRAL-INFECTION; T-HELPER IMMUNITY; LONG PEPTIDES; THERAPEUTIC VACCINATION; NATURAL-HISTORY; CD4+T-CELL IMMUNITY; GRADE-III; E6	Background: Vulvar intraepithelial neoplasia is a chronic disorder caused by high-risk types of human papillomavirus (HPV), most commonly HPV type 16 (HPV-16). Spontaneous regression occurs in less than 1.5% of patients, and the rate of recurrence after treatment is high. Methods: We investigated the immunogenicity and efficacy of a synthetic long-peptide vaccine in women with HPV-16-positive, high-grade vulvar intraepithelial neoplasia. Twenty women with HPV-16-positive, grade 3 vulvar intraepithelial neoplasia were vaccinated three or four times with a mix of long peptides from the HPV-16 viral oncoproteins E6 and E7 in incomplete Freund's adjuvant. The end points were clinical and HPV-16-specific T-cell responses. Results: The most common adverse events were local swelling in 100% of the patients and fever in 64% of the patients; none of these events exceeded grade 2 of the Common Terminology Criteria for Adverse Events of the National Cancer Institute. At 3 months after the last vaccination, 12 of 20 patients (60%; 95% confidence interval [CI], 36 to 81) had clinical responses and reported relief of symptoms. Five women had complete regression of the lesions, and HPV-16 was no longer detectable in four of them. At 12 months of follow-up, 15 of 19 patients had clinical responses (79%; 95% CI, 54 to 94), with a complete response in 9 of 19 patients (47%; 95% CI, 24 to 71). The complete-response rate was maintained at 24 months of follow-up. All patients had vaccine-induced T-cell responses, and post hoc analyses suggested that patients with a complete response at 3 months had a significantly stronger interferon-(gamma)-associated proliferative CD4+ T-cell response and a broad response of CD8+ interferon-(gamma) T cells than did patients without a complete response. Conclusions: Clinical responses in women with HPV-16-positive, grade 3 vulvar intraepithelial neoplasia can be achieved by vaccination with a synthetic long-peptide vaccine against the HPV-16 oncoproteins E6 and E7. Complete responses appear to be correlated with induction of HPV-16-specific immunity. N Engl J Med 2009;361:1838-47.	[Kenter, Gemma G.; Lowik, Margriet J. G.; Berends-van der Meer, Dorien M. A.] Leiden Univ, Med Ctr, Dept Gynecol, NL-2300 RC Leiden, Netherlands; [Welters, Marij J. P.; Vloon, Annelies P. G.; Essahsah, Farah; Offringa, Rienk; Drijfhout, Jan Wouter; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Valentijn, A. Rob P. M.; Fathers, Lorraine M.; Wafelman, Amon R.; Oostendorp, Jaap] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RC Leiden, Netherlands; [Fleuren, Gert Jan] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands; [Essahsah, Farah; Melief, Cornelis J. M.] ISA Pharmaceut, Bilthoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kenter, GG (corresponding author), Leiden Univ, Med Ctr, Dept Gynecol, Mailbox 9600, NL-2300 RC Leiden, Netherlands.	g.g.kenter@lumc.nl	Drijfhout, Jan Wouter/ABA-6318-2021; van der Burg, Sjoerd H/T-1875-2017; Kenter, Gemma/B-3132-2012	Drijfhout, Jan Wouter/0000-0003-4808-5296; van der Burg, Sjoerd H/0000-0002-6556-0354; Kenter, Gemma/0000-0002-7284-3918	Dutch Cancer Society [RUL 2000-2200]; European Union Integrated Project Cancer Immunotherapy [LSHC-CT-2006-518234]; European Union Network of Excellence DC-THERA [LSHB-CT-2004-512074]; ISA Pharmaceuticals	Dutch Cancer Society(KWF Kankerbestrijding); European Union Integrated Project Cancer Immunotherapy; European Union Network of Excellence DC-THERA; ISA Pharmaceuticals	Supported by grants from the Dutch Cancer Society (RUL 2000-2200), the European Union Integrated Project Cancer Immunotherapy (LSHC-CT-2006-518234), the European Union Network of Excellence DC-THERA (LSHB-CT-2004-512074), and ISA Pharmaceuticals. This study was conducted by the Leiden University Medical Center (LUMC), which holds a patent on the use of synthetic long peptides as vaccine ( U. S. patent number 7,202,034). The LUMC does not share the financial benefit from this patent with its employees. ISA Pharmaceuticals, a biotechnology company, has licensed the patent from the LUMC.	Baldwin PJ, 2003, CLIN CANCER RES, V9, P5205; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BUSCEMA J, 1988, OBSTET GYNECOL, V71, P601; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Davidson EJ, 2003, CANCER RES, V63, P6032; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; de Jong A, 2002, CANCER RES, V62, P472; Frazer IH, 2004, VACCINE, V23, P172, DOI 10.1016/j.vaccine.2004.05.013; Herod JJO, 1996, BRIT J OBSTET GYNAEC, V103, P446, DOI 10.1111/j.1471-0528.1996.tb09771.x; HORDING U, 1995, GYNECOL ONCOL, V56, P276, DOI 10.1006/gyno.1995.1046; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Insinga RP, 2008, CANCER EPIDEM BIOMAR, V17, P1611, DOI 10.1158/1055-9965.EPI-07-2922; Jones RW, 2005, OBSTET GYNECOL, V106, P1319, DOI 10.1097/01.AOG.0000187301.76283.7f; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Nakagawa M, 1997, J INFECT DIS, V175, P927, DOI 10.1086/513992; Nimako M, 1997, CANCER RES, V57, P4855; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Smyth LJC, 2004, CLIN CANCER RES, V10, P2954, DOI 10.1158/1078-0432.CCR-03-0703; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; TIEBEN LM, 1993, J VIROL METHODS, V42, P265, DOI 10.1016/0166-0934(93)90038-S; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; van der Burg SH, 2001, INT J CANCER, V91, P612, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; van Seters M, 2005, GYNECOL ONCOL, V97, P645, DOI 10.1016/j.ygyno.2005.02.012; van Seters M, 2008, NEW ENGL J MED, V358, P1465, DOI 10.1056/NEJMoa072685; van Steenwijk PJD, 2008, CLIN CANCER RES, V14, P7188, DOI 10.1158/1078-0432.CCR-08-0994; VANBEURDEN M, 1995, CANCER, V75, P2879, DOI 10.1002/1097-0142(19950615)75:12<2879::AID-CNCR2820751214>3.0.CO;2-W; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Welters MJP, 2003, CANCER RES, V63, P636; Zajac AJ, 1998, CURR OPIN IMMUNOL, V10, P444, DOI 10.1016/S0952-7915(98)80119-2; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	36	752	808	5	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1838	1847		10.1056/NEJMoa0810097	http://dx.doi.org/10.1056/NEJMoa0810097			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890126				2022-12-28	WOS:000271405800008
J	Nojiri, M; Koteishi, H; Nakagami, T; Kobayashi, K; Inoue, T; Yamaguchi, K; Suzuki, S				Nojiri, Masaki; Koteishi, Hiroyasu; Nakagami, Takuya; Kobayashi, Kazuo; Inoue, Tsuyoshi; Yamaguchi, Kazuya; Suzuki, Shinnichiro			Structural basis of inter-protein electron transfer for nitrite reduction in denitrification	NATURE			English	Article							X-RAY-STRUCTURE; CYTOCHROME-C; ALCALIGENES-XYLOSOXIDANS; PSEUDOMONAS-AERUGINOSA; TRANSFER COMPLEX; CRYSTAL-STRUCTURE; REDOX PROPERTIES; MOLECULAR-BASIS; COPPER; ACHROMOBACTER	Recent earth science studies have pointed out that massive acceleration of the global nitrogen cycle by anthropogenic addition of bio-available nitrogen has led to a host of environmental problems(1). Nitrous oxide (N2O) is a greenhouse gas that is an intermediate during the biological process known as denitrification(2). Copper-containing nitrite reductase (CuNIR) is a key enzyme in the process; it produces a precursor for N2O by catalysing the one-electron reduction of nitrite (NO2-) to nitric oxide (NO)(3). The reduction step is performed by an efficient electron-transfer reaction with a redox-partner protein(4-6). However, details of the mechanism during the electron-transfer reaction are still unknown. Here we show the high-resolution crystal structure of the electron-transfer complex for CuNIR with its cognate cytochrome c as the electron donor. The hydrophobic electron-transfer path is formed at the docking interface by desolvation owing to close contact between the two proteins. Structural analysis of the interface highlights an essential role for the loop region with a hydrophobic patch for protein-protein recognition; it also shows how interface construction allows the variation in atomic components to achieve diverse biological electron transfers.	[Nojiri, Masaki; Koteishi, Hiroyasu; Nakagami, Takuya; Yamaguchi, Kazuya; Suzuki, Shinnichiro] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Kobayashi, Kazuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Dept Chem Mat, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Nojiri, M (corresponding author), Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan.	nojiri@ch.wani.osaka-u.ac.jp; bic@ch.wani.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012; Koteishi, Hiroyasu/AAU-8752-2020	Kobayashi, Kazuo/0000-0002-5586-9112; Koteishi, Hiroyasu/0000-0001-5115-0963	Ministry of Education, Culture, Sports, Science and Technology of Japan [20750137]; Sumitomo Foundation;  [20350078]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; 	We thank A. Nakagawa, M. Suzuki, M. Yoshimura and E. Yamashita (beamline 44XU at SPring-8) for their support in the collection of X-ray data (proposal numbers 2007A6918 and 2007B6918, to M. N.). This work was supported in part byGrants-in-Aids for Scientific Research 20350078 (to S. S.) and Encouragement of Young Scientists 20750137 (to M. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant for Basic Science Research Projects from the Sumitomo Foundation (to M. N.).	Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bueno Emilio, 2008, FEMS Microbiol Lett, V279, P188, DOI 10.1111/j.1574-6968.2007.01034.x; Canters GW, 2000, FARADAY DISCUSS, V116, P205, DOI 10.1039/b003822i; COYNE MS, 1989, APPL ENVIRON MICROB, V55, P2924, DOI 10.1128/AEM.55.11.2924-2931.1989; Deligeer, 2000, B CHEM SOC JPN, V73, P1839, DOI 10.1246/bcsj.73.1839; DODD FE, 1995, BIOCHEMISTRY-US, V34, P10180, DOI 10.1021/bi00032a011; Ellis MJ, 2003, J MOL BIOL, V328, P429, DOI 10.1016/S0022-2836(03)00308-5; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferguson Stuart J., 2004, V16, P169; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; GLOCKNER AB, 1993, ARCH MICROBIOL, V160, P18; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hasegawa N, 2001, BIOCHEM BIOPH RES CO, V288, P1223, DOI 10.1006/bbrc.2001.5919; IWASAKI H, 1986, PLANT CELL PHYSIOL, V27, P733; Kataoka K, 2004, J BIOL CHEM, V279, P53374, DOI 10.1074/jbc.M410198200; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; Kukimoto M, 1996, FEBS LETT, V394, P87, DOI 10.1016/0014-5793(96)00934-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MASUKO M, 1984, J BIOCHEM, V96, P447, DOI 10.1093/oxfordjournals.jbchem.a134856; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyashita O, 2003, BIOCHEMISTRY-US, V42, P11651, DOI 10.1021/bi0350250; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; SUZUKI H, 1962, J BIOCHEM-TOKYO, V52, P193, DOI 10.1093/oxfordjournals.jbchem.a127596; Suzuki S, 1997, J BIOL INORG CHEM, V2, P265, DOI 10.1007/s007750050132; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vijgenboom E, 1997, MICROBIOL-SGM, V143, P2853, DOI 10.1099/00221287-143-9-2853; Vlasie MD, 2008, J MOL BIOL, V375, P1405, DOI 10.1016/j.jmb.2007.11.056; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; Zhu ZY, 1998, BIOCHEMISTRY-US, V37, P17128, DOI 10.1021/bi9817919; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	43	80	82	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					117	U132		10.1038/nature08507	http://dx.doi.org/10.1038/nature08507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890332				2022-12-28	WOS:000271419200044
J	Yanai, H; Ban, T; Wang, ZC; Choi, MK; Kawamura, T; Negishi, H; Nakasato, M; Lu, Y; Hangai, S; Koshiba, R; Savitsky, D; Ronfani, L; Akira, S; Bianchi, ME; Honda, K; Tamura, T; Kodama, T; Taniguchi, T				Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Kawamura, Takeshi; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Ronfani, Lorenza; Akira, Shizuo; Bianchi, Marco E.; Honda, Kenya; Tamura, Tomohiko; Kodama, Tatsuhiko; Taniguchi, Tadatsugu			HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses	NATURE			English	Article							RIG-I; CYTOSOLIC DNA; RNA; RECOGNITION; CELLS; INDUCTION; ACTIVATION; FAMILY; MEMBER	The activation of innate immune responses by nucleic acids is crucial to protective and pathological immunities and is mediated by the transmembrane Toll-like receptors (TLRs) and cytosolic receptors(1,2). However, it remains unknown whether a mechanism exists that integrates these nucleic-acid-sensing systems. Here we show that high-mobility group box (HMGB) proteins 1, 2 and 3 function as universal sentinels for nucleic acids. HMGBs bind to all immunogenic nucleic acids examined with a correlation between affinity and immunogenic potential. Hmgb1(-/-) and Hmgb2(-/-) mouse cells are defective in type-I interferon and inflammatory cytokine induction by DNA or RNA targeted to activate the cytosolic nucleic-acid-sensing receptors; cells in which the expression of all three HMGBs is suppressed show a more profound defect, accompanied by impaired activation of the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor (NF)-kappa B. The absence of HMGBs also severely impairs the activation of TLR3, TLR7 and TLR9 by their cognate nucleic acids. Our results therefore indicate a hierarchy in the nucleic-acid-mediated activation of immune responses, wherein the selective activation of nucleic-acid-sensing receptors is contingent on the more promiscuous sensing of nucleic acids by HMGBs. These findings may have implications for understanding the evolution of the innate immune system and for the treatment of immunological disorders.	[Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Honda, Kenya; Tamura, Tomohiko; Taniguchi, Tadatsugu] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Honda, Kenya; Tamura, Tomohiko; Taniguchi, Tadatsugu] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamura, Takeshi; Kodama, Tatsuhiko] Univ Tokyo, RCAST, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Ronfani, Lorenza; Bianchi, Marco E.] San Raffaele Univ, Fac Med, I-20132 Milan, Italy; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Vita-Salute San Raffaele University; Osaka University	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Akira, Shizuo/C-3134-2009; Honda, Kenya/N-5297-2015; Ronfani, Lorenza/AAN-7807-2020; Yanai, Hideyuki/AGK-5933-2022; Bianchi, Marco Emilio/K-3417-2018	Yanai, Hideyuki/0000-0002-0115-9000; Bianchi, Marco Emilio/0000-0002-5329-6445; Ronfani, Lorenza/0000-0002-4602-3502; Hangai, Sho/0000-0003-3657-9731	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Korea Science and Engineering Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank C. Reis e Sousa and J. Rehwinkel for 59-triphosphate RNA;, Y. Kawaguchi for HSV-1 DNA; A. Katoh and M. Kidokoro for the vaccinia virus (MO) genome for ligand stimulation; J. Vilcek, R. Medzhitov, R. Schekman, J. V. Ravetch and H. Ohno for invaluable advice; and R. Takeda, M. Shishido, Y. Nakaima and T. Oh for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas 'Integrative Research Toward the Conquest of Cancer,' Grant-in-Aid for Scientific Research (A), and Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Korea Science and Engineering Foundation Grant. T. B. and Z. W. are research fellows of the Japan Society for the Promotion of Science.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOI MK, 2009, P NATL ACAD SCI 1001, P1, DOI DOI 10.1073/PNAS.0910983106; Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	33	471	505	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					99	U110		10.1038/nature08512	http://dx.doi.org/10.1038/nature08512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890330				2022-12-28	WOS:000271419200040
J	Kennedy, AR; Klett, J; Mulvey, RE; Wright, DS				Kennedy, Alan R.; Klett, Jan; Mulvey, Robert E.; Wright, Dominic S.			Synergic Sedation of Sensitive Anions: Alkali-Mediated Zincation of Cyclic Ethers and Ethene	SCIENCE			English	Article							DEPROTONATIVE METALATION; MAGNESIUM; METALS; BASES; ARYL	Deprotonation of alkyl and vinyl carbon-hydrogen bonds for synthetic purposes is often hindered not merely by the need for an exceptionally strong base, but by the inherent instability of the resultant anion. Metalation of cyclic ethers adjacent to oxygen, for example, has invariably initiated a ring-opening decomposition pathway. Here, we show that the use of a bimetallic base can overcome such instability through a cooperative combination of zinc-carbon and sodium-oxygen bonding. Both tetrahydrofuran and tetrahydropyran reacted cleanly over days at room temperature to yield alpha-zinc-substituted products that were sufficiently stable to be isolated and crystallographically characterized. A related zincation-anion trapping strategy, with sodium replaced by potassium, induced clean deprotonation of ethene to yield a stable product. Preliminary electrophilic quenching experiments with the alpha-zinc-substituted cyclic ethers and benzoyl chloride gave satisfactory yields of the tetrahydrofuran-derived ketone but only trace amounts of the tetrahydropyran-derived ketone.	[Kennedy, Alan R.; Klett, Jan; Mulvey, Robert E.] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland; [Wright, Dominic S.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Strathclyde; University of Cambridge	Mulvey, RE (corresponding author), Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland.	r.e.mulvey@strath.ac.uk	Kennedy, Alan/I-7084-2012; Mulvey, Robert E/M-4106-2014; Klett, Jan/B-8036-2012	Mulvey, Robert E/0000-0002-1015-2564; 	UK Engineering and Physical Sciences Research Council [EP/F0637/1]; Royal Society/Wolfson Foundation; EPSRC [EP/E036244/1, EP/D076889/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E036244/1, EP/D076889/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society/Wolfson Foundation(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are indebted to the UK Engineering and Physical Sciences Research Council for financial support (through grant award EP/F0637/1) and the Royal Society/Wolfson Foundation for a research merit award (to R. E. M.). K. W. Klinkhammer, E. Hevia, and C. O'Hara are also thanked for their valuable input through many discussions. Metrical data for 1, 2, 3, and 5 are freely available from the Cambridge Crystallographic Database Center (CCDC) (codes 735270 to 735273).	Andrikopoulos PC, 2005, ANGEW CHEM INT EDIT, V44, P3459, DOI 10.1002/anie.200500379; BATES RB, 1972, J ORG CHEM, V37, P560, DOI 10.1021/jo00969a007; BAUER W, 1992, J CHEM SOC CHEM COMM, P903, DOI 10.1039/c39920000903; BRANDSMA L, 1986, J CHEM SOC CHEM COMM, P260, DOI 10.1039/c39860000260; Clayden J, 2002, NEW J CHEM, V26, P191, DOI 10.1039/b109604d; Clayden J., 2002, ORGANOLITHIUMS SELEC; Clegg W, 2009, J AM CHEM SOC, V131, P2375, DOI 10.1021/ja8087168; ENHOLM EJ, 1995, J HETEROCYCLIC CHEM, V32, P109, DOI 10.1002/jhet.5570320119; Green T. W., 1999, PROTECTIVE GROUPS OR, V3rd; Kondo Y, 1999, J AM CHEM SOC, V121, P3539, DOI 10.1021/ja984263t; Krasovskiy A, 2006, ANGEW CHEM INT EDIT, V45, P2958, DOI 10.1002/anie.200504024; MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721; MCCOY M, 2008, CHEM ENG NEWS, V86, P61; MORTON AA, 1950, J AM CHEM SOC, V72, P3785, DOI 10.1021/ja01164a125; MOWAT W, 1972, J CHEM SOC DALTON, P533, DOI 10.1039/dt9720000533; Mulvey RE, 2006, ORGANOMETALLICS, V25, P1060, DOI 10.1021/om0510223; Mulvey RE, 2007, ANGEW CHEM INT EDIT, V46, P3802, DOI 10.1002/anie.200604369; Mulvey RE, 2009, ACCOUNTS CHEM RES, V42, P743, DOI 10.1021/ar800254y; Nobutc D, 2008, J ORG CHEM, V73, P1117, DOI 10.1021/jo701895z; Schlosser M., 2002, ORGANOMETALLICS SYNT; Seyferth D, 2009, ORGANOMETALLICS, V28, P2, DOI 10.1021/om801047n; STREITWIESER A, 1978, J AM CHEM SOC, V100, P755, DOI 10.1021/ja00471a016	22	115	114	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					706	708		10.1126/science.1178165	http://dx.doi.org/10.1126/science.1178165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900927				2022-12-28	WOS:000271233200031
J	Nilius, B				Nilius, Bernd			Polycystins under Pressure	CELL			English	Editorial Material							CHANNELS		Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium	KU Leuven	Nilius, B (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium.	bernd.nilius@med.kuleuven.be						Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hill MA, 2009, TRENDS PHARMACOL SCI, V30, P363, DOI 10.1016/j.tips.2009.04.008; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006	6	8	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					466	467		10.1016/j.cell.2009.10.009	http://dx.doi.org/10.1016/j.cell.2009.10.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879836	Bronze, Green Published			2022-12-28	WOS:000271259600012
J	Glass, RI; Parashar, UD; Estes, MK				Glass, Roger I.; Parashar, Umesh D.; Estes, Mary K.			CURRENT CONCEPTS Norovirus Gastroenteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NORWALK VIRUS-INFECTION; BLOOD GROUP ANTIGENS; REVERSE TRANSCRIPTION-PCR; HUMAN CALICIVIRUS; IMMUNE-RESPONSES; SPORADIC GASTROENTERITIS; VIRAL GASTROENTERITIS; UNITED-STATES; FECAL SAMPLES; CHILDREN		[Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Glass, Roger I.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Centers for Disease Control & Prevention - USA; Baylor College of Medicine	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 31 Ctr Dr,Rm 31 B2 C02, Bethesda, MD 20892 USA.				National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (to Dr. Estes).	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842; ATMAR RL, 1995, APPL ENVIRON MICROB, V61, P3014, DOI 10.1128/AEM.61.8.3014-3018.1995; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Baert L, 2009, EPIDEMIOL INFECT, V137, P316, DOI 10.1017/S0950268808001830; Ball JM, 1999, GASTROENTEROLOGY, V117, P40, DOI 10.1016/S0016-5085(99)70548-2; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Bon F, 1999, J CLIN MICROBIOL, V37, P3055, DOI 10.1128/JCM.37.9.3055-3058.1999; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chen SY, 2009, CLIN INFECT DIS, V48, P849, DOI 10.1086/597256; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Daniels NA, 2000, J INFECT DIS, V181, P1467, DOI 10.1086/315365; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Dolin R, 2007, NEW ENGL J MED, V357, P1072, DOI 10.1056/NEJMp078050; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Food Standards Agency, 2000, REP STUD INF INT DIS; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Gray JJ, 2007, CLIN VACCINE IMMUNOL, V14, P1349, DOI 10.1128/CVI.00214-07; Guerrero RA, 2001, J VIROL, V75, P9713, DOI 10.1128/JVI.75.20.9713-9722.2001; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AE, 2005, J MED VIROL, V77, P455, DOI 10.1002/jmv.20475; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Khan RR, 2009, J PEDIATR GASTR NUTR, V48, P328, DOI 10.1097/MPG.0b013e31818255cc; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Le Guyader FS, 2004, INT J FOOD MICROBIOL, V97, P179, DOI 10.1016/j.ijfoodmicro.2004.04.018; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; LEVY AG, 1976, GASTROENTEROLOGY, V70, P321; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; MEEROFF JC, 1980, ANN INTERN MED, V92, P370, DOI 10.7326/0003-4819-92-3-370; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Nayak MK, 2008, VIROLOGY, V377, P117, DOI 10.1016/j.virol.2008.04.027; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; O'Ryan ML, 2000, J INFECT DIS, V182, P1519, DOI 10.1086/315874; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Ozawa K, 2007, J CLIN MICROBIOL, V45, P3996, DOI 10.1128/JCM.01516-07; Pang XL, 1999, PEDIATR INFECT DIS J, V18, P420, DOI 10.1097/00006454-199905000-00005; Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Periwal SB, 2003, VACCINE, V21, P376, DOI 10.1016/S0264-410X(02)00618-7; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; WIDDOWSON MA, 2004, J INFECT DIS, V190, P2198; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yee EL, 2007, CLIN INFECT DIS, V44, P1032, DOI 10.1086/512195	67	763	825	1	209	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1776	1785		10.1056/NEJMra0804575	http://dx.doi.org/10.1056/NEJMra0804575			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864676	Green Accepted			2022-12-28	WOS:000271185600010
J	Landovitz, RJ; Currier, JS				Landovitz, Raphael J.; Currier, Judith S.			Postexposure Prophylaxis for HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE WORKERS; ACUTE HEPATITIS-C; OCCUPATIONAL-EXPOSURE; HOMOSEXUAL-MEN; TENOFOVIR DF; LAMIVUDINE; SEROCONVERSION; ZIDOVUDINE; TRANSMISSION	A 24-year-old man presents to an outpatient clinic, reporting that 36 hours previously he had receptive anal intercourse without the use of a condom with an anonymous male partner who was known to have had sex with other men. The patient is known to the clinical practice and has had several negative tests for human immunodeficiency virus (HIV) infection, most recently 6 months previously. How should he be evaluated and treated?	[Landovitz, Raphael J.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Clin AIDS Res & Educ, Los Angeles, CA 90035 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Landovitz, RJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Clin AIDS Res & Educ, 9911 W Pico Blvd,Suite 980, Los Angeles, CA 90035 USA.	rlandovitz@mednet.ucla.edu		Landovitz, Raphael/0000-0002-1442-714X	Tibotec; Schering-Plough; Theratechnologies; Merck	Tibotec; Schering-Plough(Merck & CompanySchering Plough Corporation); Theratechnologies; Merck(Merck & Company)	Dr. Landovitz reports receiving lecture fees from an independent continuing-medical-education company that received support from Pfizer; and Dr. Currier, serving on paid advisory boards for Merck, Pfizer, Bristol-Myers Squibb Virology, and Tibotec and receiving consulting fees from GlaxoSmithKline, lecture fees from GlaxoSmithKline Italy, and grant support to the University of California at Los Angeles from Tibotec, Schering-Plough, Theratechnologies, and Merck. No other potential conflict of interest relevant to the article was reported.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; [Anonymous], ANT POST PROPH SEX I; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; Bessesen M, 1999, CLIN INFECT DIS, V28, P1032, DOI 10.1086/514750; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; *BROWN U AIDS PROG, 2002, NON HUM IMM VIR POST; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; *CA DEP HLTH SERV, 2004, OFF HIV POST PROPH P; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Centers for Disease Control and Prevention, 2001, UPD US PUBL HLTH SER; Centers for Disease Control and Prevention, 2005, UPD US PUBL HLTH SER; *DEP HLTH HUM SERV, 2008, GUID US ANT AG HIV 1; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; GAINES H, 1987, LANCET, V1, P1249; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Ippolito G, 1999, CLIN INFECT DIS, V28, P365, DOI 10.1086/515101; IPPOLITO G, 1993, ARCH INTERN MED, V153, P1451, DOI 10.1001/archinte.153.12.1451; Joint United Nations Programme on HIV/AIDS, REP GLOB AIDS EP; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; KAPLAN EH, 1995, J ACQ IMMUN DEF SYND, V10, P175, DOI 10.1097/00042560-199510020-00010; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; LAFON SW, 1990, 30TH INT C ANT AG CH, P167; LENNOX J, 2008, 48 INT C ANT AG CHEM; LIFSON AR, 1990, AM J PUBLIC HEALTH, V80, P1509, DOI 10.2105/AJPH.80.12.1509; MARLINK RG, 1986, NEW ENGL J MED, V315, P1549; Martin JN, 2004, AIDS, V18, P787, DOI 10.1097/00002030-200403260-00010; Mayer K, 2009, 5 IAS C HIV PATH TRE; Mayer KH, 2008, JAIDS-J ACQ IMM DEF, V47, P494, DOI 10.1097/QAI.0b013e318162afcb; Mechai F, 2008, J MED VIROL, V80, P9, DOI 10.1002/jmv.21000; *NY STAT DEP AIDS, 2004, HIV PROPH FOLL NON E; *NY STAT DEP HLTH, 2008, HIV PROPH FOLL OCC E; *OCC SAF HLTH ADM, 2009, BLOODB PATH NEEDL PR; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Patel SM, 2004, JAIDS-J ACQ IMM DEF, V35, P120, DOI 10.1097/00126334-200402010-00003; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Prada N, 2008, JAIDS-J ACQ IMM DEF, V49, P117, DOI 10.1097/QAI.0b013e3181869a9b; Puro V, 2001, J BIOL REG HOMEOS AG, V15, P238; ROLAND M, 2006, P 13 C RETR OPP INF; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Roland ME, 2004, J INFECT DIS, V190, P598, DOI 10.1086/421278; ROZENBAUM W, 1988, LANCET, V1, P1395; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Shoptaw S, 2008, AIDS CARE, V20, P376, DOI 10.1080/09540120701660353; Siegel MO, 2008, AIDS, V22, P2552, DOI 10.1097/QAD.0b013e328318f184; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; World Health Organization & International Labour Organization, 2007, POSTE PROPH PREV HIV; 2001, MMWR MORB MORTAL WKL, V49, P1153; 2007, MMWR MORB MORTAL WKL, V56, P1291	57	50	53	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1768	1775		10.1056/NEJMcp0904189	http://dx.doi.org/10.1056/NEJMcp0904189			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864675				2022-12-28	WOS:000271185600009
J	MacLeod, A				MacLeod, Alison			NCEPOD report on acute kidney injury-must do better	LANCET			English	Editorial Material									Univ Aberdeen, Sch Med, Aberdeen AB25 2ZG, Scotland	University of Aberdeen	MacLeod, A (corresponding author), Univ Aberdeen, Sch Med, Foresterhill, Aberdeen AB25 2ZG, Scotland.	mmd175@abdn.ac.uk						Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; ANSELL D, 2008, UK RENAL REGISTRY UK; FEEHALLY J, VIEW UK NEPHROLOGY B; *KDIGO, 2008, KIDN DIS IMPR GLOB O; National Institute for Health and Clinical Excellence, 2008, EARL ID MAN CHRON KI; NICE, 2007, AC ILL PAT HOSP; NIVET H, 2002, DEMOGRAPHY FRENCH NE; Stewart J, 2009, ADDING INSULT INJURY	8	45	51	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1405	1406		10.1016/S0140-6736(09)61843-2	http://dx.doi.org/10.1016/S0140-6736(09)61843-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19854359				2022-12-28	WOS:000271255000010
J	Katayama, I; Hirauchi, H; Michibayashi, K; Ando, J				Katayama, Ikuo; Hirauchi, Ken-ichi; Michibayashi, Katsuyoshi; Ando, Jun-ichi			Trench-parallel anisotropy produced by serpentine deformation in the hydrated mantle wedge	NATURE			English	Article							P-WAVE VELOCITY; SEISMIC ANISOTROPY; NORTHEASTERN JAPAN; FABRIC TRANSITIONS; SUBDUCTION; OLIVINE; BENEATH; SHEAR; FLOW; ARC	Seismic anisotropy is a powerful tool for detecting the geometry and style of deformation in the Earth's interior, as it primarily reflects the deformation-induced preferred orientation of anisotropic crystals(1,2). Although seismic anisotropy in the uppermantle is generally attributed to the crystal-preferred orientation of olivine(3), the strong trench-parallel anisotropy (delay time of one to two seconds) observed in several subduction systems(4,5) is difficult to explain in terms of olivine anisotropy, even if the entire mantle wedge were to act as an anisotropic source. Here we show that the crystal-preferred orientation of serpentine, the main hydrous mineral in the upper mantle, can produce the strong trench-parallel seismic anisotropy observed in subduction systems. High-pressure deformation experiments reveal that the serpentine c-axis tends to rotate to an orientation normal to the shear plane during deformation; consequently, seismic velocity propagating normal to the shear plane (plate interface) is much slower than that in other directions. The seismic anisotropy estimated for deformed serpentine aggregates is an order of magnitude greater than that for olivine(6), and therefore the alignment of serpentine in the hydrated mantle wedge results in a strong trench-parallel seismic anisotropy in the case of a steeply subducting slab. This hypothesis is also consistent with the presence of a hydrous phase in the mantle wedge, as inferred from anomalously low seismic-wave velocities(7).	[Katayama, Ikuo; Hirauchi, Ken-ichi; Ando, Jun-ichi] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [Michibayashi, Katsuyoshi] Shizuoka Univ, Inst Geosci, Shizuoka 4228529, Japan	Hiroshima University; Shizuoka University	Katayama, I (corresponding author), Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan.	katayama@hiroshima-u.ac.jp	Katayama, Ikuo/A-9611-2011	Michibayashi, Katsuyoshi/0000-0003-1845-7298	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank T. Watanabe and S. Karato for comments and discussions. We also thank D. Mainprice and A. Tommasi for providing the crystallographic data for serpentine. This study was supported by the Japan Society for the Promotion of Science (JSPS).	Abramson EH, 1997, J GEOPHYS RES-SOL EA, V102, P12253, DOI 10.1029/97JB00682; Ando J., 2006, JPN J STRUCT GEOL, V49, P27; Auzende AL, 2006, PHYS CHEM MINER, V33, P266, DOI 10.1007/s00269-006-0078-x; Behn MD, 2007, SCIENCE, V317, P108, DOI 10.1126/science.1141269; Buttles J, 1998, EARTH PLANET SC LETT, V164, P245, DOI 10.1016/S0012-821X(98)00211-8; Faccenda M, 2008, NATURE, V455, P1097, DOI 10.1038/nature07376; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; Hilairet N, 2007, SCIENCE, V318, P1910, DOI 10.1126/science.1148494; Hyndman RD, 2003, EARTH PLANET SC LETT, V212, P417, DOI 10.1016/S0012-821X(03)00263-2; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Katayama I, 2006, PHYS EARTH PLANET IN, V157, P33, DOI 10.1016/j.pepi.2006.03.005; Katayama I, 2009, GEOLOGY, V37, P211, DOI 10.1130/G25413A.1; Kern H, 1997, J GEOPHYS RES-SOL EA, V102, P3051, DOI 10.1029/96JB03392; Kneller EA, 2008, EARTH PLANET SC LETT, V268, P268, DOI 10.1016/j.epsl.2008.01.004; Kneller EA, 2007, NATURE, V450, P1222, DOI 10.1038/nature06429; Li C, 2006, PHYS EARTH PLANET IN, V154, P180, DOI 10.1016/j.pepi.2005.09.008; Long MD, 2008, SCIENCE, V319, P315, DOI 10.1126/science.1150809; Long MD, 2006, PHYS EARTH PLANET IN, V155, P300, DOI 10.1016/j.pepi.2006.01.003; Nakajima J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025053; Nakajima J, 2004, EARTH PLANET SC LETT, V225, P365, DOI 10.1016/j.epsl.2004.06.011; Nakajima J, 2001, J GEOPHYS RES-SOL EA, V106, P21843, DOI 10.1029/2000JB000008; Nicolas A., 1987, COMPOSITION STRUCTUR, P407; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Wang Z, 2008, TECTONOPHYSICS, V455, P1, DOI 10.1016/j.tecto.2008.03.004; Watanabe T, 2007, EARTH PLANETS SPACE, V59, P233, DOI 10.1186/BF03353100; Wiens DA, 2008, ANNU REV EARTH PL SC, V36, P421, DOI 10.1146/annurev.earth.33.092203.122633; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	27	176	185	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1114	U209		10.1038/nature08513	http://dx.doi.org/10.1038/nature08513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847262	Green Submitted			2022-12-28	WOS:000270987600042
J	Naito, K; Zhang, F; Tsukiyama, T; Saito, H; Hancock, CN; Richardson, AO; Okumoto, Y; Tanisaka, T; Wessler, SR				Naito, Ken; Zhang, Feng; Tsukiyama, Takuji; Saito, Hiroki; Hancock, C. Nathan; Richardson, Aaron O.; Okumoto, Yutaka; Tanisaka, Takatoshi; Wessler, Susan R.			Unexpected consequences of a sudden and massive transposon amplification on rice gene expression	NATURE			English	Article							NUCLEOSOME ORGANIZATION; ELEMENTS; INSERTION; GENOME; REGIONS; SYSTEM	High-copy-number transposable elements comprise the majority of eukaryotic genomes where they are major contributors to gene and genome evolution(1). However, it remains unclear how a host genome can survive a rapid burst of hundreds or thousands of insertions because such bursts are exceedingly rare in nature and therefore difficult to observe in real time(2). In a previous study we reported that in a few rice strains the DNA transposon mPing was increasing its copy number by similar to 40 per plant per generation(3). Here we exploit the completely sequenced rice genome to determine 1,664 insertion sites using high-throughput sequencing of 24 individual rice plants and assess the impact of insertion on the expression of 710 genes by comparative microarray analysis. We find that the vast majority of transposable element insertions either upregulate or have no detectable effect on gene transcription. This modest impact reflects a surprising avoidance of exon insertions by mPing and a preference for insertion into 5' flanking sequences of genes. Furthermore, we document the generation of new regulatory networks by a subset of mPing insertions that render adjacent genes stress inducible. As such, this study provides evidence for models first proposed previously(4-6) for the involvement of transposable elements and other repetitive sequences in genome restructuring and gene regulation.	[Naito, Ken; Zhang, Feng; Hancock, C. Nathan; Richardson, Aaron O.; Wessler, Susan R.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Naito, Ken; Tsukiyama, Takuji; Saito, Hiroki; Okumoto, Yutaka; Tanisaka, Takatoshi] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan	University System of Georgia; University of Georgia; Kyoto University	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	tanisaka@kais.kyoto-u.ac.jp; sue@plantbio.uga.edu	Hancock, Charles/AAA-5249-2020	Hancock, Charles Nathan/0000-0002-0875-8495; Naito, Ken/0000-0002-0273-7837	National Institute of Agrobiological Science in Japan [A123, A157]; NSF Plant Genome; University of Georgia Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institute of Agrobiological Science in Japan; NSF Plant Genome(National Science Foundation (NSF)); University of Georgia Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Rice Genome Resource Center for the use of the rice microarray system and Y. Nagamura and R. Motoyama for technical support; the GenBank project of the National Institute of Agrobiological Science in Japan for providing seeds of Gimbozu landraces (A123 and A157); and X. Zhang and C. Feschotte for critical discussions and reading of the manuscript. S. R. W. is funded by a NSF Plant Genome grant and the University of Georgia Research Foundation and T. Tanisaka by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arnold C, 1991, PCR Methods Appl, V1, P39; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CRESSE AD, 1995, GENETICS, V140, P315; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jiang N, 2002, GENETICS, V161, P1293; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McClintock B, 1944, GENETICS, V29, P478; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Monden Y, 2009, DNA RES, V16, P131, DOI 10.1093/dnares/dsp004; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Piffanelli P, 2007, PLANT MOL BIOL, V65, P587, DOI 10.1007/s11103-007-9222-3; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	30	322	334	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1130	U232		10.1038/nature08479	http://dx.doi.org/10.1038/nature08479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847266				2022-12-28	WOS:000270987600046
J	Pachauri, RK				Pachauri, Rajendra K.			India pushes for common responsibility	NATURE			English	Editorial Material												pachauri@teri.res.in						Pathak H, 2003, FIELD CROP RES, V80, P223, DOI 10.1016/S0378-4290(02)00194-6	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1054	1054		10.1038/4611054a	http://dx.doi.org/10.1038/4611054a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847243	Bronze			2022-12-28	WOS:000270987600018
J	Carney, RM; Freedland, KE; Rubin, EH; Rich, MW; Steinmeyer, BC; Harris, WS				Carney, Robert M.; Freedland, Kenneth E.; Rubin, Eugene H.; Rich, Michael W.; Steinmeyer, Brian C.; Harris, William S.			Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND; FISH-OIL; CARDIOVASCULAR-DISEASE; MAJOR DEPRESSION; RISK-FACTOR; OMEGA-3-FATTY-ACIDS; MORTALITY; ARRHYTHMIAS; CONSUMPTION	Context Studies of depressed psychiatric patients have shown that antidepressant efficacy can be increased by augmentation with omega-3 fatty acids. Objective To determine whether omega-3 improves the response to sertraline in patients with major depression and coronary heart disease (CHD). Design, Setting, and Participants Randomized controlled trial. Between May 2005 and December 2008, 122 patients in St Louis, Missouri, with major depression and CHD were randomized. Interventions After a 2-week run-in period, all patients were given 50 mg/d of sertraline and randomized in double-blind fashion to receive 2 g/d of omega-3 acid ethyl esters (930 mg of eicosapentaenoic acid [EPA] and 750 mg of docosahexaenoic acid [DHA]) (n=62) or to corn oil placebo capsules (n=60) for 10 weeks. Main Outcome Measures Scores on the Beck Depression Inventory (BDI-II) and the Hamilton Rating Scale for Depression (HAM-D). Results Adherence to the medication regimen was 97% or more in both groups for both medications. There were no differences in weekly BDI-II scores (treatment x time interaction=0.02; 95% confidence interval [CI], -0.33 to 0.36; t(112)=0.11; P=.91), pre-post BDI-II scores (placebo, 14.8 vs omega-3, 16.1; 95% difference-in-means CI, -4.5 to 2.0; t(116)=-0.77; P=.44), or HAM-D scores (placebo, 9.4 vs omega-3, 9.3; 95% difference-in-means CI, -2.2 to 2.4; t(115)=0.12; P=.90). The groups did not differ on predefined indicators of depression remission (BDI-II <= 8: placebo, 27.4% vs omega-3, 28.3%; odds ratio [OR], 0.96; 95% CI, 0.43-2.15; t(113)=-0.11; P=.91) or response (>50% reduction in BDI-II from baseline: placebo, 49.0% vs omega-3, 47.7%; OR, 1.06; 95% CI, 0.51-2.19; t(112)=0.15; P=.88). Conclusions Treatment of patients with CHD and major depression with sertraline and omega-3 fatty acids did not result in superior depression outcomes at 10 weeks, compared with sertraline and placebo. Whether higher doses of omega-3 or sertraline, a different ratio of EPA to DHA, longer treatment, or omega-3 monotherapy can improve depression in patients with CHD remains to be determined.	[Carney, Robert M.] Washington Univ, Sch Med, Dept Psychiat, Behav Med Ctr, St Louis, MO 63108 USA; [Harris, William S.] Univ S Dakota, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA	Washington University (WUSTL); University of South Dakota	Carney, RM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, Behav Med Ctr, 4320 Forest Pk Ave,Ste 301, St Louis, MO 63108 USA.	carneyr@bmc.wustl.edu	Harris, William Stephen/T-1674-2019; Rich, Michael/AAD-6167-2022	Harris, William Stephen/0000-0003-3042-9353; Rich, Michael/0000-0002-4243-9391	National Heart, Lung, and Blood Institute [RO1 HL076808-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076808] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grant RO1 HL076808-01A1 from the National Heart, Lung, and Blood Institute. GlaxoSmithKline Inc supplied omega-3 and placebo capsules and Pfizer Inc supplied sertraline.	Albert CM, 2008, AM HEART J, V155, P967, DOI 10.1016/j.ahj.2008.02.001; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Amin AA, 2008, PSYCHOSOM MED, V70, P856, DOI 10.1097/PSY.0b013e318188a01e; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Beck AT., 1990, BAI BECK ANXIETY INV; BECKER R, 1996, REV SCI INSTRUM, V67, P3; Block RC, 2008, ATHEROSCLEROSIS, V197, P821, DOI 10.1016/j.atherosclerosis.2007.07.042; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Carney RM, 2008, AM J MED, V121, P20, DOI 10.1016/j.amjmed.2008.09.010; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; FABRE LF, 1995, BIOL PSYCHIAT, V38, P592, DOI 10.1016/0006-3223(95)00178-8; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Freedland KE, 2002, PSYCHOSOM MED, V64, P897, DOI 10.1097/01.PSY.0000028826.64279.29; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; Kiecolt-Glaser JK, 2007, PSYCHOSOM MED, V69, P217, DOI 10.1097/PSY.0b013e3180313a45; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Leon H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2931; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Mallinckrodt CH, 2003, BIOL PSYCHIAT, V53, P754, DOI 10.1016/S0006-3223(02)01867-X; Nemets B, 2002, AM J PSYCHIAT, V159, P477, DOI 10.1176/appi.ajp.159.3.477; Parker GB, 2006, PSYCHIAT RES, V141, P279, DOI 10.1016/j.psychres.2005.08.005; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Psota TL, 2006, AM J CARDIOL, V98, p3I, DOI 10.1016/j.amjcard.2005.12.022; Schweizer E, 2001, INT CLIN PSYCHOPHARM, V16, P137, DOI 10.1097/00004850-200105000-00002; Severus WE, 2001, HARVARD REV PSYCHIAT, V9, P280, DOI 10.1093/hrp/9.6.280; Silvers KM, 2005, PROSTAG LEUKOTR ESS, V72, P211, DOI 10.1016/j.plefa.2004.11.004; Sontrop J, 2006, PREV MED, V42, P4, DOI 10.1016/j.ypmed.2005.11.005; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c	42	95	96	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1651	1657		10.1001/jama.2009.1487	http://dx.doi.org/10.1001/jama.2009.1487			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843899	Bronze, Green Accepted			2022-12-28	WOS:000270941200019
J	Clevers, H				Clevers, Hans			Eyeing Up New Wnt Pathway Players	CELL			English	Editorial Material							RETINAL VASCULATURE; MICE; GENE		[Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu						BERGER W, 2001, METABOLIC MOL BASES, P5977; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Warden Scott M, 2007, Semin Ophthalmol, V22, P211, DOI 10.1080/08820530701745124; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	8	18	18	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 16	2009	139	2					227	229		10.1016/j.cell.2009.09.027	http://dx.doi.org/10.1016/j.cell.2009.09.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837026	Bronze			2022-12-28	WOS:000270857500007
J	Vogtle, FN; Wortelkamp, S; Zahedi, RP; Becker, D; Leidhold, C; Gevaert, K; Kellermann, J; Voos, W; Sickmann, A; Pfanner, N; Meisinger, C				Voegtle, F. -Nora; Wortelkamp, Stefanie; Zahedi, Rene P.; Becker, Dorothea; Leidhold, Claudia; Gevaert, Kris; Kellermann, Josef; Voos, Wolfgang; Sickmann, Albert; Pfanner, Nikolaus; Meisinger, Chris			Global Analysis of the Mitochondrial N-Proteome Identifies a Processing Peptidase Critical for Protein Stability	CELL			English	Article							AMINOPEPTIDASE-P; END RULE; PREDICTION; COMPLEX; INHIBITOR; MECHANISM; CLEAVAGE; IMPORT	Many mitochondrial proteins are synthesized with N-terminal presequences that are removed by specific peptidases. The N-termini of the mature proteins and thus peptidase cleavage sites have only been determined for a small fraction of mitochondrial proteins and yielded a controversial situation for the cleavage site specificity of the major mitochondrial processing peptidase (MPP). We report a global analysis of the N-proteome of yeast mitochondria, revealing the N-termini of 615 different proteins. Significantly more proteins than predicted contained cleavable presequences. We identified the intermediate cleaving peptidase Icp55, which removes an amino acid from a characteristic set of MPP-generated N-termini, solving the controversial situation of MPP specificity and suggesting that Icp55 converts instable intermediates into stable proteins. Our results suggest that Icp55 is critical for stabilization of the mitochondrial proteome and illustrate how the N-proteome can serve as rich source for a systematic analysis of mitochondrial protein targeting, cleavage and turnover.	[Wortelkamp, Stefanie; Zahedi, Rene P.; Sickmann, Albert] ISAS, Inst Analyt Sci, D-44139 Dortmund, Germany; [Voegtle, F. -Nora; Becker, Dorothea; Leidhold, Claudia; Voos, Wolfgang; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Voegtle, F. -Nora] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Becker, Dorothea; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Gevaert, Kris] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Kellermann, Josef] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sickmann, Albert] Ruhr Univ Bochum, MPC, D-44801 Bochum, Germany; [Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Freiburg; University of Freiburg; University of Bonn; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Max Planck Society; Ruhr University Bochum; University of Freiburg	Sickmann, A (corresponding author), ISAS, Inst Analyt Sci, D-44139 Dortmund, Germany.	albert.sickmann@isas.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Zahedi, Rene/HGU-5710-2022; Pfanner, Nikolaus/AAV-7878-2021; Sickmann, Albert/A-1010-2011; Gevaert, Kris/D-6489-2017; Zahedi, René/A-9148-2012; Gevaert, Kris/H-3637-2013; Vögtle, F.-Nora/T-4290-2017; Gevaert, Kris/AAE-4212-2019; Meisinger, Chris/J-1110-2014	Sickmann, Albert/0000-0002-2388-5265; Gevaert, Kris/0000-0002-4237-0283; Zahedi, René/0000-0002-4960-5460; Gevaert, Kris/0000-0002-4237-0283; Vögtle, F.-Nora/0000-0002-5062-3287; Gevaert, Kris/0000-0002-4237-0283; Meisinger, Chris/0000-0002-8326-3548	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich 746; Excellence Initiative of the German Federal and State Governments [EXC 294]; Gottfried Wilhelm Leibniz Program; Trinational Research Training Group [GRK 1478]; Ministerium fur Innovation; Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung; Fonds der Chemischen Industrie; Fund for Scientific Research-Flanders (Belgium); Ghent University; Inter University Attraction Poles [IUAP06]; European Union Interaction Proteome (6<SUP>th</SUP> Framework Program)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich 746(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Gottfried Wilhelm Leibniz Program; Trinational Research Training Group; Ministerium fur Innovation; Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fund for Scientific Research-Flanders (Belgium)(FWO); Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office); European Union Interaction Proteome (6<SUP>th</SUP> Framework Program)(European Commission)	We thank Drs. M. Yaffe, T. Lithgow, J. Rassow, and P. Rehling for strains and antisera; Dr. N. Wiedemann for discussion; and C. Prinz and B. Schonfisch for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments (EXC 294), Gottfried Wilhelm Leibniz Program, Trinational Research Training Group (GRK 1478, fellowship to F. N. V.), the Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, the Bundesministerium fur Bildung und Forschung, the Fonds der Chemischen Industrie, the Fund for Scientific Research-Flanders (Belgium), the Concerted Research Actions from Ghent University, the Inter University Attraction Poles (IUAP06) and the European Union Interaction Proteome (6<SUP>th</SUP> Framework Program).	Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2001, METHOD CELL BIOL, V65, P175, DOI 10.1016/S0091-679X(01)65011-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ersahin C, 2005, ARCH BIOCHEM BIOPHYS, V435, P303, DOI 10.1016/j.abb.2004.12.023; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2008, NAT STRUCT MOL BIOL, V15, P1238, DOI 10.1038/nsmb1208-1238; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236	29	337	346	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					428	439		10.1016/j.cell.2009.07.045	http://dx.doi.org/10.1016/j.cell.2009.07.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837041	Bronze			2022-12-28	WOS:000270857500024
J	Falagas, ME; Karageorgopoulos, DE				Falagas, Matthew E.; Karageorgopoulos, Drosos E.			Adjustment of dosing of antimicrobial agents for bodyweight in adults	LANCET			English	Editorial Material							BODY-MASS; OBESITY; PREVALENCE; MANAGEMENT; INFECTIONS; GUIDELINES; SOCIETY; WEIGHT		[Falagas, Matthew E.; Karageorgopoulos, Drosos E.] Alfa Inst Biomed Sci, Athens 15123, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, 9 Neapoleos St, Athens 15123, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Bartelink IH, 2006, CLIN PHARMACOKINET, V45, P1077, DOI 10.2165/00003088-200645110-00003; Bauer LA, 1998, EUR J CLIN PHARMACOL, V54, P621, DOI 10.1007/s002280050524; BENEDEK IH, 1984, BRIT J CLIN PHARMACO, V18, P941, DOI 10.1111/j.1365-2125.1984.tb02567.x; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Blouin RA, 1999, J PHARM SCI, V88, P1, DOI 10.1021/js980173a; Bond CA, 2008, PHARMACOTHERAPY, V28, P1, DOI 10.1592/phco.28.1.1; Bosma RJ, 2006, CONTRIB NEPHROL, V151, P184, DOI 10.1159/000095329; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; Erstad BL, 2002, AM J HEALTH-SYST PH, V59, P2105, DOI 10.1093/ajhp/59.21.2105; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Falagas ME, 2009, OBES REV, V10, P280, DOI 10.1111/j.1467-789X.2008.00546.x; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Hall RG, 2008, AM J MED, V121, P515, DOI 10.1016/j.amjmed.2008.01.046; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Janmahasatian S, 2005, CLIN PHARMACOKINET, V44, P1051, DOI 10.2165/00003088-200544100-00004; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meisel C, 2000, CLIN CHEM LAB MED, V38, P869, DOI 10.1515/CCLM.2000.126; Nawaratne S, 1998, BRIT J CLIN PHARMACO, V46, P447, DOI 10.1046/j.1365-2125.1998.00812.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pai MP, 2007, ANTIMICROB AGENTS CH, V51, P2741, DOI 10.1128/AAC.00059-07; Pai MP, 2007, PHARMACOTHERAPY, V27, P1081, DOI 10.1592/phco.27.8.1081; PEARSON TC, 1995, BRIT J HAEMATOL, V89, P748; Peck CC, 2007, CLIN PHARMACOL THER, V82, P12, DOI 10.1038/sj.clpt.6100215; Roberts JA, 2008, CRIT CARE MED, V36, P2433, DOI 10.1097/CCM.0b013e318180fe62; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; TRAYNOR AM, 1995, ANTIMICROB AGENTS CH, V39, P545, DOI 10.1128/AAC.39.2.545; *US FDA, 2004, INN STAGN CHALL OPP; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409	30	105	106	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					248	251		10.1016/S0140-6736(09)60743-1	http://dx.doi.org/10.1016/S0140-6736(09)60743-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	19875163				2022-12-28	WOS:000273853800035
J	Zhu, FC; Wang, H; Fang, HH; Yang, JG; Lin, XJ; Liang, XF; Zhang, XF; Pan, HX; Meng, FY; Hu, YM; Liu, WD; Li, CG; Li, W; Zhang, X; Hu, JM; Peng, WB; Yang, BP; Xi, P; Wang, HQ; Zheng, JS				Zhu, Feng-Cai; Wang, Hua; Fang, Han-Hua; Yang, Jian Guo; Lin, Xiao Jun; Liang, Xiao-Feng; Zhang, Xue-Feng; Pan, Hong-Xing; Meng, Fan-Yue; Hu, Yue Mei; Liu, Wen-Dong; Li, Chang-Gui; Li, Wei; Zhang, Xiang; Hu, Jin Mei; Peng, Wei Bing; Yang, Bao Ping; Xi, Pei; Wang, Hua-Qing; Zheng, Jing-Shan		Taizhou Municipal Ctr Dis Control	A Novel Influenza A (H1N1) Vaccine in Various Age Groups.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							H5N1 VACCINE; RANDOMIZED-TRIAL; CHILDREN; IMMUNOGENICITY; IMMUNIZATION; SAFETY; VIRUS	Background: There is an urgent need for a vaccine that is effective against the 2009 pandemic influenza A (H1N1) virus. Methods: A split-virus, inactivated candidate vaccine against the 2009 H1N1 virus was manufactured, and we evaluated its safety and immunogenicity in a randomized clinical trial. Subjects were between 3 and 77 years of age, stratified into four age groups. The immunization schedule consisted of two vaccinations, 21 days apart. Subjects were injected with placebo or with vaccine, with or without alum adjuvant, at doses of 7.5 microg, 15 microg, or 30 microg. Serologic analysis was performed at baseline and on days 21 and 35. Results: A total of 2200 subjects received one dose, and 2103 (95.6%) received the second dose, of vaccine or placebo. No severe adverse side effects associated with the vaccine were noted. In the nonadjuvanted-vaccine groups, injection-site or systemic reactions, most mild in nature, were noted in 5.5 to 15.9% of subjects. Among the subjects receiving 15 microg of nonadjuvanted vaccine, a hemagglutination-inhibition titer of 1:40 or more was achieved by day 21 in 74.5% of subjects between 3 and 11 years of age, 97.1% of subjects between 12 and 17 years, 97.1% of subjects between 18 and 60 years, and 79.1% of subjects 61 years of age or older; by day 35, the titer had been achieved in 98.1%, 100%, 97.1%, and 93.3% of subjects, respectively. The proportion with a titer of 1:40 or more was generally highest among the subjects receiving 30 microg of vaccine, with or without adjuvant. Vaccine without adjuvant was associated with fewer local reactions and greater immune responses than was vaccine with adjuvant. Conclusions: These data suggest that a single dose of 15 microg of hemagglutinin antigen without alum adjuvant induces a typically protective immune response in the majority of subjects between 12 and 60 years of age. Lesser immune responses were seen after a single dose of vaccine in younger and older subjects. (ClinicalTrials.gov number, NCT00975572.) N Engl J Med 2009;361:2414-23.	[Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Ctr Vaccine Clin Trials, Nanjing 210009, Peoples R China; [Fang, Han-Hua; Li, Chang-Gui; Li, Wei; Zhang, Xiang] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; [Yang, Jian Guo; Zhang, Xiang; Hu, Jin Mei; Peng, Wei Bing] Taizhou Municipal Ctr Dis Control & Prevent, Taizhou, Peoples R China; [Lin, Xiao Jun; Yang, Bao Ping; Xi, Pei] Hualan Biol Bacterin Co, Xinxiang, Peoples R China; [Liang, Xiao-Feng; Wang, Hua-Qing; Zheng, Jing-Shan] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Chinese Center for Disease Control & Prevention	Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Ctr Vaccine Clin Trials, 172 Jiangsu Rd, Nanjing 210009, Peoples R China.	jszfc@vip.sina.com	Hu, Yue/HGE-1673-2022; fang, han/GSN-6404-2022		Hualan Biological Bacterin Company	Hualan Biological Bacterin Company	Supported by Hualan Biological Bacterin Company.	Bocchini JA, 2008, PEDIATRICS, V121, pE1016, DOI 10.1542/peds.2008-0160; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; *DIV MICR INF DIS, PED TOX TABL; *DIV MICR INF DIS, AD TOX TABL; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Englund JA, 2005, PEDIATRICS, V115, P1039, DOI 10.1542/peds.2004-2373; *EUR COMM PROP MED, 2004, CPMPVEG471703; European Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; GROSS PA, 1987, J CLIN MICROBIOL, V25, P1763, DOI 10.1128/JCM.25.9.1763-1765.1987; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; LEVINE M, 1987, CAN MED ASSOC J, V137, P722; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; *WHO, AV CAND REASS VACC V; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; Wu J, 2009, CLIN INFECT DIS, V48, P1087, DOI 10.1086/597401; 2009, MMWR MORB MORTAL WKL, V58, P435	21	289	312	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2414	2423		10.1056/NEJMoa0908535	http://dx.doi.org/10.1056/NEJMoa0908535			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	19846844				2022-12-28	WOS:000272798900006
J	Nakanishi, Y; Lu, B; Gerard, C; Iwasaki, A				Nakanishi, Yusuke; Lu, Bao; Gerard, Craig; Iwasaki, Akiko			CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; DENDRITIC CELLS; TYPE-2 INFECTION; MEMORY; LOCALIZATION; RESPONSES; EFFECTOR; IMMUNITY; CTL	CD4(+) T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD8(+) T lymphocyte (CTL) responses in vivo. T-cell help is required for the generation of primary CTL responses as well as in promoting protective CD8(+) memory T-cell development(1). However, the role of CD4 help in the control of CTL responses at the effector stage is unknown. Here we show that fully helped effector CTLs are themselves not self-sufficient for entry into the infected tissue, but rely on the CD4(+) T cells to provide the necessary cue. CD4(+) T helper cells control the migration of CTL indirectly through the secretion of IFN-gamma and induction of local chemokine secretion in the infected tissue. Our results reveal a previously unappreciated role of CD4 help in mobilizing effector CTL to the peripheral sites of infection where they help to eliminate infected cells.	[Nakanishi, Yusuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lu, Bao; Gerard, Craig] Harvard Univ, Childrens Hosp, Div Pulm, Sch Med, Boston, MA 02115 USA	Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIH [AI054359, AI062428, AI39759, HL51366]; Japan Society for the Promotion of Science; Burroughs Wellcome Investigators; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039759, R56AI062428, R01AI062428, R01AI054359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Burroughs Wellcome Investigators(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. R. Carbone and W. R. Heath for the gBT-I transgenic mouse, A. Rudensky for the foxp3 knock-in mouse, R. Medzhitov and J. M. Thompson for critical reading of the manuscript, and N. Iijima for technical assistance. This work is supported by NIH grants to A. I. (AI054359 and AI062428) and to C. G. (AI39759 and HL51366). Y. N. was a Japan Society for the Promotion of Science fellow. A. I. is a recipient of the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease.	Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	25	405	421	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					510	U205		10.1038/nature08511	http://dx.doi.org/10.1038/nature08511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19898495	Green Accepted			2022-12-28	WOS:000272144200045
J	Misra, A				Misra, Anoop			Prevention of type 2 diabetes: the long and winding road	LANCET			English	Editorial Material							LIFE-STYLE; MELLITUS		Fortis Hosp, Dept Diabet & Metab Dis, New Delhi 70, India		Misra, A (corresponding author), Fortis Hosp, Dept Diabet & Metab Dis, New Delhi 70, India.	anoopmisra@metabolicresearchindia.com						Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Crandall JP, 2008, NAT CLIN PRACT ENDOC, V4, P382, DOI 10.1038/ncpendmet0843; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Riccardi G, 2008, AM J CLIN NUTR, V87, p269S, DOI 10.1093/ajcn/87.1.269S; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Walker EA, 2006, DIABETES CARE, V29, P1997, DOI 10.2337/dc06-0454	12	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1655	1656		10.1016/S0140-6736(09)61631-7	http://dx.doi.org/10.1016/S0140-6736(09)61631-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19878987				2022-12-28	WOS:000271999700004
J	Krimigis, SM; Mitchell, DG; Roelof, EC; Hsieh, KC; McComas, DJ				Krimigis, S. M.; Mitchell, D. G.; Roelof, E. C.; Hsieh, K. C.; McComas, D. J.			Imaging the Interaction of the Heliosphere with the Interstellar Medium from Saturn with Cassini	SCIENCE			English	Article							TERMINATION SHOCK; COSMIC-RAYS; SOLAR-WIND; HELIOSHEATH; REGION; ATOMS; IONS	We report an all-sky image of energetic neutral atoms (ENAs) >6 kilo-electron volts produced by energetic protons occupying the region (heliosheath) between the boundary of the extended solar atmosphere and the local interstellar medium (LISM). The map obtained by the Ion and Neutral Camera (INCA) onboard Cassini reveals a broad belt of energetic protons whose nonthermal pressure is comparable to that of the local interstellar magnetic field. The belt, centered at similar to 260 degrees ecliptic longitude extending from north to south and looping back through similar to 80 degrees, appears to be ordered by the local interstellar magnetic field. The shape revealed by the ENA image does not conform to current models, wherein the heliosphere resembles a cometlike figure aligned in the direction of Sun's travel through the LISM.	[Krimigis, S. M.; Mitchell, D. G.; Roelof, E. C.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, S. M.] Acad Athens, Off Space Res & Technol, Athens 10679, Greece; [Hsieh, K. C.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [McComas, D. J.] SW Res Inst, San Antonio, TX 78228 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University of Arizona; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA)	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019; McComas, David J/H-6202-2011; Roelof, Edmond/G-6654-2019	Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386; McComas, David J/0000-0001-6160-1158; Roelof, Edmond/0000-0002-2270-0652	NASA [NAS5-97271, NNX07AJ69G]; University of Arizona; NASA IBEX contract	NASA(National Aeronautics & Space Administration (NASA)); University of Arizona; NASA IBEX contract	We are grateful to M. Kusterer, S. Turner, J. Aiello, and R. DeMajistre for assistance in the data reduction and analyses efforts of Cassini and the Magnetospheric Imaging Instrument in general and this work in particular. Discussions with R. B. Decker are most appreciated. The work at the Johns Hopkins University Applied Physics Laboratory was supported by NASA under contracts NAS5-97271 and NNX07AJ69G and by subcontract at University of Arizona; the work at the Southwest Research Institute was supported by the NASA IBEX contract.	AXFORD WI, 1973, SPACE SCI REV, V14, P582, DOI 10.1007/BF00214764; DAVIS L, 1955, PHYS REV, V100, P1440, DOI 10.1103/PhysRev.100.1440; Decker RB, 2008, NATURE, V454, P67, DOI 10.1038/nature07030; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Fichtner H, 2000, AIP CONF PROC, V528, P345; FISK LA, 1974, ASTROPHYS J, V190, pL35, DOI 10.1086/181498; Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Gruntman M, 2001, J GEOPHYS RES-SPACE, V106, P15767, DOI 10.1029/2000JA000328; Gurnett DA, 2006, AIP CONF PROC, V858, P129; HSIEH KC, 1992, ASTROPHYS J, V393, P756, DOI 10.1086/171543; Izmodenov V. V., 2006, PHYS HELIOSPHERIC BO, P67; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McComas DJ, 2009, SPACE SCI REV, V146, P11, DOI 10.1007/s11214-009-9499-4; PARKER EN, 1961, ASTROPHYS J, V134, P20, DOI 10.1086/147124; Richardson JD, 2008, NATURE, V454, P63, DOI 10.1038/nature07024; SIMPSON JA, 1967, ASTROPHYS J, V149, pL73, DOI 10.1086/180060	17	97	98	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					971	973		10.1126/science.1181079	http://dx.doi.org/10.1126/science.1181079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833914				2022-12-28	WOS:000271712300033
J	Califf, RM				Califf, Robert M.			Clinical Research Sites-The Underappreciated Component of the Clinical Research System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED-TRIALS; CONDUCT; CANCER		[Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA; [Califf, Robert M.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Campus Box 3850, Durham, NC 27710 USA.	robert.califf@duke.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NCRR NIH HHS [1 UL1 RR024128] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Dilts DM, 2006, J CLIN ONCOL, V24, P4553, DOI 10.1200/JCO.2006.06.7819; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Fost N, 2007, JAMA-J AM MED ASSOC, V298, P2196, DOI 10.1001/jama.298.18.2196; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; LEIBENLUFT RF, 2008, COMMUNICATION   0917; *NAT I HLTH RES, IMPL PLAN 4; Sullivan R, 2008, LANCET ONCOL, V9, P2, DOI 10.1016/S1470-2045(07)70388-1; *US FDA, 2007, FDA DUK LAUNCH PUBL; Yusur S, 2008, CLIN TRIALS, V5, P38, DOI 10.1177/1740774507088099	10	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2025	2027		10.1001/jama.2009.1655	http://dx.doi.org/10.1001/jama.2009.1655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903924				2022-12-28	WOS:000271619700031
J	Gartner, R; Jensen, MB; Nielsen, J; Ewertz, M; Kroman, N; Kehlet, H				Gartner, Rune; Jensen, Maj-Britt; Nielsen, Jeanette; Ewertz, Marianne; Kroman, Niels; Kehlet, Henrik			Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; POSTMASTECTOMY PAIN; RISK-FACTORS; INTERCOSTOBRACHIAL NERVE; AXILLARY DISSECTION; COOPERATIVE GROUP; RANDOMIZED-TRIAL; PHANTOM BREAST; DBCG	Context Persistent pain and sensory disturbances following surgical treatment for breast cancer is a significant clinical problem. The pathogenic mechanisms are complex and may be related to patient characteristics, surgical technique, and adjuvant therapy. Objective To examine prevalence of and factors associated with persistent pain after surgical treatment for breast cancer. Design, Setting, and Patients A nationwide cross-sectional questionnaire study of 3754 women aged 18 to 70 years who received surgery and adjuvant therapy (if indicated) for primary breast cancer in Denmark between January 1, 2005, and December 31, 2006. A study questionnaire was sent to the women between January and April 2008. Main Outcome Measures Prevalence, location, and severity of persistent pain and sensory disturbances in 12 well-defined treatment groups assessed an average of 26 months after surgery, and adjusted odds ratio (OR) of reported pain and sensory disturbances with respect to age, surgical technique, chemotherapy, and radiotherapy. Results By June 2008, 3253 of 3754 eligible women (87%) returned the questionnaire. A total of 1543 patients (47%) reported pain, of whom 201 (13%) had severe pain, 595 (39%) had moderate pain, and 733 (48%) had light pain. Factors associated with chronic pain included young age (18-39 years: OR, 3.62; 95% confidence interval [CI], 2.25-5.82; P<.001) and adjuvant radiotherapy (OR, 1.50; 95% CI, 1.08-2.07; P=.03), but not chemotherapy (OR, 1.01; 95% CI, 0.85-1.21; P=.91). Axillary lymph node dissection (ALND) was associated with increased likelihood of pain (OR, 1.77; 95% CI, 1.43-2.19; P<.001) compared with sentinel lymph node dissection. Risk of sensory disturbances was associated with young age (18-39 years: OR, 5.00; 95% CI, 2.87-8.69; P<.001) and ALND (OR, 4.97; 95% CI, 3.92-6.30; P<.001). Pain complaints from other parts of the body were associated with increased risk of pain in the surgical area (P<.001). A total of 306 patients (20%) with pain had contacted a physician within the prior 3 months for pain complaints in the surgical area. Conclusion Two to 3 years after breast cancer treatment, persistent pain and sensory disturbances remain clinically significant problems among Danish women who received surgery in 2005 and 2006. JAMA. 2009;302(18):1985-1992	[Gartner, Rune; Nielsen, Jeanette; Kroman, Niels] Univ Copenhagen, Rigshosp, Dept Breast Surg, DK-2100 Copenhagen, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark; [Jensen, Maj-Britt] Danish Breast Canc Cooperat Grp, Copenhagen, Denmark; [Ewertz, Marianne] Univ So Denmark, Odense Univ Hosp, Dept Oncol, Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Danish Breast Cancer Cooperative Group (DBCG); University of Southern Denmark; Odense University Hospital	Gartner, R (corresponding author), Univ Copenhagen, Rigshosp 2101, Dept Breast Surg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	runegartner@gmail.com		Ewertz, Marianne/0000-0002-5965-969X; Kehlet, Henrik/0000-0002-2209-1711	Danish Cancer Society; Breast Friends; Lundbeck Foundation	Danish Cancer Society(Danish Cancer Society); Breast Friends; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Cancer Society, Breast Friends, and the Lundbeck Foundation. The grants exclusively covered salaries.	Abdullah TI, 1998, BRIT J SURG, V85, P1443; Bjorkman B, 2008, J PAIN, V9, P1018, DOI 10.1016/j.jpain.2008.06.003; Blichert-Toft M, 2008, ACTA ONCOL, V47, P497, DOI 10.1080/02841860802068615; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Carpenter JS, 1998, J CLIN EPIDEMIOL, V51, P1285, DOI 10.1016/S0895-4356(98)00121-8; Dijkstra PU, 2007, EUR J PAIN, V11, P99, DOI 10.1016/j.ejpain.2006.01.002; Eisenberg E, 2007, J PAIN, V8, P223, DOI 10.1016/j.jpain.2006.08.003; Fassoulaki A, 2005, ANESTH ANALG, V101, P1427, DOI 10.1213/01.ANE.0000180200.11626.8E; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Gottrup H, 2000, PAIN, V87, P275, DOI 10.1016/S0304-3959(00)00291-8; Jung BF, 2005, PAIN, V118, P10, DOI 10.1016/j.pain.2005.09.014; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Kairaluoma PM, 2006, ANESTH ANALG, V103, P703, DOI 10.1213/01.ane.0000230603.92574.4e; Katz J, 2005, PAIN, V119, P16, DOI 10.1016/j.pain.2005.09.008; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; Kudel I, 2007, J PAIN SYMPTOM MANAG, V34, P619, DOI 10.1016/j.jpainsymman.2007.01.013; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Overgaard M, 2008, ACTA ONCOL, V47, P639, DOI 10.1080/02841860802078085; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Peuckmann V, 2007, BREAST CANCER RES TR, V104, P39, DOI 10.1007/s10549-006-9386-6; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Romundstad L, 2006, PAIN, V124, P92, DOI 10.1016/j.pain.2006.03.020; Rostgaard K, 2000, CANCER CAUSE CONTROL, V11, P669, DOI 10.1023/A:1008928204121; Salmon RJ, 1998, EUR J SURG ONCOL, V24, P158, DOI 10.1016/S0748-7983(98)92793-7; Steegers MA, 2008, J PAIN, V9, P813, DOI 10.1016/j.jpain.2008.04.001; Tasmuth T, 1996, BRIT J CANCER, V74, P2024, DOI 10.1038/bjc.1996.671; Tasmuth T, 1999, EUR J SURG ONCOL, V25, P38, DOI 10.1053/ejso.1998.0597; Taylor KO, 2004, ANZ J SURG, V74, P314, DOI 10.1111/j.1445-1433.2004.02992.x; Torresan Renato Zocchio, 2003, Breast J, V9, P389, DOI 10.1046/j.1524-4741.2003.09505.x; VECHT CJ, 1989, PAIN, V38, P171, DOI 10.1016/0304-3959(89)90235-2; Ververs JMMA, 2001, EUR J CANCER, V37, P991, DOI 10.1016/S0959-8049(01)00067-3; Vilholm OJ, 2008, BRIT J CANCER, V99, P604, DOI 10.1038/sj.bjc.6604534; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X	35	529	552	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1985	1992						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903919				2022-12-28	WOS:000271619700025
J	Ferreira, PG; Starkman, GD				Ferreira, Pedro G.; Starkman, Glenn D.			Einstein's Theory of Gravity and the Problem of Missing Mass	SCIENCE			English	Review							NEWTONIAN DYNAMICS; GALAXIES; MOND	The observed matter in the universe accounts for just 5% of the observed gravity. A possible explanation is that Newton's and Einstein's theories of gravity fail where gravity is either weak or enhanced. The modified theory of Newtonian dynamics (MOND) reproduces, without dark matter, spiral-galaxy orbital motions and the relation between luminosity and rotation in galaxies, although not in clusters. Recent extensions of Einstein's theory are theoretically more complete. They inevitably include dark fields that seed structure growth, and they may explain recent weak lensing data. However, the presence of dark fields reduces calculability and comes at the expense of the original MOND premise, that the matter we see is the sole source of gravity. Observational tests of the relic radiation, weak lensing, and the growth of structure may distinguish modified gravity from dark matter.	[Ferreira, Pedro G.] Univ Oxford, Dept Astrophys, Oxford OX2 7LG, England; [Starkman, Glenn D.] Case Western Reserve Univ, Dept Phys, Inst Sci Origins, Ctr Educ & Res Cosmol & Astrophys, Cleveland, OH 44106 USA	University of Oxford; Case Western Reserve University	Ferreira, PG (corresponding author), Univ Oxford, Dept Astrophys, Keble Rd, Oxford OX2 7LG, England.	p.ferreira1@physics.ox.ac.uk; glenn.starkman@case.edu		starkman, glenn/0000-0002-5053-1542	Science and Technology Facilities Council; Beecroft Institute; U. S. Department of Energy; NASA; Foundational Questions Institute in Physics and Cosmology (FXQI); STFC [ST/F003110/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003110/1] Funding Source: researchfish	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Beecroft Institute; U. S. Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Foundational Questions Institute in Physics and Cosmology (FXQI); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank S. McGaugh and P.-J. Zhang for kindly supplying us with figures, and C. Skordis and T. Zlosnik for discussions. P. G. F. is funded by the Science and Technology Facilities Council and thanks the Beecroft Institute for support. G. D. S. is funded by the U. S. Department of Energy, NASA, and the Foundational Questions Institute in Physics and Cosmology (FXQI), and thanks the Beecroft Institute for hospitality.	Angus GW, 2006, MON NOT R ASTRON SOC, V371, P138, DOI 10.1111/j.1365-2966.2006.10668.x; BEGEMAN KG, 1991, MON NOT R ASTRON SOC, V249, P523, DOI 10.1093/mnras/249.3.523; BEKENSTEIN J, 1984, ASTROPHYS J, V286, P7, DOI 10.1086/162570; Bekenstein JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.083509; Blanchet L, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.024031; Bourliot F, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.063508; Carroll SM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043528; Clowe D, 2006, ASTROPHYS J, V648, pL109, DOI 10.1086/508162; Dai DC, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.104004; DeDeo S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.141101; Deffayet C, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.044023; Diaz-Rivera LM, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.083503; Dodelson S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.231301; Feix M, 2008, ASTROPHYS J, V682, P711, DOI 10.1086/589496; Ferreira PG, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.044043; Fujii Y., 2003, CAMBRIDGE MONOGRAPHS; Kahya EO, 2007, PHYS LETT B, V652, P213, DOI 10.1016/j.physletb.2007.07.029; Li BJ, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064021; MANNHEIM PD, 1989, ASTROPHYS J, V342, P635, DOI 10.1086/167623; McGaugh SS, 1998, ASTROPHYS J, V499, P66, DOI 10.1086/305629; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Natarajan P, 2008, MON NOT R ASTRON SOC, V389, P250, DOI 10.1111/j.1365-2966.2008.13552.x; Navarro I, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/03/008; Sakharov A. D., 1968, SOV PHYS DOKL, V12, P1040, DOI DOI 10.1070/PU1991V034N05ABEH002498; Sanders RH, 1997, ASTROPHYS J, V480, P492, DOI 10.1086/303980; Sanders RH, 2003, MON NOT R ASTRON SOC, V342, P901, DOI 10.1046/j.1365-8711.2003.06596.x; Sanders RH, 2002, ANNU REV ASTRON ASTR, V40, P263, DOI 10.1146/annurev.astro.40.060401.093923; Skordis C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.011301; Wu XF, 2007, ASTROPHYS J, V665, pL101, DOI 10.1086/521103; Zhang PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.141302; Zlosnik TG, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.084010; Zlosnik TG, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.044017	33	23	23	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					812	815		10.1126/science.1172245	http://dx.doi.org/10.1126/science.1172245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892973	Green Submitted			2022-12-28	WOS:000271468000031
J	Willis, KJ; Bhagwat, SA				Willis, Kathy J.; Bhagwat, Shonil A.			Biodiversity and Climate Change	SCIENCE			English	Editorial Material							AREA		[Willis, Kathy J.; Bhagwat, Shonil A.] Univ Oxford, Long Term Ecol Lab, Ctr Environm, Oxford OX1 3QY, England; [Willis, Kathy J.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oxford; University of Bergen	Willis, KJ (corresponding author), Univ Oxford, Long Term Ecol Lab, Ctr Environm, S Parks Rd, Oxford OX1 3QY, England.	kathy.willis@ouce.ox.ac.uk		Willis, Katherine/0000-0002-6763-2489	Natural Environment Research Council [NE/G010730/1, NE/C510667/1] Funding Source: researchfish; NERC [NE/G010730/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntingford C, 2008, PHILOS T R SOC B, V363, P1857, DOI 10.1098/rstb.2007.0028; Lapola DM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003357; Larsen TB, 2008, BIODIVERS CONSERV, V17, P2833, DOI 10.1007/s10531-008-9399-z; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Parry ML, 2007, CLIMATE CHANGE 2007; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	15	170	182	23	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					806	807		10.1126/science.1178838	http://dx.doi.org/10.1126/science.1178838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892969				2022-12-28	WOS:000271468000027
J	Coombes, R				Coombes, Rebecca			Don't try this at home?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Aust T., 2009, BRIT MED J, V339, pB3220	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2009	339								b4421	10.1136/bmj.b4421	http://dx.doi.org/10.1136/bmj.b4421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UD	19892800				2022-12-28	WOS:000271567900005
J	Marek, I				Marek, Ilan			The Basics of Zinc Activation	SCIENCE			English	Editorial Material							CHEMOSELECTIVE BASE; DIRECTED ZINCATION; METALATION		Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Marek, I (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.	chilanm@tx.technion.ac.il						Kennedy AR, 2009, SCIENCE, V326, P706, DOI 10.1126/science.1178165; Kondo Y, 1999, J AM CHEM SOC, V121, P3539, DOI 10.1021/ja984263t; Leroux F., 2004, CHEM ORGANOLITHIUM C, P435, DOI DOI 10.1002/04700211X.CH9; MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721; Mosrin M, 2009, ORG LETT, V11, P1837, DOI 10.1021/ol900342a; Mulvey RE, 2009, ACCOUNTS CHEM RES, V42, P743, DOI 10.1021/ar800254y; SCHLOSSER M, 1992, MOD SYNTH METH, V6, P277; Wunderlich SH, 2007, ANGEW CHEM INT EDIT, V46, P7685, DOI 10.1002/anie.200701984	8	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					673	674		10.1126/science.1181863	http://dx.doi.org/10.1126/science.1181863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900920				2022-12-28	WOS:000271233200020
J	Gornall, J				Gornall, Jonathan			Whistleblowing The price of silence	BRITISH MEDICAL JOURNAL			English	Editorial Material												Jgornall@mac.com						*BMA, 2009, WHISTL ADV BMA MEMB; General Medical Council, 2006, GOOD MED PRACT; *HEALTHC COMM, NHS STAFF SURV 2007; Healthcare Commission, 2009, INV MID STAFF NHS FD; O'Dowd A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2297; *SECR STAT HLTH, 1997, 9765 MISC DOH SECR S; 2009, BBC NEWS        0416	7	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2009	339								b3202	10.1136/bmj.b3202	http://dx.doi.org/10.1136/bmj.b3202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AK	19861707				2022-12-28	WOS:000271365500001
J	Maron, BJ; Lesser, JR; Schiller, NB; Harris, KM; Brown, C; Rehm, HL				Maron, Barry J.; Lesser, John R.; Schiller, Nelson B.; Harris, Kevin M.; Brown, Colleen; Rehm, Heidi L.			Implications of Hypertrophic Cardiomyopathy Transmitted by Sperm Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ADULTS; DEATH	Context Sperm donation is an increasingly common practice for achieving pregnancy in the absence of a male partner or when fertility is problematic. The unintended consequence in which genetic diseases are unwittingly transmitted to offspring is an underrecognized public health issue not previously prioritized by US Food and Drug Administration guidelines. Objective To report the clinical circumstances and implication of hypertrophic cardiomyopathy (HCM) transmitted by sperm donation to recipients. Setting Voluntary sperm donation through a US Food and Drug Administration-approved tissue bank. Main Outcome Measure Incidence of genetically affected offspring and clinical outcomes to date. Results An asymptomatic 23-year-old man who had no personal knowledge of underlying heart disease and who underwent standard testing that was negative for infectious diseases, repeatedly donated sperm over a 2-year period (1990-1991). The donor was later shown to be affected (in 2005) by a novel beta-myosin heavy-chain mutation that caused HCM, after an offspring was clinically diagnosed with this disease. Of the 24 children known to be offspring of the donor, including 22 who were products of fertilization via sperm donation and 2 conceived by the donor's wife, a total of 9 genetically affected offspring, 2 to 16 years of age and 6 males, have been identified with HCM (2005-2009). Three of the 9 gene-positive children have currently expressed phenotypic evidence of HCM, including one who died at age 2 years due to progressive and unrelenting heart failure with marked hypertrophy, and also 2 survivors with extreme left ventricular hypertrophy at age 15 years. The latter 2 children and the donor are judged likely to be at increased risk for sudden death. Conclusions This case series underscores the potential risk for transmission of inherited cardiovascular diseases through voluntary sperm donation, a problem largely unappreciated by the medical community and agencies regulating tissue donation. Recommendations include improved screening guidelines for donors to exclude cardiovascular diseases (eg, HCM) such as consideration for 12-lead electrocardiograms. JAMA. 2009;302(15):1681-1684	[Maron, Barry J.; Lesser, John R.; Harris, Kevin M.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Maron, Barry J.; Lesser, John R.; Harris, Kevin M.] Abbott NW Hosp, Minneapolis, MN 55407 USA; [Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, Partners Healthcare Ctr Personalized Genet Med, Boston, MA 02115 USA; [Rehm, Heidi L.] Harvard Univ, Sch Med, Boston, MA USA; [Schiller, Nelson B.; Brown, Colleen] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA; [Schiller, Nelson B.; Brown, Colleen] Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA	Minneapolis Heart Institute Foundation; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org		Rehm, Heidi L./0000-0002-6025-0015	Hearst Foundations	Hearst Foundations	This study was supported in part with a grant from The Hearst Foundations.	Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS30, DOI 10.1016/j.fertnstert.2008.08.090; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Gazvani Rafet, 2002, Hum Fertil (Camb), V5, P183, DOI 10.1080/1464727022000199092; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; MARON BJ, 1982, CIRCULATION, V65, P7, DOI 10.1161/01.CIR.65.1.7; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119; Miller MD, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.8; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; *US FDA, 2007, GUID IND EL DET DON; Van Driest SL, 2005, MAYO CLIN PROC, V80, P739; Wirojanan J, 2008, AM J MED GENET A, V146A, P888, DOI 10.1002/ajmg.a.31876	17	29	31	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1681	1684		10.1001/jama.2009.1507	http://dx.doi.org/10.1001/jama.2009.1507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843903				2022-12-28	WOS:000270941200023
J	Roy, HK; Bianchi, LK				Roy, Hemant K.; Bianchi, Laura K.			Differences in Colon Adenomas and Carcinomas Among Women and Men Potential Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; COLONOSCOPY; NEOPLASIA; ESTROGEN; AGE		[Roy, Hemant K.] NorthShore Univ HealthSyst, Dept Internal Med, Evanston, IL 60201 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	NorthShore University Health System; University of Chicago	Roy, HK (corresponding author), NorthShore Univ HealthSyst, Dept Internal Med, 1001 Univ Pl, Evanston, IL 60201 USA.	hroy@northshore.org	Roy, Hemant/AAC-9096-2020		NCI NIH HHS [R21 CA140936, U01 CA111257-04, R21CA140936, U01CA111257, U01 CA111257-02, R21CA141112, U01 CA111257, R21 CA141112, R21 CA140936-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA141112, U01CA111257, R21CA140936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kennelly R, 2008, LANCET ONCOL, V9, P385, DOI 10.1016/S1470-2045(08)70100-1; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Zisman AL, 2006, ARCH INTERN MED, V166, P629, DOI 10.1001/archinte.166.6.629	10	29	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1696	1697		10.1001/jama.2009.1499	http://dx.doi.org/10.1001/jama.2009.1499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843905	Green Accepted			2022-12-28	WOS:000270941200026
J	Krashes, MJ; DasGupta, S; Vreede, A; White, B; Armstrong, JD; Waddell, S				Krashes, Michael J.; DasGupta, Shamik; Vreede, Andrew; White, Benjamin; Armstrong, J. Douglas; Waddell, Scott			A Neural Circuit Mechanism Integrating Motivational State with Memory Expression in Drosophila	CELL			English	Article							RAT HIPPOCAMPAL SLICE; NEUROPEPTIDE Y-LIKE; LONG-TERM-MEMORY; FEEDING-BEHAVIOR; MUSHROOM BODIES; PRESYNAPTIC INHIBITION; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; TARGETED EXPRESSION; LOCOMOTOR-ACTIVITY	Behavioral expression of food-associated memory in fruit flies is constrained by satiety and promoted by hunger, suggesting an influence of motivational state. Here, we identify a neural mechanism that integrates the internal state of hunger and appetitive memory. We show that stimulation of neurons that express neuropeptide F(dNPF), an ortholog of mammalian NPY, mimics food deprivation and promotes memory performance in satiated flies. Robust appetitive memory performance requires the dNPF receptor in six dopaminergic neurons that innervate a distinct region of the mushroom bodies. Blocking these dopaminergic neurons releases memory performance in satiated flies, whereas stimulation suppresses memory performance in hungry flies. Therefore, dNPF and dopamine provide a motivational switch in the mushroom body that controls the output of appetitive memory.	[Krashes, Michael J.; DasGupta, Shamik; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Vreede, Andrew; White, Benjamin] NIMH, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh EH1 2QL, Midlothian, Scotland; [Krashes, Michael J.] Harvard Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Edinburgh; Harvard University; Harvard Medical School	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu	Krashes, Michael/P-7677-2019	DasGupta, Shamik/0000-0001-5566-7548; Waddell, Scott/0000-0003-4503-6229; Armstrong, Douglas/0000-0002-5397-3864; DasGupta, Shamik/0000-0001-5803-8982	National Institutes of Health [MH09883, MH081982]; National Research Service Award [DA024499]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH009883, R01MH081982, R01MH069883, ZIAMH002800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Andre Fiala, Paul Garrity, Julie Simpson, Ping Shen, Tim Tully, and Troy Zars for flies. We also thank Geraldine Wright, Hans Hoffman, Tzumin Lee, and Stanley Heinze for their input. This work was supported by National Institutes of Health grants MH09883 and MH081982 to S. W. and National Research Service Award DA024499 to M. J. K.	Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; [Anonymous], 1956, LEARNING INSTINCT AN; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bindra D, 1959, MOTIVATION SYSTEMATI; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Browning KN, 2003, J PHYSIOL-LONDON, V549, P775, DOI 10.1113/jphysiol.2003.042036; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; COLMERS WF, 1991, BRIT J PHARMACOL, V102, P41, DOI 10.1111/j.1476-5381.1991.tb12129.x; COLMERS WF, 1988, J NEUROSCI, V8, P3827; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; GELPERIN A, 1967, SCIENCE, V157, P208, DOI 10.1126/science.157.3785.208; GELPERIN A, 1971, Z VERGL PHYSIOL, V72, P17, DOI 10.1007/BF00299201; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HINDE RA, 1966, ANIMAL BEHAVIOUR SYN; HUBER F, 1967, INVERTEBRATE NERVOUS, P333; Hull C.L., 1951, ESSENTIALS BEHAV; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kalra SP, 1997, NEURON, V19, P227, DOI 10.1016/S0896-6273(00)80934-4; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; KENNEDY JS, 1987, PERSPECTIVES CHEMORE; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KLAPSTEIN GJ, 1993, HIPPOCAMPUS, V3, P103, DOI 10.1002/hipo.450030111; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levin BE, 2006, DIABETES, V55, pS122, DOI 10.2337/db06-S016; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; LORENZ KZ, 1950, SYM SOC EXP BIOL, V4, P221; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Martin JR, 1998, LEARN MEMORY, V5, P179; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Qian J, 1997, J NEUROSCI, V17, P8169; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Rhim H, 1997, J NEUROSCI, V17, P2980; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roeder KD, 1955, SCI MON, V80, P362; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; SANACORA G, 1990, ENDOCRINOLOGY, V127, P730, DOI 10.1210/endo-127-2-730; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Sun QQ, 2003, J NEUROSCI, V23, P9639; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Toates F., 1986, MOTIVATIONAL SYSTEMS; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Watts Alan G., 2003, HDB BRAIN THEORY NEU, P680; Weintraub D, 2008, ANN NEUROL, V64, pS93, DOI 10.1002/ana.21454; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	82	375	387	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					416	427		10.1016/j.cell.2009.08.035	http://dx.doi.org/10.1016/j.cell.2009.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837040	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000270857500023
J	Funsten, HO; Allegrini, F; Crew, GB; DeMajistre, R; Frisch, PC; Fuselier, SA; Gruntman, M; Janzen, P; McComas, DJ; Mobius, E; Randol, B; Reisenfeld, DB; Roelof, EC; Schwadron, NA				Funsten, H. O.; Allegrini, F.; Crew, G. B.; DeMajistre, R.; Frisch, P. C.; Fuselier, S. A.; Gruntman, M.; Janzen, P.; McComas, D. J.; Moebius, E.; Randol, B.; Reisenfeld, D. B.; Roelof, E. C.; Schwadron, N. A.			Structures and Spectral Variations of the Outer Heliosphere in IBEX Energetic Neutral Atom Maps	SCIENCE			English	Article							TERMINATION SHOCK; SOLAR-WIND	The Interstellar Boundary Explorer ( IBEX) has obtained all-sky images of energetic neutral atoms emitted from the heliosheath, located between the solar wind termination shock and the local interstellar medium (LISM). These flux maps reveal distinct nonthermal (0.2 to 6 kilo-electron volts) heliosheath proton populations with spectral signatures ordered predominantly by ecliptic latitude. The maps show a globally distributed population of termination-shock-heated protons and a superimposed ribbonlike feature that forms a circular arc in the sky centered on ecliptic coordinate (longitude lambda, latitude beta) = (221 degrees, 39 degrees), probably near the direction of the LISM magnetic field. Over the IBEX energy range, the ribbon's nonthermal ion pressure multiplied by its radial thickness is in the range of 70 to 100 picodynes per square centimeter AU ( AU, astronomical unit), which is significantly larger than the 30 to 60 picodynes per square centimeter AU of the globally distributed population.	[Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Allegrini, F.; McComas, D. J.; Randol, B.] SW Res Inst, San Antonio, TX 78228 USA; [Allegrini, F.; McComas, D. J.; Randol, B.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Crew, G. B.] MIT, Cambridge, MA 02139 USA; [DeMajistre, R.; Roelof, E. C.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Frisch, P. C.] Univ Chicago, Chicago, IL 60637 USA; [Fuselier, S. A.] Lockheed Martin Adv Technol ogy Ctr, Palo Alto, CA 94304 USA; [Gruntman, M.] Univ So Calif, Los Angeles, CA 90089 USA; [Janzen, P.; Reisenfeld, D. B.] Univ Montana, Missoula, MT 59812 USA; [Moebius, E.] Univ New Hampshire, Durham, NH 03824 USA; [Schwadron, N. A.] Boston Univ, Boston, MA 02215 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Chicago; University of Southern California; University of Montana System; University of Montana; University System Of New Hampshire; University of New Hampshire; Boston University	Funsten, HO (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	hfunsten@lanl.gov	Reisenfeld, Daniel/F-7614-2015; Roelof, Edmond/G-6654-2019; McComas, David J/H-6202-2011; demajistre, robert/AAJ-7083-2020; Gruntman, Mike/A-5426-2008; Funsten, Herbert O/A-5702-2015	Roelof, Edmond/0000-0002-2270-0652; McComas, David J/0000-0001-6160-1158; demajistre, robert/0000-0003-0191-0287; Gruntman, Mike/0000-0002-0830-010X; Funsten, Herbert O/0000-0002-6817-1039; Moebius, Eberhard/0000-0002-2745-6978; Crew, Geoffrey/0000-0002-2079-3189; Allegrini, Frederic/0000-0003-0696-4380	NASA Explorer Program; U. S. Department of Energy	NASA Explorer Program(National Aeronautics & Space Administration (NASA)); U. S. Department of Energy(United States Department of Energy (DOE))	We thank all the IBEX team members, who enabled the success of IBEX through their individual talents, dedication, and hard work. This work was funded by the NASA Explorer Program. Work at Los Alamos was performed under the auspices of the U. S. Department of Energy.	Decker RB, 2008, NATURE, V454, P67, DOI 10.1038/nature07030; Funsten HO, 2009, SPACE SCI REV, V146, P75, DOI 10.1007/s11214-009-9504-y; Fuselier SA, 2009, SCIENCE, V326, P962, DOI 10.1126/science.1180981; Fuselier SA, 2009, SPACE SCI REV, V146, P117, DOI 10.1007/s11214-009-9495-8; Gruntman M, 1997, REV SCI INSTRUM, V68, P3617, DOI 10.1063/1.1148389; Gruntman M, 2001, J GEOPHYS RES-SPACE, V106, P15767, DOI 10.1029/2000JA000328; Gurnett DA, 2006, AIP CONF PROC, V858, P129; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; Lindsay BG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011298; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; McComas DJ, 2009, SPACE SCI REV, V146, P11, DOI 10.1007/s11214-009-9499-4; McComas DJ, 1998, GEOPHYS RES LETT, V25, P1, DOI 10.1029/97GL03444; Muller HR, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010269; Schwadron NA, 2009, SCIENCE, V326, P966, DOI 10.1126/science.1180986; Schwadron NA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016499	15	186	188	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					964	966		10.1126/science.1180927	http://dx.doi.org/10.1126/science.1180927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833918				2022-12-28	WOS:000271712300030
J	Srivastava, R				Srivastava, Ranjana			The Service.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Melbourne, Vic, Australia.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1922	1923		10.1056/NEJMp0904867	http://dx.doi.org/10.1056/NEJMp0904867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518AI	19907041				2022-12-28	WOS:000271660500003
J	Vedula, SS; Bero, L; Scherer, RW; Dickersin, K				Vedula, S. Swaroop; Bero, Lisa; Scherer, Roberta W.; Dickersin, Kay			Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAINFUL DIABETIC-NEUROPATHY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; PHARMACEUTICAL-INDUSTRY; MIGRAINE PROPHYLAXIS; BIPOLAR DISORDER; PUBLICATION; REGISTRATION	Background: There is good evidence of selective outcome reporting in published reports of randomized trials. Methods: We examined reporting practices for trials of gabapentin funded by Pfizer and Warner-Lambert's subsidiary, Parke-Davis (hereafter referred to as Pfizer and Parke-Davis) for off-label indications (prophylaxis against migraine and treatment of bipolar disorders, neuropathic pain, and nociceptive pain), comparing internal company documents with published reports. Results: We identified 20 clinical trials for which internal documents were available from Pfizer and Parke-Davis; of these trials, 12 were reported in publications. For 8 of the 12 reported trials, the primary outcome defined in the published report differed from that described in the protocol. Sources of disagreement included the introduction of a new primary outcome (in the case of 6 trials), failure to distinguish between primary and secondary outcomes (2 trials), relegation of primary outcomes to secondary outcomes (2 trials), and failure to report one or more protocol-defined primary outcomes (5 trials). Trials that presented findings that were not significant (P greater/equal 0.05) for the protocol-defined primary outcome in the internal documents either were not reported in full or were reported with a changed primary outcome. The primary outcome was changed in the case of 5 of 8 published trials for which statistically significant differences favoring gabapentin were reported. Of the 21 primary outcomes described in the protocols of the published trials, 6 were not reported at all and 4 were reported as secondary outcomes. Of 28 primary outcomes described in the published reports, 12 were newly introduced. Conclusions: We identified selective outcome reporting for trials of off-label use of gabapentin. This practice threatens the validity of evidence for the effectiveness of off-label interventions. N Engl J Med 2009;361:1963-71.	[Vedula, S. Swaroop; Scherer, Roberta W.; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Dept Epidemiol, Baltimore, MD USA; [Bero, Lisa] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bero, Lisa] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vedula, SS (corresponding author), 615 N Wolfe St, Baltimore, MD 21205 USA.	svedula@jhsph.edu		Bero, Lisa/0000-0003-1893-6651				Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; BACKONJA M, 2002, EUR J NEUROL S2, V9, P191; BACKONJA M, 1997, 16 ANN SCI M AM PAIN; Caraceni A, 2004, J CLIN ONCOL, V22, P2909, DOI 10.1200/jco.2004.08.141; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dallocchio C, 2000, J PAIN SYMPTOM MANAG, V20, P280, DOI 10.1016/S0885-3924(00)00181-0; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K, 1993, ONLINE J CURR CLIN T, V31, P4967; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Evans Scott, 2007, PLoS Clin Trials, V2, pe18, DOI 10.1371/journal.pctr.0020018; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P284; Gomez-Perez FJ, 2004, BRIT J DIABETES VASC, V4, P173; GOMEZPEREZ FJ, 2002, 5 INT C MECH TREATM; GORDH TE, 2002, 10 WORLD C PAIN SAN; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Gorson KC, 1999, J NEUROL NEUROSUR PS, V66, P251, DOI 10.1136/jnnp.66.2.251; Gorson KC, 1998, NEUROLOGY, V50, pA103; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P1258; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mathew NT, 1999, CEPHALALGIA, V19, P380; Mathew NT, 2001, HEADACHE, V41, P119, DOI 10.1046/j.1526-4610.2001.111006119.x; MATHEW NT, 1998, 17 ANN SCI M AM PAIN; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Pande AC, 2000, BIPOLAR DISORD, V2, P249, DOI 10.1034/j.1399-5618.2000.20305.x; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Rising K, 2009, PLOS MED, V6, P117, DOI 10.1371/journal.pmed.1000017; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Serpell MG, 2002, PAIN, V99, P557, DOI 10.1016/S0304-3959(02)00255-5; SERPELL MG, 2002, 5 INT C MECH TREATM; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vieta E, 2006, J CLIN PSYCHIAT, V67, P473, DOI 10.4088/JCP.v67n0320; Wang PW, 2002, BIPOLAR DISORD, V4, P296, DOI 10.1034/j.1399-5618.2002.01211.x; Wessely P, 1987, CEPHALALGIA, V7, P477; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]	49	232	235	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1963	1971		10.1056/NEJMsa0906126	http://dx.doi.org/10.1056/NEJMsa0906126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907043	Bronze			2022-12-28	WOS:000271660500010
J	Archer, SL; Michelakis, ED				Archer, Stephen L.; Michelakis, Evangelos D.			Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL SILDENAFIL; INHALED ILOPROST; NITRIC-OXIDE; THERAPY; EXPRESSION; PDE5; PROLIFERATION; DYSFUNCTION; ACTIVATION; BOSENTAN	A 46-year-old woman presents with progressive exertional dyspnea and recurrent exertional syncope. Her jugular venous pressure is 16 cm of water, and moderate peripheral edema is noted. Auscultation reveals a pronounced pulmonic component of the second heart sound and a grade 2/6 holosystolic murmur of tricuspid regurgitation. Echocardiography shows moderate right ventricular and right atrial enlargement, right ventricular systolic dysfunction, and an estimated right ventricular systolic pressure of 100 mm Hg. Cardiac catheterization reveals a mean right atrial pressure of 13 mm Hg, a pulmonary-artery pressure of 80/40 mm Hg (mean, 58), a mean pulmonary-capillary wedge pressure of 10 mm Hg, and a cardiac output of 5 liters per minute. The results of additional studies to detect causes of secondary pulmonary hypertension or associated conditions are unremarkable, and she receives a diagnosis of idiopathic pulmonary arterial hypertension. Her pulmonary- artery pressure does not decrease in response to inhaled nitric oxide. Therapy with sildenafil is recommended.	[Archer, Stephen L.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Michelakis, Evangelos D.] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada	University of Chicago; University of Alberta	Archer, SL (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, 5841 S Maryland Ave MC6080, Chicago, IL 60637 USA.	sarcher@medicine.bsd.uchicago.edu	Archer, Stephen L/C-3621-2013		Canadian Institutes of Health Research; American Heart Association; Roche Foundation for Anemia Research; National Institutes of Health [NIH-RO1-HL071115, 1RC1HL099462-01]; Canada Foundation for Innovation; Alberta Heart and Stroke Foundation; Alberta Heritage Foundation for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071115, RC1HL099462] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Roche Foundation for Anemia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Heart and Stroke Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the Canadian Institutes of Health Research ( to Drs. Archer and Michelakis), the American Heart Association ( to Dr. Archer), the Roche Foundation for Anemia Research ( to Dr. Archer), the National Institutes of Health (NIH-RO1-HL071115 and 1RC1HL099462-01, to Dr. Archer), the Canada Foundation for Innovation ( to Dr. Michelakis), the Alberta Heart and Stroke Foundation ( to Dr. Michelakis), and the Alberta Heritage Foundation for Medical Research ( to Dr. Michelakis).	Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Black SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1051, DOI 10.1152/ajplung.2001.281.5.L1051; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Butrous G, 2008, CIRCULATION, V118, P1758, DOI 10.1161/CIRCULATIONAHA.107.727289; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; European Medicines Agency, REV PROD INF; Galie N, 2006, NEW ENGL J MED, V354, P1092; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2003, J AM COLL CARDIOL, V42, P158, DOI 10.1016/S0735-1097(03)00555-2; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Gomberg-Maitland M, 2005, AM J CARDIOL, V96, P1334, DOI 10.1016/j.amjcard.2005.06.083; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Kalra PR, 2002, INT J CARDIOL, V85, P195, DOI 10.1016/S0167-5273(02)00182-1; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Macchia A, 2007, AM HEART J, V153, P1037, DOI 10.1016/j.ahj.2007.02.037; McLaughlin, 2009, CIRCULATION, V120, pE13, DOI 10.1161/CIRCULATIONAHA.109.192587; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; Michelakis ED, 2006, CIRC RES, V98, P172, DOI 10.1161/01.RES.0000204572.65400.a5; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Murray F, 2002, BRIT J PHARMACOL, V137, P1187, DOI 10.1038/sj.bjp.0704984; Mylona P, 1999, EUR J HEART FAIL, V1, P197, DOI 10.1016/S1388-9842(99)00022-7; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Paul GA, 2005, BRIT J CLIN PHARMACO, V60, P107, DOI 10.1111/j.1365-2125.2005.02383.x; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Rich S, 2008, CIRCULATION, V118, P2190, DOI 10.1161/CIRCULATIONAHA.107.723007; Sanchez LS, 1998, PEDIATR RES, V43, P163, DOI 10.1203/00006450-199802000-00002; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Simonneau G, 2009, ANN INTERN MED, V150, P63, DOI 10.7326/0003-4819-150-1-200901060-00024; Simonneau G, 2008, ANN INTERN MED, V149, P521, DOI 10.7326/0003-4819-149-8-200810210-00004; Tedford RJ, 2008, CIRC-HEART FAIL, V1, P213, DOI 10.1161/CIRCHEARTFAILURE.108.796789; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Voelkel NF, 1998, CHEST, V114, p225S, DOI 10.1378/chest.114.3_Supplement.225S; Wang C, 2008, J PHARMACOL SCI, V108, P71, DOI 10.1254/jphs.08069FP; Welsh DJ, 2004, AM J RESP CRIT CARE, V170, P252, DOI 10.1164/rccm.200302-264OC; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC	42	157	162	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1864	1871		10.1056/NEJMct0904473	http://dx.doi.org/10.1056/NEJMct0904473			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890129				2022-12-28	WOS:000271405800011
J	Parrish, DD; Zhu, T				Parrish, David D.; Zhu, Tong			Clean Air for Megacities	SCIENCE			English	Editorial Material							BLACK CARBON; POLLUTION; CITIES; LIFE; CITY		[Parrish, David D.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA; [Zhu, Tong] Peking Univ, State Key Lab Environm Simulat & Pollut Control, Coll Environm Sci & Engn, Beijing 100871, Peoples R China	National Oceanic Atmospheric Admin (NOAA) - USA; Peking University	Parrish, DD (corresponding author), NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA.	david.d.parrish@noaa.gov; tzhu@pku.edu.cn	Parrish, David/E-8957-2010; ZHU, TONG/H-6501-2011	Parrish, David/0000-0001-6312-2724; ZHU, TONG/0000-0002-2752-7924				Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; *BEIJ MUN ENV PROT, COMM ENV STAT BEIJ 1; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bravo HA, 2000, ATMOS ENVIRON, V34, P499, DOI 10.1016/S1352-2310(99)00382-9; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Marshall JD, 2008, ENVIRON SCI TECHNOL, V42, P3133, DOI 10.1021/es087047l; Molina MJ, 2004, J AIR WASTE MANAGE, V54, P644, DOI 10.1080/10473289.2004.10470936; PANDEY KD, 2006, AMBIENT PARTICULATE; PARRISH DD, 2009, ATMOS ENV; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Shao M, 2006, FRONT ECOL ENVIRON, V4, P353, DOI 10.1890/1540-9295(2006)004[0353:CCICAA]2.0.CO;2; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Stevenson DS, 1998, GEOPHYS RES LETT, V25, P3819, DOI 10.1029/1998GL900037; Stoeger T, 2006, ENVIRON HEALTH PERSP, V114, P328, DOI 10.1289/ehp.8266; UN, 2008, WORLD URB PROSP 2007; *UN POP DIV, WORLD URB PROSP 2007	20	158	196	13	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					674	675		10.1126/science.1176064	http://dx.doi.org/10.1126/science.1176064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900921				2022-12-28	WOS:000271233200021
J	Schmeing, TM; Voorhees, RM; Kelley, AC; Gao, YG; Murphy, FV; Weir, JR; Ramakrishnan, V				Schmeing, T. Martin; Voorhees, Rebecca M.; Kelley, Ann C.; Gao, Yong-Gui; Murphy, Frank V., IV; Weir, John R.; Ramakrishnan, V.			The Crystal Structure of the Ribosome Bound to EF-Tu and Aminoacyl-tRNA	SCIENCE			English	Article							ELONGATION-FACTOR TU; GTPASE ACTIVATION; ESCHERICHIA-COLI; ACTIVE-ROLE; CROSS-LINK; SELECTION; HYDROLYSIS; BINDING; COMPLEX; RECOGNITION	The ribosome selects a correct transfer RNA (tRNA) for each amino acid added to the polypeptide chain, as directed by messenger RNA. Aminoacyl-tRNA is delivered to the ribosome by elongation factor Tu (EF-Tu), which hydrolyzes guanosine triphosphate (GTP) and releases tRNA in response to codon recognition. The signaling pathway that leads to GTP hydrolysis upon codon recognition is critical to accurate decoding. Here we present the crystal structure of the ribosome complexed with EF-Tu and aminoacyl-tRNA, refined to 3.6 angstrom resolution. The structure reveals details of the tRNA distortion that allows aminoacyl-tRNA to interact simultaneously with the decoding center of the 30S subunit and EF-Tu at the factor binding site. A series of conformational changes in EF-Tu and aminoacyl-tRNA suggests a communication pathway between the decoding center and the guanosine triphosphatase center of EF-Tu.	[Schmeing, T. Martin; Voorhees, Rebecca M.; Kelley, Ann C.; Gao, Yong-Gui; Murphy, Frank V., IV; Weir, John R.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramakr@mrc-lmb.cam.ac.uk	Weir, John R./AAF-5435-2020; Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011	Weir, John R./0000-0002-6904-0284; Gao, Yonggui/0000-0001-7298-0835; Ramakrishnan, V/0000-0002-4699-2194; VOORHEES, REBECCA/0000-0003-1640-2293	Medical Research Council U. K.; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Gates-Cambridge scholarship; Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	Medical Research Council U. K.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Gates-Cambridge scholarship; Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge(University of Cambridge); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. M. Babu and P. Lukavski for help with data analysis, G. Leonard and S. Brockhauser for their guidance and advice with data collection at the European Synchrotron Light Source beamline ID14.4, C. Schulze-Briese and A. Pauluhn for help with initial diffraction studies performed at the Swiss Light Source, and L. Ulisko for preparation of additional images. This work was supported by the Medical Research Council U. K., the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. R. M. V. is the recipient of a Gates-Cambridge scholarship; T. M. S. received support from the Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge; and V. R. holds stock options and is on the Scientific Advisory Board of Rib-X Pharmaceuticals, a company dedicated to making antibiotics that target the ribosome. The structure has been deposited at the Protein Data Bank with accession codes 2WRN, 2WRO, 2WRQ, and 2WRR.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; FAVRE A, 1975, NUCLEIC ACIDS RES, V2, P1421, DOI 10.1093/nar/2.8.1421; Gregory ST, 2009, RNA, V15, P208, DOI 10.1261/rna.1355709; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HIRSH D, 1970, NATURE, V228, P57, DOI 10.1038/228057a0; Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Rodnina MV, 2009, P NATL ACAD SCI USA, V106, P969, DOI 10.1073/pnas.0812576106; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Saarma U, 1997, J MOL BIOL, V272, P327, DOI 10.1006/jmbi.1997.1254; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; SCHULTZ DW, 1994, J MOL BIOL, V235, P1381, DOI 10.1006/jmbi.1994.1095; SELMER M, 1935, SCIENCE, V313, P2006, DOI DOI 10.1126/SCIENCE.1131127; SMITH D, 1989, J MOL BIOL, V206, P503, DOI 10.1016/0022-2836(89)90497-X; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; SWART GWM, 1987, BIOCHEMISTRY-US, V26, P2047, DOI 10.1021/bi00381a038; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; VACHER J, 1979, J MOL BIOL, V129, P287; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Vorstenbosch E, 1996, EMBO J, V15, P6766, DOI 10.1002/j.1460-2075.1996.tb01066.x; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zeidler W, 1996, EUR J BIOCHEM, V239, P265, DOI 10.1111/j.1432-1033.1996.0265u.x	43	390	397	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					688	694		10.1126/science.1179700	http://dx.doi.org/10.1126/science.1179700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19833920	Green Accepted			2022-12-28	WOS:000271233200027
J	Murphy, AW; Cupples, ME; Smith, SM; Byrne, M; Byrne, MC; Newell, J				Murphy, A. W.; Cupples, M. E.; Smith, S. M.; Byrne, M.; Byrne, M. C.; Newell, J.		SPHERE Study Team	Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SELF-MANAGEMENT PROGRAM; CARDIOVASCULAR-DISEASE; COMPLEX INTERVENTIONS; MYOCARDIAL-INFARCTION; HEALTH-STATUS; MORTALITY; VALIDITY; IRELAND; PAY	Objective To test the effectiveness of a complex intervention designed, within a theoretical framework, to improve outcomes for patients with coronary heart disease. Design Cluster randomised controlled multicentre trial. Setting General practices in Northern Ireland and the Republic of Ireland, regions with different healthcare systems. Participants 903 patients with established coronary heart disease registered with one of 48 practices. Intervention Tailored care plans for practices ( practice based training in prescribing and behaviour change, administrative support, quarterly newsletter), and tailored care plans for patients ( motivational interviewing, goal identification, and target setting for lifestyle change) with reviews every four months at the practices. Control practices provided usual care. Main outcome measures The proportion of patients at 18 month follow-up above target levels for blood pressure and total cholesterol concentration, and those admitted to hospital, and changes in physical and mental health status (SF-12). Results At baseline the numbers ( \proportions) of patients above the recommended limits were: systolic blood pressure greater than 140 mm Hg (305/899; 33.9%, 95% confidence interval 30.8% to 33.9%), diastolic blood pressure greater than 90 mm Hg (111/901; 12.3%, 10.2% to 14.5%), and total cholesterol concentration greater than 5 mmol/l (188/860; 20.8%, 19.1% to 24.6%). At the 18 month follow-up there were no significant differences between intervention and control groups in the numbers (proportions) of patients above the recommended limits: systolic blood pressure, intervention 98/360 (27.2%) v control, 133/405 (32.8%), odds ratio 1.51 ( 95% confidence interval 0.99 to 2.30; P=0.06); diastolic blood pressure, intervention 32/360 (8.9%) v control, 40/405 (9.9%), 1.40 (0.75 to 2.64; P=0.29); and total cholesterol concentration, intervention 52/342 (15.2%) v control, 64/391 (16.4%), 1.13 (0.63 to 2.03; P=0.65). The number of patients admitted to hospital over the 18 month study period significantly decreased in the intervention group compared with the control group: 107/415 (25.8%) v 148/435 (34.0%), 1.56 (1.53 to 2.60; P=0.03). Conclusions Admissions to hospital were significantly reduced after an intensive 18 month intervention to improve outcomes for patients with coronary heart disease, but no other clinical benefits were shown, possibly because of a ceiling effect related to improved management of the disease. Trial registration Current Controlled Trials ISRCTN24081411 [controlled-trials. com].	[Murphy, A. W.; Byrne, M. C.] Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland; [Cupples, M. E.] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth No Ireland, Belfast BT7 1NN, Antrim, North Ireland; [Smith, S. M.] Univ Dublin Trinity Coll, Dept Publ Hlth & Primary Care, Dublin 2, Ireland; [Byrne, M.] Natl Univ Ireland Univ Coll Galway, Sch Psychol, Galway, Ireland; [Newell, J.] Natl Univ Ireland Univ Coll Galway, Hlth Res Board Clin Res Facil, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Queens University Belfast; Trinity College Dublin; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Murphy, AW (corresponding author), Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland.	andrew.murphy@nuigalway.ie	Smith, Susan/D-1872-2012	Smith, Susan/0000-0001-6027-2727; Cupples, Margaret/0000-0002-4248-9700; Byrne, Molly/0000-0001-8900-4320; Newell, John/0000-0001-7685-6655; Murphy, Andrew/0000-0001-5549-8246	Health Research Board; Irish Heart Foundation; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI	Health Research Board; Irish Heart Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Health Research Board and Irish Heart Foundation. The funders had no part in the design of the study; the collection, analysis, and interpretation of the data; the writing of the report; and the decision to submit the article for publication.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; BUCKLEY B, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006772; BYRNE M, 2005, IRISH J PSYCHOL, V0026; Byrne M, 2006, AM J MANAG CARE, V12, P261; BYRNE M, 2002, 2 NAT U IR DEP GEN P; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Capewell S, 2008, HEART, V94, P8, DOI 10.1136/hrt.2007.123125; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Cupples ME, 2008, HEART, V94, P1594, DOI 10.1136/hrt.2008.145912; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; DeWilde S, 2008, HEART, V94, P83, DOI 10.1136/hrt.2006.111757; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Glynn LG, 2007, NEPHROL DIAL TRANSPL, V22, P2586, DOI 10.1093/ndt/gfm222; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; *HEARTW NAT PROGR, 2006, HEARTW CLIN REP MARC; HOLM S, 1979, SCAND J STAT, V6, P65; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; Khunti K, 2007, HEART, V93, P1398, DOI 10.1136/hrt.2006.106955; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; LEATHEM CS, 2009, PRIMARY HLTH CARE RE, V0010; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; Moher M, 2001, BMJ-BRIT MED J, V322, P1338, DOI 10.1136/bmj.322.7298.1338; Murphy AW, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-11; ODowd T., 2006, STRUCTURE GEN PRACTI; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schulz KF, 2002, JAMA-J AM MED ASSOC, V288, P2406, DOI 10.1001/jama.288.19.2406; Smith SM, 2007, BRIT J GEN PRACT, V57, P268; Wheeler JRC, 2003, MED CARE, V41, P706	40	65	67	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2009	339								b4220	10.1136/bmj.b4220	http://dx.doi.org/10.1136/bmj.b4220			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AO	19875426	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000271365900004
J	Klein, MB; Kramer, CB; Nelson, J; Rivara, FP; Gibran, NS; Concannon, T				Klein, Matthew B.; Kramer, C. Bradley; Nelson, Jason; Rivara, Frederick P.; Gibran, Nicole S.; Concannon, Thomas			Geographic Access to Burn Center Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMA; TRANSPORT; CARE; RESUSCITATION; INJURIES; TIMES	Context The delivery of burn care is a resource-intensive endeavor that requires specialized personnel and equipment. The optimal geographic distribution of burn centers has long been debated; however, the current distribution of centers relative to geographic area and population is unknown. Objective To estimate the proportion of the US population living within 1 and 2 hours by rotary air transport ( helicopter) or ground transport of a burn care facility. Design and Setting A cross-sectional analysis of geographic access to US burn centers utilizing the 2000 US census, road and speed limit data, the Atlas and Database of Air Medical Services database, and the 2008 American Burn Association Directory. Main Outcome Measure The proportion of state, regional, and national population living within 1 and 2 hours by air transport or ground transport of a burn care facility. Results In 2008, there were 128 self-reported burn centers in the United States including 51 American Burn Association-verified centers. An estimated 25.1% and 46.3% of the US population live within 1 and 2 hours by ground transport, respectively, of a verified burn center. By air, 53.9% and 79.0% of the population live within 1 and 2 hours, respectively, of a verified center. There was significant regional variation in access to verified burn centers by both ground and rotary air transport. The greatest proportion of the population with access was highest in the northeast region and lowest in the southern United States. Conclusion Nearly 80% of the US population lives within 2 hours by ground or rotary air transport of a verified burn center; however, there is both state and regional variation in geographic access to these centers. JAMA. 2009; 302( 16):1774-1781 www.jama.com	[Klein, Matthew B.; Kramer, C. Bradley; Gibran, Nicole S.] Univ Washington, Burn Ctr, Seattle, WA 98195 USA; [Klein, Matthew B.] Univ Washington, Div Plast Surg, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Nelson, Jason; Concannon, Thomas] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Nelson, Jason; Concannon, Thomas] Tufts Med Ctr, Boston, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tufts University; Tufts Medical Center	Klein, MB (corresponding author), Harborview Med Ctr, UW Burn Ctr, 325 Ninth Ave,POB 359796, Seattle, WA 98104 USA.	mbklein@u.washington.edu	Concannon, Thomas/A-1610-2013		National Center for Research Resources [1KL2RR025015-01]; Centers for Disease Control and Prevention [R49/CE000197]; David and Nancy Auth-Washington Research Foundation Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); David and Nancy Auth-Washington Research Foundation Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources grant 1KL2RR025015-01, Harborview Injury Prevention and Research Center (HIPRC) grant R49/CE000197 from the Centers for Disease Control and Prevention, and by the David and Nancy Auth-Washington Research Foundation Endowment.	*AM BURN ASS, BURN CAR FAC US; American Burn Association, BURN INC TREATM US 2; Berkebile B L, 1986, J Burn Care Rehabil, V7, P411, DOI 10.1097/00004630-198609000-00007; Branas CC, 2000, HEALTH SERV RES, V35, P489; Branas Charles C, 2005, LDI Issue Brief, V11, P1; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; *CTR TRANSP INJ RE, 2006, ATL DAT AIR MED SERV; Diaz MA, 2005, J TRAUMA, V58, P148, DOI 10.1097/01.TA.0000124264.43941.41; Falcone R E, 1998, Air Med J, V17, P161, DOI 10.1016/S1067-991X(98)90043-8; Faucher LD, 2004, J BURN CARE REHABIL, V25, P464, DOI 10.1097/01.BCR.0000144534.93523.DC; HAMMOND JS, 1987, J TRAUMA, V27, P1161, DOI 10.1097/00005373-198710000-00011; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; KEARNEY PA, 1991, ANN EMERG MED, V20, P882, DOI 10.1016/S0196-0644(05)81431-3; Klein MB, 2006, BURNS, V32, P940, DOI 10.1016/j.burns.2006.04.001; Klein MB, 2007, J BURN CARE RES, V28, P49, DOI 10.1097/BCR.0B013E31802C894B; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; O'Mara MS, 2005, J TRAUMA, V58, P1011, DOI 10.1097/01.TA.0000162732.39083.15; PALMER JH, 1987, INJURY, V18, P250, DOI 10.1016/0020-1383(87)90008-8; Pruitt B A Jr, 1979, J Trauma, V19, P868; Pruitt BA, 2000, J TRAUMA, V49, P567, DOI 10.1097/00005373-200009000-00030; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Saffle JR, 2004, J TRAUMA, V57, P57, DOI 10.1097/01.TA.0000103992.21727.8F; Sheridan R, 1999, J BURN CARE REHABIL, V20, P347, DOI 10.1097/00004630-199909000-00002; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; The American College of Surgeons, 2006, RES OPT CAR INJ PAT; Warden GD, 2003, J BURN CARE REHABIL, V24, P173, DOI 10.1097/01.BCR.0000066784.94077.C6; Wong K, 2004, ANZ J SURG, V74, P318, DOI 10.1111/j.1445-1433.2003.02738.x; Young JS, 1998, AM SURGEON, V64, P88; ZONIES D, 2009, J BURN CARE RES, V30, pS85, DOI DOI 10.1097/BCR0B013E3181998FC2	29	84	84	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1774	1781		10.1001/jama.2009.1548	http://dx.doi.org/10.1001/jama.2009.1548			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861669	Bronze, Green Accepted			2022-12-28	WOS:000271150300020
J	Searchinger, TD; Hamburg, SP; Melillo, J; Chameides, W; Havlik, P; Kammen, DM; Likens, GE; Lubowski, RN; Obersteiner, M; Oppenheimer, M; Robertson, GP; Schlesinger, WH; Tilman, GD				Searchinger, Timothy D.; Hamburg, Steven P.; Melillo, Jerry; Chameides, William; Havlik, Petr; Kammen, Daniel M.; Likens, Gene E.; Lubowski, Ruben N.; Obersteiner, Michael; Oppenheimer, Michael; Robertson, G. Philip; Schlesinger, William H.; Tilman, G. David			Fixing a Critical Climate Accounting Error	SCIENCE			English	Editorial Material							LAND-USE		[Searchinger, Timothy D.; Oppenheimer, Michael] Princeton Univ, Princeton, NJ 08544 USA; [Hamburg, Steven P.; Lubowski, Ruben N.] Environm Def Fund, Boston, MA 02108 USA; [Melillo, Jerry] Marine Biol Lab, Woods Hole, MA 02543 USA; [Chameides, William] Duke Univ, Durham, NC 27708 USA; [Havlik, Petr; Obersteiner, Michael] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Kammen, Daniel M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Likens, Gene E.; Schlesinger, William H.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Robertson, G. Philip] Michigan State Univ, Hickory Corners, MI 49060 USA; [Tilman, G. David] Univ Minnesota, St Paul, MN 55108 USA	Princeton University; Environmental Defense Fund; Marine Biological Laboratory - Woods Hole; Duke University; International Institute for Applied Systems Analysis (IIASA); University of California System; University of California Berkeley; Cary Institute of Ecosystem Studies; Michigan State University; University of Minnesota System; University of Minnesota Twin Cities	Searchinger, TD (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	tsearchi@princeton.edu; shamburg@edf.org	Robertson, G Philip/H-3885-2011; Tilman, David/ABD-5309-2021	Robertson, G Philip/0000-0001-9771-9895; Oppenheimer, Michael/0000-0002-9708-5914; Obersteiner, Michael/0000-0001-6981-2769; Havlik, Petr/0000-0001-5551-5085				Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; *INT EN AG, 2008, EN TECHN PERSP SUPP; *IPCC, 2007, 2006 IPCC GUID NAT G; MANICHETTI E, 2009, BIOFUELS ENV SEQUENC, P81; MELILLO JM, 2009, MIT JOINT PROGRAM RE; Searchinger T, 2009, BIOFUELS ENV CONSEQU, P37; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; *UNFCC, 2002, REP C PART ITS 7 SES; *UNFCC, 2006, UPD UNFCC REP GUID A, P23; Watson RT, 2000, LAND USE LAND USE CH; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	11	306	314	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					527	528		10.1126/science.1178797	http://dx.doi.org/10.1126/science.1178797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19900885				2022-12-28	WOS:000271019400024
J	Yang, Y; Kim, AH; Yamada, T; Wu, B; Bilimoria, PM; Ikeuchi, Y; de la Iglesia, N; Shen, J; Bonni, A				Yang, Yue; Kim, Albert H.; Yamada, Tomoko; Wu, Bei; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; de la Iglesia, Nuria; Shen, Jie; Bonni, Azad			A Cdc20-APC Ubiquitin Signaling Pathway Regulates Presynaptic Differentiation	SCIENCE			English	Article							GROWTH	Presynaptic axonal differentiation is essential for synapse formation and the establishment of neuronal circuits. However, the mechanisms that coordinate presynaptic development in the brain are largely unknown. We found that the major mitotic E3 ubiquitin ligase Cdc20-anaphase promoting complex (Cdc20-APC) regulates presynaptic differentiation in primary postmitotic mammalian neurons and in the rat cerebellar cortex. Cdc20-APC triggered the degradation of the transcription factor NeuroD2 and thereby promoted presynaptic differentiation. The NeuroD2 target gene encoding Complexin II, which acts locally at presynaptic sites, mediated the ability of NeuroD2 to suppress presynaptic differentiation. Thus, our findings define a Cdc20-APC ubiquitin signaling pathway that governs presynaptic development, which holds important implications for neuronal connectivity and plasticity in the brain.	[Yang, Yue; Kim, Albert H.; Yamada, Tomoko; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; de la Iglesia, Nuria; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Yang, Yue; Bilimoria, Parizad M.; Shen, Jie; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kim, Albert H.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Wu, Bei; Shen, Jie] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; Shen, Jie/GXH-9449-2022; Kim, Albert H./HGF-0057-2022; de la Iglesia, Nuria/E-1420-2015; Wu, Bei/F-6659-2012; Ikeuchi, Yoshiho/C-1713-2014	de la Iglesia, Nuria/0000-0002-1083-7715; Ikeuchi, Yoshiho/0000-0002-2829-3840; Yang, Yue/0000-0002-6201-8818	NIH [NS051255, NS041021]; NSF; Lefler Fellowship; Ryan Foundation; National Research Service Award Research Training; National Cancer Institute, and Brain Science Foundation; Japan Society for the Promotion of Science; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255, R01NS041021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Lefler Fellowship; Ryan Foundation; National Research Service Award Research Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, and Brain Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Bonni laboratory for helpful discussions. This work was supported by NIH grants NS051255 and NS041021 ( A. B.); a NSF fellowship, the Lefler Fellowship, and the Ryan Foundation ( Y. Y.); a National Research Service Award Research Training grant, National Cancer Institute, and Brain Science Foundation grant ( A. H. K.); the Japan Society for the Promotion of Science ( T. Y.); and a Human Frontier Science Program long-term fellowship ( Y. I.).	Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lin CH, 2005, P NATL ACAD SCI USA, V102, P14877, DOI 10.1073/pnas.0506785102; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	10	95	99	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					575	578		10.1126/science.1177087	http://dx.doi.org/10.1126/science.1177087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900895	Green Accepted			2022-12-28	WOS:000271019400042
J	Friston, KJ				Friston, Karl J.			Modalities, Modes, and Models in Functional Neuroimaging	SCIENCE			English	Review							HUMAN BRAIN; COMPONENT ANALYSIS; DEFAULT MODE; NEURAL BASIS; FMRI; CONNECTIVITY; REWARD; MRI; INFORMATION; NETWORK	In this, the 21st century, human-brain mapping celebrates 21 years of cognitive activation studies. This review looks at imaging neuroscience and key ideas it has pursued; some ideas portend exciting developments, and others have failed gloriously. In terms of achievements, there is much to celebrate, in the sense that it is difficult to imagine modern neuroscience without brain imaging. I will look at recent advances from the perspectives of functional segregation and integration in the brain, paying special attention to approaches that deal with the distributed and integrated nature of neuronal processing and the questions they address.	UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of London; University College London	Friston, KJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Queen Sq, London WC1N 3BG, England.	k.friston@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	J. F. is funded by the Wellcome Trust. I would like to thank M. Bennett for preparing this manuscript and the reviewers for guidance in improving its presentation.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adams RW, 2009, SCIENCE, V323, P1708, DOI 10.1126/science.1168877; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodurka J, 2002, MAGNET RESON MED, V47, P1052, DOI 10.1002/mrm.10159; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Delgado MR, 2008, SCIENCE, V321, P1849, DOI 10.1126/science.1158860; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Grafton ST, 2008, NEUROIMAGE, V39, P1383, DOI 10.1016/j.neuroimage.2007.09.062; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Heller L, 2009, HUM BRAIN MAPP, V30, P1, DOI 10.1002/hbm.20484; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; JIRSA V, 2007, HDB BRAIN CONNECTIVI; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laufs H, 2008, NEUROIMAGE, V40, P515, DOI 10.1016/j.neuroimage.2007.11.039; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Lemieux L, 2004, NEUROIMAG CLIN N AM, V14, P487, DOI 10.1016/j.nic.2004.04.009; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Miller MI, 2009, NEUROIMAGE, V45, pS16, DOI 10.1016/j.neuroimage.2008.10.044; Moran RJ, 2008, NEUROIMAGE, V42, P272, DOI 10.1016/j.neuroimage.2008.01.025; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Nandy RR, 2003, MAGNET RESON MED, V50, P354, DOI 10.1002/mrm.10537; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Taylor JE, 2007, J AM STAT ASSOC, V102, P913, DOI 10.1198/016214507000000815; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; Van Horn JD, 2001, PHILOS T R SOC B, V356, P1323, DOI 10.1098/rstb.2001.0916; Wipf D, 2009, NEUROIMAGE, V44, P947, DOI 10.1016/j.neuroimage.2008.02.059	46	290	300	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					399	403		10.1126/science.1174521	http://dx.doi.org/10.1126/science.1174521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833961				2022-12-28	WOS:000270818600045
J	Acciari, VA; Aliu, E; Arlen, T; Aune, T; Bautista, M; Beilicke, M; Benbow, W; Boltuch, D; Bradbury, SM; Buckley, JH; Bugaev, V; Byrum, K; Cannon, A; Celik, O; Cesarini, A; Chow, YC; Ciupik, L; Cogan, P; Colin, P; Cui, W; Dickherber, R; Duke, C; Fegan, SJ; Finley, JP; Finnegan, G; Fortin, P; Fortson, L; Furniss, A; Galante, N; Gall, D; Gibbs, K; Gillanders, GH; Godambe, S; Grube, J; Guenette, R; Gyuk, G; Hanna, D; Holder, J; Horan, D; Hui, CM; Humensky, TB; Imran, A; Kaaret, P; Karlsson, N; Kertzman, M; Kieda, D; Kildea, J; Konopelko, A; Krawczynski, H; Krennrich, F; Lang, MJ; LeBohec, S; Maier, G; McArthur, S; McCann, A; McCutcheon, M; Millis, J; Moriarty, P; Mukherjee, R; Nagai, T; Ong, RA; Otte, AN; Pandel, D; Perkins, JS; Pizlo, F; Pohl, M; Quinn, J; Ragan, K; Reyes, LC; Reynolds, PT; Roache, E; Rose, HJ; Schroedter, M; Sembroski, GH; Smith, AW; Steele, D; Swordy, SP; Theiling, M; Thibadeau, S; Varlotta, A; Vassiliev, VV; Vincent, S; Wagner, RG; Wakely, SP; Ward, JE; Weekes, TC; Weinstein, A; Weisgarber, T; Williams, DA; Wissel, S; Wood, M; Zitzer, B				Acciari, V. A.; Aliu, E.; Arlen, T.; Aune, T.; Bautista, M.; Beilicke, M.; Benbow, W.; Boltuch, D.; Bradbury, S. M.; Buckley, J. H.; Bugaev, V.; Byrum, K.; Cannon, A.; Celik, O.; Cesarini, A.; Chow, Y. C.; Ciupik, L.; Cogan, P.; Colin, P.; Cui, W.; Dickherber, R.; Duke, C.; Fegan, S. J.; Finley, J. P.; Finnegan, G.; Fortin, P.; Fortson, L.; Furniss, A.; Galante, N.; Gall, D.; Gibbs, K.; Gillanders, G. H.; Godambe, S.; Grube, J.; Guenette, R.; Gyuk, G.; Hanna, D.; Holder, J.; Horan, D.; Hui, C. M.; Humensky, T. B.; Imran, A.; Kaaret, P.; Karlsson, N.; Kertzman, M.; Kieda, D.; Kildea, J.; Konopelko, A.; Krawczynski, H.; Krennrich, F.; Lang, M. J.; LeBohec, S.; Maier, G.; McArthur, S.; McCann, A.; McCutcheon, M.; Millis, J.; Moriarty, P.; Mukherjee, R.; Nagai, T.; Ong, R. A.; Otte, A. N.; Pandel, D.; Perkins, J. S.; Pizlo, F.; Pohl, M.; Quinn, J.; Ragan, K.; Reyes, L. C.; Reynolds, P. T.; Roache, E.; Rose, H. J.; Schroedter, M.; Sembroski, G. H.; Smith, A. W.; Steele, D.; Swordy, S. P.; Theiling, M.; Thibadeau, S.; Varlotta, A.; Vassiliev, V. V.; Vincent, S.; Wagner, R. G.; Wakely, S. P.; Ward, J. E.; Weekes, T. C.; Weinstein, A.; Weisgarber, T.; Williams, D. A.; Wissel, S.; Wood, M.; Zitzer, B.		VERITAS Collaboration	A connection between star formation activity and cosmic rays in the starburst galaxy M82	NATURE			English	Article							RADIO; EMISSION; CLUSTERS; MODEL	Although Galactic cosmic rays (protons and nuclei) are widely believed to be mainly accelerated by the winds and supernovae of massive stars, definitive evidence of this origin remains elusive nearly a century after their discovery(1). The active regions of star-burst galaxies have exceptionally high rates of star formation, and their large size-more than 50 times the diameter of similar Galactic regions-uniquely enables reliable calorimetric measurements of their potentially high cosmic-ray density(2). The cosmic rays produced in the formation, life and death of massive stars in these regions are expected to produce diffuse gamma-ray emission through interactions with interstellar gas and radiation. M82, the prototype small starburst galaxy, is predicted(3,4) to be the brightest starburst galaxy in terms of gamma-ray emission. Here we report the detection of >700-GeV gamma-rays from M82. From these data we determine a cosmic-ray density of 250 eV cm(-3) in the starburst core, which is about 500 times the average Galactic density. This links cosmic-ray acceleration to star formation activity, and suggests that supernovae and massive-star winds are the dominant accelerators.	[Acciari, V. A.; Benbow, W.; Galante, N.; Gibbs, K.; Kildea, J.; Perkins, J. S.; Roache, E.; Theiling, M.; Weekes, T. C.] Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA; [Acciari, V. A.; Aliu, E.; Boltuch, D.; Holder, J.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Acciari, V. A.; Aliu, E.; Boltuch, D.; Holder, J.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Acciari, V. A.; Arlen, T.; Celik, O.; Chow, Y. C.; Fegan, S. J.; Ong, R. A.; Vassiliev, V. V.; Weinstein, A.; Wood, M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Aune, T.; Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Aune, T.; Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Bautista, M.; Cogan, P.; Guenette, R.; Hanna, D.; Maier, G.; McCann, A.; McCutcheon, M.; Ragan, K.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Beilicke, M.; Buckley, J. H.; Bugaev, V.; Dickherber, R.; Krawczynski, H.; McArthur, S.; Thibadeau, S.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Bradbury, S. M.; Rose, H. J.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Byrum, K.; Smith, A. W.; Wagner, R. G.] Argonne Natl Lab, Argonne, IL 60439 USA; [Cannon, A.; Grube, J.; Quinn, J.; Ward, J. E.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Cesarini, A.; Gillanders, G. H.; Lang, M. J.] Natl Univ Ireland Univ Coll Galway, Sch Phys, Galway, Ireland; [Ciupik, L.; Fortson, L.; Gyuk, G.; Karlsson, N.; Steele, D.] Adler Planetarium & Astron Museum, Dept Astron, Chicago, IL 60605 USA; [Colin, P.; Finnegan, G.; Godambe, S.; Hui, C. M.; Kieda, D.; LeBohec, S.; Vincent, S.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Cui, W.; Finley, J. P.; Gall, D.; Pizlo, F.; Sembroski, G. H.; Varlotta, A.; Zitzer, B.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Duke, C.] Grinnell Coll, Dept Phys, Grinnell, IA 50112 USA; [Fortin, P.; Mukherjee, R.] Columbia Univ Barnard Coll, Dept Phys & Astron, New York, NY 10027 USA; [Horan, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Humensky, T. B.; Swordy, S. P.; Weisgarber, T.; Wissel, S.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Imran, A.; Krennrich, F.; Nagai, T.; Pohl, M.; Schroedter, M.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Kaaret, P.; Pandel, D.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Kertzman, M.] Depauw Univ, Dept Phys & Astron, Greencastle, IN 46135 USA; [Konopelko, A.] Pittsburg State Univ, Dept Phys, Pittsburg, KS 66762 USA; [Millis, J.] Anderson Univ, Dept Phys, Anderson, IN 46012 USA; [Moriarty, P.] Galway Mayo Inst Technol, Dept Life & Phys Sci, Galway, Ireland; [Reyes, L. C.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Reynolds, P. T.] Cork Inst Technol, Dept Appl Phys & Instrumentat, Cork, Ireland	Harvard University; Smithsonian Institution; University of Delaware; University of Delaware; University of California System; University of California Los Angeles; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; McGill University; Washington University (WUSTL); University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; University College Dublin; Ollscoil na Gaillimhe-University of Galway; Utah System of Higher Education; University of Utah; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Chicago; Iowa State University; University of Iowa; DePauw University; Pittsburg State University; Galway Mayo Institute of Technology; University of Chicago; Cork Institute of Technology	Benbow, W (corresponding author), Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA.	wbenbow@cfa.harvard.edu	Cesarini, Andrea/AAS-9877-2020; Weinstein, Amanda/D-1445-2019; Kildea, John/AFR-7973-2022; Otte, Adam Nepomuk/L-4638-2019; Millis, Michael/K-5346-2019; Pohl, Martin/P-4920-2017; Cui, Wei/Y-3279-2019	Cesarini, Andrea/0000-0002-8611-8610; Weinstein, Amanda/0000-0002-2126-2419; Kildea, John/0000-0002-7084-1425; Otte, Adam Nepomuk/0000-0002-5955-6383; Pohl, Martin/0000-0001-7861-1707; Cui, Wei/0000-0002-6324-5772; Pandel, Dirk/0000-0003-2085-5586; Hui, Chiumun/0000-0002-0468-6025; Ward, John E/0000-0003-1973-0794; McCann, Andrew/0000-0002-5221-6669; Wissel, Stephanie/0000-0003-0569-6978; Kieda, David/0000-0003-4785-0101; Wagner, Robert/0000-0002-8119-2176; Benbow, Wystan/0000-0003-2098-170X; Maier, Gernot/0000-0001-9868-4700; Quinn, John/0000-0002-4855-2694; Krawczynski, Henric/0000-0002-1084-6507; Fortson, Lucy/0000-0002-1067-8558; Ong, Rene/0000-0002-4837-5253; Lang, Mark/0000-0003-4641-4201	US Department of Energy; US National Science Foundation; Smithsonian Institution; National Science and Engineering Research Council of Canada; Science Foundation Ireland; UK Science and Technology Facilities Council	US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research is supported by grants from the US Department of Energy, the US National Science Foundation and the Smithsonian Institution, and by the National Science and Engineering Research Council of Canada, Science Foundation Ireland and the UK Science and Technology Facilities Council. We acknowledge the excellent work of the technical support staff at the Fred Lawrence Whipple Observatory and the institutions that collaborated in the construction and operation of the VERITAS array.	Berge D, 2007, ASTRON ASTROPHYS, V466, P1219, DOI 10.1051/0004-6361:20066674; Blom JJ, 1999, ASTROPHYS J, V516, P744, DOI 10.1086/307155; Butt Y, 2009, NATURE, V460, P701, DOI 10.1038/nature08127; CONDON JJ, 1992, ANNU REV ASTRON ASTR, V30, P575, DOI 10.1146/annurev.aa.30.090192.003043; Daniel M., 2008, P 30 INT COSM RAY C, V3, P1325; del Pozo ED, 2009, ASTROPHYS J, V698, P1054, DOI 10.1088/0004-637X/698/2/1054; Fenech DM, 2008, MON NOT R ASTRON SOC, V391, P1384, DOI 10.1111/j.1365-2966.2008.13986.x; GOTTING N, 2007, THESIS U HAMBURG; Groves BA, 2003, PUBL ASTRON SOC AUST, V20, P252, DOI 10.1071/AS03016; HELENE O, 1983, NUCL INSTRUM METHODS, V212, P319, DOI 10.1016/0167-5087(83)90709-3; HELOU G, 1993, ASTROPHYS J, V415, P93, DOI 10.1086/173146; HELOU G, 1985, ASTROPHYS J, V298, pL7, DOI 10.1086/184556; Holder J, 2009, AIP CONF PROC, V1085, P657; KLEIN U, 1988, ASTRON ASTROPHYS, V190, P41; KRONBERG PP, 1985, ASTROPHYS J, V291, P693, DOI 10.1086/163108; Melo VP, 2005, ASTROPHYS J, V619, P270, DOI 10.1086/426421; NAGAI T, 2005, THESIS U UTAH; Persic M, 2008, ASTRON ASTROPHYS, V486, P143, DOI 10.1051/0004-6361:200809525; POHL M, 1994, ASTRON ASTROPHYS, V287, P453; RIEKE GH, 1980, ASTROPHYS J, V238, P24, DOI 10.1086/157954; Sakai S, 1999, ASTROPHYS J, V526, P599, DOI 10.1086/308032; Sanders DB, 2003, ASTRON J, V126, P1607, DOI 10.1086/376841; Strickland DK, 2007, ASTROPHYS J, V658, P258, DOI 10.1086/511174; van der Kruit P. C., 1971, ASTRON ASTROPHYS, V15, P110; Volk HJ, 1996, SPACE SCI REV, V75, P279; VOLK HJ, 1989, ASTRON ASTROPHYS, V218, P67; Weiss A, 2001, ASTRON ASTROPHYS, V365, P571, DOI 10.1051/0004-6361:20000145; Wills K. A., 1999, New Astronomy Reviews, V43, P633, DOI 10.1016/S1387-6473(99)00068-8; YUN MS, 1994, NATURE, V372, P530, DOI 10.1038/372530a0	29	175	178	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					770	772		10.1038/nature08557	http://dx.doi.org/10.1038/nature08557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19881491				2022-12-28	WOS:000272559900034
J	Wheatley, K; Ives, N; Gray, R; Kalra, PA; Moss, JG; Baigent, C; Carr, S; Chalmers, N; Eadington, D; Hamilton, G; Lipkin, G; Nicholson, A; Scoble, J				Wheatley, Keith; Ives, Natalie; Gray, Richard; Kalra, Philip A.; Moss, Jonathan G.; Baigent, Colin; Carr, Susan; Chalmers, Nicholas; Eadington, David; Hamilton, George; Lipkin, Graham; Nicholson, Anthony; Scoble, John		ASTRAL Investigators	Revascularization versus Medical Therapy for Renal-Artery Stenosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATHEROSCLEROTIC RENOVASCULAR DISEASE; PULMONARY-EDEMA; ANGIOPLASTY; METAANALYSIS; HYPERTENSION; FAILURE; OLDER	Background: Percutaneous revascularization of the renal arteries improves patency in atherosclerotic renovascular disease, yet evidence of a clinical benefit is limited. Methods: In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to undergo revascularization in addition to receiving medical therapy or to receive medical therapy alone. The primary outcome was renal function, as measured by the reciprocal of the serum creatinine level (a measure that has a linear relationship with creatinine clearance). Secondary outcomes were blood pressure, the time to renal and major cardiovascular events, and mortality. The median follow-up was 34 months. Results: During a 5-year period, the rate of progression of renal impairment (as shown by the slope of the reciprocal of the serum creatinine level) was -0.07 x 10(sup -3) liters per micromole per year in the revascularization group, as compared with -0.13 x 10(sup -3) liters per micromole per year in the medical-therapy group, a difference favoring revascularization of 0.06 x 10(sup -3) liters per micromole per year (95% confidence interval [CI], -0.002 to 0.13; P=0.06). Over the same time, the mean serum creatinine level was 1.6 micromol per liter (95% CI, -8.4 to 5.2 [0.02 mg per deciliter; 95% CI, -0.10 to 0.06]) lower in the revascularization group than in the medical-therapy group. There was no significant between-group difference in systolic blood pressure; the decrease in diastolic blood pressure was smaller in the revascularization group than in the medical-therapy group. The two study groups had similar rates of renal events (hazard ratio in the revascularization group, 0.97; 95% CI, 0.67 to 1.40; P=0.88), major cardiovascular events (hazard ratio, 0.94; 95% CI, 0.75 to 1.19; P=0.61), and death (hazard ratio, 0.90; 95% CI, 0.69 to 1.18; P=0.46). Serious complications associated with revascularization occurred in 23 patients, including 2 deaths and 3 amputations of toes or limbs. Conclusions: We found substantial risks but no evidence of a worthwhile clinical benefit from revascularization in patients with atherosclerotic renovascular disease. (Current Controlled Trials number, ISRCTN59586944.) N Engl J Med 2009;361:1953-62.	[Ives, Natalie] Univ Birmingham, ASTRAL Trial Off, Birmingham Clin Trials Unit, Coll Med & Dent Sci,Robert Aitken Inst, Birmingham B15 2TT, W Midlands, England; [Kalra, Philip A.] Salford Royal Hosp, Salford, Lancs, England; [Moss, Jonathan G.] N Glasgow Univ Hosp, Glasgow, Lanark, Scotland; [Baigent, Colin] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Carr, Susan] Leicester Gen Hosp, Leicester LE5 4PW, Leics, England; [Chalmers, Nicholas] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Eadington, David] Hull Royal Infirm, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Hamilton, George] Royal Free Hosp, London NW3 2QG, England; [Lipkin, Graham] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Nicholson, Anthony] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Scoble, John] Guys Hosp, London SE1 9RT, England	University of Birmingham; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Radcliffe Infirmary; University of Oxford; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Manchester; University of Hull; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Birmingham; Leeds General Infirmary; University of Leeds; Guy's & St Thomas' NHS Foundation Trust	Ives, N (corresponding author), Univ Birmingham, ASTRAL Trial Off, Birmingham Clin Trials Unit, Coll Med & Dent Sci,Robert Aitken Inst, Birmingham B15 2TT, W Midlands, England.	n.j.ives@bham.ac.uk	Fassett, Robert G/F-1752-2010; Malik, Rayaz/H-9231-2019; moss, jon george/GWN-0387-2022; McIntyre, Christopher W/O-8927-2014; Goldsmith, David J.A./H-8500-2013; hamilton, george/K-4764-2013; Dominiczak, Anna F/P-9390-2017	Fassett, Robert G/0000-0002-5318-6940; Malik, Rayaz/0000-0002-7188-8903; Dominiczak, Anna F/0000-0003-4913-3608; Cockwell, Paul/0000-0003-1975-266X; Tibballs, Jonathan/0000-0001-6562-3434; Ives, Natalie/0000-0002-1664-7541; Hutchison, Alastair/0000-0003-3268-8324; Ball, Simon/0000-0001-7410-5268; Williams, Bryan/0000-0002-8094-1841; Dickinson, Stephen/0000-0002-9067-6957; Nigel, Brunskill/0000-0002-7109-7108; Barratt, Jonathan/0000-0002-9063-7229; Houston, Graeme/0000-0002-9786-7975; Gray, Richard/0000-0003-4440-574X; Witte, Klaus/0000-0002-7146-7105; Tomson, Charles/0000-0002-0224-8726; CARR, Susan/0000-0003-3726-3560; Handley, Kelly/0000-0003-4036-2375	Medical Research Council U. K.; Kidney Research U. K.; Medtronic; U. K. Department of Health; Medical Research Council [MC_U137686853, MC_U137686861, G0000995, G0800808] Funding Source: researchfish; MRC [MC_U137686853, G0800808, MC_U137686861, G0000995] Funding Source: UKRI	Medical Research Council U. K.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research U. K.(Kidney Research UK (KRUK)); Medtronic(Medtronic); U. K. Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by research grants from Medical Research Council U. K., Kidney Research U. K., and Medtronic. The University of Birmingham Clinical Trials Unit also receives core support from the U. K. Department of Health.	BONELLI FS, 1995, MAYO CLIN PROC, V70, P1041, DOI 10.4065/70.11.1041; Cheung CM, 2002, J AM SOC NEPHROL, V13, P149, DOI 10.1681/ASN.V131149; Cheung CM, 2005, BRIT MED BULL, V73-74, P35, DOI 10.1093/bmb/ldh049; Chrysochou C, 2009, INT J CARDIOL, V132, pE31, DOI 10.1016/j.ijcard.2007.07.121; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COLLINS R, 1996, OXFORD TXB MED, V1, P21; Dubel GJ, 2008, CARDIOVASC INTER RAD, V31, P14, DOI 10.1007/s00270-007-9211-6; Guo HF, 2007, CIRCULATION, V115, P50, DOI 10.1161/CIRCULATIONAHA.106.637751; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; Hegarty J, 2006, INT J CARDIOL, V111, P339, DOI 10.1016/j.ijcard.2005.10.020; Ives NJ, 2003, NEPHROL DIAL TRANSPL, V18, P298, DOI 10.1093/ndt/18.2.298; Kalra PA, 2005, KIDNEY INT, V68, P293, DOI 10.1111/j.1523-1755.2005.00406.x; Leertouwer TC, 2000, RADIOLOGY, V216, P78, DOI 10.1148/radiology.216.1.r00jl0778; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; PICKERING TG, 1988, LANCET, V2, P551; Plouin PF, 1998, HYPERTENSION, V31, P823, DOI 10.1161/01.HYP.31.3.823; Textor SC, 1998, KIDNEY INT, V53, P799, DOI 10.1038/ki.1998.37; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Webster J, 1998, J HUM HYPERTENS, V12, P329, DOI 10.1038/sj.jhh.1000599	19	752	786	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1953	1962						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907042	Bronze			2022-12-28	WOS:000271660500009
J	Chung, JW; Meltzer, DO				Chung, Jeanette W.; Meltzer, David O.			Estimate of the Carbon Footprint of the US Health Care Sector	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chung, Jeanette W.; Meltzer, David O.] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA	University of Chicago	Chung, JW (corresponding author), Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jchung1@bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031326] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS016967-01] Funding Source: Medline; NIA NIH HHS [K24-AG31326] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Carnegie Mellon University Green Design Institute, EC INP OUTP LIF CYCL; EPA (US Environmental Protection Agency), 2009, 430R09004 US EPA; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; Hendrickson CT, 2006, ENV LIFE CYCLE ASSES; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P351	6	191	193	4	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1970	1972		10.1001/jama.2009.1610	http://dx.doi.org/10.1001/jama.2009.1610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903917	Bronze			2022-12-28	WOS:000271619700019
J	Davies, J				Davies, Justine			Swine Flu Vaccines: Reaching the Finish Line	CELL			English	Editorial Material														Davies, Justine/0000-0001-6834-1838					0	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					449	451		10.1016/j.cell.2009.10.018	http://dx.doi.org/10.1016/j.cell.2009.10.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879829	Bronze			2022-12-28	WOS:000271259600005
J	Srinivasan, L; Sasaki, Y; Calado, DP; Zhang, BC; Paik, JH; DePinho, RA; Kutok, JL; Kearney, JF; Otipoby, KL; Rajewsky, K				Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Paik, Ji Hye; DePinho, Ronald A.; Kutok, Jeffrey L.; Kearney, John F.; Otipoby, Kevin L.; Rajewsky, Klaus			PI3 Kinase Signals BCR-Dependent Mature B Cell Survival	CELL			English	Article							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; CLASS-SWITCH RECOMBINATION; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MARGINAL ZONE; POSITIVE SELECTION; CRITICAL ROLES; LYMPHOCYTES; ACTIVATION	Previous work has shown that mature B cells depend upon survival signals delivered to the cells by their antigen receptor (BCR). To identify the molecular nature of this survival signal, we have developed a genetic approach in which ablation of the BCR is combined with the activation of specific, BCR dependent signaling cascades in mature B cells in vivo. Using this system, we provide evidence that the survival of BCR deficient mature B cells can be rescued by a single signaling pathway downstream of the BCR, namely PI3K signaling, with the FOXO1 transcription factor playing a central role.	[Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Otipoby, Kevin L.; Rajewsky, Klaus] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Otipoby, Kevin L.; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Paik, Ji Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kutok, Jeffrey L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kearney, John F.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	rajewsky@idi.harvard.edu	Kearney, John/GOV-3123-2022; Calado, Dinis/U-8379-2019	Calado, Dinis/0000-0001-8239-7184; Rajewsky, Klaus/0000-0002-6633-6370; Zhang, Baochun/0000-0003-1759-1161; DePinho, Ronald/0000-0002-5625-577X; Srinivasan, Lakshmi/0000-0003-1351-7407	NIH [AI054636, CA092625, AI014782-31]; Leukemia and Lymphoma Society; European Union through MUGEN; Hematology and Transfusion Medicine at Harvard Medical School; Portuguese Foundation for Science and Technology; Robert A. and Renee E. Belfer Foundation; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, R37AI054636, R21AI014782] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Union through MUGEN(European Commission); Hematology and Transfusion Medicine at Harvard Medical School; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Robert A. and Renee E. Belfer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ghitza, A. Pellerin, A. Monti, A. Tetreault, J. Grundy, J. Wang, J. Xia and W. F. Jia for expert technical assistance; E. Derudder for reagents; all Rajewsky lab members for discussions; and M. Janz for critical reading of the manuscript; A. Klippel for the MP110* cDNA; and K. Kaibuchi for Rac1DA cDNA. K. R. is supported by NIH grants AI054636 and CA092625, the Leukemia and Lymphoma Society and the European Union through MUGEN; L. S. by the T32 training grant of the Joint Program in Hematology and Transfusion Medicine at Harvard Medical School; J. F. K. by NIH grant AI014782-31; D. P. C. by a postdoctoral fellowship from the Portuguese Foundation for Science and Technology (FCT-MCES); B. Z. by a postdoctoral fellowship of the Leukemia and Lymphoma Society; and RAD by the NIH and the Robert A. and Renee E. Belfer Foundation.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bannish G, 2001, J EXP MED, V194, P1583, DOI 10.1084/jem.194.11.1583; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dye JR, 2007, J IMMUNOL, V179, P229, DOI 10.4049/jimmunol.179.1.229; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Grande SM, 2007, IMMUNOL REV, V218, P214, DOI 10.1111/j.1600-065X.2007.00535.x; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Matsuda S, 2009, BLOOD, V113, P1037, DOI 10.1182/blood-2008-06-163725; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Oliver AM, 1999, J IMMUNOL, V162, P7198; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	58	484	516	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					573	586		10.1016/j.cell.2009.08.041	http://dx.doi.org/10.1016/j.cell.2009.08.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879843	Bronze, Green Accepted			2022-12-28	WOS:000271259600021
J	Eichmann, U; Nubbemeyer, T; Rottke, H; Sandner, W				Eichmann, U.; Nubbemeyer, T.; Rottke, H.; Sandner, W.			Acceleration of neutral atoms in strong short-pulse laser fields	NATURE			English	Article							MULTIPHOTON IONIZATION; ELECTRON-BEAMS; PLASMA; LIGHT; PARTICLES; OPTICS; WAVES	A charged particle exposed to an oscillating electric field experiences a force proportional to the cycle-averaged intensity gradient. This so-called ponderomotive force(1) plays a major part in a variety of physical situations such as Paul traps(2,3) for charged particles, electron diffraction in strong (standing) laser fields(4-6) (the Kapitza-Dirac effect) and laser-based particle acceleration(7-9). Comparably weak forces on neutral atoms in inhomogeneous light fields may arise from the dynamical polarization of an atom(10-12); these are physically similar to the cycle-averaged forces. Here we observe previously unconsidered extremely strong kinematic forces on neutral atoms in short-pulse laser fields. We identify the ponderomotive force on electrons as the driving mechanism, leading to ultrastrong acceleration of neutral atoms with a magnitude as high as similar to 10(14) times the Earth's gravitational acceleration, g. To our knowledge, this is by far the highest observed acceleration on neutral atoms in external fields and may lead to new applications in both fundamental and applied physics.	[Eichmann, U.; Nubbemeyer, T.; Rottke, H.; Sandner, W.] Max Born Inst, D-12489 Berlin, Germany; [Eichmann, U.; Sandner, W.] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10632 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Technical University of Berlin	Eichmann, U (corresponding author), Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany.	ulli.eichmann@mbi-berlin.de						Batelaan H, 2007, REV MOD PHYS, V79, P929, DOI 10.1103/RevModPhys.79.929; BOOT HAH, 1957, NATURE, V180, P1187, DOI 10.1038/1801187a0; BUCKSBAUM PH, 1988, PHYS REV LETT, V61, P1182, DOI 10.1103/PhysRevLett.61.1182; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; CHU S, 1986, PHYS REV LETT, V57, P314, DOI 10.1103/PhysRevLett.57.314; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; DEBOER MP, 1992, PHYS REV LETT, V68, P2747, DOI 10.1103/PhysRevLett.68.2747; Dehmelt H.G., 1967, ADV ATOM MOL PHYS, V3, P53, DOI [10.1016/S0065-2199(08)60170-0, DOI 10.1016/S0065-2199(08)60170-0]; EBERLY JH, 1991, PHYS REP, V204, P331, DOI 10.1016/0370-1573(91)90131-5; Freimund DL, 2001, NATURE, V413, P142, DOI 10.1038/35093065; Fulton R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243004; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; GOULD PL, 1986, PHYS REV LETT, V56, P827, DOI 10.1103/PhysRevLett.56.827; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; HENNEBERGER WC, 1968, PHYS REV LETT, V21, P838, DOI 10.1103/PhysRevLett.21.838; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; KIBBLE TWB, 1966, PHYS REV LETT, V16, P1054, DOI 10.1103/PhysRevLett.16.1054; KRAPCHEV VB, 1979, PHYS REV LETT, V42, P497, DOI 10.1103/PhysRevLett.42.497; McNaught SJ, 1998, PHYS REV A, V58, P1399, DOI 10.1103/PhysRevA.58.1399; Mourou GA, 2006, REV MOD PHYS, V78, P309, DOI 10.1103/RevModPhys.78.309; Nubbemeyer T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.233001; Quesnel B, 1998, PHYS REV E, V58, P3719, DOI 10.1103/PhysRevE.58.3719; Stapelfeldt H, 1997, PHYS REV LETT, V79, P2787, DOI 10.1103/PhysRevLett.79.2787; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Wells E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023001	25	166	171	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 29	2009	461	7268					1261	U93		10.1038/nature08481	http://dx.doi.org/10.1038/nature08481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865167				2022-12-28	WOS:000271190800044
J	de Jager, DJ; Grootendorst, DC; Jager, KJ; van Dijk, PC; Tomas, LMJ; Ansell, D; Collart, F; Finne, P; Heaf, JG; De Meester, J; Wetzels, JFM; Rosendaal, FR; Dekker, FW				de Jager, Dinanda J.; Grootendorst, Diana C.; Jager, Kitty J.; van Dijk, Paul C.; Tomas, Lonneke M. J.; Ansell, David; Collart, Frederic; Finne, Patrik; Heaf, James G.; De Meester, Johan; Wetzels, Jack F. M.; Rosendaal, Frits R.; Dekker, Friedo W.			Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; RISK-FACTOR; HEMODIALYSIS; DEATH; DYSFUNCTION; PREVALENCE; REGISTRY; FRAILTY; GENDER	Context Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population. Objective To evaluate if high overall mortality in patients starting dialysis is a consequence of increased cardiovascular mortality risk only or whether noncardiovascular mortality is equally increased. Design, Setting, and Patients Using data from between January 1, 1994, and January 1, 2007, age-stratified mortality in a European cohort of adults starting dialysis and receiving follow-up for a mean of 1.8 (SD, 1.1) years ( European Renal Association-European Dialysis and Transplant Association [ERA-EDTA] Registry [N=123 407]) was compared with the European general population (Eurostat). Main Outcome Measures Cause of death was recorded by ERA-EDTA codes in patients and matching International Statistical Classification of Diseases, 10th Revision codes in the general population. Standardized cardiovascular and noncardiovascular mortality rates, their ratio, difference, and relative excess of cardiovascular over noncardiovascular mortality were calculated. Results Overall all-cause mortality rates in patients and the general population were 192 per 1000 person-years (95% confidence interval [CI], 190-193) and 12.055 per 1000 person-years ( 95% CI, 12.05-12.06), respectively. Cause of death was known for 90% of the patients and 99% of the general population. In patients, 16 654 deaths (39%) were cardiovascular and 21 654 (51%) were noncardiovascular. In the general population, 7 041 747 deaths (40%) were cardiovascular and 10 183 322 (58%) were noncardiovascular. Cardiovascular and noncardiovascular mortality rates in patients were respectively 38.1 per 1000 person-years ( 95% CI, 37.2-39.0) and 50.1 per 1000 person-years ( 95% CI, 48.9-51.2) higher than in the general population. On a relative scale, standardized cardiovascular and noncardiovascular mortality were respectively 8.8 ( 95% CI, 8.6-9.0) and 8.1 ( 95% CI, 7.9-8.3) times higher than in the general population. The ratio of these rates, ie, relative excess of cardiovascular over noncardiovascular mortality in patients starting dialysis compared with the general population, was 1.09 ( 95% CI, 1.06-1.12). Relative excess in a sensitivity analysis in which unknown/missing causes of death were regarded either as noncardiovascular or cardiovascular varied between 0.90 ( 95% CI, 0.88-0.93) and 1.39 ( 95% CI, 1.35-1.43). Conclusion Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality. JAMA. 2009; 302(16):1782-1789 www.jama.com	[de Jager, Dinanda J.; Grootendorst, Diana C.; Tomas, Lonneke M. J.; Rosendaal, Frits R.; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Jager, Kitty J.; van Dijk, Paul C.] Univ Amsterdam, Acad Med Ctr, ERA EDTA Registry, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Ansell, David] United Kingdom Renal Registry, Bristol, Avon, England; [Collart, Frederic] French Speaking Belgium ESRD Registry, Brussels, Belgium; [Finne, Patrik] Finnish Registry Kidney Dis, Helsinki, Finland; [Heaf, James G.] Copenhagen Univ Hosp, Dept Nephrol, Herlev, Denmark; [De Meester, Johan] AZ Nikolaas, Dept Nephrol Dialysis & Hypertens, St Niklaas, Belgium; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Universite Libre de Bruxelles; University of Copenhagen; Radboud University Nijmegen	de Jager, DJ (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C7-104,POB 9600, NL-2300 RC Leiden, Netherlands.	d.j.de_jager@lumc.nl	Rosendaal, Frits/Q-3842-2017; Dekker, Friedo W/B-6452-2011; Wetzels, Jack F.M./A-1720-2014	Rosendaal, Frits/0000-0003-2558-7496; Dekker, Friedo W/0000-0002-2433-2494; Wetzels, Jack F.M./0000-0002-0650-6921; Ansell, David/0000-0001-9575-1509; Collart, Frederic/0000-0003-1673-5450	European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	The ERA-EDTA Registry is funded by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA).	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; den Elzen WPJ, 2006, NEPHROL DIAL TRANSPL, V21, P1588, DOI 10.1093/ndt/gfk092; *ERA EDTA REG, 2007, ERA EDTA REG 2006 AN, P129; *EUR COMM, CAUS DEATH ABS NUMB; *EUR COMM, POP 1 JAN SEX AG 199; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Foley RN, 2006, ADV CHRONIC KIDNEY D, V13, P205, DOI 10.1053/j.ackd.2006.04.006; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Havekes B, 2006, AM J KIDNEY DIS, V47, P823, DOI 10.1053/j.ajkd.2006.01.019; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Jager KJ, 2000, PERITON DIALYSIS INT, V20, pS118; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Ketteler M, 2006, KIDNEY INT, V70, pS5, DOI 10.1038/sj.ki.5001996; Kielstein JT, 2005, AM J KIDNEY DIS, V46, P186, DOI 10.1053/j.ajkd.2005.05.009; Langman CB, 2005, AM J KIDNEY DIS, V46, pS6, DOI 10.1053/j.ajkd.2005.07.024; Lastra G, 2006, ADV CHRONIC KIDNEY D, V13, P365, DOI 10.1053/j.ackd.2006.07.011; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Locatelli F, 2001, NEPHROL DIAL TRANSPL, V16, P459, DOI 10.1093/ndt/16.3.459; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Shanahan CM, 2005, CURR OPIN NEPHROL HY, V14, P361, DOI 10.1097/01.mnh.0000172723.52499.38; Stack AG, 2001, J AM SOC NEPHROL, V12, P1516, DOI 10.1681/ASN.V1271516; Stel VS, 2005, NEPHROL DIAL TRANSPL, V20, P2803, DOI 10.1093/ndt/gfi099; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Stompor T, 2007, PERITON DIALYSIS INT, V27, pS215; US Renal Data System, USRDS 2008 ANN DAT R; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; World Health Organization, 1992, INT STAT CLASS DIS 1; 1992, AM J KIDNEY DIS S2, V20, P32	40	500	513	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1782	1789		10.1001/jama.2009.1488	http://dx.doi.org/10.1001/jama.2009.1488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861670	Bronze			2022-12-28	WOS:000271150300021
J	Wuhl, E; Trivelli, A; Picca, S; Litwin, M; Peco-Antic, A; Zurowska, A; Testa, S; Jankauskiene, A; Emre, S; Caldas-Afonso, A; Anarat, A; Niaudet, P; Mir, S; Bakkaloglu, A; Enke, B; Montini, G; Wingen, AM; Sallay, P; Jeck, N; Berg, U; Caliskan, S; Wygoda, S; Hohbach-Hohenfellner, K; Dusek, J; Urasinski, T; Arbeiter, K; Neuhaus, T; Gellermann, J; Drozdz, D; Fischbach, M; Moller, K; Wigger, M; Peruzzi, L; Mehls, O; Schaefer, F				Wuehl, Elke; Trivelli, Antonella; Picca, Stefano; Litwin, Mieczyslaw; Peco-Antic, Amira; Zurowska, Aleksandra; Testa, Sara; Jankauskiene, Augustina; Emre, Sevinc; Caldas-Afonso, Alberto; Anarat, Ali; Niaudet, Patrick; Mir, Sevgi; Bakkaloglu, Aysin; Enke, Barbara; Montini, Giovanni; Wingen, Ann-Margret; Sallay, Peter; Jeck, Nikola; Berg, Ulla; Caliskan, Salim; Wygoda, Simone; Hohbach-Hohenfellner, Katharina; Dusek, Jiri; Urasinski, Tomasz; Arbeiter, Klaus; Neuhaus, Thomas; Gellermann, Jutta; Drozdz, Dorota; Fischbach, Michel; Moeller, Kristina; Wigger, Marianne; Peruzzi, Licia; Mehls, Otto; Schaefer, Franz			Strict Blood-Pressure Control and Progression of Renal Failure in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME INHIBITOR; KIDNEY-DISEASE; FOLLOW-UP; RAMIPRIL; MULTICENTER; PROTEINURIA; BENAZEPRIL; CREATININE; EFFICACY; DIET	Background Although inhibition of the renin-angiotensin system delays the progression of renal failure in adults with chronic kidney disease, the blood-pressure target for optimal renal protection is controversial. We assessed the long-term renoprotective effect of intensified blood-pressure control among children who were receiving a fixed high dose of an angiotensin-converting-enzyme (ACE) inhibitor. Methods After a 6-month run-in period, 385 children, 3 to 18 years of age, with chronic kidney disease (glomerular filtration rate of 15 to 80 ml per minute per 1.73 m(2) of body-surface area) received ramipril at a dose of 6 mg per square meter of body-surface area per day. Patients were randomly assigned to intensified blood-pressure control (with a target 24-hour mean arterial pressure below the 50th percentile) or conventional blood-pressure control (mean arterial pressure in the 50th to 95th percentile), achieved by the addition of antihypertensive therapy that does not target the renin-angiotensin system; patients were followed for 5 years. The primary end point was the time to a decline of 50% in the glomerular filtration rate or progression to end-stage renal disease. Secondary end points included changes in blood pressure, glomerular filtration rate, and urinary protein excretion. Results A total of 29.9% of the patients in the group that received intensified blood-pressure control reached the primary end point, as assessed by means of a Kaplan-Meier analysis, as compared with 41.7% in the group that received conventional blood-pressure control (hazard ratio, 0.65; confidence interval, 0.44 to 0.94; P = 0.02). The two groups did not differ significantly with respect to the type or incidence of adverse events or the cumulative rates of withdrawal from the study (28.0% vs. 26.5%). Proteinuria gradually rebounded during ongoing ACE inhibition after an initial 50% decrease, despite persistently good blood-pressure control. Achievement of blood-pressure targets and a decrease in proteinuria were significant independent predictors of delayed progression of renal disease. Conclusions Intensified blood-pressure control, with target 24-hour blood-pressure levels in the low range of normal, confers a substantial benefit with respect to renal function among children with chronic kidney disease. Reappearance of proteinuria after initial successful pharmacologic blood-pressure control is common among children who are receiving long-term ACE inhibition. (ClinicalTrials.gov number, NCT00221845.)	[Wuehl, Elke; Mehls, Otto; Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, D-69120 Heidelberg, Germany; [Enke, Barbara] Childrens Hosp, Hannover Med Sch, Hannover, Germany; [Wingen, Ann-Margret] Univ Childrens Hosp Essen, Essen, Germany; [Jeck, Nikola] Univ Marburg, Dept Pediat, Marburg, Germany; [Wygoda, Simone] Urban Hosp St Georg, Leipzig, Germany; [Hohbach-Hohenfellner, Katharina] Univ Childrens Hosp, Mainz, Germany; [Gellermann, Jutta] Charite Childrens Hosp, Berlin, Germany; [Moeller, Kristina] Univ Childrens Hosp Hamburg Eppendorf, Hamburg, Germany; [Wigger, Marianne] Univ Childrens Hosp, Rostock, Germany; [Trivelli, Antonella] G Gaslini, Genoa, Italy; [Picca, Stefano] Osped Pediat Bambino Gesu, Rome, Italy; [Testa, Sara] Policlin Mangiagalli, Ist Ricovero & Cura, Carattere Sci Osp Maggiore, Milan, Italy; [Montini, Giovanni] Univ Padua, Azienda Osped, Padua, Italy; [Peruzzi, Licia] Osped Infantile Regina Margherita, Turin, Italy; [Litwin, Mieczyslaw] Childrens Mem Hlth Hosp, Warsaw, Poland; [Zurowska, Aleksandra] Med Univ Gdansk, Dept Pediat & Adolescent Nephrol & Hypertens, Gdansk, Poland; [Urasinski, Tomasz] Pomeranian Acad Med, Szczecin, Poland; [Drozdz, Dorota] Jagiellonian Univ, Coll Med, Polish Amer Childrens Hosp, Krakow, Poland; [Peco-Antic, Amira] Univ Childrens Hosp, Belgrade, Serbia; [Jankauskiene, Augustina] Vilnius State Univ, Childrens Hosp, Vilnius, Lithuania; [Emre, Sevinc] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Anarat, Ali] Cukurova Univ, Sch Med, Adana, Turkey; [Mir, Sevgi] Ege Univ, Fac Med, Dept Pediat, Izmir, Turkey; [Bakkaloglu, Aysin] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey; [Caliskan, Salim] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey; [Niaudet, Patrick] Hop Necker Enfants Malad, Paris, France; [Caldas-Afonso, Alberto] Hosp Sao Joao, Oporto, Portugal; [Fischbach, Michel] Hop Univ Strasbourg, Strasbourg, France; [Sallay, Peter] Semmelweis Univ Budapest, Dept Pediat 1, Budapest, Hungary; [Berg, Ulla] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Dusek, Jiri] Univ Hosp Motol, Dept Pediat, Prague, Czech Republic; [Arbeiter, Klaus] Univ Childrens Hosp, Vienna, Austria; [Neuhaus, Thomas] Univ Childrens Hosp, Zurich, Switzerland	Ruprecht Karls University Heidelberg; Hannover Medical School; University of Duisburg Essen; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rostock; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu; University of Padua; Azienda Ospedaliera - Universita di Padova; A.O.U. Citta della Salute e della Scienza di Torino; Children's Memorial Health Institute; Fahrenheit Universities; Medical University Gdansk; Pomeranian Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Belgrade; Vilnius University; Istanbul University; Cukurova University; Ege University; Hacettepe University; Istanbul University; Istanbul University - Cerrahpasa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Sao Joao Hospital; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Semmelweis University; Karolinska Institutet; Motol University Hospital; University Children's Hospital Zurich	Schaefer, F (corresponding author), Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Neuenheimer Feld 430, D-69120 Heidelberg, Germany.	franz.schaefer@med.uni-heidelberg.de	Urasinski, Tomasz F./I-3066-2014; Çalışkan, Salim/ABC-1479-2020; Litwin, Mieczyslaw/C-3868-2012; PERUZZI, LICIA/I-1873-2012; Trivelli, Antonella/AAA-7282-2020; Montini, Giovanni/AAC-6612-2022; Litwin, Mieczyslaw/ABH-4315-2020; Urasinski, Tomasz F./O-7155-2014; Zurowska, Aleksandra/AAA-3131-2021; Schaefer, Franz/G-4365-2010; Litwin, Mieczyslaw/L-4648-2017	Çalışkan, Salim/0000-0002-3316-8032; Montini, Giovanni/0000-0002-7350-4475; Litwin, Mieczyslaw/0000-0002-5241-2483; Urasinski, Tomasz F./0000-0003-3107-8575; Zurowska, Aleksandra/0000-0002-3354-5344; Litwin, Mieczyslaw/0000-0002-5241-2483; Peruzzi, Licia/0000-0002-5704-3867; Caldas Afonso, Alberto/0000-0002-2574-4132; Testa, Sara/0000-0003-3062-8985; Gimpel, Charlotte/0000-0003-1296-9081	Boehringer Ingelheim Stiftung; European Commission [QLRT-2001-00908]; Kuratorium fur Dialyse und Nierentransplantation, Neu-Isenburg; Baxter Extramural Grant Program	Boehringer Ingelheim Stiftung(Boehringer Ingelheim); European Commission(European CommissionEuropean Commission Joint Research Centre); Kuratorium fur Dialyse und Nierentransplantation, Neu-Isenburg; Baxter Extramural Grant Program	Supported by grants from the Boehringer Ingelheim Stiftung; the European Commission (Fifth Framework Programme, QLRT-2001-00908); Kuratorium fur Dialyse und Nierentransplantation, Neu-Isenburg; and the Baxter Extramural Grant Program.	Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Flynn JT, 2008, HYPERTENSION, V52, P631, DOI 10.1161/HYPERTENSIONAHA.108.110635; Gansevoort RT, 1996, PHARM WORLD SCI, V18, P204, DOI 10.1007/BF00735961; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Jafar TH, 2002, ANN INTERN MED, V137, P299; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Locatelli F, 1996, NEPHROL DIAL TRANSPL, V11, P461; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mitsnefes M, 2003, J AM SOC NEPHROL, V14, P2618, DOI 10.1097/01.ASN.0000089565.04535.4B; Nakao N, 2003, LANCET, V361, P1230; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Soergel M, 2000, PEDIATR NEPHROL, V15, P113, DOI 10.1007/s004670000422; Soergel M, 2001, PEDIATR NEPHROL, V16, P202; Wingen AM, 1997, LANCET, V349, P1117, DOI 10.1016/S0140-6736(96)09260-4; Wright JT, 2006, JAMA-J AM MED ASSOC, V295, P2726; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Wuhl E, 2007, PEDIATR NEPHROL, V22, P1458; Wuhl E, 2004, KIDNEY INT, V66, P768, DOI 10.1111/j.1523-1755.2004.00802.x; Wuhl E, 2003, J HYPERTENS, V21, P2205; Wuhl E, 2002, J HYPERTENS, V20, P1995, DOI 10.1097/00004872-200210000-00019	33	528	553	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1639	1650						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846849	Bronze			2022-12-28	WOS:000270977400006
J	Sudore, RL				Sudore, Rebecca L.			Can We Agree to Disagree?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rsucsf@yahoo.com	Sudore, Rebecca/AAF-1635-2021						0	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1629	1630		10.1001/jama.2009.1422	http://dx.doi.org/10.1001/jama.2009.1422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843890				2022-12-28	WOS:000270941200001
J	Adameyko, I; Lallemend, F; Aquino, JB; Pereira, JA; Topilko, P; Muller, T; Fritz, N; Beljajeva, A; Mochii, M; Liste, I; Usoskin, D; Suter, U; Birchmeier, C; Ernfors, P				Adameyko, Igor; Lallemend, Francois; Aquino, Jorge B.; Pereira, Jorge A.; Topilko, Piotr; Mueller, Thomas; Fritz, Nicolas; Beljajeva, Anna; Mochii, Makoto; Liste, Isabel; Usoskin, Dmitry; Suter, Ueli; Birchmeier, Carmen; Ernfors, Patrik			Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin	CELL			English	Article							NEURAL CREST CELLS; LINEAGE SEGREGATION; GROWTH-FACTOR; MOUSE EMBRYO; GLIAL-CELLS; EXPRESSION; MIGRATION; DIFFERENTIATION; MELANOBLASTS; SYSTEM	Current opinion holds that pigment cells, melanocytes, are derived from neural crest cells produced at the dorsal neural tube and that migrate under the epidermis to populate all parts of the skin. Here, we identify growing nerves projecting throughout the body as a stem/progenitor niche containing Schwann cell precursors (SCPs) from which large numbers of skin melanocytes originate. SCPs arise as a result of lack of neuronal specification by Hmx1 homeobox gene function in the neural crest ventral migratory pathway. Schwann cell and melanocyte development share signaling molecules with both the glial and melanocyte cell fates intimately linked to nerve contact and regulated in an opposing manner by Neuregulin and soluble signals including insulin-like growth factor and platelet-derived growth factor. These results reveal SCPs as a cellular origin of melanocytes, and have broad implications on the molecular mechanisms regulating skin pigmentation during development, in health and pigmentation disorders.	[Adameyko, Igor; Lallemend, Francois; Aquino, Jorge B.; Fritz, Nicolas; Liste, Isabel; Usoskin, Dmitry; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; [Aquino, Jorge B.] Austral Univ, Sch Med, Liver Unit, Buenos Aires, DF, Argentina; [Pereira, Jorge A.; Suter, Ueli] ETH, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Topilko, Piotr] Ecole Normale Super, Inserm 784, Lab Genet Mol Dev, F-75230 Paris 05, France; [Mueller, Thomas; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; [Beljajeva, Anna] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Mochii, Makoto] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Karolinska Institutet; Austral University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet; University of Hyogo	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Fritz, Nicolas/N-1030-2013; Suter, Ueli/A-1624-2010; Fritz, Nicolas/P-1290-2019	Fritz, Nicolas/0000-0002-9722-7425; Fritz, Nicolas/0000-0002-9722-7425; Liste, Isabel/0000-0002-3294-9558; Ernfors, Patrik/0000-0002-1140-3986; Muller, Thomas/0000-0001-8096-1853; Adameyko, Igor/0000-0001-5471-0356; Aquino, Jorge B/0000-0002-3818-5181	Swedish Research Council [K2007-77PK-20285-01-6]; Swedish Foundation for Strategic Research; Linne grants; Swedish Cancer Foundation; Swedish Child Cancer Foundation; Swedish Brain Foundation; Bertil Hallsten Research Foundation; EU [FP7 MOLPARK, Marie Curie MEIF-CT-2006-039237]; ERC [232675]; Knut and Alice Wallenberg Foundation; Swiss National Science Foundation; National Center for Competence in Research Neural Plasticity and Repair	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Linne grants; Swedish Cancer Foundation; Swedish Child Cancer Foundation; Swedish Brain Foundation; Bertil Hallsten Research Foundation; EU(European Commission); ERC(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research Neural Plasticity and Repair	We thank Michael Wegner, Vince Hearing, and Yoshio Wakamatsu for the generous gifts of antibodies directed against Sox10, Dct and MEBL-1, respectively. This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, Linne grants (CEDB and DBRM grants), the Swedish Cancer Foundation, Swedish Child Cancer Foundation, the Swedish Brain Foundation, Bertil Hallsten Research Foundation, EU FP7 MOLPARK collaborative project, and ERC advanced grant (232675) to P. E., and Knut and Alice Wallenberg Foundation (CLICK Imaging Facility). I. A. was supported by the Swedish Research Council. F. L. was supported by the Swedish Medical Research Council (K2007-77PK-20285-01-6) and the European Union (Marie Curie MEIF-CT-2006-039237). U.S. was supported by the Swiss National Science Foundation and the National Center for Competence in Research Neural Plasticity and Repair.	Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; DORRIS F, 1939, J EXP ZOOL, V86, P315; Dorris F, 1938, ROUX ARCH DEV BIOL, V138, P323, DOI 10.1007/BF00573807; Dorsky RI, 2000, GENE DEV, V14, P158; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Dushane GP, 1935, J EXP ZOOL, V72, P1, DOI 10.1002/jez.1400720102; ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x; Fetsch JF, 2000, AM J SURG PATHOL, V24, P331, DOI 10.1097/00000478-200003000-00001; FOX MH, 1949, PHYSIOL ZOOL, V22, P1; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; HUSZAR D, 1991, DEVELOPMENT, V113, P653; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; JOHNSTON MC, 1966, ANAT RECORD, V156, P143, DOI 10.1002/ar.1091560204; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LEMKE GE, 1984, J NEUROSCI, V4, P75; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Meier C, 1999, J NEUROSCI, V19, P3847; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; RIS HANS, 1941, PHYSIOL ZOOL, V14, P48; Rizvi TA, 2002, J NEUROSCI, V22, P9831; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Twitty VC, 1936, J EXP ZOOL, V74, P239, DOI 10.1002/jez.1400740206; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Weinreb I, 2007, J CUTAN PATHOL, V34, P52, DOI 10.1111/j.1600-0560.2007.00733.x; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	48	349	357	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					366	379		10.1016/j.cell.2009.07.049	http://dx.doi.org/10.1016/j.cell.2009.07.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837037	Bronze			2022-12-28	WOS:000270857500019
J	Benton, R				Benton, Richard			EPPENDORF WINNER Evolution and Revolution in Odor Detection	SCIENCE			English	Editorial Material							MEMBRANE TOPOLOGY; DROSOPHILA; RECEPTORS; SENSITIVITY; CHANNELS; SMELL		Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Benton, R (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	richard.benton@unil.ch						Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	13	9	10	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					382	383		10.1126/science.1181998	http://dx.doi.org/10.1126/science.1181998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833953				2022-12-28	WOS:000270818600038
J	Falkenberg, M; Larsson, NG				Falkenberg, Maria; Larsson, Nils-Goran			Structure Casts Light on mtDNA Replication	CELL			English	Editorial Material							DNA-POLYMERASE-GAMMA		[Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, SE-14186 Stockholm, Sweden	University of Gothenburg; Max Planck Society; Karolinska Institutet	Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.	maria.falkenberg@medkem.gu.se; larsson@age.mpg.de	Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X	Swedish Research Council; Swedish Heart and Lung Foundation; Swedish Foundation for Strategic Research; Swedish Royal Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Royal Academy of Sciences	We thank the Swedish Research Council (M. F. and N. G. L.), the Swedish Heart and Lung Foundation (N. G. L.), the Swedish Foundation for Strategic Research (M. F.), and the Swedish Royal Academy of Sciences (M. F.) for financial support.	Altmann R, 1890, ELEMENTARORGANISMEN; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	9	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 16	2009	139	2					231	233		10.1016/j.cell.2009.09.030	http://dx.doi.org/10.1016/j.cell.2009.09.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837028	Bronze			2022-12-28	WOS:000270857500009
J	Junge, HJ; Yang, S; Burton, JB; Paes, K; Shu, X; French, DM; Costa, M; Rice, DS; Ye, WL				Junge, Harald J.; Yang, Stacey; Burton, Jeremy B.; Paes, Kim; Shu, Xiao; French, Dorothy M.; Costa, Mike; Rice, Dennis S.; Ye, Weilan			TSPAN12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4/beta-Catenin Signaling	CELL			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; CATENIN PATHWAY; DISEASE GENE; ANGIOGENESIS; MUTATIONS; EXPRESSION; RECEPTORS; EVOLUTION; OLIGOMERS; ACTIVATE	Mutations in the genes encoding the Wnt receptor Frizzled-4 (FZD4), coreceptor LRP5, or the ligand Norrin disrupt retinal vascular development and cause ophthalmic diseases. Although Norrin is structurally unrelated to Wnts, it binds FZD4 and activates the canonical Wnt pathway. Here we show that the tetraspanin Tspan12 is expressed in the retinal vasculature, and loss of Tspan12 phenocopies defects seen in Fzd4, Lrp5, and Norrin mutant mice. In addition, Tspan12 genetically interacts with Norrin or Lrp5. Overexpressed TSPAN12 associates with the Norrin-receptor complex and significantly increases Norrin/beta-catenin but not Wnt/beta-catenin signaling, whereas Tspan12 siRNA abolishes transcriptional responses to Norrin but not Wnt3A in retinal endothelial cells. Signaling defects caused by Norrin or FZD4 mutations that are predicted to impair receptor multimerization are rescued by overexpression of TSPAN12. Our data indicate that Norrin multimers and TSPAN12 cooperatively promote multimerization of FZD4 and its associated proteins to elicit physiological levels of signaling.	[Junge, Harald J.; Yang, Stacey; Burton, Jeremy B.; Shu, Xiao; Ye, Weilan] Genentech Inc, Tumor Biol & Angiogenesis Dept, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Paes, Kim; Rice, Dennis S.] Lexicon Pharmaceut Inc, Dept Ophthalmol, The Woodlands, TX 77381 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Lexicon Pharmaceuticals	Ye, WL (corresponding author), Genentech Inc, Tumor Biol & Angiogenesis Dept, 1 DNA Way, San Francisco, CA 94080 USA.	loni@gene.com		JUNGE, HARALD/0000-0003-2458-6010; Ye, Weilan/0000-0002-6219-3982				BERGER W, 2001, METABOLIC MOL BASES, P5977; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hartzer MK, 1999, BRAIN RES BULL, V49, P355, DOI 10.1016/S0361-9230(99)00071-4; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; ISASHIKI Y, 1995, BRIT J OPHTHALMOL, V79, P703, DOI 10.1136/bjo.79.7.703; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Toomes C, 2005, BRIT J OPHTHALMOL, V89, P194, DOI 10.1136/bjo.2004.042507; Toomes C, 2004, INVEST OPHTH VIS SCI, V45, P2083, DOI 10.1167/iovs.03-1044; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Warden Scott M, 2007, Semin Ophthalmol, V22, P211, DOI 10.1080/08820530701745124; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	33	248	269	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					299	311		10.1016/j.cell.2009.07.048	http://dx.doi.org/10.1016/j.cell.2009.07.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837033	Bronze			2022-12-28	WOS:000270857500014
J	Korkut, C; Ataman, B; Ramachandran, P; Ashley, J; Barria, R; Gherbesi, N; Budnik, V				Korkut, Ceren; Ataman, Bulent; Ramachandran, Preethi; Ashley, James; Barria, Romina; Gherbesi, Norberto; Budnik, Vivian			Trans-Synaptic Transmission of Vesicular Wnt Signals through Evi/Wntless	CELL			English	Article							SYNAPSE DEVELOPMENT; WINGLESS; REQUIRES; SECRETION; EXOSOMES; GENE; TRAFFICKING; MORPHOGENS; PATHWAYS; PROTEINS	Wnts play pivotal roles during development and in the mature nervous system. However, the mechanism by which Wnts traffic between cells has remained elusive. Here we demonstrate a mechanism of Wnt transmission through release of exosome-like vesicles containing the Wnt-binding protein Evenness Interrupted/Wntless/Sprinter (Evi/Wls/Srt). We show that at the Drosophila larval neuromuscular junction (NMJ), presynaptic vesicular release of Evi is required for the secretion of the Wnt, Wingless (Wg). We also show that Evi acts cell-autonomously in the postsynaptic Wnt-receiving cell to target dGRIP, a Wg-receptor-interacting protein, to postsynaptic sites. Upon Evi loss of function, dGRIP is not properly targeted to synaptic sites, interfering with postsynaptic Wnt signal transduction. These findings uncover a previously unknown cellular mechanism by which a secreted Wnt is transported across synapses by Evi-containing vesicles and reveal trafficking functions of Evi in both the Wnt-producing and the Wnt-receiving cells.	[Korkut, Ceren; Ataman, Bulent; Ramachandran, Preethi; Ashley, James; Barria, Romina; Gherbesi, Norberto; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA.	vivian.budnik@umassmed.edu		Tezer, Ceren/0000-0001-9276-3264; Ashley, James/0000-0002-6693-1014	NIH [RO1 MH070000]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Marc Freeman, Michael Francis, and Motojiro Yoshihara as well as members of the Budnik lab for helpful comments and critical discussion on the manuscript. We especially thank John Nunnari for great help with immunoelectron microscopy, Yuly Fuentes for providing the images with UAS-LacZ-NLS, and Dr. Sean Speese for help with the qPCR. We also thank Dr. Michael Boutros for providing the evi<SUP>2</SUP> and Evi-EGFP fly lines as well as the Evi-EGFP and Wg plasmids for studies in S2 cells. This work was supported by NIH grant RO1 MH070000 to V. B. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. This paper is dedicated to Susan Cumberledge (3/5/1956-7/28/2008).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Baeg GH, 2001, DEVELOPMENT, V128, P87; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mendoza-Topaz C, 2008, J NEUROSCI, V28, P304, DOI 10.1523/JNEUROSCI.4395-07.2008; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871	41	309	317	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					393	404		10.1016/j.cell.2009.07.051	http://dx.doi.org/10.1016/j.cell.2009.07.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837038	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000270857500021
J	Lamia, KA; Sachdeva, UM; DiTacchio, L; Williams, EC; Alvarez, JG; Egan, DF; Vasquez, DS; Juguilon, H; Panda, S; Shaw, RJ; Thompson, CB; Evans, RM				Lamia, Katja A.; Sachdeva, Uma M.; DiTacchio, Luciano; Williams, Elliot C.; Alvarez, Jacqueline G.; Egan, Daniel F.; Vasquez, Debbie S.; Juguilon, Henry; Panda, Satchidananda; Shaw, Reuben J.; Thompson, Craig B.; Evans, Ronald M.			AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; LIVER; OSCILLATORS; BMAL1; FORM	Circadian clocks coordinate behavioral and physiological processes with daily light-dark cycles by driving rhythmic transcription of thousands of genes. Whereas the master clock in the brain is set by light, pacemakers in peripheral organs, such as the liver, are reset by food availability, although the setting, or "entrainment," mechanisms remain mysterious. Studying mouse fibroblasts, we demonstrated that the nutrient-responsive adenosine monophosphate-activated protein kinase (AMPK) phosphorylates and destabilizes the clock component cryptochrome 1 (CRY1). In mouse livers, AMPK activity and nuclear localization were rhythmic and inversely correlated with CRY1 nuclear protein abundance. Stimulation of AMPK destabilized cryptochromes and altered circadian rhythms, and mice in which the AMPK pathway was genetically disrupted showed alterations in peripheral clocks. Thus, phosphorylation by AMPK enables cryptochrome to transduce nutrient signals to circadian clocks in mammalian peripheral organs.	[Sachdeva, Uma M.; Thompson, Craig B.] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lamia, Katja A.; Williams, Elliot C.; Alvarez, Jacqueline G.; Juguilon, Henry; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [DiTacchio, Luciano; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Alvarez, Jacqueline G.; Juguilon, Henry; Shaw, Reuben J.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Egan, Daniel F.; Vasquez, Debbie S.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA	University of Pennsylvania; Pennsylvania Medicine; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Thompson, CB (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu; evans@salk.edu	DiTacchio, Luciano/D-6341-2011; Evans, Ronald/AAF-4001-2019; Williams, Elliot/CAH-1352-2022; Panda, Satchidananda/J-6891-2012	DiTacchio, Luciano/0000-0001-9570-7348; Evans, Ronald/0000-0002-9986-5965; Williams, Elliot/0000-0001-7839-3658	NIH [DK057978, DK062434, CA104838, DK080425, EY016807, T32-HL07439-27]; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014195, P01CA104838] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, U19DK062434, R01DK080425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Asara and the Beth Israel Deaconess Medical Center Mass Spectrometry facility for phosphopeptide detection; A. Sancar for mouse strains; C. Weitz and S. Reppert for clock gene expression plasmids; and M. Downes and R. Yu for critical reading of the manuscript. Supported by NIH grants DK057978 and DK062434 (R. M. E.), CA104838 (C. B. T.), DK080425 (R. J. S.), EY016807 (S. P.), and T32-HL07439-27 (U. M. S.) and by the Pew Charitable Trust (S. P.). K. A. L. is a Merck fellow of the Life Sciences Research Foundation. Several of the authors (K. A. L., U. M. S., L. D., S. P., R. J. S., C. B. T., and R. M. E.) have filed preliminary patent applications related to this work.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	28	590	624	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					437	440		10.1126/science.1172156	http://dx.doi.org/10.1126/science.1172156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833968	Green Accepted			2022-12-28	WOS:000270818600056
J	Zarnescu, DC; Zinsmaier, KE				Zarnescu, Daniela C.; Zinsmaier, Konrad E.			Ferrying Wingless across the Synaptic Cleft	CELL			English	Editorial Material							WNT; SECRETION		[Zarnescu, Daniela C.; Zinsmaier, Konrad E.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Zarnescu, Daniela C.; Zinsmaier, Konrad E.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Zinsmaier, KE (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu			NINDS [R01NS052664]; DOD [W81X-WH09-1-0273]; AHA [SDG 0930170N]; ABRC [0820]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052664] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD(United States Department of Defense); AHA(American Heart Association); ABRC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jinhui Zhang for help preparing the figure. K.E.Z. is supported by funds from NINDS (R01NS052664) and D.C.Z. from DOD (W81X-WH09-1-0273), AHA (SDG 0930170N), and ABRC (0820).	Baeg GH, 2001, DEVELOPMENT, V128, P87; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504	9	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					229	231		10.1016/j.cell.2009.09.032	http://dx.doi.org/10.1016/j.cell.2009.09.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837027	Bronze			2022-12-28	WOS:000270857500008
J	Zuend, SJ; Coughlin, MP; Lalonde, MP; Jacobsen, EN				Zuend, Stephan J.; Coughlin, Matthew P.; Lalonde, Mathieu P.; Jacobsen, Eric N.			Scaleable catalytic asymmetric Strecker syntheses of unnatural alpha-amino acids	NATURE			English	Article							HEPATITIS-C-VIRUS; IMINES; ADDITIONS; CYANIDE; AGENTS	alpha-Amino acids are the building blocks of proteins and are widely used as components of medicinally active molecules and chiral catalysts(1-5). Efficient chemo-enzymatic methods for the synthesis of enantioenriched alpha-amino acids have been developed, but it is still a challenge to obtain non-naturalamino acids(6,7). Alkene hydrogenation is broadly useful for the enantioselective catalytic synthesis of many classes of amino acids(8,9), but it is not possible to obtain zeta-amino acids bearing aryl or quaternary alkyl alpha-substituents using this method. The Strecker synthesis-the reaction of an imine or imine equivalent with hydrogen cyanide, followed by nitrile hydrolysis-is an especially versatile chemical method for the synthesis of racemic alpha-amino acids(10,11). Asymmetric Strecker syntheses using stoichiometric amounts of a chiral reagent have been applied successfully on gram-to-kilogram scales, yielding enantiomerically enriched alpha-amino acids(12-14). In principle, Strecker syntheses employing sub-stoichiometric quantities of a chiral reagent could provide a practical alternative to these approaches, but the reported catalytic asymmetric methods have seen limited use on preparative scales (more than a gram)(15,16). The limited utility of existing catalytic methods may be due to several important factors, including the relatively complex and precious nature of the catalysts and the requisite use of hazardous cyanide sources. Here we report a new catalytic asymmetric method for the syntheses of highly enantiomerically enriched non-natural amino acids using a simple chiral amido-thiourea catalyst to control the key hydrocyanation step. This catalyst is robust, without sensitive functional groups, so it is compatible with aqueous cyanide salts, which are safer and easier to handle than other cyanide sources; this makes the method adaptable to large-scale synthesis. We have used this new method to obtain enantiopure amino acids that are not readily prepared by enzymatic methods or by chemical hydrogenation.	[Zuend, Stephan J.; Coughlin, Matthew P.; Lalonde, Mathieu P.; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NIH; American Chemical Society and Roche; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM069721, R37GM043214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society and Roche; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH, and through fellowships from the American Chemical Society and Roche (to S. J. Z.) and the Natural Sciences and Engineering Research Council of Canada (to M. P. L.).	Anderson JC, 2004, TETRAHEDRON, V60, P2327, DOI 10.1016/j.tet.2004.01.021; Arasappan A, 2007, TETRAHEDRON LETT, V48, P6343, DOI 10.1016/j.tetlet.2007.07.002; Belanger E, 2009, ORG LETT, V11, P2201, DOI 10.1021/ol9005618; Bhat S. V., 2005, CHEM NATURAL PRODUCT, P317; BLOCK RJ, 1946, CHEM REV, V38, P501, DOI 10.1021/cr60121a004; Bommarius AS, 2001, CHIMIA, V55, P50; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Corey EJ, 1999, ORG LETT, V1, P157, DOI 10.1021/ol990623l; Davie EAC, 2007, CHEM REV, V107, P5759, DOI 10.1021/cr068377w; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Frisch M.J., 2016, GAUSSIAN16 REV B01; Groger H, 2003, CHEM REV, V103, P2795, DOI 10.1021/cr020038p; HARADA K, 1963, NATURE, V200, P1201, DOI 10.1038/2001201a0; Helmchen G, 2000, ACCOUNTS CHEM RES, V33, P336, DOI 10.1021/ar9900865; KNOWLES WS, 1983, ACCOUNTS CHEM RES, V16, P106, DOI 10.1021/ar00087a006; Krueger CA, 1999, J AM CHEM SOC, V121, P4284, DOI 10.1021/ja9840605; Kuethe JT, 2007, J ORG CHEM, V72, P7469, DOI 10.1021/jo7012862; MAI K, 1986, J ORG CHEM, V51, P3545, DOI 10.1021/jo00368a030; Merino P, 2009, TETRAHEDRON, V65, P1219, DOI 10.1016/j.tet.2008.11.020; MILLER SL, 1955, J AM CHEM SOC, V77, P2351, DOI 10.1021/ja01614a001; Mita T, 2009, SYNLETT, P1680, DOI 10.1055/s-0029-1217344; Najera C, 2007, CHEM REV, V107, P4584, DOI 10.1021/cr050580o; Ooi T, 2006, J AM CHEM SOC, V128, P2548, DOI 10.1021/ja058066n; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; Shu LH, 2008, ORG PROCESS RES DEV, V12, P298, DOI 10.1021/op700286u; Sigman MS, 2000, ANGEW CHEM INT EDIT, V39, P1279, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1279::AID-ANIE1279>3.0.CO;2-U; Tsantrizos YS, 2008, ACCOUNTS CHEM RES, V41, P1252, DOI 10.1021/ar8000519; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wenzel AG, 2003, SYNLETT, P1919; Zuend SJ, 2009, J AM CHEM SOC, V131, P15358, DOI 10.1021/ja9058958	30	258	263	4	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					968	U223		10.1038/nature08484	http://dx.doi.org/10.1038/nature08484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	506ZF	19829379	Green Accepted			2022-12-28	WOS:000270817700044
J	Mullany, LC; Biggar, RJ				Mullany, Luke C.; Biggar, Robert J.			Vaginal and neonatal skin cleansing with chlorhexidine	LANCET			English	Editorial Material							MORTALITY; MORBIDITY; TRIAL; INFANTS; IMPACT; NEPAL		[Mullany, Luke C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Biggar, Robert J.] State Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Biggar, Robert J.] Int Agcy Res Canc, F-69372 Lyon, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Statens Serum Institut; World Health Organization; International Agency for Research on Cancer (IARC)	Mullany, LC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	lmullany@jhsph.edu						Bakr AF, 2005, J WOMENS HEALTH, V14, P496, DOI 10.1089/jwh.2005.14.496; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; Denton GW, 2001, DISINFECTION STERILI, P321; *DEP MAK PREGN SAF, 2007, NEON PER MORT COUNTR; McClure EM, 2007, INT J GYNECOL OBSTET, V97, P89, DOI 10.1016/j.ijgo.2007.01.014; Mullany LC, 2008, PEDIATR INFECT DIS J, V27, P505, DOI 10.1097/INF.0b013e31816791a2; STADE B, 2004, COCHRANE DB SYST REV, V1; Taha TE, 1997, BRIT MED J, V315, P216, DOI 10.1136/bmj.315.7102.216; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	10	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1873	1875		10.1016/S0140-6736(09)61593-2	http://dx.doi.org/10.1016/S0140-6736(09)61593-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19846213				2022-12-28	WOS:000272646900007
J	Siegrist, J; Wahrendorf, M				Siegrist, Johannes; Wahrendorf, Morten			Quality of work, health, and retirement	LANCET			English	Editorial Material									[Siegrist, Johannes; Wahrendorf, Morten] Univ Dusseldorf, Dept Med Sociol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Siegrist, J (corresponding author), Univ Dusseldorf, Dept Med Sociol, D-40225 Dusseldorf, Germany.	siegrist@uni-duesseldorf.de	Siegrist, Johannes/AAL-6814-2021	Siegrist, Johannes/0000-0002-7530-4178				Banks JA, 2003, HLTH WEALTH LIFESTYL; Blondal S., 1999, RETIREMENT DECISION; Borsch-Supan A., 2005, HLTH AGEING RETIREME; Borsch-Supan A., 2005, SURVEY HLTH AGEING R; Cartwright S., 2009, OXFORD HDB ORG WELL; Gruber J., 1999, SOCIAL SECURITY RETI; Kohli M., 2008, HLTH AGEING RETIREME, P166; Marmot M., 2006, SOCIAL DETERMINANTS, P97; Schnall P., 2009, UNHEALTHY WORK CAUSE; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J, 2007, EUR J PUBLIC HEALTH, V17, P62, DOI 10.1093/eurpub/ckl084; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1	13	14	14	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1872	1873		10.1016/S0140-6736(09)61666-4	http://dx.doi.org/10.1016/S0140-6736(09)61666-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19897237				2022-12-28	WOS:000272646900006
J	Howell, MD				Howell, Michael D.			A 37-Year-Old Man Trying to Choose a High-Quality Hospital Review of Hospital Quality Indicators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CONGESTIVE-HEART-FAILURE; PRIMARY-CARE PHYSICIANS; PAY-FOR-PERFORMANCE; OF-CARE; HEALTH-CARE; UNITED-STATES; MEDICARE PATIENTS; PATIENT-OUTCOMES; CARDIAC-SURGERY	Mr A, a previously healthy 37-year-old man, was diagnosed as having Prinzmetal angina and a hypercoagulable state 3 years ago after an ST-elevation myocardial infarction. Now, his cardiologist is moving and Mr A must select a new physician and health system. Geographic relocation, insurance changes, and other events force millions in the United States to change physicians and hospitals every year. Mr A should begin by choosing a primary care physician, since continuity and coordination of care improves outcomes. Evidence for evaluating specific physicians is less robust, though a variety of sources are available. A broad range of detailed quality information, such as Medicare's Hospital Compare (http://www.hospitalcompare.hhs.gov/), is available for selecting a hospital. However, the relationship of these metrics to patient outcomes is variable, and different Web sites provide meaningfully different rankings and data interpretations. For Mr A in particular, a warfarin management team, the hospital's location, and a cardiologist with whom he feels comfortable and who can communicate with his primary care physician are important factors. Nevertheless, hospital quality information and metrics are an important component of the strategy Mr A should take to solve this challenging problem. JAMA. 2009;302(21):2353-2360	[Howell, Michael D.] Beth Israel Deaconess Med Ctr, Silverman Inst Hlth Care Qual & Safety, Boston, MA 02215 USA; [Howell, Michael D.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Howell, Michael D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Howell, MD (corresponding author), Beth Israel Deaconess Med Ctr, Silverman Inst Hlth Care Qual & Safety, 330 Brookline Ave, Boston, MA 02215 USA.	mhowell@bidmc.harvard.edu	Howell, Michael/B-8065-2009	Howell, Michael/0000-0001-7003-6971	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Dr Howell reports that he receives grant support from the Robert Wood Johnson Foundation's Advancing the Science of Continuous Quality Improvement and Physician Faculty Scholars Program.	[Anonymous], 2008, US NEWS WORLD REP, V145, P76; [Anonymous], 2008, US NEWS WORLD REP, V145, P78; Atherly A, 2005, INQUIRY-J HEALTH CAR, V42, P255, DOI 10.5034/inquiryjrnl_42.3.255; Aujesky D, 2008, CAN MED ASSOC J, V178, P27, DOI 10.1503/cmaj.070743; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; *BUR LAB STAT, EMPL SIT SUMM MAY 20; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Campbell RJ, 2003, FAM MED, V35, P60; Casalino LP, 2007, HEALTH AFFAIR, V26, P492, DOI 10.1377/hlthaff.26.2.492; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Chen J, 2003, HEALTH AFFAIR, V22, P243, DOI 10.1377/hlthaff.22.2.243; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; Christian CK, 2005, WORLD J SURG, V29, P1241, DOI 10.1007/s00268-005-7993-8; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; COMAROW A, 2008, US NEWSS BEST HOSP C; Cunningham PJ, 2000, HEALTH AFFAIR, V19, P158, DOI 10.1377/hlthaff.19.3.158; de Jong JD, 2006, HEALTH SERV RES, V41, P374, DOI 10.1111/j.1475-6773.2005.00486.x; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Durairaj L, 2005, CHEST, V128, P1682, DOI 10.1378/chest.128.3.1682; Esserman L, 2002, JNCI-J NATL CANCER I, V94, P369; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Faber M, 2009, MED CARE, V47, P1, DOI 10.1097/MLR.0b013e3181808bb5; *FAM US, 2009, UN UN AM; Forrest CB, 2002, J FAM PRACTICE, V51, P215; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gorey KM, 2009, CANCER-AM CANCER SOC, V115, P3563, DOI 10.1002/cncr.24401; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; *HEALTHGRADES, 2009, 3 ANN HEALTHGRADES A; Hibbard JH, 2008, ANN INTERN MED, V148, P160, DOI 10.7326/0003-4819-148-2-200801150-00011; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; HUNINK MG, 2001, DECISION MAKING HLTH, P364; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2008, JT COMM J QUAL PATIE, V34, P318, DOI 10.1016/S1553-7250(08)34040-9; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; *KAIS FAM FDN AG H, 2006 UPD CONS VIEWS; Kellum JA, 2009, JAMA-J AM MED ASSOC, V301, P2496, DOI 10.1001/jama.2009.850; Kernisan LP, 2009, JAMA-J AM MED ASSOC, V301, P1341, DOI 10.1001/jama.2009.422; Ketcham JD, 2007, HEALTH AFFAIR, V26, P195, DOI 10.1377/hlthaff.26.1.195; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; KLEIN MW, 1961, J HEALTH HUM BEHAV, V2, P138, DOI 10.2307/2948811; Kostopoulou O, 2008, FAM PRACT, V25, P400, DOI 10.1093/fampra/cmn071; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Landon BE, 2008, ANN INTERN MED, V148, P353, DOI 10.7326/0003-4819-148-5-200803040-00006; Lavarreda SA, 2008, MED CARE, V46, P1055, DOI 10.1097/MLR.0b013e318187d8db; *LEAPFR GROUP, LEAPFR HOSP SURV RES; Leonardi MJ, 2007, ARCH SURG-CHICAGO, V142, P863, DOI 10.1001/archsurg.142.9.863; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; O'Malley AS, 2005, ARCH INTERN MED, V165, P2129, DOI 10.1001/archinte.165.18.2129; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Reed M C, 2000, Data Bull (Cent Stud Health Syst Change), P1; Reis SE, 1997, J AM COLL CARDIOL, V30, P733, DOI 10.1016/S0735-1097(97)00214-3; ROAN S, 2008, LOS ANGELES TIM 0519; Roetzheim RG, 2001, J FAM PRACTICE, V50, P1027; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; ROTHBERG MB, 2009, J HOSP MED, DOI DOI 10.1002/JHM.481; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Scholle SH, 2008, AM J MANAG CARE, V14, P829; Schull MJ, 2006, ANN EMERG MED, V48, P647, DOI 10.1016/j.annemergmed.2006.03.025; Schwartz LM, 2005, BMJ-BRIT MED J, V331, P821, DOI 10.1136/bmj.38614.449016.DE; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; SHI LY, 1994, INT J HEALTH SERV, V24, P431, DOI 10.2190/BDUU-J0JD-BVEX-N90B; Sofaer S, 2005, HEALTH SERV RES, V40, P2018, DOI 10.1111/j.1475-6773.2005.00473.x; Song HK, 2009, J THORAC CARDIOV SUR, V137, P65, DOI 10.1016/j.jtcvs.2008.09.053; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Staiger DO, 2009, MED CARE, V47, P226, DOI 10.1097/MLR.0b013e3181847574; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; *THOMS REUT, 100 TOP HOSP NAT BEN; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; *UCOMPAREHEALTHCAR, METH; *US BUR CENS, DET TABL GEOGR MOB 2; Wang OJ, 2007, ARCH INTERN MED, V167, P1345, DOI 10.1001/archinte.167.13.1345; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2006, CIRCULATION, V114, P558, DOI 10.1161/CIRCULATIONAHA.105.600973; Wilson CT, 2007, ARCH SURG-CHICAGO, V142, P242, DOI 10.1001/archsurg.142.3.242; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; 2008, US NEWS WORLD REP, V145, P74	92	8	8	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2353	2360		10.1001/jama.2009.1684	http://dx.doi.org/10.1001/jama.2009.1684			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525TK	19887653				2022-12-28	WOS:000272239000024
J	Etgen, T; Greil, O; Walter, T; Viermetz, M; Freudenberger, T				Etgen, Thorleif; Greil, Oliver; Walter, Thomas; Viermetz, Michael; Freudenberger, Thomas			Headaches, delusions, and catharsis	LANCET			English	Editorial Material							SPONTANEOUS INTRACRANIAL HYPOTENSION; FRONTOTEMPORAL DEMENTIA		[Etgen, Thorleif; Walter, Thomas; Freudenberger, Thomas] Klinikum Traunstein, Dept Neurol, D-83278 Traunstein, Germany; [Greil, Oliver] Klinikum Traunstein, Dept Radiol, D-83278 Traunstein, Germany; [Etgen, Thorleif] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-8000 Munich, Germany; [Viermetz, Michael] Ctr Radiol, Traunstein, Germany	Technical University of Munich; University of Munich	Etgen, T (corresponding author), Klinikum Traunstein, Dept Neurol, Cuno Niggl Str 3, D-83278 Traunstein, Germany.	thorleif.etgen@klinikum-traunstein.de	Etgen, Thorleif/ABB-3610-2020	Etgen, Thorleif/0000-0002-7857-6435				Fitzek S, 2004, PSYCHIAT RES-NEUROIM, V131, P177, DOI 10.1016/j.pscychresns.2004.01.006; Hong M, 2002, NEUROLOGY, V58, P1285, DOI 10.1212/WNL.58.8.1285; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Walker L, 2008, CLIN NEUROPSYCHOL, V22, P1035, DOI 10.1080/13854040701874386	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 7	2009	374	9701					1652	1652		10.1016/S0140-6736(09)61300-3	http://dx.doi.org/10.1016/S0140-6736(09)61300-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19897131				2022-12-28	WOS:000271674600039
J	Ren, D; Labandeira, CC; Santiago-Blay, JA; Rasnitsyn, A; Shih, C; Bashkuev, A; Logan, MAV; Hotton, CL; Dilcher, D				Ren, Dong; Labandeira, Conrad C.; Santiago-Blay, Jorge A.; Rasnitsyn, Alexandr; Shih, ChungKun; Bashkuev, Alexei; Logan, M. Amelia V.; Hotton, Carol L.; Dilcher, David			A Probable Pollination Mode Before Angiosperms: Eurasian, Long-Proboscid Scorpionflies	SCIENCE			English	Article							REPRODUCTIVE STRUCTURES; INSECT POLLINATION; POLLEN MORPHOLOGY; FOSSIL EVIDENCE; DIVERSIFICATION; BRACHYCERA; MOUTHPARTS; DIVERSITY; TABANIDAE; EVOLUTION	The head and mouthpart structures of 11 species of Eurasian scorpionflies represent three extinct and closely related families during a 62-million-year interval from the late Middle Jurassic to the late Early Cretaceous. These taxa had elongate, siphonate ( tubular) proboscides and fed on ovular secretions of extinct gymnosperms. Five potential ovulate host-plant taxa co-occur with these insects: a seed fern, conifer, ginkgoopsid, pentoxylalean, and gnetalean. The presence of scorpionfly taxa suggests that siphonate proboscides fed on gymnosperm pollination drops and likely engaged in pollination mutualisms with gymnosperms during the mid-Mesozoic, long before the similar and independent coevolution of nectar-feeding flies, moths, and beetles on angiosperms. All three scorpionfly families became extinct during the later Early Cretaceous, coincident with global gymnosperm-to-angiosperm turnover.	[Ren, Dong; Shih, ChungKun] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Labandeira, Conrad C.; Santiago-Blay, Jorge A.; Hotton, Carol L.; Dilcher, David] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Santiago-Blay, Jorge A.] Gallaudet Univ, Dept Biol, Washington, DC 20003 USA; [Rasnitsyn, Alexandr] Russian Acad Sci, Inst Paleontol, Moscow 117997, Russia; [Rasnitsyn, Alexandr] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Logan, M. Amelia V.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20013 USA; [Hotton, Carol L.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Dilcher, David] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Capital Normal University; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Russian Academy of Sciences; Natural History Museum London; Smithsonian Institution; Smithsonian National Museum of Natural History; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); State University System of Florida; University of Florida	Labandeira, CC (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	labandec@si.edu	Rasnitsyn, Alexandr/P-2393-2015; Bashkuev, Alexey/AGT-3561-2022	Bashkuev, Alexey/0000-0001-7929-8759; Ren, Dong/0000-0001-8660-0901; Rasnitsyn, Alexandr/0000-0002-6350-0040	National Science Foundation of China [30430100, 40872022]; Natural Science Foundation of Beijing [5082002]; Key and PHR Program of the Beijing Municipal Commission of Education; Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences; Intramural Research Program of the National Library of Medicine	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Key and PHR Program of the Beijing Municipal Commission of Education; Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Intramural Research Program of the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This is contribution 152 of the Evolution of Terrestrial Ecosystems consortium at the National Museum of Natural History and contribution 614 of the Florida Museum of Natural History. Supported by the National Science Foundation of China ( grants 30430100 and 40872022), the Natural Science Foundation of Beijing ( grant 5082002), and the Key and PHR Program of the Beijing Municipal Commission of Education ( D. R.); the Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences ( A. B.); and the Intramural Research Program of the National Library of Medicine. We thank F. Marsh for drafting the figures, T. Lott for a presubmission review, P. Crane for comments, T. Rose for assistance on the geochemical analyses, J. Corman for collection of data, B. Wagner and R. Johnson for translations, P. Peltier for proofreading, and W. Wu for general assistance. X. Wang provided data and images for Problematospermum ovale, and D. Grimaldi of the American Museum of Natural History ( New York) made an important specimen available for study.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; ANDERSON JM, 2008, STRELITZIA, V20; Axsmith BJ, 2004, J PALEONTOL, V78, P402, DOI 10.1666/0022-3360(2004)078<0402:CPCFTC>2.0.CO;2; Beutel RG, 2008, J ZOOL SYST EVOL RES, V46, P346, DOI 10.1111/j.1439-0469.2008.00473.x; Beutel RG, 2009, ARTHROPOD STRUCT DEV, V38, P427, DOI 10.1016/j.asd.2009.05.002; Borrell BJ, 2006, ECOLOGY AND BIOMECHANICS, P185; BOSE MN, 1985, PHILOS T ROY SOC B, V310, P77, DOI 10.1098/rstb.1985.0100; BURGER JF, 1988, P ENTOMOL SOC WASH, V90, P12; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CAZIER MA, 1985, B AM MUS NAT HIST, V182, P183; Chaudonneret J, 1990, PIECES BUCCALES INSE; Crepet WL, 2008, ANN MO BOT GARD, V95, P3, DOI 10.3417/2007065; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; CREPET WL, 1972, AM J BOT, V59, P1048, DOI 10.2307/2441490; DEHGAN B, 1988, AM J BOT, V75, P1501, DOI 10.2307/2444700; Friis EM, 1999, ANN MO BOT GARD, V86, P259, DOI 10.2307/2666179; Gonzalez CR, 2004, ZOOTAXA, P1; Gorelick R, 2001, BIOL J LINN SOC, V74, P407, DOI 10.1111/j.1095-8312.2001.tb01403.x; Grimaldi D, 2005, INSECT SYST EVOL, V36, P443, DOI 10.1163/187631205794761021; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; GRINFEL'D E K, 1975, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V54, P18; HARRIS T. M., 1951, PHYTOMORPHOLOGY [DELHI], V1, P29; HARRIS T. M., 1933, NEW PHYTOLOGIST, V32, P97, DOI 10.1111/j.1469-8137.1933.tb07001.x; HARRIS TM, 1951, PHILOS T ROY SOC B, V235, P483, DOI 10.1098/rstb.1951.0006; Harris TM, 1940, ANN BOT-LONDON, V4, P713, DOI 10.1093/aob/4.4.713; Holmes P. L., 1993, FOSS REC, P809; KNIEPERT FW, 1980, OECOLOGIA, V46, P125, DOI 10.1007/BF00346976; Krassillov VA, 2007, AFR INVERTEBR, V48, P3; Krenn HW, 2005, ARTHROPOD STRUCT DEV, V34, P1, DOI 10.1016/j.asd.2004.10.002; Krenn HW, 2002, ARTHROPOD STRUCT DEV, V31, P103, DOI 10.1016/S1467-8039(02)00025-7; Kvacek J, 2000, REV PALAEOBOT PALYNO, V112, P51, DOI 10.1016/S0034-6667(00)00035-X; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Labandeira CC, 2007, TAXON, V56, P663, DOI 10.2307/25065853; Labandeira Conrad C., 2005, P217; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; MIDGLEY JJ, 1991, PHILOS T R SOC B, V333, P209, DOI 10.1098/rstb.1991.0069; Nepi M, 2009, ANN BOT-LONDON, V104, P205, DOI 10.1093/aob/mcp124; NOVOKSHONOV VG, 1997, EARLY EVOLUTION SCOR; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Porsch O, 1957, OSTERR BOT Z, V104, P115; Proctor M., 1996, NATURAL HIST POLLINA; Rasnitsyn A. P., 1991, T USSR ACAD SCI EART, V310, P233; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; SAHNI B, 1948, BOT GAZ, V110, P47, DOI 10.1086/335517; Snodgrass R. E., 1943, SMITHSONIAN MISC COLL, V104, P1; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; STELLEMAN P, 1976, Tijdschrift voor Entomologie, V119, P15; Stuckenberg Brian R., 2000, Annals of the Natal Museum, V41, P181; Sun G, 2001, EARLY ANGIOSPERMS TH; Szucsich NU, 2000, ZOOMORPHOLOGY, V120, P79, DOI 10.1007/s004350000025; Tekleva MV, 2009, REV PALAEOBOT PALYNO, V156, P130, DOI 10.1016/j.revpalbo.2008.12.007; WANG X, 2009, COMMUNICATION    JUL	54	201	223	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					840	847		10.1126/science.1178338	http://dx.doi.org/10.1126/science.1178338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892981	Green Accepted			2022-12-28	WOS:000271468000041
J	Kuper, H; Nicholson, A; Kivimaki, M; Aitsi-Selmi, A; Cavalleri, G; Deanfield, JE; Heuschmann, P; Jouven, X; Malyutina, S; Mayosi, BM; Sans, S; Thomsen, T; Witteman, JCM; Hingorani, AD; Lawlor, DA; Hemingway, H				Kuper, Hannah; Nicholson, Amanda; Kivimaki, Mika; Aitsi-Selmi, Amina; Cavalleri, Gianpiero; Deanfield, John E.; Heuschmann, Peter; Jouven, Xavier; Malyutina, Sofia; Mayosi, Bongani M.; Sans, Susanna; Thomsen, Troels; Witteman, Jacqueline C. M.; Hingorani, Aroon D.; Lawlor, Debbie A.; Hemingway, Harry			Evaluating the causal relevance of diverse risk markers: horizontal systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; RANDOMIZED CONTROLLED-TRIALS; APOLIPOPROTEIN-E GENOTYPES; CARDIOVASCULAR-DISEASE; EUROPEAN GUIDELINES; CLINICAL-PRACTICE; MENDELIAN RANDOMIZATION; ARTERY-DISEASE; BLOOD-PRESSURE	Objectives To develop a new methodology to systematically compare evidence across diverse risk markers for coronary heart disease and to compare this evidence with guideline recommendations. Design "Horizontal" systematic review incorporating different sources of evidence. Data sources Electronic search of Medline and hand search of guidelines. Study selection Two reviewers independently determined eligibility of studies across three sources of evidence (observational studies, genetic association studies, and randomised controlled trials) related to four risk markers: depression, exercise, C reactive protein, and type 2 diabetes. Data extraction For each risk marker, the largest meta-analyses of observational studies and genetic association studies, and meta-analyses or individual randomised controlled trials were analysed. Results Meta-analyses of observational studies reported adjusted relative risks of coronary heart disease for depression of 1.9 (95% confidence interval 1.5 to 2.4), for top compared with bottom fourths of exercise 0.7 (0.5 to 1.0), for top compared with bottom thirds of C reactive protein 1.6 (1.5 to 1.7), and for diabetes in women 3.0 (2.4 to 3.7) and in men 2.0 (1.8 to 2.3). Prespecified study limitations were more common for depression and exercise. Meta-analyses of studies that allowed formal Mendelian randomisation were identified for C reactive protein (and did not support a causal effect), and were lacking for exercise, diabetes, and depression. Randomised controlled trials were not available for depression, exercise, or C reactive protein in relation to incidence of coronary heart disease, but trials in patients with diabetes showed some preventive effect of glucose control on risk of coronary heart disease. None of the four randomised controlled trials of treating depression in patients with coronary heart disease reduced the risk of further coronary events. Comparisons of this horizontal evidence review with two guidelines published in 2007 showed inconsistencies, with depression prioritised more in the guidelines than in our review. Conclusions This horizontal systematic review pinpoints deficiencies and strengths in the evidence for depression, exercise, C reactive protein, and diabetes as unconfounded and unbiased causes of coronary heart disease. This new method could be used to develop a field synopsis and prioritise future development of guidelines and research.	[Kuper, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kivimaki, Mika; Hingorani, Aroon D.; Hemingway, Harry] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Cavalleri, Gianpiero] Beaumont Hosp, Royal Coll Surg Ireland, Dublin 9, Ireland; [Deanfield, John E.] Great Ormond St Hosp Sick Children, Cardiothorac Unit, London, England; [Heuschmann, Peter] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Jouven, Xavier] INSERM, Villejuif, France; [Malyutina, Sofia] Russian Acad Med Sci, Inst Internal Med, Novosibirsk, Russia; [Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Sans, Susanna] Inst Estudios Salud, Monitoring & Res Programme Chron Dis, Barcelona, Spain; [Thomsen, Troels] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Lawlor, Debbie A.] MRC CAiTE Ctr, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; Royal College of Surgeons - Ireland; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Russian Academy of Medical Sciences; University of Cape Town; University of Cape Town; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; University of Bristol	Kuper, H (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	hannah.kuper@lshtm.ac.uk	Sans, Susana/ABD-5378-2021; Hemingway, Harry/C-1219-2009; Malyutina, Sofia/J-1651-2018; Kivimaki, Mika/B-3607-2012; Cavalleri, Gianpiero/A-6632-2010	Sans, Susana/0000-0002-0400-5197; Hemingway, Harry/0000-0003-2279-0624; Malyutina, Sofia/0000-0001-6539-0466; Kivimaki, Mika/0000-0002-4699-5627; Hingorani, Aroon/0000-0001-8365-0081; Deanfield, John/0000-0001-8806-6052; Lawlor, Debbie A/0000-0002-6793-2262; Cavalleri, Gianpiero/0000-0002-9802-0506; Mayosi, Bongani/0000-0001-6641-8950	Academy of Finland; Wellcome Trust; UK Department of Health; UK Medical Research Council; British Heart Foundation [FS 05/125]; MRC [G0600705] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G0100222, G0600705, G19/35] Funding Source: researchfish	Academy of Finland(Academy of Finland); Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MK is supported by the Academy of Finland. HK is supported by a grant from the Wellcome Trust. DAL is supported by a UK Department of Health Career Scientist Award and works in a centre that receives support from the UK Medical Research Council. ADH is supported by a British Heart Foundation senior research fellowship (FS 05/125).	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hemingway H, 2008, ANN INTERN MED, V149, P221, DOI 10.7326/0003-4819-149-4-200808190-00003; HOPKINS PN, 1981, ATHEROSCLEROSIS, V40, P1, DOI 10.1016/0021-9150(81)90122-2; Katz AM, 2003, MED CLIN N AM, V87, P303, DOI 10.1016/S0025-7125(02)00188-8; Kivimaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003013; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lopez LS, 2005, BIOL PSYCHIAT, V57, P999, DOI 10.1016/j.biopsych.2005.01.030; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOUCHART M, 2008, CAUSAL ANAL POPULATI; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Schneiderman N, 2004, PSYCHOSOM MED, V66, P475, DOI 10.1097/01.psy.0000133217.96180.e8; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Wald NJ, 2003, BRIT MED J, V327, P616, DOI 10.1136/bmj.327.7415.616	38	38	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2009	339								b4265	10.1136/bmj.b4265	http://dx.doi.org/10.1136/bmj.b4265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UD	19892791	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000271567900002
J	Jafar, TH; Hatcher, J; Poulter, N; Islam, M; Hashmi, S; Qadri, Z; Bux, R; Khan, A; Jafary, FH; Hameed, A; Khan, A; Badruddin, SH; Chaturvedi, N				Jafar, Tazeen H.; Hatcher, Juanita; Poulter, Neil; Islam, Muhammad; Hashmi, Shiraz; Qadri, Zeeshan; Bux, Rasool; Khan, Ayesha; Jafary, Fahim H.; Hameed, Aamir; Khan, Ata; Badruddin, Salma H.; Chaturvedi, Nish		Hypertension Res Grp	Community-Based Interventions to Promote Blood Pressure Control in a Developing Country A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							IMPROVING HYPERTENSION CONTROL; CONSORT STATEMENT; PATIENT EDUCATION; HEALTH-EDUCATION; UNITED-STATES; PRIMARY-CARE; RISK-FACTORS; ALMA-ATA; MANAGEMENT; DISEASE	Background: Despite convincing evidence that lowering blood pressure decreases cardiovascular morbidity and mortality, the hypertension burden remains high and control rates are poor in developing countries. Objective: To assess the effectiveness of 2 community-based interventions on blood pressure in hypertensive adults. Design: Cluster randomized, 2 x 2 factorial, controlled trial. (ClinicalTrials. gov registration number: NCT00327574) Setting: 12 randomly selected communities in Karachi, Pakistan. Patients: 1341 patients 40 years or older with hypertension (systolic blood pressure >= 140 mm Hg, diastolic blood pressure >= 90 mm Hg, or already receiving treatment). Measurements: Reduction in systolic blood pressure from baseline to end of follow-up at 2 years. Intervention: Family-based home health education (HHE) from lay health workers every 3 months and annual training of general practitioners (GPs) in hypertension management. Results: The age, sex, and baseline blood pressure-adjusted decrease in systolic blood pressure was significantly greater in the HHE and GP group (10.8 mm Hg [95% CI, 8.9 to 12.8 mm Hg]) than in the GP-only, HHE-only, or no intervention groups (5.8 mm Hg [CI, 3.9 to 7.7 mm Hg] in each; P < 0.001). The interaction between the main effects of GP training and HHE on the primary outcome approached significance (interaction P = 0.004 in intention-to-treat analysis and P = 0.044 in per-protocol analysis). Limitations: Follow-up blood pressure measurements were missing for 22% of patients. No mechanism was detected by which interventions lowered blood pressure. Conclusion: Family-based HHE delivered by trained lay health workers, coupled with educating GPs on hypertension, can lead to significant blood pressure reductions among patients with hypertension in Pakistan. Both strategies in combination may be feasible for upscaling within the existing health care systems of Indo-Asian countries.	[Jafar, Tazeen H.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; Tufts Med Sch, Boston, MA USA; Univ London Imperial Coll Sci Technol & Med, London, England	Aga Khan University; Tufts Medical Center; Tufts University; Imperial College London	Jafar, TH (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Stadium Rd, Karachi, Pakistan.	tazeen.jafar@aku.edu			Wellcome Trust, United Kingdom [070854/Z/03/Z]	Wellcome Trust, United Kingdom(Wellcome Trust)	By the Wellcome Trust, United Kingdom (research award 070854/Z/03/Z).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BILLAULT B, 1995, M D COMPUT, V12, P31; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; CARLETON RA, 1995, AM J PUBLIC HEALTH, V85, P777, DOI 10.2105/AJPH.85.6.777; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COE FL, 1977, J CHRON DIS, V30, P81, DOI 10.1016/0021-9681(77)90077-7; Conlin PR, 2000, AM J HYPERTENS, V13, P949, DOI 10.1016/S0895-7061(99)00284-8; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; DICKINSON JC, 1981, MED CARE, V19, P843, DOI 10.1097/00005650-198108000-00004; Dummer TJB, 2008, SOC SCI MED, V67, P590, DOI 10.1016/j.socscimed.2008.04.019; EARP JAL, 1982, AM J PUBLIC HEALTH, V72, P1146, DOI 10.2105/AJPH.72.10.1146; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; EVANS CE, 1986, JAMA-J AM MED ASSOC, V255, P501; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Fahey T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; FIELDING JE, 1994, J OCCUP ENVIRON MED, V36, P743; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hetlevik I, 1999, SCAND J PRIM HEALTH, V17, P35; HSIAO WC, 1984, NEW ENGL J MED, V310, P932, DOI 10.1056/NEJM198404053101428; Jafar TH, 2008, HEART, V94, P408, DOI 10.1136/hrt.2007.120774; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Khan Muhammad S, 2006, BMC Cardiovasc Disord, V6, P18, DOI 10.1186/1471-2261-6-18; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maue Susan K, 2003, J Clin Hypertens (Greenwich), V5, P33, DOI 10.1111/j.1524-6175.2003.02466.x; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; MCALISTER NH, 1986, BRIT MED J, V293, P670, DOI 10.1136/bmj.293.6548.670; McKinstry B, 2006, BRIT J GEN PRACT, V56, P842; *MIN HLTH, 2003, LAD HLTH WORK PROGR; Mohan S, 2009, HYPERTENSION, V53, P450, DOI 10.1161/HYPERTENSIONAHA.108.127076; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; MORISKY DE, 1983, AM J PUBLIC HEALTH, V73, P153, DOI 10.2105/AJPH.73.2.153; Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; MUHLHAUSER I, 1993, CLIN EXP HYPERTENS, V15, P125, DOI 10.3109/10641969309041615; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Parker DR, 2005, CONTEMP CLIN TRIALS, V26, P260, DOI 10.1016/j.cct.2005.01.002; Peters TJ, 2003, INT J EPIDEMIOL, V32, P840, DOI 10.1093/ije/dyg228; PIERCE JP, 1984, PREV MED, V13, P185, DOI 10.1016/0091-7435(84)90050-1; Qureshi NN, 2007, BMJ-BRIT MED J, V335, P1030, DOI 10.1136/bmj.39360.617986.AE; ROCACUSACHS A, 1991, J HUM HYPERTENS, V5, P437; Roumie CL, 2006, ANN INTERN MED, V145, P165, DOI 10.7326/0003-4819-145-3-200608010-00004; SACKETT DL, 1975, LANCET, V1, P1205; Sanders Karen M, 2002, J Contin Educ Health Prof, V22, P23, DOI 10.1002/chp.1340220104; Santos Carlos Antonio S T, 2008, BMC Med Res Methodol, V8, P80, DOI 10.1186/1471-2288-8-80; STARK R, 1985, SOC SCI MED, V20, P269, DOI 10.1016/0277-9536(85)90241-2; Taljaard M, 2008, BIOMETRICAL J, V50, P329, DOI 10.1002/bimj.200710423; TANNER GA, 1981, J ADV NURS, V6, P99, DOI 10.1111/j.1365-2648.1981.tb03198.x; Thompson Matthew J, 2002, Pac Health Dialog, V9, P11; Ukoumunne OC, 2007, STAT MED, V26, P3415, DOI 10.1002/sim.2769; Wang ZW, 2004, HYPERTENS RES, V27, P703, DOI 10.1291/hypres.27.703; WATKINS CJ, 1987, J ROY COLL GEN PRACT, V37, P548; WEBB CH, 1980, PRIMARY CARE, V7, P637; Weiss B D, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P603; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Williams DM, 2001, HEALTH AFFAIR, V20, P212, DOI 10.1377/hlthaff.20.3.212; ZISMER DK, 1982, ARCH INTERN MED, V142, P297, DOI 10.1001/archinte.142.2.297	66	123	126	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					593	W195		10.7326/0003-4819-151-9-200911030-00004	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514IM	19884620				2022-12-28	WOS:000271387700001
J	Qaseem, A; Snow, V; Denberg, TD; Casey, DE; Forciea, MA; Owens, DK; Shekelle, P				Qaseem, Amir; Snow, Vincenza; Denberg, Thomas D.; Casey, Donald E., Jr.; Forciea, Mary Ann; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							SILDENAFIL CITRATE VIAGRA((R)); PLACEBO-CONTROLLED TRIAL; RANDOMIZED DOUBLE-BLIND; URINARY-TRACT SYMPTOMS; ON-DEMAND TADALAFIL; PHOSPHODIESTERASE TYPE-5 INHIBITOR; SPARING RADICAL PROSTATECTOMY; INCREASES PENILE RIGIDITY; SERUM TESTOSTERONE LEVELS; FLEXIBLE-DOSE VARDENAFIL	Description: The American College of Physicians developed this guideline to present the available evidence on hormonal testing in and pharmacologic management of erectile dysfunction. Current pharmacologic therapies include phosphodiesterase-5 (PDE-5) inhibitors, such as sildenafil, vardenafil, tadalafil, mirodenafil, and udenafil, and hormonal treatment. Methods: Published literature on this topic was identified by using MEDLINE (1966 to May 2007), EMBASE (1980 to week 22 of 2007), Cochrane Central Register of Controlled Trials (second quarter of 2007), PsycINFO (1985 to June 2007), AMED (1985 to June 2007), and SCOPUS (2006). The literature search was updated by searching for articles in MEDLINE and EMBASE published between May 2007 and April 2009. Searches were limited to English-language publications. This guideline grades the evidence and recommendations by using the American College of Physicians' clinical practice guidelines grading system. Recommendation 1: The American College of Physicians recommends that clinicians initiate therapy with a PDE-5 inhibitor in men who seek treatment for erectile dysfunction and who do not have a contraindication to PDE-5 inhibitor use (Grade: strong recommendation; high-quality evidence). Recommendation 2: The American College of Physicians recommends that clinicians base the choice of a specific PDE-5 inhibitor on the individual preferences of men with erectile dysfunction, including ease of use, cost of medication, and adverse effects profile (Grade: weak recommendation; low-quality evidence). Recommendation 3: The American College of Physicians does not recommend for or against routine use of hormonal blood tests or hormonal treatment in the management of patients with erectile dysfunction (Grade: insufficient evidence to determine net benefits and harms).	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Colorado, Aurora, CO USA; Atlantic Hlth, Morristown, NJ USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	American College of Physicians; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; Atlantic Health System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19104 USA.	aqaseem@acponline.org	Casey, Donald/AFM-6658-2022	Casey, Donald/0000-0002-3820-598X	American College of Physicians' operating budget	American College of Physicians' operating budget	Financial support for the development of this guideline comes exclusively from the American College of Physicians' operating budget.	Abdel-Naser MB, 2004, INT J IMPOT RES, V16, P552, DOI 10.1038/sj.ijir.3901245; Acar D, 2004, ARCH ANDROLOGY, V50, P247, DOI 10.1080/01485010490448769; AKPUNONU BE, 1994, J GEN INTERN MED, V9, P336, DOI 10.1007/BF02599183; Albuquerque Denilson C., 2005, Int. braz j urol., V31, P342, DOI 10.1590/S1677-55382005000400008; Althof SE, 2006, J SEX MED, V3, P521, DOI 10.1111/j.1743-6109.2006.00234.x; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Aversa A, 2007, INT J IMPOT RES, V19, P200, DOI 10.1038/sj.ijir.3901513; Aversa A, 2003, CLIN ENDOCRINOL, V58, P632, DOI 10.1046/j.1365-2265.2003.01764.x; Aytac IA, 1999, BJU INT, V84, P50; Bank AJ, 2006, VASC MED, V11, P251, DOI 10.1177/1358863x06072221; Bannowsky A, 2008, BJU INT, V101, P1279, DOI 10.1111/j.1464-410X.2008.07515.x; Becher E, 2002, INT J IMPOT RES, V14, pS33, DOI 10.1038/sj.ijir.3900896; Bocchio M, 2008, ATHEROSCLEROSIS, V196, P313, DOI 10.1016/j.atherosclerosis.2006.09.035; Boolell M, 1996, BRIT J UROL, V78, P257, DOI 10.1046/j.1464-410X.1996.10220.x; Boulton AJM, 2001, DIABETOLOGIA, V44, P1296, DOI 10.1007/s001250100656; Boyanov M A, 2003, Aging Male, V6, P1; Bunch T J, 2002, Aging Male, V5, P38, DOI 10.1080/713604648; Buranakitjaroen Peera, 2007, Journal of the Medical Association of Thailand, V90, P1100; Burnett AL, 2009, J UROLOGY, V181, P245, DOI 10.1016/j.juro.2008.09.005; Buvat J, 1997, J UROLOGY, V158, P1764, DOI 10.1016/S0022-5347(01)64123-5; Buvat J, 2008, BJU INT, V102, P1645, DOI 10.1111/j.1464-410X.2008.07908.x; Cappelleri JC, 2000, UROLOGY, V56, P477, DOI 10.1016/S0090-4295(00)00697-X; Carrier S, 2005, J SEX MED, V2, P685, DOI 10.1111/j.1743-6109.2005.00097.x; Carson C, 2005, UROLOGY, V65, P353, DOI 10.1016/j.urology.2004.09.056; Carson CC, 2004, BJU INT, V94, P1301, DOI 10.1111/j.1464-410X.2004.05161.x; Cavallini G, 2005, UROLOGY, V66, P1080, DOI 10.1016/j.urology.2005.05.014; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; Chen KK, 2001, INT J IMPOT RES, V13, P221, DOI 10.1038/sj.ijir.3900685; Chen KK, 2004, J SEX MED, V1, P201, DOI 10.1111/j.1743-6109.2004.04029.x; Chiang HS, 2007, INT J IMPOT RES, V19, P411, DOI 10.1038/sj.ijir.3901562; Choi HK, 2003, INT J IMPOT RES, V15, P80, DOI 10.1038/sj.ijir.3900944; CHOI HK, 2006, TAEHAN PINYOGIKWA HA, V47, P852; Choppin A, 2001, INT J IMPOT RES, V13, P157, DOI 10.1038/sj.ijir.3900653; Christiansen E, 2000, INT J IMPOT RES, V12, P177, DOI 10.1038/sj.ijir.3900527; Citron JT, 1996, J UROLOGY, V155, P529, DOI 10.1016/S0022-5347(01)66441-3; CLOPPER RR, 1993, PSYCHONEUROENDOCRINO, V18, P149, DOI 10.1016/0306-4530(93)90066-T; Corona G, 2008, J SEX MED, V5, P2454, DOI 10.1111/j.1743-6109.2008.00856.x; De Rose AF, 2005, INT J IMPOT RES, V17, P76, DOI 10.1038/sj.ijir.3901265; de Tejada IS, 2002, DIABETES CARE, V25, P2159; DeBusk RF, 2004, AM J CARDIOL, V93, P147, DOI 10.1016/j.amjcard.2003.09.030; Demir E, 2006, TRANSPL P, V38, P1379, DOI 10.1016/j.transproceed.2006.02.076; Diamond LE, 2005, UROLOGY, V65, P755, DOI 10.1016/j.urology.2004.10.060; Dinsmore WW, 1999, UROLOGY, V53, P800, DOI 10.1016/S0090-4295(98)00586-X; DRINKA PJ, 1993, SOUTHERN MED J, V86, P1264, DOI 10.1097/00007611-199311000-00017; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Dunzendorfer U, 2002, IN VIVO, V16, P345; Eardley I, 2002, BRIT J CLIN PHARMACO, V53, p61S, DOI 10.1046/j.0306-5251.2001.00034.x; Eardley I, 2005, BJU INT, V96, P1323, DOI 10.1111/j.1464-410X.2005.05892.x; Eardley I, 2004, BJU INT, V94, P871, DOI 10.1111/j.1464-410X.2004.05049.x; Eardley I, 2004, BJU INT, V93, P1271, DOI 10.1111/j.1464-410X.2004.04816.x; Eardley I, 2001, BRIT J PSYCHIAT, V178, P325, DOI 10.1192/bjp.178.4.325; Earle CM, 2003, UROLOGY, V62, P727, DOI 10.1016/S0090-4295(03)00508-9; Edwards D, 2006, J SEX MED, V3, P1028, DOI 10.1111/j.1743-6109.2006.00329.x; El-Sakka AI, 2007, J SEX MED, V4, P1691, DOI 10.1111/j.1743-6109.2006.00342.x; El-Sakka AI, 2006, J UROLOGY, V176, P2589, DOI 10.1016/j.juro.2006.08.005; El-Sakka AI, 2005, J SEX MED, V2, P551, DOI 10.1111/j.1743-6109.2005.00082.x; Fahmy AK, 1999, BJU INT, V84, P482; Fava M, 2006, J CLIN PSYCHIAT, V67, P240, DOI 10.4088/JCP.v67n0210; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FORSBERG L, 1990, SCAND J UROL NEPHROL, V24, P83, DOI 10.3109/00365599009180368; Fowler CJ, 2005, J NEUROL NEUROSUR PS, V76, P700, DOI 10.1136/jnnp.2004.038695; Gentile V, 2004, CURR MED RES OPIN, V20, P1377, DOI 10.1185/030079904x2394; GLINA S, 2001, BRAZ J UROL, V27, P148; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Goldstein I, 2005, J SEX MED, V2, P819, DOI 10.1111/j.1743-6109.2005.00147.x; Goldstein I, 2003, DIABETES CARE, V26, P777, DOI 10.2337/diacare.26.3.777; GOMAA AA, 2006, J MENS HLTH GEND, V3, P47; Gomez F, 2002, INT J IMPOT RES, V14, pS42, DOI 10.1038/sj.ijir.3900897; Gopalakrishnan R, 2006, AM J PSYCHIAT, V163, P494, DOI 10.1176/appi.ajp.163.3.494; Govier F, 2003, CLIN THER, V25, P2709, DOI 10.1016/S0149-2918(03)80328-4; Guay A, 2007, J SEX MED, V4, P1046, DOI 10.1111/j.1743-6109.2007.00530.x; GUAY AT, 1991, UROLOGY, V38, P317, DOI 10.1016/0090-4295(91)80143-U; Guo YL, 2006, INT J UROL, V13, P721, DOI 10.1111/j.1442-2042.2006.01393.x; Haren M, 2005, AGE AGEING, V34, P125, DOI 10.1093/ageing/afi003; Hatzichristou D, 2004, EUR UROL, V45, P634, DOI 10.1016/j.eururo.2004.01.014; Hatzichristou D, 2008, DIABETIC MED, V25, P138, DOI 10.1111/j.1464-5491.2007.02338.x; Hatzichristou D, 2002, J UROLOGY, V168, P615, DOI 10.1016/S0022-5347(05)64690-3; Heiman JR, 2007, BJOG-INT J OBSTET GY, V114, P437, DOI 10.1111/j.1471-0528.2006.01228.x; Hellstrom WJG, 2002, J ANDROL, V23, P763; Herrmann HC, 2006, J SEX MED, V3, P303, DOI 10.1111/j.1743-6109.2005.00156.x; Hong SK, 2007, J UROLOGY, V178, P613, DOI 10.1016/j.juro.2007.03.132; Hundertmark J, 2007, J SEX MED, V4, P1126, DOI 10.1111/j.1743-6109.2007.00536.x; Hussain IF, 2001, J NEUROL NEUROSUR PS, V71, P371, DOI 10.1136/jnnp.71.3.371; Incrocci L, 2001, INT J RADIAT ONCOL, V51, P1190, DOI 10.1016/S0360-3016(01)01767-9; Incrocci L, 2006, INT J RADIAT ONCOL, V66, P439, DOI 10.1016/j.ijrobp.2006.04.047; Ishii N, 2006, INT J UROL, V13, P1066, DOI 10.1111/j.1442-2042.2006.01480.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; JOHNSON AR, 1992, J UROLOGY, V147, P1542, DOI 10.1016/S0022-5347(17)37620-6; Jones LA, 2008, J SEX MED, V5, P1955, DOI 10.1111/j.1743-6109.2008.00879.x; Kadioglu A, 2008, J SEX MED, V5, P726, DOI 10.1111/j.1743-6109.2007.00701.x; Kaplan SA, 2007, EUR UROL, V51, P1717, DOI 10.1016/j.eururo.2007.01.033; Katz SD, 2005, AM J CARDIOL, V95, P36, DOI 10.1016/j.amjcard.2004.08.060; Klotz T, 2001, WORLD J UROL, V19, P32, DOI 10.1007/s003450000168; Kohler Tobias S, 2008, Urology, V71, P693, DOI 10.1016/j.urology.2007.11.073; Kongkanand Apichat, 2003, J Med Assoc Thai, V86, P195; Koulikov D, 2007, J UROLOGY, V177, P2267, DOI 10.1016/j.juro.2007.01.123; Kupelian V, 2006, J UROLOGY, V176, P2584, DOI 10.1016/j.juro.2006.08.020; Levinson IP, 2003, INT J IMPOT RES, V15, pS25, DOI 10.1038/sj.ijir.3900970; Lindsey I, 2002, DIS COLON RECTUM, V45, P727, DOI 10.1007/s10350-004-6287-9; LOW WY, 2006, J MENS HLTH GEND, V3, P263; Mahon A, 2005, AM J KIDNEY DIS, V45, P381, DOI 10.1053/j.ajkd.2004.10.012; Makhlouf AA, 2008, INT J IMPOT RES, V20, P157, DOI 10.1038/sj.ijir.3901576; Margo CE, 2007, AM J OPHTHALMOL, V143, P538, DOI 10.1016/j.ajo.2006.10.006; Martin-Morales A, 2007, J SEX MED, V4, P440, DOI 10.1111/j.1743-6109.2006.00426.x; Mazo E, 2006, INT J IMPOT RES, V18, P464, DOI 10.1038/sj.ijir.3901454; McCullough AR, 2008, INT J IMPOT RES, V20, P388, DOI 10.1038/ijir.2008.21; McCullough AR, 2008, UROLOGY, V71, P686, DOI 10.1016/j.urology.2007.12.025; McCullough AR, 2008, J SEX MED, V5, P476, DOI 10.1111/j.1743-6109.2007.00700.x; MCEVOY GK, 2008, AHFS DRUG INFORM; McMahon C, 2005, J SEX MED, V2, P415, DOI 10.1111/j.1743-6109.2005.20360.x; McMahon CG, 2005, INT J CLIN PRACT, V59, P143, DOI 10.1111/j.1742-1241.2005.00451.x; McVary KT, 2007, J UROLOGY, V177, P1401, DOI 10.1016/j.juro.2006.11.037; McVary KT, 2007, J UROLOGY, V177, P1071, DOI 10.1016/j.juro.2006.10.055; Melnik T, 2005, J SEX MARITAL THER, V31, P243, DOI 10.1080/00926230590513465; Merza Z, 2006, INT J ANDROL, V29, P381, DOI 10.1111/j.1365-2605.2005.00612.x; Meuleman E, 2001, BJU INT, V87, P75, DOI 10.1046/j.1464-410x.2001.00998.x; Miner M, 2008, J SEX MED, V5, P1455, DOI 10.1111/j.1743-6109.2008.00820.x; Mirone V, 2005, EUR UROL, V47, P846, DOI 10.1016/j.eururo.2005.02.019; Montorsi F, 2004, J UROLOGY, V172, P1036, DOI 10.1097/01.ju.0000136448.71773.2b; Montorsi F, 1999, UROLOGY, V53, P1011, DOI 10.1016/S0090-4295(98)00643-8; Montorsi F, 2000, UROLOGY, V56, P906, DOI 10.1016/S0090-4295(00)00841-4; Montorsi F, 2008, EUR UROL, V54, P924, DOI 10.1016/j.eururo.2008.06.083; Montorsi F, 2004, J SEX MED, V1, P168, DOI 10.1111/j.1743-6109.2004.04025.x; Morano S, 2007, EUR UROL, V52, P1768, DOI 10.1016/j.eururo.2007.04.042; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; Nagao K, 2004, INT J UROL, V11, P515, DOI 10.1111/j.1442-2042.2004.00833.x; Nagao K, 2006, UROLOGY, V68, P845, DOI 10.1016/j.urology.2006.05.001; Nehra A, 2005, J UROLOGY, V173, P2067, DOI 10.1097/01.ju.0000158456.41788.93; Netto Junior N R, 1993, Rev Paul Med, V111, P454; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; O'Leary MP, 2006, J UROLOGY, V175, P1058, DOI 10.1016/S0022-5347(05)00418-0; Olsson AM, 2001, INT J CLIN PRACT, V55, P171; Olsson AM, 2000, INT J CLIN PRACT, V54, P561; Orr G, 2006, J CLIN PSYCHOPHARM, V26, P426, DOI 10.1097/01.jcp.0000227701.33999.b3; Padma-Nathan H, 2003, UROLOGY, V62, P400, DOI 10.1016/S0090-4295(03)00567-3; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Paick JS, 2008, J SEX MED, V5, P2672, DOI 10.1111/j.1743-6109.2008.00945.x; Paick JS, 2008, ASIAN J ANDROL, V10, P791, DOI 10.1111/j.1745-7262.2008.00422.x; Paick JS, 2008, J SEX MED, V5, P946, DOI 10.1111/j.1743-6109.2007.00723.x; Palmer JS, 2000, J UROLOGY, V164, P958, DOI 10.1016/S0022-5347(05)67225-4; Pavone C, 2004, J UROLOGY, V172, P2347, DOI 10.1097/01.ju.0000144032.39336.28; Perimenis P, 2004, ANDROLOGIA, V36, P106, DOI 10.1111/j.1439-0272.2004.00614.x; Perimenis P, 2004, INT J IMPOT RES, V16, P2, DOI 10.1038/sj.ijir.3901119; Perimenis P, 2007, ASIAN J ANDROL, V9, P259, DOI 10.1111/j.1745-7262.2007.00085.x; Pickering TG, 2004, AM J HYPERTENS, V17, P1135, DOI 10.1016/j.amjhyper.2004.07.004; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Porst H, 2007, EUR J MED RES, V12, P61; Porst H, 2003, UROLOGY, V62, P121, DOI 10.1016/S0090-4295(03)00359-5; Porst H, 2006, EUR UROL, V50, P1086, DOI 10.1016/j.eururo.2006.05.036; Price DE, 1998, DIABETIC MED, V15, P821, DOI 10.1002/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P; Rabkin JG, 2000, ARCH GEN PSYCHIAT, V57, P141, DOI 10.1001/archpsyc.57.2.141; Rajfer J, 2007, INT J IMPOT RES, V19, P95, DOI 10.1038/sj.ijir.3901496; Ralph D, 2007, BJU INT, V100, P130, DOI 10.1111/j.1464-410X.2007.06900.x; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Reyes-Vallejo L, 2007, J SEX MED, V4, P1757, DOI 10.1111/j.1743-6109.2006.00381.x; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Tolra JR, 2006, J SEX MED, V3, P901, DOI 10.1111/j.1743-6109.2006.00297.x; Rosanoa GMC, 2005, EUR UROL, V47, P214, DOI 10.1016/j.eururo.2004.10.002; Rosen R, 2006, AM J PSYCHIAT, V163, P79, DOI 10.1176/appi.ajp.163.1.79; Rosen RC, 2004, J SEX MED, V1, P193, DOI 10.1111/j.1743-6109.2004.04028.x; Safarinejad MR, 2006, INT J IMPOT RES, V18, P550, DOI 10.1038/sj.ijir.3901476; Safarinejad MR, 2009, J UROLOGY, V181, P252, DOI 10.1016/j.juro.2008.09.003; Safarinejad MR, 2004, J DIABETES COMPLICAT, V18, P205, DOI 10.1016/S1056-8727(03)00056-4; Saylan M, 2006, INT J CLIN PRACT, V60, P812, DOI 10.1111/j.1742-1241.2006.00993.x; Schiavi RC, 1997, ARCH SEX BEHAV, V26, P231, DOI 10.1023/A:1024518730222; Seftel AD, 2004, J UROLOGY, V172, P652, DOI 10.1097/01.ju.0000132857.39680.ce; Seftel AD, 2004, J ANDROL, V25, P963; Seibel I, 2002, J AM SOC NEPHROL, V13, P2770, DOI 10.1097/01.ASN.0000034201.97937.3E; Seidman SN, 2006, J SEX MARITAL THER, V32, P267, DOI 10.1080/00926230600575355; Seidman SN, 2001, AM J PSYCHIAT, V158, P1623, DOI 10.1176/appi.ajp.158.10.1623; Shabsigh R, 2004, J UROLOGY, V172, P658, DOI 10.1097/01.ju.0000132389.97804.d7; Shamloul R, 2005, J SEX MED, V2, P559, DOI 10.1111/j.1743-6109.2005.00071.x; Sharma RK, 2006, AM J KIDNEY DIS, V48, P128, DOI 10.1053/j.ajkd.2006.04.061; Skoumal R, 2004, EUR UROL, V46, P362, DOI 10.1016/j.eururo.2004.04.026; Sommer F, 2007, ASIAN J ANDROL, V9, P134, DOI 10.1111/j.1745-7262.2007.00233.x; Staab A, 2004, PHARM RES-DORDR, V21, P1463, DOI 10.1023/B:PHAM.0000036922.03519.40; Stark S, 2001, EUR UROL, V40, P181, DOI 10.1159/000049770; Stief C, 2004, INT J CLIN PRACT, V58, P230, DOI 10.1111/j.1368-5031.2004.00128.x; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Tan HM, 2000, UROLOGY, V56, P635, DOI 10.1016/S0090-4295(00)00688-9; Tan HM, 2008, ASIAN J ANDROL, V10, P495, DOI 10.1111/j.1745-7262.2008.00388.x; Tignol J, 2004, INT CLIN PSYCHOPHARM, V19, P191, DOI 10.1097/01.yic.0000117902.43995.b0; Tsertsvadze A, 2009, EVID REP TECHNOL ASS, V171, P98; Tsertsvadze A, 2009, ANN INTERN MED, V151, P650, DOI 10.7326/0003-4819-151-9-200911030-00150; Tsujimura A, 2005, INT J IMPOT RES, V17, P259, DOI 10.1038/sj.ijir.3901300; Ugarte F, 2002, INT J IMPOT RES, V14, pS48, DOI 10.1038/sj.ijir.3900898; Valiquette L, 2005, MAYO CLIN PROC, V80, P1291, DOI 10.4065/80.10.1291; van Ahlen H, 2005, J SEX MED, V2, P856, DOI 10.1111/j.1743-6109.2005.00150.x; Virag R, 1999, UROLOGY, V54, P1073, DOI 10.1016/S0090-4295(99)00310-6; von Keitz A, 2004, EUR UROL, V45, P499, DOI 10.1016/j.eururo.2003.11.030; Warburton I, 2004, J SEX MED, V1, P179, DOI 10.1111/j.1743-6109.2004.04026.x; Webster LJ, 2004, ARCH INTERN MED, V164, P514, DOI 10.1001/archinte.164.5.514; Wessells H, 2007, J UROLOGY, V177, P1675, DOI 10.1016/j.juro.2007.01.057; Yassin AA, 2006, ANDROLOGIA, V38, P61, DOI 10.1111/j.1439-0272.2006.00712.x; Yip WCA, 2006, ASIAN J ANDROL, V8, P685, DOI 10.1111/j.1745-7262.2006.00213.x; Young JM, 2005, J ANDROL, V26, P310, DOI 10.2164/jandrol.04126; Young JM, 2002, UROLOGY, V60, P39, DOI 10.1016/S0090-4295(02)01689-8; Ziegler D, 2006, J SEX MED, V3, P883, DOI 10.1111/j.1743-6109.2006.00295.x; Zinner N, 2007, J SEX MED, V4, P137, DOI 10.1111/j.1743-6109.2006.00400.x; Zohdy W, 2007, J SEX MED, V4, P797, DOI 10.1111/j.1743-6109.2007.00499.x; Zumbe J, 2008, EUR UROL, V54, P204, DOI 10.1016/j.eururo.2008.03.056	202	53	54	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					639	W208		10.7326/0003-4819-151-9-200911030-00151	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00151			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884625				2022-12-28	WOS:000271387700006
J	Atkinson, P; Chesters, A; Heinz, P				Atkinson, Paul; Chesters, Adam; Heinz, Peter			Pain management and sedation for children in the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; INTRAVENOUS CANNULATION; VAPOCOOLANT SPRAY; ANALGESIA		[Atkinson, Paul; Chesters, Adam; Heinz, Peter] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Emergency Dept, Cambridge CB2 0QQ, England	Addenbrooke's Hospital; University of Cambridge	Atkinson, P (corresponding author), Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Emergency Dept, Cambridge CB2 0QQ, England.	Paul.atkinson@addenbrookes.nhs.uk		Atkinson, Paul/0000-0001-9900-4594				ATKINSON P, 2010, EMERGENCY MED ILLUST, P32; Atkinson PRT, 2006, EMERG MED J, V23, P503, DOI 10.1136/emj.2005.028456; Bauchner H, 1996, PEDIATRICS, V98, P861; Borland M, 2007, ANN EMERG MED, V49, P335, DOI 10.1016/j.annemergmed.2006.06.016; Buttner W, 2000, PAEDIATR ANAESTH, V10, P303, DOI 10.1046/j.1460-9592.2000.00530.x; *COLL EM MED CLIN, 2004, MAN PAIN CHILDR; Costello M, 2006, CLIN PEDIATR, V45, P628, DOI 10.1177/0009922806291013; Ekbom K, 2005, ARCH DIS CHILD, V90, P1073, DOI 10.1136/adc.2004.060319; Farion KJ, 2008, CAN MED ASSOC J, V179, P31, DOI 10.1503/cmaj.070874; Ferguson C, 2005, EMERG MED J, V22, P507, DOI 10.1136/emj.2005.026575; Godwin SA, 2005, ANN EMERG MED, V45, P177, DOI 10.1016/j.annemergmed.2004.11.002; GREEN SM, 2009, ANN EMERG MED; Harrop JE, 2007, ARCH DIS CHILDHOOD-E, V92, pEP101, DOI 10.1136/adc.2006.109447; Horwitz N, 2002, ARCH DIS CHILD, V87, P80, DOI 10.1136/adc.87.1.80; Kendall JM, 2001, BMJ-BRIT MED J, V322, P261, DOI 10.1136/bmj.322.7281.261; Lander JA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004236.pub2; MCGRATH PJ, 1985, ADV PAIN RES THER, V9, P395; Merkel S I, 1997, Pediatr Nurs, V23, P293; O'Donnell JJ, 2002, EMERG MED J, V19, P195, DOI 10.1136/emj.19.3.195; Quinn J, 1998, ANN EMERG MED, V32, P645, DOI 10.1016/S0196-0644(98)70061-7; *SCOTT INT GUID NE, 2004, SAF SED CHILDR UND D; Spagrud LJ, 2003, AM J NURS, V103, P62, DOI 10.1097/00000446-200312000-00020; Treston Greg, 2004, Emerg Med Australas, V16, P145, DOI 10.1111/j.1742-6723.2004.00583.x; Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179; Wong D L, 1988, Pediatr Nurs, V14, P9	25	23	23	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2009	339								b4234	10.1136/bmj.b4234	http://dx.doi.org/10.1136/bmj.b4234			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AQ	19880530				2022-12-28	WOS:000271366100003
J	Bollenbach, T; Kishony, R				Bollenbach, Tobias; Kishony, Roy			Quiet Gene Circuit More Fragile Than Its Noisy Peer	CELL			English	Editorial Material							TOPOLOGIES; NETWORKS		[Bollenbach, Tobias; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X				Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951	9	4	4	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					460	461		10.1016/j.cell.2009.10.005	http://dx.doi.org/10.1016/j.cell.2009.10.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879833	Bronze			2022-12-28	WOS:000271259600009
J	Cagatay, T; Turcotte, M; Elowitz, MB; Garcia-Ojalvo, J; Suel, GM				Cagatay, Tolga; Turcotte, Marc; Elowitz, Michael B.; Garcia-Ojalvo, Jordi; Suel, Guerol M.			Architecture-Dependent Noise Discriminates Functionally Analogous Differentiation Circuits	CELL			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; FLUCTUATING ENVIRONMENTS; DESIGN PRINCIPLES; GENE-EXPRESSION; CIRCADIAN CLOCK; NETWORKS; COMK; OSCILLATOR	Gene regulatory circuits with different architectures (patterns of regulatory interactions) can generate similar dynamics. This raises the question of why a particular circuit architecture is selected to implement a given cellular process. To investigate this problem, we compared the Bacillus subtilis circuit that regulates differentiation into the competence state to an engineered circuit with an alternative architecture (SynEx) in silico and in vivo. Time-lapse microscopy measurements showed that SynEx cells generated competence dynamics similar to native cells and reconstituted the physiology of differentiation. However, architectural differences between the circuits altered the dynamic distribution of stochastic fluctuations (noise) during circuit operation. This distinction in noise causes functional differences between the circuits by selectively controlling the timing of competence episodes and response of the system to various DNA concentrations. These results reveal a tradeoff between temporal precision and physiological response range that is controlled by distinct noise characteristics of alternative circuit architectures.	[Cagatay, Tolga; Suel, Guerol M.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Cagatay, Tolga; Turcotte, Marc; Suel, Guerol M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; California Institute of Technology; Universitat Politecnica de Catalunya	Suel, GM (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	gurol.suel@utsouthwestern.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	National Institutes of Health [K25 GM071957]; Ministerio de Ciencia e Innovacion; European Commission; Welch Foundation [I-1674]; James S. McDonnell Foundation [220020141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428, K25GM071957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Welch Foundation(The Welch Foundation); James S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steve Altschuler, Robin Hiesinger, Rama Ranganathan, Michael Rosen, Elliott Ross, Katherine Suel, and Lani Wu for critical reading of this manuscript and helpful discussions. We also thank Alma Alvarado of the Suel laboratory for technical assistance. The authors acknowledge the Texas Advanced Computing Center at University of Texas, Austin, for providing computing resources. M. T. is supported by National Institutes of Health grant K25 GM071957. J.G.-O. acknowledges financial support from Ministerio de Ciencia e Innovacion (Spain, project ORDEN and I3 program) and from the European Commission (project GABA). This work was supported by research grants to G. M. S. by the Welch Foundation (I-1674) and the James S. McDonnell Foundation (220020141). G. M. S. is a W. W. Caruth Jr. Scholar of Biomedical Research. This work is dedicated to the memory of Merdol and Nursxat Suel.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Dekel E, 2005, PHYS BIOL, V2, P81, DOI 10.1088/1478-3975/2/2/001; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Quisel JD, 2001, J BACTERIOL, V183, P6573, DOI 10.1128/JB.183.22.6573-6578.2001; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; Smits WK, 2007, MOL MICROBIOL, V65, P103, DOI 10.1111/j.1365-2958.2007.05776.x; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Susanna KA, 2007, J BACTERIOL, V189, P4718, DOI 10.1128/JB.00281-07; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Turcotte M, 2008, P NATL ACAD SCI USA, V105, P15732, DOI 10.1073/pnas.0806349105; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Wall ME, 2003, J MOL BIOL, V332, P861, DOI 10.1016/S0022-2836(03)00948-3; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	42	204	214	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					512	522		10.1016/j.cell.2009.07.046	http://dx.doi.org/10.1016/j.cell.2009.07.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19853288	Bronze			2022-12-28	WOS:000271259600016
J	Rohs, R; West, SM; Sosinsky, A; Liu, P; Mann, RS; Honig, B				Rohs, Remo; West, Sean M.; Sosinsky, Alona; Liu, Peng; Mann, Richard S.; Honig, Barry			The role of DNA shape in protein-DNA recognition	NATURE			English	Article							CRYSTAL-STRUCTURE; NUCLEOSOME CORE; BINDING-SITES; A-TRACT; NUCLEIC-ACIDS; MINOR-GROOVE; SEQUENCE; COMPLEX; RESOLUTION; REPRESSOR	The recognition of specific DNA sequences by proteins is thought to depend on two types of mechanism: one that involves the formation of hydrogen bonds with specific bases, primarily in the major groove, and one involving sequence-dependent deformations of the DNA helix. By comprehensively analysing the three-dimensional structures of protein-DNA complexes, here we show that the binding of arginine residues to narrow minor grooves is a widely used mode for protein-DNA recognition. This readout mechanism exploits the phenomenon that narrow minor grooves strongly enhance the negative electrostatic potential of the DNA. The nucleosome core particle offers a prominent example of this effect. Minor-groove narrowing is often associated with the presence of A-tracts, AT-rich sequences that exclude the flexible TpA step. These findings indicate that the ability to detect local variations in DNA shape and electrostatic potential is a general mechanism that enables proteins to use information in the minor groove, which otherwise offers few opportunities for the formation of base-specific hydrogen bonds, to achieve DNA-binding specificity.	[Rohs, Remo; West, Sean M.; Sosinsky, Alona; Liu, Peng; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Honig, B (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, Howard Hughes Med Inst, 1130 St Nicholas Ave, New York, NY 10032 USA.	rsm10@columbia.edu; bh6@columbia.edu	Rohs, Remo/F-5752-2011	West, Sean/0000-0003-1038-0222	National Institutes of Health (NIH) [GM54510, U54 CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518, R01GM054510] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM54510 (R. S. M.) and U54 CA121852 (B. H. and R. S. M.). The authors thank A. Califano for many helpful conversations.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JAYARAM B, 1989, BIOPOLYMERS, V28, P975, DOI 10.1002/bip.360280506; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Li T, 1998, NUCLEIC ACIDS RES, V26, P5707, DOI 10.1093/nar/26.24.5707; Locasale JW, 2009, J MOL BIOL, V386, P1054, DOI 10.1016/j.jmb.2009.01.007; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; Shakked Z., 1999, OXFORD HDB NUCL ACID, P455; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Stefl R, 2004, P NATL ACAD SCI USA, V101, P1177, DOI 10.1073/pnas.0308143100; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Tolstorukov MY, 2005, NUCLEIC ACIDS RES, V33, P3907, DOI 10.1093/nar/gki699; Travers A. A., 1990, DNA TOPOLOGY ITS BIO, P57; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770	49	687	694	4	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1248	U81		10.1038/nature08473	http://dx.doi.org/10.1038/nature08473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865164	Green Accepted			2022-12-28	WOS:000271190800041
J	Pawlowski, M; Paterek, T; Kaszlikowski, D; Scarani, V; Winter, A; Zukowski, M				Pawlowski, Marcin; Paterek, Tomasz; Kaszlikowski, Dagomir; Scarani, Valerio; Winter, Andreas; Zukowski, Marek			Information causality as a physical principle	NATURE			English	Article							QUANTUM; COMMUNICATION	Quantum physics has remarkable distinguishing characteristics. For example, it gives only probabilistic predictions (non-determinism) and does not allow copying of unknown states (no-cloning(1)). Quantum correlations may be stronger than any classical ones(2), but information cannot be transmitted faster than light (no-signalling). However, these features do not uniquely define quantum physics. A broad class of theories exist that share such traits and allow even stronger (than quantum) correlations(3). Here we introduce the principle of 'information causality' and show that it is respected by classical and quantum physics but violated by all no-signalling theories with stronger than (the strongest) quantum correlations. The principle relates to the amount of information that an observer ( Bob) can gain about a data set belonging to another observer (Alice), the contents of which are completely unknown to him. Using all his local resources (which may be correlated with her resources) and allowing classical communication from her, the amount of information that Bob can recover is bounded by the information volume (m) of the communication. Namely, if Alice communicates m bits to Bob, the total information obtainable by Bob cannot be greater than m. For m = 0, information causality reduces to the standard no-signalling principle. However, no-signalling theories with maximally strong correlations would allow Bob access to all the data in any m-bit subset of the whole data set held by Alice. If only one bit is sent by Alice (m = 1), this is tantamount to Bob's being able to access the value of any single bit of Alice's data (but not all of them). Information causality may therefore help to distinguish physical theories from non-physical ones. We suggest that information causality-a generalization of the no-signalling condition-might be one of the foundational properties of nature.	[Pawlowski, Marcin; Zukowski, Marek] Univ Gdansk, Inst Theoret Phys & Astrophys, PL-80952 Gdansk, Poland; [Paterek, Tomasz; Kaszlikowski, Dagomir; Scarani, Valerio; Winter, Andreas] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; [Paterek, Tomasz; Kaszlikowski, Dagomir; Scarani, Valerio; Winter, Andreas] Natl Univ Singapore, Dept Phys, Singapore 117543, Singapore; [Winter, Andreas] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England	Fahrenheit Universities; University of Gdansk; National University of Singapore; National University of Singapore; University of Bristol	Pawlowski, M (corresponding author), Univ Gdansk, Inst Theoret Phys & Astrophys, PL-80952 Gdansk, Poland.	dokmpa@univ.gda.pl	Winter, Andreas/K-4200-2019; Pawlowski, Marcin/B-2137-2013; Winter, Andreas/C-4185-2016; Scarani, Valerio/G-1109-2012; Kaszlikowski, Dagomir/G-1974-2012	Winter, Andreas/0000-0001-6344-4870; Pawlowski, Marcin/0000-0002-8611-947X; Winter, Andreas/0000-0001-6344-4870; Scarani, Valerio/0000-0001-5594-5616; Zukowski, Marek/0000-0001-7882-7962	National Research Foundation; Ministry of Education in Singapore; European Commission through the Integrated Project Qubit Applications; UK Engineering and Physical Sciences Research Council through the Quantum Information Processing Interdisciplinary Research Collaboration; Royal Society Wolfson Merit Award; Philip Leverhulme Prize; EPSRC [EP/D071461/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D071461/1] Funding Source: researchfish	National Research Foundation; Ministry of Education in Singapore(Ministry of Education, Singapore); European Commission through the Integrated Project Qubit Applications; UK Engineering and Physical Sciences Research Council through the Quantum Information Processing Interdisciplinary Research Collaboration(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Merit Award(Royal Society of London); Philip Leverhulme Prize; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Christandl, V. Vedral and S. Wehner for stimulating discussions. This work was supported by the National Research Foundation and the Ministry of Education in Singapore, and by the European Commission through the Integrated Project Qubit Applications. A. W. acknowledges support by the UK Engineering and Physical Sciences Research Council through the Quantum Information Processing Interdisciplinary Research Collaboration and an Advanced Fellowship, by a Royal Society Wolfson Merit Award, and by a Philip Leverhulme Prize.	Acin A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120405; Ambainis A, 2002, J ACM, V49, P496, DOI 10.1145/581771.581773; Barnum H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.240501; Barnum Howard, 2008, TELEPORTATION GEN PR; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Barrett J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032304; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Brassard G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250401; Brassard G, 2003, FOUND PHYS, V33, P1593, DOI 10.1023/A:1026009100467; Brunner N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.160403; Cerf NJ, 1997, PHYS REV LETT, V79, P5194, DOI 10.1103/PhysRevLett.79.5194; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Linden N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.180502; Masanes L, 2006, PHYS REV A, V73, DOI [10.1103/PhysRevA.73.012112, 10.1103/PhysREvA.73.012112]; Masanes L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140501; Nielsen Michael A., 2002, QUANTUM COMPUTATION; POPESCU S, 1994, FOUND PHYS, V24, P379, DOI 10.1007/BF02058098; Short AJ, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012101; Skrzypczyk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.110402; STEEG GV, 2009, RELAXED UNCERTAINTY; VANDAM W, 2005, THESIS U OXFORD; WOLF S, 2005, OBLIVIOUS TRANSFER Q; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	30	408	409	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1101	1104		10.1038/nature08400	http://dx.doi.org/10.1038/nature08400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847260	Green Submitted			2022-12-28	WOS:000270987600039
J	Sidransky, E; Nalls, MA; Aasly, JO; Aharon-Peretz, J; Annesi, G; Barbosa, ER; Bar-Shira, A; Berg, D; Bras, J; Brice, A; Chen, CM; Clark, LN; Condroyer, C; De Marco, EV; Durr, A; Eblan, MJ; Fahn, S; Farrer, MJ; Fung, HC; Gan-Or, Z; Gasser, T; Gershoni-Baruch, R; Giladi, N; Griffith, A; Gurevich, T; Januario, C; Kropp, P; Lang, AE; Lee-Chen, GJ; Lesage, S; Marder, K; Mata, IF; Mirelman, A; Mitsui, J; Mizuta, I; Nicoletti, G; Oliveira, C; Ottman, R; Orr-Urtreger, A; Pereira, LV; Quattrone, A; Rogaeva, E; Rolfs, A; Rosenbaum, H; Rozenberg, R; Samii, A; Samaddar, T; Schulte, C; Sharma, M; Singleton, A; Spitz, M; Tan, EK; Tayebi, N; Toda, T; Troiano, AR; Tsuji, S; Wittstock, M; Wolfsberg, TG; Wu, YR; Zabetian, CP; Zhao, Y; Ziegler, SG				Sidransky, E.; Nalls, M. A.; Aasly, J. O.; Aharon-Peretz, J.; Annesi, G.; Barbosa, E. R.; Bar-Shira, A.; Berg, D.; Bras, J.; Brice, A.; Chen, C. -M.; Clark, L. N.; Condroyer, C.; De Marco, E. V.; Duerr, A.; Eblan, M. J.; Fahn, S.; Farrer, M. J.; Fung, H. -C.; Gan-Or, Z.; Gasser, T.; Gershoni-Baruch, R.; Giladi, N.; Griffith, A.; Gurevich, T.; Januario, C.; Kropp, P.; Lang, A. E.; Lee-Chen, G. -J.; Lesage, S.; Marder, K.; Mata, I. F.; Mirelman, A.; Mitsui, J.; Mizuta, I.; Nicoletti, G.; Oliveira, C.; Ottman, R.; Orr-Urtreger, A.; Pereira, L. V.; Quattrone, A.; Rogaeva, E.; Rolfs, A.; Rosenbaum, H.; Rozenberg, R.; Samii, A.; Samaddar, T.; Schulte, C.; Sharma, M.; Singleton, A.; Spitz, M.; Tan, E. -K.; Tayebi, N.; Toda, T.; Troiano, A. R.; Tsuji, S.; Wittstock, M.; Wolfsberg, T. G.; Wu, Y. -R.; Zabetian, C. P.; Zhao, Y.; Ziegler, S. G.			Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEWY BODY DISORDERS; GAUCHER-DISEASE; GENE-MUTATIONS; EARLY-ONSET; RISK-FACTOR; GBA; SUSCEPTIBILITY; MANIFESTATIONS; POLYMORPHISM; ASSOCIATION	Background Recent studies indicate an increased frequency of mutations in the gene encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among patients with Parkinson's disease. We aimed to ascertain the frequency of GBA mutations in an ethnically diverse group of patients with Parkinson's disease. Methods Sixteen centers participated in our international, collaborative study: five from the Americas, six from Europe, two from Israel, and three from Asia. Each center genotyped a standard DNA panel to permit comparison of the genotyping results across centers. Genotypes and phenotypic data from a total of 5691 patients with Parkinson's disease (780 Ashkenazi Jews) and 4898 controls (387 Ashkenazi Jews) were analyzed, with multivariate logistic-regression models and the Mantel-Haenszel procedure used to estimate odds ratios across centers. Results All 16 centers could detect two GBA mutations, L444P and N370S. Among Ashkenazi Jewish subjects, either mutation was found in 15% of patients and 3% of controls, and among non-Ashkenazi Jewish subjects, either mutation was found in 3% of patients and less than 1% of controls. GBA was fully sequenced for 1883 non-Ashkenazi Jewish patients, and mutations were identified in 7%, showing that limited mutation screening can miss half the mutant alleles. The odds ratio for any GBA mutation in patients versus controls was 5.43 across centers. As compared with patients who did not carry a GBA mutation, those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were more likely to have atypical clinical manifestations. Conclusions Data collected from 16 centers demonstrate that there is a strong association between GBA mutations and Parkinson's disease.	[Sidransky, E.; Eblan, M. J.; Samaddar, T.; Tayebi, N.; Ziegler, S. G.] NHGRI, Sect Mol Neurogenet, Med Genet Branch, Bethesda, MD 20892 USA; [Nalls, M. A.; Bras, J.; Samii, A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Wolfsberg, T. G.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Aasly, J. O.] St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Aasly, J. O.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Aharon-Peretz, J.] Technion Israel Inst Technol, Cognit Neurol & Movement Disorder Unit, Haifa, Israel; [Gershoni-Baruch, R.] Technion Israel Inst Technol, Human Genet Rambam Med Ctr, Haifa, Israel; [Gershoni-Baruch, R.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Rosenbaum, H.] Technion Israel Inst Technol, Dept Hematol, IL-31096 Haifa, Israel; [Rosenbaum, H.] Technion Israel Inst Technol, Dept Bone Marrow Transplant, IL-31096 Haifa, Israel; [Nicoletti, G.; Quattrone, A.] Magna Graecia Univ Catanzaro, Dept Med Sci, Inst Neurol, Catanzaro, Italy; [Annesi, G.; De Marco, E. V.; Nicoletti, G.; Quattrone, A.] CNR, Inst Neurol Sci, Cosenza, Italy; [Barbosa, E. R.; Spitz, M.] Univ Sao Paulo, Sch Med, Dept Neurol, Movement Disorders Unit, Sao Paulo, Brazil; [Pereira, L. V.; Rozenberg, R.] Univ Sao Paulo, Biosci Inst, Dept Genet & Evolutionary Biol, Mol Genet Lab, Sao Paulo, Brazil; [Bar-Shira, A.; Gan-Or, Z.; Orr-Urtreger, A.] Tel Aviv Univ, Genet Inst, IL-69978 Tel Aviv, Israel; [Giladi, N.; Gurevich, T.; Mirelman, A.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Movement Disorders Unit,Parkinson Ctr, IL-69978 Tel Aviv, Israel; [Gan-Or, Z.; Giladi, N.; Gurevich, T.; Orr-Urtreger, A.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Berg, D.; Gasser, T.; Schulte, C.; Sharma, M.] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany; [Bras, J.; Oliveira, C.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Januario, C.; Oliveira, C.] Univ Coimbra Hosp, Neurol Serv, Coimbra, Portugal; [Brice, A.; Condroyer, C.; Duerr, A.; Lesage, S.] Univ Paris 06, INSERM, Ctr Rech,Inst Cerveau & Moelle Epiniere, Unite Mixte Rech S679, Paris, France; [Brice, A.; Duerr, A.] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France; [Brice, A.; Duerr, A.] Grp Hosp Pitie Salpetriere, Dept Genet & Cytogenet, F-75634 Paris, France; [Chen, C. -M.; Fung, H. -C.; Wu, Y. -R.] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Clark, L. N.; Marder, K.] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Clark, L. N.] Columbia Univ Coll Phys & Surg, Ctr Human Genet, New York, NY 10032 USA; [Clark, L. N.] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Fahn, S.; Marder, K.; Ottman, R.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Marder, K.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Marder, K.; Ottman, R.] Columbia Univ Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Ottman, R.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Ottman, R.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Farrer, M. J.] Mayo Clin, Coll Med, Dept Neurosci, Neurogenet Lab, Jacksonville, FL 32224 USA; [Griffith, A.] Evergreen Hosp Med Ctr, Booth Gardner Parkinsons Care Ctr, Kirkland, WA USA; [Kropp, P.] Univ Rostock, Inst Med Psychol, Rostock, Germany; [Rolfs, A.] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany; [Wittstock, M.] Univ Rostock, Dept Neurol, Rostock, Germany; [Lang, A. E.] Toronto Western Hosp, Movement Disorders Ctr, Div Neurol, Dept Med, Toronto, ON M5T 2S8, Canada; [Rogaeva, E.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Lee-Chen, G. -J.] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Mata, I. F.; Samii, A.; Zabetian, C. P.] VA Puget Sound Hlth Care Syst, Parkinsons Dis & Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Mata, I. F.; Samii, A.; Zabetian, C. P.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Mitsui, J.; Tsuji, S.] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Mizuta, I.; Toda, T.] Kobe Univ, Grad Sch Med, Div Neurol & Mol Brain Sci, Kobe, Hyogo 657, Japan; [Tan, E. -K.] Singapore Gen Hosp, Natl Inst Neurosci, Singapore 0316, Singapore; [Tan, E. -K.] Duke NUS Grada Med Sch, Singapore, Singapore	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); Universidade de Sao Paulo; Universidade de Sao Paulo; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Chang Gung Memorial Hospital; Chang Gung University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Mayo Clinic; University of Rostock; University of Rostock; University of Rostock; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; National Taiwan Normal University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Tokyo; Kobe University; National Neuroscience Institute (NNI); Singapore General Hospital; National University of Singapore	Sidransky, E (corresponding author), NHGRI, Sect Mol Neurogenet, Med Genet Branch, Rm 1A213,35 Convent Dr, Bethesda, MD 20892 USA.	sidranse@mail.nih.gov	Bras, Jose/D-3366-2009; Mitsui, Jun/B-5455-2012; brice, alexis/AAE-8275-2019; Kropp, Peter/B-8132-2012; Ottman, Ruth/O-2371-2013; Brice, Alexis/A-2170-2009; Berg, Daniela/A-8728-2019; Annesi, Grazia/AAX-5732-2020; Pereira, Lygia V/C-1049-2012; Barbosa, Egberto R/G-7763-2012; Chen, Chiung-Mei/AAL-6260-2020; Bras, Jose MT/A-1428-2011; Giladi, Nir/AAU-8660-2020; Singleton, Andrew B/C-3010-2009; Wolfsberg, Tyra/D-8296-2017; Lang, Anthony/ABF-8114-2021; QUATTRONE, Aldo/A-6734-2016; Gasser, Thomas/GNH-5293-2022; Januario Santos, Maria Cristina/O-5939-2015	Mitsui, Jun/0000-0001-7425-4765; brice, alexis/0000-0002-0941-3990; Ottman, Ruth/0000-0001-7074-242X; Berg, Daniela/0000-0001-5796-5442; Pereira, Lygia V/0000-0002-0002-725X; Giladi, Nir/0000-0003-1482-8522; Wolfsberg, Tyra/0000-0001-5646-9455; QUATTRONE, Aldo/0000-0003-2001-957X; Gasser, Thomas/0000-0002-1069-1146; Nicoletti, Giuseppe/0000-0002-0761-6188; Farrer, Matthew/0000-0003-1159-5321; DEMARCO, ELVIRAVALERIA/0000-0002-4947-8481; Mizuta, Ikuko/0000-0002-2775-2507; Zabetian, Cyrus/0000-0002-7739-4306; Januario Santos, Maria Cristina/0000-0001-5402-3978; Rozenberg, Roberto/0000-0002-4897-2971; Orr-Urtreger, Avi/0000-0001-9305-6203; Toda, Tatsushi/0000-0002-0717-1123; Reis Barbosa, Egberto/0000-0002-6996-9130; Spitz, Mariana/0000-0001-7548-2313; Gan-Or, Ziv/0000-0003-0332-234X; Bras, Jose/0000-0001-8186-0333; Schulte, Claudia/0000-0003-4006-1265; Lang, Anthony/0000-0003-1229-3667; Fernandez Mata, Ignacio/0000-0003-1198-0633; Oliveira, Catarina/0000-0001-6942-4328	National Institutes of Health [Z01AG000957-05]; National Institute of Neurological Disorders and Stroke and the National Center for Research Resources [NS050487, NS060113, NS40256]; Parkinson's Disease Foundation; Department of Veterans Affairs, Seattle; German National Genome Network, German Ministry for Education and Research [01GS08134]; French Parkinson's Disease Genetics Study Group; Duke-National University of Singapore (NUS) Graduate Medical School, National Medical Research Council, Biomedical Research Council, Singapore Millennium Foundation; SingHealth, Singapore General Hospital, National Neuroscience Institute; Tel Aviv Sourasky Medical Center Grant of Excellence; Wolfson and Kahn Foundations; Portuguese Fundacao para a Ciencia e a Tecnologia; National Science Council, Executive Yuan, Taiwan [NSC-95-2314-B-182A-061]; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIHHG200345, ZIAHG200336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050487, P01NS040256, R01NS036630, R56NS036630, P50NS040256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000957, ZIAAG000957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke and the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Parkinson's Disease Foundation; Department of Veterans Affairs, Seattle(US Department of Veterans Affairs); German National Genome Network, German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); French Parkinson's Disease Genetics Study Group; Duke-National University of Singapore (NUS) Graduate Medical School, National Medical Research Council, Biomedical Research Council, Singapore Millennium Foundation(National University of SingaporeAgency for Science Technology & Research (A*STAR)Singapore Millennium Foundation); SingHealth, Singapore General Hospital, National Neuroscience Institute; Tel Aviv Sourasky Medical Center Grant of Excellence; Wolfson and Kahn Foundations; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by the Intramural Research Programs of NHGRI and the National Institute on Aging (project Z01AG000957-05), National Institutes of Health; grants from the National Institute of Neurological Disorders and Stroke and the National Center for Research Resources (NS050487, NS060113, and NS40256); grants from the Parkinson's Disease Foundation; a Merit Review Award from the Department of Veterans Affairs, Seattle; a grant from the German National Genome Network, German Ministry for Education and Research (01GS08134); a grant from the French Parkinson's Disease Genetics Study Group; a grant from the Duke-National University of Singapore (NUS) Graduate Medical School, National Medical Research Council, Biomedical Research Council, Singapore Millennium Foundation; a grant from SingHealth, Singapore General Hospital, National Neuroscience Institute; the Tel Aviv Sourasky Medical Center Grant of Excellence; grants from the Wolfson and Kahn Foundations; a grant from the Portuguese Fundacao para a Ciencia e a Tecnologia; a grant from the National Science Council, Executive Yuan, Taiwan (NSC-95-2314-B-182A-061); and a Grant-in-Aid for Scientific Research on Priority Areas, Applied Genomics, and Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; [Anonymous], 2005, R LANG ENV STAT COMP; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bras J, 2009, NEUROBIOL AGING, V30, P1515, DOI 10.1016/j.neurobiolaging.2007.11.016; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Clark LN, 2009, ARCH NEUROL-CHICAGO, V66, P578, DOI 10.1001/archneurol.2009.54; De Marco EV, 2008, MOVEMENT DISORD, V23, P460, DOI 10.1002/mds.21892; DEPAOLO J, 2009, MOV DISORD      0507; Eblan MJ, 2006, MOVEMENT DISORD, V21, P282, DOI 10.1002/mds.20766; Farrer MJ, 2009, PARKINSONISM RELAT D, V15, P414, DOI 10.1016/j.parkreldis.2008.08.004; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; Halperin A, 2006, BLOOD CELL MOL DIS, V36, P426, DOI 10.1016/j.bcmd.2006.02.004; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Kalinderi K, 2009, NEUROSCI LETT, V452, P87, DOI 10.1016/j.neulet.2009.01.029; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Machaczka M, 1999, AM J HEMATOL, V61, P216, DOI 10.1002/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.3.CO;2-2; Mata IF, 2008, ARCH NEUROL-CHICAGO, V65, P379, DOI 10.1001/archneurol.2007.68; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Montfort M, 2005, HUM MUTAT, V26, P276, DOI 10.1002/humu.20219; Montfort M, 2004, HUM MUTAT, V23, P567, DOI 10.1002/humu.20043; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Park JK, 2002, CLIN GENET, V61, P32, DOI 10.1034/j.1399-0004.2002.610106.x; *PDGENE DAT, ALZH RES FOR; Sato C, 2005, MOVEMENT DISORD, V20, P367, DOI 10.1002/mds.20319; Segarane B, 2009, NEUROLOGY, V72, P1185, DOI 10.1212/01.wnl.0000345356.40399.eb; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Spitz M, 2008, PARKINSONISM RELAT D, V14, P58, DOI 10.1016/j.parkreldis.2007.06.010; Tan EK, 2007, ARCH NEUROL-CHICAGO, V64, P1056, DOI 10.1001/archneur.64.7.1056; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Tayebi N, 2003, AM J HUM GENET, V72, P519, DOI 10.1086/367850; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Toft M, 2006, NEUROLOGY, V66, P415, DOI 10.1212/01.wnl.0000196492.80676.7c; Wan L, 2006, BLOOD CELL MOL DIS, V36, P422, DOI 10.1016/j.bcmd.2006.02.001; Winfield SL, 1997, GENOME RES, V7, P1020, DOI 10.1101/gr.7.10.1020; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu YR, 2007, J NEUROL NEUROSUR PS, V78, P977, DOI 10.1136/jnnp.2006.105940; Ziegler SG, 2007, MOL GENET METAB, V91, P195, DOI 10.1016/j.ymgme.2007.03.004	44	1303	1335	2	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1651	1661		10.1056/NEJMoa0901281	http://dx.doi.org/10.1056/NEJMoa0901281			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846850	Green Accepted			2022-12-28	WOS:000270977400007
J	Vecsey, CG; Baillie, GS; Jaganath, D; Havekes, R; Daniels, A; Wimmer, M; Huang, T; Brown, KM; Li, XY; Descalzi, G; Kim, SS; Chen, T; Shang, YZ; Zhuo, M; Houslay, MD; Abel, T				Vecsey, Christopher G.; Baillie, George S.; Jaganath, Devan; Havekes, Robbert; Daniels, Andrew; Wimmer, Mathieu; Huang, Ted; Brown, Kim M.; Li, Xiang-Yao; Descalzi, Giannina; Kim, Susan S.; Chen, Tao; Shang, Yu-Ze; Zhuo, Min; Houslay, Miles D.; Abel, Ted			Sleep deprivation impairs cAMP signalling in the hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; CYCLIC-AMP PHOSPHODIESTERASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; LATE-PHASE; INSUFFICIENT SLEEP; CA1 REGION; MEMORY; RECEPTOR; ACTIVATION	Millions of people regularly obtain insufficient sleep(1). Given the effect of sleep deprivation on our lives, understanding the cellular and molecular pathways affected by sleep deprivation is clearly of social and clinical importance. One of the major effects of sleep deprivation on the brain is to produce memory deficits in learning models that are dependent on the hippocampus(2-5). Here we have identified a molecular mechanism by which brief sleep deprivation alters hippocampal function. Sleep deprivation selectively impaired 3',5'-cyclic AMP (cAMP)- and protein kinase A (PKA)-dependent forms of synaptic plasticity(6) in the mouse hippocampus, reduced cAMP signalling, and increased activity and protein levels of phosphodiesterase 4 (PDE4), an enzyme that degrades cAMP. Treatment of mice with phosphodiesterase inhibitors rescued the sleep-deprivation-induced deficits in cAMP signalling, synaptic plasticity and hippocampus-dependent memory. These findings demonstrate that brief sleep deprivation disrupts hippocampal function by interfering with cAMP signalling through increased PDE4 activity. Thus, drugs that enhance cAMP signalling may provide a new therapeutic approach to counteract the cognitive effects of sleep deprivation.	[Vecsey, Christopher G.; Jaganath, Devan; Havekes, Robbert; Daniels, Andrew; Wimmer, Mathieu; Huang, Ted; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Vecsey, Christopher G.; Wimmer, Mathieu; Huang, Ted] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Baillie, George S.; Brown, Kim M.; Houslay, Miles D.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Li, Xiang-Yao; Descalzi, Giannina; Kim, Susan S.; Chen, Tao; Shang, Yu-Ze; Zhuo, Min] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Pennsylvania; University of Pennsylvania; University of Glasgow; University of Toronto	Abel, T (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	abele@sas.upenn.edu	DTC, Cell & Proteomics/C-8374-2011; Abel, Ted/AAX-2825-2021; Houslay, Miles D/A-6825-2011; Wimmer, Mathieu E/P-8091-2018; Zhuo, Min/A-2072-2008; Li, xiang-Yao/B-7622-2011; Houslay, Miles/AAM-5281-2020; Vecsey, Christopher/AAP-6002-2020	Abel, Ted/0000-0003-2423-4592; Zhuo, Min/0000-0001-9062-3241; Li, xiang-Yao/0000-0002-4793-0550; Havekes, Robbert/0000-0003-0757-4739; Baillie, George/0000-0003-2469-6316; Houslay, Miles/0000-0002-3826-8091; Descalzi, Giannina/0000-0003-3734-394X; Jaganath, Devan/0000-0002-8555-5667	Systems and Integrative Biology Training [GM07517]; NIH; Netherlands Organization for Scientific Research NWO-Rubicon [825.07.029]; National Institutes of Health [AG017628]; SCOR [HL060287]; HFSP [RGSP/2005]; Medical Research Council (UK); European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02, CIHR84256]; UK Engineering and Physical Sciences Research Council; Medical Research Council [G0600765] Funding Source: researchfish; MRC [G0600765] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953, P50HL060287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	Systems and Integrative Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR; HFSP(Human Frontier Science Program); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Sehgal and J. Hawk for their comments on the manuscript. We thank J. O'Donnell for his help with planning rolipram treatment experiments. We thank J. Bibb for discussions and comments on the manuscript. We thank S. Fluharty and J. Lindstrom for the use of their gamma scintillation counters, and T. Bale, N. Goel, K. Semsar and S. Teegarden for their help with corticosterone assays. We also thank P. Hernandez, N. Khatib, A. Park, J. Lederman, C. Florian and W. Lu for their help with experiments. This research was supported by Systems and Integrative Biology Training grant GM07517 ( to C. G. V., M. Nusbaum PI), NIH training grant HL07953 ( to C. G. V., A. I. Pack PI), the Netherlands Organization for Scientific Research NWO-Rubicon grant 825.07.029 ( to R. H.), the National Institutes of Health (AG017628; to T. A., A. I. Pack PI), SCOR grant HL060287 ( to T. A., A. I. Pack PI), HFSP grant RGSP/2005 ( to T. A.), the Medical Research Council (UK) grant G0600765 ( to M. D. H. and G. S. B.), the European Union grant LSHB-CT-2006-037189 ( to M. D. H.), the Fondation Leducq grant 06CVD02 ( to M. D. H. and G. S. B.), CIHR84256 ( to M. Z.), and a UK Engineering and Physical Sciences Research Council training grant ( to K. M. B.).	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BEAVO JA, 1971, ANN NY ACAD SCI, V185, P129; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DALY JW, 1982, J NEUROCHEM, V38, P532, DOI 10.1111/j.1471-4159.1982.tb08660.x; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Huang Y Y, 1994, Learn Mem, V1, P74; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Huston E, 2000, J BIOL CHEM, V275, P28063; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Ledoux L, 1996, BRAIN RES, V735, P108; LOBBAN M, 1994, BIOCHEM J, V304, P399, DOI 10.1042/bj3040399; LYNCH G, 1983, FED PROC, V42, P2886; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MARCHMONT RJ, 1980, NATURE, V286, P904, DOI 10.1038/286904a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matthies H, 1997, J NEUROSCI METH, V78, P173, DOI 10.1016/S0165-0270(97)00149-0; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; McDermott CM, 2003, J NEUROSCI, V23, P9687; McPhee I, 2001, CELL SIGNAL, V13, P911, DOI 10.1016/S0898-6568(01)00217-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Tartar JL, 2006, EUR J NEUROSCI, V23, P2739, DOI 10.1111/j.1460-9568.2006.04808.x; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wallace DA, 2005, MOL PHARMACOL, V67, P1920, DOI 10.1124/mol.104.009423; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wu LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001407	41	276	291	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1122	U221		10.1038/nature08488	http://dx.doi.org/10.1038/nature08488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847264	Green Accepted, Green Submitted			2022-12-28	WOS:000270987600044
J	Hagoort, P; Levelt, WJM				Hagoort, Peter; Levelt, Willem J. M.			The Speaking Brain	SCIENCE			English	Editorial Material							LEXICAL ACCESS; WORD PRODUCTION; LANGUAGE		[Hagoort, Peter; Levelt, Willem J. M.] Max Planck Inst Psycholinguist, NL-6500 HB Nijmegen, Netherlands; [Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Hagoort, P (corresponding author), Max Planck Inst Psycholinguist, NL-6500 HB Nijmegen, Netherlands.	peter.hagoort@donders.ru.nl	Hagoort, Peter/B-7417-2012					Broca Paul P, 1865, B SOCIETE ANTHROPOLO, V6, P377; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/S1364-6613(04)00116-0; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Hagoort P, 1997, INT CONGR SER, V1146, P351; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; LEVELT WJM, 1989, SPEAKING INTENTION A; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Tyler LK, 2008, PHILOS T R SOC B, V363, P1037, DOI 10.1098/rstb.2007.2158	15	43	44	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					372	373		10.1126/science.1181675	http://dx.doi.org/10.1126/science.1181675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZM	19833945	Green Submitted			2022-12-28	WOS:000270818600030
J	Silva, AJ; Zhou, Y; Rogerson, T; Shobe, J; Balaji, J				Silva, Alcino J.; Zhou, Yu; Rogerson, Thomas; Shobe, Justin; Balaji, J.			Molecular and Cellular Approaches to Memory Allocation in Neural Circuits	SCIENCE			English	Review							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; LONG-TERM POTENTIATION; ADULT NEUROGENESIS; GENE-EXPRESSION; NEURONS; ACTIVATION; AMYGDALA; HIPPOCAMPUS; MECHANISMS	Although memory allocation is a subject of active research in computer science, little is known about how the brain allocates information within neural circuits. There is an extensive literature on how specific types of memory engage different parts of the brain, and how neurons in these regions process and store information. Until recently, however, the mechanisms that determine how specific cells and synapses within a neural circuit ( and not their neighbors) are recruited during learning have received little attention. Recent findings suggest that memory allocation is not random, but rather specific mechanisms regulate where information is stored within a neural circuit. New methods that allow tagging, imaging, activation, and inactivation of neurons in behaving animals promise to revolutionize studies of brain circuits, including memory allocation. Results from these studies are likely to have a considerable impact on computer science, as well as on the understanding of memory and its disorders.	[Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	silvaa@ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	NIH [R37-AG013622, P50-MH0779720]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Silva lab, especially S. Josselyn, S. Kushner, J. Won, M. Zhou, and M. Karlsson, as well as our colleagues D. Buonomano, F. Gage, P. Golshani, and P Poirazi, for discussions that helped shape the ideas summarized here. This work was supported by grants from NIH (R37-AG013622 and P50-MH0779720) to A. J. S.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Mehta MR, 2004, TRENDS NEUROSCI, V27, P69, DOI 10.1016/j.tins.2003.12.004; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sidiropoulou K, 2006, EMBO REP, V7, P886, DOI 10.1038/sj.embor.7400789; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Xu J, 2005, REV NEUROSCIENCE, V16, P311; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	39	156	158	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					391	395		10.1126/science.1174519	http://dx.doi.org/10.1126/science.1174519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833959	Green Accepted			2022-12-28	WOS:000270818600043
J	Kim, MS; Kondo, T; Takada, I; Youn, MY; Yamamoto, Y; Takahashi, S; Matsumoto, T; Fujiyama, S; Shirode, Y; Yamaoka, I; Kitagawa, H; Takeyama, KI; Shibuya, H; Ohtake, F; Kato, S				Kim, Mi-Sun; Kondo, Takeshi; Takada, Ichiro; Youn, Min-Young; Yamamoto, Yoko; Takahashi, Sayuri; Matsumoto, Takahiro; Fujiyama, Sally; Shirode, Yuko; Yamaoka, Ikuko; Kitagawa, Hirochika; Takeyama, Ken-Ichi; Shibuya, Hiroshi; Ohtake, Fumiaki; Kato, Shigeaki			RETRACTED: DNA demethylation in hormone-induced transcriptional derepression (Retracted article. See vol. 486, pg. 280, 2012)	NATURE			English	Article; Retracted Publication							VITAMIN-D-RECEPTOR; NUCLEAR RECEPTOR; GLYCOSYLASE; EPIGENETICS; PROMOTER; ACTIVATION; METHYLATION; REPAIR; SITES; DNMT1	Epigenetic modifications at the histone level affect gene regulation in response to extracellular signals(1,2). However, regulated epigenetic modifications at the DNA level, especially active DNA demethylation, in gene activation are not well understood(3-5). Here we report that DNA methylation/demethylation is hormonally switched to control transcription of the cytochrome p450 27B1 (CYP27B1) gene. Reflecting vitamin-D-mediated transrepression of the CYP27B1 gene by the negative vitamin D response element (nVDRE)(6,7), methylation of CpG sites ((5m)CpG) is induced by vitamin D in this gene promoter. Conversely, treatment with parathyroid hormone, a hormone known to activate the CYP27B1 gene(8), induces active demethylation of the (5m)CpG sites in this promoter. Biochemical purification of a complex associated with the nVDRE-binding protein (VDIR, also known as TCF3)(6,7) identified two DNA methyl-transferases, DNMT1 and DNMT3B, for methylation of CpG sites(9), as well as a DNA glycosylase, MBD4 (ref. 10). Protein-kinase-C-phosphorylated MBD4 by parathyroid hormone stimulation promotes incision of methylated DNA through glycosylase activity(11), and a base-excision repair process seems to complete DNA demethylation in the MBD4-bound promoter. Such parathyroid-hormone- induced DNA demethylation and subsequent transcriptional derepression are impaired in Mbd4(-/-) mice(12). Thus, the present findings suggest that methylation switching at the DNA level contributes to the hormonal control of transcription.	[Kim, Mi-Sun; Matsumoto, Takahiro; Fujiyama, Sally; Shirode, Yuko; Yamaoka, Ikuko; Ohtake, Fumiaki; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchisi, Saitama 3320012, Japan; [Kim, Mi-Sun; Kondo, Takeshi; Takada, Ichiro; Youn, Min-Young; Yamamoto, Yoko; Takahashi, Sayuri; Matsumoto, Takahiro; Fujiyama, Sally; Shirode, Yuko; Yamaoka, Ikuko; Kitagawa, Hirochika; Takeyama, Ken-Ichi; Ohtake, Fumiaki; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kim, Mi-Sun; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Kim, Mi-Sun; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan	Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kato, S (corresponding author), Japan Sci & Technol Agcy, ERATO, 4-1-8 Honcho, Kawaguchisi, Saitama 3320012, Japan.	uskato@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Murayama, K. Saito and A. Matsukage for discussions, Y. Imai and R. Fujiki for technical assistance, K. Sugasawa for plasmids, and M. Yamaki and H. Yamazaki for preparing the manuscript. This work was supported in part by priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to F. O. and S. K.).	Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	30	173	180	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					1007	1012		10.1038/nature08456	http://dx.doi.org/10.1038/nature08456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829383				2022-12-28	WOS:000270817700053
J	Poznanski, D; Chornock, R; Nugent, PE; Bloom, JS; Filippenko, AV; Ganeshalingam, M; Leonard, DC; Li, WD; Thomas, RC				Poznanski, Dovi; Chornock, Ryan; Nugent, Peter E.; Bloom, Joshua S.; Filippenko, Alexei V.; Ganeshalingam, Mohan; Leonard, Douglas C.; Li, Weidong; Thomas, Rollin C.			An Unusually Fast-Evolving Supernova	SCIENCE			English	Article							IA SUPERNOVAE; WHITE-DWARFS; PHOTOMETRY	Analyses of supernovae (SNe) have revealed two main types of progenitors: exploding white dwarfs and collapsing massive stars. Here we describe SN 2002bj, which stands out as different from any SN reported to date. Its light curve rose and declined very rapidly, yet reached a peak intrinsic brightness greater than-18 magnitude. A spectrum obtained 7 days after discovery shows the presence of helium and intermediate-mass elements, yet no clear hydrogen or iron-peak elements. The spectrum only barely resembles that of a type Ia SN, with added carbon and helium. Its properties suggest that SN 2002bj may be representative of a class of progenitors that previously has been only hypothesized: a helium detonation on a white dwarf, ejecting a small envelope of material. New surveys should find many such objects, despite their scarcity.	[Poznanski, Dovi; Chornock, Ryan; Bloom, Joshua S.; Filippenko, Alexei V.; Ganeshalingam, Mohan; Li, Weidong] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Poznanski, Dovi; Nugent, Peter E.; Thomas, Rollin C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Computat Cosmol Ctr, Berkeley, CA 94720 USA; [Leonard, Douglas C.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Diego State University	Poznanski, D (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	dovi@berkeley.edu	Nugent, Peter Edward/AGG-8472-2022	Chornock, Ryan/0000-0002-7706-5668; Bloom, Joshua/0000-0002-7777-216X; Nugent, Peter/0000-0002-3389-0586; Poznanski, Dovi/0000-0003-1470-7173				ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Bildsten L, 2007, ASTROPHYS J, V662, pL95, DOI 10.1086/519489; Fassia A, 2000, MON NOT R ASTRON SOC, V318, P1093, DOI 10.1046/j.1365-8711.2000.03797.x; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Fisher A, 1997, ASTROPHYS J, V481, pL89, DOI 10.1086/310660; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Hicken M, 2007, ASTROPHYS J, V669, pL17, DOI 10.1086/523301; Howell DA, 2006, NATURE, V443, P308, DOI 10.1038/nature05103; Kasen D, 2006, ASTROPHYS J, V649, P939, DOI 10.1086/506588; MATHESON T, 2002, IAU CIRC, V7844, P5; Modjaz M, 2009, ASTROPHYS J, V702, P226, DOI 10.1088/0004-637X/702/1/226; Nugent P, 2006, ASTROPHYS J, V645, P841, DOI 10.1086/504413; Puckett T., 2002, IAU CIRC, V7839, P1; Richmond MW, 1996, ASTRON J, V111, P327, DOI 10.1086/117785; Shen KJ, 2009, ASTROPHYS J, V699, P1365, DOI 10.1088/0004-637X/699/2/1365; SUTHERLAND PG, 1984, ASTROPHYS J, V280, P282, DOI 10.1086/161995; Valenti S, 2009, NATURE, V459, P674, DOI 10.1038/nature08023; Wang X, 2009, ASTROPHYS J LETT, V699, pL139, DOI 10.1088/0004-637X/699/2/L139; Wang X, 2009, ASTROPHYS J, V697, P380, DOI 10.1088/0004-637X/697/1/380	19	98	98	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					58	60		10.1126/science.1181709	http://dx.doi.org/10.1126/science.1181709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19892941	Green Submitted			2022-12-28	WOS:000273395400028
J	Chernichovsky, D				Chernichovsky, Dov			Not "Socialized Medicine" - An Israeli View of Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chernichovsky, Dov] Ben Gurion Univ Negev, Dept Hlth Syst Adm, IL-84105 Beer Sheva, Israel; [Chernichovsky, Dov] Taub Ctr Social Policy Studies Israel, Jerusalem, Israel; [Chernichovsky, Dov] Natl Bur Econ Res, Cambridge, MA 02138 USA	Ben Gurion University; National Bureau of Economic Research	Chernichovsky, D (corresponding author), Ben Gurion Univ Negev, Dept Hlth Syst Adm, IL-84105 Beer Sheva, Israel.							Chernichovsky D, 2002, MILBANK Q, V80, P5, DOI 10.1111/1468-0009.00002; Rosen B., 2009, ISRAEL HLTH SYSTEM R, V11	2	28	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21								10.1056/NEJMp0908269	http://dx.doi.org/10.1056/NEJMp0908269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521DA	19890109				2022-12-28	WOS:000271898600004
J	Schwadron, NA; Bzowski, M; Crew, GB; Gruntman, M; Fahr, H; Fichtner, H; Frisch, PC; Funsten, HO; Fuselier, S; Heerikhuisen, J; Izmodenov, V; Kucharek, H; Lee, M; Livadiotis, G; McComas, DJ; Moebius, E; Moore, T; Mukherjee, J; Pogorelov, NV; Prested, C; Reisenfeld, D; Roelof, E; Zank, GP				Schwadron, N. A.; Bzowski, M.; Crew, G. B.; Gruntman, M.; Fahr, H.; Fichtner, H.; Frisch, P. C.; Funsten, H. O.; Fuselier, S.; Heerikhuisen, J.; Izmodenov, V.; Kucharek, H.; Lee, M.; Livadiotis, G.; McComas, D. J.; Moebius, E.; Moore, T.; Mukherjee, J.; Pogorelov, N. V.; Prested, C.; Reisenfeld, D.; Roelof, E.; Zank, G. P.			Comparison of Interstellar Boundary Explorer Observations with 3D Global Heliospheric Models	SCIENCE			English	Article							VOYAGER-1; FLUX; WIND	Simulations of energetic neutral atom (ENA) maps predict flux magnitudes that are, in some cases, similar to those observed by the Interstellar Boundary Explorer ( IBEX) spacecraft, but they miss the ribbon. Our model of the heliosphere indicates that the local interstellar medium (LISM) magnetic field (B-LISM) is transverse to the line of sight (LOS) along the ribbon, suggesting that the ribbon may carry its imprint. The force-per-unit area on the heliopause from field line draping and the LISM ram pressure is comparable with the ribbon pressure if the LOS similar to 30 to 60 astronomical units and B-LISM similar to 2.5 microgauss. Although various models have advantages in accounting for some of the observations, no model can explain all the dominant features, which probably requires a substantial change in our understanding of the processes that shape our heliosphere.	[Schwadron, N. A.; Prested, C.] Boston Univ, Dept Astron, Boston, MA 02215 USA; [Bzowski, M.] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [Crew, G. B.] MIT, Kavli Inst, Cambridge, MA 02139 USA; [Gruntman, M.] Univ So Calif, Astron Engn Div, Los Angeles, CA 90089 USA; [Fahr, H.] Univ Bonn, Inst Astrophys & Extraterr Forsch, D-53115 Bonn, Germany; [Fichtner, H.] Ruhr Univ Bochum, Inst Theoret Phys 4, D-44780 Bochum, Germany; [Frisch, P. C.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Funsten, H. O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Fuselier, S.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA; [Heerikhuisen, J.; Pogorelov, N. V.; Zank, G. P.] Univ Alabama, Dept Phys, Huntsville, AL 35805 USA; [Izmodenov, V.] Moscow MV Lomonosov State Univ, Dept Aeromech & Gas Dynam, Moscow 117997, Russia; [Izmodenov, V.] Russian Acad Sci, Space Res Inst IKI, Moscow 117997, Russia; [Izmodenov, V.] Russian Acad Sci, Inst Problems Mech, Moscow 117997, Russia; [Kucharek, H.; Lee, M.; Moebius, E.] Univ New Hampshire, Dept Phys, Ctr Space Sci, Durham, NH 03824 USA; [Livadiotis, G.; McComas, D. J.; Mukherjee, J.] SW Res Inst, Dept Space Sci & Engn, San Antonio, TX 78228 USA; [McComas, D. J.] Univ Texas San Antonio, Dept Phys, San Antonio, TX 78249 USA; [Moore, T.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Reisenfeld, D.] Univ Montana, Dept Phys, Missoula, MT 59812 USA; [Roelof, E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Boston University; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Massachusetts Institute of Technology (MIT); University of Southern California; University of Bonn; Ruhr University Bochum; University of Chicago; United States Department of Energy (DOE); Los Alamos National Laboratory; Lockheed Martin; University of Alabama System; University of Alabama Huntsville; Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Ishlinsky Institute for Problems in Mechanics RAS; University System Of New Hampshire; University of New Hampshire; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Montana System; University of Montana; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Schwadron, NA (corresponding author), Boston Univ, Dept Astron, 725 Commonwealth Ave, Boston, MA 02215 USA.	nathanas@bu.edu	Funsten, Herbert O/A-5702-2015; Moore, Thomas Earle/D-4675-2012; McComas, David J/H-6202-2011; Reisenfeld, Daniel/F-7614-2015; Gruntman, Mike/A-5426-2008; Izmodenov, Vladislav V/K-6073-2012; Roelof, Edmond/G-6654-2019	Funsten, Herbert O/0000-0002-6817-1039; Moore, Thomas Earle/0000-0002-3150-1137; McComas, David J/0000-0001-6160-1158; Gruntman, Mike/0000-0002-0830-010X; Izmodenov, Vladislav V/0000-0002-1748-0982; Roelof, Edmond/0000-0002-2270-0652; Heerikhuisen, Jacob/0000-0001-7867-3633; Bzowski, Maciej/0000-0003-3957-2359; Crew, Geoffrey/0000-0002-2079-3189; Fichtner, Horst/0000-0002-9151-5127; Moebius, Eberhard/0000-0002-2745-6978	IBEX program	IBEX program	We thank the many dedicated people who have made IBEX a success. Special thanks to K. Goodrich, J. Siegel, K. Maynard, and M. Schwadron for their help. This work was primarily supported by the IBEX program.	FRISCH PC, 2009, IBEX MISSION, P28; Funsten HO, 2009, SCIENCE, V326, P964, DOI 10.1126/science.1180927; Fuselier SA, 2009, SCIENCE, V326, P962, DOI 10.1126/science.1180981; Gruntman M, 2001, J GEOPHYS RES-SPACE, V106, P15767, DOI 10.1029/2000JA000328; Izmodenov V, 2005, ASTRON ASTROPHYS, V437, pL35, DOI 10.1051/0004-6361:200500132; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; Opher M, 2007, SCIENCE, V316, P875, DOI 10.1126/science.1139480; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; PARKER EN, 1961, ASTROPHYS J, V134, P20, DOI 10.1086/147124; Pogorelov NV, 2009, ASTROPHYS J LETT, V695, pL31, DOI 10.1088/0004-637X/695/1/L31; Prested C, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012758; Richardson JD, 2008, NATURE, V454, P63, DOI 10.1038/nature07024; Scherer K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016073; Sternal O, 2008, ASTRON ASTROPHYS, V477, P365, DOI 10.1051/0004-6361:20077715; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; VASYLIUNAS VM, 1968, J GEOPHYS RES, V73, P2839, DOI 10.1029/JA073i009p02839; Wu P, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013082	18	209	211	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					966	968		10.1126/science.1180986	http://dx.doi.org/10.1126/science.1180986			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19833915				2022-12-28	WOS:000271712300031
J	Kilpatrick, ES; Bloomgarden, ZT; Zimmet, PZ				Kilpatrick, Eric S.; Bloomgarden, Zachary T.; Zimmet, Paul Z.			Is haemoglobin A(1c) a step forward for diagnosing diabetes?	BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPERT COMMITTEE; IRON-DEFICIENCY; A1C; CLASSIFICATION; MELLITUS; GLUCOSE		[Kilpatrick, Eric S.] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Kilpatrick, Eric S.] Hull York Med Sch, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bloomgarden, Zachary T.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Caulfield 3162, Australia	University of Hull; University of Hull; University of York - UK; Icahn School of Medicine at Mount Sinai; Baker Heart and Diabetes Institute	Kilpatrick, ES (corresponding author), Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England.	eric.kilpatrick@hey.nhs.uk	Zimmet, Paul/O-8486-2019; Bloomgarden, Zachary/AAF-5163-2020	Zimmet, Paul/0000-0003-0627-0776; 				Bloomgarden ZT, 2008, DIABETOLOGIA, V51, P1111, DOI 10.1007/s00125-008-1027-7; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; El-Agouza I, 2002, CLIN LAB HAEMATOL, V24, P285, DOI 10.1046/j.1365-2257.2002.00464.x; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Miedema K, 2004, DIABETOLOGIA, V47, P1143, DOI 10.1007/s00125-004-1453-0; *NAT DIAB INF CLEA, SICKL CELL TRAIT OTH; *NAT GLYC STAND PR, 2009, HBA1C METH HEM VAR H; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Roberts WL, 2002, CLIN CHEM, V48, P383; Sabanayagam C, 2009, DIABETOLOGIA, V52, P1279, DOI 10.1007/s00125-009-1360-5; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; W.H. Organization, 1999, DEFINITION DIAGNOSIS	17	67	67	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2009	339								b4432	10.1136/bmj.b4432	http://dx.doi.org/10.1136/bmj.b4432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HL	19903702				2022-12-28	WOS:000271833800003
J	Eldakar, OT; Dlugos, MJ; Pepper, JW; Wilson, DS				Eldakar, Omar Tonsi; Dlugos, Michael J.; Pepper, John W.; Wilson, David Sloan			Population Structure Mediates Sexual Conflict in Water Striders	SCIENCE			English	Article							TRAGEDY; COMMONS		[Eldakar, Omar Tonsi; Pepper, John W.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Eldakar, Omar Tonsi; Dlugos, Michael J.; Wilson, David Sloan] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Pepper, John W.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Arizona	Eldakar, OT (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.		Pepper, John W/O-1662-2013; Pepper, John/W-5578-2019	Pepper, John W/0000-0001-9888-0437; Pepper, John/0000-0001-9888-0437; Eldakar, Omar/0000-0002-4807-4979	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 K12 GM000708, K12 GM000708] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNQVIST G, 1997, SOCIAL COMPETITION C, V1, P146; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Eldakar OT, 2009, BEHAV ECOL SOCIOBIOL, V64, P25, DOI 10.1007/s00265-009-0814-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; KRUPA JJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P107, DOI 10.1007/BF00171662; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rankin DJ, 2005, OIKOS, V111, P616; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	8	61	61	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					816	816		10.1126/science.1180183	http://dx.doi.org/10.1126/science.1180183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892974				2022-12-28	WOS:000271468000032
J	Mattsson, J; Wyss, HM; Fernandez-Nieves, A; Miyazaki, K; Hu, ZB; Reichman, DR; Weitz, DA				Mattsson, Johan; Wyss, Hans M.; Fernandez-Nieves, Alberto; Miyazaki, Kunimasa; Hu, Zhibing; Reichman, David R.; Weitz, David A.			Soft colloids make strong glasses	NATURE			English	Article							DYNAMIC LIGHT-SCATTERING; HARD-SPHERE SUSPENSIONS; FORMING LIQUIDS; AMORPHOUS SOLIDS; TRANSITION; FRAGILITY; VISCOELASTICITY; RELAXATION; DEPENDENCE; VISCOSITY	Glass formation in colloidal suspensions has many of the hallmarks of glass formation in molecular materials(1-5). For hard-sphere colloids, which interact only as a result of excluded volume, phase behaviour is controlled by volume fraction, phi; an increase in phi drives the system towards its glassy state, analogously to a decrease in temperature, T, in molecular systems. When phi increases above phi* approximate to 0.53, the viscosity starts to increase significantly, and the system eventually moves out of equilibrium at the glass transition, phi(g) approximate to 0.58, where particle crowding greatly restricts structural relaxation(1-4). The large particle size makes it possible to study both structure and dynamics with light scattering(1) and imaging(3,4); colloidal suspensions have therefore provided considerable insight into the glass transition. However, hard-sphere colloidal suspensions do not exhibit the same diversity of behaviour as molecular glasses. This is highlighted by the wide variation in behaviour observed for the viscosity or structural relaxation time, tau(alpha), when the glassy state is approached in supercooled molecular liquids(5). This variation is characterized by the unifying concept of fragility(5), which has spurred the search for a 'universal' description of dynamic arrest in glass-forming liquids. For 'fragile' liquids, tau(alpha) is highly sensitive to changes in T, whereas non-fragile, or 'strong', liquids show a much lower T sensitivity. In contrast, hard-sphere colloidal suspensions are restricted to fragile behaviour, as determined by their phi dependence(1,6), ultimately limiting their utility in the study of the glass transition. Here we show that deformable colloidal particles, when studied through their concentration dependence at fixed temperature, do exhibit the same variation in fragility as that observed in the T dependence of molecular liquids at fixed volume. Their fragility is dictated by elastic properties on the scale of individual colloidal particles. Furthermore, we find an equivalent effect in molecular systems, where elasticity directly reflects fragility. Colloidal suspensions may thus provide new insight into glass formation in molecular systems.	[Mattsson, Johan; Wyss, Hans M.; Fernandez-Nieves, Alberto; Weitz, David A.] Harvard Univ, Harvard Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Miyazaki, Kunimasa; Reichman, David R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Hu, Zhibing] Univ N Texas, Dept Phys, Denton, TX 76203 USA; [Mattsson, Johan; Wyss, Hans M.; Fernandez-Nieves, Alberto; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Columbia University; University of North Texas System; University of North Texas Denton; Harvard University	Mattsson, J (corresponding author), Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.	johanm@chalmers.se	Miyazaki, Kunimasa/C-3956-2009; Wyss, Hans/B-7894-2010; Wyss, Hans/A-9404-2008; Fernandez-Nieves, Alberto/S-1955-2018	Wyss, Hans/0000-0001-6564-3398; Fernandez-Nieves, Alberto/0000-0002-1286-9809; Mattsson, Johan/0000-0001-7057-2192	US National Science Foundation; Harvard University's Materials Research Science and Engineering Center; Hans Werthen Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation; Royal Society of Arts and Sciences in Goteborg; Ministerio de Ciencia e Innovacion; University of Almeria; KAKENHI; Grants-in-Aid for Scientific Research [21540416] Funding Source: KAKEN	US National Science Foundation(National Science Foundation (NSF)); Harvard University's Materials Research Science and Engineering Center(National Science Foundation (NSF)); Hans Werthen Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Society of Arts and Sciences in Goteborg; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of Almeria; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to J. Zhou for technical assistance, to J. Bergenholtz for complimentary use of his light-scattering equipment and to J.-W. Kim for discussions. This work was supported by the US National Science Foundation and Harvard University's Materials Research Science and Engineering Center; by the Hans Werthen Foundation, the Wenner-Gren Foundation, the Knut and Alice Wallenberg Foundation and the Royal Society of Arts and Sciences in Goteborg (J. M.); by the Ministerio de Ciencia e Innovacion and the University of Almeria (A. F.-N.); and by KAKENHI (K. M.).	Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; BARTSCH E, 1992, J CHEM PHYS, V97, P3950, DOI 10.1063/1.462934; Brumer Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041202; Buitenhuis J, 1997, J CHEM PHYS, V107, P262, DOI 10.1063/1.474346; Cheng ZD, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041405; Dyre JC, 2006, REV MOD PHYS, V78, P953, DOI 10.1103/RevModPhys.78.953; ENRIGHT GD, 1976, J CHEM PHYS, V64, P3658, DOI 10.1063/1.432729; HERBST CA, 1994, J NON-CRYST SOLIDS, V172, P265, DOI 10.1016/0022-3093(94)90445-6; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Kumar SK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192769; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770; Nemilov S. V, 1995, THERMODYNAMIC KINETI; Novikov VN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061501; Novikov VN, 2004, NATURE, V431, P961, DOI 10.1038/nature02947; Polian A, 2002, EUROPHYS LETT, V57, P375, DOI 10.1209/epl/i2002-00470-4; ROOVERS J, 1994, MACROMOLECULES, V27, P5359, DOI 10.1021/ma00097a015; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Scarponi F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054203; Scopigno T, 2003, SCIENCE, V302, P849, DOI 10.1126/science.1089446; SHIKATA T, 1994, J RHEOL, V38, P601, DOI 10.1122/1.550477; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Stieger M, 2004, LANGMUIR, V20, P7283, DOI 10.1021/la049518x; Tobolsky A, 1943, FRONTIERS CHEM, V1, P125; VANMEGEN W, 1991, PHYS REV A, V43, P5429, DOI 10.1103/PhysRevA.43.5429; WANG CH, 1987, MOL PHYS, V62, P749, DOI 10.1080/00268978700102531; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wyart M, 2005, ANN PHYS-PARIS, V30, P1, DOI 10.1051/anphys:2006003; Xia XH, 2004, LANGMUIR, V20, P2094, DOI 10.1021/la0354483	30	416	419	2	292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 5	2009	462	7269					83	86		10.1038/nature08457	http://dx.doi.org/10.1038/nature08457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890327				2022-12-28	WOS:000271419200036
J	Du, JF; Rong, X; Zhao, N; Wang, Y; Yang, JH; Liu, RB				Du, Jiangfeng; Rong, Xing; Zhao, Nan; Wang, Ya; Yang, Jiahui; Liu, R. B.			Preserving electron spin coherence in solids by optimal dynamical decoupling	NATURE			English	Article							COUPLED ELECTRON; QUANTUM; MANIPULATION; QUBITS	To exploit the quantum coherence of electron spins in solids in future technologies such as quantum computing(1,2), it is first vital to overcome the problem of spin decoherence due to their coupling to the noisy environment. Dynamical decoupling(3-9), which uses stroboscopic spin flips to give an average coupling to the environment that is effectively zero, is a particularly promising strategy for combating decoherence because it can be naturally integrated with other desired functionalities, such as quantum gates. Errors are inevitably introduced in each spin flip, so it is desirable to minimize the number of control pulses used to realize dynamical decoupling having a given level of precision. Such optimal dynamical decoupling sequences have recently been explored(9-12). The experimental realization of optimal dynamical decoupling in solid-state systems, however, remains elusive. Here we use pulsed electron paramagnetic resonance to demonstrate experimentally optimal dynamical decoupling for preserving electron spin coherence in irradiated malonic acid crystals at temperatures from 50 K to room temperature. Using a seven-pulse optimal dynamical decoupling sequence, we prolonged the spin coherence time to about 30 mu s; it would otherwise be about 0.04 mu s without control or 6.2 mu s under one-pulse control. By comparing experiments with microscopic theories, we have identified the relevant electron spin decoherence mechanisms in the solid. Optimal dynamical decoupling may be applied to other solid-state systems, such as diamonds with nitrogen-vacancy centres(13-15), and so lay the foundation for quantum coherence control of spins in solids at room temperature.	[Du, Jiangfeng; Rong, Xing; Wang, Ya; Yang, Jiahui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Du, Jiangfeng; Rong, Xing; Wang, Ya; Yang, Jiahui] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Zhao, Nan; Liu, R. B.] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese University of Hong Kong	Du, JF (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	djf@ustc.edu.cn; rbliu@phy.cuhk.edu.hk	Zhao, Nan/G-9063-2011; Liu, Ren-Bao/B-3729-2011; rong, xing/N-3145-2015; Liu, Ren-Bao/AAZ-8261-2021; rong, xing/T-2896-2019	Zhao, Nan/0000-0002-4521-709X; Liu, Ren-Bao/0000-0002-0620-2370; rong, xing/0000-0001-8788-0896; rong, xing/0000-0001-8788-0896; Wang, Ya/0000-0001-6232-7234	National Natural Science Foundation of China; Chinese Academy of Sciences; Ministry of Education of PRC; National Fundamental Research Program [2007CB925200]; Hong Kong GRF Projects [CUHK401906, CUHK402209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Education of PRC(Ministry of Education, China); National Fundamental Research Program; Hong Kong GRF Projects	J. D. thanks J. F. Chen for discussions on sample preparation. This work was supported by the National Natural Science Foundation of China, the Chinese Academy of Sciences, the Ministry of Education of PRC, the National Fundamental Research Program 2007CB925200, and Hong Kong GRF Projects CUHK401906 and CUHK402209.	Awschalom DD, 2002, NANOSCI TECHNOL, P147; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; DALTON LR, 1972, CHEM PHYS LIPIDS, V14, P77, DOI 10.1016/0009-2614(72)87146-X; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Hodges JS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010303; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Kern O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.250501; Khodjasteh K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.180501; Lee B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160505; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MCCALLEY RC, 1993, J PHYS CHEM-US, V97, P2888, DOI 10.1021/j100114a011; MCCONNELL HM, 1960, J AM CHEM SOC, V82, P766, DOI 10.1021/ja01489a002; Morton JJL, 2006, NAT PHYS, V2, P40, DOI 10.1038/nphys192; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; Santos LF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150501; Schweiger A., 2001, PRINCIPLES PULSE ELE; Tyryshkin AM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.193207; Uhrig GS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100504; Viola L, 1999, PHYS REV LETT, V82, P2417, DOI 10.1103/PhysRevLett.82.2417; Witzel WM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035322; Witzel WM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241303; Yang W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180403; Yang W, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085315; Yao W, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195301	30	283	293	9	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1265	1268		10.1038/nature08470	http://dx.doi.org/10.1038/nature08470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865168				2022-12-28	WOS:000271190800045
J	Lambracht-Washington, D; Qu, BX; Fu, M; Eagar, TN; Stuve, O; Rosenberg, RN				Lambracht-Washington, Doris; Qu, Bao-Xi; Fu, Min; Eagar, Todd N.; Stueve, Olaf; Rosenberg, Roger N.			DNA beta-Amyloid(1-42) Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID-BETA-PROTEIN; A-BETA; TRANSGENIC MICE; BEHAVIORAL IMPAIRMENT; ADENOVIRUS VECTOR; GENE VACCINATION; IMMUNE-RESPONSE; EPITOPE VACCINE; PEPTIDE; PATHOLOGY	Context DNA beta-amyloid(1-42) (A beta 42) trimer immunization was developed to produce specific T helper 2 cell (T(H)2)-type antibodies to provide an effective and safe therapy for Alzheimer disease (AD) by reducing elevated levels of A beta 42 peptide that occur in the brain of patients with AD. Objective To compare the immune response in wild-type mice after immunization with DNA A beta 42 trimer and A beta 42 peptide. Design and Intervention Wild-type mice received either 4 mu g of DNA A beta 42 trimer immunization administered with gene gun (n=8) or intraperitoneal injection of 100 mu g of human A beta 42 peptide with the adjuvant Quil A (n=8). Titers, epitope mapping, and isotypes of the A beta 42-specific antibodies were analyzed. Main Outcome Measures Antibody titers, mapping of binding sites (epitopes), isotype profiles of the A beta 42-specific antibodies, and T-cell activation. Results DNA A beta 42 trimer immunization resulted in antibody titers with a mean of 15 mu g per milliliter of plasma. The isotype profile of the antibodies differed markedly. A predominant IgG1 antibody response was found in the DNA-immunized mice, indicating a T(H)2 type of immune response (IgG1/IgG2a ratio of 10). The peptide-immunized mice showed a mixed T(H)1/T(H)2 immune response (IgG1/IgG2a ratio of 1) (P<.001). No increased T-cell proliferation was observed in the DNA-immunized mice (P=.03). Conclusion In this preliminary study in a wild-type mouse model, DNA A beta 42 trimer immunization protocol produced a T(H)2 immune response and appeared to have low potential to cause an inflammatory T-cell response. JAMA. 2009; 302(16):1796-1802 www.jama.com	[Lambracht-Washington, Doris; Qu, Bao-Xi; Fu, Min; Eagar, Todd N.; Stueve, Olaf; Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Rush Alzheimers Dis Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenberg, RN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Rush Alzheimers Dis Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	roger.rosenberg@utsouthwestern.edu		Lambracht-Washington, Doris/0000-0002-3161-9207	National Institutes of Health National Institute on Aging [P30AG12300-16]; Alzheimer's Association [IIRG-06-24428]; NATIONAL INSTITUTE ON AGING [P30AG012300] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the University of Texas Southwestern Alzheimer's Disease Center, grant P30AG12300-16 from the National Institutes of Health National Institute on Aging, the Rudman Foundation, and research grant IIRG-06-24428 from the Alzheimer's Association.	Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Choi P, 2005, GENES IMMUN, V6, P290, DOI 10.1038/sj.gene.6364192; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; DaSilva KA, 2009, VACCINE, V27, P1365, DOI 10.1016/j.vaccine.2008.12.044; Dodart JC, 2002, GENES BRAIN BEHAV, V1, P142, DOI 10.1034/j.1601-183X.2002.10302.x; Erickson LD, 2001, J IMMUNOL, V166, P1531, DOI 10.4049/jimmunol.166.3.1531; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 1996, ANN MED, V28, P255, DOI 10.3109/07853899609033127; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holtzman DM, 2002, ADV DRUG DELIVER REV, V54, P1603, DOI 10.1016/S0169-409X(02)00158-8; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kim HD, 2007, IMMUNOL LETT, V112, P30, DOI 10.1016/j.imlet.2007.06.006; Kim HD, 2007, J GENE MED, V9, P88, DOI 10.1002/jgm.993; Lemere CA, 2007, CURR ALZHEIMER RES, V4, P427, DOI 10.2174/156720507781788800; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Mohajeri MH, 2004, NEURODEGENER DIS, V1, P160, DOI 10.1159/000080981; Monsonego A, 2003, SCIENCE, V302, P834, DOI 10.1126/science.1088469; Monsonego A, 2006, P NATL ACAD SCI USA, V103, P5048, DOI 10.1073/pnas.0506209103; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Movsesyan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002124; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Qu BX, 2007, J NEUROL SCI, V260, P204, DOI 10.1016/j.jns.2007.05.012; Qu BX, 2006, J NEUROL SCI, V244, P151, DOI 10.1016/j.jns.2006.02.006; Qu BX, 2004, ARCH NEUROL-CHICAGO, V61, P1859, DOI 10.1001/archneur.61.12.1859; QU BX, 2008, ALZHEIMER DEMENT S2, V4, pT477; Rosenberg RN, 2005, ARCH GEN PSYCHIAT, V62, P1186, DOI 10.1001/archpsyc.62.11.1186; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Vanderlugt CL, 1998, IMMUNOL REV, V164, P63, DOI 10.1111/j.1600-065X.1998.tb01208.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Zou JT, 2008, J NEUROL SCI, V272, P87, DOI 10.1016/j.jns.2008.05.003	43	43	49	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1796	1802		10.1001/jama.2009.1547	http://dx.doi.org/10.1001/jama.2009.1547			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861672	Bronze, Green Accepted			2022-12-28	WOS:000271150300023
J	Siebers, AG; Klinkhamer, PJJM; Grefte, JMM; Massuger, LFAG; Vedder, JEM; Beijers-Broos, A; Bulten, J; Arbyn, M				Siebers, Albertus G.; Klinkhamer, Paul J. J. M.; Grefte, Johanna M. M.; Massuger, Leon F. A. G.; Vedder, Judith E. M.; Beijers-Broos, Angelique; Bulten, Johan; Arbyn, Marc			Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THINPREP PAP TEST; FOLLOW-UP; DIAGNOSTIC-ACCURACY; PAPANICOLAOU SMEAR; COMMON OUTCOMES; SCREENING POPULATION; CLINICAL-PRACTICE; RELATIVE RISK; LAYER METHOD; EXPERIENCE	Context Liquid-based cytology has been developed as an alternative for conventional cervical cytology. Despite numerous studies and systematic reviews, controversy remains about its diagnostic accuracy. Objective To assess the performance of liquid-based cytology compared with conventional cytology in terms of detection of histologically confirmed cervical intraepithelial neoplasia (CIN). Design, Setting, and Participants Cluster randomized controlled trial involving 89 784 women aged 30 to 60 years participating in the Dutch cervical screening program at 246 family practices. One hundred twenty-two practices were assigned to use liquid-based cytology and screened 49 222 patients and 124 practices were assigned to use the conventional Papanicolaou ( Pap) test and screened 40 562 patients between April 2004 and July 1, 2006. Patients were followed up for 18 months through January 31, 2008. Intervention Screening for CIN using liquid-based cytology or conventional papanicolaou ( Pap) test and the blinded review of all follow-up of screen-positive women ( blinded to the type of cytology and the initial result). Main Outcome Measures Intention-to-treat and per-protocol analysis of the detection rates of and positive predictive values for histologically verified CIN in both cytology systems. Outcomes are presented as crude and adjusted rate ratios ( adjustment for age, urbanization, study site, and period). Results The adjusted detection rate ratios for CIN grade 1 + was 1.01 (95% confidence interval [CI], 0.85-1.19); for CIN grade 2 +, 1.00 ( 95% CI, 0.84-1.20); for CIN grade 3 +, 1.05 ( 95% CI, 0.86-1.29); and for carcinoma, 1.69 ( 95% CI, 0.96-2.99). The adjusted positive predictive value (PPV) ratios, considered at several cytological cutoffs and for various outcomes of CIN did not differ significantly from unity. Conclusion This study indicates that liquid-based cytology does not perform better than conventional Pap tests in terms of relative sensitivity and PPV for detection of cervical cancer precursors. Trial Registration trialregister.nl Identifier: NTR1032 JAMA. 2009;302(16):1757-1764 www.jama.com	[Siebers, Albertus G.; Grefte, Johanna M. M.; Vedder, Judith E. M.; Bulten, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands; [Klinkhamer, Paul J. J. M.; Beijers-Broos, Angelique] PAMM Labs, Pathol Lab, Eindhoven, Netherlands; [Arbyn, Marc] Sci Inst Publ Hlth, Brussels, Belgium	Radboud University Nijmegen; Radboud University Nijmegen	Siebers, AG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pathol, 824,POB 9101, NL-6500 HB Nijmegen, Netherlands.	b.siebers@pathol.umcn.nl	Massuger, Leon F.A.G./H-8072-2014; Bulten, J./L-4237-2015; Siebers, Albert/D-6300-2015	Bulten, J./0000-0002-8168-6045; Siebers, Albert/0000-0002-6085-0678; Siebers, Albert Siebers/0000-0001-5413-9903	European Commission [2002475]; Dutch Ministry of Health through the National Institute for Public Health and Environment [25141652]; Belgian Foundation Against Cancer	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health through the National Institute for Public Health and Environment; Belgian Foundation Against Cancer	This study was supported by grant SPC. 2002475 of the European Commission (Directorate-general for Health and Consumer), Luxembourg, Grand Duchy of Luxembourg) through the European Network for Cervical Cancer Screening, the European Cooperation on Development and Implementation of Cancer Screening and Prevention Guidelines, and grant 25141652 from the Dutch Ministry of Health through the National Institute for Public Health and Environment. Dr Arbyn also received funding from the Belgian Foundation Against Cancer.	Abulafia O, 2003, GYNECOL ONCOL, V90, P137, DOI 10.1016/S0090-8258(03)00176-8; [Anonymous], 1992, Acta Cytol, V36, P273; Arbyn M, 2007, CYTOPATHOLOGY, V18, P133, DOI 10.1111/j.1365-2303.2007.00464.x; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Arbyn M, 2009, INT J CANCER, V125, P2489, DOI 10.1002/ijc.24774; Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z; Casparie M, 2007, CELL ONCOL, V29, P19; Cheung ANY, 2003, CANCER CYTOPATHOL, V99, P331, DOI 10.1002/cncr.11786; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Diaz-Rosario LA, 1999, ARCH PATHOL LAB MED, V123, P817; Duggan MA, 2006, CYTOPATHOLOGY, V17, P73, DOI 10.1111/j.1365-2303.2006.00340.x; Dupree WB, 1998, CANCER CYTOPATHOL, V84, P202, DOI 10.1002/(SICI)1097-0142(19980825)84:4<202::AID-CNCR4>3.0.CO;2-O; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Farnsworth A, 2003, CYTOPATHOLOGY, V14, P48, DOI 10.1046/j.1365-2303.2003.00037.x; Ferreccio C, 2003, CANCER EPIDEM BIOMAR, V12, P815; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guidos BJ, 1999, DIAGN CYTOPATHOL, V20, P70, DOI 10.1002/(SICI)1097-0339(199902)20:2<70::AID-DC5>3.0.CO;2-E; HANSELAAR AGJ, 1996, GUIDELINES IMPLEMENT; HILBE J, 1995, STATA TECH B, V28, P20; Hodgson W, 2005, GYNECOL ONCOL, V99, P422, DOI 10.1016/j.ygyno.2005.06.046; Hoelund B, 2003, CYTOPATHOLOGY, V14, P269, DOI 10.1046/j.1365-2303.2003.00080.x; Hussein T, 2005, BJOG-INT J OBSTET GY, V112, P1542, DOI 10.1111/j.1471-0528.2005.00699.x; HUTCHINSON ML, 1994, AM J CLIN PATHOL, V101, P215, DOI 10.1093/ajcp/101.2.215; Klinkhamer PJJM, 2003, CANCER CYTOPATHOL, V99, P263, DOI 10.1002/cncr.11673; Limaye A, 2003, ARCH PATHOL LAB MED, V127, P200; Louro AP, 2003, AM J CLIN PATHOL, V120, P392, DOI 10.1309/NPU3WRQCTAB81XLW; Malle D, 2003, ACTA CYTOL, V47, P129, DOI 10.1159/000326492; Masumoto N, 2003, BRIT J CANCER, V88, P1883, DOI 10.1038/sj.bjc.6601023; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Negri G, 2003, CANCER CYTOPATHOL, V99, P342, DOI 10.1002/cncr.11856; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; Papillo JL, 1998, ACTA CYTOL, V42, P203, DOI 10.1159/000331547; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Schledermann D, 2004, CYTOPATHOLOGY, V15, P148, DOI 10.1111/j.1365-2303.2004.00139.x; Schledermann D, 2006, DIAGN CYTOPATHOL, V34, P780, DOI 10.1002/dc.20515; Siebers AG, 2008, OBSTET GYNECOL, V112, P1327, DOI 10.1097/AOG.0b013e31818c2b20; Strander B, 2007, CANCER CYTOPATHOL, V111, P285, DOI 10.1002/cncr.22953; Taylor S, 2006, INT J CANCER, V118, P957, DOI 10.1002/ijc.21434; Weintraub J, 2000, DIAGN CYTOPATHOL, V22, P52, DOI 10.1002/(SICI)1097-0339(200001)22:1<52::AID-DC14>3.0.CO;2-#; Williams ARW, 2006, CYTOPATHOLOGY, V17, P82, DOI 10.1111/j.1365-2303.2006.00339.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	44	146	155	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1757	1764		10.1001/jama.2009.1569	http://dx.doi.org/10.1001/jama.2009.1569			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861667	Bronze			2022-12-28	WOS:000271150300018
J	Moazed, D				Moazed, Danesh			Rejoice-RNAi for Yeast	SCIENCE			English	Editorial Material							GENOME		[Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh_moazed@hms.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM072805, R01 GM072805-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756	11	10	10	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					533	534		10.1126/science.1182102	http://dx.doi.org/10.1126/science.1182102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900888	Green Accepted			2022-12-28	WOS:000271019400029
J	Basbaum, AI; Bautista, DM; Scherrer, G; Julius, D				Basbaum, Allan I.; Bautista, Diana M.; Scherrer, Gregory; Julius, David			Cellular and Molecular Mechanisms of Pain	CELL			English	Review							GATED CALCIUM-CHANNELS; SENSING ION CHANNELS; SPINAL DORSAL-HORN; LAMINA-I NEURONS; NEUROPATHIC PAIN; NERVE INJURY; SENSORY NEURONS; CAPSAICIN-RECEPTOR; CATION CHANNEL; UP-REGULATION		[Basbaum, Allan I.; Scherrer, Gregory] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Basbaum, AI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	allan.basbaum@ucsf.edu; julius@cmp.ucsf.edu		Scherrer, Gregory/0000-0002-1983-5126	NINDS NIH HHS [R37 NS047723-17, R01 NS055299-02, R37 NS047723-14, R37 NS047723, R37 NS047723-13, R01 NS055299, R01 NS055299-04, R01 NS055299-01, R01 NS055299-03, R37 NS047723-18, R37 NS047723-15, R37 NS047723-16] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723, R01NS055299] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Atzeni F, 2005, ANN NY ACAD SCI, V1051, P559, DOI 10.1196/annals.1361.100; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Cao YQ, 2006, PAIN, V126, P5, DOI 10.1016/j.pain.2006.10.019; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen XJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-31; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cho H, 2006, EUR J NEUROSCI, V23, P2543, DOI 10.1111/j.1460-9568.2006.04802.x; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; DeLeo JA, 2007, IMMUNE GLIAL REGULAT; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Dick IE, 2007, J PAIN, V8, P315, DOI 10.1016/j.jpain.2006.10.001; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Guler AD, 2002, J NEUROSCI, V22, P6408; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Honore P, 2009, PAIN, V142, P27, DOI 10.1016/j.pain.2008.11.004; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kirschstein T, 1997, NEUROSCI LETT, V231, P33, DOI 10.1016/S0304-3940(97)00533-8; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Leffler A, 2007, EUR J NEUROSCI, V26, P12, DOI 10.1111/j.1460-9568.2007.05643.x; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McMahon S.B., 2008, WALL MELZACKS TXB PA, P49; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Meyer R.A., 2008, WALL MELZACKS TXB PA, P3; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Miraucourt LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001116; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Obata K, 2008, J NEUROCHEM, V105, P2249, DOI 10.1111/j.1471-4159.2008.05353.x; Olausson H, 2008, EXP BRAIN RES, V184, P135, DOI 10.1007/s00221-007-1175-x; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Polgar E, 2005, J NEUROSCI, V25, P6658, DOI 10.1523/JNEUROSCI.1490-05.2005; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Rau KK, 2007, J NEUROPHYSIOL, V97, P2651, DOI 10.1152/jn.00840.2006; Rauck RL, 2009, PAIN PRACT, V9, P327, DOI 10.1111/j.1533-2500.2009.00303.x; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Ren K, 2008, CURR OPIN ANESTHESIO, V21, P570, DOI 10.1097/ACO.0b013e32830edbdf; RITNER HL, 2009, SCI PAIN, P407; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; SCHMIDT R, 1995, J NEUROSCI, V15, P333; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Swayne LA, 2008, PFLUG ARCH EUR J PHY, V456, P459, DOI 10.1007/s00424-007-0390-4; Takahashi A, 2000, BRAIN RES, V869, P225, DOI 10.1016/S0006-8993(00)02366-0; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; 2002, SCIENCE, V296, P2046	160	2264	2372	27	590	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					267	284		10.1016/j.cell.2009.09.028	http://dx.doi.org/10.1016/j.cell.2009.09.028			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837031	Green Accepted, Bronze			2022-12-28	WOS:000270857500012
J	Chandrashekar, J; Yarmolinsky, D; von Buchholtz, L; Oka, Y; Sly, W; Ryba, NJP; Zuker, CS				Chandrashekar, Jayaram; Yarmolinsky, David; von Buchholtz, Lars; Oka, Yuki; Sly, William; Ryba, Nicholas J. P.; Zuker, Charles S.			The Taste of Carbonation	SCIENCE			English	Article							CARBONIC-ANHYDRASE; MAMMALIAN SWEET; RECEPTOR-CELLS; ORAL SENSATION; BITTER TASTE; UMAMI TASTE; FAMILY; RAT; ACETAZOLAMIDE; DROSOPHILA	Carbonated beverages are commonly available and immensely popular, but little is known about the cellular and molecular mechanisms underlying the perception of carbonation in the mouth. In mammals, carbonation elicits both somatosensory and chemosensory responses, including activation of taste neurons. We have identified the cellular and molecular substrates for the taste of carbonation. By targeted genetic ablation and the silencing of synapses in defined populations of taste receptor cells, we demonstrated that the sour-sensing cells act as the taste sensors for carbonation, and showed that carbonic anhydrase 4, a glycosylphosphatidylinositol-anchored enzyme, functions as the principal CO2 taste sensor. Together, these studies reveal the basis of the taste of carbonation as well as the contribution of taste cells in the orosensory response to CO2.	[Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [von Buchholtz, Lars; Ryba, Nicholas J. P.] NIDCR, Bethesda, MD 20892 USA; [Sly, William] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Saint Louis University	Zuker, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	cz2195@columbia.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Oka, Yuki/0000-0003-2686-0677; Ryba, Nicholas/0000-0002-2060-8393	NIH; NIDCR; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank W. Guo and A. Becker for generation and maintenance of mouse lines, M. Hoon for help in the initial phase of this work, E. R. Swenson for a generous gift of benzolamide, M. Goulding for Rosa26-flox-STOP-TeNT mice, A. Waheed for Car4 antibodies, and members of the Zuker laboratory for valuable comments. Supported in part by the intramural research program of the NIH, NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akiba Y, 2008, GUT, V57, P1654, DOI 10.1136/gut.2007.144378; BOTTGER B, 1996, CHEM SENSES, V21, P580; BROWN D, 1984, BRAIN RES, V324, P346, DOI 10.1016/0006-8993(84)90046-5; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Daikoku H, 1999, CHEM SENSES, V24, P255, DOI 10.1093/chemse/24.3.255; Dessirier JM, 2001, CHEM SENSES, V26, P639, DOI 10.1093/chemse/26.6.639; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; GRABER M, 1988, AM J MED, V84, P979, DOI 10.1016/0002-9343(88)90091-5; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; KAWAMURA AA, 1967, OLFACTION TASTE, V2, P431; KOMAI M, 1993, BRAIN RES, V612, P122, DOI 10.1016/0006-8993(93)91652-9; KOMAI M, 1994, OLFACTION TASTE, V11, P92; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MILLER LG, 1990, J FAM PRACTICE, V31, P199; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OKUYAMA T, 1995, ARCH BIOCHEM BIOPHYS, V320, P315, DOI 10.1016/0003-9861(95)90015-2; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Simons CT, 1999, J NEUROSCI, V19, P8134; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Vullo D, 2005, BIOORG MED CHEM LETT, V15, P971, DOI 10.1016/j.bmcl.2004.12.052; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	38	237	242	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					443	445		10.1126/science.1174601	http://dx.doi.org/10.1126/science.1174601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833970	Green Accepted			2022-12-28	WOS:000270818600058
J	Dowswell, C				Dowswell, Christopher			Norman Ernest Borlaug (1914-2009)	SCIENCE			English	Biographical-Item												c.dowswell@cgiar.org						BORLAUG NE, PUBLICATION LIST	1	3	3	4	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					381	381		10.1126/science.1182211	http://dx.doi.org/10.1126/science.1182211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833952				2022-12-28	WOS:000270818600037
J	O'Connor, DH; Huber, D; Svoboda, K				O'Connor, Daniel H.; Huber, Daniel; Svoboda, Karel			Reverse engineering the mouse brain	NATURE			English	Review							SUBJECTIVE SENSORY EXPERIENCE; PRIMARY SOMATOSENSORY CORTEX; VISUAL-CORTEX; NEURAL ACTIVITY; MILLISECOND-TIMESCALE; CELLULAR RESOLUTION; SENSORIMOTOR SYSTEM; PERCEPTUAL DECISION; ASSOCIATIVE MEMORY; EXPRESSING NEURONS	Behaviour is governed by activity in highly structured neural circuits. Genetically targeted sensors and switches facilitate measurement and manipulation of activity in vivo, linking activity in defined nodes of neural circuits to behaviour. Because of access to specific cell types, these molecular tools will have the largest impact in genetic model systems such as the mouse. Emerging assays of mouse behaviour are beginning to rival those of behaving monkeys in terms of stimulus and behavioural control. We predict that the confluence of new behavioural and molecular tools in the mouse will reveal the logic of complex mammalian circuits.	[O'Connor, Daniel H.; Huber, Daniel; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marom S, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.005.2009; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Papagiakoumou E, 2008, OPT EXPRESS, V16, P22039, DOI 10.1364/OE.16.022039; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Siegel RM, 2004, PLOS BIOL, V2, P2029, DOI 10.1371/journal.pbio.0020419; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WHITE EL, 1978, J COMP NEUROL, V181, P627, DOI 10.1002/cne.901810310; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	75	89	91	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					923	929		10.1038/nature08539	http://dx.doi.org/10.1038/nature08539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829372				2022-12-28	WOS:000270817700037
J	Homoud, MK				Homoud, Munther K.			Prolonged PR intervals were associated with increased risk for atrial fibrillation, pacemaker implantation, and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOCK		Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Homoud, MK (corresponding author), Tufts Med Ctr, Boston, MA USA.							Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; Josephson ME, 2008, CLIN CARDIAC ELECTRO, P93; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2	4	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10							JC5-13	10.7326/0003-4819-151-10-200911170-02013	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920258				2022-12-28	WOS:000272145100024
